Diagnosis_Code,Description,CMS-HCC Model Category V28,Potential Co-existing Diagnoses
A0103,Typhoid pneumonia,
A0104,Typhoid arthritis,92,M069 (25%); M08859 (18%); M0880 (18%); M08819 (18%); M08849 (18%)
A0105,Typhoid osteomyelitis,92,A021 (0%); A065 (0%); A072 (0%); A207 (0%); A227 (0%)
A021,Salmonella sepsis,2,A0223 (73%); A0224 (70%); B377 (34%); A0104 (0%); A0105 (0%)
A0222,Salmonella pneumonia,,
A0223,Salmonella arthritis,92,A021 (73%); M069 (26%); M08859 (18%); M0880 (18%); M08819 (18%)
A0224,Salmonella osteomyelitis,92,A021 (70%); A065 (0%); A072 (0%); A207 (0%); A227 (0%)
A065,Amebic lung abscess,283,K50914 (35%); K51814 (33%); K651 (32%); K6819 (32%); K51914 (32%)
A072,Cryptosporidiosis,6,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
A202,Pneumonic plague,,
A207,Septicemic plague,2,A0104 (0%); A0105 (0%); A0223 (0%); A0224 (0%); A065 (0%)
A212,Pulmonary tularemia,,
A221,Pulmonary anthrax,,
A227,Anthrax sepsis,2,B377 (32%); A0104 (0%); A0105 (0%); A0223 (0%); A0224 (0%)
A267,Erysipelothrix sepsis,2,B377 (32%); A0104 (0%); A0105 (0%); A0223 (0%); A0224 (0%)
A310,Pulmonary mycobacterial infection,6,J440 (36%); I2782 (34%); J810 (33%); I279 (31%); I2720 (30%)
A312,Disseminated mycobacterium avium-intracellulare complex (DMAC),6,C800 (28%); G369 (21%); B007 (21%); G368 (20%); R5601 (19%)
A327,Listerial sepsis,2,B377 (32%); A0104 (0%); A0105 (0%); A0223 (0%); A0224 (0%)
A3681,Diphtheritic cardiomyopathy,227,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
A3684,Diphtheritic tubulo-interstitial nephropathy,,
A391,Waterhouse-Friderichsen syndrome,,
A392,Acute meningococcemia,2,M86159 (27%); M86152 (26%); M86151 (26%); M8618 (26%); M8610 (25%)
A393,Chronic meningococcemia,2,M8668 (19%); M8660 (18%); M86619 (18%); M86649 (18%); K739 (18%)
A394,"Meningococcemia, unspecified",2,G8330 (12%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
A3983,Meningococcal arthritis,92,M069 (24%); M08859 (17%); M0880 (17%); M08819 (17%); M08849 (17%)
A3984,Postmeningococcal arthritis,92,M069 (24%); M08859 (17%); M0880 (17%); M08819 (17%); M08849 (17%)
A400,"Sepsis due to streptococcus, group A",2,T362X2A (33%); B377 (27%); A0104 (0%); A0105 (0%); A0223 (0%)
A401,"Sepsis due to streptococcus, group B",2,T362X2A (33%); B377 (27%); A0104 (0%); A0105 (0%); A0223 (0%)
A403,Sepsis due to Streptococcus pneumoniae,2,J150 (39%); B377 (26%); A0104 (0%); A0105 (0%); A0223 (0%)
A408,Other streptococcal sepsis,2,M00259 (51%); M00219 (51%); M00249 (51%); M00252 (50%); M00251 (50%)
A409,"Streptococcal sepsis, unspecified",2,M00259 (56%); M00219 (55%); M00249 (55%); M00229 (54%); M00269 (54%)
A4101,Sepsis due to Methicillin susceptible Staphylococcus aureus,2,J15211 (86%); J15212 (61%); J1529 (32%); J1520 (31%); B377 (20%)
A4102,Sepsis due to Methicillin resistant Staphylococcus aureus,2,J15212 (86%); J15211 (61%); J1529 (32%); J1520 (31%); B377 (20%)
A411,Sepsis due to other specified staphylococcus,2,J1529 (52%); J1520 (51%); B377 (34%); J15211 (30%); J15212 (30%)
A412,Sepsis due to unspecified staphylococcus,2,J1520 (59%); J1529 (55%); B377 (36%); J15211 (32%); J15212 (32%)
A413,Sepsis due to Hemophilus influenzae,2,B377 (25%); A0104 (0%); A0105 (0%); A0223 (0%); A0224 (0%)
A414,Sepsis due to anaerobes,2,B377 (34%); A0104 (0%); A0105 (0%); A0223 (0%); A0224 (0%)
A4150,"Gram-negative sepsis, unspecified",2,J156 (64%); J1569 (64%); B377 (28%); C8470 (27%); C847A (24%)
A4151,Sepsis due to Escherichia coli [E. coli],2,J155 (78%); B377 (18%); A0104 (0%); A0105 (0%); A0223 (0%)
A4152,Sepsis due to Pseudomonas,2,J151 (64%); B377 (34%); A0104 (0%); A0105 (0%); A0223 (0%)
A4153,Sepsis due to Serratia,2,B377 (32%); A0104 (0%); A0105 (0%); A0223 (0%); A0224 (0%)
A4154,Sepsis due to Acinetobacter baumannii,2,J1561 (78%); B377 (26%); A0104 (0%); A0105 (0%); A0223 (0%)
A4159,Other Gram-negative sepsis,2,J156 (65%); J1569 (65%); B377 (29%); C8470 (25%); C847A (24%)
A4181,Sepsis due to Enterococcus,2,B377 (32%); A0104 (0%); A0105 (0%); A0223 (0%); A0224 (0%)
A4189,Other specified sepsis,2,B377 (48%); M068A (42%); E1369 (41%); M06859 (27%); M0680 (27%)
A419,"Sepsis, unspecified organism",2,B377 (32%); G8330 (9%); L97909 (9%); G8190 (9%); C8510 (9%)
A420,Pulmonary actinomycosis,,
A427,Actinomycotic sepsis,2,B377 (32%); A0104 (0%); A0105 (0%); A0223 (0%); A0224 (0%)
A430,Pulmonary nocardiosis,,
A480,Gas gangrene,263,T593X2A (39%); T594X2A (39%); J850 (38%); N493 (34%); T5812XA (32%)
A481,Legionnaires' disease,282,G959 (22%); I120 (21%); G20 (19%); G308 (19%); B259 (18%)
A483,Toxic shock syndrome,2,R579 (72%); R570 (48%); E340 (26%); G839 (25%); G8382 (23%)
A5055,Late congenital syphilitic arthropathy,92,G301 (33%); G112 (32%); G7129 (29%); G7120 (28%); Q038 (28%)
A5440,"Gonococcal infection of musculoskeletal system, unspecified",92,A5486 (46%); A5485 (40%); K9402 (26%); K9422 (26%); T8623 (25%)
A5441,Gonococcal spondylopathy,92,A5486 (50%); A5485 (45%); A021 (0%); A065 (0%); A072 (0%)
A5442,Gonococcal arthritis,92,A5486 (70%); A5485 (62%); M069 (27%); M08859 (20%); M0880 (20%)
A5443,Gonococcal osteomyelitis,92,A5486 (67%); A5485 (59%); A021 (0%); A065 (0%); A072 (0%)
A5449,Gonococcal infection of other musculoskeletal tissue,92,A5486 (41%); A5485 (36%); K9402 (23%); K9422 (23%); C499 (23%)
A5484,Gonococcal pneumonia,,
A5485,Gonococcal peritonitis,78,A5442 (62%); A5443 (59%); A5486 (54%); A5441 (45%); A5440 (40%)
A5486,Gonococcal sepsis,2,A5442 (70%); A5443 (67%); A5485 (54%); A5441 (50%); A5440 (46%)
A666,Bone and joint lesions of yaws,92,S78019A (23%); S48019A (23%); S78012A (23%); S78011A (23%); S48012A (23%)
A6923,Arthritis due to Lyme disease,92,M05359 (24%); M0530 (24%); M05159 (24%); M0510 (24%); M05319 (24%)
A8100,"Creutzfeldt-Jakob disease, unspecified",127,G959 (22%); K50919 (20%); B259 (18%); I279 (18%); M02359 (18%)
A8101,Variant Creutzfeldt-Jakob disease,127,G959 (14%); I120 (13%); G20 (12%); B259 (12%); I279 (12%)
A8109,Other Creutzfeldt-Jakob disease,127,G959 (17%); I120 (16%); G20 (15%); B259 (15%); I279 (15%)
A811,Subacute sclerosing panencephalitis,127,K654 (39%); K8301 (35%); M86259 (33%); M86252 (32%); M86251 (32%)
A812,Progressive multifocal leukoencephalopathy,127,M340 (36%); G9343 (35%); M86359 (33%); M86352 (33%); M86351 (33%)
A8181,Kuru,127,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
A8182,Gerstmann-Straussler-Scheinker syndrome,127,E340 (16%); G839 (15%); G8382 (14%); G8383 (14%); D469 (12%)
A8183,Fatal familial insomnia,127,E8331 (35%); G1224 (31%); G901 (24%); A0104 (0%); A0105 (0%)
A8189,Other atypical virus infections of central nervous system,127,C729 (44%); D339 (40%); G370 (37%); G379 (36%); G378 (34%)
A819,"Atypical virus infection of central nervous system, unspecified",127,C729 (51%); D339 (46%); G379 (42%); G370 (40%); D439 (38%)
A985,Hemorrhagic fever with renal syndrome,,
B007,Disseminated herpesviral disease,2,C800 (48%); B447 (41%); B457 (41%); B464 (41%); G369 (36%)
B0082,Herpes simplex myelitis,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
B0112,Varicella myelitis,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
B0221,Postherpetic geniculate ganglionitis,,
B0222,Postherpetic trigeminal neuralgia,,
B0223,Postherpetic polyneuropathy,,
B0224,Postherpetic myelitis,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
B0229,Other postherpetic nervous system involvement,,
B0682,Rubella arthritis,92,M069 (24%); M08859 (17%); M0880 (17%); M08819 (17%); M08849 (17%)
B1710,Acute hepatitis C without hepatic coma,,
B1711,Acute hepatitis C with hepatic coma,,
B180,Chronic viral hepatitis B with delta-agent,65,B3324 (34%); D562 (33%); B251 (28%); T4992XA (27%); T50B92A (26%)
B181,Chronic viral hepatitis B without delta-agent,65,B3324 (34%); D562 (33%); B251 (28%); T4992XA (27%); T50B92A (26%)
B182,Chronic viral hepatitis C,65,B3324 (50%); B251 (40%); T50B92A (38%); M8668 (16%); M8660 (15%)
B188,Other chronic viral hepatitis,65,B3324 (50%); B251 (40%); T50B92A (38%); M8668 (16%); M8660 (15%)
B189,"Chronic viral hepatitis, unspecified",65,B3324 (49%); B251 (40%); T50B92A (37%); M8660 (20%); M86619 (20%)
B1920,Unspecified viral hepatitis C without hepatic coma,,
B1921,Unspecified viral hepatitis C with hepatic coma,,
B20,Human immunodeficiency virus [HIV] disease,1,D819 (32%); A819 (25%); A8189 (23%); D839 (23%); D805 (18%)
B250,Cytomegaloviral pneumonitis,6,J84114 (45%); J84113 (33%); J678 (31%); J679 (31%); J690 (30%)
B251,Cytomegaloviral hepatitis,6,K739 (55%); K738 (48%); K754 (43%); B182 (40%); B188 (40%)
B252,Cytomegaloviral pancreatitis,6,K861 (66%); K860 (51%); A0104 (0%); A0105 (0%); A021 (0%)
B258,Other cytomegaloviral diseases,6,J84178 (34%); G9589 (31%); G914 (29%); M9058 (29%); M9050 (28%)
B259,"Cytomegaloviral disease, unspecified",6,G959 (30%); K50919 (27%); I279 (25%); M02359 (25%); M0230 (25%)
B2685,Mumps arthritis,92,M069 (24%); M08859 (17%); M0880 (17%); M08819 (17%); M08849 (17%)
B3324,Viral cardiomyopathy,227,B182 (50%); B188 (50%); B189 (49%); T50B92A (38%); B180 (34%)
B371,Pulmonary candidiasis,6,I2782 (38%); J810 (37%); I279 (35%); I2720 (34%); J8410 (33%)
B377,Candidal sepsis,2,B377 (100%); B3781 (54%); A0104 (0%); A0105 (0%); A0223 (0%)
B377,Candidal sepsis,6,B377 (100%); A4189 (48%); A408 (40%); A409 (39%); A5486 (36%)
B3781,Candidal esophagitis,6,B377 (54%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
B380,Acute pulmonary coccidioidomycosis,,
B381,Chronic pulmonary coccidioidomycosis,,
B382,"Pulmonary coccidioidomycosis, unspecified",,
B390,Acute pulmonary histoplasmosis capsulati,,
B391,Chronic pulmonary histoplasmosis capsulati,,
B392,"Pulmonary histoplasmosis capsulati, unspecified",,
B400,Acute pulmonary blastomycosis,,
B401,Chronic pulmonary blastomycosis,,
B402,"Pulmonary blastomycosis, unspecified",,
B410,Pulmonary paracoccidioidomycosis,,
B4282,Sporotrichosis arthritis,92,M069 (24%); M08859 (17%); M0880 (17%); M08819 (17%); M08849 (17%)
B440,Invasive pulmonary aspergillosis,6,I2782 (31%); J810 (30%); B4481 (30%); I279 (28%); I2720 (28%)
B441,Other pulmonary aspergillosis,6,I2782 (42%); J810 (42%); B4481 (41%); I279 (39%); I2720 (38%)
B442,Tonsillar aspergillosis,6,C090 (47%); C091 (39%); B4481 (35%); A0104 (0%); A0105 (0%)
B447,Disseminated aspergillosis,6,C800 (55%); G369 (42%); B007 (41%); G368 (40%); B4481 (37%)
B4481,Allergic bronchopulmonary aspergillosis,280,B449 (50%); B441 (41%); B447 (37%); B4489 (36%); B442 (35%)
B4489,Other forms of aspergillosis,6,I248 (41%); I2489 (41%); M328 (40%); B4481 (36%); A0104 (0%)
B449,"Aspergillosis, unspecified",6,B4481 (50%); G8330 (13%); L97909 (13%); G8190 (13%); C8510 (13%)
B450,Pulmonary cryptococcosis,6,I2782 (42%); J810 (42%); I279 (39%); I2720 (38%); J8410 (37%)
B451,Cerebral cryptococcosis,6,I6349 (39%); I6339 (39%); G936 (39%); I6340 (39%); I6330 (39%)
B452,Cutaneous cryptococcosis,6,C84A0 (38%); C84A7 (38%); Z9351 (35%); C84A2 (33%); C84A6 (33%)
B453,Osseous cryptococcosis,6,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
B457,Disseminated cryptococcosis,6,C800 (55%); G369 (42%); B007 (41%); G368 (40%); C960 (28%)
B458,Other forms of cryptococcosis,6,I248 (41%); I2489 (41%); M328 (40%); A0104 (0%); A0105 (0%)
B459,"Cryptococcosis, unspecified",6,G8330 (13%); L97909 (13%); G8190 (13%); C8510 (13%); M08959 (13%)
B460,Pulmonary mucormycosis,6,I2782 (42%); J810 (41%); I279 (38%); I2720 (38%); J8410 (37%)
B461,Rhinocerebral mucormycosis,6,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
B462,Gastrointestinal mucormycosis,6,C49A9 (37%); C49A0 (37%); C464 (36%); C49A2 (34%); C49A5 (34%)
B463,Cutaneous mucormycosis,6,C84A0 (38%); C84A7 (38%); Z9351 (35%); C84A2 (33%); C84A6 (33%)
B464,Disseminated mucormycosis,6,C800 (55%); G369 (42%); B007 (41%); G368 (40%); C960 (28%)
B465,"Mucormycosis, unspecified",6,G8330 (13%); L97909 (13%); G8190 (12%); C8510 (12%); M08959 (12%)
B468,Other zygomycoses,6,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
B469,"Zygomycosis, unspecified",6,G8330 (11%); L97909 (11%); G8190 (11%); C8510 (11%); M08959 (11%)
B484,Penicillosis,6,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
B488,Other specified mycoses,6,M068A (31%); E1369 (30%); A4189 (23%); M06859 (20%); M0680 (20%)
B520,Plasmodium malariae malaria with nephropathy,,
B582,Toxoplasma meningoencephalitis,6,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
B583,Pulmonary toxoplasmosis,6,I2782 (38%); J810 (37%); I279 (35%); I2720 (34%); J8410 (33%)
B59,Pneumocystosis,6,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
B664,Paragonimiasis,,
B671,Echinococcus granulosus infection of lung,,
B9735,"Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere",1,D819 (27%); G914 (26%); M9058 (26%); M9050 (25%); M90519 (25%)
C01,Malignant neoplasm of base of tongue,21,C380 (31%); S0219XB (31%); S0219XA (30%); S02109B (30%); S02109A (30%)
C020,Malignant neoplasm of dorsal surface of tongue,21,C380 (25%); C720 (23%); C261 (23%); C719 (23%); C7650 (23%)
C021,Malignant neoplasm of border of tongue,21,C380 (27%); C720 (25%); C261 (25%); C719 (25%); C7650 (25%)
C022,Malignant neoplasm of ventral surface of tongue,21,C380 (25%); C720 (23%); C261 (23%); C719 (23%); C7650 (23%)
C023,"Malignant neoplasm of anterior two-thirds of tongue, part unspecified",21,C673 (32%); C6990 (27%); C719 (27%); C7650 (27%); C7640 (25%)
C024,Malignant neoplasm of lingual tonsil,21,C380 (26%); C720 (24%); C261 (24%); C719 (24%); C7650 (24%)
C028,Malignant neoplasm of overlapping sites of tongue,21,C718 (64%); C188 (61%); C168 (59%); C678 (59%); C258 (58%)
C029,"Malignant neoplasm of tongue, unspecified",21,C6990 (40%); C719 (40%); C7650 (40%); C7640 (38%); C189 (37%)
C030,Malignant neoplasm of upper gum,21,C7640 (51%); C7642 (50%); C7641 (50%); C153 (42%); C773 (33%)
C031,Malignant neoplasm of lower gum,21,C7650 (47%); C7652 (46%); C7651 (46%); C155 (38%); C380 (33%)
C039,"Malignant neoplasm of gum, unspecified",21,C6990 (38%); C719 (38%); C7650 (38%); C7640 (36%); C189 (35%)
C040,Malignant neoplasm of anterior floor of mouth,21,C673 (35%); S0230XB (33%); S0230XA (33%); S0232XB (33%); S0231XB (33%)
C041,Malignant neoplasm of lateral floor of mouth,21,C672 (39%); S0230XB (32%); S0230XA (32%); S0232XB (32%); S0231XB (32%)
C048,Malignant neoplasm of overlapping sites of floor of mouth,21,C718 (54%); C188 (52%); C168 (50%); C678 (50%); C258 (50%)
C049,"Malignant neoplasm of floor of mouth, unspecified",21,S0230XB (39%); S0230XA (39%); S0232XB (35%); S0231XB (35%); S0232XA (35%)
C050,Malignant neoplasm of hard palate,21,C380 (27%); C720 (25%); C261 (25%); C719 (24%); C7650 (24%)
C051,Malignant neoplasm of soft palate,21,C494 (41%); C380 (30%); C720 (27%); C261 (27%); C719 (27%)
C052,Malignant neoplasm of uvula,21,C380 (34%); C720 (31%); C261 (31%); C719 (31%); C7650 (31%)
C058,Malignant neoplasm of overlapping sites of palate,21,C718 (63%); C188 (60%); C168 (58%); C678 (58%); C258 (57%)
C059,"Malignant neoplasm of palate, unspecified",21,C6990 (39%); C719 (39%); C7650 (39%); C7640 (37%); C189 (36%)
C060,Malignant neoplasm of cheek mucosa,21,C380 (26%); C720 (24%); C261 (24%); C719 (24%); C7650 (24%)
C061,Malignant neoplasm of vestibule of mouth,21,C380 (27%); C720 (25%); C261 (25%); C719 (25%); C7650 (25%)
C062,Malignant neoplasm of retromolar area,21,C380 (25%); C720 (23%); C261 (23%); C719 (23%); C7650 (23%)
C0680,Malignant neoplasm of overlapping sites of unspecified parts of mouth,21,C718 (55%); C188 (53%); C168 (51%); C678 (51%); C258 (50%)
C0689,Malignant neoplasm of overlapping sites of other parts of mouth,21,C718 (56%); C188 (54%); C168 (51%); C678 (51%); C258 (51%)
C069,"Malignant neoplasm of mouth, unspecified",21,C6990 (41%); C719 (40%); C7650 (40%); C7640 (38%); C189 (38%)
C07,Malignant neoplasm of parotid gland,21,C751 (48%); C7492 (48%); C7491 (48%); C759 (48%); C753 (47%)
C080,Malignant neoplasm of submandibular gland,21,C751 (48%); C7492 (48%); C7491 (48%); C759 (48%); C753 (47%)
C081,Malignant neoplasm of sublingual gland,21,C751 (48%); C7492 (48%); C7491 (48%); C759 (48%); C753 (47%)
C089,"Malignant neoplasm of major salivary gland, unspecified",21,C7490 (45%); C7492 (43%); C7491 (43%); C759 (43%); C751 (41%)
C090,Malignant neoplasm of tonsillar fossa,21,B442 (47%); P526 (37%); C380 (27%); C720 (25%); C261 (25%)
C091,Malignant neoplasm of tonsillar pillar (anterior) (posterior),21,B442 (39%); C674 (30%); C673 (30%); G8383 (23%); C380 (23%)
C098,Malignant neoplasm of overlapping sites of tonsil,21,C718 (61%); C188 (59%); C168 (56%); C678 (56%); C258 (56%)
C099,"Malignant neoplasm of tonsil, unspecified",21,C6990 (38%); C719 (38%); C7650 (38%); C7640 (36%); C189 (35%)
C100,Malignant neoplasm of vallecula,21,C380 (34%); C720 (31%); C261 (31%); C719 (31%); C7650 (31%)
C101,Malignant neoplasm of anterior surface of epiglottis,21,C673 (36%); C380 (27%); G8382 (27%); C720 (25%); C261 (25%)
C102,Malignant neoplasm of lateral wall of oropharynx,21,C672 (61%); S02849B (42%); S02849A (42%); S02842B (41%); S02841B (41%)
C103,Malignant neoplasm of posterior wall of oropharynx,21,C674 (59%); S32423B (39%); C673 (39%); S32426B (39%); S32423A (39%)
C104,Malignant neoplasm of branchial cleft,21,C380 (25%); C720 (23%); C261 (23%); C719 (23%); C7650 (23%)
C108,Malignant neoplasm of overlapping sites of oropharynx,21,C718 (62%); C188 (60%); C168 (57%); C678 (57%); C258 (57%)
C109,"Malignant neoplasm of oropharynx, unspecified",21,C6990 (39%); C719 (38%); C7650 (38%); C7640 (36%); C189 (36%)
C110,Malignant neoplasm of superior wall of nasopharynx,21,C673 (36%); C674 (36%); C672 (35%); S32519B (28%); S32519A (28%)
C111,Malignant neoplasm of posterior wall of nasopharynx,21,C674 (60%); S32423B (39%); C673 (39%); S32426B (39%); S32423A (39%)
C112,Malignant neoplasm of lateral wall of nasopharynx,21,C672 (62%); S02849B (42%); S02849A (42%); S02842B (42%); S02841B (42%)
C113,Malignant neoplasm of anterior wall of nasopharynx,21,C673 (59%); C674 (39%); S32413B (39%); S32416B (39%); S32413A (38%)
C118,Malignant neoplasm of overlapping sites of nasopharynx,21,C718 (63%); C188 (61%); C168 (58%); C678 (58%); C258 (58%)
C119,"Malignant neoplasm of nasopharynx, unspecified",21,C6990 (40%); C719 (40%); C7650 (39%); C7640 (37%); C189 (37%)
C12,Malignant neoplasm of pyriform sinus,21,C380 (29%); M86459 (28%); M86452 (27%); M86451 (27%); M8648 (27%)
C130,Malignant neoplasm of postcricoid region,21,C380 (30%); C720 (28%); C261 (28%); C719 (27%); C7650 (27%)
C131,"Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect",21,C380 (19%); C720 (17%); C261 (17%); C719 (17%); C7650 (17%)
C132,Malignant neoplasm of posterior wall of hypopharynx,21,C674 (58%); S32423B (38%); C673 (38%); S32426B (38%); S32423A (38%)
C138,Malignant neoplasm of overlapping sites of hypopharynx,21,C718 (61%); C188 (59%); C168 (56%); C678 (56%); C258 (56%)
C139,"Malignant neoplasm of hypopharynx, unspecified",21,C6990 (38%); C719 (38%); C7650 (38%); C7640 (36%); C189 (35%)
C140,"Malignant neoplasm of pharynx, unspecified",21,C6990 (37%); C719 (37%); C7650 (37%); C7640 (35%); C189 (34%)
C142,Malignant neoplasm of Waldeyer's ring,21,D461 (28%); C380 (28%); C720 (25%); C261 (25%); C719 (25%)
C148,"Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx",21,C718 (40%); C430 (39%); C188 (38%); C168 (37%); C678 (37%)
C153,Malignant neoplasm of upper third of esophagus,20,C7640 (53%); C7642 (52%); C7641 (52%); C030 (42%); C49A1 (40%)
C154,Malignant neoplasm of middle third of esophagus,20,C301 (55%); C49A1 (36%); I6010 (29%); I6012 (29%); I6011 (29%)
C155,Malignant neoplasm of lower third of esophagus,20,C7650 (49%); C7652 (48%); C7651 (48%); C49A1 (42%); C031 (38%)
C158,Malignant neoplasm of overlapping sites of esophagus,20,C188 (61%); C678 (58%); C028 (57%); C118 (57%); C058 (57%)
C159,"Malignant neoplasm of esophagus, unspecified",20,C49A1 (44%); C6990 (40%); C7650 (39%); C7640 (37%); C189 (37%)
C160,Malignant neoplasm of cardia,20,C411 (32%); C261 (31%); C7650 (31%); C763 (30%); C7652 (30%)
C161,Malignant neoplasm of fundus of stomach,20,C543 (63%); C7A092 (46%); D3A092 (34%); C49A2 (31%); C411 (26%)
C162,Malignant neoplasm of body of stomach,20,C7A092 (56%); C754 (52%); C602 (46%); C6940 (44%); C6942 (44%)
C163,Malignant neoplasm of pyloric antrum,20,Q400 (37%); C411 (25%); C261 (24%); C7650 (24%); C763 (23%)
C164,Malignant neoplasm of pylorus,20,C411 (32%); C261 (31%); C7650 (31%); C763 (30%); C7652 (30%)
C165,"Malignant neoplasm of lesser curvature of stomach, unspecified",20,C7A092 (40%); D3A092 (30%); C49A2 (27%); C6990 (26%); S72123A (26%)
C166,"Malignant neoplasm of greater curvature of stomach, unspecified",20,C7A092 (41%); D3A092 (31%); C49A2 (28%); C6990 (27%); C7650 (27%)
C168,Malignant neoplasm of overlapping sites of stomach,20,C188 (62%); C678 (59%); C028 (59%); C118 (58%); C058 (58%)
C169,"Malignant neoplasm of stomach, unspecified",20,C7A092 (62%); D3A092 (46%); C49A2 (42%); C6990 (41%); C7650 (41%)
C170,Malignant neoplasm of duodenum,20,C7A010 (67%); D3A010 (52%); Q410 (44%); C411 (35%); C261 (34%)
C171,Malignant neoplasm of jejunum,20,C7A011 (67%); D3A011 (52%); Q411 (44%); C411 (35%); C261 (34%)
C172,Malignant neoplasm of ileum,20,C7A012 (67%); D3A012 (52%); Q412 (44%); C411 (35%); C261 (34%)
C173,"Meckel's diverticulum, malignant",20,C411 (12%); C261 (12%); C7650 (12%); C763 (11%); C7652 (11%)
C178,Malignant neoplasm of overlapping sites of small intestine,20,C784 (71%); C188 (58%); C678 (56%); C028 (55%); C118 (55%)
C179,"Malignant neoplasm of small intestine, unspecified",20,C784 (86%); C7A019 (62%); K50019 (59%); K5000 (56%); K50018 (56%)
C180,Malignant neoplasm of cecum,22,C7A021 (68%); C380 (36%); C411 (34%); C720 (33%); C719 (33%)
C181,Malignant neoplasm of appendix,22,C7A020 (68%); C380 (36%); C411 (34%); C720 (33%); C719 (33%)
C182,Malignant neoplasm of ascending colon,22,C7A022 (75%); I71010 (41%); C7A023 (38%); I7111 (37%); C7A024 (35%)
C183,Malignant neoplasm of hepatic flexure,22,K7682 (41%); K7290 (40%); K7291 (40%); K7210 (38%); K7211 (38%)
C184,Malignant neoplasm of transverse colon,22,C7A023 (70%); C7A024 (40%); C7A022 (40%); C7A025 (39%); C380 (34%)
C185,Malignant neoplasm of splenic flexure,22,D57812 (31%); D57412 (31%); D57212 (29%); D5702 (29%); C380 (28%)
C186,Malignant neoplasm of descending colon,22,C7A024 (75%); C7A023 (39%); I71012 (38%); C7A022 (35%); C7A025 (35%)
C187,Malignant neoplasm of sigmoid colon,22,C7A025 (76%); C7A023 (37%); C7A024 (35%); C7A022 (34%); C380 (30%)
C188,Malignant neoplasm of overlapping sites of colon,22,C718 (67%); C168 (62%); C258 (62%); C028 (61%); C118 (61%)
C189,"Malignant neoplasm of colon, unspecified",22,C7A023 (51%); C7A024 (47%); C7A022 (47%); C7A025 (46%); C6990 (44%)
C19,Malignant neoplasm of rectosigmoid junction,22,C380 (25%); C411 (24%); C720 (23%); C719 (23%); C7650 (23%)
C20,Malignant neoplasm of rectum,22,C785 (68%); C7A026 (64%); C49A5 (43%); C380 (39%); Q420 (37%)
C210,"Malignant neoplasm of anus, unspecified",22,Q422 (40%); Q423 (40%); C6990 (39%); C719 (38%); C7650 (38%)
C211,Malignant neoplasm of anal canal,22,C4351 (52%); D0351 (39%); C4A51 (37%); C4320 (33%); C4322 (33%)
C212,Malignant neoplasm of cloacogenic zone,22,S32119B (29%); C380 (29%); S32119A (29%); S32110B (27%); S32110A (27%)
C218,"Malignant neoplasm of overlapping sites of rectum, anus and anal canal",22,C718 (42%); C168 (39%); C258 (38%); C028 (38%); C118 (38%)
C220,Liver cell carcinoma,20,C4A9 (57%); C7B1 (52%); C4A30 (49%); C4A8 (47%); K717 (47%)
C221,Intrahepatic bile duct carcinoma,20,C787 (73%); K831 (60%); Q442 (29%); C4A9 (26%); D353 (26%)
C222,Hepatoblastoma,20,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
C223,Angiosarcoma of liver,20,K717 (42%); K7469 (38%); Z944 (37%); K7460 (37%); T8649 (37%)
C224,Other sarcomas of liver,20,K717 (42%); K7469 (38%); Z944 (37%); K7460 (37%); T8649 (37%)
C227,Other specified carcinomas of liver,20,K717 (40%); K7469 (36%); Z944 (35%); K7460 (35%); T8649 (34%)
C228,"Malignant neoplasm of liver, primary, unspecified as to type",20,C801 (76%); K717 (42%); K7460 (40%); T8640 (38%); K7469 (37%)
C229,"Malignant neoplasm of liver, not specified as primary or secondary",20,C801 (65%); C7989 (58%); C799 (47%); C7951 (46%); C7981 (45%)
C23,Malignant neoplasm of gallbladder,20,C411 (32%); C261 (31%); C7650 (31%); C763 (30%); C7652 (30%)
C240,Malignant neoplasm of extrahepatic bile duct,20,K831 (61%); C787 (55%); C6950 (38%); C6952 (37%); C6951 (37%)
C241,Malignant neoplasm of ampulla of Vater,20,C411 (24%); C261 (23%); C7650 (23%); C763 (23%); C7652 (23%)
C248,Malignant neoplasm of overlapping sites of biliary tract,20,C260 (51%); C188 (51%); C678 (49%); C399 (49%); C028 (48%)
C249,"Malignant neoplasm of biliary tract, unspecified",20,C260 (63%); C399 (60%); C390 (58%); K745 (49%); K744 (42%)
C250,Malignant neoplasm of head of pancreas,20,Z9483 (49%); C760 (47%); C770 (38%); C470 (36%); C490 (32%)
C251,Malignant neoplasm of body of pancreas,20,C754 (52%); Z9483 (50%); C602 (46%); C6940 (44%); C6942 (43%)
C252,Malignant neoplasm of tail of pancreas,20,C50619 (48%); C50629 (48%); C50612 (48%); C50622 (48%); C50611 (48%)
C253,Malignant neoplasm of pancreatic duct,20,C6950 (44%); C6952 (44%); C6951 (44%); D353 (39%); C787 (37%)
C254,Malignant neoplasm of endocrine pancreas,20,C759 (62%); Z9483 (43%); E3121 (33%); E3120 (32%); E3122 (28%)
C257,Malignant neoplasm of other parts of pancreas,20,C7949 (53%); C0689 (46%); Z9483 (46%); C0680 (45%); C4339 (45%)
C258,Malignant neoplasm of overlapping sites of pancreas,20,C188 (62%); C678 (59%); C028 (58%); C118 (58%); C058 (57%)
C259,"Malignant neoplasm of pancreas, unspecified",20,Z9483 (55%); C6990 (41%); C7650 (40%); C7640 (38%); C189 (38%)
C260,"Malignant neoplasm of intestinal tract, part unspecified",22,C399 (66%); C390 (64%); C249 (63%); C248 (51%); C6990 (34%)
C261,Malignant neoplasm of spleen,22,C8517 (53%); C8177 (52%); C8197 (50%); C8297 (50%); C8387 (47%)
C269,Malignant neoplasm of ill-defined sites within the digestive system,22,C768 (82%); C7880 (46%); C7889 (45%); C7989 (30%); C718 (27%)
C300,Malignant neoplasm of nasal cavity,21,C860 (39%); C380 (26%); C720 (24%); C261 (24%); C719 (24%)
C301,Malignant neoplasm of middle ear,21,C154 (55%); C342 (45%); C4320 (36%); C4322 (36%); C4321 (36%)
C310,Malignant neoplasm of maxillary sinus,21,S02401B (48%); S02401A (48%); S0240DB (47%); S0240CB (47%); S0240DA (47%)
C311,Malignant neoplasm of ethmoidal sinus,21,C380 (29%); M86459 (28%); M86452 (27%); M86451 (27%); M8648 (27%)
C312,Malignant neoplasm of frontal sinus,21,C711 (67%); Q010 (51%); C380 (30%); M86459 (29%); M86452 (29%)
C313,Malignant neoplasm of sphenoid sinus,21,C380 (29%); M86459 (28%); M86452 (27%); M86451 (27%); M8648 (27%)
C318,Malignant neoplasm of overlapping sites of accessory sinuses,21,C718 (50%); C188 (48%); C168 (45%); C678 (45%); C258 (45%)
C319,"Malignant neoplasm of accessory sinus, unspecified",21,C6990 (32%); M86459 (32%); C719 (32%); C7650 (32%); M8640 (31%)
C320,Malignant neoplasm of glottis,21,C380 (34%); C720 (31%); C261 (31%); C719 (31%); C7650 (31%)
C321,Malignant neoplasm of supraglottis,21,C380 (34%); C720 (31%); C261 (31%); C719 (31%); C7650 (31%)
C322,Malignant neoplasm of subglottis,21,C380 (34%); C720 (31%); C261 (31%); C719 (31%); C7650 (31%)
C323,Malignant neoplasm of laryngeal cartilage,21,C380 (27%); C720 (25%); C261 (25%); C719 (25%); C7650 (25%)
C328,Malignant neoplasm of overlapping sites of larynx,21,C718 (60%); C188 (58%); C168 (56%); C678 (56%); C258 (55%)
C329,"Malignant neoplasm of larynx, unspecified",21,C6990 (37%); C719 (37%); C7650 (37%); C7640 (35%); C189 (34%)
C33,Malignant neoplasm of trachea,20,C411 (32%); C261 (31%); C7650 (31%); C763 (30%); C7652 (30%)
C3400,Malignant neoplasm of unspecified main bronchus,20,C7A090 (39%); C6990 (32%); C7650 (31%); C7640 (30%); C189 (29%)
C3401,Malignant neoplasm of right main bronchus,20,C7A090 (39%); C7651 (34%); C7641 (32%); C6991 (32%); C7801 (29%)
C3402,Malignant neoplasm of left main bronchus,20,C7A090 (39%); C7652 (34%); C7642 (32%); C6992 (31%); I2101 (31%)
C3410,"Malignant neoplasm of upper lobe, unspecified bronchus or lung",20,C7A090 (52%); C7800 (47%); C7640 (45%); C7802 (43%); C7801 (43%)
C3411,"Malignant neoplasm of upper lobe, right bronchus or lung",20,C7A090 (51%); C7801 (49%); C7641 (47%); C7800 (43%); C7802 (42%)
C3412,"Malignant neoplasm of upper lobe, left bronchus or lung",20,C7A090 (51%); C7802 (49%); C7642 (47%); C7800 (43%); C7801 (42%)
C342,"Malignant neoplasm of middle lobe, bronchus or lung",20,C7A090 (49%); C301 (45%); C7800 (41%); C7802 (40%); C7801 (40%)
C3430,"Malignant neoplasm of lower lobe, unspecified bronchus or lung",20,C7A090 (53%); C7800 (48%); C7802 (44%); C7801 (44%); C7650 (42%)
C3431,"Malignant neoplasm of lower lobe, right bronchus or lung",20,C7A090 (52%); C7801 (50%); C7800 (44%); C7651 (44%); C7802 (43%)
C3432,"Malignant neoplasm of lower lobe, left bronchus or lung",20,C7A090 (52%); C7802 (50%); C7800 (44%); C7652 (44%); C7801 (43%)
C3480,Malignant neoplasm of overlapping sites of unspecified bronchus and lung,20,C188 (57%); C678 (55%); C7A090 (55%); C028 (54%); C118 (54%)
C3481,Malignant neoplasm of overlapping sites of right bronchus and lung,20,C188 (57%); C50811 (54%); C50821 (54%); C678 (54%); C7A090 (54%)
C3482,Malignant neoplasm of overlapping sites of left bronchus and lung,20,C188 (57%); C50812 (54%); C50822 (54%); C678 (54%); C7A090 (54%)
C3490,Malignant neoplasm of unspecified part of unspecified bronchus or lung,20,C7A090 (64%); C7800 (63%); C7802 (52%); C7801 (52%); D3A090 (50%)
C3491,Malignant neoplasm of unspecified part of right bronchus or lung,20,C7A090 (65%); C7801 (62%); C7800 (60%); C7802 (54%); D3A090 (51%)
C3492,Malignant neoplasm of unspecified part of left bronchus or lung,20,C7A090 (65%); C7802 (62%); C7800 (60%); C7801 (54%); D3A090 (51%)
C37,Malignant neoplasm of thymus,21,D3A091 (53%); C380 (36%); C720 (33%); C261 (33%); C719 (33%)
C380,Malignant neoplasm of heart,20,I110 (51%); I5089 (48%); C388 (47%); I50814 (47%); I509 (47%)
C381,Malignant neoplasm of anterior mediastinum,21,C781 (75%); J853 (54%); C673 (42%); C380 (33%); G8382 (32%)
C382,Malignant neoplasm of posterior mediastinum,21,C781 (75%); J853 (54%); C674 (43%); G8383 (33%); C380 (32%)
C383,"Malignant neoplasm of mediastinum, part unspecified",21,C781 (85%); J853 (61%); C6990 (40%); C719 (40%); C7650 (39%)
C384,Malignant neoplasm of pleura,20,C782 (88%); C388 (62%); C450 (60%); C411 (35%); C261 (34%)
C388,"Malignant neoplasm of overlapping sites of heart, mediastinum and pleura",21,C384 (62%); C782 (54%); C781 (53%); C718 (49%); C380 (47%)
C390,"Malignant neoplasm of upper respiratory tract, part unspecified",21,C260 (64%); C249 (58%); C7640 (51%); C7830 (50%); C248 (48%)
C399,"Malignant neoplasm of lower respiratory tract, part unspecified",21,C260 (66%); C249 (60%); C7830 (51%); C248 (49%); C7650 (47%)
C4000,Malignant neoplasm of scapula and long bones of unspecified upper limb,21,C7640 (54%); C7642 (49%); C7641 (49%); C7650 (40%); C7652 (36%)
C4001,Malignant neoplasm of scapula and long bones of right upper limb,21,C7641 (55%); C7640 (50%); C7642 (49%); C7651 (41%); C7650 (36%)
C4002,Malignant neoplasm of scapula and long bones of left upper limb,21,C7642 (55%); C7640 (50%); C7641 (49%); C7652 (41%); C7650 (36%)
C4010,Malignant neoplasm of short bones of unspecified upper limb,21,C7640 (64%); C7642 (58%); C7641 (58%); C7650 (47%); C7652 (42%)
C4011,Malignant neoplasm of short bones of right upper limb,21,C7641 (65%); C7640 (59%); C7642 (58%); C7651 (49%); C7650 (43%)
C4012,Malignant neoplasm of short bones of left upper limb,21,C7642 (65%); C7640 (59%); C7641 (58%); C7652 (49%); C7650 (43%)
C4020,Malignant neoplasm of long bones of unspecified lower limb,21,C7650 (62%); C7652 (56%); C7651 (56%); C7640 (46%); C7642 (41%)
C4021,Malignant neoplasm of long bones of right lower limb,21,C7651 (63%); C7650 (57%); C7652 (56%); C7641 (48%); C7640 (42%)
C4022,Malignant neoplasm of long bones of left lower limb,21,C7652 (63%); C7650 (57%); C7651 (56%); C7642 (48%); C7640 (42%)
C4030,Malignant neoplasm of short bones of unspecified lower limb,21,C7650 (62%); C7652 (56%); C7651 (56%); C7640 (46%); C7642 (41%)
C4031,Malignant neoplasm of short bones of right lower limb,21,C7651 (63%); C7650 (57%); C7652 (55%); C7641 (47%); C7640 (41%)
C4032,Malignant neoplasm of short bones of left lower limb,21,C7652 (63%); C7650 (57%); C7651 (55%); C7642 (47%); C7640 (41%)
C4080,Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb,21,C718 (49%); C188 (47%); C168 (45%); C678 (45%); C258 (45%)
C4081,Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb,21,C718 (49%); C188 (47%); C50811 (45%); C50821 (45%); C3481 (45%)
C4082,Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb,21,C718 (49%); C188 (47%); C50812 (45%); C50822 (45%); C3482 (45%)
C4090,Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb,21,C7650 (47%); C7640 (45%); C7652 (39%); C7651 (39%); C7642 (37%)
C4091,Malignant neoplasm of unspecified bones and articular cartilage of right limb,21,C7651 (46%); C7650 (44%); C7641 (44%); C7640 (42%); C7652 (39%)
C4092,Malignant neoplasm of unspecified bones and articular cartilage of left limb,21,C7652 (46%); C7650 (44%); C7642 (44%); C7640 (42%); C7651 (39%)
C410,Malignant neoplasm of bones of skull and face,21,S0280XB (48%); S0280XA (48%); S0282XB (48%); S0281XB (48%); S0282XA (47%)
C411,Malignant neoplasm of mandible,21,S02609B (45%); C380 (45%); S02609A (45%); C720 (41%); C261 (41%)
C412,Malignant neoplasm of vertebral column,21,I63119 (36%); I63019 (36%); I63112 (36%); I63111 (36%); I63012 (36%)
C413,"Malignant neoplasm of ribs, sternum and clavicle",21,C380 (21%); C720 (19%); C261 (19%); C719 (19%); C7650 (19%)
C414,"Malignant neoplasm of pelvic bones, sacrum and coccyx",21,S322XXB (40%); S322XXA (40%); S3219XB (25%); S3219XA (25%); S3210XB (25%)
C419,"Malignant neoplasm of bone and articular cartilage, unspecified",21,C7951 (49%); C7952 (38%); M8780 (36%); C6990 (30%); M8730 (30%)
C430,Malignant melanoma of lip,23,C4A0 (47%); C148 (39%); C380 (16%); C411 (15%); C720 (15%)
C4310,"Malignant melanoma of unspecified eyelid, including canthus",23,C4A10 (65%); C4A122 (60%); C4A112 (60%); C4A121 (59%); C4A111 (59%)
C43111,"Malignant melanoma of right upper eyelid, including canthus",23,C4A111 (68%); C4A121 (65%); C4A112 (60%); C4A10 (59%); C4A122 (57%)
C43112,"Malignant melanoma of right lower eyelid, including canthus",23,C4A112 (67%); C4A122 (64%); C4A111 (60%); C4A10 (60%); C4A121 (57%)
C43121,"Malignant melanoma of left upper eyelid, including canthus",23,C4A121 (68%); C4A111 (65%); C4A122 (60%); C4A10 (59%); C4A112 (57%)
C43122,"Malignant melanoma of left lower eyelid, including canthus",23,C4A122 (67%); C4A112 (64%); C4A121 (60%); C4A10 (60%); C4A111 (57%)
C4320,Malignant melanoma of unspecified ear and external auricular canal,23,C4A20 (74%); C4A22 (72%); C4A21 (72%); C301 (36%); C211 (33%)
C4321,Malignant melanoma of right ear and external auricular canal,23,C4A21 (74%); C4A20 (72%); C4A22 (71%); C301 (36%); C211 (33%)
C4322,Malignant melanoma of left ear and external auricular canal,23,C4A22 (74%); C4A20 (72%); C4A21 (71%); C301 (36%); C211 (33%)
C4330,Malignant melanoma of unspecified part of face,23,C410 (42%); C770 (41%); C470 (35%); C4A30 (35%); C8511 (32%)
C4331,Malignant melanoma of nose,23,C4A31 (50%); C380 (15%); C411 (15%); C720 (14%); C261 (14%)
C4339,Malignant melanoma of other parts of face,23,C4A39 (52%); C257 (45%); C7949 (43%); C481 (42%); S128XXA (41%)
C434,Malignant melanoma of scalp and neck,23,C4A4 (57%); S129XXA (33%); C675 (33%); C770 (25%); S128XXA (25%)
C4351,Malignant melanoma of anal skin,23,C4A51 (56%); C211 (52%); C792 (41%); C218 (35%); L98491 (32%)
C4352,Malignant melanoma of skin of breast,23,C4A52 (47%); C792 (46%); C7981 (46%); L98491 (36%); E10622 (33%)
C4359,Malignant melanoma of other part of trunk,23,C476 (52%); C496 (46%); C4A59 (45%); T71222A (32%); C380 (16%)
C4360,"Malignant melanoma of unspecified upper limb, including shoulder",23,C4710 (64%); C4712 (61%); C4711 (61%); C4A60 (58%); C4910 (57%)
C4361,"Malignant melanoma of right upper limb, including shoulder",23,C4711 (65%); C4710 (61%); C4712 (60%); C4A61 (59%); C4911 (58%)
C4362,"Malignant melanoma of left upper limb, including shoulder",23,C4712 (65%); C4710 (61%); C4711 (60%); C4A62 (59%); C4912 (58%)
C4370,"Malignant melanoma of unspecified lower limb, including hip",23,C4720 (62%); C4722 (59%); C4721 (59%); C4A70 (56%); C4920 (55%)
C4371,"Malignant melanoma of right lower limb, including hip",23,C4721 (63%); C4720 (59%); C4722 (59%); C4A71 (57%); C4921 (56%)
C4372,"Malignant melanoma of left lower limb, including hip",23,C4722 (63%); C4720 (59%); C4721 (59%); C4A72 (57%); C4922 (56%)
C438,Malignant melanoma of overlapping sites of skin,23,C718 (54%); C188 (52%); C168 (50%); C678 (50%); C258 (49%)
C439,"Malignant melanoma of skin, unspecified",23,C792 (53%); L98491 (41%); E10622 (38%); E10622 (38%); E11622 (38%)
C450,Mesothelioma of pleura,19,C384 (60%); C782 (53%); C388 (37%); A0104 (0%); A0105 (0%)
C451,Mesothelioma of peritoneum,19,C482 (56%); C481 (43%); C7B04 (40%); C786 (39%); K67 (37%)
C452,Mesothelioma of pericardium,19,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
C457,Mesothelioma of other sites,19,M868X9 (33%); M868X0 (27%); M8789 (27%); M8669 (25%); Q018 (25%)
C459,"Mesothelioma, unspecified",19,G8330 (13%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
C460,Kaposi's sarcoma of skin,21,C9231 (37%); C9232 (36%); L98491 (33%); C439 (31%); E10622 (31%)
C461,Kaposi's sarcoma of soft tissue,21,D0352 (43%); C494 (42%); C9231 (31%); C9232 (30%); C9230 (24%)
C462,Kaposi's sarcoma of palate,21,C9231 (34%); C9232 (32%); C9230 (26%); A0104 (0%); A0105 (0%)
C463,Kaposi's sarcoma of lymph nodes,21,C9231 (37%); C9232 (35%); C9230 (29%); C771 (27%); C775 (27%)
C464,Kaposi's sarcoma of gastrointestinal sites,21,C49A9 (42%); B462 (36%); C9231 (33%); C9232 (31%); C49A0 (29%)
C4650,Kaposi's sarcoma of unspecified lung,21,C9231 (37%); C9232 (36%); C7800 (30%); C3490 (29%); C9230 (29%)
C4651,Kaposi's sarcoma of right lung,21,C9231 (37%); C9232 (35%); C7801 (32%); C3491 (29%); C9230 (29%)
C4652,Kaposi's sarcoma of left lung,21,C9231 (37%); C9232 (35%); C7802 (32%); C9230 (29%); C3492 (29%)
C467,Kaposi's sarcoma of other sites,21,C9231 (39%); C9232 (37%); C9230 (30%); M868X9 (28%); M868X0 (22%)
C469,"Kaposi's sarcoma, unspecified",21,C9231 (42%); C9232 (40%); C9230 (33%); G8330 (10%); L97909 (10%)
C470,"Malignant neoplasm of peripheral nerves of head, face and neck",21,C760 (76%); C770 (60%); C8441 (60%); C474 (58%); C8371 (46%)
C4710,"Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder",21,C4360 (64%); C4362 (61%); C4361 (61%); C7640 (57%); C474 (56%)
C4711,"Malignant neoplasm of peripheral nerves of right upper limb, including shoulder",21,C4361 (65%); C4360 (61%); C4362 (60%); C7641 (58%); C474 (56%)
C4712,"Malignant neoplasm of peripheral nerves of left upper limb, including shoulder",21,C4362 (65%); C4360 (61%); C4361 (60%); C7642 (58%); C474 (56%)
C4720,"Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip",21,C4370 (62%); C4372 (59%); C4371 (59%); C474 (57%); C7650 (55%)
C4721,"Malignant neoplasm of peripheral nerves of right lower limb, including hip",21,C4371 (63%); C4370 (59%); C4372 (59%); C474 (57%); C7651 (56%)
C4722,"Malignant neoplasm of peripheral nerves of left lower limb, including hip",21,C4372 (63%); C4370 (59%); C4371 (59%); C474 (57%); C7652 (56%)
C473,Malignant neoplasm of peripheral nerves of thorax,21,C761 (72%); C474 (61%); C7259 (46%); D333 (35%); D433 (30%)
C474,Malignant neoplasm of peripheral nerves of abdomen,23,C475 (67%); C476 (62%); C473 (61%); C470 (58%); C4720 (57%)
C475,Malignant neoplasm of peripheral nerves of pelvis,21,C474 (67%); C763 (66%); C7259 (50%); C659 (50%); C652 (49%)
C476,"Malignant neoplasm of peripheral nerves of trunk, unspecified",21,C474 (62%); C4359 (52%); C7259 (47%); D0359 (38%); D333 (35%)
C478,Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system,21,C474 (51%); C718 (46%); C188 (44%); C168 (42%); C678 (42%)
C479,"Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified",21,C474 (56%); C7940 (50%); C729 (48%); G903 (44%); C7259 (42%)
C480,Malignant neoplasm of retroperitoneum,20,C786 (72%); C411 (34%); C261 (33%); C7650 (33%); C763 (32%)
C481,Malignant neoplasm of specified parts of peritoneum,20,C786 (52%); C7949 (49%); D337 (45%); C451 (43%); C0689 (43%)
C482,"Malignant neoplasm of peritoneum, unspecified",20,C786 (66%); C451 (56%); C7B04 (47%); K67 (44%); C6990 (40%)
C488,Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum,20,C786 (79%); C188 (50%); C678 (48%); C028 (47%); C118 (47%)
C490,"Malignant neoplasm of connective and soft tissue of head, face and neck",21,C494 (67%); C760 (67%); C770 (53%); C8371 (41%); C8411 (40%)
C4910,"Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder",21,C494 (66%); C4360 (57%); C4362 (54%); C4361 (54%); C7640 (51%)
C4911,"Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder",21,C494 (65%); C4361 (58%); C4360 (54%); C4362 (54%); C7641 (52%)
C4912,"Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder",21,C494 (65%); C4362 (58%); C4360 (54%); C4361 (54%); C7642 (52%)
C4920,"Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip",21,C494 (67%); C4370 (55%); C4372 (52%); C4371 (52%); C7650 (49%)
C4921,"Malignant neoplasm of connective and soft tissue of right lower limb, including hip",21,C494 (66%); C4371 (56%); C4370 (53%); C4372 (52%); C7651 (50%)
C4922,"Malignant neoplasm of connective and soft tissue of left lower limb, including hip",21,C494 (66%); C4372 (56%); C4370 (53%); C4371 (52%); C7652 (50%)
C493,Malignant neoplasm of connective and soft tissue of thorax,21,C494 (70%); C761 (63%); D0352 (38%); C380 (23%); C720 (21%)
C494,Malignant neoplasm of connective and soft tissue of abdomen,23,C499 (83%); C495 (75%); C498 (73%); C496 (71%); C493 (70%)
C495,Malignant neoplasm of connective and soft tissue of pelvis,21,C494 (75%); C763 (56%); C659 (42%); C652 (42%); C651 (42%)
C496,"Malignant neoplasm of connective and soft tissue of trunk, unspecified",21,C494 (71%); C4359 (46%); D0352 (39%); D0359 (33%); C6990 (25%)
C498,Malignant neoplasm of overlapping sites of connective and soft tissue,21,C494 (73%); C718 (50%); C188 (48%); C168 (46%); C678 (46%)
C499,"Malignant neoplasm of connective and soft tissue, unspecified",21,C494 (83%); D0352 (45%); C6990 (29%); C719 (28%); C7650 (28%)
C49A0,"Gastrointestinal stromal tumor, unspecified site",23,C7A00 (45%); D3A00 (40%); B462 (37%); C464 (29%); C8510 (27%)
C49A1,Gastrointestinal stromal tumor of esophagus,23,C159 (44%); C155 (42%); C153 (40%); C154 (36%); C158 (35%)
C49A2,Gastrointestinal stromal tumor of stomach,23,C7A092 (54%); D3A092 (49%); C169 (42%); C162 (37%); B462 (34%)
C49A3,Gastrointestinal stromal tumor of small intestine,23,C7A019 (51%); C179 (48%); D3A019 (48%); C784 (44%); C178 (39%)
C49A4,Gastrointestinal stromal tumor of large intestine,23,C7A029 (50%); D3A029 (47%); K5010 (36%); K50118 (36%); K50119 (36%)
C49A5,Gastrointestinal stromal tumor of rectum,23,C7A026 (54%); D3A026 (50%); C20 (43%); B462 (34%); C785 (30%)
C49A9,Gastrointestinal stromal tumor of other sites,23,C464 (42%); B462 (37%); Z934 (25%); C7A00 (25%); T478X2A (25%)
C4A0,Merkel cell carcinoma of lip,21,C7B1 (69%); C430 (47%); C220 (45%); D030 (42%); C221 (21%)
C4A10,"Merkel cell carcinoma of unspecified eyelid, including canthus",21,C4310 (65%); D0310 (60%); C43122 (60%); C43112 (60%); C43121 (59%)
C4A111,"Merkel cell carcinoma of right upper eyelid, including canthus",21,C43111 (68%); C43121 (65%); D03111 (64%); D03121 (60%); C43112 (60%)
C4A112,"Merkel cell carcinoma of right lower eyelid, including canthus",21,C43112 (67%); C43122 (64%); D03112 (63%); C4310 (60%); C43111 (60%)
C4A121,"Merkel cell carcinoma of left upper eyelid, including canthus",21,C43121 (68%); C43111 (65%); D03121 (64%); D03111 (60%); C43122 (60%)
C4A122,"Merkel cell carcinoma of left lower eyelid, including canthus",21,C43122 (67%); C43112 (64%); D03122 (63%); C4310 (60%); C43121 (60%)
C4A20,Merkel cell carcinoma of unspecified ear and external auricular canal,21,C4320 (74%); C4322 (72%); C4321 (72%); D0320 (70%); D0322 (68%)
C4A21,Merkel cell carcinoma of right ear and external auricular canal,21,C4321 (74%); C4320 (72%); C4322 (71%); D0321 (70%); D0320 (68%)
C4A22,Merkel cell carcinoma of left ear and external auricular canal,21,C4322 (74%); C4320 (72%); C4321 (71%); D0322 (70%); D0320 (68%)
C4A30,Merkel cell carcinoma of unspecified part of face,21,C7B1 (75%); C220 (49%); C4330 (35%); C84A1 (33%); D0330 (30%)
C4A31,Merkel cell carcinoma of nose,21,C7B1 (68%); C4331 (50%); C220 (44%); C221 (20%); C9511 (14%)
C4A39,Merkel cell carcinoma of other parts of face,21,C7B1 (66%); C4339 (52%); D0339 (47%); C220 (43%); S128XXA (34%)
C4A4,Merkel cell carcinoma of scalp and neck,21,C7B1 (63%); C434 (57%); D034 (52%); C220 (41%); S129XXA (28%)
C4A51,Merkel cell carcinoma of anal skin,21,C7B1 (64%); C4351 (56%); D0351 (51%); C220 (42%); C211 (37%)
C4A52,Merkel cell carcinoma of skin of breast,21,C7B1 (69%); C4352 (47%); C220 (45%); D0352 (33%); L98491 (29%)
C4A59,Merkel cell carcinoma of other part of trunk,21,C7B1 (70%); C220 (46%); C4359 (45%); D0359 (40%); T71222A (26%)
C4A60,"Merkel cell carcinoma of unspecified upper limb, including shoulder",21,C7B1 (62%); C4360 (58%); C4362 (55%); C4361 (55%); D0360 (53%)
C4A61,"Merkel cell carcinoma of right upper limb, including shoulder",21,C7B1 (62%); C4361 (59%); C4360 (55%); C4362 (54%); D0361 (54%)
C4A62,"Merkel cell carcinoma of left upper limb, including shoulder",21,C7B1 (62%); C4362 (59%); C4360 (55%); C4361 (54%); D0362 (54%)
C4A70,"Merkel cell carcinoma of unspecified lower limb, including hip",21,C7B1 (64%); C4370 (56%); C4372 (53%); C4371 (53%); D0370 (51%)
C4A71,"Merkel cell carcinoma of right lower limb, including hip",21,C7B1 (63%); C4371 (57%); C4370 (53%); C4372 (53%); D0371 (52%)
C4A72,"Merkel cell carcinoma of left lower limb, including hip",21,C7B1 (63%); C4372 (57%); C4370 (53%); C4371 (53%); D0372 (52%)
C4A8,Merkel cell carcinoma of overlapping sites,21,C7B1 (71%); C220 (47%); C718 (41%); C188 (39%); C438 (37%)
C4A9,"Merkel cell carcinoma, unspecified",21,C7B1 (87%); C220 (57%); C221 (26%); C84A0 (24%); C9511 (22%)
C50011,"Malignant neoplasm of nipple and areola, right female breast",23,C7981 (42%); C579 (34%); C577 (32%); C578 (29%); C7801 (24%)
C50012,"Malignant neoplasm of nipple and areola, left female breast",23,C7981 (42%); C579 (34%); C577 (32%); C578 (29%); C7802 (24%)
C50019,"Malignant neoplasm of nipple and areola, unspecified female breast",23,C7981 (42%); C579 (37%); C577 (32%); C578 (29%); C719 (25%)
C50021,"Malignant neoplasm of nipple and areola, right male breast",23,C7981 (42%); C7801 (24%); C380 (23%); C561 (23%); C661 (22%)
C50022,"Malignant neoplasm of nipple and areola, left male breast",23,C7981 (42%); C7802 (24%); C380 (23%); C562 (23%); C662 (22%)
C50029,"Malignant neoplasm of nipple and areola, unspecified male breast",23,C7981 (42%); C719 (25%); C189 (23%); C380 (23%); C799 (23%)
C50111,Malignant neoplasm of central portion of right female breast,23,C7981 (47%); C729 (42%); C579 (39%); C577 (36%); C578 (33%)
C50112,Malignant neoplasm of central portion of left female breast,23,C7981 (47%); C729 (42%); C579 (39%); C577 (36%); C578 (33%)
C50119,Malignant neoplasm of central portion of unspecified female breast,23,C7981 (47%); C729 (46%); C579 (42%); C577 (37%); C578 (33%)
C50121,Malignant neoplasm of central portion of right male breast,23,C7981 (47%); C729 (42%); C7A029 (28%); C7A019 (28%); S73041A (27%)
C50122,Malignant neoplasm of central portion of left male breast,23,C7981 (47%); C729 (42%); C7A029 (28%); C7A019 (28%); S73042A (27%)
C50129,Malignant neoplasm of central portion of unspecified male breast,23,C7981 (47%); C729 (46%); C7A029 (31%); C7A019 (31%); C719 (28%)
C50211,Malignant neoplasm of upper-inner quadrant of right female breast,23,C7981 (42%); C579 (35%); C577 (33%); C153 (30%); C578 (30%)
C50212,Malignant neoplasm of upper-inner quadrant of left female breast,23,C7981 (42%); C579 (35%); C577 (33%); C153 (30%); C578 (30%)
C50219,Malignant neoplasm of upper-inner quadrant of unspecified female breast,23,C7981 (43%); C579 (38%); C577 (33%); C153 (30%); C578 (30%)
C50221,Malignant neoplasm of upper-inner quadrant of right male breast,23,C7981 (42%); C153 (30%); C030 (29%); C4011 (27%); C3411 (27%)
C50222,Malignant neoplasm of upper-inner quadrant of left male breast,23,C7981 (42%); C153 (30%); C030 (29%); C4012 (27%); C3412 (27%)
C50229,Malignant neoplasm of upper-inner quadrant of unspecified male breast,23,C7981 (43%); C153 (30%); C030 (29%); C390 (29%); C773 (26%)
C50311,Malignant neoplasm of lower-inner quadrant of right female breast,23,C7981 (43%); C579 (35%); C577 (33%); C578 (30%); C155 (27%)
C50312,Malignant neoplasm of lower-inner quadrant of left female breast,23,C7981 (43%); C579 (35%); C577 (33%); C578 (30%); C155 (27%)
C50319,Malignant neoplasm of lower-inner quadrant of unspecified female breast,23,C7981 (43%); C579 (38%); C577 (33%); C578 (30%); C155 (27%)
C50321,Malignant neoplasm of lower-inner quadrant of right male breast,23,C7981 (43%); C155 (27%); C031 (26%); C4021 (25%); C4031 (25%)
C50322,Malignant neoplasm of lower-inner quadrant of left male breast,23,C7981 (43%); C155 (27%); C031 (26%); C4022 (25%); C4032 (25%)
C50329,Malignant neoplasm of lower-inner quadrant of unspecified male breast,23,C7981 (43%); C155 (27%); C031 (26%); C399 (26%); C719 (26%)
C50411,Malignant neoplasm of upper-outer quadrant of right female breast,23,C7981 (42%); C579 (35%); C577 (33%); C153 (30%); C578 (30%)
C50412,Malignant neoplasm of upper-outer quadrant of left female breast,23,C7981 (42%); C579 (35%); C577 (33%); C153 (30%); C578 (30%)
C50419,Malignant neoplasm of upper-outer quadrant of unspecified female breast,23,C7981 (43%); C579 (38%); C577 (33%); C153 (30%); C578 (30%)
C50421,Malignant neoplasm of upper-outer quadrant of right male breast,23,C7981 (42%); C153 (30%); C030 (29%); C4011 (27%); C3411 (27%)
C50422,Malignant neoplasm of upper-outer quadrant of left male breast,23,C7981 (42%); C153 (30%); C030 (29%); C4012 (27%); C3412 (27%)
C50429,Malignant neoplasm of upper-outer quadrant of unspecified male breast,23,C7981 (43%); C153 (30%); C030 (29%); C390 (29%); C773 (26%)
C50511,Malignant neoplasm of lower-outer quadrant of right female breast,23,C7981 (43%); C579 (35%); C577 (33%); C578 (30%); C155 (27%)
C50512,Malignant neoplasm of lower-outer quadrant of left female breast,23,C7981 (43%); C579 (35%); C577 (33%); C578 (30%); C155 (27%)
C50519,Malignant neoplasm of lower-outer quadrant of unspecified female breast,23,C7981 (43%); C579 (38%); C577 (33%); C578 (30%); C155 (27%)
C50521,Malignant neoplasm of lower-outer quadrant of right male breast,23,C7981 (43%); C155 (27%); C031 (26%); C4021 (25%); C4031 (25%)
C50522,Malignant neoplasm of lower-outer quadrant of left male breast,23,C7981 (43%); C155 (27%); C031 (26%); C4022 (25%); C4032 (25%)
C50529,Malignant neoplasm of lower-outer quadrant of unspecified male breast,23,C7981 (43%); C155 (27%); C031 (26%); C399 (26%); C719 (26%)
C50611,Malignant neoplasm of axillary tail of right female breast,23,C252 (48%); C7981 (43%); C579 (35%); C577 (33%); I82A21 (33%)
C50612,Malignant neoplasm of axillary tail of left female breast,23,C252 (48%); C7981 (43%); C579 (35%); C577 (33%); I82A22 (33%)
C50619,Malignant neoplasm of axillary tail of unspecified female breast,23,C252 (48%); C7981 (43%); C579 (38%); C577 (33%); I82A29 (32%)
C50621,Malignant neoplasm of axillary tail of right male breast,23,C252 (48%); C7981 (43%); I82A21 (33%); I82A11 (32%); I82A29 (29%)
C50622,Malignant neoplasm of axillary tail of left male breast,23,C252 (48%); C7981 (43%); I82A22 (33%); I82A12 (32%); I82A29 (29%)
C50629,Malignant neoplasm of axillary tail of unspecified male breast,23,C252 (48%); C7981 (43%); I82A29 (32%); I82A19 (31%); I82A22 (29%)
C50811,Malignant neoplasm of overlapping sites of right female breast,23,C578 (64%); C718 (59%); C188 (57%); C3481 (54%); C168 (54%)
C50812,Malignant neoplasm of overlapping sites of left female breast,23,C578 (64%); C718 (59%); C188 (57%); C3482 (54%); C168 (54%)
C50819,Malignant neoplasm of overlapping sites of unspecified female breast,23,C578 (65%); C718 (60%); C188 (58%); C168 (55%); C678 (55%)
C50821,Malignant neoplasm of overlapping sites of right male breast,23,C718 (59%); C188 (57%); C3481 (54%); C168 (54%); C678 (54%)
C50822,Malignant neoplasm of overlapping sites of left male breast,23,C718 (59%); C188 (57%); C3482 (54%); C168 (54%); C678 (54%)
C50829,Malignant neoplasm of overlapping sites of unspecified male breast,23,C718 (60%); C188 (58%); C168 (55%); C678 (55%); C258 (55%)
C50911,Malignant neoplasm of unspecified site of right female breast,23,C7981 (54%); C799 (51%); C579 (48%); C577 (42%); C578 (38%)
C50912,Malignant neoplasm of unspecified site of left female breast,23,C7981 (54%); C799 (51%); C579 (48%); C577 (42%); C578 (38%)
C50919,Malignant neoplasm of unspecified site of unspecified female breast,23,C799 (54%); C7981 (53%); C579 (50%); C577 (41%); C8510 (39%)
C50921,Malignant neoplasm of unspecified site of right male breast,23,C7981 (54%); C799 (51%); C7A00 (33%); C719 (33%); C3491 (31%)
C50922,Malignant neoplasm of unspecified site of left male breast,23,C7981 (54%); C799 (51%); C7A00 (33%); C719 (33%); C3492 (31%)
C50929,Malignant neoplasm of unspecified site of unspecified male breast,23,C799 (54%); C7981 (53%); C8510 (39%); M0890 (38%); C8190 (37%)
C510,Malignant neoplasm of labium majus,22,C380 (26%); C411 (25%); C720 (24%); C719 (24%); C7650 (24%)
C511,Malignant neoplasm of labium minus,22,C380 (26%); C411 (25%); C720 (24%); C719 (24%); C7650 (24%)
C512,Malignant neoplasm of clitoris,22,C380 (34%); C411 (32%); C720 (31%); C719 (31%); C7650 (31%)
C518,Malignant neoplasm of overlapping sites of vulva,22,C718 (61%); C168 (56%); C258 (56%); C028 (56%); C118 (55%)
C519,"Malignant neoplasm of vulva, unspecified",22,N7682 (45%); C6990 (38%); C719 (38%); C7650 (38%); C7640 (36%)
C52,Malignant neoplasm of vagina,22,N7682 (48%); C380 (35%); C411 (33%); C720 (32%); C719 (32%)
C530,Malignant neoplasm of endocervix,22,C380 (34%); C411 (32%); C720 (31%); C719 (31%); C7650 (31%)
C531,Malignant neoplasm of exocervix,22,C380 (34%); C411 (32%); C720 (31%); C719 (31%); C7650 (31%)
C538,Malignant neoplasm of overlapping sites of cervix uteri,22,C548 (67%); C718 (51%); C168 (47%); C258 (47%); C028 (47%)
C539,"Malignant neoplasm of cervix uteri, unspecified",22,C549 (56%); C543 (53%); C540 (52%); C548 (46%); C6990 (30%)
C540,Malignant neoplasm of isthmus uteri,23,C539 (52%); C538 (45%); C380 (27%); C411 (25%); C720 (25%)
C541,Malignant neoplasm of endometrium,23,C380 (34%); C411 (32%); C720 (31%); C261 (31%); C719 (31%)
C542,Malignant neoplasm of myometrium,23,C380 (34%); C411 (32%); C720 (31%); C261 (31%); C719 (31%)
C543,Malignant neoplasm of fundus uteri,23,C161 (63%); C539 (53%); C538 (46%); C380 (28%); C411 (26%)
C548,Malignant neoplasm of overlapping sites of corpus uteri,23,C538 (67%); C718 (52%); C188 (50%); C168 (48%); C678 (48%)
C549,"Malignant neoplasm of corpus uteri, unspecified",23,C539 (56%); C538 (47%); Q040 (34%); G371 (33%); C719 (30%)
C55,"Malignant neoplasm of uterus, part unspecified",23,C719 (36%); C189 (33%); C380 (33%); C799 (32%); C411 (31%)
C561,Malignant neoplasm of right ovary,22,C7961 (88%); C7960 (82%); C7962 (80%); C7651 (42%); C7641 (40%)
C562,Malignant neoplasm of left ovary,22,C7962 (88%); C7960 (82%); C7961 (80%); C7652 (42%); C7642 (40%)
C563,Malignant neoplasm of bilateral ovaries,22,C7963 (90%); C380 (32%); C411 (30%); C720 (29%); C719 (29%)
C569,Malignant neoplasm of unspecified ovary,22,C7960 (88%); C7962 (82%); C7961 (82%); C6990 (40%); C719 (40%)
C5700,Malignant neoplasm of unspecified fallopian tube,22,C6990 (29%); C719 (29%); C7650 (29%); C7640 (27%); C380 (27%)
C5701,Malignant neoplasm of right fallopian tube,22,C7651 (31%); C7641 (30%); C6991 (29%); C7801 (27%); C380 (27%)
C5702,Malignant neoplasm of left fallopian tube,22,C7652 (31%); C7642 (29%); C6992 (29%); C7802 (27%); C380 (27%)
C5710,Malignant neoplasm of unspecified broad ligament,22,C6990 (30%); C719 (30%); C7650 (30%); C7640 (28%); C380 (28%)
C5711,Malignant neoplasm of right broad ligament,22,C7651 (32%); C7641 (30%); C6991 (30%); C7801 (28%); C380 (27%)
C5712,Malignant neoplasm of left broad ligament,22,C7652 (32%); C7642 (30%); C6992 (30%); C7802 (28%); C380 (27%)
C5720,Malignant neoplasm of unspecified round ligament,22,C6990 (30%); C719 (30%); C7650 (30%); C7640 (28%); C380 (28%)
C5721,Malignant neoplasm of right round ligament,22,C7651 (32%); C7641 (30%); C6991 (30%); C7801 (28%); C380 (27%)
C5722,Malignant neoplasm of left round ligament,22,C7652 (32%); C7642 (30%); C6992 (30%); C7802 (28%); C380 (27%)
C573,Malignant neoplasm of parametrium,22,C380 (34%); C411 (32%); C720 (31%); C719 (31%); C7650 (31%)
C574,"Malignant neoplasm of uterine adnexa, unspecified",22,C6980 (55%); C6982 (52%); C6981 (52%); C6990 (28%); C719 (28%)
C577,Malignant neoplasm of other specified female genital organs,22,C637 (77%); C7982 (75%); C638 (62%); C639 (49%); C7839 (42%)
C578,Malignant neoplasm of overlapping sites of female genital organs,22,C638 (81%); C7982 (68%); C50819 (65%); C50812 (64%); C50811 (64%)
C579,"Malignant neoplasm of female genital organ, unspecified",22,C639 (74%); C7982 (54%); C50919 (50%); C637 (49%); C50912 (48%)
C58,Malignant neoplasm of placenta,22,C380 (34%); C411 (32%); C720 (31%); C719 (31%); C7650 (31%)
C600,Malignant neoplasm of prepuce,23,C380 (34%); C411 (32%); C720 (31%); C261 (31%); C719 (31%)
C601,Malignant neoplasm of glans penis,23,C380 (27%); C411 (25%); C720 (24%); C261 (24%); C719 (24%)
C602,Malignant neoplasm of body of penis,23,C162 (46%); C251 (46%); C380 (32%); C411 (30%); C720 (30%)
C608,Malignant neoplasm of overlapping sites of penis,23,C718 (62%); C188 (60%); C168 (57%); C678 (57%); C258 (57%)
C609,"Malignant neoplasm of penis, unspecified",23,C719 (38%); C189 (36%); C380 (36%); C799 (35%); C411 (34%)
C61,Malignant neoplasm of prostate,23,C380 (34%); C411 (32%); C720 (31%); C261 (31%); C719 (31%)
C6200,Malignant neoplasm of unspecified undescended testis,23,C719 (31%); C189 (29%); C380 (29%); C799 (28%); C411 (27%)
C6201,Malignant neoplasm of undescended right testis,23,C7801 (29%); C380 (29%); C561 (28%); C661 (27%); C411 (27%)
C6202,Malignant neoplasm of undescended left testis,23,C7802 (29%); C380 (29%); C562 (28%); C662 (27%); C411 (27%)
C6210,Malignant neoplasm of unspecified descended testis,23,C719 (31%); C189 (29%); C380 (29%); C799 (28%); C411 (27%)
C6211,Malignant neoplasm of descended right testis,23,C7801 (29%); C380 (29%); C561 (28%); C661 (27%); C411 (27%)
C6212,Malignant neoplasm of descended left testis,23,C7802 (29%); C380 (29%); C562 (28%); C662 (27%); C411 (27%)
C6290,"Malignant neoplasm of unspecified testis, unspecified whether descended or undescended",23,C719 (29%); C189 (27%); C3490 (27%); C799 (26%); C709 (25%)
C6291,"Malignant neoplasm of right testis, unspecified whether descended or undescended",23,C719 (26%); C3491 (24%); C7801 (24%); C189 (24%); C380 (24%)
C6292,"Malignant neoplasm of left testis, unspecified whether descended or undescended",23,C719 (26%); C3492 (24%); C7802 (24%); C189 (24%); C380 (24%)
C6300,Malignant neoplasm of unspecified epididymis,23,C719 (38%); C189 (35%); C380 (35%); C799 (34%); C411 (33%)
C6301,Malignant neoplasm of right epididymis,23,C7801 (35%); C380 (34%); C561 (34%); C661 (33%); C411 (33%)
C6302,Malignant neoplasm of left epididymis,23,C7802 (35%); C380 (34%); C562 (34%); C662 (33%); C411 (33%)
C6310,Malignant neoplasm of unspecified spermatic cord,23,C720 (51%); C719 (35%); C189 (32%); C380 (32%); C799 (31%)
C6311,Malignant neoplasm of right spermatic cord,23,C720 (51%); C7801 (32%); C380 (32%); C561 (31%); C661 (30%)
C6312,Malignant neoplasm of left spermatic cord,23,C720 (51%); C7802 (32%); C380 (32%); C562 (31%); C662 (30%)
C632,Malignant neoplasm of scrotum,23,C380 (34%); C411 (32%); C720 (31%); C261 (31%); C719 (31%)
C637,Malignant neoplasm of other specified male genital organs,23,C577 (77%); C7982 (75%); C578 (62%); C579 (49%); C7839 (42%)
C638,Malignant neoplasm of overlapping sites of male genital organs,23,C578 (81%); C7982 (68%); C577 (62%); C688 (60%); C718 (51%)
C639,"Malignant neoplasm of male genital organ, unspecified",23,C579 (74%); C7982 (54%); C577 (49%); C578 (45%); C689 (43%)
C641,"Malignant neoplasm of right kidney, except renal pelvis",22,C7901 (92%); C7900 (89%); C7902 (88%); C763 (64%); C475 (42%)
C642,"Malignant neoplasm of left kidney, except renal pelvis",22,C7902 (92%); C7900 (89%); C7901 (88%); C763 (64%); C475 (42%)
C649,"Malignant neoplasm of unspecified kidney, except renal pelvis",22,C7900 (92%); C7902 (89%); C7901 (89%); C763 (64%); C475 (43%)
C651,Malignant neoplasm of right renal pelvis,22,C7901 (80%); C7900 (75%); C7902 (75%); C763 (74%); C475 (49%)
C652,Malignant neoplasm of left renal pelvis,22,C7902 (80%); C7900 (75%); C7901 (75%); C763 (74%); C475 (49%)
C659,Malignant neoplasm of unspecified renal pelvis,22,C7900 (79%); C7902 (76%); C7901 (76%); C763 (75%); C475 (50%)
C661,Malignant neoplasm of right ureter,22,C7651 (40%); C7641 (38%); C6991 (38%); C7801 (35%); C380 (34%)
C662,Malignant neoplasm of left ureter,22,C7652 (40%); C7642 (38%); C6992 (38%); C7802 (35%); C380 (34%)
C669,Malignant neoplasm of unspecified ureter,22,C6990 (38%); C719 (38%); C7650 (38%); C7640 (36%); C380 (35%)
C670,Malignant neoplasm of trigone of bladder,22,C7911 (61%); C380 (27%); C411 (26%); C720 (25%); C719 (25%)
C671,Malignant neoplasm of dome of bladder,22,C7911 (68%); S32483B (35%); S32486B (35%); S32483A (35%); S32486A (35%)
C672,Malignant neoplasm of lateral wall of bladder,22,C7911 (63%); C112 (62%); C102 (61%); S02849B (43%); S02849A (43%)
C673,Malignant neoplasm of anterior wall of bladder,22,C7911 (65%); C113 (59%); C381 (42%); C111 (39%); S32413B (39%)
C674,Malignant neoplasm of posterior wall of bladder,22,C7911 (65%); C111 (60%); C103 (59%); C132 (58%); C382 (43%)
C675,Malignant neoplasm of bladder neck,22,C7911 (74%); C760 (48%); S129XXA (38%); C770 (38%); C470 (36%)
C676,Malignant neoplasm of ureteric orifice,22,C380 (25%); C411 (24%); C720 (23%); C719 (23%); C7650 (23%)
C677,Malignant neoplasm of urachus,22,C380 (34%); C411 (32%); C720 (31%); C719 (31%); C7650 (31%)
C678,Malignant neoplasm of overlapping sites of bladder,22,C7911 (66%); C718 (64%); C168 (59%); C258 (59%); C028 (59%)
C679,"Malignant neoplasm of bladder, unspecified",22,C7911 (84%); C6990 (41%); C719 (41%); C7650 (41%); C7640 (39%)
C680,Malignant neoplasm of urethra,22,C380 (34%); C411 (32%); C720 (31%); C719 (31%); C7650 (31%)
C681,Malignant neoplasm of paraurethral glands,22,C380 (25%); C411 (24%); C720 (23%); C719 (23%); C7650 (23%)
C688,Malignant neoplasm of overlapping sites of urinary organs,22,C7919 (75%); C7910 (74%); C638 (60%); C718 (56%); C168 (51%)
C689,"Malignant neoplasm of urinary organ, unspecified",22,C7910 (66%); C7919 (63%); C7830 (49%); C7880 (44%); C639 (43%)
C6900,Malignant neoplasm of unspecified conjunctiva,23,C719 (38%); C189 (35%); C380 (35%); C799 (34%); C411 (33%)
C6901,Malignant neoplasm of right conjunctiva,23,C7801 (35%); C380 (34%); C561 (34%); C661 (33%); C411 (33%)
C6902,Malignant neoplasm of left conjunctiva,23,C7802 (35%); C380 (34%); C562 (34%); C662 (33%); C411 (33%)
C6910,Malignant neoplasm of unspecified cornea,23,C719 (38%); C189 (35%); C380 (35%); C799 (34%); C411 (33%)
C6911,Malignant neoplasm of right cornea,23,C7801 (35%); C380 (34%); C561 (34%); C661 (33%); C411 (33%)
C6912,Malignant neoplasm of left cornea,23,C7802 (35%); C380 (34%); C562 (34%); C662 (33%); C411 (33%)
C6920,Malignant neoplasm of unspecified retina,23,C719 (38%); C189 (35%); C380 (35%); C799 (34%); C411 (33%)
C6921,Malignant neoplasm of right retina,23,C7801 (35%); C380 (34%); C561 (34%); C661 (33%); C411 (33%)
C6922,Malignant neoplasm of left retina,23,C7802 (35%); C380 (34%); C562 (34%); C662 (33%); C411 (33%)
C6930,Malignant neoplasm of unspecified choroid,23,C719 (38%); C189 (35%); C380 (35%); C799 (34%); C411 (33%)
C6931,Malignant neoplasm of right choroid,23,C7801 (35%); C380 (34%); C561 (34%); C661 (33%); C411 (33%)
C6932,Malignant neoplasm of left choroid,23,C7802 (35%); C380 (34%); C562 (34%); C662 (33%); C411 (33%)
C6940,Malignant neoplasm of unspecified ciliary body,23,C162 (44%); C251 (44%); C719 (34%); C189 (31%); C380 (31%)
C6941,Malignant neoplasm of right ciliary body,23,C162 (44%); C251 (43%); C7801 (31%); C380 (31%); C561 (30%)
C6942,Malignant neoplasm of left ciliary body,23,C162 (44%); C251 (43%); C7802 (31%); C380 (31%); C562 (30%)
C6950,Malignant neoplasm of unspecified lacrimal gland and duct,23,C7490 (46%); C752 (46%); C7492 (45%); C7491 (45%); C253 (44%)
C6951,Malignant neoplasm of right lacrimal gland and duct,23,C7491 (46%); C752 (46%); C253 (44%); C7971 (43%); C751 (42%)
C6952,Malignant neoplasm of left lacrimal gland and duct,23,C7492 (46%); C752 (46%); C253 (44%); C7972 (43%); C751 (42%)
C6960,Malignant neoplasm of unspecified orbit,23,S0285XB (63%); S0285XA (62%); C719 (39%); C189 (36%); C380 (36%)
C6961,Malignant neoplasm of right orbit,23,S0285XB (57%); S0285XA (57%); C7801 (36%); C380 (36%); C561 (35%)
C6962,Malignant neoplasm of left orbit,23,S0285XB (57%); S0285XA (57%); C7802 (36%); C380 (36%); C562 (35%)
C6980,Malignant neoplasm of overlapping sites of unspecified eye and adnexa,23,C718 (58%); C188 (56%); C574 (55%); C168 (53%); C678 (53%)
C6981,Malignant neoplasm of overlapping sites of right eye and adnexa,23,C718 (57%); C188 (55%); C3481 (53%); C168 (53%); C678 (53%)
C6982,Malignant neoplasm of overlapping sites of left eye and adnexa,23,C718 (57%); C188 (55%); C3482 (53%); C168 (53%); C678 (53%)
C6990,Malignant neoplasm of unspecified site of unspecified eye,23,C799 (70%); C8510 (50%); M0890 (50%); C8190 (48%); C8290 (48%)
C6991,Malignant neoplasm of unspecified site of right eye,23,C799 (67%); C7A00 (43%); C719 (43%); C3491 (41%); C7801 (41%)
C6992,Malignant neoplasm of unspecified site of left eye,23,C799 (67%); C7A00 (43%); C719 (43%); C3492 (41%); C8510 (40%)
C700,Malignant neoplasm of cerebral meninges,20,C7932 (89%); D320 (78%); D420 (65%); D329 (63%); D321 (59%)
C701,Malignant neoplasm of spinal meninges,20,D321 (77%); C7932 (70%); D421 (64%); D329 (64%); D320 (59%)
C709,"Malignant neoplasm of meninges, unspecified",20,C7932 (76%); D329 (74%); D321 (65%); D320 (64%); D429 (60%)
C710,"Malignant neoplasm of cerebrum, except lobes and ventricles",20,C411 (22%); C261 (21%); C7650 (21%); C763 (21%); C7652 (21%)
C711,Malignant neoplasm of frontal lobe,20,C312 (67%); Q010 (49%); C411 (27%); C261 (26%); C7650 (26%)
C712,Malignant neoplasm of temporal lobe,20,C411 (26%); C261 (25%); C7650 (25%); C763 (25%); C7652 (25%)
C713,Malignant neoplasm of parietal lobe,20,C411 (26%); C261 (25%); C7650 (25%); C763 (25%); C7652 (25%)
C714,Malignant neoplasm of occipital lobe,20,Q012 (38%); S02113B (34%); S02113A (34%); S02110B (33%); S02110A (32%)
C715,Malignant neoplasm of cerebral ventricle,20,C7932 (38%); I6349 (32%); I6339 (32%); G936 (32%); I6340 (31%)
C716,Malignant neoplasm of cerebellum,20,I614 (49%); S06370A (41%); C411 (38%); S06379A (37%); C261 (37%)
C717,Malignant neoplasm of brain stem,20,I613 (64%); C7931 (58%); T865 (46%); D332 (44%); D496 (43%)
C718,Malignant neoplasm of overlapping sites of brain,20,C188 (67%); C678 (64%); C028 (64%); C118 (63%); C058 (63%)
C719,"Malignant neoplasm of brain, unspecified",20,C7931 (80%); D332 (67%); D496 (65%); D432 (53%); G935 (49%)
C720,Malignant neoplasm of spinal cord,20,D334 (67%); G959 (61%); D434 (53%); G9589 (52%); C6310 (51%)
C721,Malignant neoplasm of cauda equina,20,G834 (85%); S343XXA (80%); Q063 (69%); C411 (26%); C261 (26%)
C7220,Malignant neoplasm of unspecified olfactory nerve,20,C6990 (31%); C7650 (30%); C7640 (29%); C189 (28%); C801 (28%)
C7221,Malignant neoplasm of right olfactory nerve,20,C7651 (32%); C7641 (31%); C6991 (30%); C7801 (28%); C561 (28%)
C7222,Malignant neoplasm of left olfactory nerve,20,C7652 (32%); C7642 (31%); C6992 (30%); C7802 (28%); C562 (28%)
C7230,Malignant neoplasm of unspecified optic nerve,20,Q044 (34%); C6990 (31%); C7650 (31%); C7640 (29%); C189 (29%)
C7231,Malignant neoplasm of right optic nerve,20,Q044 (34%); C7651 (33%); C7641 (31%); C6991 (31%); C7801 (29%)
C7232,Malignant neoplasm of left optic nerve,20,Q044 (34%); C7652 (33%); C7642 (31%); C6992 (31%); C7802 (29%)
C7240,Malignant neoplasm of unspecified acoustic nerve,20,C6990 (31%); C7650 (30%); C7640 (29%); C189 (28%); C801 (28%)
C7241,Malignant neoplasm of right acoustic nerve,20,C7651 (32%); C7641 (31%); C6991 (30%); C7801 (28%); C561 (28%)
C7242,Malignant neoplasm of left acoustic nerve,20,C7652 (32%); C7642 (31%); C6992 (30%); C7802 (28%); C562 (28%)
C7250,Malignant neoplasm of unspecified cranial nerve,20,D333 (50%); D433 (43%); C6990 (31%); C7650 (31%); C7640 (29%)
C7259,Malignant neoplasm of other cranial nerves,20,D333 (83%); D433 (72%); C475 (50%); C476 (47%); C473 (46%)
C729,"Malignant neoplasm of central nervous system, unspecified",20,D339 (78%); C7940 (71%); D439 (66%); D337 (62%); G379 (61%)
C73,Malignant neoplasm of thyroid gland,23,C751 (50%); C7492 (49%); C7491 (49%); C753 (48%); C7490 (48%)
C7400,Malignant neoplasm of cortex of unspecified adrenal gland,22,C7970 (72%); C7972 (69%); C7971 (69%); C759 (44%); C751 (42%)
C7401,Malignant neoplasm of cortex of right adrenal gland,22,C7971 (73%); C7970 (69%); C7972 (68%); C751 (42%); C759 (41%)
C7402,Malignant neoplasm of cortex of left adrenal gland,22,C7972 (73%); C7970 (69%); C7971 (68%); C751 (42%); C759 (41%)
C7410,Malignant neoplasm of medulla of unspecified adrenal gland,22,C7970 (72%); C7972 (69%); C7971 (69%); C759 (44%); C751 (42%)
C7411,Malignant neoplasm of medulla of right adrenal gland,22,C7971 (73%); C7970 (69%); C7972 (68%); C751 (42%); C759 (41%)
C7412,Malignant neoplasm of medulla of left adrenal gland,22,C7972 (73%); C7970 (69%); C7971 (68%); C751 (42%); C759 (41%)
C7490,Malignant neoplasm of unspecified part of unspecified adrenal gland,22,C7970 (89%); C7972 (81%); C7971 (81%); C759 (56%); C751 (50%)
C7491,Malignant neoplasm of unspecified part of right adrenal gland,22,C7971 (89%); C7970 (87%); C7972 (83%); C759 (54%); C751 (51%)
C7492,Malignant neoplasm of unspecified part of left adrenal gland,22,C7972 (89%); C7970 (87%); C7971 (83%); C759 (54%); C751 (51%)
C750,Malignant neoplasm of parathyroid gland,23,C751 (48%); C7492 (48%); C7491 (48%); C753 (47%); C7490 (47%)
C751,Malignant neoplasm of pituitary gland,20,D352 (82%); D443 (70%); C7492 (51%); C7491 (51%); C759 (51%)
C752,Malignant neoplasm of craniopharyngeal duct,20,D353 (84%); D444 (73%); C6950 (46%); C6952 (46%); C6951 (46%)
C753,Malignant neoplasm of pineal gland,20,D354 (83%); D445 (71%); C7492 (50%); C7491 (50%); C759 (50%)
C754,Malignant neoplasm of carotid body,23,C162 (52%); C251 (52%); C380 (37%); C411 (35%); I63139 (34%)
C755,Malignant neoplasm of aortic body and other paraganglia,23,C162 (37%); C251 (37%); I71011 (29%); I718 (28%); I7110 (28%)
C758,"Malignant neoplasm with pluriglandular involvement, unspecified",23,C719 (32%); C189 (30%); C380 (30%); C799 (29%); C411 (28%)
C759,"Malignant neoplasm of endocrine gland, unspecified",23,C254 (62%); C7490 (56%); C7492 (54%); C7491 (54%); C751 (51%)
C760,"Malignant neoplasm of head, face and neck",23,C770 (79%); C470 (76%); C490 (67%); C8511 (65%); C8171 (64%)
C761,Malignant neoplasm of thorax,23,C473 (72%); C493 (63%); C380 (36%); C411 (34%); C720 (33%)
C762,Malignant neoplasm of abdomen,23,C380 (36%); C411 (34%); C720 (33%); C261 (33%); C719 (33%)
C763,Malignant neoplasm of pelvis,23,C659 (75%); C652 (74%); C651 (74%); C475 (66%); C649 (64%)
C7640,Malignant neoplasm of unspecified upper limb,23,C773 (64%); C4010 (64%); C4012 (59%); C4011 (59%); C4710 (57%)
C7641,Malignant neoplasm of right upper limb,23,C4011 (65%); C773 (58%); C4010 (58%); C4711 (58%); C4012 (58%)
C7642,Malignant neoplasm of left upper limb,23,C4012 (65%); C773 (58%); C4010 (58%); C4712 (58%); C4011 (58%)
C7650,Malignant neoplasm of unspecified lower limb,23,C4020 (62%); C774 (62%); C4030 (62%); C4022 (57%); C4021 (57%)
C7651,Malignant neoplasm of right lower limb,23,C4021 (63%); C4031 (63%); C4721 (56%); C4020 (56%); C774 (56%)
C7652,Malignant neoplasm of left lower limb,23,C4022 (63%); C4032 (63%); C4722 (56%); C4020 (56%); C774 (56%)
C768,Malignant neoplasm of other specified ill-defined sites,23,C269 (82%); C7989 (46%); C718 (30%); C188 (29%); C168 (27%)
C770,"Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck",18,C760 (79%); C8511 (75%); C8191 (73%); C8291 (73%); C8171 (71%)
C771,Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes,17,C775 (71%); C8512 (64%); C774 (63%); C772 (63%); C773 (62%)
C772,Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes,18,C8513 (72%); C8193 (70%); C8293 (70%); C8173 (68%); C8593 (66%)
C773,Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes,20,C8514 (73%); C8194 (71%); C8294 (71%); C8174 (69%); C8594 (67%)
C774,Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes,18,C773 (67%); C8515 (66%); C8195 (64%); C8295 (64%); C771 (63%)
C775,Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes,18,C771 (71%); C8516 (64%); C773 (62%); C8196 (62%); C8296 (62%)
C778,Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions,17,C775 (57%); C774 (51%); C772 (50%); C773 (50%); C770 (48%)
C779,"Secondary and unspecified malignant neoplasm of lymph node, unspecified",18,C771 (54%); C7800 (52%); C7940 (48%); C773 (47%); C7931 (44%)
C7800,Secondary malignant neoplasm of unspecified lung,17,C799 (69%); C3490 (63%); C7951 (62%); C7981 (61%); C792 (61%)
C7801,Secondary malignant neoplasm of right lung,17,C799 (62%); C3491 (62%); C7951 (61%); C7981 (60%); C792 (60%)
C7802,Secondary malignant neoplasm of left lung,17,C799 (62%); C3492 (62%); C7951 (61%); C7981 (60%); C792 (60%)
C781,Secondary malignant neoplasm of mediastinum,17,C383 (85%); C381 (75%); C382 (75%); C799 (55%); J853 (54%)
C782,Secondary malignant neoplasm of pleura,17,C384 (88%); C388 (54%); C799 (54%); C450 (53%); C7951 (53%)
C7830,Secondary malignant neoplasm of unspecified respiratory organ,17,C799 (57%); C7951 (52%); C399 (51%); C7981 (51%); C792 (51%)
C7839,Secondary malignant neoplasm of other respiratory organs,17,C7982 (66%); C7919 (65%); C7910 (64%); C799 (52%); C7951 (51%)
C784,Secondary malignant neoplasm of small intestine,17,C179 (86%); C178 (71%); C7A019 (54%); C799 (52%); K5000 (51%)
C785,Secondary malignant neoplasm of large intestine and rectum,17,C20 (68%); C179 (45%); C7A026 (44%); C799 (44%); C7951 (43%)
C786,Secondary malignant neoplasm of retroperitoneum and peritoneum,17,C488 (79%); C480 (72%); C482 (66%); C481 (52%); C799 (43%)
C787,Secondary malignant neoplasm of liver and intrahepatic bile duct,17,C221 (73%); C240 (55%); K831 (54%); C229 (45%); C752 (38%)
C7880,Secondary malignant neoplasm of unspecified digestive organ,17,C799 (51%); C7951 (46%); C7981 (46%); C269 (46%); C792 (45%)
C7889,Secondary malignant neoplasm of other digestive organs,17,C7982 (59%); C7919 (59%); C7910 (58%); C799 (47%); C7951 (45%)
C7900,Secondary malignant neoplasm of unspecified kidney and renal pelvis,17,C649 (92%); C642 (89%); C641 (89%); C659 (79%); C652 (75%)
C7901,Secondary malignant neoplasm of right kidney and renal pelvis,17,C641 (92%); C649 (89%); C642 (88%); C651 (80%); C659 (76%)
C7902,Secondary malignant neoplasm of left kidney and renal pelvis,17,C642 (92%); C649 (89%); C641 (88%); C652 (80%); C659 (76%)
C7910,Secondary malignant neoplasm of unspecified urinary organs,18,C688 (74%); C689 (66%); C7839 (64%); C7889 (58%); C7800 (49%)
C7911,Secondary malignant neoplasm of bladder,18,C679 (84%); C675 (74%); C671 (68%); C678 (66%); C673 (65%)
C7919,Secondary malignant neoplasm of other urinary organs,18,C688 (75%); C7839 (65%); C689 (63%); C7889 (59%); C7800 (46%)
C792,Secondary malignant neoplasm of skin,18,C7800 (61%); C7931 (60%); C7802 (60%); C7801 (60%); C7940 (56%)
C7931,Secondary malignant neoplasm of brain,17,C719 (80%); C799 (63%); C7951 (61%); C7981 (61%); C792 (60%)
C7932,Secondary malignant neoplasm of cerebral meninges,17,C700 (89%); C709 (76%); C701 (70%); D320 (69%); D420 (58%)
C7940,Secondary malignant neoplasm of unspecified part of nervous system,17,C729 (71%); C799 (63%); C7951 (57%); C7981 (56%); C792 (56%)
C7949,Secondary malignant neoplasm of other parts of nervous system,17,D337 (62%); C729 (56%); D438 (54%); C257 (53%); C799 (49%)
C7951,Secondary malignant neoplasm of bone,18,M8730 (68%); C7800 (62%); C7931 (61%); C7802 (61%); C7801 (61%)
C7952,Secondary malignant neoplasm of bone marrow,18,Z9481 (60%); T8609 (59%); T8602 (59%); T8603 (59%); T8600 (58%)
C7960,Secondary malignant neoplasm of unspecified ovary,18,C569 (88%); C562 (82%); C561 (82%); C7800 (56%); C7940 (52%)
C7961,Secondary malignant neoplasm of right ovary,18,C561 (88%); C569 (82%); C562 (80%); C7801 (58%); C7800 (51%)
C7962,Secondary malignant neoplasm of left ovary,18,C562 (88%); C569 (82%); C561 (80%); C7802 (58%); C7800 (51%)
C7963,Secondary malignant neoplasm of bilateral ovaries,18,C563 (90%); C7800 (46%); C7931 (46%); C7802 (45%); C7801 (45%)
C7970,Secondary malignant neoplasm of unspecified adrenal gland,17,C7490 (89%); C7492 (87%); C7491 (87%); C7400 (72%); C7410 (72%)
C7971,Secondary malignant neoplasm of right adrenal gland,17,C7491 (89%); C7492 (83%); C7490 (81%); C7401 (73%); C7411 (73%)
C7972,Secondary malignant neoplasm of left adrenal gland,17,C7492 (89%); C7491 (83%); C7490 (81%); C7402 (73%); C7412 (73%)
C7981,Secondary malignant neoplasm of breast,18,C7800 (61%); C7931 (61%); C7802 (60%); C7801 (60%); C7940 (56%)
C7982,Secondary malignant neoplasm of genital organs,18,C577 (75%); C637 (75%); C578 (68%); C638 (68%); C7839 (66%)
C7989,Secondary malignant neoplasm of other specified sites,18,C7800 (59%); C7931 (59%); C7802 (58%); C7801 (58%); C229 (58%)
C799,Secondary malignant neoplasm of unspecified site,18,C6990 (70%); C7800 (69%); C6992 (67%); C6991 (67%); M8738 (64%)
C7A00,Malignant carcinoid tumor of unspecified site,21,D3A00 (79%); D3A093 (54%); D3A092 (51%); D3A094 (51%); D3A095 (51%)
C7A010,Malignant carcinoid tumor of the duodenum,21,D3A010 (84%); C170 (67%); D3A00 (49%); D3A093 (46%); D3A092 (44%)
C7A011,Malignant carcinoid tumor of the jejunum,21,D3A011 (84%); C171 (67%); D3A00 (49%); D3A093 (46%); D3A092 (44%)
C7A012,Malignant carcinoid tumor of the ileum,21,D3A012 (84%); C172 (67%); D3A00 (49%); D3A093 (46%); D3A092 (44%)
C7A019,"Malignant carcinoid tumor of the small intestine, unspecified portion",21,D3A019 (88%); D3A029 (71%); C179 (62%); C784 (54%); C49A3 (51%)
C7A020,Malignant carcinoid tumor of the appendix,21,D3A020 (84%); C181 (68%); D3A00 (48%); D3A093 (46%); D3A092 (44%)
C7A021,Malignant carcinoid tumor of the cecum,21,D3A021 (84%); C180 (68%); D3A00 (48%); D3A093 (46%); D3A092 (44%)
C7A022,Malignant carcinoid tumor of the ascending colon,21,D3A022 (87%); C182 (75%); D3A023 (60%); D3A024 (56%); D3A025 (55%)
C7A023,Malignant carcinoid tumor of the transverse colon,21,D3A023 (85%); C184 (70%); D3A024 (61%); D3A022 (60%); D3A025 (60%)
C7A024,Malignant carcinoid tumor of the descending colon,21,D3A024 (87%); C186 (75%); D3A023 (60%); D3A022 (56%); D3A025 (55%)
C7A025,Malignant carcinoid tumor of the sigmoid colon,21,D3A025 (87%); C187 (76%); D3A023 (59%); D3A024 (55%); D3A022 (55%)
C7A026,Malignant carcinoid tumor of the rectum,21,D3A026 (83%); C20 (64%); C49A5 (54%); D3A00 (50%); D3A093 (48%)
C7A029,"Malignant carcinoid tumor of the large intestine, unspecified portion",21,D3A029 (87%); D3A019 (71%); C49A4 (50%); D3A00 (45%); C785 (43%)
C7A090,Malignant carcinoid tumor of the bronchus and lung,21,D3A090 (85%); C3492 (65%); C3491 (65%); C3490 (64%); C3480 (55%)
C7A091,Malignant carcinoid tumor of the thymus,21,D3A091 (84%); D3A00 (48%); D3A093 (46%); D3A092 (44%); D3A026 (43%)
C7A092,Malignant carcinoid tumor of the stomach,21,D3A092 (83%); C169 (62%); C162 (56%); C49A2 (54%); D3A00 (50%)
C7A093,Malignant carcinoid tumor of the kidney,21,D3A093 (81%); D3A00 (53%); D3A092 (48%); D3A026 (48%); D3A010 (47%)
C7A094,"Malignant carcinoid tumor of the foregut, unspecified",21,D3A094 (85%); D3A00 (50%); D3A093 (44%); D3A092 (42%); D3A095 (42%)
C7A095,"Malignant carcinoid tumor of the midgut, unspecified",21,D3A095 (85%); D3A00 (50%); D3A093 (44%); D3A092 (42%); D3A094 (42%)
C7A096,"Malignant carcinoid tumor of the hindgut, unspecified",21,D3A096 (85%); D3A00 (50%); D3A093 (44%); D3A092 (42%); D3A094 (42%)
C7A098,Malignant carcinoid tumors of other sites,21,C7B09 (84%); D3A098 (81%); C7B00 (66%); C7B03 (65%); C7B02 (62%)
C7A1,Malignant poorly differentiated neuroendocrine tumors,21,C7B8 (57%); D3A8 (55%); C7B09 (26%); C7B00 (25%); C7B03 (25%)
C7A8,Other malignant neuroendocrine tumors,21,C7B8 (85%); D3A8 (82%); C7B09 (39%); C7B00 (38%); C7B03 (37%)
C7B00,"Secondary carcinoid tumors, unspecified site",17,C7A098 (66%); D3A098 (60%); C799 (50%); C7A00 (49%); M8738 (48%)
C7B01,Secondary carcinoid tumors of distant lymph nodes,17,C7A098 (51%); D3A098 (46%); C775 (36%); C774 (32%); C772 (32%)
C7B02,Secondary carcinoid tumors of liver,17,C7A098 (62%); D3A098 (57%); C229 (44%); K717 (38%); C7A8 (36%)
C7B03,Secondary carcinoid tumors of bone,17,C7A098 (65%); D3A098 (59%); C7951 (52%); M8730 (51%); C7952 (40%)
C7B04,Secondary carcinoid tumors of peritoneum,17,C7A098 (59%); D3A098 (54%); C482 (47%); C451 (40%); C481 (36%)
C7B09,Secondary carcinoid tumors of other sites,17,C7A098 (84%); D3A098 (76%); C7989 (43%); M8739 (41%); C7A8 (39%)
C7B1,Secondary Merkel cell carcinoma,17,C4A9 (87%); C4A30 (75%); C4A8 (71%); C4A59 (70%); C4A0 (69%)
C7B8,Other secondary neuroendocrine tumors,17,C7A8 (85%); D3A8 (78%); C7A1 (57%); C7A098 (39%); D3A098 (35%)
C800,"Disseminated malignant neoplasm, unspecified",18,B447 (55%); B457 (55%); B464 (55%); G369 (52%); B007 (48%)
C801,"Malignant (primary) neoplasm, unspecified",23,C228 (76%); C229 (65%); D6949 (47%); E7253 (45%); G1223 (45%)
C802,Malignant neoplasm associated with transplanted organ,23,C689 (39%); C7830 (38%); C7880 (34%); C579 (34%); I25750 (30%)
C8100,"Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site",21,C8370 (31%); C84A0 (30%); C8310 (28%); C8440 (27%); C8350 (26%)
C8101,"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck",21,C8371 (59%); C84A1 (57%); C8311 (56%); C8441 (55%); C8351 (54%)
C8102,"Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes",21,C8372 (47%); C84A2 (45%); C8312 (44%); C8442 (43%); C8352 (43%)
C8103,"Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes",21,C8373 (55%); C84A3 (53%); C8313 (52%); C8443 (51%); C8353 (51%)
C8104,"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb",21,C8374 (56%); C84A4 (54%); C8314 (53%); C8444 (52%); C8354 (52%)
C8105,"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb",21,C8375 (60%); C84A5 (58%); C8315 (57%); C8445 (56%); C8355 (55%)
C8106,"Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes",21,C8376 (47%); C84A6 (45%); C8316 (44%); C8446 (43%); C8356 (43%)
C8107,"Nodular lymphocyte predominant Hodgkin lymphoma, spleen",21,C8377 (35%); C84A7 (33%); C8317 (32%); C261 (32%); C8447 (31%)
C8108,"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites",21,C8378 (50%); C84A8 (48%); C8318 (47%); C8448 (46%); C8358 (45%)
C8109,"Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites",21,C8379 (58%); C84A9 (56%); C8319 (55%); C8449 (54%); C8359 (54%)
C8110,"Nodular sclerosis Hodgkin lymphoma, unspecified site",21,M349 (41%); G35 (40%); M3489 (38%); C8370 (35%); C84A0 (34%)
C8111,"Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck",21,C8371 (64%); C84A1 (62%); C8311 (61%); C8441 (60%); C8351 (59%)
C8112,"Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes",21,C8372 (53%); C84A2 (50%); C8312 (49%); C8442 (48%); C8352 (47%)
C8113,"Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes",21,C8373 (61%); C84A3 (58%); C8313 (57%); C8443 (56%); C8353 (56%)
C8114,"Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb",21,C8374 (62%); C84A4 (59%); C8314 (58%); C8444 (57%); C8354 (57%)
C8115,"Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb",21,C8375 (65%); C84A5 (63%); C8315 (62%); C8445 (61%); C8355 (60%)
C8116,"Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes",21,C8376 (53%); C84A6 (50%); C8316 (49%); C8446 (48%); C8356 (47%)
C8117,"Nodular sclerosis Hodgkin lymphoma, spleen",21,C8377 (40%); G35 (39%); C84A7 (37%); M3489 (37%); C8317 (37%)
C8118,"Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites",21,G35 (56%); C8378 (56%); C84A8 (53%); C8318 (52%); C8448 (51%)
C8119,"Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites",21,C8379 (63%); C84A9 (61%); C8319 (60%); C8449 (59%); C8359 (58%)
C8120,"Mixed cellularity Hodgkin lymphoma, unspecified site",21,C8370 (34%); C84A0 (33%); C8310 (31%); C8440 (30%); C8350 (29%)
C8121,"Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck",21,C8371 (63%); C84A1 (60%); C8311 (59%); C8441 (58%); C8351 (58%)
C8122,"Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes",21,C8372 (51%); C84A2 (49%); C8312 (48%); C8442 (47%); C8352 (46%)
C8123,"Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes",21,C8373 (59%); C84A3 (57%); C8313 (56%); C8443 (55%); C8353 (54%)
C8124,"Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb",21,C8374 (60%); C84A4 (58%); C8314 (57%); C8444 (56%); C8354 (55%)
C8125,"Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb",21,C8375 (64%); C84A5 (61%); C8315 (61%); C8445 (60%); C8355 (59%)
C8126,"Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes",21,C8376 (51%); C84A6 (49%); C8316 (48%); C8446 (47%); C8356 (46%)
C8127,"Mixed cellularity Hodgkin lymphoma, spleen",21,C8377 (39%); C84A7 (36%); C8317 (35%); C261 (35%); C8447 (34%)
C8128,"Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites",21,C8378 (54%); C84A8 (52%); C8318 (51%); C8448 (50%); C8358 (49%)
C8129,"Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites",21,C8379 (62%); C84A9 (60%); C8319 (59%); C8449 (58%); C8359 (57%)
C8130,"Lymphocyte depleted Hodgkin lymphoma, unspecified site",21,C8370 (34%); C84A0 (34%); C8310 (31%); C8440 (30%); C8350 (29%)
C8131,"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck",21,C8371 (63%); C84A1 (61%); C8311 (60%); C8441 (59%); C8351 (58%)
C8132,"Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes",21,C8372 (52%); C84A2 (49%); C8312 (48%); C8442 (47%); C8352 (47%)
C8133,"Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes",21,C8373 (60%); C84A3 (57%); C8313 (57%); C8443 (56%); C8353 (55%)
C8134,"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb",21,C8374 (61%); C84A4 (58%); C8314 (58%); C8444 (56%); C8354 (56%)
C8135,"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb",21,C8375 (64%); C84A5 (62%); C8315 (61%); C8445 (60%); C8355 (60%)
C8136,"Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes",21,C8376 (52%); C84A6 (49%); C8316 (48%); C8446 (47%); C8356 (47%)
C8137,"Lymphocyte depleted Hodgkin lymphoma, spleen",21,C8377 (40%); C84A7 (37%); C8317 (36%); C261 (35%); C8447 (35%)
C8138,"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites",21,C8378 (55%); C84A8 (52%); C8318 (51%); C8448 (50%); C8358 (50%)
C8139,"Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites",21,C8379 (63%); C84A9 (60%); C8319 (59%); C8449 (58%); C8359 (58%)
C8140,"Lymphocyte-rich Hodgkin lymphoma, unspecified site",21,C8370 (34%); C84A0 (34%); C8310 (31%); C8440 (30%); C8350 (29%)
C8141,"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck",21,C8371 (63%); C84A1 (61%); C8311 (60%); C8441 (59%); C8351 (58%)
C8142,"Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes",21,C8372 (52%); C84A2 (49%); C8312 (48%); C8442 (47%); C8352 (47%)
C8143,"Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes",21,C8373 (60%); C84A3 (57%); C8313 (57%); C8443 (56%); C8353 (55%)
C8144,"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb",21,C8374 (61%); C84A4 (58%); C8314 (58%); C8444 (56%); C8354 (56%)
C8145,"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb",21,C8375 (64%); C84A5 (62%); C8315 (61%); C8445 (60%); C8355 (60%)
C8146,"Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes",21,C8376 (52%); C84A6 (49%); C8316 (48%); C8446 (47%); C8356 (47%)
C8147,"Lymphocyte-rich Hodgkin lymphoma, spleen",21,C8377 (40%); C84A7 (37%); C8317 (36%); C261 (35%); C8447 (35%)
C8148,"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites",21,C8378 (55%); C84A8 (52%); C8318 (51%); C8448 (50%); C8358 (50%)
C8149,"Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites",21,C8379 (63%); C84A9 (60%); C8319 (59%); C8449 (58%); C8359 (58%)
C8170,"Other Hodgkin lymphoma, unspecified site",21,C8370 (53%); C84A0 (52%); C8310 (47%); C8440 (46%); C8350 (45%)
C8171,"Other Hodgkin lymphoma, lymph nodes of head, face, and neck",21,C8371 (79%); C84A1 (76%); C8311 (74%); C8441 (73%); C8351 (73%)
C8172,"Other Hodgkin lymphoma, intrathoracic lymph nodes",21,C8372 (70%); C84A2 (66%); C8312 (65%); C8442 (63%); C8352 (63%)
C8173,"Other Hodgkin lymphoma, intra-abdominal lymph nodes",21,C8373 (76%); C84A3 (73%); C8313 (72%); C8443 (70%); C8353 (70%)
C8174,"Other Hodgkin lymphoma, lymph nodes of axilla and upper limb",21,C8374 (77%); C84A4 (74%); C8314 (73%); C8444 (71%); C8354 (70%)
C8175,"Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb",21,C8375 (79%); C84A5 (76%); C8315 (75%); C8445 (74%); C8355 (73%)
C8176,"Other Hodgkin lymphoma, intrapelvic lymph nodes",21,C8376 (70%); C84A6 (66%); C8316 (65%); C8446 (63%); C8356 (63%)
C8177,"Other Hodgkin lymphoma, spleen",21,C8377 (58%); C84A7 (54%); C8317 (53%); C261 (52%); C8447 (51%)
C8178,"Other Hodgkin lymphoma, lymph nodes of multiple sites",21,C8378 (72%); C84A8 (69%); C8318 (67%); C8448 (66%); C8358 (65%)
C8179,"Other Hodgkin lymphoma, extranodal and solid organ sites",21,C8379 (78%); C84A9 (75%); C8319 (74%); C8449 (73%); C8359 (72%)
C8190,"Hodgkin lymphoma, unspecified, unspecified site",21,C84A0 (56%); C8370 (53%); M0890 (49%); C8310 (48%); C6990 (48%)
C8191,"Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck",21,C8371 (78%); C84A1 (77%); C8311 (74%); C770 (73%); C8441 (72%)
C8192,"Hodgkin lymphoma, unspecified, intrathoracic lymph nodes",21,C8372 (68%); C84A2 (68%); C8312 (64%); C8442 (62%); C771 (62%)
C8193,"Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes",21,C8373 (75%); C84A3 (74%); C8313 (71%); C772 (70%); C8443 (69%)
C8194,"Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb",21,C8374 (76%); C84A4 (75%); C8314 (72%); C773 (71%); C8444 (70%)
C8195,"Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb",21,C8375 (78%); C84A5 (78%); C8315 (74%); C8445 (73%); C8355 (72%)
C8196,"Hodgkin lymphoma, unspecified, intrapelvic lymph nodes",21,C8376 (68%); C84A6 (68%); C8316 (64%); C8446 (62%); C775 (62%)
C8197,"Hodgkin lymphoma, unspecified, spleen",21,C84A7 (57%); C8377 (57%); C8317 (51%); C261 (50%); C8447 (50%)
C8198,"Hodgkin lymphoma, unspecified, lymph nodes of multiple sites",21,C8378 (71%); C84A8 (70%); C8318 (66%); C8448 (65%); C8358 (64%)
C8199,"Hodgkin lymphoma, unspecified, extranodal and solid organ sites",21,C8379 (77%); C84A9 (77%); C8319 (73%); C8449 (72%); C8359 (71%)
C8200,"Follicular lymphoma grade I, unspecified site",21,C8370 (43%); C84A0 (43%); C8310 (39%); C8440 (38%); C8350 (37%)
C8201,"Follicular lymphoma grade I, lymph nodes of head, face, and neck",21,C8371 (72%); C84A1 (69%); C8311 (68%); C8441 (67%); C8351 (66%)
C8202,"Follicular lymphoma grade I, intrathoracic lymph nodes",21,C8372 (62%); C84A2 (58%); C8312 (57%); C8442 (56%); C8352 (55%)
C8203,"Follicular lymphoma grade I, intra-abdominal lymph nodes",21,C8373 (69%); C84A3 (66%); C8313 (65%); C8443 (64%); C8353 (63%)
C8204,"Follicular lymphoma grade I, lymph nodes of axilla and upper limb",21,C8374 (70%); C84A4 (67%); C8314 (66%); C8444 (65%); C8354 (64%)
C8205,"Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb",21,C8375 (73%); C84A5 (70%); C8315 (69%); C8445 (68%); C8355 (67%)
C8206,"Follicular lymphoma grade I, intrapelvic lymph nodes",21,C8376 (62%); C84A6 (58%); C8316 (57%); C8446 (56%); C8356 (55%)
C8207,"Follicular lymphoma grade I, spleen",21,C8377 (49%); C84A7 (46%); C8317 (44%); C261 (44%); C8447 (43%)
C8208,"Follicular lymphoma grade I, lymph nodes of multiple sites",21,C8378 (64%); C84A8 (61%); C8318 (60%); C8448 (59%); C8358 (58%)
C8209,"Follicular lymphoma grade I, extranodal and solid organ sites",21,C8379 (71%); C84A9 (69%); C8319 (68%); C8449 (67%); C8359 (66%)
C8210,"Follicular lymphoma grade II, unspecified site",21,C8370 (40%); C84A0 (39%); C8310 (36%); C8440 (34%); C8350 (34%)
C8211,"Follicular lymphoma grade II, lymph nodes of head, face, and neck",21,C8371 (69%); C84A1 (66%); C8311 (65%); C8441 (64%); C8351 (63%)
C8212,"Follicular lymphoma grade II, intrathoracic lymph nodes",21,C8372 (58%); C84A2 (55%); C8312 (54%); C8442 (52%); C8352 (52%)
C8213,"Follicular lymphoma grade II, intra-abdominal lymph nodes",21,C8373 (65%); C84A3 (63%); C8313 (62%); C8443 (61%); C8353 (60%)
C8214,"Follicular lymphoma grade II, lymph nodes of axilla and upper limb",21,C8374 (66%); C84A4 (64%); C8314 (63%); C8444 (62%); C8354 (61%)
C8215,"Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb",21,C8375 (70%); C84A5 (67%); C8315 (66%); C8445 (65%); C8355 (64%)
C8216,"Follicular lymphoma grade II, intrapelvic lymph nodes",21,C8376 (58%); C84A6 (55%); C8316 (54%); C8446 (52%); C8356 (52%)
C8217,"Follicular lymphoma grade II, spleen",21,C8377 (45%); C84A7 (42%); C8317 (41%); C261 (40%); C8447 (40%)
C8218,"Follicular lymphoma grade II, lymph nodes of multiple sites",21,C8378 (60%); C84A8 (58%); C8318 (56%); C8448 (55%); C8358 (55%)
C8219,"Follicular lymphoma grade II, extranodal and solid organ sites",21,C8379 (68%); C84A9 (65%); C8319 (64%); C8449 (63%); C8359 (63%)
C8220,"Follicular lymphoma grade III, unspecified, unspecified site",21,C84A0 (42%); C8370 (39%); M0890 (36%); C8310 (35%); C6990 (35%)
C8221,"Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck",21,C8371 (66%); C84A1 (65%); C8311 (62%); C770 (62%); C8441 (61%)
C8222,"Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes",21,C8372 (55%); C84A2 (54%); C8312 (51%); C8442 (50%); C771 (49%)
C8223,"Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes",21,C8373 (63%); C84A3 (62%); C8313 (59%); C772 (58%); C8443 (58%)
C8224,"Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb",21,C8374 (63%); C84A4 (63%); C8314 (60%); C773 (59%); C8444 (59%)
C8225,"Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb",21,C8375 (67%); C84A5 (66%); C8315 (63%); C8445 (62%); C8355 (62%)
C8226,"Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes",21,C8376 (55%); C84A6 (54%); C8316 (51%); C8446 (50%); C775 (49%)
C8227,"Follicular lymphoma grade III, unspecified, spleen",21,C84A7 (42%); C8377 (42%); C8317 (38%); C261 (37%); C8447 (37%)
C8228,"Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites",21,C8378 (57%); C84A8 (57%); C8318 (54%); C8448 (53%); C8358 (52%)
C8229,"Follicular lymphoma grade III, unspecified, extranodal and solid organ sites",21,C8379 (65%); C84A9 (65%); C8319 (62%); C8449 (61%); C8359 (60%)
C8230,"Follicular lymphoma grade IIIa, unspecified site",21,C8370 (39%); C84A0 (39%); C8310 (35%); C8440 (34%); C8350 (34%)
C8231,"Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck",21,C8371 (68%); C84A1 (66%); C8311 (65%); C8441 (64%); C8351 (63%)
C8232,"Follicular lymphoma grade IIIa, intrathoracic lymph nodes",21,C8372 (58%); C84A2 (55%); C8312 (53%); C8442 (52%); C8352 (52%)
C8233,"Follicular lymphoma grade IIIa, intra-abdominal lymph nodes",21,C8373 (65%); C84A3 (63%); C8313 (61%); C8443 (60%); C8353 (60%)
C8234,"Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb",21,C8374 (66%); C84A4 (63%); C8314 (62%); C8444 (61%); C8354 (61%)
C8235,"Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb",21,C8375 (69%); C84A5 (67%); C8315 (66%); C8445 (65%); C8355 (64%)
C8236,"Follicular lymphoma grade IIIa, intrapelvic lymph nodes",21,C8376 (58%); C84A6 (55%); C8316 (53%); C8446 (52%); C8356 (52%)
C8237,"Follicular lymphoma grade IIIa, spleen",21,C8377 (45%); C84A7 (42%); C8317 (41%); C261 (40%); C8447 (39%)
C8238,"Follicular lymphoma grade IIIa, lymph nodes of multiple sites",21,C8378 (60%); C84A8 (57%); C8318 (56%); C8448 (55%); C8358 (54%)
C8239,"Follicular lymphoma grade IIIa, extranodal and solid organ sites",21,C8379 (68%); C84A9 (65%); C8319 (64%); C8449 (63%); C8359 (62%)
C8240,"Follicular lymphoma grade IIIb, unspecified site",21,C8370 (39%); C84A0 (39%); C8310 (35%); C8440 (34%); C8350 (34%)
C8241,"Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck",21,C8371 (68%); C84A1 (66%); C8311 (65%); C8441 (64%); C8351 (63%)
C8242,"Follicular lymphoma grade IIIb, intrathoracic lymph nodes",21,C8372 (58%); C84A2 (55%); C8312 (53%); C8442 (52%); C8352 (52%)
C8243,"Follicular lymphoma grade IIIb, intra-abdominal lymph nodes",21,C8373 (65%); C84A3 (63%); C8313 (61%); C8443 (60%); C8353 (60%)
C8244,"Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb",21,C8374 (66%); C84A4 (63%); C8314 (62%); C8444 (61%); C8354 (61%)
C8245,"Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb",21,C8375 (69%); C84A5 (67%); C8315 (66%); C8445 (65%); C8355 (64%)
C8246,"Follicular lymphoma grade IIIb, intrapelvic lymph nodes",21,C8376 (58%); C84A6 (55%); C8316 (53%); C8446 (52%); C8356 (52%)
C8247,"Follicular lymphoma grade IIIb, spleen",21,C8377 (45%); C84A7 (42%); C8317 (41%); C261 (40%); C8447 (39%)
C8248,"Follicular lymphoma grade IIIb, lymph nodes of multiple sites",21,C8378 (60%); C84A8 (57%); C8318 (56%); C8448 (55%); C8358 (54%)
C8249,"Follicular lymphoma grade IIIb, extranodal and solid organ sites",21,C8379 (68%); C84A9 (65%); C8319 (64%); C8449 (63%); C8359 (62%)
C8250,"Diffuse follicle center lymphoma, unspecified site",21,C8350 (53%); C8330 (53%); C8370 (34%); C84A0 (34%); C8357 (33%)
C8251,"Diffuse follicle center lymphoma, lymph nodes of head, face, and neck",21,C8351 (72%); C8331 (72%); C8371 (63%); C84A1 (61%); C8311 (60%)
C8252,"Diffuse follicle center lymphoma, intrathoracic lymph nodes",21,C8352 (64%); C8332 (64%); C8372 (52%); C84A2 (49%); C8312 (48%)
C8253,"Diffuse follicle center lymphoma, intra-abdominal lymph nodes",21,C8353 (69%); C8333 (69%); C8373 (60%); C84A3 (57%); C8313 (56%)
C8254,"Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb",21,C8354 (70%); C8334 (70%); C8374 (61%); C84A4 (58%); C8314 (57%)
C8255,"Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb",21,C8355 (73%); C8335 (73%); C8375 (64%); C84A5 (62%); C8315 (61%)
C8256,"Diffuse follicle center lymphoma, intrapelvic lymph nodes",21,C8356 (64%); C8336 (64%); C8376 (52%); C84A6 (49%); C8316 (48%)
C8257,"Diffuse follicle center lymphoma, spleen",21,C8357 (56%); C8337 (56%); C8377 (39%); C84A7 (37%); C8317 (36%)
C8258,"Diffuse follicle center lymphoma, lymph nodes of multiple sites",21,C8358 (66%); C8338 (66%); C8378 (55%); C84A8 (52%); C8318 (51%)
C8259,"Diffuse follicle center lymphoma, extranodal and solid organ sites",21,C8359 (71%); C8339 (71%); C8379 (62%); C84A9 (60%); C8319 (59%)
C8260,"Cutaneous follicle center lymphoma, unspecified site",21,C84A0 (62%); C84A7 (43%); C84A2 (38%); C84A6 (38%); C84A8 (37%)
C8261,"Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck",21,C84A1 (77%); C8371 (62%); C8311 (59%); C8441 (58%); C8351 (57%)
C8262,"Cutaneous follicle center lymphoma, intrathoracic lymph nodes",21,C84A2 (71%); C8372 (51%); C84A6 (51%); C84A8 (49%); C8312 (47%)
C8263,"Cutaneous follicle center lymphoma, intra-abdominal lymph nodes",21,C84A3 (75%); C8373 (59%); C8313 (55%); C8443 (54%); C8353 (54%)
C8264,"Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb",21,C84A4 (76%); C8374 (60%); C8314 (56%); C8444 (55%); C8354 (55%)
C8265,"Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb",21,C84A5 (78%); C8375 (63%); C8315 (60%); C8445 (59%); C8355 (58%)
C8266,"Cutaneous follicle center lymphoma, intrapelvic lymph nodes",21,C84A6 (71%); C8376 (51%); C84A2 (51%); C84A8 (49%); C8316 (47%)
C8267,"Cutaneous follicle center lymphoma, spleen",21,C84A7 (64%); C84A0 (39%); C8377 (38%); C8317 (35%); C261 (34%)
C8268,"Cutaneous follicle center lymphoma, lymph nodes of multiple sites",21,C84A8 (72%); C8378 (54%); C8318 (50%); C84A2 (49%); C84A6 (49%)
C8269,"Cutaneous follicle center lymphoma, extranodal and solid organ sites",21,C84A9 (77%); C8379 (61%); C8319 (58%); C8449 (57%); C8359 (57%)
C8280,"Other types of follicular lymphoma, unspecified site",21,C8370 (41%); C84A0 (40%); C8310 (37%); C8440 (36%); C8350 (35%)
C8281,"Other types of follicular lymphoma, lymph nodes of head, face, and neck",21,C8371 (70%); C84A1 (67%); C8311 (66%); C8441 (65%); C8351 (65%)
C8282,"Other types of follicular lymphoma, intrathoracic lymph nodes",21,C8372 (59%); C84A2 (56%); C8312 (55%); C8442 (54%); C8352 (53%)
C8283,"Other types of follicular lymphoma, intra-abdominal lymph nodes",21,C8373 (67%); C84A3 (64%); C8313 (63%); C8443 (62%); C8353 (61%)
C8284,"Other types of follicular lymphoma, lymph nodes of axilla and upper limb",21,C8374 (68%); C84A4 (65%); C8314 (64%); C8444 (63%); C8354 (62%)
C8285,"Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb",21,C8375 (71%); C84A5 (68%); C8315 (67%); C8445 (66%); C8355 (66%)
C8286,"Other types of follicular lymphoma, intrapelvic lymph nodes",21,C8376 (59%); C84A6 (56%); C8316 (55%); C8446 (54%); C8356 (53%)
C8287,"Other types of follicular lymphoma, spleen",21,C8377 (47%); C84A7 (43%); C8317 (42%); C261 (41%); C8447 (41%)
C8288,"Other types of follicular lymphoma, lymph nodes of multiple sites",21,C8378 (62%); C84A8 (59%); C8318 (58%); C8448 (57%); C8358 (56%)
C8289,"Other types of follicular lymphoma, extranodal and solid organ sites",21,C8379 (70%); C84A9 (67%); C8319 (66%); C8449 (65%); C8359 (64%)
C8290,"Follicular lymphoma, unspecified, unspecified site",21,C84A0 (56%); C8370 (53%); M0890 (49%); C8310 (48%); C6990 (48%)
C8291,"Follicular lymphoma, unspecified, lymph nodes of head, face, and neck",21,C8371 (78%); C84A1 (77%); C8311 (74%); C770 (73%); C8441 (72%)
C8292,"Follicular lymphoma, unspecified, intrathoracic lymph nodes",21,C8372 (68%); C84A2 (68%); C8312 (64%); C8442 (62%); C771 (62%)
C8293,"Follicular lymphoma, unspecified, intra-abdominal lymph nodes",21,C8373 (75%); C84A3 (74%); C8313 (71%); C772 (70%); C8443 (69%)
C8294,"Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb",21,C8374 (76%); C84A4 (75%); C8314 (72%); C773 (71%); C8444 (70%)
C8295,"Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb",21,C8375 (78%); C84A5 (78%); C8315 (74%); C8445 (73%); C8355 (72%)
C8296,"Follicular lymphoma, unspecified, intrapelvic lymph nodes",21,C8376 (68%); C84A6 (68%); C8316 (64%); C8446 (62%); C775 (62%)
C8297,"Follicular lymphoma, unspecified, spleen",21,C84A7 (57%); C8377 (57%); C8317 (51%); C261 (50%); C8447 (50%)
C8298,"Follicular lymphoma, unspecified, lymph nodes of multiple sites",21,C8378 (71%); C84A8 (70%); C8318 (66%); C8448 (65%); C8358 (64%)
C8299,"Follicular lymphoma, unspecified, extranodal and solid organ sites",21,C8379 (77%); C84A9 (77%); C8319 (73%); C8449 (72%); C8359 (71%)
C8300,"Small cell B-cell lymphoma, unspecified site",21,C84A0 (62%); C8310 (60%); C8440 (58%); C8330 (57%); C8470 (42%)
C8301,"Small cell B-cell lymphoma, lymph nodes of head, face, and neck",21,C84A1 (78%); C8311 (77%); C8441 (75%); C8331 (75%); C8371 (64%)
C8302,"Small cell B-cell lymphoma, intrathoracic lymph nodes",21,C84A2 (71%); C8312 (70%); C8442 (68%); C8332 (67%); C8472 (54%)
C8303,"Small cell B-cell lymphoma, intra-abdominal lymph nodes",21,C84A3 (76%); C8313 (75%); C8443 (73%); C8333 (73%); C8373 (61%)
C8304,"Small cell B-cell lymphoma, lymph nodes of axilla and upper limb",21,C84A4 (77%); C8314 (75%); C8444 (74%); C8334 (73%); C8374 (62%)
C8305,"Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb",21,C84A5 (79%); C8315 (77%); C8445 (76%); C8335 (75%); C8375 (65%)
C8306,"Small cell B-cell lymphoma, intrapelvic lymph nodes",21,C84A6 (71%); C8316 (70%); C8446 (68%); C8336 (67%); C8476 (54%)
C8307,"Small cell B-cell lymphoma, spleen",21,C84A7 (64%); C8317 (63%); C8447 (61%); C8337 (60%); C8477 (45%)
C8308,"Small cell B-cell lymphoma, lymph nodes of multiple sites",21,C84A8 (73%); C8318 (72%); C8448 (70%); C8338 (69%); C8378 (56%)
C8309,"Small cell B-cell lymphoma, extranodal and solid organ sites",21,C84A9 (78%); C8319 (76%); C8449 (75%); C8339 (74%); C8379 (64%)
C8310,"Mantle cell lymphoma, unspecified site",20,C8510 (71%); C8300 (60%); C8440 (52%); C8190 (48%); C8290 (48%)
C8311,"Mantle cell lymphoma, lymph nodes of head, face, and neck",20,C8511 (85%); C8301 (77%); C8171 (74%); C8441 (74%); C8191 (74%)
C8312,"Mantle cell lymphoma, intrathoracic lymph nodes",20,C8512 (80%); C8302 (70%); C8442 (65%); C8172 (65%); C8192 (64%)
C8313,"Mantle cell lymphoma, intra-abdominal lymph nodes",20,C8513 (84%); C8303 (75%); C8173 (72%); C8443 (71%); C8193 (71%)
C8314,"Mantle cell lymphoma, lymph nodes of axilla and upper limb",20,C8514 (84%); C8304 (75%); C8174 (73%); C8444 (72%); C8194 (72%)
C8315,"Mantle cell lymphoma, lymph nodes of inguinal region and lower limb",20,C8515 (86%); C8305 (77%); C8175 (75%); C8445 (75%); C8195 (74%)
C8316,"Mantle cell lymphoma, intrapelvic lymph nodes",20,C8516 (80%); C8306 (70%); C8446 (65%); C8176 (65%); C8196 (64%)
C8317,"Mantle cell lymphoma, spleen",20,C8517 (73%); C8307 (63%); C8447 (56%); C8177 (53%); C8197 (51%)
C8318,"Mantle cell lymphoma, lymph nodes of multiple sites",20,C8518 (81%); C8308 (72%); C8448 (67%); C8178 (67%); C8198 (66%)
C8319,"Mantle cell lymphoma, extranodal and solid organ sites",20,C8519 (85%); C8309 (76%); C8179 (74%); C8449 (73%); C8199 (73%)
C8330,"Diffuse large B-cell lymphoma, unspecified site",20,C8510 (67%); C8390 (62%); C8520 (58%); C8300 (57%); C8470 (54%)
C8331,"Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck",20,C8511 (83%); C8391 (78%); C8301 (75%); C8521 (74%); C8171 (72%)
C8332,"Diffuse large B-cell lymphoma, intrathoracic lymph nodes",20,C8512 (77%); C8392 (71%); C8302 (67%); C8522 (67%); C8252 (64%)
C8333,"Diffuse large B-cell lymphoma, intra-abdominal lymph nodes",20,C8513 (81%); C8393 (76%); C8303 (73%); C8523 (72%); C8173 (70%)
C8334,"Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb",20,C8514 (82%); C8394 (76%); C8304 (73%); C8524 (72%); C8174 (70%)
C8335,"Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb",20,C8515 (83%); C8395 (78%); C8305 (75%); C8525 (74%); C8175 (73%)
C8336,"Diffuse large B-cell lymphoma, intrapelvic lymph nodes",20,C8516 (77%); C8396 (71%); C8306 (67%); C8526 (67%); C8256 (64%)
C8337,"Diffuse large B-cell lymphoma, spleen",20,C8517 (70%); C8397 (63%); C8527 (61%); C8307 (60%); C8477 (57%)
C8338,"Diffuse large B-cell lymphoma, lymph nodes of multiple sites",20,C8518 (79%); C8398 (73%); C8308 (69%); C8528 (69%); C8258 (66%)
C8339,"Diffuse large B-cell lymphoma, extranodal and solid organ sites",20,C8519 (83%); C8399 (77%); C8309 (74%); C8529 (73%); C8179 (72%)
C8350,"Lymphoblastic (diffuse) lymphoma, unspecified site",20,C8390 (62%); C8250 (53%); C8510 (48%); C8190 (46%); C8290 (46%)
C8351,"Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck",20,C8391 (78%); C8511 (73%); C8171 (73%); C8251 (72%); C8191 (72%)
C8352,"Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes",20,C8392 (71%); C8252 (64%); C8512 (64%); C8172 (63%); C8192 (61%)
C8353,"Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes",20,C8393 (76%); C8513 (71%); C8173 (70%); C8253 (69%); C8193 (69%)
C8354,"Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb",20,C8394 (76%); C8514 (72%); C8174 (70%); C8254 (70%); C8194 (69%)
C8355,"Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb",20,C8395 (78%); C8515 (74%); C8175 (73%); C8255 (73%); C8195 (72%)
C8356,"Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes",20,C8396 (71%); C8256 (64%); C8516 (64%); C8176 (63%); C8196 (61%)
C8357,"Lymphoblastic (diffuse) lymphoma, spleen",20,C8397 (63%); C8257 (56%); C8517 (52%); C8177 (50%); C8197 (49%)
C8358,"Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites",20,C8398 (73%); C8518 (66%); C8258 (66%); C8178 (65%); C8198 (64%)
C8359,"Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites",20,C8399 (77%); C8519 (73%); C8179 (72%); C8259 (71%); C8299 (71%)
C8370,"Burkitt lymphoma, unspecified site",20,C8510 (56%); C8190 (53%); C8290 (53%); C8170 (53%); C8590 (49%)
C8371,"Burkitt lymphoma, lymph nodes of head, face, and neck",20,C8511 (80%); C8171 (79%); C8191 (78%); C8291 (78%); C8381 (75%)
C8372,"Burkitt lymphoma, intrathoracic lymph nodes",20,C8512 (71%); C8172 (70%); C8192 (68%); C8292 (68%); C8382 (65%)
C8373,"Burkitt lymphoma, intra-abdominal lymph nodes",20,C8513 (77%); C8173 (76%); C8193 (75%); C8293 (75%); C8383 (72%)
C8374,"Burkitt lymphoma, lymph nodes of axilla and upper limb",20,C8514 (78%); C8174 (77%); C8194 (76%); C8294 (76%); C8384 (73%)
C8375,"Burkitt lymphoma, lymph nodes of inguinal region and lower limb",20,C8515 (80%); C8175 (79%); C8195 (78%); C8295 (78%); C8385 (76%)
C8376,"Burkitt lymphoma, intrapelvic lymph nodes",20,C8516 (71%); C8176 (70%); C8196 (68%); C8296 (68%); C8386 (65%)
C8377,"Burkitt lymphoma, spleen",20,C8517 (60%); C8177 (58%); C8197 (57%); C8297 (57%); C8387 (53%)
C8378,"Burkitt lymphoma, lymph nodes of multiple sites",20,C8518 (73%); C8178 (72%); C8198 (71%); C8298 (71%); C8388 (68%)
C8379,"Burkitt lymphoma, extranodal and solid organ sites",20,C8519 (79%); C8179 (78%); C8299 (77%); C8199 (77%); C8389 (74%)
C8380,"Other non-follicular lymphoma, unspecified site",21,C8370 (47%); C84A0 (46%); C8310 (42%); C8440 (41%); C8350 (40%)
C8381,"Other non-follicular lymphoma, lymph nodes of head, face, and neck",21,C8371 (75%); C84A1 (72%); C8311 (71%); C8441 (70%); C8351 (69%)
C8382,"Other non-follicular lymphoma, intrathoracic lymph nodes",21,C8372 (65%); C84A2 (62%); C8312 (61%); C8442 (59%); C8352 (58%)
C8383,"Other non-follicular lymphoma, intra-abdominal lymph nodes",21,C8373 (72%); C84A3 (69%); C8313 (68%); C8443 (67%); C8353 (66%)
C8384,"Other non-follicular lymphoma, lymph nodes of axilla and upper limb",21,C8374 (73%); C84A4 (70%); C8314 (69%); C8444 (68%); C8354 (67%)
C8385,"Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb",21,C8375 (76%); C84A5 (73%); C8315 (72%); C8445 (71%); C8355 (70%)
C8386,"Other non-follicular lymphoma, intrapelvic lymph nodes",21,C8376 (65%); C84A6 (62%); C8316 (61%); C8446 (59%); C8356 (58%)
C8387,"Other non-follicular lymphoma, spleen",21,C8377 (53%); C84A7 (49%); C8317 (48%); C261 (47%); C8447 (47%)
C8388,"Other non-follicular lymphoma, lymph nodes of multiple sites",21,C8378 (68%); C84A8 (64%); C8318 (63%); C8448 (62%); C8358 (61%)
C8389,"Other non-follicular lymphoma, extranodal and solid organ sites",21,C8379 (74%); C84A9 (72%); C8319 (71%); C8449 (69%); C8359 (69%)
C8390,"Non-follicular (diffuse) lymphoma, unspecified, unspecified site",21,C8350 (62%); C8330 (62%); C84A0 (44%); C8370 (42%); M0890 (39%)
C8391,"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck",21,C8351 (78%); C8331 (78%); C8371 (68%); C84A1 (68%); C8311 (65%)
C8392,"Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes",21,C8352 (71%); C8332 (71%); C8372 (57%); C84A2 (57%); C8312 (53%)
C8393,"Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes",21,C8353 (76%); C8333 (76%); C8373 (65%); C84A3 (65%); C8313 (61%)
C8394,"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb",21,C8354 (76%); C8334 (76%); C8374 (66%); C84A4 (66%); C8314 (62%)
C8395,"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb",21,C8355 (78%); C8335 (78%); C8375 (69%); C84A5 (69%); C8315 (66%)
C8396,"Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes",21,C8356 (71%); C8336 (71%); C8376 (57%); C84A6 (57%); C8316 (53%)
C8397,"Non-follicular (diffuse) lymphoma, unspecified, spleen",21,C8357 (63%); C8337 (63%); C84A7 (45%); C8377 (45%); C8350 (41%)
C8398,"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites",21,C8358 (73%); C8338 (73%); C8378 (60%); C84A8 (60%); C8318 (56%)
C8399,"Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites",21,C8359 (77%); C8339 (77%); C8379 (68%); C84A9 (67%); C8319 (64%)
C8400,"Mycosis fungoides, unspecified site",20,C8510 (31%); M0890 (30%); C6990 (29%); M8660 (29%); C8190 (29%)
C8401,"Mycosis fungoides, lymph nodes of head, face, and neck",20,C8511 (64%); C8171 (63%); C8191 (63%); C8291 (63%); C770 (61%)
C8402,"Mycosis fungoides, intrathoracic lymph nodes",20,C8512 (51%); C8172 (50%); C8192 (49%); C8292 (49%); C771 (48%)
C8403,"Mycosis fungoides, intra-abdominal lymph nodes",20,C8513 (61%); C8173 (60%); C8193 (59%); C8293 (59%); C772 (57%)
C8404,"Mycosis fungoides, lymph nodes of axilla and upper limb",20,C8514 (62%); C8174 (61%); C8194 (60%); C8294 (60%); C8384 (58%)
C8405,"Mycosis fungoides, lymph nodes of inguinal region and lower limb",20,C8515 (65%); C8175 (65%); C8195 (64%); C8295 (64%); C8385 (62%)
C8406,"Mycosis fungoides, intrapelvic lymph nodes",20,C8516 (51%); C8176 (50%); C8196 (49%); C8296 (49%); C775 (48%)
C8407,"Mycosis fungoides, spleen",20,C261 (39%); C8517 (35%); C8177 (34%); C8197 (33%); C8297 (33%)
C8408,"Mycosis fungoides, lymph nodes of multiple sites",20,C8518 (55%); C8178 (54%); C8198 (53%); C8298 (53%); C8388 (50%)
C8409,"Mycosis fungoides, extranodal and solid organ sites",20,C8519 (64%); C8179 (63%); C8199 (62%); C8299 (62%); C8389 (60%)
C8410,"Sezary disease, unspecified site",17,M0230 (47%); M0530 (36%); M0510 (36%); C8510 (36%); M0890 (36%)
C8411,"Sezary disease, lymph nodes of head, face, and neck",17,C8511 (70%); C8171 (69%); C8191 (68%); C8291 (68%); C770 (67%)
C8412,"Sezary disease, intrathoracic lymph nodes",17,C8512 (57%); C8172 (56%); C8192 (55%); C8292 (55%); C8382 (53%)
C8413,"Sezary disease, intra-abdominal lymph nodes",17,C8513 (66%); C8173 (65%); C8193 (64%); C8293 (64%); C772 (63%)
C8414,"Sezary disease, lymph nodes of axilla and upper limb",17,C8514 (67%); C8174 (66%); C8194 (65%); C8294 (65%); C773 (64%)
C8415,"Sezary disease, lymph nodes of inguinal region and lower limb",17,C8515 (71%); C8175 (70%); C8195 (69%); C8295 (69%); C8385 (67%)
C8416,"Sezary disease, intrapelvic lymph nodes",17,C8516 (57%); C8176 (56%); C8196 (55%); C8296 (55%); C775 (53%)
C8417,"Sezary disease, spleen",17,C261 (45%); C8517 (41%); C8177 (40%); C8197 (38%); C8297 (38%)
C8418,"Sezary disease, lymph nodes of multiple sites",17,C8518 (61%); C8178 (60%); C8198 (59%); C8298 (59%); C8388 (56%)
C8419,"Sezary disease, extranodal and solid organ sites",17,C8519 (69%); C8179 (68%); C8199 (67%); C8299 (67%); C8389 (65%)
C8440,"Peripheral T-cell lymphoma, not elsewhere classified, unspecified site",19,C8510 (69%); C8300 (58%); C84A0 (55%); C8310 (52%); C8330 (49%)
C8441,"Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of head, face, and neck",19,C8511 (84%); C8301 (75%); C84A1 (75%); C8311 (74%); C8171 (73%)
C8442,"Peripheral T-cell lymphoma, not elsewhere classified, intrathoracic lymph nodes",19,C8512 (78%); C8302 (68%); C84A2 (67%); C8312 (65%); C8172 (63%)
C8443,"Peripheral T-cell lymphoma, not elsewhere classified, intra-abdominal lymph nodes",19,C8513 (82%); C8303 (73%); C84A3 (72%); C8313 (71%); C8173 (70%)
C8444,"Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of axilla and upper limb",19,C8514 (83%); C8304 (74%); C84A4 (73%); C8314 (72%); C8174 (71%)
C8445,"Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of inguinal region and lower limb",19,C8515 (84%); C8305 (76%); C84A5 (76%); C8315 (75%); C8175 (74%)
C8446,"Peripheral T-cell lymphoma, not elsewhere classified, intrapelvic lymph nodes",19,C8516 (78%); C8306 (68%); C84A6 (67%); C8316 (65%); C8176 (63%)
C8447,"Peripheral T-cell lymphoma, not elsewhere classified, spleen",19,C8517 (71%); C8307 (61%); C84A7 (57%); C8317 (56%); C8337 (53%)
C8448,"Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of multiple sites",19,C8518 (80%); C8308 (70%); C84A8 (69%); C8318 (67%); C8178 (66%)
C8449,"Peripheral T-cell lymphoma, not elsewhere classified, extranodal and solid organ sites",19,C8519 (84%); C8309 (75%); C84A9 (74%); C8319 (73%); C8179 (73%)
C8460,"Anaplastic large cell lymphoma, ALK-positive, unspecified site",20,C8470 (79%); C847A (66%); C8477 (66%); C8472 (61%); C8476 (61%)
C8461,"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck",20,C8471 (85%); C8511 (69%); C8472 (63%); C8476 (63%); C8301 (62%)
C8462,"Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes",20,C8472 (82%); C8476 (69%); C8478 (67%); C8473 (65%); C8474 (64%)
C8463,"Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes",20,C8473 (84%); C8513 (66%); C8472 (65%); C8476 (65%); C8478 (63%)
C8464,"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb",20,C8474 (85%); C8514 (67%); C8472 (64%); C8476 (64%); C8475 (64%)
C8465,"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb",20,C8475 (85%); C8515 (70%); C8474 (64%); C8305 (63%); C8472 (62%)
C8466,"Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes",20,C8476 (82%); C8472 (69%); C8478 (67%); C8473 (65%); C8474 (64%)
C8467,"Anaplastic large cell lymphoma, ALK-positive, spleen",20,C8477 (80%); C8470 (66%); C847A (65%); C8472 (60%); C8476 (60%)
C8468,"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites",20,C8478 (83%); C8472 (67%); C8476 (67%); C8473 (63%); C8518 (63%)
C8469,"Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites",20,C8479 (85%); C8519 (68%); C8309 (61%); C8529 (61%); C8179 (60%)
C8470,"Anaplastic large cell lymphoma, ALK-negative, unspecified site",19,C8460 (79%); C8467 (66%); C8462 (61%); C8466 (61%); C8468 (60%)
C8471,"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck",19,C8461 (85%); C8331 (71%); C8511 (69%); C8462 (63%); C8466 (63%)
C8472,"Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes",19,C8462 (82%); C8466 (69%); C8468 (67%); C8463 (65%); C8464 (64%)
C8473,"Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes",19,C8463 (84%); C8333 (69%); C8513 (67%); C8462 (65%); C8466 (65%)
C8474,"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb",19,C8464 (85%); C8334 (69%); C8514 (67%); C8462 (64%); C8466 (64%)
C8475,"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb",19,C8465 (85%); C8335 (71%); C8515 (70%); C8464 (64%); C8305 (63%)
C8476,"Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes",19,C8466 (82%); C8462 (69%); C8468 (67%); C8463 (65%); C8464 (64%)
C8477,"Anaplastic large cell lymphoma, ALK-negative, spleen",19,C8467 (80%); C8460 (66%); C8462 (60%); C8466 (60%); C8468 (58%)
C8478,"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites",19,C8468 (83%); C8462 (67%); C8466 (67%); C8338 (65%); C8463 (63%)
C8479,"Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites",19,C8469 (85%); C8339 (70%); C8519 (69%); C8309 (62%); C84A9 (61%)
C847A,"Anaplastic large cell lymphoma, ALK-negative, breast",19,C8460 (66%); C8467 (65%); C8462 (60%); C8466 (60%); C8468 (59%)
C8490,"Mature T/NK-cell lymphomas, unspecified, unspecified site",20,C8510 (49%); C8300 (39%); C864 (35%); M0890 (33%); C8440 (32%)
C8491,"Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck",20,C8511 (69%); C8301 (61%); C8191 (59%); C8291 (59%); C8441 (58%)
C8492,"Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes",20,C8512 (60%); C8302 (51%); C8442 (47%); C8192 (46%); C8292 (46%)
C8493,"Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes",20,C8513 (66%); C8303 (58%); C8193 (55%); C8293 (55%); C8443 (55%)
C8494,"Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb",20,C8514 (67%); C8304 (59%); C8194 (56%); C8294 (56%); C8444 (56%)
C8495,"Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb",20,C8515 (70%); C8305 (62%); C8195 (60%); C8295 (60%); C8445 (59%)
C8496,"Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes",20,C8516 (60%); C8306 (51%); C8446 (47%); C8196 (46%); C8296 (46%)
C8497,"Mature T/NK-cell lymphomas, unspecified, spleen",20,C8517 (49%); C8307 (41%); C864 (35%); C8447 (35%); C261 (34%)
C8498,"Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites",20,C8518 (62%); C8308 (54%); C8198 (50%); C8298 (50%); C8448 (49%)
C8499,"Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites",20,C8519 (69%); C8309 (61%); C8299 (58%); C8199 (58%); C8449 (57%)
C84A0,"Cutaneous T-cell lymphoma, unspecified, unspecified site",20,C8510 (80%); C8300 (62%); C8260 (62%); C8190 (56%); C8290 (56%)
C84A1,"Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck",20,C8511 (89%); C8301 (78%); C8261 (77%); C8191 (77%); C8291 (77%)
C84A2,"Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes",20,C8512 (85%); C8302 (71%); C8262 (71%); C8192 (68%); C8292 (68%)
C84A3,"Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes",20,C8513 (88%); C8303 (76%); C8263 (75%); C8193 (74%); C8293 (74%)
C84A4,"Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb",20,C8514 (88%); C8304 (77%); C8264 (76%); C8194 (75%); C8294 (75%)
C84A5,"Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb",20,C8515 (89%); C8305 (79%); C8265 (78%); C8195 (78%); C8295 (78%)
C84A6,"Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes",20,C8516 (85%); C8306 (71%); C8266 (71%); C8196 (68%); C8296 (68%)
C84A7,"Cutaneous T-cell lymphoma, unspecified, spleen",20,C8517 (80%); C8307 (64%); C8267 (64%); C8197 (57%); C8297 (57%)
C84A8,"Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites",20,C8518 (86%); C8308 (73%); C8268 (72%); C8198 (70%); C8298 (70%)
C84A9,"Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites",20,C8519 (89%); C8309 (78%); C8269 (77%); C8299 (77%); C8199 (77%)
C84Z0,"Other mature T/NK-cell lymphomas, unspecified site",20,C8510 (43%); C8300 (38%); C864 (37%); C8440 (30%); M0890 (26%)
C84Z1,"Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck",20,C8511 (68%); C8301 (62%); C8441 (59%); C8171 (58%); C8191 (58%)
C84Z2,"Other mature T/NK-cell lymphomas, intrathoracic lymph nodes",20,C8512 (58%); C8302 (52%); C8442 (47%); C8172 (45%); C8192 (44%)
C84Z3,"Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes",20,C8513 (65%); C8303 (59%); C8443 (55%); C8173 (54%); C8193 (54%)
C84Z4,"Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb",20,C8514 (66%); C8304 (59%); C8444 (56%); C8174 (56%); C8194 (55%)
C84Z5,"Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb",20,C8515 (69%); C8305 (63%); C8445 (60%); C8175 (59%); C8195 (59%)
C84Z6,"Other mature T/NK-cell lymphomas, intrapelvic lymph nodes",20,C8516 (58%); C8306 (52%); C8446 (47%); C8176 (45%); C8196 (44%)
C84Z7,"Other mature T/NK-cell lymphomas, spleen",20,C8517 (46%); C8307 (42%); C864 (36%); C8447 (35%); C261 (34%)
C84Z8,"Other mature T/NK-cell lymphomas, lymph nodes of multiple sites",20,C8518 (60%); C8308 (54%); C8448 (50%); C8178 (48%); C8198 (48%)
C84Z9,"Other mature T/NK-cell lymphomas, extranodal and solid organ sites",20,C8519 (67%); C8309 (61%); C8449 (58%); C8179 (58%); C8299 (57%)
C8510,"Unspecified B-cell lymphoma, unspecified site",21,C84A0 (80%); C8310 (71%); C8440 (69%); C8330 (67%); C8370 (56%)
C8511,"Unspecified B-cell lymphoma, lymph nodes of head, face, and neck",21,C84A1 (89%); C8311 (85%); C8441 (84%); C8331 (83%); C8371 (80%)
C8512,"Unspecified B-cell lymphoma, intrathoracic lymph nodes",21,C84A2 (85%); C8312 (80%); C8442 (78%); C8332 (77%); C8372 (71%)
C8513,"Unspecified B-cell lymphoma, intra-abdominal lymph nodes",21,C84A3 (88%); C8313 (84%); C8443 (82%); C8333 (81%); C8373 (77%)
C8514,"Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb",21,C84A4 (88%); C8314 (84%); C8444 (83%); C8334 (82%); C8374 (78%)
C8515,"Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb",21,C84A5 (89%); C8315 (86%); C8445 (84%); C8335 (83%); C8375 (80%)
C8516,"Unspecified B-cell lymphoma, intrapelvic lymph nodes",21,C84A6 (85%); C8316 (80%); C8446 (78%); C8336 (77%); C8376 (71%)
C8517,"Unspecified B-cell lymphoma, spleen",21,C84A7 (80%); C8317 (73%); C8447 (71%); C8337 (70%); C8377 (60%)
C8518,"Unspecified B-cell lymphoma, lymph nodes of multiple sites",21,C84A8 (86%); C8318 (81%); C8448 (80%); C8338 (79%); C8378 (73%)
C8519,"Unspecified B-cell lymphoma, extranodal and solid organ sites",21,C84A9 (89%); C8319 (85%); C8449 (84%); C8339 (83%); C8379 (79%)
C8520,"Mediastinal (thymic) large B-cell lymphoma, unspecified site",21,C8330 (58%); C8470 (43%); C8460 (43%); C84A0 (43%); C8310 (40%)
C8521,"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck",21,C8331 (74%); C84A1 (65%); C8311 (64%); C8441 (63%); C8471 (62%)
C8522,"Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes",21,C8332 (67%); C84A2 (55%); C8312 (54%); C8472 (54%); C8462 (53%)
C8523,"Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes",21,C8333 (72%); C84A3 (62%); C8313 (61%); C8443 (60%); C8473 (59%)
C8524,"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb",21,C8334 (72%); C84A4 (63%); C8314 (62%); C8444 (60%); C8474 (60%)
C8525,"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb",21,C8335 (74%); C84A5 (65%); C8315 (64%); C8445 (63%); C8475 (62%)
C8526,"Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes",21,C8336 (67%); C84A6 (55%); C8316 (54%); C8476 (54%); C8466 (53%)
C8527,"Mediastinal (thymic) large B-cell lymphoma, spleen",21,C8337 (61%); C8477 (46%); C8467 (46%); C84A7 (45%); C8317 (44%)
C8528,"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites",21,C8338 (69%); C84A8 (57%); C8318 (56%); C8478 (55%); C8448 (55%)
C8529,"Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites",21,C8339 (73%); C84A9 (64%); C8319 (63%); C8449 (62%); C8479 (61%)
C8580,"Other specified types of non-Hodgkin lymphoma, unspecified site",21,M068A (42%); M0680 (41%); M089A (39%); M0888 (36%); C8370 (36%)
C8581,"Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck",21,C8371 (65%); C84A1 (63%); C8311 (62%); C8441 (61%); C8351 (60%)
C8582,"Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes",21,C8372 (54%); C84A2 (51%); C8312 (50%); C8442 (49%); C8352 (48%)
C8583,"Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes",21,C8373 (62%); C84A3 (59%); C8313 (58%); C8443 (57%); C8353 (57%)
C8584,"Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb",21,C8374 (63%); C84A4 (60%); C8314 (59%); C8444 (58%); C8354 (58%)
C8585,"Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb",21,C8375 (66%); C84A5 (64%); C8315 (63%); C8445 (62%); C8355 (61%)
C8586,"Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes",21,C8376 (54%); C84A6 (51%); C8316 (50%); C8446 (49%); C8356 (48%)
C8587,"Other specified types of non-Hodgkin lymphoma, spleen",21,C8377 (41%); C84A7 (39%); C8317 (38%); C261 (37%); C8447 (36%)
C8588,"Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites",21,C8378 (57%); C84A8 (54%); C8318 (53%); C8448 (52%); C8358 (51%)
C8589,"Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites",21,C8379 (65%); C84A9 (62%); C8319 (61%); C8449 (60%); C8359 (59%)
C8590,"Non-Hodgkin lymphoma, unspecified, unspecified site",21,C84A0 (51%); C8370 (49%); M0890 (45%); C8310 (44%); C6990 (43%)
C8591,"Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck",21,C8371 (74%); C84A1 (73%); C8311 (70%); C770 (70%); C8441 (69%)
C8592,"Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes",21,C8372 (64%); C84A2 (64%); C8312 (60%); C8442 (58%); C771 (58%)
C8593,"Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes",21,C8373 (71%); C84A3 (71%); C8313 (67%); C772 (66%); C8443 (66%)
C8594,"Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb",21,C8374 (72%); C84A4 (72%); C8314 (68%); C773 (67%); C8444 (67%)
C8595,"Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb",21,C8375 (75%); C84A5 (74%); C8315 (71%); C8445 (70%); C8355 (69%)
C8596,"Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes",21,C8376 (64%); C84A6 (64%); C8316 (60%); C8446 (58%); C775 (58%)
C8597,"Non-Hodgkin lymphoma, unspecified, spleen",21,C84A7 (52%); C8377 (52%); C8317 (47%); C261 (46%); C8447 (46%)
C8598,"Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites",21,C8378 (67%); C84A8 (66%); C8318 (62%); C8448 (61%); C8358 (60%)
C8599,"Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites",21,C8379 (74%); C84A9 (73%); C8319 (70%); C8449 (68%); C8359 (68%)
C860,"Extranodal NK/T-cell lymphoma, nasal type",20,C864 (44%); C8309 (40%); C8519 (39%); C300 (39%); C8449 (34%)
C861,Hepatosplenic T-cell lymphoma,20,C8300 (40%); C8307 (38%); C8510 (37%); C8517 (37%); C8302 (35%)
C862,Enteropathy-type (intestinal) T-cell lymphoma,20,C8300 (33%); C8307 (32%); C8510 (31%); C8517 (31%); C8302 (29%)
C863,Subcutaneous panniculitis-like T-cell lymphoma,19,C8300 (26%); C8307 (25%); C8510 (25%); C8517 (24%); C8302 (23%)
C864,Blastic NK-cell lymphoma,19,C860 (44%); C84Z0 (37%); C84Z7 (36%); C8490 (35%); C8497 (35%)
C865,Angioimmunoblastic T-cell lymphoma,19,C8300 (40%); C8307 (38%); C8510 (37%); C8517 (37%); C8302 (35%)
C866,Primary cutaneous CD30-positive T-cell proliferations,20,C801 (28%); B452 (23%); B463 (23%); D6949 (22%); E7253 (22%)
C880,Waldenstrom macroglobulinemia,21,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
C882,Heavy chain disease,21,E8581 (33%); G959 (17%); I120 (15%); G20 (14%); G308 (14%)
C883,Immunoproliferative small intestinal disease,21,K50012 (50%); K50012 (50%); K50812 (47%); K50812 (47%); K50912 (36%)
C884,Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma],21,C860 (27%); C84A9 (26%); C8319 (26%); C8449 (25%); C9151 (25%)
C888,Other malignant immunoproliferative diseases,21,J84178 (31%); G9589 (28%); B258 (27%); G914 (26%); M9058 (26%)
C889,"Malignant immunoproliferative disease, unspecified",21,G959 (27%); K50919 (25%); C6990 (23%); B259 (23%); I279 (23%)
C9000,Multiple myeloma not having achieved remission,19,C9590 (62%); C92Z0 (55%); C9510 (54%); C9290 (54%); C91Z0 (54%)
C9001,Multiple myeloma in remission,19,C9591 (31%); M868X0 (29%); G35 (29%); M8789 (29%); M8669 (27%)
C9002,Multiple myeloma in relapse,19,C9592 (38%); C92Z2 (31%); C9512 (30%); C9292 (30%); C91Z2 (30%)
C9010,Plasma cell leukemia not having achieved remission,19,C9590 (76%); C9510 (75%); C9500 (74%); C9430 (69%); C9140 (68%)
C9011,Plasma cell leukemia in remission,19,C9511 (61%); C9591 (59%); C9501 (59%); C9431 (53%); C9141 (51%)
C9012,Plasma cell leukemia in relapse,19,C9512 (64%); C9592 (63%); C9502 (62%); C9432 (56%); C9142 (55%)
C9020,Extramedullary plasmacytoma not having achieved remission,19,C9590 (58%); C92Z0 (51%); C9510 (50%); C9290 (50%); C91Z0 (50%)
C9021,Extramedullary plasmacytoma in remission,19,C9591 (28%); F1421 (23%); F1021 (23%); F1521 (23%); F1411 (23%)
C9022,Extramedullary plasmacytoma in relapse,19,C9592 (34%); C92Z2 (27%); C9512 (27%); C9292 (27%); C91Z2 (27%)
C9030,Solitary plasmacytoma not having achieved remission,19,C9590 (58%); C92Z0 (51%); C9510 (50%); C9290 (50%); C91Z0 (50%)
C9031,Solitary plasmacytoma in remission,19,C9591 (28%); F1421 (23%); F1021 (23%); F1521 (23%); F1411 (23%)
C9032,Solitary plasmacytoma in relapse,19,C9592 (34%); C92Z2 (27%); C9512 (27%); C9292 (27%); C91Z2 (27%)
C9100,Acute lymphoblastic leukemia not having achieved remission,18,C9590 (79%); C9250 (74%); C9200 (71%); C9240 (71%); C9400 (71%)
C9101,"Acute lymphoblastic leukemia, in remission",18,C9591 (63%); C9251 (58%); C9201 (56%); C9241 (56%); C9401 (56%)
C9102,"Acute lymphoblastic leukemia, in relapse",18,C9592 (67%); C9252 (61%); C9202 (59%); C9242 (59%); C9402 (59%)
C9110,Chronic lymphocytic leukemia of B-cell type not having achieved remission,22,C9500 (75%); C9130 (69%); C9160 (69%); C9430 (66%); C9310 (65%)
C9111,Chronic lymphocytic leukemia of B-cell type in remission,22,C9501 (62%); C9131 (54%); C9161 (54%); C9431 (49%); C91A1 (49%)
C9112,Chronic lymphocytic leukemia of B-cell type in relapse,22,C9502 (65%); C9132 (57%); C9162 (57%); C9432 (52%); C91A2 (52%)
C9130,Prolymphocytic leukemia of B-cell type not having achieved remission,19,C9510 (80%); C9500 (79%); C9590 (75%); C9430 (69%); C9110 (69%)
C9131,"Prolymphocytic leukemia of B-cell type, in remission",19,C9511 (69%); C9501 (67%); C9591 (59%); C9111 (54%); C9431 (53%)
C9132,"Prolymphocytic leukemia of B-cell type, in relapse",19,C9512 (71%); C9502 (69%); C9592 (62%); C9112 (57%); C9432 (56%)
C9140,Hairy cell leukemia not having achieved remission,22,C9500 (74%); C9430 (69%); C9010 (68%); C9130 (68%); C9160 (68%)
C9141,"Hairy cell leukemia, in remission",22,C9501 (59%); C9431 (53%); C9011 (51%); C9131 (51%); C9161 (51%)
C9142,"Hairy cell leukemia, in relapse",22,C9502 (62%); C9432 (56%); C9012 (55%); C9132 (54%); C9162 (54%)
C9150,Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission,19,C9590 (61%); C9510 (61%); C9500 (60%); C9430 (56%); C9140 (55%)
C9151,"Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission",19,C9511 (45%); C9591 (44%); C9501 (44%); C9431 (40%); C9141 (38%)
C9152,"Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse",19,C9512 (48%); C9592 (48%); C9502 (47%); C9432 (43%); C9142 (41%)
C9160,Prolymphocytic leukemia of T-cell type not having achieved remission,19,C9510 (80%); C9500 (79%); C9590 (75%); C9430 (69%); C9110 (69%)
C9161,"Prolymphocytic leukemia of T-cell type, in remission",19,C9511 (69%); C9501 (67%); C9591 (59%); C9111 (54%); C9431 (53%)
C9162,"Prolymphocytic leukemia of T-cell type, in relapse",19,C9512 (71%); C9502 (69%); C9592 (62%); C9112 (57%); C9432 (56%)
C9190,"Lymphoid leukemia, unspecified not having achieved remission",22,C9290 (73%); C9500 (72%); C92Z0 (72%); C9390 (71%); C93Z0 (70%)
C9191,"Lymphoid leukemia, unspecified, in remission",22,C9291 (55%); C9501 (54%); C9391 (53%); C92Z1 (52%); C93Z1 (50%)
C9192,"Lymphoid leukemia, unspecified, in relapse",22,C9292 (59%); C9502 (58%); C9392 (56%); C92Z2 (56%); C93Z2 (54%)
C91A0,Mature B-cell leukemia Burkitt-type not having achieved remission,20,C9510 (75%); C9500 (74%); C9590 (70%); C9130 (67%); C9160 (67%)
C91A1,"Mature B-cell leukemia Burkitt-type, in remission",20,C9511 (62%); C9501 (60%); C9591 (53%); C9131 (52%); C9161 (52%)
C91A2,"Mature B-cell leukemia Burkitt-type, in relapse",20,C9512 (65%); C9502 (63%); C9592 (57%); C9132 (55%); C9162 (55%)
C91Z0,Other lymphoid leukemia not having achieved remission,22,C92Z0 (73%); C9290 (72%); C9500 (71%); C93Z0 (71%); C9390 (70%)
C91Z1,"Other lymphoid leukemia, in remission",22,C92Z1 (53%); C9291 (52%); C9501 (51%); C93Z1 (51%); C9391 (50%)
C91Z2,"Other lymphoid leukemia, in relapse",22,C92Z2 (57%); C9292 (56%); C9502 (55%); C93Z2 (55%); C9392 (54%)
C9200,"Acute myeloblastic leukemia, not having achieved remission",17,C9590 (75%); C9500 (74%); C9100 (71%); C9240 (68%); C92Z0 (66%)
C9201,"Acute myeloblastic leukemia, in remission",17,C9501 (60%); C9591 (59%); C9101 (56%); C9241 (52%); C92Z1 (46%)
C9202,"Acute myeloblastic leukemia, in relapse",17,C9592 (63%); C9502 (62%); C9102 (59%); C9242 (55%); C92Z2 (50%)
C9210,"Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission",22,C9220 (80%); C92Z0 (69%); C9290 (69%); C9221 (67%); C9222 (58%)
C9211,"Chronic myeloid leukemia, BCR/ABL-positive, in remission",22,C9221 (76%); C9220 (68%); C9222 (66%); C92Z1 (59%); C9291 (58%)
C9212,"Chronic myeloid leukemia, BCR/ABL-positive, in relapse",22,C9222 (77%); C9221 (66%); C92Z2 (61%); C9292 (60%); C9220 (59%)
C9220,"Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission",20,C9210 (80%); C9211 (68%); C9212 (59%); C9590 (55%); C9510 (53%)
C9221,"Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission",20,C9211 (76%); C9210 (67%); C9212 (66%); C9591 (39%); C9511 (37%)
C9222,"Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse",20,C9212 (77%); C9211 (66%); C9210 (58%); C9592 (42%); C9512 (40%)
C9230,"Myeloid sarcoma, not having achieved remission",17,C92Z0 (79%); C9290 (78%); C9590 (63%); C9210 (55%); C9510 (55%)
C9231,"Myeloid sarcoma, in remission",17,C92Z1 (65%); C9291 (64%); C92Z0 (49%); C9290 (48%); C469 (42%)
C9232,"Myeloid sarcoma, in relapse",17,C92Z2 (68%); C9292 (67%); C9212 (42%); C469 (40%); C9592 (39%)
C9240,"Acute promyelocytic leukemia, not having achieved remission",22,C9500 (74%); C9100 (71%); C9250 (70%); C9200 (68%); C9400 (68%)
C9241,"Acute promyelocytic leukemia, in remission",22,C9501 (60%); C9101 (56%); C9251 (54%); C9201 (52%); C9401 (52%)
C9242,"Acute promyelocytic leukemia, in relapse",22,C9502 (62%); C9102 (59%); C9252 (58%); C9202 (55%); C9402 (55%)
C9250,"Acute myelomonocytic leukemia, not having achieved remission",17,C9310 (91%); C9330 (89%); C9590 (78%); C9500 (77%); C9100 (74%)
C9251,"Acute myelomonocytic leukemia, in remission",17,C9311 (86%); C9331 (83%); C9310 (68%); C9330 (66%); C9501 (63%)
C9252,"Acute myelomonocytic leukemia, in relapse",17,C9312 (87%); C9332 (84%); C9592 (66%); C9502 (66%); C9311 (62%)
C9260,Acute myeloid leukemia with 11q23-abnormality not having achieved remission,17,C92Z0 (72%); C9290 (72%); C9590 (62%); C9500 (61%); C9100 (58%)
C9261,Acute myeloid leukemia with 11q23-abnormality in remission,17,C92Z1 (62%); C9291 (61%); C92Z0 (47%); C9290 (46%); C9501 (45%)
C9262,Acute myeloid leukemia with 11q23-abnormality in relapse,17,C92Z2 (64%); C9292 (63%); C9592 (48%); C9502 (48%); C9102 (45%)
C9290,"Myeloid leukemia, unspecified, not having achieved remission",20,C9590 (86%); C9230 (78%); C9510 (75%); C9500 (74%); C9190 (73%)
C9291,"Myeloid leukemia, unspecified in remission",20,C9591 (75%); C9231 (64%); C92A1 (63%); C9261 (61%); C9211 (58%)
C9292,"Myeloid leukemia, unspecified in relapse",20,C9592 (78%); C9232 (67%); C92A2 (65%); C9262 (63%); C9512 (61%)
C92A0,"Acute myeloid leukemia with multilineage dysplasia, not having achieved remission",17,C92Z0 (74%); C9290 (73%); C9590 (63%); C9500 (62%); C9100 (60%)
C92A1,"Acute myeloid leukemia with multilineage dysplasia, in remission",17,C92Z1 (64%); C9291 (63%); D46A (48%); C92Z0 (48%); C9290 (48%)
C92A2,"Acute myeloid leukemia with multilineage dysplasia, in relapse",17,C92Z2 (66%); C9292 (65%); C9592 (49%); C9502 (49%); D46A (47%)
C92Z0,Other myeloid leukemia not having achieved remission,20,C9590 (85%); C9230 (79%); C92A0 (74%); C9510 (74%); C91Z0 (73%)
C92Z1,"Other myeloid leukemia, in remission",20,C9591 (71%); C9231 (65%); C92A1 (64%); C9261 (62%); C9211 (59%)
C92Z2,"Other myeloid leukemia, in relapse",20,C9592 (74%); C9232 (68%); C92A2 (66%); C9262 (64%); C9212 (61%)
C9300,"Acute monoblastic/monocytic leukemia, not having achieved remission",17,C93Z0 (82%); C9390 (81%); C9590 (67%); C9500 (66%); C9100 (64%)
C9301,"Acute monoblastic/monocytic leukemia, in remission",17,C93Z1 (74%); C9391 (73%); C93Z0 (57%); C9390 (56%); C93Z2 (53%)
C9302,"Acute monoblastic/monocytic leukemia, in relapse",17,C93Z2 (75%); C9392 (74%); C93Z1 (54%); C9592 (54%); C9502 (54%)
C9310,Chronic myelomonocytic leukemia not having achieved remission,20,C9250 (91%); C9590 (79%); C9510 (76%); C91Z0 (68%); C9251 (68%)
C9311,"Chronic myelomonocytic leukemia, in remission",20,C9251 (86%); C9250 (69%); C9591 (64%); C9252 (62%); C9511 (61%)
C9312,"Chronic myelomonocytic leukemia, in relapse",20,C9252 (87%); C9592 (67%); C9512 (64%); C9251 (62%); C91Z2 (52%)
C9330,"Juvenile myelomonocytic leukemia, not having achieved remission",20,C9250 (89%); C9590 (77%); C9510 (67%); C91Z0 (67%); C9251 (66%)
C9331,"Juvenile myelomonocytic leukemia, in remission",20,C9251 (83%); C9250 (66%); C9591 (61%); C9252 (60%); C9511 (47%)
C9332,"Juvenile myelomonocytic leukemia, in relapse",20,C9252 (84%); C9592 (65%); C9251 (60%); C9512 (51%); C91Z2 (50%)
C9390,"Monocytic leukemia, unspecified, not having achieved remission",20,C9590 (84%); C9300 (81%); C9510 (73%); C9500 (72%); C9190 (71%)
C9391,"Monocytic leukemia, unspecified in remission",20,C9301 (73%); C9591 (72%); C9300 (62%); C9511 (55%); C9501 (53%)
C9392,"Monocytic leukemia, unspecified in relapse",20,C9592 (74%); C9302 (74%); C9512 (59%); C9502 (57%); C9192 (56%)
C93Z0,"Other monocytic leukemia, not having achieved remission",20,C9590 (82%); C9300 (82%); C9510 (71%); C91Z0 (71%); C9500 (70%)
C93Z1,"Other monocytic leukemia, in remission",20,C9301 (74%); C9591 (68%); C9300 (63%); C9302 (54%); C9511 (52%)
C93Z2,"Other monocytic leukemia, in relapse",20,C9302 (75%); C9592 (71%); C9512 (56%); C91Z2 (55%); C9502 (54%)
C9400,"Acute erythroid leukemia, not having achieved remission",17,C9590 (75%); C9500 (74%); C9100 (71%); C9240 (68%); C92Z0 (66%)
C9401,"Acute erythroid leukemia, in remission",17,C9501 (60%); C9591 (59%); C9101 (56%); C9241 (52%); C92Z1 (46%)
C9402,"Acute erythroid leukemia, in relapse",17,C9592 (63%); C9502 (62%); C9102 (59%); C9242 (55%); C92Z2 (50%)
C9420,Acute megakaryoblastic leukemia not having achieved remission,17,C9590 (75%); C9500 (74%); C9100 (71%); C9240 (68%); C92Z0 (66%)
C9421,"Acute megakaryoblastic leukemia, in remission",17,C9501 (60%); C9591 (59%); C9101 (56%); C9241 (52%); C92Z1 (46%)
C9422,"Acute megakaryoblastic leukemia, in relapse",17,C9592 (63%); C9502 (62%); C9102 (59%); C9242 (55%); C92Z2 (50%)
C9430,Mast cell leukemia not having achieved remission,20,C9590 (77%); C9510 (77%); C9500 (76%); C9010 (69%); C9140 (69%)
C9431,"Mast cell leukemia, in remission",20,C9629 (66%); C9620 (65%); C9511 (63%); C9591 (61%); C9501 (61%)
C9432,"Mast cell leukemia, in relapse",20,C9512 (66%); C9592 (65%); C9502 (64%); C9629 (64%); C9620 (62%)
C9440,Acute panmyelosis with myelofibrosis not having achieved remission,17,C9500 (56%); C9590 (55%); C9100 (54%); C9240 (51%); D7581 (50%)
C9441,"Acute panmyelosis with myelofibrosis, in remission",17,D7581 (59%); C9501 (33%); C9101 (31%); C9241 (29%); C9591 (26%)
C9442,"Acute panmyelosis with myelofibrosis, in relapse",17,D7581 (58%); C9502 (38%); C9102 (35%); C9242 (33%); C9592 (32%)
C946,"Myelodysplastic disease, not elsewhere classified",19,I96 (29%); G7081 (27%); K738 (24%); G914 (23%); M9058 (23%)
C9480,Other specified leukemias not having achieved remission,20,C9590 (64%); C9510 (56%); C91Z0 (55%); C9500 (55%); C9190 (54%)
C9481,"Other specified leukemias, in remission",20,C9591 (33%); M068A (29%); E1369 (28%); F1421 (28%); F1021 (28%)
C9482,"Other specified leukemias, in relapse",20,C9592 (40%); C9512 (31%); C91Z2 (31%); C9502 (31%); C9192 (30%)
C9500,Acute leukemia of unspecified cell type not having achieved remission,18,C9510 (90%); C9590 (85%); C9130 (79%); C9160 (79%); C9250 (77%)
C9501,"Acute leukemia of unspecified cell type, in remission",18,C9511 (84%); C9591 (74%); C9131 (67%); C9161 (67%); C9510 (64%)
C9502,"Acute leukemia of unspecified cell type, in relapse",18,C9512 (85%); C9592 (76%); C9132 (69%); C9162 (69%); C9252 (66%)
C9510,Chronic leukemia of unspecified cell type not having achieved remission,22,C9500 (90%); C9130 (80%); C9160 (80%); C9430 (77%); C9310 (76%)
C9511,"Chronic leukemia of unspecified cell type, in remission",22,C9501 (84%); C9131 (69%); C9161 (69%); C9500 (64%); C9431 (63%)
C9512,"Chronic leukemia of unspecified cell type, in relapse",22,C9502 (85%); C9132 (71%); C9162 (71%); C9432 (66%); C91A2 (65%)
C9590,"Leukemia, unspecified not having achieved remission",22,C9290 (86%); C9500 (85%); C92Z0 (85%); C9390 (84%); C93Z0 (82%)
C9591,"Leukemia, unspecified, in remission",22,C9291 (75%); C9501 (74%); C9391 (72%); C92Z1 (71%); C93Z1 (68%)
C9592,"Leukemia, unspecified, in relapse",22,C9292 (78%); C9502 (76%); C9392 (74%); C92Z2 (74%); C93Z2 (71%)
C960,Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis,21,J8482 (53%); D763 (34%); C800 (33%); B447 (28%); B457 (28%)
C9620,"Malignant mast cell neoplasm, unspecified",21,C9431 (65%); C9432 (62%); C9430 (52%); C6990 (36%); C719 (36%)
C9621,Aggressive systemic mastocytosis,21,M3489 (27%); M349 (26%); M3482 (22%); E853 (22%); M3483 (22%)
C9622,Mast cell sarcoma,21,C9431 (60%); C9432 (58%); C9430 (48%); C9231 (38%); C9232 (37%)
C9629,Other malignant mast cell neoplasm,21,C9431 (66%); C9432 (64%); C9430 (53%); C380 (34%); C720 (31%)
C964,Sarcoma of dendritic cells (accessory cells),21,Z9484 (45%); D832 (35%); C9231 (20%); C9232 (19%); C9230 (15%)
C965,Multifocal and unisystemic Langerhans-cell histiocytosis,21,J8482 (58%); D763 (37%); M86359 (25%); M86352 (25%); M86351 (25%)
C966,Unifocal Langerhans-cell histiocytosis,21,J8482 (63%); D763 (40%); C220 (12%); C9511 (12%); C9501 (11%)
C969,"Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified",21,C9191 (35%); C9192 (33%); C91Z1 (33%); C91Z2 (31%); C494 (30%)
C96A,Histiocytic sarcoma,21,C9231 (38%); C9232 (36%); C9230 (30%); A0104 (0%); A0105 (0%)
C96Z,"Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue",21,C91Z1 (28%); C9191 (28%); C91Z2 (27%); C9192 (26%); J842 (24%)
D030,Melanoma in situ of lip,23,C4A0 (42%); C148 (29%); A0104 (0%); A0105 (0%); A021 (0%)
D0310,"Melanoma in situ of unspecified eyelid, including canthus",23,C4A10 (60%); C4A122 (56%); C4A112 (56%); C4A121 (55%); C4A111 (55%)
D03111,"Melanoma in situ of right upper eyelid, including canthus",23,C4A111 (64%); C4A121 (60%); C4A112 (56%); C4A10 (55%); C4A122 (53%)
D03112,"Melanoma in situ of right lower eyelid, including canthus",23,C4A112 (63%); C4A122 (59%); C4A111 (56%); C4A10 (56%); C4A121 (53%)
D03121,"Melanoma in situ of left upper eyelid, including canthus",23,C4A121 (64%); C4A111 (60%); C4A122 (56%); C4A10 (55%); C4A112 (53%)
D03122,"Melanoma in situ of left lower eyelid, including canthus",23,C4A122 (63%); C4A112 (59%); C4A121 (56%); C4A10 (56%); C4A111 (53%)
D0320,Melanoma in situ of unspecified ear and external auricular canal,23,C4A20 (70%); C4A22 (68%); C4A21 (68%); C301 (27%); C211 (25%)
D0321,Melanoma in situ of right ear and external auricular canal,23,C4A21 (70%); C4A20 (68%); C4A22 (68%); C301 (27%); C211 (25%)
D0322,Melanoma in situ of left ear and external auricular canal,23,C4A22 (70%); C4A20 (68%); C4A21 (68%); C301 (27%); C211 (25%)
D0330,Melanoma in situ of unspecified part of face,23,C4A30 (30%); C8511 (28%); C8191 (27%); C8291 (27%); C770 (26%)
D0339,Melanoma in situ of other parts of face,23,C4A39 (47%); S128XXA (37%); C257 (31%); I7419 (30%); S3289XB (30%)
D034,Melanoma in situ of scalp and neck,23,C4A4 (52%); S129XXA (30%); S128XXA (22%); S72002A (20%); S72001A (20%)
D0351,Melanoma in situ of anal skin,23,C4A51 (51%); C211 (39%); L98491 (29%); E10622 (27%); E10622 (27%)
D0352,Melanoma in situ of breast (skin) (soft tissue),23,C499 (45%); C461 (43%); C495 (41%); C498 (40%); C496 (39%)
D0359,Melanoma in situ of other part of trunk,23,C4A59 (40%); C476 (38%); C496 (33%); T71222A (28%); A0104 (0%)
D0360,"Melanoma in situ of unspecified upper limb, including shoulder",23,C4A60 (53%); C4710 (52%); C4A62 (50%); C4A61 (50%); C4712 (49%)
D0361,"Melanoma in situ of right upper limb, including shoulder",23,C4A61 (54%); C4711 (53%); C4A60 (50%); C4A62 (50%); C4710 (49%)
D0362,"Melanoma in situ of left upper limb, including shoulder",23,C4A62 (54%); C4712 (53%); C4A60 (50%); C4A61 (50%); C4710 (49%)
D0370,"Melanoma in situ of unspecified lower limb, including hip",23,C4A70 (51%); C4720 (50%); C4A72 (48%); C4A71 (48%); C4722 (47%)
D0371,"Melanoma in situ of right lower limb, including hip",23,C4A71 (52%); C4721 (51%); C4A70 (48%); C4A72 (48%); C4720 (47%)
D0372,"Melanoma in situ of left lower limb, including hip",23,C4A72 (52%); C4722 (51%); C4A70 (48%); C4A71 (48%); C4720 (47%)
D038,Melanoma in situ of other sites,23,M868X9 (31%); M868X0 (25%); M8789 (25%); M8669 (23%); C457 (23%)
D039,"Melanoma in situ, unspecified",23,G8330 (11%); L97909 (11%); G8190 (11%); C8510 (11%); M08959 (11%)
D1802,Hemangioma of intracranial structures,23,I629 (24%); P529 (21%); S069X0A (21%); S06890A (19%); I607 (18%)
D320,Benign neoplasm of cerebral meninges,23,C700 (78%); C7932 (69%); C709 (64%); C701 (59%); I6349 (31%)
D321,Benign neoplasm of spinal meninges,23,C701 (77%); C709 (65%); C700 (59%); C7932 (52%); C720 (36%)
D329,"Benign neoplasm of meninges, unspecified",23,C709 (74%); C701 (64%); C700 (63%); C7932 (56%); D3A00 (35%)
D330,"Benign neoplasm of brain, supratentorial",23,C719 (46%); C7931 (40%); C718 (34%); C717 (33%); G935 (31%)
D331,"Benign neoplasm of brain, infratentorial",23,C719 (46%); C7931 (40%); C718 (34%); C717 (33%); G935 (31%)
D332,"Benign neoplasm of brain, unspecified",23,C719 (67%); C7931 (53%); C718 (46%); C717 (44%); G935 (42%)
D333,Benign neoplasm of cranial nerves,23,C7259 (83%); C7250 (50%); C475 (38%); C476 (35%); C473 (35%)
D334,Benign neoplasm of spinal cord,23,C720 (67%); G959 (51%); G9589 (44%); S14139A (43%); S14129A (42%)
D337,Benign neoplasm of other specified parts of central nervous system,23,C729 (62%); C7949 (62%); G378 (49%); G3789 (49%); C481 (45%)
D339,"Benign neoplasm of central nervous system, unspecified",23,C729 (78%); G379 (55%); G370 (53%); C7940 (53%); G378 (48%)
D352,Benign neoplasm of pituitary gland,23,C751 (82%); C7492 (38%); C7491 (38%); C753 (37%); C7490 (37%)
D353,Benign neoplasm of craniopharyngeal duct,23,C752 (84%); C253 (39%); C240 (33%); K831 (32%); C787 (29%)
D354,Benign neoplasm of pineal gland,23,C753 (83%); C751 (37%); C7492 (37%); C7491 (37%); C7490 (36%)
D3A00,Benign carcinoid tumor of unspecified site,22,C7A00 (79%); C7A093 (53%); C7A092 (50%); C7A026 (50%); C7A094 (50%)
D3A010,Benign carcinoid tumor of the duodenum,22,C7A010 (84%); C170 (52%); C7A00 (50%); C7A093 (47%); C7A092 (44%)
D3A011,Benign carcinoid tumor of the jejunum,22,C7A011 (84%); C171 (52%); C7A00 (50%); C7A093 (47%); C7A092 (44%)
D3A012,Benign carcinoid tumor of the ileum,22,C7A012 (84%); C172 (52%); C7A00 (50%); C7A093 (47%); C7A092 (44%)
D3A019,"Benign carcinoid tumor of the small intestine, unspecified portion",22,C7A019 (88%); C7A029 (71%); C179 (50%); C49A3 (48%); C7A00 (46%)
D3A020,Benign carcinoid tumor of the appendix,22,C7A020 (84%); C7A00 (49%); C7A093 (46%); C7A092 (44%); C7A026 (44%)
D3A021,Benign carcinoid tumor of the cecum,22,C7A021 (84%); C7A00 (49%); C7A093 (46%); C7A092 (44%); C7A026 (44%)
D3A022,Benign carcinoid tumor of the ascending colon,22,C7A022 (87%); C7A023 (60%); C7A024 (56%); C7A025 (55%); C7A00 (45%)
D3A023,Benign carcinoid tumor of the transverse colon,22,C7A023 (85%); C7A024 (60%); C7A022 (60%); C7A025 (59%); C7A00 (48%)
D3A024,Benign carcinoid tumor of the descending colon,22,C7A024 (87%); C7A023 (61%); C7A022 (56%); C7A025 (55%); C7A00 (45%)
D3A025,Benign carcinoid tumor of the sigmoid colon,22,C7A025 (87%); C7A023 (60%); C7A024 (55%); C7A022 (55%); C7A00 (44%)
D3A026,Benign carcinoid tumor of the rectum,22,C7A026 (83%); C7A00 (51%); C49A5 (50%); C7A093 (48%); C7A092 (46%)
D3A029,"Benign carcinoid tumor of the large intestine, unspecified portion",22,C7A029 (87%); C7A019 (71%); C7A00 (47%); C49A4 (47%); C7A093 (41%)
D3A090,Benign carcinoid tumor of the bronchus and lung,22,C7A090 (85%); C3492 (51%); C3491 (51%); C3490 (50%); C7A00 (49%)
D3A091,Benign carcinoid tumor of the thymus,22,C7A091 (84%); C37 (53%); C7A00 (49%); C7A093 (46%); C7A092 (44%)
D3A092,Benign carcinoid tumor of the stomach,22,C7A092 (83%); C7A00 (51%); C49A2 (49%); C7A093 (48%); C169 (46%)
D3A093,Benign carcinoid tumor of the kidney,22,C7A093 (81%); C7A00 (54%); C7A092 (48%); C7A026 (48%); C7A010 (46%)
D3A094,"Benign carcinoid tumor of the foregut, unspecified",22,C7A094 (85%); C7A00 (51%); C7A093 (45%); C7A092 (43%); C7A026 (43%)
D3A095,"Benign carcinoid tumor of the midgut, unspecified",22,C7A095 (85%); C7A00 (51%); C7A093 (45%); C7A092 (43%); C7A026 (43%)
D3A096,"Benign carcinoid tumor of the hindgut, unspecified",22,C7A096 (85%); C7A00 (51%); C7A093 (45%); C7A092 (43%); C7A026 (43%)
D3A098,Benign carcinoid tumors of other sites,22,C7A098 (81%); C7B09 (76%); C7B00 (60%); C7B03 (59%); C7B02 (57%)
D3A8,Other benign neuroendocrine tumors,22,C7A8 (82%); C7B8 (78%); C7A1 (55%); C7A098 (37%); C7B09 (35%)
D420,Neoplasm of uncertain behavior of cerebral meninges,23,C700 (65%); C7932 (58%); C709 (53%); C701 (49%); D479 (45%)
D421,Neoplasm of uncertain behavior of spinal meninges,23,C701 (64%); C709 (54%); C700 (49%); D479 (45%); C7932 (44%)
D429,"Neoplasm of uncertain behavior of meninges, unspecified",23,C709 (60%); C701 (52%); C700 (51%); D479 (49%); C7932 (45%)
D430,"Neoplasm of uncertain behavior of brain, supratentorial",23,D479 (41%); C719 (40%); C7931 (34%); D47Z9 (32%); C718 (29%)
D431,"Neoplasm of uncertain behavior of brain, infratentorial",23,D479 (41%); C719 (40%); C7931 (34%); D47Z9 (32%); C718 (29%)
D432,"Neoplasm of uncertain behavior of brain, unspecified",23,C719 (53%); D479 (52%); C7931 (42%); D47Z9 (39%); C718 (36%)
D433,Neoplasm of uncertain behavior of cranial nerves,23,C7259 (72%); C7250 (43%); D479 (41%); C475 (33%); D47Z9 (32%)
D434,Neoplasm of uncertain behavior of spinal cord,23,C720 (53%); D479 (50%); G959 (40%); D47Z9 (39%); G9589 (34%)
D438,Neoplasm of uncertain behavior of other specified parts of central nervous system,23,C729 (55%); C7949 (54%); G378 (43%); G3789 (43%); C481 (39%)
D439,"Neoplasm of uncertain behavior of central nervous system, unspecified",23,C729 (66%); D479 (46%); G379 (46%); G370 (44%); C7940 (44%)
D443,Neoplasm of uncertain behavior of pituitary gland,23,C751 (70%); D479 (42%); D47Z9 (33%); C7492 (32%); C7491 (32%)
D444,Neoplasm of uncertain behavior of craniopharyngeal duct,23,C752 (73%); D479 (40%); C253 (34%); D47Z9 (31%); C240 (29%)
D445,Neoplasm of uncertain behavior of pineal gland,23,C753 (71%); D479 (41%); C751 (32%); D47Z9 (32%); C7492 (32%)
D446,Neoplasm of uncertain behavior of carotid body,23,D479 (46%); D47Z9 (36%); C162 (28%); C251 (28%); I63139 (25%)
D447,Neoplasm of uncertain behavior of aortic body and other paraganglia,23,D479 (37%); D47Z9 (29%); I71011 (24%); I718 (23%); I7110 (23%)
D45,Polycythemia vera,23,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D460,"Refractory anemia without ring sideroblasts, so stated",19,D4622 (38%); C142 (24%); D613 (22%); D599 (22%); D5919 (21%)
D461,Refractory anemia with ring sideroblasts,19,D4622 (44%); C142 (28%); D613 (25%); D599 (25%); D5919 (24%)
D4620,"Refractory anemia with excess of blasts, unspecified",19,D4622 (99%); D599 (27%); D5910 (26%); D613 (24%); D5919 (24%)
D4621,Refractory anemia with excess of blasts 1,19,D4622 (100%); D613 (25%); D599 (25%); D5919 (24%); D5910 (23%)
D4622,Refractory anemia with excess of blasts 2,17,D4621 (100%); D4620 (99%); D464 (64%); D461 (44%); D460 (38%)
D464,"Refractory anemia, unspecified",19,D4622 (64%); D599 (40%); D5910 (39%); D613 (37%); D5919 (36%)
D469,"Myelodysplastic syndrome, unspecified",19,G839 (32%); E340 (28%); M05059 (26%); M0500 (26%); M05019 (26%)
D46A,Refractory cytopenia with multilineage dysplasia,19,C92A1 (48%); C92A2 (47%); C92A0 (42%); Q061 (27%); Q044 (23%)
D46B,Refractory cytopenia with multilineage dysplasia and ring sideroblasts,19,C92A1 (39%); C92A2 (39%); C92A0 (34%); Q061 (22%); C142 (21%)
D46C,Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality,19,C9261 (18%); C9262 (18%); C9260 (16%); E340 (12%); G839 (11%)
D46Z,Other myelodysplastic syndromes,19,G8389 (40%); D763 (38%); M048 (36%); G733 (30%); M041 (28%)
D4701,Cutaneous mastocytosis,,
D4702,Systemic mastocytosis,,
D4709,Other mast cell neoplasms of uncertain behavior,,
D471,Chronic myeloproliferative disease,21,I120 (29%); N185 (29%); N1830 (28%); I130 (28%); I1311 (26%)
D473,Essential (hemorrhagic) thrombocythemia,23,G361 (28%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
D474,Osteomyelofibrosis,19,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D479,"Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified",21,D432 (52%); D434 (50%); D429 (49%); D446 (46%); D439 (46%)
D47Z1,Post-transplant lymphoproliferative disorder (PTLD),21,R561 (35%); G913 (35%); Z941 (21%); Z942 (21%); T86298 (20%)
D47Z2,Castleman disease,21,G959 (22%); I120 (21%); G20 (19%); G308 (19%); B259 (18%)
D47Z9,"Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue",21,D434 (39%); D432 (39%); D429 (37%); D446 (36%); D438 (36%)
D496,Neoplasm of unspecified behavior of brain,23,C719 (65%); C7931 (51%); C718 (44%); C717 (43%); G935 (40%)
D550,Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency,,
D551,Anemia due to other disorders of glutathione metabolism,,
D5521,Anemia due to pyruvate kinase deficiency,,
D5529,Anemia due to other disorders of glycolytic enzymes,,
D553,Anemia due to disorders of nucleotide metabolism,,
D558,Other anemias due to enzyme disorders,,
D559,"Anemia due to enzyme disorder, unspecified",,
D560,Alpha thalassemia,,
D561,Beta thalassemia,108,D5742 (59%); D57439 (59%); D57434 (57%); D57433 (55%); D57438 (54%)
D562,Delta-beta thalassemia,108,D5742 (45%); D57439 (44%); D57434 (43%); D57433 (41%); D57438 (41%)
D564,Hereditary persistence of fetal hemoglobin [HPFH],,
D565,Hemoglobin E-beta thalassemia,108,D5742 (42%); D57439 (42%); D57434 (41%); D57433 (39%); D57438 (39%)
D568,Other thalassemias,,
D5700,"Hb-SS disease with crisis, unspecified",107,D57219 (67%); D5720 (65%); D57218 (57%); D57214 (37%); D57213 (35%)
D5701,Hb-SS disease with acute chest syndrome,107,D57211 (74%); D57811 (46%); D57411 (46%); D57451 (38%); D5720 (34%)
D5702,Hb-SS disease with splenic sequestration,107,D57212 (76%); D57812 (51%); D57412 (50%); D57452 (42%); D5720 (33%)
D5703,Hb-SS disease with cerebral vascular involvement,107,D57213 (72%); D57813 (43%); D57413 (43%); D5720 (35%); D57219 (35%)
D5704,Hb-SS disease with dactylitis,107,D57214 (69%); D5720 (38%); D57219 (37%); D57814 (34%); D57414 (34%)
D5709,Hb-SS disease with crisis with other specified complication,107,D57218 (74%); D5720 (58%); D57219 (57%); D57818 (46%); D57418 (45%)
D571,Sickle-cell disease without crisis,107,D5720 (83%); D57219 (82%); D5740 (77%); D5780 (76%); D57419 (76%)
D5720,Sickle-cell/Hb-C disease without crisis,108,D571 (83%); D5700 (65%); D5709 (58%); D5742 (49%); D57439 (48%)
D57211,Sickle-cell/Hb-C disease with acute chest syndrome,108,D5701 (74%); D57431 (59%); D571 (44%); H36823 (34%); H36829 (34%)
D57212,Sickle-cell/Hb-C disease with splenic sequestration,108,D5702 (76%); D57432 (62%); D571 (42%); H36823 (32%); H36829 (32%)
D57213,Sickle-cell/Hb-C disease with cerebral vascular involvement,108,D5703 (72%); D57433 (57%); D571 (45%); H36823 (35%); H36829 (35%)
D57214,Sickle-cell/Hb-C disease with dactylitis,108,D5704 (69%); D57434 (52%); D571 (48%); H36823 (37%); H36829 (37%)
D57218,Sickle-cell/Hb-C disease with crisis with other specified complication,108,D5709 (74%); D571 (73%); D57438 (59%); D5700 (57%); D5742 (43%)
D57219,"Sickle-cell/Hb-C disease with crisis, unspecified",108,D571 (82%); D5700 (67%); D5709 (57%); D57439 (50%); D5742 (48%)
D573,Sickle-cell trait,,
D5740,Sickle-cell thalassemia without crisis,108,D571 (77%); D5742 (76%); D57439 (75%); D57438 (69%); D57434 (50%)
D57411,"Sickle-cell thalassemia, unspecified, with acute chest syndrome",108,D57431 (80%); D5701 (46%); D57439 (45%); D5742 (43%); D57434 (42%)
D57412,"Sickle-cell thalassemia, unspecified, with splenic sequestration",108,D57432 (81%); D5702 (50%); D57439 (43%); D5742 (41%); D57434 (40%)
D57413,"Sickle-cell thalassemia, unspecified, with cerebral vascular involvement",108,D57433 (79%); D57439 (46%); D5742 (44%); D57434 (43%); D5703 (43%)
D57414,"Sickle-cell thalassemia, unspecified, with dactylitis",108,D57434 (76%); D57439 (50%); D5742 (48%); D57433 (44%); D57438 (44%)
D57418,"Sickle-cell thalassemia, unspecified, with crisis with other specified complication",108,D57438 (79%); D57439 (66%); D571 (65%); D5742 (64%); D5709 (45%)
D57419,"Sickle-cell thalassemia, unspecified, with crisis",108,D57439 (76%); D571 (76%); D5742 (75%); D57438 (68%); D57434 (49%)
D5742,Sickle-cell thalassemia beta zero without crisis,107,D5740 (76%); D5744 (76%); D57459 (75%); D57419 (75%); D57458 (69%)
D57431,Sickle-cell thalassemia beta zero with acute chest syndrome,107,D57451 (80%); D57411 (80%); D57811 (62%); D57211 (59%); D561 (54%)
D57432,Sickle-cell thalassemia beta zero with splenic sequestration,107,D57452 (81%); D57412 (81%); D57812 (65%); D57212 (62%); D561 (52%)
D57433,Sickle-cell thalassemia beta zero with cerebral vascular involvement,107,D57453 (79%); D57413 (79%); D57813 (60%); D57213 (57%); D561 (55%)
D57434,Sickle-cell thalassemia beta zero with dactylitis,107,D57454 (77%); D57414 (76%); D561 (57%); D57814 (56%); D5744 (55%)
D57438,Sickle-cell thalassemia beta zero with crisis with other specified complication,107,D57458 (80%); D57418 (79%); D5740 (69%); D5744 (69%); D57459 (68%)
D57439,"Sickle-cell thalassemia beta zero with crisis, unspecified",107,D57419 (76%); D57459 (76%); D5740 (75%); D5744 (75%); D57458 (68%)
D5744,Sickle-cell thalassemia beta plus without crisis,108,D5742 (76%); D57439 (75%); D57438 (69%); D571 (58%); D57434 (55%)
D57451,Sickle-cell thalassemia beta plus with acute chest syndrome,108,D57431 (80%); D5742 (51%); D57439 (51%); D57434 (50%); D57433 (48%)
D57452,Sickle-cell thalassemia beta plus with splenic sequestration,108,D57432 (81%); D5742 (50%); D57439 (49%); D57434 (49%); D57433 (46%)
D57453,Sickle-cell thalassemia beta plus with cerebral vascular involvement,108,D57433 (79%); D5742 (53%); D57439 (52%); D57434 (51%); D57438 (48%)
D57454,Sickle-cell thalassemia beta plus with dactylitis,108,D57434 (77%); D5742 (55%); D57439 (55%); D57433 (51%); D57438 (50%)
D57458,Sickle-cell thalassemia beta plus with crisis with other specified complication,108,D57438 (80%); D5742 (69%); D57439 (68%); D571 (53%); D57434 (50%)
D57459,"Sickle-cell thalassemia beta plus with crisis, unspecified",108,D57439 (76%); D5742 (75%); D57438 (68%); D571 (58%); D57434 (55%)
D5780,Other sickle-cell disorders without crisis,108,D571 (76%); D5742 (52%); D57439 (52%); D57438 (48%); H36823 (42%)
D57811,Other sickle-cell disorders with acute chest syndrome,108,D57431 (62%); D5701 (46%); H36823 (36%); H36829 (36%); H36822 (35%)
D57812,Other sickle-cell disorders with splenic sequestration,108,D57432 (65%); D5702 (51%); H36823 (34%); H36829 (34%); H36822 (33%)
D57813,Other sickle-cell disorders with cerebral vascular involvement,108,D57433 (60%); D5703 (43%); H36823 (37%); H36829 (37%); H36822 (36%)
D57814,Other sickle-cell disorders with dactylitis,108,D57434 (56%); H36823 (40%); H36829 (40%); H36822 (39%); H36821 (39%)
D57818,Other sickle-cell disorders with crisis with other specified complication,108,D571 (66%); D57438 (62%); D5709 (46%); D5742 (45%); D57439 (45%)
D57819,"Other sickle-cell disorders with crisis, unspecified",108,D571 (75%); D57439 (54%); D5742 (52%); D57438 (47%); H36829 (45%)
D580,Hereditary spherocytosis,,
D581,Hereditary elliptocytosis,,
D582,Other hemoglobinopathies,,
D588,Other specified hereditary hemolytic anemias,,
D589,"Hereditary hemolytic anemia, unspecified",,
D590,Drug-induced autoimmune hemolytic anemia,,
D5910,"Autoimmune hemolytic anemia, unspecified",109,K754 (45%); D464 (39%); E310 (37%); D4620 (26%); D461 (24%)
D5911,Warm autoimmune hemolytic anemia,109,K754 (37%); E310 (30%); D464 (29%); D461 (20%); D4621 (19%)
D5912,Cold autoimmune hemolytic anemia,109,K754 (38%); E310 (31%); D464 (30%); X832XXA (27%); T485X2A (26%)
D5913,Mixed type autoimmune hemolytic anemia,109,K754 (39%); E310 (32%); D464 (30%); C8120 (23%); C8127 (23%)
D5919,Other autoimmune hemolytic anemia,109,K754 (46%); E310 (37%); D464 (36%); D461 (24%); D4621 (24%)
D592,Drug-induced nonautoimmune hemolytic anemia,,
D5930,"Hemolytic-uremic syndrome, unspecified",109,G839 (26%); E340 (22%); D469 (21%); M05059 (21%); M0500 (21%)
D5931,Infection-associated hemolytic-uremic syndrome,109,J95851 (24%); K9402 (23%); K9422 (23%); T8623 (23%); C802 (23%)
D5932,Hereditary hemolytic-uremic syndrome,109,G119 (35%); D800 (32%); G118 (32%); G114 (29%); E800 (27%)
D5939,Other hemolytic-uremic syndrome,109,E340 (23%); G839 (21%); G8382 (20%); G8383 (20%); D469 (17%)
D594,Other nonautoimmune hemolytic anemias,109,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D595,Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli],109,I479 (29%); I480 (26%); A0104 (0%); A0105 (0%); A021 (0%)
D596,Hemoglobinuria due to hemolysis from other external causes,109,G40501 (38%); G40509 (38%); T71192A (19%); C4320 (18%); C4322 (18%)
D598,Other acquired hemolytic anemias,109,Z89449 (33%); Z89439 (33%); Z89442 (33%); Z89441 (33%); Z89432 (33%)
D599,"Acquired hemolytic anemia, unspecified",109,D464 (40%); Z89449 (39%); Z89439 (39%); Z89519 (35%); Z89619 (35%)
D600,Chronic acquired pure red cell aplasia,109,Z89449 (25%); Z89439 (25%); Z89442 (25%); Z89441 (25%); Z89432 (25%)
D601,Transient acquired pure red cell aplasia,,
D608,Other acquired pure red cell aplasias,109,Z89449 (25%); Z89439 (25%); Z89442 (25%); Z89441 (25%); Z89432 (25%)
D609,"Acquired pure red cell aplasia, unspecified",109,Z89449 (28%); Z89439 (28%); Z89519 (26%); Z89619 (26%); Z89442 (25%)
D6101,Constitutional (pure) red blood cell aplasia,109,T372X2A (19%); C8300 (15%); C8307 (15%); C8302 (13%); C8306 (13%)
D6102,Shwachman-Diamond syndrome,109,E340 (19%); G839 (18%); G8382 (17%); G8383 (17%); D469 (15%)
D6109,Other constitutional aplastic anemia,109,D464 (32%); D461 (22%); D4621 (22%); D4622 (22%); D4620 (21%)
D611,Drug-induced aplastic anemia,,
D612,Aplastic anemia due to other external agents,109,D464 (30%); T498X2A (23%); T440X2A (22%); T508X2A (22%); C4320 (21%)
D613,Idiopathic aplastic anemia,109,D464 (37%); D461 (25%); M87059 (25%); D4621 (25%); D4622 (25%)
D61810,Antineoplastic chemotherapy induced pancytopenia,,
D61811,Other drug-induced pancytopenia,,
D61818,Other pancytopenia,109,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D6182,Myelophthisis,109,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D6189,Other specified aplastic anemias and other bone marrow failure syndromes,109,T8602 (54%); C7952 (41%); Z9481 (40%); T8609 (39%); T8603 (39%)
D619,"Aplastic anemia, unspecified",,
D640,Hereditary sideroblastic anemia,109,G119 (37%); D800 (34%); G118 (34%); D464 (34%); G114 (30%)
D641,Secondary sideroblastic anemia due to disease,109,D464 (35%); M87353 (25%); M87352 (25%); M87351 (25%); M8738 (24%)
D642,Secondary sideroblastic anemia due to drugs and toxins,,
D643,Other sideroblastic anemias,109,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D644,Congenital dyserythropoietic anemia,109,D464 (34%); G7129 (34%); G7120 (33%); Q038 (32%); Q039 (32%)
D65,Disseminated intravascular coagulation [defibrination syndrome],,
D66,Hereditary factor VIII deficiency,111,D681 (61%); D682 (42%); G119 (33%); D800 (30%); G118 (30%)
D67,Hereditary factor IX deficiency,111,D681 (61%); D682 (42%); G119 (33%); D800 (30%); G118 (30%)
D6800,"Von Willebrand disease, unspecified",112,E7401 (49%); Q8583 (29%); G959 (25%); K50919 (22%); B259 (21%)
D6801,"Von Willebrand disease, type 1",112,E7401 (48%); Q8583 (29%); E10630 (22%); E11630 (22%); E1022 (21%)
D68020,"Von Willebrand disease, type 2A",112,E7401 (38%); Q8583 (23%); E10630 (17%); E11630 (17%); E1022 (17%)
D68021,"Von Willebrand disease, type 2B",112,E7401 (38%); Q8583 (23%); E10630 (17%); E11630 (17%); E1022 (17%)
D68022,"Von Willebrand disease, type 2M",112,E7401 (38%); Q8583 (23%); E10630 (17%); E11630 (17%); E1022 (17%)
D68023,"Von Willebrand disease, type 2N",112,E7401 (38%); Q8583 (23%); E10630 (17%); E11630 (17%); E1022 (17%)
D68029,"Von Willebrand disease, type 2, unspecified",112,E7401 (47%); Q8583 (28%); G959 (24%); K50919 (21%); E10630 (21%)
D6803,"Von Willebrand disease, type 3",112,E7401 (48%); Q8583 (29%); E10630 (22%); E11630 (22%); E1022 (21%)
D6804,Acquired von Willebrand disease,112,E7401 (43%); Z89449 (32%); Z89439 (32%); Z89442 (32%); Z89441 (32%)
D6809,Other von Willebrand disease,112,E7401 (50%); Q8583 (30%); G959 (20%); I120 (18%); G20 (17%)
D681,Hereditary factor XI deficiency,112,D66 (61%); D67 (61%); G119 (33%); D800 (30%); G118 (30%)
D682,Hereditary deficiency of other clotting factors,112,D66 (42%); D67 (42%); G119 (30%); D800 (27%); G118 (27%)
D68311,Acquired hemophilia,112,Z89449 (38%); Z89439 (38%); Z89442 (37%); Z89441 (37%); Z89432 (37%)
D68312,Antiphospholipid antibody with hemorrhagic disorder,,
D68318,"Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors",,
D6832,Hemorrhagic disorder due to extrinsic circulating anticoagulants,,
D684,Acquired coagulation factor deficiency,,
D6851,Activated protein C resistance,,
D6852,Prothrombin gene mutation,,
D6859,Other primary thrombophilia,,
D6861,Antiphospholipid syndrome,,
D6862,Lupus anticoagulant syndrome,,
D6869,Other thrombophilia,,
D688,Other specified coagulation defects,,
D689,"Coagulation defect, unspecified",,
D690,Allergic purpura,,
D691,Qualitative platelet defects,112,D841 (37%); E803 (30%); A0104 (0%); A0105 (0%); A021 (0%)
D692,Other nonthrombocytopenic purpura,,
D693,Immune thrombocytopenic purpura,112,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D6941,Evans syndrome,112,E340 (26%); G839 (25%); G8382 (23%); G8383 (23%); D469 (20%)
D6942,Congenital and hereditary thrombocytopenia purpura,112,G119 (31%); D800 (29%); G118 (29%); G7129 (28%); G7120 (27%)
D6949,Other primary thrombocytopenia,112,C801 (47%); E7253 (36%); G1223 (36%); I270 (36%); C228 (36%)
D696,"Thrombocytopenia, unspecified",,
D698,Other specified hemorrhagic conditions,,
D699,"Hemorrhagic condition, unspecified",,
D700,Congenital agranulocytosis,115,G7129 (40%); G7120 (39%); Q038 (38%); Q039 (37%); Q046 (31%)
D701,Agranulocytosis secondary to cancer chemotherapy,,
D702,Other drug-induced agranulocytosis,,
D703,Neutropenia due to infection,,
D704,Cyclic neutropenia,115,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D708,Other neutropenia,,
D709,"Neutropenia, unspecified",,
D71,Functional disorders of polymorphonuclear neutrophils,115,Q432 (49%); R532 (36%); F258 (25%); F22 (24%); G7089 (23%)
D720,Genetic anomalies of leukocytes,115,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D7581,Myelofibrosis,19,C9441 (59%); C9442 (58%); C9440 (50%); A0104 (0%); A0105 (0%)
D75821,Non-immune heparin-induced thrombocytopenia,,
D75822,Immune-mediated heparin-induced thrombocytopenia,,
D75828,Other heparin-induced thrombocytopenia syndrome,,
D75829,"Heparin-induced thrombocytopenia, unspecified",,
D7584,Other platelet-activating anti-PF4 disorders,112,T490X2A (25%); F258 (23%); F22 (21%); G7089 (21%); J99 (21%)
D761,Hemophagocytic lymphohistiocytosis,115,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D762,"Hemophagocytic syndrome, infection-associated",,
D763,Other histiocytosis syndromes,115,G8389 (40%); C966 (40%); J8482 (40%); D46Z (38%); C965 (37%)
D800,Hereditary hypogammaglobulinemia,115,G119 (42%); G118 (38%); D640 (34%); G114 (34%); D5932 (32%)
D801,Nonfamilial hypogammaglobulinemia,,
D802,Selective deficiency of immunoglobulin A [IgA],115,T50Z12A (33%); D8132 (22%); D8139 (22%); D8130 (21%); E8801 (21%)
D803,Selective deficiency of immunoglobulin G [IgG] subclasses,115,T50Z12A (29%); D8132 (19%); D8139 (19%); D8130 (19%); E8801 (18%)
D804,Selective deficiency of immunoglobulin M [IgM],115,T50Z12A (33%); D8132 (22%); D8139 (22%); D8130 (22%); E8801 (21%)
D805,Immunodeficiency with increased immunoglobulin M [IgM],115,T50Z12A (32%); D819 (32%); D839 (23%); B20 (18%); D8131 (18%)
D806,Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia,,
D807,Transient hypogammaglobulinemia of infancy,,
D808,Other immunodeficiencies with predominantly antibody defects,,
D809,"Immunodeficiency with predominantly antibody defects, unspecified",,
D810,Severe combined immunodeficiency [SCID] with reticular dysgenesis,114,D805 (16%); B20 (16%); F03C4 (15%); F03C11 (14%); B9735 (13%)
D811,Severe combined immunodeficiency [SCID] with low T- and B-cell numbers,114,D805 (16%); B20 (16%); C8300 (16%); C8307 (15%); F03C4 (15%)
D812,Severe combined immunodeficiency [SCID] with low or normal B-cell numbers,114,G912 (27%); D805 (15%); B20 (15%); C8300 (14%); C8307 (14%)
D8130,"Adenosine deaminase deficiency, unspecified",114,E8801 (25%); D66 (24%); D67 (24%); D681 (24%); D804 (22%)
D8131,Severe combined immunodeficiency due to adenosine deaminase deficiency,114,E8801 (19%); D66 (19%); D67 (19%); D681 (19%); D805 (18%)
D8132,Adenosine deaminase 2 deficiency,114,E8801 (25%); D66 (24%); D67 (24%); D681 (24%); D804 (22%)
D8139,Other adenosine deaminase deficiency,114,E8801 (25%); D66 (24%); D67 (24%); D681 (24%); D804 (22%)
D814,Nezelof's syndrome,115,E340 (26%); G839 (25%); G8382 (23%); G8383 (23%); D469 (20%)
D815,Purine nucleoside phosphorylase [PNP] deficiency,114,E8801 (17%); D66 (16%); D67 (16%); D681 (16%); D804 (15%)
D816,Major histocompatibility complex class I deficiency,114,R5601 (23%); C089 (21%); F331 (20%); E8801 (19%); F321 (19%)
D817,Major histocompatibility complex class II deficiency,114,R5601 (22%); C089 (21%); F331 (20%); E8801 (18%); F321 (18%)
D8182,Activated Phosphoinositide 3-kinase Delta Syndrome [APDS],114,D562 (26%); B180 (20%); B181 (20%); G4042 (19%); E340 (13%)
D8189,Other combined immunodeficiencies,114,G320 (23%); I5040 (16%); E103543 (16%); E103543 (16%); E113543 (16%)
D819,"Combined immunodeficiency, unspecified",114,D805 (32%); B20 (32%); B9735 (27%); Z21 (26%); G320 (26%)
D820,Wiskott-Aldrich syndrome,115,E340 (19%); G839 (18%); G8382 (17%); G8383 (17%); D469 (15%)
D821,Di George's syndrome,115,E340 (19%); G839 (18%); G8382 (17%); G8383 (17%); D469 (15%)
D822,Immunodeficiency with short-limbed stature,,
D823,Immunodeficiency following hereditary defective response to Epstein-Barr virus,,
D824,Hyperimmunoglobulin E [IgE] syndrome,,
D828,Immunodeficiency associated with other specified major defects,,
D829,"Immunodeficiency associated with major defect, unspecified",,
D830,Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function,114,C8100 (16%); T485X2A (15%); C8107 (15%); C8102 (14%); C8106 (14%)
D831,Common variable immunodeficiency with predominant immunoregulatory T-cell disorders,114,D5780 (27%); D57819 (27%); D57814 (26%); D57813 (24%); D57818 (23%)
D832,Common variable immunodeficiency with autoantibodies to B- or T-cells,114,C964 (35%); Z9484 (27%); T485X2A (19%); D805 (17%); B20 (17%)
D838,Other common variable immunodeficiencies,114,T485X2A (24%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
D839,"Common variable immunodeficiency, unspecified",114,T485X2A (26%); D805 (23%); B20 (23%); B9735 (19%); Z21 (19%)
D840,Lymphocyte function antigen-1 [LFA-1] defect,,
D841,Defects in the complement system,115,D691 (37%); E803 (37%); A0104 (0%); A0105 (0%); A021 (0%)
D8481,Immunodeficiency due to conditions classified elsewhere,,
D84821,Immunodeficiency due to drugs,,
D84822,Immunodeficiency due to external causes,,
D8489,Other immunodeficiencies,,
D849,"Immunodeficiency, unspecified",,
D860,Sarcoidosis of lung,,
D862,Sarcoidosis of lung with sarcoidosis of lymph nodes,,
D863,Sarcoidosis of skin,387,L98491 (35%); C439 (33%); E10622 (33%); E10622 (33%); E11622 (33%)
D8682,Multiple cranial nerve palsies in sarcoidosis,,
D8684,Sarcoid pyelonephritis,,
D8686,Sarcoid arthropathy,93,M029 (34%); E10618 (33%); E11618 (33%); E13618 (32%); M02159 (30%)
D8687,Sarcoid myositis,93,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
D890,Polyclonal hypergammaglobulinemia,,
D891,Cryoglobulinemia,,
D893,Immune reconstitution syndrome,,
D8940,"Mast cell activation, unspecified",,
D8941,Monoclonal mast cell activation syndrome,,
D8942,Idiopathic mast cell activation syndrome,,
D8943,Secondary mast cell activation,,
D8944,Hereditary alpha tryptasemia,,
D8949,Other mast cell activation disorder,,
D89810,Acute graft-versus-host disease,454,K56699 (24%); I249 (24%); K56609 (24%); K5650 (23%); I248 (20%)
D89811,Chronic graft-versus-host disease,454,K56699 (25%); K56609 (24%); K5650 (24%); I120 (23%); N185 (23%)
D89812,Acute on chronic graft-versus-host disease,454,J441 (25%); J440 (23%); K56699 (23%); I50813 (23%); I249 (23%)
D89813,"Graft-versus-host disease, unspecified",454,K56609 (29%); K56699 (27%); K5650 (26%); G959 (21%); K50919 (19%)
D8982,Autoimmune lymphoproliferative syndrome [ALPS],,
D8984,IgG4-related disease,115,G128 (21%); C969 (20%); M308 (20%); H353230 (19%); H353220 (19%)
D8989,"Other specified disorders involving the immune mechanism, not elsewhere classified",,
D899,"Disorder involving the immune mechanism, unspecified",,
E000,"Congenital iodine-deficiency syndrome, neurological type",,
E001,"Congenital iodine-deficiency syndrome, myxedematous type",,
E002,"Congenital iodine-deficiency syndrome, mixed type",,
E009,"Congenital iodine-deficiency syndrome, unspecified",,
E010,Iodine-deficiency related diffuse (endemic) goiter,,
E011,Iodine-deficiency related multinodular (endemic) goiter,,
E012,"Iodine-deficiency related (endemic) goiter, unspecified",,
E018,Other iodine-deficiency related thyroid disorders and allied conditions,,
E02,Subclinical iodine-deficiency hypothyroidism,,
E030,Congenital hypothyroidism with diffuse goiter,,
E031,Congenital hypothyroidism without goiter,,
E032,Hypothyroidism due to medicaments and other exogenous substances,,
E033,Postinfectious hypothyroidism,,
E034,Atrophy of thyroid (acquired),,
E035,Myxedema coma,202,K7290 (26%); K7291 (26%); E1010 (25%); E1011 (25%); E10641 (25%)
E038,Other specified hypothyroidism,,
E039,"Hypothyroidism, unspecified",,
E040,Nontoxic diffuse goiter,,
E041,Nontoxic single thyroid nodule,,
E042,Nontoxic multinodular goiter,,
E048,Other specified nontoxic goiter,,
E049,"Nontoxic goiter, unspecified",,
E0500,Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm,,
E0501,Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm,,
E0510,Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm,,
E0511,Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm,,
E0520,Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm,,
E0521,Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm,,
E0530,Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm,,
E0531,Thyrotoxicosis from ectopic thyroid tissue with thyrotoxic crisis or storm,,
E0540,Thyrotoxicosis factitia without thyrotoxic crisis or storm,,
E0541,Thyrotoxicosis factitia with thyrotoxic crisis or storm,,
E0580,Other thyrotoxicosis without thyrotoxic crisis or storm,,
E0581,Other thyrotoxicosis with thyrotoxic crisis or storm,,
E0590,"Thyrotoxicosis, unspecified without thyrotoxic crisis or storm",,
E0591,"Thyrotoxicosis, unspecified with thyrotoxic crisis or storm",,
E060,Acute thyroiditis,,
E061,Subacute thyroiditis,,
E062,Chronic thyroiditis with transient thyrotoxicosis,,
E063,Autoimmune thyroiditis,,
E064,Drug-induced thyroiditis,,
E065,Other chronic thyroiditis,,
E069,"Thyroiditis, unspecified",,
E070,Hypersecretion of calcitonin,,
E071,Dyshormogenetic goiter,,
E0789,Other specified disorders of thyroid,,
E079,"Disorder of thyroid, unspecified",,
E0800,Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC),36,E08649 (39%); R402A (36%); E089 (34%); E088 (33%); E08621 (33%)
E0801,Diabetes mellitus due to underlying condition with hyperosmolarity with coma,36,E08649 (64%); R402A (59%); E089 (56%); E088 (55%); E08621 (55%)
E0810,Diabetes mellitus due to underlying condition with ketoacidosis without coma,36,E08649 (65%); R402A (60%); E089 (57%); E088 (56%); E08621 (56%)
E0811,Diabetes mellitus due to underlying condition with ketoacidosis with coma,36,E08649 (65%); R402A (60%); E089 (57%); E088 (56%); E08621 (56%)
E0821,Diabetes mellitus due to underlying condition with diabetic nephropathy,37,E08311 (60%); E089 (59%); E088 (57%); E08621 (57%); E08622 (54%)
E0821,Diabetes mellitus due to underlying condition with diabetic nephropathy,,
E0822,Diabetes mellitus due to underlying condition with diabetic chronic kidney disease,37,E08311 (58%); E089 (57%); N185 (56%); E088 (56%); E08621 (56%)
E0822,Diabetes mellitus due to underlying condition with diabetic chronic kidney disease,,
E0829,Diabetes mellitus due to underlying condition with other diabetic kidney complication,37,E08311 (57%); E089 (56%); E088 (55%); E08621 (55%); E08622 (52%)
E0829,Diabetes mellitus due to underlying condition with other diabetic kidney complication,,
E08311,Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema,37,E08311 (100%); E083519 (89%); E083599 (89%); E083513 (86%); E083593 (86%)
E08311,Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema,298,E08311 (100%); E08319 (100%); E083519 (89%); E083599 (89%); E083513 (86%)
E08319,Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema,37,E08311 (100%); E083519 (89%); E083599 (89%); E083513 (86%); E083593 (86%)
E083211,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye",37,E083211 (100%); E083219 (97%); E083212 (96%); E083213 (89%); E083411 (86%)
E083211,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye",298,E083211 (100%); E083291 (100%); E083219 (97%); E083299 (97%); E083212 (96%)
E083212,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye",37,E083212 (100%); E083219 (97%); E083211 (96%); E083213 (89%); E083412 (86%)
E083212,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye",298,E083212 (100%); E083292 (100%); E083219 (97%); E083299 (97%); E083211 (96%)
E083213,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral",37,E083213 (100%); E083219 (90%); E083212 (89%); E083211 (89%); E083413 (86%)
E083213,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral",298,E083213 (100%); E083293 (100%); E083219 (90%); E083299 (90%); E083212 (89%)
E083219,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E083219 (100%); E083212 (97%); E083211 (97%); E083213 (90%); E083419 (86%)
E083219,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E083219 (100%); E083299 (100%); E083212 (97%); E083292 (97%); E083211 (97%)
E083291,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, right eye",37,E083211 (100%); E083219 (97%); E083212 (96%); E083213 (89%); E083411 (86%)
E083292,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, left eye",37,E083212 (100%); E083219 (97%); E083211 (96%); E083213 (89%); E083412 (86%)
E083293,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, bilateral",37,E083213 (100%); E083219 (90%); E083212 (89%); E083211 (89%); E083413 (86%)
E083299,"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E083219 (100%); E083212 (97%); E083211 (97%); E083213 (90%); E083419 (86%)
E083311,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, right eye",37,E083311 (99%); E083319 (97%); E083312 (96%); E083313 (89%); E083411 (86%)
E083311,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, right eye",298,E083311 (99%); E083391 (99%); E083319 (97%); E083399 (97%); E083312 (96%)
E083312,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, left eye",37,E083312 (99%); E083319 (97%); E083311 (96%); E083313 (89%); E083412 (86%)
E083312,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, left eye",298,E083312 (99%); E083392 (99%); E083319 (97%); E083399 (97%); E083311 (96%)
E083313,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, bilateral",37,E083313 (100%); E083319 (90%); E083312 (89%); E083311 (89%); E083413 (86%)
E083313,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, bilateral",298,E083313 (100%); E083393 (100%); E083319 (90%); E083399 (90%); E083312 (89%)
E083319,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E083319 (100%); E083312 (97%); E083311 (97%); E083313 (90%); E083419 (86%)
E083319,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E083319 (100%); E083399 (100%); E083312 (97%); E083392 (97%); E083311 (97%)
E083391,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, right eye",37,E083311 (99%); E083319 (97%); E083312 (96%); E083313 (89%); E083411 (86%)
E083392,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, left eye",37,E083312 (99%); E083319 (97%); E083311 (96%); E083313 (89%); E083412 (86%)
E083393,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, bilateral",37,E083313 (100%); E083319 (90%); E083312 (89%); E083311 (89%); E083413 (86%)
E083399,"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E083319 (100%); E083312 (97%); E083311 (97%); E083313 (90%); E083419 (86%)
E083411,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, right eye",37,E083411 (99%); E083419 (97%); E083412 (96%); E083413 (89%); E083311 (86%)
E083411,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, right eye",298,E083411 (99%); E083491 (99%); E083419 (97%); E083499 (97%); E083412 (96%)
E083412,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, left eye",37,E083412 (100%); E083419 (97%); E083411 (96%); E083413 (89%); E083312 (86%)
E083412,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, left eye",298,E083412 (100%); E083492 (100%); E083419 (97%); E083499 (97%); E083411 (96%)
E083413,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, bilateral",37,E083413 (100%); E083419 (90%); E083412 (89%); E083411 (89%); E083313 (86%)
E083413,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, bilateral",298,E083413 (100%); E083493 (100%); E083419 (90%); E083499 (90%); E083412 (89%)
E083419,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E083419 (100%); E083412 (97%); E083411 (97%); E083413 (90%); E083319 (86%)
E083419,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E083419 (100%); E083499 (100%); E083412 (97%); E083492 (97%); E083411 (97%)
E083491,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, right eye",37,E083411 (99%); E083419 (97%); E083412 (96%); E083413 (89%); E083311 (86%)
E083492,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, left eye",37,E083412 (100%); E083419 (97%); E083411 (96%); E083413 (89%); E083312 (86%)
E083493,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, bilateral",37,E083413 (100%); E083419 (90%); E083412 (89%); E083411 (89%); E083313 (86%)
E083499,"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E083419 (100%); E083412 (97%); E083411 (97%); E083413 (90%); E083319 (86%)
E083511,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, right eye",37,E083511 (100%); E083591 (100%); E083519 (96%); E083599 (96%); E083512 (95%)
E083511,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, right eye",298,E083511 (100%); E083591 (100%); E083519 (96%); E083599 (96%); E083512 (95%)
E083512,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, left eye",37,E083512 (100%); E083592 (100%); E083519 (96%); E083599 (96%); E083511 (95%)
E083512,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, left eye",298,E083512 (100%); E083592 (100%); E083519 (96%); E083599 (96%); E083511 (95%)
E083513,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, bilateral",37,E083513 (100%); E083593 (100%); E083519 (88%); E083599 (88%); E083512 (87%)
E083513,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, bilateral",298,E083513 (100%); E083593 (100%); E083519 (88%); E083599 (88%); E083512 (87%)
E083519,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, unspecified eye",37,E083519 (100%); E083599 (100%); E083512 (96%); E083592 (96%); E083511 (96%)
E083519,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, unspecified eye",298,E083519 (100%); E083599 (100%); E083512 (96%); E083592 (96%); E083511 (96%)
E083521,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye",37,E083521 (100%); E083531 (100%); E083529 (97%); E083539 (97%); E083522 (97%)
E083521,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye",298,E083521 (100%); E083531 (100%); E083529 (97%); E083539 (97%); E083522 (97%)
E083522,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye",37,E083522 (100%); E083532 (100%); E083529 (97%); E083539 (97%); E083521 (97%)
E083522,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye",298,E083522 (100%); E083532 (100%); E083529 (97%); E083539 (97%); E083521 (97%)
E083523,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral",37,E083523 (100%); E083533 (100%); E083529 (92%); E083539 (92%); E083522 (91%)
E083523,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral",298,E083523 (100%); E083533 (100%); E083529 (92%); E083539 (92%); E083522 (91%)
E083529,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye",37,E083529 (100%); E083539 (100%); E083522 (97%); E083532 (97%); E083521 (97%)
E083529,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye",298,E083529 (100%); E083539 (100%); E083522 (97%); E083532 (97%); E083521 (97%)
E083531,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye",37,E083521 (100%); E083531 (100%); E083529 (97%); E083539 (97%); E083522 (97%)
E083531,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye",298,E083521 (100%); E083531 (100%); E083529 (97%); E083539 (97%); E083522 (97%)
E083532,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye",37,E083522 (100%); E083532 (100%); E083529 (97%); E083539 (97%); E083521 (97%)
E083532,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye",298,E083522 (100%); E083532 (100%); E083529 (97%); E083539 (97%); E083521 (97%)
E083533,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral",37,E083523 (100%); E083533 (100%); E083529 (92%); E083539 (92%); E083522 (91%)
E083533,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral",298,E083523 (100%); E083533 (100%); E083529 (92%); E083539 (92%); E083522 (91%)
E083539,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye",37,E083529 (100%); E083539 (100%); E083522 (97%); E083532 (97%); E083521 (97%)
E083539,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye",298,E083529 (100%); E083539 (100%); E083522 (97%); E083532 (97%); E083521 (97%)
E083541,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye",37,E083541 (100%); E083549 (98%); E083542 (98%); E083543 (95%); E103541 (93%)
E083541,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye",298,E083541 (100%); E083549 (98%); E083542 (98%); E083543 (95%); E103541 (93%)
E083542,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye",37,E083542 (100%); E083549 (98%); E083541 (98%); E083543 (95%); E103542 (93%)
E083542,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye",298,E083542 (100%); E083549 (98%); E083541 (98%); E083543 (95%); E103542 (93%)
E083543,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral",37,E083543 (100%); E083549 (95%); E083542 (95%); E083541 (95%); E103543 (93%)
E083543,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral",298,E083543 (100%); E083549 (95%); E083542 (95%); E083541 (95%); E103543 (93%)
E083549,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye",37,E083549 (100%); E083542 (98%); E083541 (98%); E083543 (95%); E103549 (93%)
E083549,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye",298,E083549 (100%); E083542 (98%); E083541 (98%); E083543 (95%); E103549 (93%)
E083551,"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, right eye",37,E083551 (100%); E083559 (96%); E083552 (95%); E083553 (87%); E103551 (82%)
E083551,"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, right eye",298,E083551 (100%); E083559 (96%); E083552 (95%); E083553 (87%); E103551 (82%)
E083552,"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, left eye",37,E083552 (100%); E083559 (96%); E083551 (95%); E083553 (87%); E103552 (82%)
E083552,"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, left eye",298,E083552 (100%); E083559 (96%); E083551 (95%); E083553 (87%); E103552 (82%)
E083553,"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, bilateral",37,E083553 (100%); E083559 (87%); E083552 (87%); E083551 (87%); E103553 (81%)
E083553,"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, bilateral",298,E083553 (100%); E083559 (87%); E083552 (87%); E083551 (87%); E103553 (81%)
E083559,"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, unspecified eye",37,E083559 (100%); E083552 (96%); E083551 (96%); E083553 (87%); E103559 (81%)
E083559,"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, unspecified eye",298,E083559 (100%); E083552 (96%); E083551 (96%); E083553 (87%); E103559 (81%)
E083591,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, right eye",37,E083511 (100%); E083591 (100%); E083519 (96%); E083599 (96%); E083512 (95%)
E083591,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, right eye",298,E083511 (100%); E083591 (100%); E083519 (96%); E083599 (96%); E083512 (95%)
E083592,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, left eye",37,E083512 (100%); E083592 (100%); E083519 (96%); E083599 (96%); E083511 (95%)
E083592,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, left eye",298,E083512 (100%); E083592 (100%); E083519 (96%); E083599 (96%); E083511 (95%)
E083593,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, bilateral",37,E083513 (100%); E083593 (100%); E083519 (88%); E083599 (88%); E083512 (87%)
E083593,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, bilateral",298,E083513 (100%); E083593 (100%); E083519 (88%); E083599 (88%); E083512 (87%)
E083599,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, unspecified eye",37,E083519 (100%); E083599 (100%); E083512 (96%); E083592 (96%); E083511 (96%)
E083599,"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, unspecified eye",298,E083519 (100%); E083599 (100%); E083512 (96%); E083592 (96%); E083511 (96%)
E0836,Diabetes mellitus due to underlying condition with diabetic cataract,37,E08311 (59%); E089 (58%); E088 (57%); E08621 (57%); E08622 (54%)
E0837X1,"Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, right eye",37,E083511 (67%); E083591 (67%); E083519 (64%); E083599 (64%); E083512 (63%)
E0837X2,"Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, left eye",37,E083512 (67%); E083592 (67%); E083519 (64%); E083599 (64%); E083511 (63%)
E0837X3,"Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, bilateral",37,E083513 (66%); E083593 (66%); E08311 (64%); E083413 (61%); E083313 (61%)
E0837X9,"Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, unspecified eye",37,E083519 (66%); E083599 (66%); E08311 (66%); E083512 (64%); E083592 (64%)
E0839,Diabetes mellitus due to underlying condition with other diabetic ophthalmic complication,37,E08311 (53%); E089 (53%); E088 (52%); E08621 (52%); E08622 (49%)
E0840,"Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified",37,E08311 (63%); E088 (62%); E089 (59%); E08621 (58%); E083559 (57%)
E0840,"Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified",,
E0841,Diabetes mellitus due to underlying condition with diabetic mononeuropathy,37,E08311 (59%); E089 (58%); E088 (57%); E08621 (57%); E08622 (54%)
E0841,Diabetes mellitus due to underlying condition with diabetic mononeuropathy,,
E0842,Diabetes mellitus due to underlying condition with diabetic polyneuropathy,37,E08311 (64%); E089 (63%); E088 (62%); E08621 (62%); E08622 (59%)
E0842,Diabetes mellitus due to underlying condition with diabetic polyneuropathy,,
E0843,Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy,37,E08311 (45%); E089 (45%); E088 (44%); E08621 (44%); E08622 (41%)
E0843,Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy,,
E0844,Diabetes mellitus due to underlying condition with diabetic amyotrophy,37,E08311 (59%); E089 (58%); E088 (57%); E08621 (57%); E08622 (54%)
E0844,Diabetes mellitus due to underlying condition with diabetic amyotrophy,,
E0849,Diabetes mellitus due to underlying condition with other diabetic neurological complication,37,E08311 (53%); E089 (53%); E088 (52%); E08621 (52%); E08622 (49%)
E0849,Diabetes mellitus due to underlying condition with other diabetic neurological complication,,
E0851,Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene,37,E0852 (100%); E1052 (85%); E1152 (85%); E1352 (83%); E08311 (50%)
E0851,Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene,,
E0852,Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene,37,E0852 (100%); E1052 (85%); E1152 (85%); E1352 (83%); E08311 (50%)
E0852,Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene,263,E0851 (100%); E0852 (100%); E1051 (85%); E1052 (85%); E1151 (85%)
E0859,Diabetes mellitus due to underlying condition with other circulatory complications,37,E089 (78%); E088 (77%); E08621 (54%); E109 (53%); E119 (53%)
E08610,Diabetes mellitus due to underlying condition with diabetic neuropathic arthropathy,37,E08311 (54%); E089 (54%); E088 (52%); E08621 (52%); E08622 (50%)
E08618,Diabetes mellitus due to underlying condition with other diabetic arthropathy,37,E08311 (67%); E089 (66%); E088 (64%); E08621 (64%); E08622 (61%)
E08620,Diabetes mellitus due to underlying condition with diabetic dermatitis,37,E08311 (59%); E089 (58%); E088 (57%); E08621 (57%); E08622 (54%)
E08621,Diabetes mellitus due to underlying condition with foot ulcer,37,E08621 (100%); E08622 (77%); E10621 (69%); E11621 (69%); E089 (69%)
E08621,Diabetes mellitus due to underlying condition with foot ulcer,383,E08621 (100%); E08622 (77%); E10621 (69%); E11621 (69%); E089 (69%)
E08622,Diabetes mellitus due to underlying condition with other skin ulcer,37,E08622 (100%); E08621 (77%); E10622 (72%); E11622 (72%); E13622 (70%)
E08622,Diabetes mellitus due to underlying condition with other skin ulcer,383,E08622 (100%); E08628 (82%); E08621 (77%); E10622 (72%); E11622 (72%)
E08628,Diabetes mellitus due to underlying condition with other skin complications,37,E089 (87%); E088 (85%); E08622 (82%); E08621 (60%); E109 (59%)
E08630,Diabetes mellitus due to underlying condition with periodontal disease,37,E089 (58%); E088 (56%); E08621 (56%); E08622 (53%); E0865 (50%)
E08638,Diabetes mellitus due to underlying condition with other oral complications,37,E089 (80%); E088 (78%); E08621 (55%); E109 (54%); E119 (54%)
E08641,Diabetes mellitus due to underlying condition with hypoglycemia with coma,36,E08649 (100%); E10649 (79%); E11649 (79%); E13649 (77%); R402A (60%)
E08649,Diabetes mellitus due to underlying condition with hypoglycemia without coma,38,E08641 (100%); E10641 (79%); E11641 (79%); E13641 (77%); E0810 (65%)
E0865,Diabetes mellitus due to underlying condition with hyperglycemia,38,E08621 (60%); E08621 (60%); E08618 (57%); E08622 (57%); E08622 (57%)
E0869,Diabetes mellitus due to underlying condition with other specified complication,37,E089 (65%); E088 (63%); E08621 (63%); E08622 (60%); E0865 (56%)
E088,Diabetes mellitus due to underlying condition with unspecified complications,38,E08628 (85%); E08638 (78%); E0859 (77%); E08621 (67%); E08621 (67%)
E089,Diabetes mellitus due to underlying condition without complications,38,E08628 (87%); E08638 (80%); E0859 (78%); E08621 (69%); E08621 (69%)
E0900,Drug or chemical induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC),,
E0901,Drug or chemical induced diabetes mellitus with hyperosmolarity with coma,,
E0910,Drug or chemical induced diabetes mellitus with ketoacidosis without coma,,
E0911,Drug or chemical induced diabetes mellitus with ketoacidosis with coma,,
E0921,Drug or chemical induced diabetes mellitus with diabetic nephropathy,,
E0921,Drug or chemical induced diabetes mellitus with diabetic nephropathy,,
E0922,Drug or chemical induced diabetes mellitus with diabetic chronic kidney disease,,
E0922,Drug or chemical induced diabetes mellitus with diabetic chronic kidney disease,,
E0929,Drug or chemical induced diabetes mellitus with other diabetic kidney complication,,
E0929,Drug or chemical induced diabetes mellitus with other diabetic kidney complication,,
E09311,Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema,,
E09319,Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy without macular edema,,
E093211,"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye",,
E093212,"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye",,
E093213,"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral",,
E093219,"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye",,
E093291,"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye",,
E093292,"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye",,
E093293,"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral",,
E093299,"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye",,
E093311,"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye",,
E093312,"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye",,
E093313,"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral",,
E093319,"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye",,
E093391,"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye",,
E093392,"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye",,
E093393,"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral",,
E093399,"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye",,
E093411,"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye",,
E093412,"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye",,
E093413,"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral",,
E093419,"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye",,
E093491,"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye",,
E093492,"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye",,
E093493,"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral",,
E093499,"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye",,
E093511,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye",,
E093511,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye",,
E093512,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye",,
E093512,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye",,
E093513,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral",,
E093513,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral",,
E093519,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye",,
E093519,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye",,
E093521,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye",,
E093521,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye",,
E093522,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye",,
E093522,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye",,
E093523,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral",,
E093523,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral",,
E093529,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye",,
E093529,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye",,
E093531,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye",,
E093531,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye",,
E093532,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye",,
E093532,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye",,
E093533,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral",,
E093533,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral",,
E093539,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye",,
E093539,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye",,
E093541,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye",,
E093541,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye",,
E093542,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye",,
E093542,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye",,
E093543,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral",,
E093543,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral",,
E093549,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye",,
E093549,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye",,
E093551,"Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, right eye",,
E093551,"Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, right eye",,
E093552,"Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, left eye",,
E093552,"Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, left eye",,
E093553,"Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, bilateral",,
E093553,"Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, bilateral",,
E093559,"Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye",,
E093559,"Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye",,
E093591,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye",,
E093591,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye",,
E093592,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye",,
E093592,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye",,
E093593,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral",,
E093593,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral",,
E093599,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye",,
E093599,"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye",,
E0936,Drug or chemical induced diabetes mellitus with diabetic cataract,,
E0937X1,"Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, right eye",,
E0937X2,"Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, left eye",,
E0937X3,"Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral",,
E0937X9,"Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye",,
E0939,Drug or chemical induced diabetes mellitus with other diabetic ophthalmic complication,,
E0940,"Drug or chemical induced diabetes mellitus with neurological complications with diabetic neuropathy, unspecified",,
E0940,"Drug or chemical induced diabetes mellitus with neurological complications with diabetic neuropathy, unspecified",,
E0941,Drug or chemical induced diabetes mellitus with neurological complications with diabetic mononeuropathy,,
E0941,Drug or chemical induced diabetes mellitus with neurological complications with diabetic mononeuropathy,,
E0942,Drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy,,
E0942,Drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy,,
E0943,Drug or chemical induced diabetes mellitus with neurological complications with diabetic autonomic (poly)neuropathy,,
E0943,Drug or chemical induced diabetes mellitus with neurological complications with diabetic autonomic (poly)neuropathy,,
E0944,Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy,,
E0944,Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy,,
E0949,Drug or chemical induced diabetes mellitus with neurological complications with other diabetic neurological complication,,
E0949,Drug or chemical induced diabetes mellitus with neurological complications with other diabetic neurological complication,,
E0951,Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene,,
E0951,Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene,,
E0952,Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene,,
E0952,Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene,,
E0959,Drug or chemical induced diabetes mellitus with other circulatory complications,,
E09610,Drug or chemical induced diabetes mellitus with diabetic neuropathic arthropathy,,
E09618,Drug or chemical induced diabetes mellitus with other diabetic arthropathy,,
E09620,Drug or chemical induced diabetes mellitus with diabetic dermatitis,,
E09621,Drug or chemical induced diabetes mellitus with foot ulcer,,
E09621,Drug or chemical induced diabetes mellitus with foot ulcer,,
E09622,Drug or chemical induced diabetes mellitus with other skin ulcer,,
E09622,Drug or chemical induced diabetes mellitus with other skin ulcer,,
E09628,Drug or chemical induced diabetes mellitus with other skin complications,,
E09630,Drug or chemical induced diabetes mellitus with periodontal disease,,
E09638,Drug or chemical induced diabetes mellitus with other oral complications,,
E09641,Drug or chemical induced diabetes mellitus with hypoglycemia with coma,,
E09649,Drug or chemical induced diabetes mellitus with hypoglycemia without coma,,
E0965,Drug or chemical induced diabetes mellitus with hyperglycemia,,
E0969,Drug or chemical induced diabetes mellitus with other specified complication,,
E098,Drug or chemical induced diabetes mellitus with unspecified complications,,
E099,Drug or chemical induced diabetes mellitus without complications,,
E1010,Type 1 diabetes mellitus with ketoacidosis without coma,36,E10649 (54%); E11649 (54%); R4020 (46%); E13649 (44%); E109 (40%)
E1011,Type 1 diabetes mellitus with ketoacidosis with coma,36,E10649 (54%); E11649 (54%); R4020 (46%); E13649 (44%); E109 (40%)
E1021,Type 1 diabetes mellitus with diabetic nephropathy,37,E10311 (46%); E11311 (46%); E109 (42%); E119 (42%); E103553 (40%)
E1021,Type 1 diabetes mellitus with diabetic nephropathy,,
E1022,Type 1 diabetes mellitus with diabetic chronic kidney disease,37,N185 (64%); N1830 (63%); I130 (62%); I120 (58%); N184 (57%)
E1022,Type 1 diabetes mellitus with diabetic chronic kidney disease,,
E1029,Type 1 diabetes mellitus with other diabetic kidney complication,37,E10311 (44%); E11311 (44%); E109 (40%); E119 (40%); E103553 (38%)
E1029,Type 1 diabetes mellitus with other diabetic kidney complication,,
E10311,Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema,37,E10311 (100%); E11311 (100%); E13311 (87%); E103519 (86%); E103599 (86%)
E10311,Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema,298,E10311 (100%); E10319 (100%); E11311 (100%); E11319 (100%); E13311 (87%)
E10319,Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema,37,E10311 (100%); E11311 (100%); E13311 (87%); E103519 (86%); E103599 (86%)
E103211,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye",37,E103211 (99%); E113211 (99%); E103219 (96%); E113219 (96%); E103212 (95%)
E103211,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye",298,E103211 (99%); E103291 (99%); E113211 (99%); E113291 (99%); E103219 (96%)
E103212,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye",37,E103212 (100%); E113212 (100%); E103219 (96%); E113219 (96%); E103211 (95%)
E103212,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye",298,E103212 (100%); E103292 (100%); E113212 (100%); E113292 (100%); E103219 (96%)
E103213,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral",37,E103213 (100%); E113213 (100%); E133213 (92%); E103219 (88%); E113219 (88%)
E103213,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral",298,E103213 (100%); E103293 (100%); E113213 (100%); E113293 (100%); E133213 (92%)
E103219,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E103219 (100%); E113219 (100%); E103212 (96%); E113212 (96%); E103211 (96%)
E103219,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E103219 (100%); E103299 (100%); E113219 (100%); E113299 (100%); E103212 (96%)
E103291,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye",37,E103211 (99%); E113211 (99%); E103219 (96%); E113219 (96%); E103212 (95%)
E103292,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye",37,E103212 (100%); E113212 (100%); E103219 (96%); E113219 (96%); E103211 (95%)
E103293,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral",37,E103213 (100%); E113213 (100%); E133213 (92%); E103219 (88%); E113219 (88%)
E103299,"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E103219 (100%); E113219 (100%); E103212 (96%); E113212 (96%); E103211 (96%)
E103311,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye",37,E103311 (99%); E113311 (99%); E103319 (96%); E113319 (96%); E103312 (95%)
E103311,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye",298,E103311 (99%); E103391 (99%); E113311 (99%); E113391 (99%); E103319 (96%)
E103312,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye",37,E103312 (100%); E113312 (100%); E103319 (96%); E113319 (96%); E103311 (95%)
E103312,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye",298,E103312 (100%); E103392 (100%); E113312 (100%); E113392 (100%); E103319 (96%)
E103313,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral",37,E103313 (100%); E113313 (100%); E133313 (92%); E103319 (88%); E113319 (88%)
E103313,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral",298,E103313 (100%); E103393 (100%); E113313 (100%); E113393 (100%); E133313 (92%)
E103319,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E103319 (99%); E113319 (99%); E103312 (96%); E113312 (96%); E103311 (96%)
E103319,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E103319 (99%); E103399 (99%); E113319 (99%); E113399 (99%); E103312 (96%)
E103391,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye",37,E103311 (99%); E113311 (99%); E103319 (96%); E113319 (96%); E103312 (95%)
E103392,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye",37,E103312 (100%); E113312 (100%); E103319 (96%); E113319 (96%); E103311 (95%)
E103393,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral",37,E103313 (100%); E113313 (100%); E133313 (92%); E103319 (88%); E113319 (88%)
E103399,"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E103319 (99%); E113319 (99%); E103312 (96%); E113312 (96%); E103311 (96%)
E103411,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye",37,E103411 (100%); E113411 (100%); E103419 (96%); E113419 (96%); E103412 (95%)
E103411,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye",298,E103411 (100%); E103491 (100%); E113411 (100%); E113491 (100%); E103419 (96%)
E103412,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye",37,E103412 (100%); E113412 (100%); E103419 (96%); E113419 (96%); E103411 (95%)
E103412,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye",298,E103412 (100%); E103492 (100%); E113412 (100%); E113492 (100%); E103419 (96%)
E103413,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral",37,E103413 (100%); E113413 (100%); E133413 (92%); E103419 (87%); E113419 (87%)
E103413,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral",298,E103413 (100%); E103493 (100%); E113413 (100%); E113493 (100%); E133413 (92%)
E103419,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E103419 (100%); E113419 (100%); E103412 (96%); E113412 (96%); E103411 (96%)
E103419,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E103419 (100%); E103499 (100%); E113419 (100%); E113499 (100%); E103412 (96%)
E103491,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye",37,E103411 (100%); E113411 (100%); E103419 (96%); E113419 (96%); E103412 (95%)
E103492,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye",37,E103412 (100%); E113412 (100%); E103419 (96%); E113419 (96%); E103411 (95%)
E103493,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral",37,E103413 (100%); E113413 (100%); E133413 (92%); E103419 (87%); E113419 (87%)
E103499,"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E103419 (100%); E113419 (100%); E103412 (96%); E113412 (96%); E103411 (96%)
E103511,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye",37,E103511 (100%); E103591 (100%); E113511 (100%); E113591 (100%); E103519 (95%)
E103511,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye",298,E103511 (100%); E103591 (100%); E113511 (100%); E113591 (100%); E103519 (95%)
E103512,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye",37,E103512 (100%); E103592 (100%); E113512 (100%); E113592 (100%); E103519 (95%)
E103512,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye",298,E103512 (100%); E103592 (100%); E113512 (100%); E113592 (100%); E103519 (95%)
E103513,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral",37,E103513 (100%); E103593 (100%); E113513 (100%); E113593 (100%); E133513 (90%)
E103513,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral",298,E103513 (100%); E103593 (100%); E113513 (100%); E113593 (100%); E133513 (90%)
E103519,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye",37,E103519 (100%); E103599 (100%); E113519 (100%); E113599 (100%); E103512 (95%)
E103519,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye",298,E103519 (100%); E103599 (100%); E113519 (100%); E113599 (100%); E103512 (95%)
E103521,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye",37,E103521 (100%); E103531 (100%); E113521 (100%); E113531 (100%); E103529 (97%)
E103521,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye",298,E103521 (100%); E103531 (100%); E113521 (100%); E113531 (100%); E103529 (97%)
E103522,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye",37,E103522 (100%); E103532 (100%); E113522 (100%); E113532 (100%); E103529 (97%)
E103522,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye",298,E103522 (100%); E103532 (100%); E113522 (100%); E113532 (100%); E103529 (97%)
E103523,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral",37,E103523 (100%); E103533 (100%); E113523 (100%); E113533 (100%); E133523 (94%)
E103523,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral",298,E103523 (100%); E103533 (100%); E113523 (100%); E113533 (100%); E133523 (94%)
E103529,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye",37,E103529 (100%); E103539 (100%); E113529 (100%); E113539 (100%); E103522 (97%)
E103529,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye",298,E103529 (100%); E103539 (100%); E113529 (100%); E113539 (100%); E103522 (97%)
E103531,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye",37,E103521 (100%); E103531 (100%); E113521 (100%); E113531 (100%); E103529 (97%)
E103531,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye",298,E103521 (100%); E103531 (100%); E113521 (100%); E113531 (100%); E103529 (97%)
E103532,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye",37,E103522 (100%); E103532 (100%); E113522 (100%); E113532 (100%); E103529 (97%)
E103532,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye",298,E103522 (100%); E103532 (100%); E113522 (100%); E113532 (100%); E103529 (97%)
E103533,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral",37,E103523 (100%); E103533 (100%); E113523 (100%); E113533 (100%); E133523 (94%)
E103533,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral",298,E103523 (100%); E103533 (100%); E113523 (100%); E113533 (100%); E133523 (94%)
E103539,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye",37,E103529 (100%); E103539 (100%); E113529 (100%); E113539 (100%); E103522 (97%)
E103539,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye",298,E103529 (100%); E103539 (100%); E113529 (100%); E113539 (100%); E103522 (97%)
E103541,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye",37,E103541 (100%); E113541 (100%); E103549 (98%); E113549 (98%); E103542 (98%)
E103541,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye",298,E103541 (100%); E113541 (100%); E103549 (98%); E113549 (98%); E103542 (98%)
E103542,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye",37,E103542 (100%); E113542 (100%); E103549 (98%); E113549 (98%); E103541 (98%)
E103542,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye",298,E103542 (100%); E113542 (100%); E103549 (98%); E113549 (98%); E103541 (98%)
E103543,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral",37,E103543 (100%); E113543 (100%); E133543 (96%); E103549 (94%); E113549 (94%)
E103543,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral",298,E103543 (100%); E113543 (100%); E133543 (96%); E103549 (94%); E113549 (94%)
E103549,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye",37,E103549 (100%); E113549 (100%); E103542 (98%); E113542 (98%); E103541 (98%)
E103549,"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye",298,E103549 (100%); E113549 (100%); E103542 (98%); E113542 (98%); E103541 (98%)
E103551,"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, right eye",37,E103551 (100%); E113551 (100%); E103559 (95%); E113559 (95%); E103552 (94%)
E103551,"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, right eye",298,E103551 (100%); E113551 (100%); E103559 (95%); E113559 (95%); E103552 (94%)
E103552,"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, left eye",37,E103552 (100%); E113552 (100%); E103559 (95%); E113559 (95%); E103551 (94%)
E103552,"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, left eye",298,E103552 (100%); E113552 (100%); E103559 (95%); E113559 (95%); E103551 (94%)
E103553,"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral",37,E103553 (100%); E113553 (100%); E133553 (90%); E103559 (84%); E113559 (84%)
E103553,"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral",298,E103553 (100%); E113553 (100%); E133553 (90%); E103559 (84%); E113559 (84%)
E103559,"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye",37,E103559 (100%); E113559 (100%); E103552 (95%); E113552 (95%); E103551 (95%)
E103559,"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye",298,E103559 (100%); E113559 (100%); E103552 (95%); E113552 (95%); E103551 (95%)
E103591,"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye",37,E103511 (100%); E103591 (100%); E113511 (100%); E113591 (100%); E103519 (95%)
E103591,"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye",298,E103511 (100%); E103591 (100%); E113511 (100%); E113591 (100%); E103519 (95%)
E103592,"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye",37,E103512 (100%); E103592 (100%); E113512 (100%); E113592 (100%); E103519 (95%)
E103592,"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye",298,E103512 (100%); E103592 (100%); E113512 (100%); E113592 (100%); E103519 (95%)
E103593,"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral",37,E103513 (100%); E103593 (100%); E113513 (100%); E113593 (100%); E133513 (90%)
E103593,"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral",298,E103513 (100%); E103593 (100%); E113513 (100%); E113593 (100%); E133513 (90%)
E103599,"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye",37,E103519 (100%); E103599 (100%); E113519 (100%); E113599 (100%); E103512 (95%)
E103599,"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye",298,E103519 (100%); E103599 (100%); E113519 (100%); E113599 (100%); E103512 (95%)
E1036,Type 1 diabetes mellitus with diabetic cataract,37,E10311 (45%); E11311 (45%); E109 (41%); E119 (41%); E103553 (40%)
E1037X1,"Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, right eye",37,E103511 (60%); E103591 (60%); E113511 (60%); E113591 (60%); E103519 (57%)
E1037X2,"Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye",37,E103512 (60%); E103592 (60%); E113512 (60%); E113592 (60%); E103519 (57%)
E1037X3,"Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral",37,E103513 (60%); E103593 (60%); E113513 (60%); E113593 (60%); E10311 (56%)
E1037X9,"Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye",37,E103519 (60%); E103599 (60%); E113519 (60%); E113599 (60%); E10311 (59%)
E1039,Type 1 diabetes mellitus with other diabetic ophthalmic complication,37,E10311 (40%); E11311 (40%); E109 (36%); E119 (36%); E103553 (35%)
E1040,"Type 1 diabetes mellitus with diabetic neuropathy, unspecified",37,E10311 (51%); E11311 (51%); E108 (46%); E118 (46%); E103559 (45%)
E1040,"Type 1 diabetes mellitus with diabetic neuropathy, unspecified",,
E1041,Type 1 diabetes mellitus with diabetic mononeuropathy,37,E10311 (45%); E11311 (45%); E109 (41%); E119 (41%); E103553 (40%)
E1041,Type 1 diabetes mellitus with diabetic mononeuropathy,,
E1042,Type 1 diabetes mellitus with diabetic polyneuropathy,37,E10311 (51%); E11311 (51%); E109 (46%); E119 (46%); E103553 (45%)
E1042,Type 1 diabetes mellitus with diabetic polyneuropathy,,
E1043,Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy,37,E10311 (33%); E11311 (33%); G6182 (30%); E109 (30%); E119 (30%)
E1043,Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy,,
E1044,Type 1 diabetes mellitus with diabetic amyotrophy,37,E10311 (45%); E11311 (45%); E109 (41%); E119 (41%); E103553 (40%)
E1044,Type 1 diabetes mellitus with diabetic amyotrophy,,
E1049,Type 1 diabetes mellitus with other diabetic neurological complication,37,E10311 (40%); E11311 (40%); E109 (36%); E119 (36%); E103553 (35%)
E1049,Type 1 diabetes mellitus with other diabetic neurological complication,,
E1051,Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene,37,E1052 (100%); E1152 (100%); E1352 (92%); E0852 (85%); E10311 (37%)
E1051,Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene,,
E1052,Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene,37,E1052 (100%); E1152 (100%); E1352 (92%); E0852 (85%); E10311 (37%)
E1052,Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene,263,E1051 (100%); E1052 (100%); E1151 (100%); E1152 (100%); E1351 (92%)
E1059,Type 1 diabetes mellitus with other circulatory complications,37,E109 (71%); E119 (71%); E108 (69%); E118 (69%); E139 (57%)
E10610,Type 1 diabetes mellitus with diabetic neuropathic arthropathy,37,E10311 (41%); E11311 (41%); E109 (37%); E119 (37%); E851 (37%)
E10618,Type 1 diabetes mellitus with other diabetic arthropathy,37,E10311 (54%); E11311 (54%); E109 (49%); E119 (49%); E103553 (47%)
E10620,Type 1 diabetes mellitus with diabetic dermatitis,37,E10311 (45%); E11311 (45%); E109 (41%); E119 (41%); E103553 (40%)
E10621,Type 1 diabetes mellitus with foot ulcer,37,E10621 (100%); E11621 (100%); E13621 (81%); E08621 (69%); E10622 (66%)
E10621,Type 1 diabetes mellitus with foot ulcer,383,E10621 (100%); E11621 (100%); E13621 (81%); E08621 (69%); E10622 (66%)
E10622,Type 1 diabetes mellitus with other skin ulcer,37,E10622 (100%); E11622 (100%); E13622 (84%); E08622 (72%); E10621 (66%)
E10622,Type 1 diabetes mellitus with other skin ulcer,383,E10622 (100%); E11622 (100%); E13622 (84%); E10628 (75%); E11628 (75%)
E10628,Type 1 diabetes mellitus with other skin complications,37,E109 (81%); E119 (81%); E108 (79%); E118 (79%); E10622 (75%)
E10630,Type 1 diabetes mellitus with periodontal disease,37,E109 (41%); E119 (41%); E108 (39%); E118 (39%); E10621 (39%)
E10638,Type 1 diabetes mellitus with other oral complications,37,E109 (73%); E119 (73%); E108 (71%); E118 (71%); E139 (59%)
E10641,Type 1 diabetes mellitus with hypoglycemia with coma,36,E10649 (100%); E11649 (100%); E13649 (89%); E08649 (79%); R4020 (46%)
E10649,Type 1 diabetes mellitus with hypoglycemia without coma,38,E10641 (100%); E11641 (100%); E13641 (89%); E08641 (79%); E1010 (54%)
E1065,Type 1 diabetes mellitus with hyperglycemia,38,E10621 (42%); E10621 (42%); E11621 (42%); E11621 (42%); E10618 (40%)
E1069,Type 1 diabetes mellitus with other specified complication,37,E139 (53%); E138 (52%); E13621 (52%); E13622 (48%); E109 (48%)
E108,Type 1 diabetes mellitus with unspecified complications,38,E10628 (79%); E11628 (79%); E10638 (71%); E11638 (71%); E1059 (69%)
E109,Type 1 diabetes mellitus without complications,38,E10628 (81%); E11628 (81%); E10638 (73%); E11638 (73%); E1059 (71%)
E1100,Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC),36,E10649 (30%); E11649 (30%); R4020 (25%); E13649 (24%); E109 (22%)
E1101,Type 2 diabetes mellitus with hyperosmolarity with coma,36,E10649 (53%); E11649 (53%); R4020 (45%); E13649 (44%); E109 (39%)
E1110,Type 2 diabetes mellitus with ketoacidosis without coma,36,E10649 (54%); E11649 (54%); R4020 (46%); E13649 (44%); E109 (40%)
E1111,Type 2 diabetes mellitus with ketoacidosis with coma,36,E10649 (54%); E11649 (54%); R4020 (46%); E13649 (44%); E109 (40%)
E1121,Type 2 diabetes mellitus with diabetic nephropathy,37,E10311 (46%); E11311 (46%); E109 (42%); E119 (42%); E103553 (40%)
E1121,Type 2 diabetes mellitus with diabetic nephropathy,,
E1122,Type 2 diabetes mellitus with diabetic chronic kidney disease,37,N185 (64%); N1830 (63%); I130 (62%); I120 (58%); N184 (57%)
E1122,Type 2 diabetes mellitus with diabetic chronic kidney disease,,
E1129,Type 2 diabetes mellitus with other diabetic kidney complication,37,E10311 (44%); E11311 (44%); E109 (40%); E119 (40%); E103553 (38%)
E1129,Type 2 diabetes mellitus with other diabetic kidney complication,,
E11311,Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema,37,E10311 (100%); E11311 (100%); E13311 (87%); E103519 (86%); E103599 (86%)
E11311,Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema,298,E10311 (100%); E10319 (100%); E11311 (100%); E11319 (100%); E13311 (87%)
E11319,Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema,37,E10311 (100%); E11311 (100%); E13311 (87%); E103519 (86%); E103599 (86%)
E113211,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye",37,E103211 (99%); E113211 (99%); E103219 (96%); E113219 (96%); E103212 (95%)
E113211,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye",298,E103211 (99%); E103291 (99%); E113211 (99%); E113291 (99%); E103219 (96%)
E113212,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye",37,E103212 (100%); E113212 (100%); E103219 (96%); E113219 (96%); E103211 (95%)
E113212,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye",298,E103212 (100%); E103292 (100%); E113212 (100%); E113292 (100%); E103219 (96%)
E113213,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral",37,E103213 (100%); E113213 (100%); E133213 (92%); E103219 (88%); E113219 (88%)
E113213,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral",298,E103213 (100%); E103293 (100%); E113213 (100%); E113293 (100%); E133213 (92%)
E113219,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E103219 (100%); E113219 (100%); E103212 (96%); E113212 (96%); E103211 (96%)
E113219,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E103219 (100%); E103299 (100%); E113219 (100%); E113299 (100%); E103212 (96%)
E113291,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye",37,E103211 (99%); E113211 (99%); E103219 (96%); E113219 (96%); E103212 (95%)
E113292,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye",37,E103212 (100%); E113212 (100%); E103219 (96%); E113219 (96%); E103211 (95%)
E113293,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral",37,E103213 (100%); E113213 (100%); E133213 (92%); E103219 (88%); E113219 (88%)
E113299,"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E103219 (100%); E113219 (100%); E103212 (96%); E113212 (96%); E103211 (96%)
E113311,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye",37,E103311 (99%); E113311 (99%); E103319 (96%); E113319 (96%); E103312 (95%)
E113311,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye",298,E103311 (99%); E103391 (99%); E113311 (99%); E113391 (99%); E103319 (96%)
E113312,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye",37,E103312 (100%); E113312 (100%); E103319 (96%); E113319 (96%); E103311 (95%)
E113312,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye",298,E103312 (100%); E103392 (100%); E113312 (100%); E113392 (100%); E103319 (96%)
E113313,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral",37,E103313 (100%); E113313 (100%); E133313 (92%); E103319 (88%); E113319 (88%)
E113313,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral",298,E103313 (100%); E103393 (100%); E113313 (100%); E113393 (100%); E133313 (92%)
E113319,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E103319 (99%); E113319 (99%); E103312 (96%); E113312 (96%); E103311 (96%)
E113319,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E103319 (99%); E103399 (99%); E113319 (99%); E113399 (99%); E103312 (96%)
E113391,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye",37,E103311 (99%); E113311 (99%); E103319 (96%); E113319 (96%); E103312 (95%)
E113392,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye",37,E103312 (100%); E113312 (100%); E103319 (96%); E113319 (96%); E103311 (95%)
E113393,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral",37,E103313 (100%); E113313 (100%); E133313 (92%); E103319 (88%); E113319 (88%)
E113399,"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E103319 (99%); E113319 (99%); E103312 (96%); E113312 (96%); E103311 (96%)
E113411,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye",37,E103411 (100%); E113411 (100%); E103419 (96%); E113419 (96%); E103412 (95%)
E113411,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye",298,E103411 (100%); E103491 (100%); E113411 (100%); E113491 (100%); E103419 (96%)
E113412,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye",37,E103412 (100%); E113412 (100%); E103419 (96%); E113419 (96%); E103411 (95%)
E113412,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye",298,E103412 (100%); E103492 (100%); E113412 (100%); E113492 (100%); E103419 (96%)
E113413,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral",37,E103413 (100%); E113413 (100%); E133413 (92%); E103419 (87%); E113419 (87%)
E113413,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral",298,E103413 (100%); E103493 (100%); E113413 (100%); E113493 (100%); E133413 (92%)
E113419,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E103419 (100%); E113419 (100%); E103412 (96%); E113412 (96%); E103411 (96%)
E113419,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E103419 (100%); E103499 (100%); E113419 (100%); E113499 (100%); E103412 (96%)
E113491,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye",37,E103411 (100%); E113411 (100%); E103419 (96%); E113419 (96%); E103412 (95%)
E113492,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye",37,E103412 (100%); E113412 (100%); E103419 (96%); E113419 (96%); E103411 (95%)
E113493,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral",37,E103413 (100%); E113413 (100%); E133413 (92%); E103419 (87%); E113419 (87%)
E113499,"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E103419 (100%); E113419 (100%); E103412 (96%); E113412 (96%); E103411 (96%)
E113511,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye",37,E103511 (100%); E103591 (100%); E113511 (100%); E113591 (100%); E103519 (95%)
E113511,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye",298,E103511 (100%); E103591 (100%); E113511 (100%); E113591 (100%); E103519 (95%)
E113512,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye",37,E103512 (100%); E103592 (100%); E113512 (100%); E113592 (100%); E103519 (95%)
E113512,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye",298,E103512 (100%); E103592 (100%); E113512 (100%); E113592 (100%); E103519 (95%)
E113513,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral",37,E103513 (100%); E103593 (100%); E113513 (100%); E113593 (100%); E133513 (90%)
E113513,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral",298,E103513 (100%); E103593 (100%); E113513 (100%); E113593 (100%); E133513 (90%)
E113519,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye",37,E103519 (100%); E103599 (100%); E113519 (100%); E113599 (100%); E103512 (95%)
E113519,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye",298,E103519 (100%); E103599 (100%); E113519 (100%); E113599 (100%); E103512 (95%)
E113521,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye",37,E103521 (100%); E103531 (100%); E113521 (100%); E113531 (100%); E103529 (97%)
E113521,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye",298,E103521 (100%); E103531 (100%); E113521 (100%); E113531 (100%); E103529 (97%)
E113522,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye",37,E103522 (100%); E103532 (100%); E113522 (100%); E113532 (100%); E103529 (97%)
E113522,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye",298,E103522 (100%); E103532 (100%); E113522 (100%); E113532 (100%); E103529 (97%)
E113523,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral",37,E103523 (100%); E103533 (100%); E113523 (100%); E113533 (100%); E133523 (94%)
E113523,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral",298,E103523 (100%); E103533 (100%); E113523 (100%); E113533 (100%); E133523 (94%)
E113529,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye",37,E103529 (100%); E103539 (100%); E113529 (100%); E113539 (100%); E103522 (97%)
E113529,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye",298,E103529 (100%); E103539 (100%); E113529 (100%); E113539 (100%); E103522 (97%)
E113531,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye",37,E103521 (100%); E103531 (100%); E113521 (100%); E113531 (100%); E103529 (97%)
E113531,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye",298,E103521 (100%); E103531 (100%); E113521 (100%); E113531 (100%); E103529 (97%)
E113532,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye",37,E103522 (100%); E103532 (100%); E113522 (100%); E113532 (100%); E103529 (97%)
E113532,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye",298,E103522 (100%); E103532 (100%); E113522 (100%); E113532 (100%); E103529 (97%)
E113533,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral",37,E103523 (100%); E103533 (100%); E113523 (100%); E113533 (100%); E133523 (94%)
E113533,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral",298,E103523 (100%); E103533 (100%); E113523 (100%); E113533 (100%); E133523 (94%)
E113539,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye",37,E103529 (100%); E103539 (100%); E113529 (100%); E113539 (100%); E103522 (97%)
E113539,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye",298,E103529 (100%); E103539 (100%); E113529 (100%); E113539 (100%); E103522 (97%)
E113541,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye",37,E103541 (100%); E113541 (100%); E103549 (98%); E113549 (98%); E103542 (98%)
E113541,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye",298,E103541 (100%); E113541 (100%); E103549 (98%); E113549 (98%); E103542 (98%)
E113542,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye",37,E103542 (100%); E113542 (100%); E103549 (98%); E113549 (98%); E103541 (98%)
E113542,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye",298,E103542 (100%); E113542 (100%); E103549 (98%); E113549 (98%); E103541 (98%)
E113543,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral",37,E103543 (100%); E113543 (100%); E133543 (96%); E103549 (94%); E113549 (94%)
E113543,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral",298,E103543 (100%); E113543 (100%); E133543 (96%); E103549 (94%); E113549 (94%)
E113549,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye",37,E103549 (100%); E113549 (100%); E103542 (98%); E113542 (98%); E103541 (98%)
E113549,"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye",298,E103549 (100%); E113549 (100%); E103542 (98%); E113542 (98%); E103541 (98%)
E113551,"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, right eye",37,E103551 (100%); E113551 (100%); E103559 (95%); E113559 (95%); E103552 (94%)
E113551,"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, right eye",298,E103551 (100%); E113551 (100%); E103559 (95%); E113559 (95%); E103552 (94%)
E113552,"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, left eye",37,E103552 (100%); E113552 (100%); E103559 (95%); E113559 (95%); E103551 (94%)
E113552,"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, left eye",298,E103552 (100%); E113552 (100%); E103559 (95%); E113559 (95%); E103551 (94%)
E113553,"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral",37,E103553 (100%); E113553 (100%); E133553 (90%); E103559 (84%); E113559 (84%)
E113553,"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral",298,E103553 (100%); E113553 (100%); E133553 (90%); E103559 (84%); E113559 (84%)
E113559,"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye",37,E103559 (100%); E113559 (100%); E103552 (95%); E113552 (95%); E103551 (95%)
E113559,"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye",298,E103559 (100%); E113559 (100%); E103552 (95%); E113552 (95%); E103551 (95%)
E113591,"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye",37,E103511 (100%); E103591 (100%); E113511 (100%); E113591 (100%); E103519 (95%)
E113591,"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye",298,E103511 (100%); E103591 (100%); E113511 (100%); E113591 (100%); E103519 (95%)
E113592,"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye",37,E103512 (100%); E103592 (100%); E113512 (100%); E113592 (100%); E103519 (95%)
E113592,"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye",298,E103512 (100%); E103592 (100%); E113512 (100%); E113592 (100%); E103519 (95%)
E113593,"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral",37,E103513 (100%); E103593 (100%); E113513 (100%); E113593 (100%); E133513 (90%)
E113593,"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral",298,E103513 (100%); E103593 (100%); E113513 (100%); E113593 (100%); E133513 (90%)
E113599,"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye",37,E103519 (100%); E103599 (100%); E113519 (100%); E113599 (100%); E103512 (95%)
E113599,"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye",298,E103519 (100%); E103599 (100%); E113519 (100%); E113599 (100%); E103512 (95%)
E1136,Type 2 diabetes mellitus with diabetic cataract,37,E10311 (45%); E11311 (45%); E109 (41%); E119 (41%); E103553 (40%)
E1137X1,"Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, right eye",37,E103511 (60%); E103591 (60%); E113511 (60%); E113591 (60%); E103519 (57%)
E1137X2,"Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye",37,E103512 (60%); E103592 (60%); E113512 (60%); E113592 (60%); E103519 (57%)
E1137X3,"Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral",37,E103513 (60%); E103593 (60%); E113513 (60%); E113593 (60%); E10311 (56%)
E1137X9,"Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye",37,E103519 (60%); E103599 (60%); E113519 (60%); E113599 (60%); E10311 (59%)
E1139,Type 2 diabetes mellitus with other diabetic ophthalmic complication,37,E10311 (40%); E11311 (40%); E109 (36%); E119 (36%); E103553 (35%)
E1140,"Type 2 diabetes mellitus with diabetic neuropathy, unspecified",37,E10311 (51%); E11311 (51%); E108 (46%); E118 (46%); E103559 (45%)
E1140,"Type 2 diabetes mellitus with diabetic neuropathy, unspecified",,
E1141,Type 2 diabetes mellitus with diabetic mononeuropathy,37,E10311 (45%); E11311 (45%); E109 (41%); E119 (41%); E103553 (40%)
E1141,Type 2 diabetes mellitus with diabetic mononeuropathy,,
E1142,Type 2 diabetes mellitus with diabetic polyneuropathy,37,E10311 (51%); E11311 (51%); E109 (46%); E119 (46%); E103553 (45%)
E1142,Type 2 diabetes mellitus with diabetic polyneuropathy,,
E1143,Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy,37,E10311 (33%); E11311 (33%); G6182 (30%); E109 (30%); E119 (30%)
E1143,Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy,,
E1144,Type 2 diabetes mellitus with diabetic amyotrophy,37,E10311 (45%); E11311 (45%); E109 (41%); E119 (41%); E103553 (40%)
E1144,Type 2 diabetes mellitus with diabetic amyotrophy,,
E1149,Type 2 diabetes mellitus with other diabetic neurological complication,37,E10311 (40%); E11311 (40%); E109 (36%); E119 (36%); E103553 (35%)
E1149,Type 2 diabetes mellitus with other diabetic neurological complication,,
E1151,Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene,37,E1052 (100%); E1152 (100%); E1352 (92%); E0852 (85%); E10311 (37%)
E1151,Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene,,
E1152,Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene,37,E1052 (100%); E1152 (100%); E1352 (92%); E0852 (85%); E10311 (37%)
E1152,Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene,263,E1051 (100%); E1052 (100%); E1151 (100%); E1152 (100%); E1351 (92%)
E1159,Type 2 diabetes mellitus with other circulatory complications,37,E109 (71%); E119 (71%); E108 (69%); E118 (69%); E139 (57%)
E11610,Type 2 diabetes mellitus with diabetic neuropathic arthropathy,37,E10311 (41%); E11311 (41%); E109 (37%); E119 (37%); E851 (37%)
E11618,Type 2 diabetes mellitus with other diabetic arthropathy,37,E10311 (54%); E11311 (54%); E109 (49%); E119 (49%); E103553 (47%)
E11620,Type 2 diabetes mellitus with diabetic dermatitis,37,E10311 (45%); E11311 (45%); E109 (41%); E119 (41%); E103553 (40%)
E11621,Type 2 diabetes mellitus with foot ulcer,37,E10621 (100%); E11621 (100%); E13621 (81%); E08621 (69%); E10622 (66%)
E11621,Type 2 diabetes mellitus with foot ulcer,383,E10621 (100%); E11621 (100%); E13621 (81%); E08621 (69%); E10622 (66%)
E11622,Type 2 diabetes mellitus with other skin ulcer,37,E10622 (100%); E11622 (100%); E13622 (84%); E08622 (72%); E10621 (66%)
E11622,Type 2 diabetes mellitus with other skin ulcer,383,E10622 (100%); E11622 (100%); E13622 (84%); E10628 (75%); E11628 (75%)
E11628,Type 2 diabetes mellitus with other skin complications,37,E109 (81%); E119 (81%); E108 (79%); E118 (79%); E10622 (75%)
E11630,Type 2 diabetes mellitus with periodontal disease,37,E109 (41%); E119 (41%); E108 (39%); E118 (39%); E10621 (39%)
E11638,Type 2 diabetes mellitus with other oral complications,37,E109 (73%); E119 (73%); E108 (71%); E118 (71%); E139 (59%)
E11641,Type 2 diabetes mellitus with hypoglycemia with coma,36,E10649 (100%); E11649 (100%); E13649 (89%); E08649 (79%); R4020 (46%)
E11649,Type 2 diabetes mellitus with hypoglycemia without coma,38,E10641 (100%); E11641 (100%); E13641 (89%); E08641 (79%); E1010 (54%)
E1165,Type 2 diabetes mellitus with hyperglycemia,38,E10621 (42%); E10621 (42%); E11621 (42%); E11621 (42%); E10618 (40%)
E1169,Type 2 diabetes mellitus with other specified complication,37,E139 (53%); E138 (52%); E13621 (52%); E13622 (48%); E109 (48%)
E118,Type 2 diabetes mellitus with unspecified complications,38,E10628 (79%); E11628 (79%); E10638 (71%); E11638 (71%); E1059 (69%)
E119,Type 2 diabetes mellitus without complications,38,E10628 (81%); E11628 (81%); E10638 (73%); E11638 (73%); E1059 (71%)
E1300,Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC),36,E13649 (31%); E1369 (26%); R4020 (25%); E10649 (25%); E11649 (25%)
E1301,Other specified diabetes mellitus with hyperosmolarity with coma,36,E13649 (55%); E1369 (46%); R4020 (44%); E10649 (44%); E11649 (44%)
E1310,Other specified diabetes mellitus with ketoacidosis without coma,36,E13649 (56%); E1369 (46%); R4020 (44%); E10649 (44%); E11649 (44%)
E1311,Other specified diabetes mellitus with ketoacidosis with coma,36,E13649 (56%); E1369 (46%); R4020 (44%); E10649 (44%); E11649 (44%)
E1321,Other specified diabetes mellitus with diabetic nephropathy,37,E13311 (49%); E139 (45%); E138 (44%); E13621 (44%); E133553 (43%)
E1321,Other specified diabetes mellitus with diabetic nephropathy,,
E1322,Other specified diabetes mellitus with diabetic chronic kidney disease,37,N185 (63%); N1830 (61%); I130 (60%); I120 (56%); N184 (55%)
E1322,Other specified diabetes mellitus with diabetic chronic kidney disease,,
E1329,Other specified diabetes mellitus with other diabetic kidney complication,37,E13311 (47%); E139 (43%); E138 (42%); E13621 (42%); E133553 (41%)
E1329,Other specified diabetes mellitus with other diabetic kidney complication,,
E13311,Other specified diabetes mellitus with unspecified diabetic retinopathy with macular edema,37,E13311 (100%); E10311 (87%); E11311 (87%); E133519 (86%); E133599 (86%)
E13311,Other specified diabetes mellitus with unspecified diabetic retinopathy with macular edema,298,E13311 (100%); E13319 (100%); E10311 (87%); E10319 (87%); E11311 (87%)
E13319,Other specified diabetes mellitus with unspecified diabetic retinopathy without macular edema,37,E13311 (100%); E10311 (87%); E11311 (87%); E133519 (86%); E133599 (86%)
E133211,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye",37,E133211 (100%); E133219 (96%); E133212 (95%); E103211 (92%); E113211 (92%)
E133211,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye",298,E133211 (100%); E133291 (100%); E133219 (96%); E133299 (96%); E133212 (95%)
E133212,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye",37,E133212 (100%); E133219 (96%); E133211 (95%); E103212 (92%); E113212 (92%)
E133212,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye",298,E133212 (100%); E133292 (100%); E133219 (96%); E133299 (96%); E133211 (95%)
E133213,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral",37,E133213 (100%); E103213 (92%); E113213 (92%); E133219 (88%); E133212 (87%)
E133213,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral",298,E133213 (100%); E133293 (100%); E103213 (92%); E103293 (92%); E113213 (92%)
E133219,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E133219 (100%); E133212 (96%); E133211 (96%); E103219 (92%); E113219 (92%)
E133219,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E133219 (100%); E133299 (100%); E133212 (96%); E133292 (96%); E133211 (96%)
E133291,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye",37,E133211 (100%); E133219 (96%); E133212 (95%); E103211 (92%); E113211 (92%)
E133292,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye",37,E133212 (100%); E133219 (96%); E133211 (95%); E103212 (92%); E113212 (92%)
E133293,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral",37,E133213 (100%); E103213 (92%); E113213 (92%); E133219 (88%); E133212 (87%)
E133299,"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E133219 (100%); E133212 (96%); E133211 (96%); E103219 (92%); E113219 (92%)
E133311,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye",37,E133311 (100%); E133319 (96%); E133312 (95%); E103311 (92%); E113311 (92%)
E133311,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye",298,E133311 (100%); E133391 (100%); E133319 (96%); E133399 (96%); E133312 (95%)
E133312,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye",37,E133312 (99%); E133319 (96%); E133311 (95%); E103312 (92%); E113312 (92%)
E133312,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye",298,E133312 (99%); E133392 (99%); E133319 (96%); E133399 (96%); E133311 (95%)
E133313,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral",37,E133313 (100%); E103313 (92%); E113313 (92%); E133319 (88%); E133312 (87%)
E133313,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral",298,E133313 (100%); E133393 (100%); E103313 (92%); E103393 (92%); E113313 (92%)
E133319,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E133319 (100%); E133312 (96%); E133311 (96%); E103319 (92%); E113319 (92%)
E133319,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E133319 (100%); E133399 (100%); E133312 (96%); E133392 (96%); E133311 (96%)
E133391,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye",37,E133311 (100%); E133319 (96%); E133312 (95%); E103311 (92%); E113311 (92%)
E133392,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye",37,E133312 (99%); E133319 (96%); E133311 (95%); E103312 (92%); E113312 (92%)
E133393,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral",37,E133313 (100%); E103313 (92%); E113313 (92%); E133319 (88%); E133312 (87%)
E133399,"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E133319 (100%); E133312 (96%); E133311 (96%); E103319 (92%); E113319 (92%)
E133411,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye",37,E133411 (100%); E133419 (96%); E133412 (95%); E103411 (92%); E113411 (92%)
E133411,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye",298,E133411 (100%); E133491 (100%); E133419 (96%); E133499 (96%); E133412 (95%)
E133412,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye",37,E133412 (100%); E133419 (96%); E133411 (95%); E103412 (92%); E113412 (92%)
E133412,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye",298,E133412 (100%); E133492 (100%); E133419 (96%); E133499 (96%); E133411 (95%)
E133413,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral",37,E133413 (100%); E103413 (92%); E113413 (92%); E133419 (88%); E133412 (87%)
E133413,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral",298,E133413 (100%); E133493 (100%); E103413 (92%); E103493 (92%); E113413 (92%)
E133419,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye",37,E133419 (100%); E133412 (96%); E133411 (96%); E103419 (92%); E113419 (92%)
E133419,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye",298,E133419 (100%); E133499 (100%); E133412 (96%); E133492 (96%); E133411 (96%)
E133491,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye",37,E133411 (100%); E133419 (96%); E133412 (95%); E103411 (92%); E113411 (92%)
E133492,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye",37,E133412 (100%); E133419 (96%); E133411 (95%); E103412 (92%); E113412 (92%)
E133493,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral",37,E133413 (100%); E103413 (92%); E113413 (92%); E133419 (88%); E133412 (87%)
E133499,"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye",37,E133419 (100%); E133412 (96%); E133411 (96%); E103419 (92%); E113419 (92%)
E133511,"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye",37,E133511 (100%); E133591 (100%); E133519 (95%); E133599 (95%); E133512 (94%)
E133511,"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye",298,E133511 (100%); E133591 (100%); E133519 (95%); E133599 (95%); E133512 (94%)
E133512,"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye",37,E133512 (100%); E133592 (100%); E133519 (95%); E133599 (95%); E133511 (94%)
E133512,"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye",298,E133512 (100%); E133592 (100%); E133519 (95%); E133599 (95%); E133511 (94%)
E133513,"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral",37,E133513 (100%); E133593 (100%); E103513 (90%); E103593 (90%); E113513 (90%)
E133513,"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral",298,E133513 (100%); E133593 (100%); E103513 (90%); E103593 (90%); E113513 (90%)
E133519,"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye",37,E133519 (100%); E133599 (100%); E133512 (95%); E133592 (95%); E133511 (95%)
E133519,"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye",298,E133519 (100%); E133599 (100%); E133512 (95%); E133592 (95%); E133511 (95%)
E133521,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye",37,E133521 (100%); E133531 (100%); E133529 (97%); E133539 (97%); E133522 (96%)
E133521,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye",298,E133521 (100%); E133531 (100%); E133529 (97%); E133539 (97%); E133522 (96%)
E133522,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye",37,E133522 (100%); E133532 (100%); E133529 (97%); E133539 (97%); E133521 (96%)
E133522,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye",298,E133522 (100%); E133532 (100%); E133529 (97%); E133539 (97%); E133521 (96%)
E133523,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral",37,E133523 (100%); E133533 (100%); E103523 (94%); E103533 (94%); E113523 (94%)
E133523,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral",298,E133523 (100%); E133533 (100%); E103523 (94%); E103533 (94%); E113523 (94%)
E133529,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye",37,E133529 (100%); E133539 (100%); E133522 (97%); E133532 (97%); E133521 (97%)
E133529,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye",298,E133529 (100%); E133539 (100%); E133522 (97%); E133532 (97%); E133521 (97%)
E133531,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye",37,E133521 (100%); E133531 (100%); E133529 (97%); E133539 (97%); E133522 (96%)
E133531,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye",298,E133521 (100%); E133531 (100%); E133529 (97%); E133539 (97%); E133522 (96%)
E133532,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye",37,E133522 (100%); E133532 (100%); E133529 (97%); E133539 (97%); E133521 (96%)
E133532,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye",298,E133522 (100%); E133532 (100%); E133529 (97%); E133539 (97%); E133521 (96%)
E133533,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral",37,E133523 (100%); E133533 (100%); E103523 (94%); E103533 (94%); E113523 (94%)
E133533,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral",298,E133523 (100%); E133533 (100%); E103523 (94%); E103533 (94%); E113523 (94%)
E133539,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye",37,E133529 (100%); E133539 (100%); E133522 (97%); E133532 (97%); E133521 (97%)
E133539,"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye",298,E133529 (100%); E133539 (100%); E133522 (97%); E133532 (97%); E133521 (97%)
E133541,"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye",37,E133541 (100%); E133549 (98%); E133542 (98%); E103541 (96%); E113541 (96%)
E133541,"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye",298,E133541 (100%); E133549 (98%); E133542 (98%); E103541 (96%); E113541 (96%)
E133542,"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye",37,E133542 (100%); E133549 (98%); E133541 (98%); E103542 (96%); E113542 (96%)
E133542,"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye",298,E133542 (100%); E133549 (98%); E133541 (98%); E103542 (96%); E113542 (96%)
E133543,"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral",37,E133543 (100%); E103543 (96%); E113543 (96%); E133549 (95%); E133542 (94%)
E133543,"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral",298,E133543 (100%); E103543 (96%); E113543 (96%); E133549 (95%); E133542 (94%)
E133549,"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye",37,E133549 (100%); E133542 (98%); E133541 (98%); E103549 (96%); E113549 (96%)
E133549,"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye",298,E133549 (100%); E133542 (98%); E133541 (98%); E103549 (96%); E113549 (96%)
E133551,"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, right eye",37,E133551 (100%); E133559 (95%); E133552 (94%); E103551 (90%); E113551 (90%)
E133551,"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, right eye",298,E133551 (100%); E133559 (95%); E133552 (94%); E103551 (90%); E113551 (90%)
E133552,"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, left eye",37,E133552 (100%); E133559 (95%); E133551 (94%); E103552 (90%); E113552 (90%)
E133552,"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, left eye",298,E133552 (100%); E133559 (95%); E133551 (94%); E103552 (90%); E113552 (90%)
E133553,"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, bilateral",37,E133553 (100%); E103553 (90%); E113553 (90%); E133559 (85%); E133552 (84%)
E133553,"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, bilateral",298,E133553 (100%); E103553 (90%); E113553 (90%); E133559 (85%); E133552 (84%)
E133559,"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye",37,E133559 (100%); E133552 (95%); E133551 (95%); E103559 (90%); E113559 (90%)
E133559,"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye",298,E133559 (100%); E133552 (95%); E133551 (95%); E103559 (90%); E113559 (90%)
E133591,"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye",37,E133511 (100%); E133591 (100%); E133519 (95%); E133599 (95%); E133512 (94%)
E133591,"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye",298,E133511 (100%); E133591 (100%); E133519 (95%); E133599 (95%); E133512 (94%)
E133592,"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye",37,E133512 (100%); E133592 (100%); E133519 (95%); E133599 (95%); E133511 (94%)
E133592,"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye",298,E133512 (100%); E133592 (100%); E133519 (95%); E133599 (95%); E133511 (94%)
E133593,"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral",37,E133513 (100%); E133593 (100%); E103513 (90%); E103593 (90%); E113513 (90%)
E133593,"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral",298,E133513 (100%); E133593 (100%); E103513 (90%); E103593 (90%); E113513 (90%)
E133599,"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye",37,E133519 (100%); E133599 (100%); E133512 (95%); E133592 (95%); E133511 (95%)
E133599,"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye",298,E133519 (100%); E133599 (100%); E133512 (95%); E133592 (95%); E133511 (95%)
E1336,Other specified diabetes mellitus with diabetic cataract,37,E13311 (48%); E139 (45%); E138 (44%); E13621 (44%); E133553 (43%)
E1337X1,"Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, right eye",37,E133511 (62%); E133591 (62%); E133519 (58%); E133599 (58%); E133512 (57%)
E1337X2,"Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, left eye",37,E133512 (62%); E133592 (62%); E133519 (58%); E133599 (58%); E133511 (57%)
E1337X3,"Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral",37,E133513 (61%); E133593 (61%); E13311 (57%); E133413 (56%); E133313 (55%)
E1337X9,"Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye",37,E133519 (61%); E133599 (61%); E13311 (60%); E133512 (58%); E133592 (58%)
E1339,Other specified diabetes mellitus with other diabetic ophthalmic complication,37,E13311 (43%); E139 (40%); E138 (39%); E13621 (39%); E133553 (38%)
E1340,"Other specified diabetes mellitus with diabetic neuropathy, unspecified",37,E13311 (53%); E138 (49%); E133559 (47%); E133519 (46%); E133599 (46%)
E1340,"Other specified diabetes mellitus with diabetic neuropathy, unspecified",,
E1341,Other specified diabetes mellitus with diabetic mononeuropathy,37,E13311 (48%); E139 (45%); E138 (44%); E13621 (44%); E133553 (43%)
E1341,Other specified diabetes mellitus with diabetic mononeuropathy,,
E1342,Other specified diabetes mellitus with diabetic polyneuropathy,37,E13311 (54%); E139 (50%); E138 (49%); E13621 (49%); E133553 (48%)
E1342,Other specified diabetes mellitus with diabetic polyneuropathy,,
E1343,Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy,37,E13311 (35%); E139 (33%); E138 (32%); E13621 (32%); E133553 (31%)
E1343,Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy,,
E1344,Other specified diabetes mellitus with diabetic amyotrophy,37,E13311 (48%); E139 (45%); E138 (44%); E13621 (44%); E133553 (43%)
E1344,Other specified diabetes mellitus with diabetic amyotrophy,,
E1349,Other specified diabetes mellitus with other diabetic neurological complication,37,E13311 (43%); E139 (40%); E138 (39%); E13621 (39%); E133553 (38%)
E1349,Other specified diabetes mellitus with other diabetic neurological complication,,
E1351,Other specified diabetes mellitus with diabetic peripheral angiopathy without gangrene,37,E1352 (100%); E1052 (92%); E1152 (92%); E0852 (83%); E13311 (40%)
E1351,Other specified diabetes mellitus with diabetic peripheral angiopathy without gangrene,,
E1352,Other specified diabetes mellitus with diabetic peripheral angiopathy with gangrene,37,E1352 (100%); E1052 (92%); E1152 (92%); E0852 (83%); E13311 (40%)
E1352,Other specified diabetes mellitus with diabetic peripheral angiopathy with gangrene,263,E1351 (100%); E1352 (100%); E1051 (92%); E1052 (92%); E1151 (92%)
E1359,Other specified diabetes mellitus with other circulatory complications,37,E139 (73%); E138 (70%); E109 (58%); E119 (58%); E108 (57%)
E13610,Other specified diabetes mellitus with diabetic neuropathic arthropathy,37,E13311 (44%); E139 (41%); E138 (39%); E13621 (39%); E133553 (39%)
E13618,Other specified diabetes mellitus with other diabetic arthropathy,37,E13311 (57%); E139 (53%); E138 (51%); E13621 (51%); E133553 (50%)
E13620,Other specified diabetes mellitus with diabetic dermatitis,37,E13311 (48%); E139 (45%); E138 (44%); E13621 (44%); E133553 (43%)
E13621,Other specified diabetes mellitus with foot ulcer,37,E13621 (100%); E10621 (81%); E11621 (81%); E13622 (68%); E08621 (66%)
E13621,Other specified diabetes mellitus with foot ulcer,383,E13621 (100%); E10621 (81%); E11621 (81%); E13622 (68%); E08621 (66%)
E13622,Other specified diabetes mellitus with other skin ulcer,37,E13622 (100%); E10622 (84%); E11622 (84%); E08622 (70%); E13621 (68%)
E13622,Other specified diabetes mellitus with other skin ulcer,383,E13622 (100%); E10622 (84%); E11622 (84%); E13628 (77%); E08622 (70%)
E13628,Other specified diabetes mellitus with other skin complications,37,E139 (83%); E138 (80%); E13622 (77%); E109 (67%); E119 (67%)
E13630,Other specified diabetes mellitus with periodontal disease,37,E139 (44%); E138 (43%); E13621 (43%); E13622 (40%); E1365 (37%)
E13638,Other specified diabetes mellitus with other oral complications,37,E139 (74%); E138 (72%); E109 (60%); E119 (60%); E108 (58%)
E13641,Other specified diabetes mellitus with hypoglycemia with coma,36,E13649 (100%); E10649 (89%); E11649 (89%); E08649 (77%); E1369 (46%)
E13649,Other specified diabetes mellitus with hypoglycemia without coma,38,E13641 (100%); E10641 (89%); E11641 (89%); E08641 (77%); E1310 (56%)
E1365,Other specified diabetes mellitus with hyperglycemia,38,E1369 (51%); E13621 (46%); E13621 (46%); E1069 (44%); E1169 (44%)
E1369,Other specified diabetes mellitus with other specified complication,37,E139 (61%); E138 (60%); E13621 (60%); E13622 (55%); M068A (54%)
E138,Other specified diabetes mellitus with unspecified complications,38,E13628 (80%); E13638 (72%); E1359 (70%); E10628 (64%); E11628 (64%)
E139,Other specified diabetes mellitus without complications,38,E13628 (83%); E13638 (74%); E1359 (73%); E10628 (66%); E11628 (66%)
E15,Nondiabetic hypoglycemic coma,,
E163,Increased secretion of glucagon,,
E164,Increased secretion of gastrin,,
E168,Other specified disorders of pancreatic internal secretion,,
E169,"Disorder of pancreatic internal secretion, unspecified",,
E200,Idiopathic hypoparathyroidism,,
E208,Other hypoparathyroidism,,
E20810,Autosomal dominant hypocalcemia,,
E20811,Secondary hypoparathyroidism in diseases classified elsewhere,,
E20812,Autoimmune hypoparathyroidism,,
E20818,Other specified hypoparathyroidism due to impaired parathyroid hormone secretion,,
E20819,"Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified",,
E2089,Other specified hypoparathyroidism,,
E209,"Hypoparathyroidism, unspecified",,
E210,Primary hyperparathyroidism,,
E211,"Secondary hyperparathyroidism, not elsewhere classified",,
E212,Other hyperparathyroidism,,
E213,"Hyperparathyroidism, unspecified",,
E214,Other specified disorders of parathyroid gland,,
E215,"Disorder of parathyroid gland, unspecified",,
E220,Acromegaly and pituitary gigantism,51,C751 (35%); D352 (32%); D443 (28%); T38812A (22%); A0104 (0%)
E221,Hyperprolactinemia,,
E222,Syndrome of inappropriate secretion of antidiuretic hormone,,
E228,Other hyperfunction of pituitary gland,,
E229,"Hyperfunction of pituitary gland, unspecified",,
E230,Hypopituitarism,,
E231,Drug-induced hypopituitarism,,
E232,Diabetes insipidus,,
E233,"Hypothalamic dysfunction, not elsewhere classified",,
E236,Other disorders of pituitary gland,,
E237,"Disorder of pituitary gland, unspecified",,
E240,Pituitary-dependent Cushing's disease,51,F607 (38%); C751 (35%); D352 (32%); D443 (27%); G4042 (24%)
E241,Nelson's syndrome,,
E242,Drug-induced Cushing's syndrome,,
E243,Ectopic ACTH syndrome,,
E244,Alcohol-induced pseudo-Cushing's syndrome,,
E248,Other Cushing's syndrome,,
E249,"Cushing's syndrome, unspecified",,
E250,Congenital adrenogenital disorders associated with enzyme deficiency,,
E258,Other adrenogenital disorders,,
E259,"Adrenogenital disorder, unspecified",,
E2601,Conn's syndrome,,
E2602,Glucocorticoid-remediable aldosteronism,,
E2609,Other primary hyperaldosteronism,,
E261,Secondary hyperaldosteronism,,
E2681,Bartter's syndrome,,
E2689,Other hyperaldosteronism,,
E269,"Hyperaldosteronism, unspecified",,
E270,Other adrenocortical overactivity,,
E271,Primary adrenocortical insufficiency,51,C801 (35%); D6949 (28%); E7253 (27%); G1223 (27%); I270 (27%)
E272,Addisonian crisis,,
E273,Drug-induced adrenocortical insufficiency,,
E2740,Unspecified adrenocortical insufficiency,,
E2749,Other adrenocortical insufficiency,,
E275,Adrenomedullary hyperfunction,,
E278,Other specified disorders of adrenal gland,,
E279,"Disorder of adrenal gland, unspecified",,
E310,Autoimmune polyglandular failure,51,K754 (45%); D5919 (37%); D5910 (37%); I5089 (33%); D5913 (32%)
E311,Polyglandular hyperfunction,51,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
E3120,"Multiple endocrine neoplasia [MEN] syndrome, unspecified",51,C759 (36%); C254 (32%); M0509 (28%); M0899 (21%); M868X0 (21%)
E3121,Multiple endocrine neoplasia [MEN] type I,51,C759 (34%); C254 (33%); M868X0 (21%); G35 (21%); M8789 (21%)
E3122,Multiple endocrine neoplasia [MEN] type IIA,51,C759 (29%); C254 (28%); M868X0 (18%); G35 (18%); M8789 (18%)
E3123,Multiple endocrine neoplasia [MEN] type IIB,51,C759 (29%); C254 (28%); M868X0 (18%); G35 (18%); M8789 (18%)
E318,Other polyglandular dysfunction,51,J4A8 (31%); J4A9 (31%); I2481 (28%); I21B (25%); F14281 (23%)
E319,"Polyglandular dysfunction, unspecified",51,J4A9 (33%); J4A8 (30%); I2481 (27%); F14981 (25%); F10981 (25%)
E320,Persistent hyperplasia of thymus,,
E321,Abscess of thymus,,
E328,Other diseases of thymus,,
E329,"Disease of thymus, unspecified",,
E340,Carcinoid syndrome,17,C7A00 (44%); C7A098 (42%); C7A093 (42%); D3A00 (40%); C7A092 (40%)
E344,Constitutional tall stature,,
E40,Kwashiorkor,,
E41,Nutritional marasmus,,
E42,Marasmic kwashiorkor,,
E43,Unspecified severe protein-calorie malnutrition,,
E440,Moderate protein-calorie malnutrition,,
E441,Mild protein-calorie malnutrition,,
E45,Retarded development following protein-calorie malnutrition,,
E46,Unspecified protein-calorie malnutrition,,
E550,"Rickets, active",,
E640,Sequelae of protein-calorie malnutrition,,
E6601,Morbid (severe) obesity due to excess calories,48,D4621 (23%); D4622 (23%); D4620 (23%); F03C4 (15%); F03C11 (14%)
E662,Morbid (severe) obesity with alveolar hypoventilation,48,J8409 (36%); J8401 (30%); J8402 (27%); F03C4 (15%); F03C11 (14%)
E700,Classical phenylketonuria,,
E701,Other hyperphenylalaninemias,,
E7020,"Disorder of tyrosine metabolism, unspecified",,
E7021,Tyrosinemia,,
E7029,Other disorders of tyrosine metabolism,,
E7030,"Albinism, unspecified",,
E70310,X-linked ocular albinism,,
E70311,Autosomal recessive ocular albinism,,
E70318,Other ocular albinism,,
E70319,"Ocular albinism, unspecified",,
E70320,Tyrosinase negative oculocutaneous albinism,,
E70321,Tyrosinase positive oculocutaneous albinism,,
E70328,Other oculocutaneous albinism,,
E70329,"Oculocutaneous albinism, unspecified",,
E70330,Chediak-Higashi syndrome,,
E70331,Hermansky-Pudlak syndrome,,
E70338,Other albinism with hematologic abnormality,,
E70339,"Albinism with hematologic abnormality, unspecified",,
E7039,Other specified albinism,,
E7040,"Disorders of histidine metabolism, unspecified",,
E7041,Histidinemia,,
E7049,Other disorders of histidine metabolism,,
E705,Disorders of tryptophan metabolism,,
E7081,Aromatic L-amino acid decarboxylase deficiency,,
E7089,Other disorders of aromatic amino-acid metabolism,,
E709,"Disorder of aromatic amino-acid metabolism, unspecified",,
E710,Maple-syrup-urine disease,,
E71110,Isovaleric acidemia,,
E71111,3-methylglutaconic aciduria,,
E71118,Other branched-chain organic acidurias,,
E71120,Methylmalonic acidemia,,
E71121,Propionic acidemia,,
E71128,Other disorders of propionate metabolism,,
E7119,Other disorders of branched-chain amino-acid metabolism,,
E712,"Disorder of branched-chain amino-acid metabolism, unspecified",,
E7130,"Disorder of fatty-acid metabolism, unspecified",,
E71310,Long chain/very long chain acyl CoA dehydrogenase deficiency,,
E71311,Medium chain acyl CoA dehydrogenase deficiency,,
E71312,Short chain acyl CoA dehydrogenase deficiency,,
E71313,Glutaric aciduria type II,,
E71314,Muscle carnitine palmitoyltransferase deficiency,,
E71318,Other disorders of fatty-acid oxidation,,
E7132,Disorders of ketone metabolism,,
E7139,Other disorders of fatty-acid metabolism,,
E7140,"Disorder of carnitine metabolism, unspecified",,
E7141,Primary carnitine deficiency,,
E7142,Carnitine deficiency due to inborn errors of metabolism,,
E7143,Iatrogenic carnitine deficiency,,
E71440,Ruvalcaba-Myhre-Smith syndrome,,
E71448,Other secondary carnitine deficiency,,
E7150,"Peroxisomal disorder, unspecified",,
E71510,Zellweger syndrome,,
E71511,Neonatal adrenoleukodystrophy,,
E71518,Other disorders of peroxisome biogenesis,,
E71520,Childhood cerebral X-linked adrenoleukodystrophy,,
E71521,Adolescent X-linked adrenoleukodystrophy,,
E71522,Adrenomyeloneuropathy,,
E71528,Other X-linked adrenoleukodystrophy,,
E71529,"X-linked adrenoleukodystrophy, unspecified type",,
E7153,Other group 2 peroxisomal disorders,,
E71540,Rhizomelic chondrodysplasia punctata,,
E71541,Zellweger-like syndrome,,
E71542,Other group 3 peroxisomal disorders,,
E71548,Other peroxisomal disorders,,
E7200,"Disorders of amino-acid transport, unspecified",,
E7201,Cystinuria,,
E7202,Hartnup's disease,,
E7203,Lowe's syndrome,,
E7204,Cystinosis,,
E7209,Other disorders of amino-acid transport,,
E7210,"Disorders of sulfur-bearing amino-acid metabolism, unspecified",,
E7211,Homocystinuria,,
E7212,Methylenetetrahydrofolate reductase deficiency,,
E7219,Other disorders of sulfur-bearing amino-acid metabolism,,
E7220,"Disorder of urea cycle metabolism, unspecified",,
E7221,Argininemia,,
E7222,Arginosuccinic aciduria,,
E7223,Citrullinemia,,
E7229,Other disorders of urea cycle metabolism,,
E723,Disorders of lysine and hydroxylysine metabolism,,
E724,Disorders of ornithine metabolism,,
E7250,"Disorder of glycine metabolism, unspecified",,
E7251,Non-ketotic hyperglycinemia,,
E7252,Trimethylaminuria,,
E7253,Primary hyperoxaluria,50,C801 (45%); D6949 (36%); G1223 (35%); I270 (35%); C228 (35%)
E7259,Other disorders of glycine metabolism,,
E7281,Disorders of gamma aminobutyric acid metabolism,,
E7289,Other specified disorders of amino-acid metabolism,,
E729,"Disorder of amino-acid metabolism, unspecified",,
E7400,"Glycogen storage disease, unspecified",50,G959 (21%); K50919 (19%); B259 (18%); I279 (18%); M02359 (18%)
E7401,von Gierke disease,50,D6809 (50%); D6800 (49%); D6801 (48%); D6803 (48%); D68029 (47%)
E7402,Pompe disease,49,G959 (22%); I120 (21%); G20 (19%); G308 (19%); B259 (18%)
E7403,Cori disease,50,G959 (22%); I120 (21%); G20 (19%); G308 (19%); B259 (18%)
E7404,McArdle disease,50,G959 (22%); I120 (21%); G20 (19%); G308 (19%); B259 (18%)
E7405,Lysosome-associated membrane protein 2 [LAMP2] deficiency,50,D8132 (17%); D8139 (17%); J95851 (17%); D8130 (17%); C802 (16%)
E7409,Other glycogen storage disease,50,G959 (17%); I120 (16%); G20 (15%); G308 (14%); B259 (14%)
E7420,"Disorders of galactose metabolism, unspecified",,
E7421,Galactosemia,,
E7429,Other disorders of galactose metabolism,,
E7431,Sucrase-isomaltase deficiency,,
E744,Disorders of pyruvate metabolism and gluconeogenesis,,
E74810,Glucose transporter protein type 1 deficiency,,
E74818,Other disorders of glucose transport,,
E74819,"Disorders of glucose transport, unspecified",,
E7489,Other specified disorders of carbohydrate metabolism,,
E749,"Disorder of carbohydrate metabolism, unspecified",,
E7500,"GM2 gangliosidosis, unspecified",,
E7501,Sandhoff disease,,
E7502,Tay-Sachs disease,,
E7509,Other GM2 gangliosidosis,,
E7510,Unspecified gangliosidosis,,
E7511,Mucolipidosis IV,,
E7519,Other gangliosidosis,,
E7521,Fabry (-Anderson) disease,49,G959 (16%); I120 (15%); G20 (14%); G308 (14%); B259 (14%)
E7522,Gaucher disease,49,G959 (22%); I120 (21%); G20 (19%); G308 (19%); B259 (18%)
E7523,Krabbe disease,,
E75240,Niemann-Pick disease type A,,
E75241,Niemann-Pick disease type B,,
E75242,Niemann-Pick disease type C,,
E75243,Niemann-Pick disease type D,,
E75244,Niemann-Pick disease type A/B,,
E75248,Other Niemann-Pick disease,,
E75249,"Niemann-Pick disease, unspecified",,
E7525,Metachromatic leukodystrophy,,
E7526,Sulfatase deficiency,,
E7527,Pelizaeus-Merzbacher disease,,
E7528,Canavan disease,,
E7529,Other sphingolipidosis,,
E753,"Sphingolipidosis, unspecified",,
E754,Neuronal ceroid lipofuscinosis,,
E755,Other lipid storage disorders,,
E756,"Lipid storage disorder, unspecified",,
E7601,Hurler's syndrome,49,E340 (27%); G839 (25%); G8382 (24%); G8383 (24%); D469 (21%)
E7602,Hurler-Scheie syndrome,49,E340 (20%); G839 (19%); G8382 (18%); G8383 (18%); D469 (16%)
E7603,Scheie's syndrome,49,E340 (27%); G839 (25%); G8382 (24%); G8383 (24%); D469 (21%)
E761,"Mucopolysaccharidosis, type II",49,S728X9B (30%); S728X2B (29%); S728X1B (29%); S7292XB (29%); S7291XB (29%)
E76210,Morquio A mucopolysaccharidoses,49,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
E76211,Morquio B mucopolysaccharidoses,49,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
E76219,"Morquio mucopolysaccharidoses, unspecified",49,G8330 (9%); L97909 (9%); G8190 (8%); C8510 (8%); M08959 (8%)
E7622,Sanfilippo mucopolysaccharidoses,49,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
E7629,Other mucopolysaccharidoses,49,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
E763,"Mucopolysaccharidosis, unspecified",49,G8330 (12%); L97909 (11%); G8190 (11%); C8510 (11%); M08959 (11%)
E768,Other disorders of glucosaminoglycan metabolism,,
E769,"Glucosaminoglycan metabolism disorder, unspecified",,
E770,Defects in post-translational modification of lysosomal enzymes,,
E771,Defects in glycoprotein degradation,,
E778,Other disorders of glycoprotein metabolism,,
E779,"Disorder of glycoprotein metabolism, unspecified",,
E7800,"Pure hypercholesterolemia, unspecified",,
E7801,Familial hypercholesterolemia,,
E781,Pure hyperglyceridemia,,
E782,Mixed hyperlipidemia,,
E783,Hyperchylomicronemia,,
E7841,Elevated Lipoprotein(a),,
E7849,Other hyperlipidemia,,
E785,"Hyperlipidemia, unspecified",,
E786,Lipoprotein deficiency,,
E7870,"Disorder of bile acid and cholesterol metabolism, unspecified",,
E7879,Other disorders of bile acid and cholesterol metabolism,,
E7881,Lipoid dermatoarthritis,,
E7889,Other lipoprotein metabolism disorders,,
E789,"Disorder of lipoprotein metabolism, unspecified",,
E791,Lesch-Nyhan syndrome,50,E340 (19%); G839 (18%); G8382 (17%); G8383 (17%); D469 (15%)
E792,Myoadenylate deaminase deficiency,,
E798,Other disorders of purine and pyrimidine metabolism,,
E7981,Aicardi-Goutieres syndrome,,
E7982,Hereditary xanthinuria,,
E7989,Other specified disorders of purine and pyrimidine metabolism,,
E799,"Disorder of purine and pyrimidine metabolism, unspecified",,
E800,Hereditary erythropoietic porphyria,50,G119 (34%); D800 (32%); G118 (32%); D640 (28%); G114 (28%)
E801,Porphyria cutanea tarda,50,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
E8020,Unspecified porphyria,50,G8330 (13%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
E8021,Acute intermittent (hepatic) porphyria,50,K7682 (35%); K7290 (33%); K7291 (33%); K7210 (32%); K7211 (32%)
E8029,Other porphyria,50,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
E803,Defects of catalase and peroxidase,50,D841 (37%); D691 (30%); A0104 (0%); A0105 (0%); A021 (0%)
E8300,"Disorder of copper metabolism, unspecified",50,T564X2A (36%); T504X2A (28%); F319 (22%); F609 (20%); F12959 (19%)
E8301,Wilson's disease,50,P270 (58%); G959 (23%); I120 (21%); G20 (20%); G308 (19%)
E8309,Other disorders of copper metabolism,50,T564X2A (34%); F258 (31%); F22 (29%); G7089 (29%); J99 (29%)
E8310,"Disorder of iron metabolism, unspecified",,
E83110,Hereditary hemochromatosis,,
E83118,Other hemochromatosis,,
E83119,"Hemochromatosis, unspecified",,
E8319,Other disorders of iron metabolism,,
E8330,"Disorder of phosphorus metabolism, unspecified",,
E8331,Familial hypophosphatemia,50,G1224 (38%); A8183 (35%); G901 (30%); A0104 (0%); A0105 (0%)
E8332,Hereditary vitamin D-dependent rickets (type 1) (type 2),,
E8339,Other disorders of phosphorus metabolism,,
E840,Cystic fibrosis with pulmonary manifestations,277,J8410 (61%); J84112 (54%); J84178 (35%); I2782 (27%); J631 (27%)
E8411,Meconium ileus in cystic fibrosis,277,K567 (48%); K560 (40%); J8410 (33%); K563 (33%); J84112 (29%)
E8419,Cystic fibrosis with other intestinal manifestations,277,J8410 (36%); J84112 (32%); J631 (27%); J633 (27%); K56691 (24%)
E848,Cystic fibrosis with other manifestations,277,J8410 (40%); J84112 (35%); J631 (30%); J633 (30%); J84178 (23%)
E849,"Cystic fibrosis, unspecified",277,J8410 (54%); J84112 (44%); J631 (37%); J633 (37%); J84178 (29%)
E850,Non-neuropathic heredofamilial amyloidosis,50,E10610 (35%); E11610 (35%); E13610 (34%); E08610 (31%); C8380 (12%)
E851,Neuropathic heredofamilial amyloidosis,50,E10610 (37%); E11610 (37%); E13610 (36%); E08610 (32%); A0104 (0%)
E852,"Heredofamilial amyloidosis, unspecified",50,G8330 (9%); L97909 (9%); G8190 (9%); C8510 (9%); M08959 (9%)
E853,Secondary systemic amyloidosis,50,M3489 (35%); M349 (34%); M87353 (30%); M87352 (29%); M3482 (29%)
E854,Organ-limited amyloidosis,50,L98421 (27%); L97301 (26%); L97501 (26%); L97321 (25%); L97311 (25%)
E8581,Light chain (AL) amyloidosis,50,C882 (33%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
E8582,Wild-type transthyretin-related (ATTR) amyloidosis,50,D8984 (16%); G128 (13%); C969 (12%); M308 (12%); H353230 (12%)
E8589,Other amyloidosis,50,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
E859,"Amyloidosis, unspecified",50,G8330 (14%); L97909 (13%); G8190 (13%); C8510 (13%); M08959 (13%)
E8801,Alpha-1-antitrypsin deficiency,50,T446X2A (28%); G710341 (25%); D8132 (25%); D8139 (25%); D8130 (25%)
E882,"Lipomatosis, not elsewhere classified",,
E8840,"Mitochondrial metabolism disorder, unspecified",,
E8841,MELAS syndrome,,
E8842,MERRF syndrome,,
E8843,Disorders of mitochondrial tRNA synthetases,,
E8849,Other mitochondrial metabolism disorders,,
E8889,Other specified metabolic disorders,50,G7089 (45%); D57818 (37%); F258 (35%); F22 (33%); J99 (32%)
E88A,Wasting disease (syndrome) due to underlying condition,,
E890,Postprocedural hypothyroidism,,
E892,Postprocedural hypoparathyroidism,,
E893,Postprocedural hypopituitarism,,
E896,Postprocedural adrenocortical (-medullary) hypofunction,,
F0150,"Vascular dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",127,F01C0 (93%); F01B0 (93%); F03C0 (90%); F03B0 (89%); F02C0 (85%)
F01511,"Vascular dementia, unspecified severity, with agitation",127,F01C11 (79%); F01B11 (78%); F03C11 (64%); F03B11 (63%); F02C11 (51%)
F01518,"Vascular dementia, unspecified severity, with other behavioral disturbance",127,F01C18 (81%); F01B18 (81%); F03C18 (69%); F03B18 (68%); F01C0 (67%)
F0152,"Vascular dementia, unspecified severity, with psychotic disturbance",127,F01C2 (79%); F01B2 (78%); F03C2 (65%); F01C0 (64%); F01B0 (64%)
F0153,"Vascular dementia, unspecified severity, with mood disturbance",127,F01C3 (80%); F01B3 (80%); F03C3 (67%); F03B3 (66%); F01C0 (66%)
F0154,"Vascular dementia, unspecified severity, with anxiety",127,F01C4 (76%); F01B4 (75%); F03C4 (59%); F03B4 (58%); F01C11 (47%)
F01A0,"Vascular dementia, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",127,F01C0 (94%); F01B0 (94%); F03C0 (89%); F03B0 (89%); F02C0 (85%)
F01A11,"Vascular dementia, mild, with agitation",127,F01C11 (80%); F01B11 (79%); F03C11 (61%); F03B11 (61%); F02C11 (52%)
F01A18,"Vascular dementia, mild, with other behavioral disturbance",127,F01C18 (82%); F01B18 (82%); F01C0 (68%); F01B0 (68%); F03C18 (67%)
F01A2,"Vascular dementia, mild, with psychotic disturbance",127,F01C2 (80%); F01B2 (80%); F01C0 (66%); F01B0 (65%); F03C2 (62%)
F01A3,"Vascular dementia, mild, with mood disturbance",127,F01C3 (82%); F01B3 (81%); F01C0 (67%); F01B0 (67%); F03C3 (65%)
F01A4,"Vascular dementia, mild, with anxiety",127,F01C4 (77%); F01B4 (77%); F03C4 (56%); F03B4 (55%); F01C11 (48%)
F01B0,"Vascular dementia, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",126,F01C0 (94%); F01A0 (94%); F0150 (93%); F03C0 (89%); F03A0 (89%)
F01B11,"Vascular dementia, moderate, with agitation",126,F01C11 (80%); F01A11 (79%); F01511 (78%); F03C11 (61%); F03A11 (61%)
F01B18,"Vascular dementia, moderate, with other behavioral disturbance",126,F01C18 (82%); F01A18 (82%); F01518 (81%); F01C0 (68%); F01A0 (68%)
F01B2,"Vascular dementia, moderate, with psychotic disturbance",126,F01C2 (80%); F01A2 (80%); F0152 (78%); F01C0 (66%); F01A0 (65%)
F01B3,"Vascular dementia, moderate, with mood disturbance",126,F01C3 (82%); F01A3 (81%); F0153 (80%); F01C0 (67%); F01A0 (67%)
F01B4,"Vascular dementia, moderate, with anxiety",126,F01C4 (77%); F01A4 (77%); F0154 (75%); F03C4 (56%); F03A4 (55%)
F01C0,"Vascular dementia, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",125,F01B0 (94%); F01A0 (94%); F0150 (93%); F03B0 (89%); F03A0 (89%)
F01C11,"Vascular dementia, severe, with agitation",125,F01B11 (80%); F01A11 (80%); F01511 (79%); F03B11 (61%); F03A11 (61%)
F01C18,"Vascular dementia, severe, with other behavioral disturbance",125,F01B18 (82%); F01A18 (82%); F01518 (81%); F01B0 (68%); F01A0 (68%)
F01C2,"Vascular dementia, severe, with psychotic disturbance",125,F01B2 (80%); F01A2 (80%); F0152 (79%); F01B0 (66%); F01A0 (66%)
F01C3,"Vascular dementia, severe, with mood disturbance",125,F01B3 (82%); F01A3 (82%); F0153 (80%); F01B0 (67%); F01A0 (67%)
F01C4,"Vascular dementia, severe, with anxiety",125,F01B4 (77%); F01A4 (77%); F0154 (76%); F03B4 (56%); F03A4 (56%)
F0280,"Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",127,F02C0 (93%); F02B0 (93%); F03C0 (89%); F03B0 (89%); F01C0 (85%)
F02811,"Dementia in other diseases classified elsewhere, unspecified severity, with agitation",127,F02C11 (80%); F02B11 (79%); F03C11 (61%); F03B11 (61%); F02C4 (51%)
F02818,"Dementia in other diseases classified elsewhere, unspecified severity, with other behavioral disturbance",127,F02C18 (82%); F02B18 (82%); F02C0 (68%); F02B0 (68%); F03C18 (67%)
F0282,"Dementia in other diseases classified elsewhere, unspecified severity, with psychotic disturbance",127,F02C2 (80%); F02B2 (80%); F02C0 (65%); F02B0 (65%); F02C3 (64%)
F0283,"Dementia in other diseases classified elsewhere, unspecified severity, with mood disturbance",127,F02C3 (82%); F02B3 (81%); F02C0 (67%); F02B0 (67%); F03C3 (65%)
F0284,"Dementia in other diseases classified elsewhere, unspecified severity, with anxiety",127,F02C4 (78%); F02B4 (77%); F03C4 (56%); F03B4 (56%); F02C11 (51%)
F02A0,"Dementia in other diseases classified elsewhere, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",127,F02C0 (94%); F02B0 (94%); F03C0 (88%); F03B0 (88%); F01C0 (85%)
F02A11,"Dementia in other diseases classified elsewhere, mild, with agitation",127,F02C11 (81%); F02B11 (81%); F03C11 (59%); F03B11 (59%); F02C4 (52%)
F02A18,"Dementia in other diseases classified elsewhere, mild, with other behavioral disturbance",127,F02C18 (83%); F02B18 (83%); F02C0 (69%); F02B0 (69%); F03C18 (65%)
F02A2,"Dementia in other diseases classified elsewhere, mild, with psychotic disturbance",127,F02C2 (82%); F02B2 (81%); F02C0 (66%); F02B0 (66%); F02C3 (65%)
F02A3,"Dementia in other diseases classified elsewhere, mild, with mood disturbance",127,F02C3 (83%); F02B3 (82%); F02C0 (68%); F02B0 (68%); F02C2 (65%)
F02A4,"Dementia in other diseases classified elsewhere, mild, with anxiety",127,F02C4 (79%); F02B4 (79%); F03C4 (54%); F03B4 (53%); F02C11 (52%)
F02B0,"Dementia in other diseases classified elsewhere, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",126,F02C0 (94%); F02A0 (94%); F0280 (93%); F03C0 (88%); F03A0 (88%)
F02B11,"Dementia in other diseases classified elsewhere, moderate, with agitation",126,F02C11 (81%); F02A11 (81%); F02811 (79%); F03C11 (59%); F03A11 (59%)
F02B18,"Dementia in other diseases classified elsewhere, moderate, with other behavioral disturbance",126,F02C18 (84%); F02A18 (83%); F02818 (82%); F02C0 (69%); F02A0 (69%)
F02B2,"Dementia in other diseases classified elsewhere, moderate, with psychotic disturbance",126,F02C2 (82%); F02A2 (81%); F0282 (80%); F02C0 (66%); F02A0 (66%)
F02B3,"Dementia in other diseases classified elsewhere, moderate, with mood disturbance",126,F02C3 (83%); F02A3 (82%); F0283 (81%); F02C0 (68%); F02A0 (68%)
F02B4,"Dementia in other diseases classified elsewhere, moderate, with anxiety",126,F02C4 (79%); F02A4 (79%); F0284 (77%); F03C4 (54%); F03A4 (53%)
F02C0,"Dementia in other diseases classified elsewhere, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",125,F02B0 (94%); F02A0 (94%); F0280 (93%); F03B0 (88%); F03A0 (88%)
F02C11,"Dementia in other diseases classified elsewhere, severe, with agitation",125,F02B11 (81%); F02A11 (81%); F02811 (80%); F03B11 (59%); F03A11 (59%)
F02C18,"Dementia in other diseases classified elsewhere, severe, with other behavioral disturbance",125,F02B18 (84%); F02A18 (83%); F02818 (82%); F02B0 (69%); F02A0 (69%)
F02C2,"Dementia in other diseases classified elsewhere, severe, with psychotic disturbance",125,F02B2 (82%); F02A2 (82%); F0282 (80%); F02B0 (67%); F02A0 (67%)
F02C3,"Dementia in other diseases classified elsewhere, severe, with mood disturbance",125,F02B3 (83%); F02A3 (83%); F0283 (82%); F02B0 (68%); F02A0 (68%)
F02C4,"Dementia in other diseases classified elsewhere, severe, with anxiety",125,F02B4 (79%); F02A4 (79%); F0284 (78%); F03B4 (53%); F03A4 (53%)
F0390,"Unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",127,F03C0 (93%); F03B0 (93%); F01C0 (88%); F01B0 (88%); F02C0 (87%)
F03911,"Unspecified dementia, unspecified severity, with agitation",127,F03C11 (73%); F03B11 (73%); F01C11 (58%); F01B11 (57%); F02C11 (56%)
F03918,"Unspecified dementia, unspecified severity, with other behavioral disturbance",127,F03C18 (77%); F03B18 (77%); F03C0 (64%); F03B0 (64%); F01C18 (63%)
F0392,"Unspecified dementia, unspecified severity, with psychotic disturbance",127,F03C2 (74%); F03B2 (74%); F03C0 (61%); F03B0 (61%); F01C2 (59%)
F0393,"Unspecified dementia, unspecified severity, with mood disturbance",127,F03C3 (76%); F03B3 (76%); F03C0 (63%); F03B0 (62%); F01C3 (61%)
F0394,"Unspecified dementia, unspecified severity, with anxiety",127,F03C4 (69%); F03B4 (69%); F01C4 (52%); F01B4 (52%); F02C4 (50%)
F03A0,"Unspecified dementia, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",127,F03C0 (93%); F03B0 (93%); F01C0 (89%); F01B0 (89%); F02C0 (88%)
F03A11,"Unspecified dementia, mild, with agitation",127,F03C11 (74%); F03B11 (73%); F01C11 (61%); F01B11 (61%); F02C11 (59%)
F03A18,"Unspecified dementia, mild, with other behavioral disturbance",127,F03C18 (78%); F03B18 (77%); F01C18 (67%); F01B18 (66%); F03C0 (65%)
F03A2,"Unspecified dementia, mild, with psychotic disturbance",127,F03C2 (75%); F03B2 (74%); F03C0 (63%); F03B0 (63%); F01C2 (62%)
F03A3,"Unspecified dementia, mild, with mood disturbance",127,F03C3 (77%); F03B3 (76%); F01C3 (65%); F01B3 (64%); F03C0 (64%)
F03A4,"Unspecified dementia, mild, with anxiety",127,F03C4 (70%); F03B4 (69%); F01C4 (56%); F01B4 (55%); F02C4 (53%)
F03B0,"Unspecified dementia, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",126,F03C0 (93%); F03A0 (93%); F0390 (93%); F0150 (89%); F01C0 (89%)
F03B11,"Unspecified dementia, moderate, with agitation",126,F03C11 (74%); F03A11 (73%); F03911 (73%); F01511 (63%); F01C11 (61%)
F03B18,"Unspecified dementia, moderate, with other behavioral disturbance",126,F03C18 (78%); F03A18 (77%); F03918 (77%); F01518 (68%); F01C18 (67%)
F03B2,"Unspecified dementia, moderate, with psychotic disturbance",126,F03C2 (75%); F03A2 (74%); F0392 (74%); F0152 (64%); F0390 (64%)
F03B3,"Unspecified dementia, moderate, with mood disturbance",126,F03C3 (77%); F03A3 (76%); F0393 (76%); F0153 (66%); F0390 (65%)
F03B4,"Unspecified dementia, moderate, with anxiety",126,F03C4 (70%); F03A4 (69%); F0394 (69%); F0154 (58%); F0284 (56%)
F03C0,"Unspecified dementia, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",125,F03B0 (93%); F03A0 (93%); F0390 (93%); F0150 (90%); F01B0 (89%)
F03C11,"Unspecified dementia, severe, with agitation",125,F03B11 (74%); F03A11 (74%); F03911 (73%); F01511 (64%); F02811 (61%)
F03C18,"Unspecified dementia, severe, with other behavioral disturbance",125,F03B18 (78%); F03A18 (78%); F03918 (77%); F01518 (69%); F01B18 (67%)
F03C2,"Unspecified dementia, severe, with psychotic disturbance",125,F03B2 (75%); F03A2 (75%); F0392 (74%); F0152 (65%); F0390 (64%)
F03C3,"Unspecified dementia, severe, with mood disturbance",125,F03B3 (77%); F03A3 (77%); F0393 (76%); F0153 (67%); F0390 (66%)
F03C4,"Unspecified dementia, severe, with anxiety",125,F03B4 (70%); F03A4 (70%); F0394 (69%); F0154 (59%); F0284 (56%)
F04,Amnestic disorder due to known physiological condition,,
F10120,"Alcohol abuse with intoxication, uncomplicated",,
F10121,Alcohol abuse with intoxication delirium,,
F10129,"Alcohol abuse with intoxication, unspecified",,
F10130,"Alcohol abuse with withdrawal, uncomplicated",139,F10131 (71%); F19130 (65%); F10132 (63%); F13130 (59%); F10159 (54%)
F10131,Alcohol abuse with withdrawal delirium,136,F10139 (81%); F10130 (71%); F19131 (67%); F10239 (60%); F13131 (60%)
F10132,Alcohol abuse with withdrawal with perceptual disturbance,136,F19132 (73%); F10139 (72%); F13132 (67%); F10130 (63%); F19232 (60%)
F10139,"Alcohol abuse with withdrawal, unspecified",139,F10131 (81%); F10132 (72%); F10159 (65%); F1413 (64%); F10931 (63%)
F1014,Alcohol abuse with alcohol-induced mood disorder,139,F10159 (86%); F10150 (80%); F10151 (80%); F10259 (75%); F10959 (73%)
F10150,Alcohol abuse with alcohol-induced psychotic disorder with delusions,136,F10188 (86%); F1014 (80%); F10180 (80%); F10182 (78%); F10288 (76%)
F10151,Alcohol abuse with alcohol-induced psychotic disorder with hallucinations,136,F10188 (86%); F1014 (80%); F10180 (80%); F10182 (78%); F10288 (76%)
F10159,"Alcohol abuse with alcohol-induced psychotic disorder, unspecified",136,F10188 (93%); F1014 (86%); F10180 (86%); F10182 (84%); F1029 (83%)
F10180,Alcohol abuse with alcohol-induced anxiety disorder,139,F10159 (86%); F10150 (80%); F10151 (80%); F10259 (75%); F10959 (73%)
F10181,Alcohol abuse with alcohol-induced sexual dysfunction,139,F10159 (73%); F10150 (68%); F10151 (68%); F10259 (63%); F10959 (61%)
F10182,Alcohol abuse with alcohol-induced sleep disorder,139,F10159 (84%); F10150 (78%); F10151 (78%); F10259 (74%); F10959 (71%)
F10188,Alcohol abuse with other alcohol-induced disorder,139,F10159 (93%); F10150 (86%); F10151 (86%); F10259 (82%); F10959 (79%)
F1019,Alcohol abuse with unspecified alcohol-induced disorder,,
F1020,"Alcohol dependence, uncomplicated",139,F10259 (63%); F1420 (62%); F1520 (62%); F1120 (62%); F1620 (61%)
F1021,"Alcohol dependence, in remission",139,F10259 (66%); F1027 (62%); F10250 (61%); F10251 (61%); F1421 (59%)
F10220,"Alcohol dependence with intoxication, uncomplicated",139,F14220 (71%); F15220 (71%); F11220 (71%); F16220 (70%); F18220 (70%)
F10221,Alcohol dependence with intoxication delirium,139,F10231 (75%); F14221 (72%); F15221 (72%); F11221 (72%); F16221 (71%)
F10229,"Alcohol dependence with intoxication, unspecified",139,F10259 (67%); F14229 (62%); F15229 (62%); F11229 (61%); F16229 (61%)
F10230,"Alcohol dependence with withdrawal, uncomplicated",139,F10231 (71%); F19230 (65%); F10232 (63%); F13230 (59%); F10259 (54%)
F10231,Alcohol dependence with withdrawal delirium,136,F10239 (81%); F10221 (75%); F10230 (71%); F19231 (66%); F10139 (60%)
F10232,Alcohol dependence with withdrawal with perceptual disturbance,136,F19232 (73%); F10239 (72%); F13232 (67%); F10230 (63%); F19132 (60%)
F10239,"Alcohol dependence with withdrawal, unspecified",139,F10231 (81%); F10232 (72%); F10259 (65%); F10931 (63%); F1423 (61%)
F1024,Alcohol dependence with alcohol-induced mood disorder,139,F10259 (86%); F10250 (79%); F10251 (79%); F10159 (75%); F1026 (74%)
F10250,Alcohol dependence with alcohol-induced psychotic disorder with delusions,136,F10288 (86%); F1029 (85%); F1024 (79%); F10280 (79%); F10282 (78%)
F10251,Alcohol dependence with alcohol-induced psychotic disorder with hallucinations,136,F10288 (86%); F1029 (85%); F1024 (79%); F10280 (79%); F10282 (78%)
F10259,"Alcohol dependence with alcohol-induced psychotic disorder, unspecified",136,F1029 (94%); F10288 (93%); F1024 (86%); F10280 (86%); F10282 (84%)
F1026,Alcohol dependence with alcohol-induced persisting amnestic disorder,136,F10288 (80%); F1029 (80%); F1024 (74%); F10280 (74%); F10282 (72%)
F1027,Alcohol dependence with alcohol-induced persisting dementia,136,F10288 (80%); F1029 (79%); F1024 (73%); F10280 (73%); F10282 (72%)
F10280,Alcohol dependence with alcohol-induced anxiety disorder,139,F10259 (86%); F10250 (79%); F10251 (79%); F10159 (75%); F1026 (74%)
F10281,Alcohol dependence with alcohol-induced sexual dysfunction,139,F10259 (73%); F1027 (69%); F10250 (68%); F10251 (68%); F10159 (63%)
F10282,Alcohol dependence with alcohol-induced sleep disorder,139,F10259 (84%); F10250 (78%); F10251 (78%); F10159 (74%); F1026 (72%)
F10288,Alcohol dependence with other alcohol-induced disorder,139,F10259 (93%); F10250 (86%); F10251 (86%); F10159 (82%); F1026 (80%)
F1029,Alcohol dependence with unspecified alcohol-induced disorder,139,F10259 (94%); F10250 (85%); F10251 (85%); F10159 (83%); F10959 (83%)
F10920,"Alcohol use, unspecified with intoxication, uncomplicated",,
F10921,"Alcohol use, unspecified with intoxication delirium",,
F10929,"Alcohol use, unspecified with intoxication, unspecified",,
F10930,"Alcohol use, unspecified with withdrawal, uncomplicated",139,F10931 (72%); F19930 (66%); F10932 (64%); F13930 (60%); F10959 (57%)
F10931,"Alcohol use, unspecified with withdrawal delirium",136,F10939 (82%); F10930 (72%); F19931 (67%); F10239 (63%); F10139 (63%)
F10932,"Alcohol use, unspecified with withdrawal with perceptual disturbance",136,F19932 (73%); F10939 (73%); F10930 (64%); F14922 (60%); F15922 (60%)
F10939,"Alcohol use, unspecified with withdrawal, unspecified",139,F10931 (82%); F10932 (73%); F10959 (67%); F1493 (64%); F1593 (64%)
F1094,"Alcohol use, unspecified with alcohol-induced mood disorder",139,F10959 (86%); F10950 (80%); F10951 (80%); F10259 (77%); F10159 (77%)
F10950,"Alcohol use, unspecified with alcohol-induced psychotic disorder with delusions",136,F10988 (86%); F1094 (80%); F10980 (80%); F10982 (78%); F1029 (76%)
F10951,"Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations",136,F10988 (86%); F1094 (80%); F10980 (80%); F10982 (78%); F1029 (76%)
F10959,"Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified",136,F10988 (93%); F1094 (86%); F10980 (86%); F10982 (84%); F1029 (83%)
F1096,"Alcohol use, unspecified with alcohol-induced persisting amnestic disorder",136,F10988 (81%); F1094 (75%); F10980 (75%); F10982 (73%); F1029 (71%)
F1097,"Alcohol use, unspecified with alcohol-induced persisting dementia",136,F10988 (80%); F1094 (74%); F10980 (74%); F10982 (72%); F1029 (70%)
F10980,"Alcohol use, unspecified with alcohol-induced anxiety disorder",139,F10959 (86%); F10950 (80%); F10951 (80%); F10259 (77%); F10159 (77%)
F10981,"Alcohol use, unspecified with alcohol-induced sexual dysfunction",139,F10959 (74%); F1097 (69%); F10950 (68%); F10951 (68%); F10259 (65%)
F10982,"Alcohol use, unspecified with alcohol-induced sleep disorder",139,F10959 (84%); F10950 (78%); F10951 (78%); F10259 (75%); F10159 (75%)
F10988,"Alcohol use, unspecified with other alcohol-induced disorder",139,F10959 (93%); F10950 (86%); F10951 (86%); F10259 (83%); F10159 (83%)
F1099,"Alcohol use, unspecified with unspecified alcohol-induced disorder",,
F1110,"Opioid abuse, uncomplicated",138,F11120 (87%); F1120 (74%); F11188 (68%); F1119 (68%); F11220 (65%)
F1111,"Opioid abuse, in remission",138,F1121 (72%); F11188 (71%); F1119 (70%); F11159 (66%); F11129 (66%)
F11120,"Opioid abuse with intoxication, uncomplicated",137,F1110 (87%); F1111 (57%); F11159 (56%); F1410 (54%); F1510 (54%)
F11121,Opioid abuse with intoxication delirium,137,F1111 (56%); F11159 (55%); F1110 (54%); F10221 (53%); F11150 (51%)
F11122,Opioid abuse with intoxication with perceptual disturbance,137,F10132 (59%); F19132 (55%); F13132 (50%); F1111 (50%); F11159 (49%)
F11129,"Opioid abuse with intoxication, unspecified",137,F11159 (67%); F1111 (66%); F1110 (63%); F11150 (60%); F11151 (60%)
F1113,Opioid abuse with withdrawal,137,F1111 (66%); F11159 (64%); F1110 (63%); F10139 (61%); F11150 (59%)
F1114,Opioid abuse with opioid-induced mood disorder,137,F11159 (86%); F11150 (80%); F11151 (80%); F11259 (76%); F11959 (74%)
F11150,Opioid abuse with opioid-induced psychotic disorder with delusions,135,F11188 (86%); F1119 (86%); F1114 (80%); F11182 (78%); F11288 (76%)
F11151,Opioid abuse with opioid-induced psychotic disorder with hallucinations,135,F11188 (86%); F1119 (86%); F1114 (80%); F11182 (78%); F11288 (76%)
F11159,"Opioid abuse with opioid-induced psychotic disorder, unspecified",135,F1119 (94%); F11188 (93%); F1114 (86%); F11182 (84%); F1129 (83%)
F11181,Opioid abuse with opioid-induced sexual dysfunction,137,F11159 (73%); F11150 (68%); F11151 (68%); F11259 (64%); F11959 (62%)
F11182,Opioid abuse with opioid-induced sleep disorder,137,F11159 (84%); F11150 (78%); F11151 (78%); F11259 (74%); F11959 (72%)
F11188,Opioid abuse with other opioid-induced disorder,137,F11159 (93%); F11150 (86%); F11151 (86%); F11259 (82%); F11959 (80%)
F1119,Opioid abuse with unspecified opioid-induced disorder,137,F11159 (94%); F11150 (86%); F11151 (86%); F11259 (83%); F11959 (83%)
F1120,"Opioid dependence, uncomplicated",137,F1110 (74%); F11259 (64%); F1020 (62%); F11250 (59%); F11251 (59%)
F1121,"Opioid dependence, in remission",137,F1111 (72%); F11259 (66%); F11250 (61%); F11251 (61%); F1021 (59%)
F11220,"Opioid dependence with intoxication, uncomplicated",137,F10220 (71%); F1110 (65%); F11259 (56%); F1020 (54%); F11250 (52%)
F11221,Opioid dependence with intoxication delirium,137,F10221 (72%); F11259 (54%); F11250 (51%); F11251 (51%); F10231 (48%)
F11222,Opioid dependence with intoxication with perceptual disturbance,137,F10232 (59%); F19232 (54%); F13232 (50%); F11259 (48%); F11250 (45%)
F11229,"Opioid dependence with intoxication, unspecified",137,F11259 (67%); F10229 (61%); F11250 (59%); F11251 (59%); F11959 (53%)
F1123,Opioid dependence with withdrawal,137,F11259 (64%); F10239 (60%); F11250 (59%); F11251 (59%); F10230 (52%)
F1124,Opioid dependence with opioid-induced mood disorder,137,F11259 (86%); F11250 (80%); F11251 (80%); F11159 (76%); F11959 (74%)
F11250,Opioid dependence with opioid-induced psychotic disorder with delusions,135,F11288 (86%); F1129 (85%); F1124 (80%); F11282 (78%); F11188 (76%)
F11251,Opioid dependence with opioid-induced psychotic disorder with hallucinations,135,F11288 (86%); F1129 (85%); F1124 (80%); F11282 (78%); F11188 (76%)
F11259,"Opioid dependence with opioid-induced psychotic disorder, unspecified",135,F1129 (94%); F11288 (93%); F1124 (86%); F11282 (84%); F11988 (83%)
F11281,Opioid dependence with opioid-induced sexual dysfunction,137,F11259 (73%); F11250 (68%); F11251 (68%); F11159 (64%); F11959 (62%)
F11282,Opioid dependence with opioid-induced sleep disorder,137,F11259 (84%); F11250 (78%); F11251 (78%); F11159 (74%); F11959 (72%)
F11288,Opioid dependence with other opioid-induced disorder,137,F11259 (93%); F11250 (86%); F11251 (86%); F11159 (82%); F11959 (80%)
F1129,Opioid dependence with unspecified opioid-induced disorder,137,F11259 (94%); F11250 (85%); F11251 (85%); F11159 (83%); F11959 (83%)
F11920,"Opioid use, unspecified with intoxication, uncomplicated",137,F1110 (63%); F11959 (58%); F11950 (53%); F11951 (53%); F10220 (50%)
F11921,"Opioid use, unspecified with intoxication delirium",137,F11959 (57%); F10221 (52%); F11950 (52%); F11951 (52%); F10931 (50%)
F11922,"Opioid use, unspecified with intoxication with perceptual disturbance",137,F10932 (60%); F19932 (56%); F11959 (51%); F11950 (46%); F11951 (46%)
F11929,"Opioid use, unspecified with intoxication, unspecified",137,F11959 (69%); F11950 (60%); F11951 (60%); F11259 (51%); F11159 (50%)
F1193,"Opioid use, unspecified with withdrawal",137,F11959 (66%); F10939 (64%); F11950 (60%); F11951 (60%); F10930 (55%)
F1194,"Opioid use, unspecified with opioid-induced mood disorder",137,F11959 (86%); F11950 (80%); F11951 (80%); F11259 (77%); F11159 (77%)
F11950,"Opioid use, unspecified with opioid-induced psychotic disorder with delusions",135,F11988 (87%); F1199 (86%); F1194 (80%); F11982 (78%); F1129 (77%)
F11951,"Opioid use, unspecified with opioid-induced psychotic disorder with hallucinations",135,F11988 (87%); F1199 (86%); F1194 (80%); F11982 (78%); F1129 (77%)
F11959,"Opioid use, unspecified with opioid-induced psychotic disorder, unspecified",135,F1199 (94%); F11988 (93%); F1194 (86%); F11982 (84%); F1129 (83%)
F11981,"Opioid use, unspecified with opioid-induced sexual dysfunction",137,F11959 (74%); F11950 (69%); F11951 (69%); F11259 (65%); F11159 (65%)
F11982,"Opioid use, unspecified with opioid-induced sleep disorder",137,F11959 (84%); F11950 (78%); F11951 (78%); F11259 (75%); F11159 (75%)
F11988,"Opioid use, unspecified with other opioid-induced disorder",137,F11959 (93%); F11950 (87%); F11951 (87%); F11259 (83%); F11159 (83%)
F1199,"Opioid use, unspecified with unspecified opioid-induced disorder",137,F11959 (94%); F11950 (86%); F11951 (86%); F11259 (83%); F11159 (83%)
F12120,"Cannabis abuse with intoxication, uncomplicated",,
F12121,Cannabis abuse with intoxication delirium,,
F12122,Cannabis abuse with intoxication with perceptual disturbance,,
F12129,"Cannabis abuse with intoxication, unspecified",,
F1213,Cannabis abuse with withdrawal,137,F12159 (61%); F10139 (59%); F12150 (53%); F12151 (53%); F10130 (51%)
F12150,Cannabis abuse with psychotic disorder with delusions,135,F12188 (67%); F12180 (63%); F12288 (54%); F10150 (54%); F1229 (54%)
F12151,Cannabis abuse with psychotic disorder with hallucinations,135,F12188 (67%); F12180 (63%); F12288 (54%); F10151 (54%); F1229 (54%)
F12159,"Cannabis abuse with psychotic disorder, unspecified",135,F12188 (78%); F12180 (72%); F1229 (65%); F12988 (65%); F12288 (63%)
F12180,Cannabis abuse with cannabis-induced anxiety disorder,137,F12159 (72%); F12150 (63%); F12151 (63%); F12259 (58%); F12959 (55%)
F12188,Cannabis abuse with other cannabis-induced disorder,137,F12159 (78%); F12150 (67%); F12151 (67%); F12259 (63%); F12959 (59%)
F1219,Cannabis abuse with unspecified cannabis-induced disorder,,
F1220,"Cannabis dependence, uncomplicated",137,F12259 (61%); F1020 (60%); F12250 (53%); F12251 (53%); F10220 (52%)
F1221,"Cannabis dependence, in remission",137,F12259 (63%); F1021 (57%); F12250 (55%); F12251 (55%); F12159 (40%)
F12220,"Cannabis dependence with intoxication, uncomplicated",137,F10220 (69%); F12259 (53%); F1020 (53%); F10229 (48%); F12250 (46%)
F12221,Cannabis dependence with intoxication delirium,137,F10221 (70%); F12259 (52%); F10231 (47%); F10229 (47%); F12250 (45%)
F12222,Cannabis dependence with intoxication with perceptual disturbance,137,F10232 (58%); F19232 (53%); F13232 (49%); F12259 (47%); F10132 (44%)
F12229,"Cannabis dependence with intoxication, unspecified",137,F12259 (65%); F10229 (59%); F12250 (53%); F12251 (53%); F10220 (47%)
F1223,Cannabis dependence with withdrawal,137,F12259 (61%); F10239 (58%); F12250 (53%); F12251 (53%); F10230 (51%)
F12250,Cannabis dependence with psychotic disorder with delusions,135,F12288 (67%); F1229 (66%); F12280 (62%); F1221 (55%); F12188 (54%)
F12251,Cannabis dependence with psychotic disorder with hallucinations,135,F12288 (67%); F1229 (66%); F12280 (62%); F1221 (55%); F12188 (54%)
F12259,"Cannabis dependence with psychotic disorder, unspecified",135,F1229 (79%); F12288 (77%); F12280 (72%); F12229 (65%); F12988 (65%)
F12280,Cannabis dependence with cannabis-induced anxiety disorder,137,F12259 (72%); F12250 (62%); F12251 (62%); F12159 (58%); F12959 (55%)
F12288,Cannabis dependence with other cannabis-induced disorder,137,F12259 (77%); F12250 (67%); F12251 (67%); F12159 (63%); F12959 (59%)
F1229,Cannabis dependence with unspecified cannabis-induced disorder,137,F12259 (79%); F12250 (66%); F12251 (66%); F12159 (65%); F12959 (64%)
F12920,"Cannabis use, unspecified with intoxication, uncomplicated",,
F12921,"Cannabis use, unspecified with intoxication delirium",,
F12922,"Cannabis use, unspecified with intoxication with perceptual disturbance",,
F12929,"Cannabis use, unspecified with intoxication, unspecified",,
F1293,"Cannabis use, unspecified with withdrawal",137,F12959 (64%); F10939 (62%); F12950 (55%); F12951 (55%); F10930 (53%)
F12950,"Cannabis use, unspecified with psychotic disorder with delusions",135,F12988 (68%); F12980 (64%); F1229 (55%); F10950 (55%); F1293 (55%)
F12951,"Cannabis use, unspecified with psychotic disorder with hallucinations",135,F12988 (68%); F12980 (64%); F1229 (55%); F10951 (55%); F1293 (55%)
F12959,"Cannabis use, unspecified with psychotic disorder, unspecified",135,F12988 (78%); F12980 (74%); F1293 (64%); F1229 (64%); F12288 (59%)
F12980,"Cannabis use, unspecified with anxiety disorder",137,F12959 (74%); F12950 (64%); F12951 (64%); F12259 (54%); F12159 (54%)
F12988,"Cannabis use, unspecified with other cannabis-induced disorder",137,F12959 (78%); F12950 (68%); F12951 (68%); F12259 (65%); F12159 (65%)
F1299,"Cannabis use, unspecified with unspecified cannabis-induced disorder",,
F1310,"Sedative, hypnotic or anxiolytic abuse, uncomplicated",138,F13120 (91%); F13130 (90%); F1320 (84%); F13188 (82%); F1319 (82%)
F1311,"Sedative, hypnotic or anxiolytic abuse, in remission",138,F13188 (84%); F1321 (84%); F1319 (83%); F13159 (81%); F1314 (81%)
F13120,"Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated",137,F1310 (91%); F13159 (73%); F1311 (73%); F13150 (70%); F13151 (70%)
F13121,"Sedative, hypnotic or anxiolytic abuse with intoxication delirium",137,F13131 (83%); F13159 (72%); F1311 (72%); F13231 (71%); F1310 (70%)
F13129,"Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified",137,F13159 (81%); F1311 (80%); F1310 (78%); F13150 (77%); F13151 (77%)
F13130,"Sedative, hypnotic or anxiolytic abuse with withdrawal, uncomplicated",137,F1310 (90%); F13131 (80%); F13132 (74%); F13159 (72%); F1311 (72%)
F13131,"Sedative, hypnotic or anxiolytic abuse with withdrawal delirium",135,F13139 (88%); F13121 (83%); F13130 (80%); F13239 (74%); F13188 (73%)
F13132,"Sedative, hypnotic or anxiolytic abuse with withdrawal with perceptual disturbance",135,F13139 (81%); F13130 (74%); F13239 (68%); F13188 (68%); F1319 (67%)
F13139,"Sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified",137,F13131 (88%); F13132 (81%); F13159 (80%); F1311 (78%); F1310 (77%)
F1314,"Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder",137,F13159 (93%); F13150 (90%); F13151 (90%); F13259 (88%); F13959 (87%)
F13150,"Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions",135,F13188 (93%); F1319 (92%); F1314 (90%); F13180 (90%); F13182 (89%)
F13151,"Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations",135,F13188 (93%); F1319 (92%); F1314 (90%); F13180 (90%); F13182 (89%)
F13159,"Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified",135,F1319 (97%); F13188 (96%); F1314 (93%); F13180 (93%); F1329 (92%)
F13180,"Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder",137,F13159 (93%); F13150 (90%); F13151 (90%); F13259 (88%); F13959 (87%)
F13181,"Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction",137,F13159 (86%); F13150 (83%); F13151 (83%); F13259 (82%); F13959 (80%)
F13182,"Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder",137,F13159 (92%); F13150 (89%); F13151 (89%); F13259 (87%); F13959 (86%)
F13188,"Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder",137,F13159 (96%); F13150 (93%); F13151 (93%); F13259 (91%); F13959 (90%)
F1319,"Sedative, hypnotic or anxiolytic abuse with unspecified sedative, hypnotic or anxiolytic-induced disorder",137,F13159 (97%); F13150 (92%); F13151 (92%); F13259 (92%); F13959 (91%)
F1320,"Sedative, hypnotic or anxiolytic dependence, uncomplicated",137,F1310 (84%); F13259 (80%); F1327 (77%); F13250 (77%); F13251 (77%)
F1321,"Sedative, hypnotic or anxiolytic dependence, in remission",137,F1311 (84%); F13259 (81%); F1327 (79%); F13250 (78%); F13251 (78%)
F13220,"Sedative, hypnotic or anxiolytic dependence with intoxication, uncomplicated",137,F1310 (77%); F13259 (73%); F1327 (71%); F13250 (70%); F13251 (70%)
F13221,"Sedative, hypnotic or anxiolytic dependence with intoxication delirium",137,F13231 (83%); F13259 (72%); F13131 (71%); F13931 (70%); F1327 (70%)
F13229,"Sedative, hypnotic or anxiolytic dependence with intoxication, unspecified",137,F13259 (81%); F1327 (78%); F13250 (77%); F13251 (77%); F1326 (74%)
F13230,"Sedative, hypnotic or anxiolytic dependence with withdrawal, uncomplicated",137,F13231 (80%); F1310 (76%); F13232 (74%); F13259 (72%); F1327 (70%)
F13231,"Sedative, hypnotic or anxiolytic dependence with withdrawal delirium",135,F13239 (88%); F13221 (83%); F13230 (80%); F13139 (74%); F13288 (73%)
F13232,"Sedative, hypnotic or anxiolytic dependence with withdrawal with perceptual disturbance",135,F13239 (81%); F13230 (74%); F13139 (68%); F13288 (68%); F1329 (67%)
F13239,"Sedative, hypnotic or anxiolytic dependence with withdrawal, unspecified",137,F13231 (88%); F13232 (81%); F13259 (80%); F1327 (76%); F13931 (76%)
F1324,"Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder",137,F13259 (93%); F13250 (90%); F13251 (90%); F13159 (88%); F13959 (87%)
F13250,"Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions",135,F13288 (93%); F1329 (92%); F1324 (90%); F13280 (90%); F13282 (88%)
F13251,"Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations",135,F13288 (93%); F1329 (92%); F1324 (90%); F13280 (90%); F13282 (88%)
F13259,"Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified",135,F1329 (97%); F13288 (96%); F1324 (93%); F13280 (93%); F13988 (92%)
F1326,"Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder",135,F13288 (90%); F1329 (89%); F1324 (86%); F13280 (86%); F13282 (85%)
F1327,"Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia",135,F13288 (90%); F1329 (89%); F1324 (87%); F13280 (87%); F13282 (86%)
F13280,"Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder",137,F13259 (93%); F13250 (90%); F13251 (90%); F13159 (88%); F13959 (87%)
F13281,"Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction",137,F13259 (86%); F1327 (84%); F13250 (83%); F13251 (83%); F13159 (82%)
F13282,"Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder",137,F13259 (92%); F13250 (88%); F13251 (88%); F13159 (87%); F13959 (86%)
F13288,"Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder",137,F13259 (96%); F13250 (93%); F13251 (93%); F13159 (91%); F13959 (90%)
F1329,"Sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder",137,F13259 (97%); F13250 (92%); F13251 (92%); F13159 (92%); F13959 (92%)
F13920,"Sedative, hypnotic or anxiolytic use, unspecified with intoxication, uncomplicated",137,F1310 (76%); F13959 (74%); F1397 (71%); F13950 (71%); F13951 (71%)
F13921,"Sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium",137,F13931 (84%); F13959 (73%); F1397 (70%); F13231 (70%); F13131 (70%)
F13929,"Sedative, hypnotic or anxiolytic use, unspecified with intoxication, unspecified",137,F13959 (82%); F1397 (77%); F13950 (76%); F13951 (76%); F1396 (74%)
F13930,"Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated",137,F13931 (81%); F1310 (75%); F13959 (73%); F1397 (70%); F13950 (70%)
F13931,"Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium",135,F13939 (88%); F13921 (84%); F13930 (81%); F13239 (76%); F13139 (76%)
F13932,"Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances",135,F13939 (75%); F13930 (69%); F13239 (65%); F13139 (65%); F1399 (63%)
F13939,"Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified",137,F13931 (88%); F13959 (80%); F1397 (76%); F13932 (75%); F13950 (75%)
F1394,"Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder",137,F13959 (93%); F13950 (90%); F13951 (90%); F13259 (89%); F13159 (88%)
F13950,"Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions",135,F13988 (93%); F1399 (93%); F1394 (90%); F13980 (90%); F13982 (89%)
F13951,"Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations",135,F13988 (93%); F1399 (93%); F1394 (90%); F13980 (90%); F13982 (89%)
F13959,"Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified",135,F1399 (97%); F13988 (97%); F1394 (93%); F13980 (93%); F13982 (92%)
F1396,"Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder",135,F13988 (90%); F1399 (89%); F1394 (86%); F13980 (86%); F13982 (85%)
F1397,"Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia",135,F13988 (90%); F1399 (90%); F1394 (87%); F13980 (87%); F13982 (86%)
F13980,"Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder",137,F13959 (93%); F13950 (90%); F13951 (90%); F13259 (89%); F13159 (88%)
F13981,"Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction",137,F13959 (87%); F1397 (84%); F13950 (83%); F13951 (83%); F13259 (82%)
F13982,"Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder",137,F13959 (92%); F13950 (89%); F13951 (89%); F13259 (88%); F13159 (87%)
F13988,"Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder",137,F13959 (97%); F13950 (93%); F13951 (93%); F13259 (92%); F13159 (92%)
F1399,"Sedative, hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic or anxiolytic-induced disorder",137,F13959 (97%); F13950 (93%); F13951 (93%); F13259 (92%); F13159 (91%)
F1410,"Cocaine abuse, uncomplicated",138,F14120 (87%); F1420 (74%); F14188 (68%); F1419 (67%); F14220 (64%)
F1411,"Cocaine abuse, in remission",138,F1421 (72%); F14188 (70%); F1419 (70%); F14159 (66%); F14129 (65%)
F14120,"Cocaine abuse with intoxication, uncomplicated",137,F1410 (87%); F1411 (57%); F14159 (55%); F1510 (54%); F1110 (54%)
F14121,Cocaine abuse with intoxication with delirium,137,F1411 (56%); F14159 (54%); F1410 (54%); F10221 (53%); F14150 (50%)
F14122,Cocaine abuse with intoxication with perceptual disturbance,137,F10132 (59%); F19132 (55%); F13132 (50%); F1411 (49%); F14159 (48%)
F14129,"Cocaine abuse with intoxication, unspecified",137,F14159 (67%); F1411 (65%); F1410 (63%); F14150 (59%); F14151 (59%)
F1413,"Cocaine abuse, unspecified with withdrawal",137,F14159 (65%); F10139 (64%); F1411 (63%); F1410 (61%); F14150 (57%)
F1414,Cocaine abuse with cocaine-induced mood disorder,137,F14159 (86%); F14150 (79%); F14151 (79%); F14259 (75%); F14959 (73%)
F14150,Cocaine abuse with cocaine-induced psychotic disorder with delusions,135,F14188 (86%); F1419 (85%); F1414 (79%); F14180 (79%); F14182 (78%)
F14151,Cocaine abuse with cocaine-induced psychotic disorder with hallucinations,135,F14188 (86%); F1419 (85%); F1414 (79%); F14180 (79%); F14182 (78%)
F14159,"Cocaine abuse with cocaine-induced psychotic disorder, unspecified",135,F1419 (94%); F14188 (93%); F1414 (86%); F14180 (86%); F14182 (84%)
F14180,Cocaine abuse with cocaine-induced anxiety disorder,137,F14159 (86%); F14150 (79%); F14151 (79%); F14259 (75%); F14959 (73%)
F14181,Cocaine abuse with cocaine-induced sexual dysfunction,137,F14159 (73%); F14150 (68%); F14151 (68%); F14259 (63%); F14959 (61%)
F14182,Cocaine abuse with cocaine-induced sleep disorder,137,F14159 (84%); F14150 (78%); F14151 (78%); F14259 (74%); F14959 (71%)
F14188,Cocaine abuse with other cocaine-induced disorder,137,F14159 (93%); F14150 (86%); F14151 (86%); F14259 (82%); F14959 (79%)
F1419,Cocaine abuse with unspecified cocaine-induced disorder,137,F14159 (94%); F14150 (85%); F14151 (85%); F14259 (83%); F14959 (82%)
F1420,"Cocaine dependence, uncomplicated",137,F1410 (74%); F14259 (63%); F1020 (62%); F14250 (58%); F14251 (58%)
F1421,"Cocaine dependence, in remission",137,F1411 (72%); F14259 (65%); F14250 (61%); F14251 (61%); F1021 (59%)
F14220,"Cocaine dependence with intoxication, uncomplicated",137,F10220 (71%); F1410 (64%); F14259 (55%); F1020 (54%); F14250 (51%)
F14221,Cocaine dependence with intoxication delirium,137,F10221 (72%); F14259 (54%); F14250 (50%); F14251 (50%); F10231 (48%)
F14222,Cocaine dependence with intoxication with perceptual disturbance,137,F10232 (59%); F19232 (55%); F13232 (50%); F14259 (48%); F10132 (45%)
F14229,"Cocaine dependence with intoxication, unspecified",137,F14259 (66%); F10229 (62%); F14250 (59%); F14251 (59%); F14959 (52%)
F1423,Cocaine dependence with withdrawal,137,F14259 (63%); F10239 (61%); F14250 (58%); F14251 (58%); F10230 (53%)
F1424,Cocaine dependence with cocaine-induced mood disorder,137,F14259 (86%); F14250 (79%); F14251 (79%); F14159 (75%); F14959 (73%)
F14250,Cocaine dependence with cocaine-induced psychotic disorder with delusions,135,F14288 (86%); F1429 (85%); F1424 (79%); F14280 (79%); F14282 (77%)
F14251,Cocaine dependence with cocaine-induced psychotic disorder with hallucinations,135,F14288 (86%); F1429 (85%); F1424 (79%); F14280 (79%); F14282 (77%)
F14259,"Cocaine dependence with cocaine-induced psychotic disorder, unspecified",135,F1429 (94%); F14288 (93%); F1424 (86%); F14280 (86%); F14282 (84%)
F14280,Cocaine dependence with cocaine-induced anxiety disorder,137,F14259 (86%); F14250 (79%); F14251 (79%); F14159 (75%); F14959 (73%)
F14281,Cocaine dependence with cocaine-induced sexual dysfunction,137,F14259 (73%); F14250 (67%); F14251 (67%); F14159 (63%); F14959 (61%)
F14282,Cocaine dependence with cocaine-induced sleep disorder,137,F14259 (84%); F14250 (77%); F14251 (77%); F14159 (74%); F14959 (71%)
F14288,Cocaine dependence with other cocaine-induced disorder,137,F14259 (93%); F14250 (86%); F14251 (86%); F14159 (82%); F14959 (79%)
F1429,Cocaine dependence with unspecified cocaine-induced disorder,137,F14259 (94%); F14250 (85%); F14251 (85%); F14159 (83%); F14959 (83%)
F14920,"Cocaine use, unspecified with intoxication, uncomplicated",137,F1410 (63%); F14959 (58%); F14950 (52%); F14951 (52%); F10220 (51%)
F14921,"Cocaine use, unspecified with intoxication delirium",137,F14959 (57%); F10221 (53%); F14950 (51%); F14951 (51%); F10931 (50%)
F14922,"Cocaine use, unspecified with intoxication with perceptual disturbance",137,F10932 (60%); F19932 (56%); F14959 (50%); F14950 (45%); F14951 (45%)
F14929,"Cocaine use, unspecified with intoxication, unspecified",137,F14959 (69%); F14950 (60%); F14951 (60%); F14259 (50%); F14159 (50%)
F1493,"Cocaine use, unspecified with withdrawal",137,F14959 (66%); F10939 (64%); F14950 (59%); F14951 (59%); F10930 (55%)
F1494,"Cocaine use, unspecified with cocaine-induced mood disorder",137,F14959 (86%); F14950 (80%); F14951 (80%); F14259 (77%); F14159 (76%)
F14950,"Cocaine use, unspecified with cocaine-induced psychotic disorder with delusions",135,F14988 (86%); F1499 (85%); F1494 (80%); F14980 (80%); F14982 (78%)
F14951,"Cocaine use, unspecified with cocaine-induced psychotic disorder with hallucinations",135,F14988 (86%); F1499 (85%); F1494 (80%); F14980 (80%); F14982 (78%)
F14959,"Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified",135,F1499 (94%); F14988 (93%); F1494 (86%); F14980 (86%); F14982 (84%)
F14980,"Cocaine use, unspecified with cocaine-induced anxiety disorder",137,F14959 (86%); F14950 (80%); F14951 (80%); F14259 (77%); F14159 (76%)
F14981,"Cocaine use, unspecified with cocaine-induced sexual dysfunction",137,F14959 (74%); F14950 (68%); F14951 (68%); F14259 (65%); F14159 (64%)
F14982,"Cocaine use, unspecified with cocaine-induced sleep disorder",137,F14959 (84%); F14950 (78%); F14951 (78%); F14259 (75%); F14159 (75%)
F14988,"Cocaine use, unspecified with other cocaine-induced disorder",137,F14959 (93%); F14950 (86%); F14951 (86%); F14259 (83%); F14159 (83%)
F1499,"Cocaine use, unspecified with unspecified cocaine-induced disorder",137,F14959 (94%); F14950 (85%); F14951 (85%); F14259 (82%); F14159 (82%)
F1510,"Other stimulant abuse, uncomplicated",138,F15120 (87%); F1520 (74%); F15188 (68%); F1519 (67%); F15220 (64%)
F1511,"Other stimulant abuse, in remission",138,F1521 (72%); F15188 (71%); F1519 (70%); F15159 (66%); F15129 (65%)
F15120,"Other stimulant abuse with intoxication, uncomplicated",137,F1510 (87%); F1511 (57%); F15159 (55%); F1410 (55%); F1110 (54%)
F15121,Other stimulant abuse with intoxication delirium,137,F1511 (56%); F15159 (54%); F1510 (54%); F10221 (53%); F15150 (50%)
F15122,Other stimulant abuse with intoxication with perceptual disturbance,137,F10132 (59%); F19132 (55%); F13132 (50%); F1511 (49%); F15159 (48%)
F15129,"Other stimulant abuse with intoxication, unspecified",137,F15159 (67%); F1511 (65%); F1510 (63%); F15150 (59%); F15151 (59%)
F1513,Other stimulant abuse with withdrawal,137,F1511 (65%); F15159 (63%); F1510 (63%); F10139 (61%); F15150 (59%)
F1514,Other stimulant abuse with stimulant-induced mood disorder,137,F15159 (86%); F15150 (80%); F15151 (80%); F15259 (76%); F15959 (73%)
F15150,Other stimulant abuse with stimulant-induced psychotic disorder with delusions,135,F15188 (86%); F1519 (85%); F1514 (80%); F15180 (80%); F15182 (78%)
F15151,Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations,135,F15188 (86%); F1519 (85%); F1514 (80%); F15180 (80%); F15182 (78%)
F15159,"Other stimulant abuse with stimulant-induced psychotic disorder, unspecified",135,F1519 (94%); F15188 (93%); F1514 (86%); F15180 (86%); F15182 (84%)
F15180,Other stimulant abuse with stimulant-induced anxiety disorder,137,F15159 (86%); F15150 (80%); F15151 (80%); F15259 (76%); F15959 (73%)
F15181,Other stimulant abuse with stimulant-induced sexual dysfunction,137,F15159 (73%); F15150 (68%); F15151 (68%); F15259 (63%); F15959 (62%)
F15182,Other stimulant abuse with stimulant-induced sleep disorder,137,F15159 (84%); F15150 (78%); F15151 (78%); F15259 (74%); F15959 (71%)
F15188,Other stimulant abuse with other stimulant-induced disorder,137,F15159 (93%); F15150 (86%); F15151 (86%); F15259 (82%); F15959 (79%)
F1519,Other stimulant abuse with unspecified stimulant-induced disorder,137,F15159 (94%); F15150 (85%); F15151 (85%); F15259 (83%); F15959 (83%)
F1520,"Other stimulant dependence, uncomplicated",137,F1510 (74%); F15259 (63%); F1020 (62%); F15250 (59%); F15251 (59%)
F1521,"Other stimulant dependence, in remission",137,F1511 (72%); F15259 (66%); F15250 (61%); F15251 (61%); F1021 (59%)
F15220,"Other stimulant dependence with intoxication, uncomplicated",137,F10220 (71%); F1510 (64%); F15259 (55%); F1020 (54%); F15250 (51%)
F15221,Other stimulant dependence with intoxication delirium,137,F10221 (72%); F15259 (54%); F15250 (50%); F15251 (50%); F10231 (48%)
F15222,Other stimulant dependence with intoxication with perceptual disturbance,137,F10232 (59%); F19232 (54%); F13232 (50%); F15259 (48%); F10132 (45%)
F15229,"Other stimulant dependence with intoxication, unspecified",137,F15259 (67%); F10229 (62%); F15250 (59%); F15251 (59%); F15959 (52%)
F1523,Other stimulant dependence with withdrawal,137,F15259 (63%); F10239 (60%); F15250 (59%); F15251 (59%); F10230 (53%)
F1524,Other stimulant dependence with stimulant-induced mood disorder,137,F15259 (86%); F15250 (80%); F15251 (80%); F15159 (76%); F15959 (73%)
F15250,Other stimulant dependence with stimulant-induced psychotic disorder with delusions,135,F15288 (86%); F1529 (85%); F1524 (80%); F15280 (80%); F15282 (78%)
F15251,Other stimulant dependence with stimulant-induced psychotic disorder with hallucinations,135,F15288 (86%); F1529 (85%); F1524 (80%); F15280 (80%); F15282 (78%)
F15259,"Other stimulant dependence with stimulant-induced psychotic disorder, unspecified",135,F1529 (94%); F15288 (93%); F1524 (86%); F15280 (86%); F15282 (84%)
F15280,Other stimulant dependence with stimulant-induced anxiety disorder,137,F15259 (86%); F15250 (80%); F15251 (80%); F15159 (76%); F15959 (73%)
F15281,Other stimulant dependence with stimulant-induced sexual dysfunction,137,F15259 (73%); F15250 (68%); F15251 (68%); F15159 (63%); F15959 (62%)
F15282,Other stimulant dependence with stimulant-induced sleep disorder,137,F15259 (84%); F15250 (78%); F15251 (78%); F15159 (74%); F15959 (72%)
F15288,Other stimulant dependence with other stimulant-induced disorder,137,F15259 (93%); F15250 (86%); F15251 (86%); F15159 (82%); F15959 (80%)
F1529,Other stimulant dependence with unspecified stimulant-induced disorder,137,F15259 (94%); F15250 (85%); F15251 (85%); F15159 (83%); F15959 (83%)
F15920,"Other stimulant use, unspecified with intoxication, uncomplicated",137,F1510 (63%); F15959 (58%); F15950 (52%); F15951 (52%); F10220 (51%)
F15921,"Other stimulant use, unspecified with intoxication delirium",137,F15959 (57%); F10221 (53%); F15950 (51%); F15951 (51%); F10931 (50%)
F15922,"Other stimulant use, unspecified with intoxication with perceptual disturbance",137,F10932 (60%); F19932 (56%); F15959 (50%); F15950 (46%); F15951 (46%)
F15929,"Other stimulant use, unspecified with intoxication, unspecified",137,F15959 (69%); F15950 (60%); F15951 (60%); F15259 (50%); F15159 (50%)
F1593,"Other stimulant use, unspecified with withdrawal",137,F15959 (66%); F10939 (64%); F15950 (60%); F15951 (60%); F10930 (55%)
F1594,"Other stimulant use, unspecified with stimulant-induced mood disorder",137,F15959 (86%); F15950 (80%); F15951 (80%); F15259 (77%); F15159 (77%)
F15950,"Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusions",135,F15988 (86%); F1599 (86%); F1594 (80%); F15980 (80%); F15982 (78%)
F15951,"Other stimulant use, unspecified with stimulant-induced psychotic disorder with hallucinations",135,F15988 (86%); F1599 (86%); F1594 (80%); F15980 (80%); F15982 (78%)
F15959,"Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecified",135,F1599 (94%); F15988 (93%); F1594 (86%); F15980 (86%); F15982 (84%)
F15980,"Other stimulant use, unspecified with stimulant-induced anxiety disorder",137,F15959 (86%); F15950 (80%); F15951 (80%); F15259 (77%); F15159 (77%)
F15981,"Other stimulant use, unspecified with stimulant-induced sexual dysfunction",137,F15959 (74%); F15950 (68%); F15951 (68%); F15259 (65%); F15159 (65%)
F15982,"Other stimulant use, unspecified with stimulant-induced sleep disorder",137,F15959 (84%); F15950 (78%); F15951 (78%); F15259 (75%); F15159 (75%)
F15988,"Other stimulant use, unspecified with other stimulant-induced disorder",137,F15959 (93%); F15950 (86%); F15951 (86%); F15259 (83%); F15159 (83%)
F1599,"Other stimulant use, unspecified with unspecified stimulant-induced disorder",137,F15959 (94%); F15950 (86%); F15951 (86%); F15259 (82%); F15159 (82%)
F1610,"Hallucinogen abuse, uncomplicated",138,F16120 (87%); F1620 (75%); F16188 (69%); F1619 (68%); F16220 (65%)
F1611,"Hallucinogen abuse, in remission",138,F1621 (73%); F16188 (72%); F1619 (71%); F16159 (67%); F16129 (66%)
F16120,"Hallucinogen abuse with intoxication, uncomplicated",137,F1610 (87%); F1611 (58%); F16159 (57%); F1410 (54%); F1510 (54%)
F16121,Hallucinogen abuse with intoxication with delirium,137,F1611 (57%); F16159 (55%); F1610 (55%); F10221 (53%); F16150 (52%)
F16122,Hallucinogen abuse with intoxication with perceptual disturbance,137,F10132 (59%); F19132 (54%); F1611 (50%); F13132 (50%); F16159 (49%)
F16129,"Hallucinogen abuse with intoxication, unspecified",137,F16159 (68%); F1611 (66%); F1610 (64%); F16150 (60%); F16151 (60%)
F1614,Hallucinogen abuse with hallucinogen-induced mood disorder,137,F16159 (86%); F16150 (80%); F16151 (80%); F16259 (77%); F16959 (74%)
F16150,Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions,135,F16188 (87%); F1619 (86%); F1614 (80%); F16180 (80%); F16288 (77%)
F16151,Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations,135,F16188 (87%); F1619 (86%); F1614 (80%); F16180 (80%); F16288 (77%)
F16159,"Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified",135,F1619 (94%); F16188 (93%); F1614 (86%); F16180 (86%); F1629 (84%)
F16180,Hallucinogen abuse with hallucinogen-induced anxiety disorder,137,F16159 (86%); F16150 (80%); F16151 (80%); F16259 (77%); F16959 (74%)
F16183,Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks),137,F16159 (63%); F16150 (59%); F16151 (59%); F16259 (55%); F16959 (54%)
F16188,Hallucinogen abuse with other hallucinogen-induced disorder,137,F16159 (93%); F16150 (87%); F16151 (87%); F16259 (83%); F16959 (80%)
F1619,Hallucinogen abuse with unspecified hallucinogen-induced disorder,137,F16159 (94%); F16150 (86%); F16151 (86%); F16259 (84%); F16959 (83%)
F1620,"Hallucinogen dependence, uncomplicated",137,F1610 (75%); F16259 (64%); F1020 (61%); F16250 (60%); F16251 (60%)
F1621,"Hallucinogen dependence, in remission",137,F1611 (73%); F16259 (67%); F16250 (62%); F16251 (62%); F1021 (58%)
F16220,"Hallucinogen dependence with intoxication, uncomplicated",137,F10220 (70%); F1610 (65%); F16259 (56%); F1020 (53%); F16250 (52%)
F16221,Hallucinogen dependence with intoxication with delirium,137,F10221 (71%); F16259 (55%); F16250 (51%); F16251 (51%); F10231 (48%)
F16229,"Hallucinogen dependence with intoxication, unspecified",137,F16259 (68%); F10229 (61%); F16250 (60%); F16251 (60%); F16959 (54%)
F1624,Hallucinogen dependence with hallucinogen-induced mood disorder,137,F16259 (86%); F16250 (80%); F16251 (80%); F16159 (77%); F16959 (75%)
F16250,Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions,135,F16288 (87%); F1629 (86%); F1624 (80%); F16280 (80%); F16188 (77%)
F16251,Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations,135,F16288 (87%); F1629 (86%); F1624 (80%); F16280 (80%); F16188 (77%)
F16259,"Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified",135,F1629 (94%); F16288 (93%); F1624 (86%); F16280 (86%); F16988 (84%)
F16280,Hallucinogen dependence with hallucinogen-induced anxiety disorder,137,F16259 (86%); F16250 (80%); F16251 (80%); F16159 (77%); F16959 (75%)
F16283,Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks),137,F16259 (63%); F16250 (59%); F16251 (59%); F16159 (55%); F16959 (54%)
F16288,Hallucinogen dependence with other hallucinogen-induced disorder,137,F16259 (93%); F16250 (87%); F16251 (87%); F16159 (83%); F16959 (80%)
F1629,Hallucinogen dependence with unspecified hallucinogen-induced disorder,137,F16259 (94%); F16250 (86%); F16251 (86%); F16159 (84%); F16959 (84%)
F16920,"Hallucinogen use, unspecified with intoxication, uncomplicated",137,F1610 (64%); F16959 (59%); F16950 (54%); F16951 (54%); F10220 (50%)
F16921,"Hallucinogen use, unspecified with intoxication with delirium",137,F16959 (58%); F16950 (53%); F16951 (53%); F10221 (52%); F10931 (50%)
F16929,"Hallucinogen use, unspecified with intoxication, unspecified",137,F16959 (70%); F16950 (61%); F16951 (61%); F16259 (52%); F16159 (51%)
F1694,"Hallucinogen use, unspecified with hallucinogen-induced mood disorder",137,F16959 (87%); F16950 (81%); F16951 (81%); F16259 (78%); F16159 (78%)
F16950,"Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with delusions",135,F16988 (87%); F1699 (86%); F1694 (81%); F16980 (81%); F1629 (77%)
F16951,"Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations",135,F16988 (87%); F1699 (86%); F1694 (81%); F16980 (81%); F1629 (77%)
F16959,"Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified",135,F1699 (95%); F16988 (94%); F1694 (87%); F16980 (87%); F1629 (84%)
F16980,"Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder",137,F16959 (87%); F16950 (81%); F16951 (81%); F16259 (78%); F16159 (78%)
F16983,"Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)",137,F16959 (64%); F16950 (59%); F16951 (59%); F16259 (57%); F16159 (56%)
F16988,"Hallucinogen use, unspecified with other hallucinogen-induced disorder",137,F16959 (94%); F16950 (87%); F16951 (87%); F16259 (84%); F16159 (84%)
F1699,"Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder",137,F16959 (95%); F16950 (86%); F16951 (86%); F16259 (83%); F16159 (83%)
F1810,"Inhalant abuse, uncomplicated",138,F18120 (87%); F1820 (75%); F18188 (69%); F1819 (68%); F1817 (67%)
F1811,"Inhalant abuse, in remission",138,F1821 (73%); F18188 (72%); F1819 (71%); F1817 (70%); F18159 (67%)
F18120,"Inhalant abuse with intoxication, uncomplicated",137,F1810 (87%); F1817 (59%); F1811 (58%); F18159 (57%); F1410 (54%)
F18121,Inhalant abuse with intoxication delirium,137,F1817 (58%); F1811 (57%); F18159 (56%); F1810 (55%); F10221 (53%)
F18129,"Inhalant abuse with intoxication, unspecified",137,F18159 (68%); F1817 (68%); F1811 (67%); F1810 (64%); F18150 (61%)
F1814,Inhalant abuse with inhalant-induced mood disorder,137,F18159 (86%); F1817 (82%); F18150 (80%); F18151 (80%); F18259 (77%)
F18150,Inhalant abuse with inhalant-induced psychotic disorder with delusions,135,F18188 (87%); F1819 (86%); F1814 (80%); F18180 (80%); F18288 (77%)
F18151,Inhalant abuse with inhalant-induced psychotic disorder with hallucinations,135,F18188 (87%); F1819 (86%); F1814 (80%); F18180 (80%); F18288 (77%)
F18159,"Inhalant abuse with inhalant-induced psychotic disorder, unspecified",135,F1819 (94%); F18188 (93%); F1814 (86%); F18180 (86%); F1829 (84%)
F1817,Inhalant abuse with inhalant-induced dementia,135,F18188 (89%); F1819 (88%); F1814 (82%); F18180 (82%); F18288 (78%)
F18180,Inhalant abuse with inhalant-induced anxiety disorder,137,F18159 (86%); F1817 (82%); F18150 (80%); F18151 (80%); F18259 (77%)
F18188,Inhalant abuse with other inhalant-induced disorder,137,F18159 (93%); F1817 (89%); F18150 (87%); F18151 (87%); F18259 (83%)
F1819,Inhalant abuse with unspecified inhalant-induced disorder,137,F18159 (94%); F1817 (88%); F18150 (86%); F18151 (86%); F18259 (84%)
F1820,"Inhalant dependence, uncomplicated",137,F1810 (75%); F1827 (67%); F18259 (65%); F1020 (61%); F18250 (60%)
F1821,"Inhalant dependence, in remission",137,F1811 (73%); F1827 (70%); F18259 (67%); F18250 (62%); F18251 (62%)
F18220,"Inhalant dependence with intoxication, uncomplicated",137,F10220 (70%); F1810 (65%); F1827 (59%); F18259 (56%); F1020 (53%)
F18221,Inhalant dependence with intoxication delirium,137,F10221 (71%); F1827 (58%); F18259 (55%); F18250 (52%); F18251 (52%)
F18229,"Inhalant dependence with intoxication, unspecified",137,F18259 (68%); F1827 (68%); F10229 (61%); F18250 (60%); F18251 (60%)
F1824,Inhalant dependence with inhalant-induced mood disorder,137,F18259 (86%); F1827 (82%); F18250 (80%); F18251 (80%); F18159 (77%)
F18250,Inhalant dependence with inhalant-induced psychotic disorder with delusions,135,F18288 (87%); F1829 (86%); F1824 (80%); F18280 (80%); F18188 (77%)
F18251,Inhalant dependence with inhalant-induced psychotic disorder with hallucinations,135,F18288 (87%); F1829 (86%); F1824 (80%); F18280 (80%); F18188 (77%)
F18259,"Inhalant dependence with inhalant-induced psychotic disorder, unspecified",135,F1829 (94%); F18288 (93%); F1824 (86%); F18280 (86%); F18988 (84%)
F1827,Inhalant dependence with inhalant-induced dementia,135,F18288 (89%); F1829 (88%); F1824 (82%); F18280 (82%); F18188 (78%)
F18280,Inhalant dependence with inhalant-induced anxiety disorder,137,F18259 (86%); F1827 (82%); F18250 (80%); F18251 (80%); F18159 (77%)
F18288,Inhalant dependence with other inhalant-induced disorder,137,F18259 (93%); F1827 (89%); F18250 (87%); F18251 (87%); F18159 (83%)
F1829,Inhalant dependence with unspecified inhalant-induced disorder,137,F18259 (94%); F1827 (88%); F18250 (86%); F18251 (86%); F18159 (84%)
F18920,"Inhalant use, unspecified with intoxication, uncomplicated",137,F1810 (64%); F18959 (59%); F1897 (55%); F18950 (54%); F18951 (54%)
F18921,"Inhalant use, unspecified with intoxication with delirium",137,F18959 (58%); F1897 (54%); F18950 (53%); F18951 (53%); F10221 (52%)
F18929,"Inhalant use, unspecified with intoxication, unspecified",137,F18959 (70%); F1897 (62%); F18950 (61%); F18951 (61%); F18259 (52%)
F1894,"Inhalant use, unspecified with inhalant-induced mood disorder",137,F18959 (87%); F18950 (81%); F18951 (81%); F18259 (78%); F18159 (78%)
F18950,"Inhalant use, unspecified with inhalant-induced psychotic disorder with delusions",135,F18988 (87%); F1899 (86%); F1894 (81%); F18980 (81%); F1829 (78%)
F18951,"Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations",135,F18988 (87%); F1899 (86%); F1894 (81%); F18980 (81%); F1829 (78%)
F18959,"Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified",135,F1899 (95%); F18988 (94%); F1894 (87%); F18980 (87%); F1829 (84%)
F1897,"Inhalant use, unspecified with inhalant-induced persisting dementia",135,F18988 (81%); F1899 (80%); F1894 (75%); F18980 (75%); F1829 (71%)
F18980,"Inhalant use, unspecified with inhalant-induced anxiety disorder",137,F18959 (87%); F18950 (81%); F18951 (81%); F18259 (78%); F18159 (78%)
F18988,"Inhalant use, unspecified with other inhalant-induced disorder",137,F18959 (94%); F18950 (87%); F18951 (87%); F18259 (84%); F18159 (84%)
F1899,"Inhalant use, unspecified with unspecified inhalant-induced disorder",137,F18959 (95%); F18950 (86%); F18951 (86%); F18259 (83%); F18159 (83%)
F1910,"Other psychoactive substance abuse, uncomplicated",138,F19120 (89%); F19130 (88%); F1920 (80%); F19188 (76%); F1919 (76%)
F1911,"Other psychoactive substance abuse, in remission",138,F1921 (79%); F19188 (79%); F1919 (78%); F19159 (75%); F1914 (75%)
F19120,"Other psychoactive substance abuse with intoxication, uncomplicated",137,F1910 (89%); F1911 (66%); F19159 (66%); F1917 (63%); F19150 (62%)
F19121,Other psychoactive substance abuse with intoxication delirium,137,F19131 (80%); F1911 (65%); F19159 (65%); F19231 (64%); F19931 (63%)
F19122,Other psychoactive substance abuse with intoxication with perceptual disturbances,137,F19132 (61%); F1911 (53%); F19159 (53%); F1910 (52%); F1917 (51%)
F19129,"Other psychoactive substance abuse with intoxication, unspecified",137,F19159 (76%); F1911 (74%); F1910 (72%); F1917 (71%); F19150 (70%)
F19130,"Other psychoactive substance abuse with withdrawal, uncomplicated",137,F1910 (88%); F19131 (76%); F19132 (69%); F10130 (65%); F1911 (65%)
F19131,Other psychoactive substance abuse with withdrawal delirium,135,F19139 (85%); F19121 (80%); F19130 (76%); F19239 (68%); F10131 (67%)
F19132,Other psychoactive substance abuse with withdrawal with perceptual disturbance,135,F19139 (77%); F10132 (73%); F19222 (71%); F19922 (70%); F19130 (69%)
F19139,"Other psychoactive substance abuse with withdrawal, unspecified",137,F19131 (85%); F19132 (77%); F19159 (74%); F1911 (72%); F19931 (70%)
F1914,Other psychoactive substance abuse with psychoactive substance-induced mood disorder,137,F19159 (90%); F19150 (86%); F19151 (86%); F19259 (83%); F1917 (82%)
F19150,Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions,135,F19188 (90%); F1919 (90%); F1914 (86%); F19180 (86%); F19182 (84%)
F19151,Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations,135,F19188 (90%); F1919 (90%); F1914 (86%); F19180 (86%); F19182 (84%)
F19159,"Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified",135,F1919 (96%); F19188 (95%); F1914 (90%); F19180 (90%); F19182 (89%)
F1916,Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder,135,F19188 (86%); F1919 (85%); F1914 (82%); F19180 (82%); F19182 (80%)
F1917,Other psychoactive substance abuse with psychoactive substance-induced persisting dementia,135,F19188 (86%); F1919 (86%); F1914 (82%); F19180 (82%); F19182 (80%)
F19180,Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder,137,F19159 (90%); F19150 (86%); F19151 (86%); F19259 (83%); F1917 (82%)
F19181,Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction,137,F19159 (81%); F1917 (78%); F19150 (77%); F19151 (77%); F19259 (75%)
F19182,Other psychoactive substance abuse with psychoactive substance-induced sleep disorder,137,F19159 (89%); F19150 (84%); F19151 (84%); F19259 (82%); F1917 (80%)
F19188,Other psychoactive substance abuse with other psychoactive substance-induced disorder,137,F19159 (95%); F19150 (90%); F19151 (90%); F19259 (88%); F1917 (86%)
F1919,Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder,137,F19159 (96%); F19150 (90%); F19151 (90%); F19259 (89%); F19959 (88%)
F1920,"Other psychoactive substance dependence, uncomplicated",137,F1910 (80%); F19259 (73%); F1927 (70%); F19250 (69%); F19251 (69%)
F1921,"Other psychoactive substance dependence, in remission",137,F1911 (79%); F19259 (75%); F1927 (72%); F19250 (71%); F19251 (71%)
F19220,"Other psychoactive substance dependence with intoxication, uncomplicated",137,F1910 (72%); F19259 (65%); F10220 (64%); F1927 (63%); F19250 (62%)
F19221,Other psychoactive substance dependence with intoxication delirium,137,F19231 (79%); F10221 (65%); F19131 (64%); F19259 (64%); F19931 (64%)
F19222,Other psychoactive substance dependence with intoxication with perceptual disturbance,137,F19232 (83%); F19132 (71%); F19932 (70%); F19259 (58%); F1927 (56%)
F19229,"Other psychoactive substance dependence with intoxication, unspecified",137,F19259 (75%); F1927 (70%); F19250 (70%); F19251 (70%); F1926 (66%)
F19230,"Other psychoactive substance dependence with withdrawal, uncomplicated",137,F19231 (76%); F1910 (70%); F19232 (69%); F10230 (65%); F19259 (64%)
F19231,Other psychoactive substance dependence with withdrawal delirium,135,F19239 (85%); F19221 (79%); F19230 (76%); F19139 (68%); F10231 (66%)
F19232,Other psychoactive substance dependence with withdrawal with perceptual disturbance,135,F19222 (83%); F19239 (77%); F10232 (73%); F19922 (70%); F19230 (69%)
F19239,"Other psychoactive substance dependence with withdrawal, unspecified",137,F19231 (85%); F19232 (77%); F19259 (74%); F19931 (70%); F1927 (69%)
F1924,Other psychoactive substance dependence with psychoactive substance-induced mood disorder,137,F19259 (90%); F19250 (86%); F19251 (86%); F19159 (83%); F19959 (82%)
F19250,Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with delusions,135,F19288 (90%); F1929 (90%); F1924 (86%); F19280 (86%); F19282 (84%)
F19251,Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with hallucinations,135,F19288 (90%); F1929 (90%); F1924 (86%); F19280 (86%); F19282 (84%)
F19259,"Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified",135,F1929 (96%); F19288 (95%); F1924 (90%); F19280 (90%); F19282 (89%)
F1926,Other psychoactive substance dependence with psychoactive substance-induced persisting amnestic disorder,135,F19288 (86%); F1929 (85%); F1924 (82%); F19280 (82%); F19282 (80%)
F1927,Other psychoactive substance dependence with psychoactive substance-induced persisting dementia,135,F19288 (86%); F1929 (85%); F1924 (82%); F19280 (82%); F19282 (80%)
F19280,Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder,137,F19259 (90%); F19250 (86%); F19251 (86%); F19159 (83%); F19959 (82%)
F19281,Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction,137,F19259 (81%); F1927 (78%); F19250 (77%); F19251 (77%); F19159 (75%)
F19282,Other psychoactive substance dependence with psychoactive substance-induced sleep disorder,137,F19259 (89%); F19250 (84%); F19251 (84%); F19159 (82%); F19959 (80%)
F19288,Other psychoactive substance dependence with other psychoactive substance-induced disorder,137,F19259 (95%); F19250 (90%); F19251 (90%); F19159 (88%); F19959 (86%)
F1929,Other psychoactive substance dependence with unspecified psychoactive substance-induced disorder,137,F19259 (96%); F19250 (90%); F19251 (90%); F19159 (89%); F19959 (88%)
F19920,"Other psychoactive substance use, unspecified with intoxication, uncomplicated",137,F1910 (70%); F19959 (67%); F1997 (64%); F19950 (63%); F19951 (63%)
F19921,"Other psychoactive substance use, unspecified with intoxication with delirium",137,F19931 (80%); F19959 (66%); F19231 (64%); F19131 (63%); F1997 (63%)
F19922,"Other psychoactive substance use, unspecified with intoxication with perceptual disturbance",137,F19932 (83%); F19232 (70%); F19132 (70%); F19959 (60%); F1997 (57%)
F19929,"Other psychoactive substance use, unspecified with intoxication, unspecified",137,F19959 (76%); F1997 (70%); F19950 (70%); F19951 (70%); F1996 (66%)
F19930,"Other psychoactive substance use, unspecified with withdrawal, uncomplicated",137,F19931 (77%); F19932 (70%); F1910 (69%); F10930 (66%); F19959 (66%)
F19931,"Other psychoactive substance use, unspecified with withdrawal delirium",135,F19939 (85%); F19921 (80%); F19930 (77%); F19239 (70%); F19139 (70%)
F19932,"Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance",135,F19922 (83%); F19939 (78%); F10932 (73%); F19222 (70%); F19930 (70%)
F19939,"Other psychoactive substance use, unspecified with withdrawal, unspecified",137,F19931 (85%); F19932 (78%); F19959 (75%); F1997 (69%); F19950 (68%)
F1994,"Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder",137,F19959 (90%); F19950 (86%); F19951 (86%); F19259 (84%); F19159 (84%)
F19950,"Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions",135,F19988 (90%); F1999 (90%); F1994 (86%); F19980 (86%); F19982 (85%)
F19951,"Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations",135,F19988 (90%); F1999 (90%); F1994 (86%); F19980 (86%); F19982 (85%)
F19959,"Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified",135,F1999 (96%); F19988 (95%); F1994 (90%); F19980 (90%); F19982 (89%)
F1996,"Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder",135,F19988 (86%); F1999 (86%); F1994 (82%); F19980 (82%); F19982 (81%)
F1997,"Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia",135,F19988 (86%); F1999 (86%); F1994 (82%); F19980 (82%); F19982 (81%)
F19980,"Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder",137,F19959 (90%); F19950 (86%); F19951 (86%); F19259 (84%); F19159 (84%)
F19981,"Other psychoactive substance use, unspecified with psychoactive substance-induced sexual dysfunction",137,F19959 (82%); F1997 (78%); F19950 (77%); F19951 (77%); F19259 (76%)
F19982,"Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder",137,F19959 (89%); F19950 (85%); F19951 (85%); F19259 (83%); F19159 (83%)
F19988,"Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder",137,F19959 (95%); F19950 (90%); F19951 (90%); F19259 (89%); F19159 (89%)
F1999,"Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder",137,F19959 (96%); F19950 (90%); F19951 (90%); F19259 (88%); F19159 (88%)
F200,Paranoid schizophrenia,151,F600 (53%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
F201,Disorganized schizophrenia,151,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
F202,Catatonic schizophrenia,151,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
F203,Undifferentiated schizophrenia,151,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
F205,Residual schizophrenia,151,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
F2081,Schizophreniform disorder,151,F3189 (23%); F319 (22%); F609 (21%); F3181 (20%); G709 (19%)
F2089,Other schizophrenia,151,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
F209,"Schizophrenia, unspecified",151,G8330 (13%); L97909 (13%); G8190 (13%); C8510 (13%); M08959 (13%)
F21,Schizotypal disorder,153,F3189 (23%); F319 (22%); F3181 (20%); F259 (19%); G709 (19%)
F22,Delusional disorders,152,F258 (38%); G7089 (35%); J99 (35%); G701 (34%); E8889 (33%)
F23,Brief psychotic disorder,152,F12259 (36%); F12159 (36%); F12959 (34%); F12250 (31%); F12251 (31%)
F24,Shared psychotic disorder,152,F12259 (36%); F12159 (36%); F12959 (34%); F12250 (31%); F12251 (31%)
F250,"Schizoaffective disorder, bipolar type",151,F3189 (66%); F319 (64%); F3181 (57%); F3160 (37%); F310 (35%)
F251,"Schizoaffective disorder, depressive type",151,F331 (40%); F321 (37%); F332 (35%); F333 (35%); F322 (33%)
F258,Other schizoaffective disorders,151,F22 (38%); G7089 (37%); J99 (37%); G701 (36%); E8889 (35%)
F259,"Schizoaffective disorder, unspecified",151,F319 (29%); F609 (27%); F12959 (25%); G709 (25%); F3189 (24%)
F28,Other psychotic disorder not due to a substance or known physiological condition,152,F19259 (36%); F19159 (36%); F19959 (35%); F19250 (34%); F19251 (34%)
F29,Unspecified psychosis not due to a substance or known physiological condition,152,F1999 (23%); F19959 (22%); F1929 (22%); F19988 (22%); F1919 (22%)
F3010,"Manic episode without psychotic symptoms, unspecified",154,F302 (91%); F312 (50%); F333 (34%); F3164 (28%); F315 (28%)
F3011,"Manic episode without psychotic symptoms, mild",154,F302 (85%); F312 (47%); F03A2 (35%); F333 (32%); F01A2 (31%)
F3012,"Manic episode without psychotic symptoms, moderate",154,F302 (85%); F312 (47%); F03B2 (35%); F333 (32%); F01B2 (31%)
F3013,"Manic episode, severe, without psychotic symptoms",154,F302 (100%); F312 (58%); F333 (44%); F3164 (38%); F315 (37%)
F302,"Manic episode, severe with psychotic symptoms",152,F3013 (100%); F3010 (91%); F3012 (85%); F3011 (85%); F309 (65%)
F303,Manic episode in partial remission,154,F302 (52%); F312 (43%); C9591 (29%); F1421 (24%); F1021 (24%)
F304,Manic episode in full remission,,
F308,Other manic episodes,154,F302 (30%); F312 (25%); A0104 (0%); A0105 (0%); A021 (0%)
F309,"Manic episode, unspecified",154,F302 (65%); F312 (53%); F321 (25%); F3164 (24%); F315 (23%)
F310,"Bipolar disorder, current episode hypomanic",154,F3164 (56%); F312 (55%); F315 (54%); F250 (35%); F321 (24%)
F3110,"Bipolar disorder, current episode manic without psychotic features, unspecified",154,F312 (94%); F3164 (77%); F315 (75%); F302 (49%); F322 (44%)
F3111,"Bipolar disorder, current episode manic without psychotic features, mild",154,F312 (90%); F3164 (73%); F315 (72%); F302 (47%); F322 (42%)
F3112,"Bipolar disorder, current episode manic without psychotic features, moderate",154,F312 (90%); F3164 (73%); F315 (72%); F302 (47%); F322 (42%)
F3113,"Bipolar disorder, current episode manic without psychotic features, severe",154,F312 (100%); F3164 (83%); F315 (81%); F302 (58%); F322 (51%)
F312,"Bipolar disorder, current episode manic severe with psychotic features",152,F3113 (100%); F3110 (94%); F3112 (90%); F3111 (90%); F3163 (83%)
F3130,"Bipolar disorder, current episode depressed, mild or moderate severity, unspecified",154,F315 (66%); F3164 (47%); F312 (47%); F321 (31%); F250 (30%)
F3131,"Bipolar disorder, current episode depressed, mild",154,F315 (75%); F3164 (54%); F312 (53%); F250 (34%); F321 (23%)
F3132,"Bipolar disorder, current episode depressed, moderate",154,F315 (75%); F3164 (54%); F312 (53%); F321 (35%); F250 (34%)
F314,"Bipolar disorder, current episode depressed, severe, without psychotic features",154,F315 (100%); F3164 (82%); F312 (81%); F322 (50%); F323 (50%)
F315,"Bipolar disorder, current episode depressed, severe, with psychotic features",152,F314 (100%); F3163 (82%); F3113 (81%); F3132 (75%); F3131 (75%)
F3160,"Bipolar disorder, current episode mixed, unspecified",154,F3164 (79%); F312 (59%); F315 (58%); F250 (37%); C8120 (27%)
F3161,"Bipolar disorder, current episode mixed, mild",154,F3164 (74%); F312 (55%); F315 (54%); F250 (35%); F321 (24%)
F3162,"Bipolar disorder, current episode mixed, moderate",154,F3164 (74%); F312 (55%); F315 (54%); F321 (36%); F250 (35%)
F3163,"Bipolar disorder, current episode mixed, severe, without psychotic features",154,F3164 (100%); F312 (83%); F315 (82%); F322 (51%); F323 (51%)
F3164,"Bipolar disorder, current episode mixed, severe, with psychotic features",152,F3163 (100%); F3113 (83%); F314 (82%); F3160 (79%); F3110 (77%)
F3170,"Bipolar disorder, currently in remission, most recent episode unspecified",,
F3171,"Bipolar disorder, in partial remission, most recent episode hypomanic",154,F3164 (34%); F312 (34%); F315 (33%); F250 (30%); F321 (20%)
F3172,"Bipolar disorder, in full remission, most recent episode hypomanic",,
F3173,"Bipolar disorder, in partial remission, most recent episode manic",154,F312 (53%); F302 (38%); F3164 (36%); F315 (35%); F250 (31%)
F3174,"Bipolar disorder, in full remission, most recent episode manic",,
F3175,"Bipolar disorder, in partial remission, most recent episode depressed",154,F315 (54%); F3164 (35%); F312 (35%); F250 (30%); F321 (21%)
F3176,"Bipolar disorder, in full remission, most recent episode depressed",,
F3177,"Bipolar disorder, in partial remission, most recent episode mixed",154,F3164 (52%); F312 (36%); F315 (35%); F250 (31%); F321 (21%)
F3178,"Bipolar disorder, in full remission, most recent episode mixed",,
F3181,Bipolar II disorder,154,F250 (57%); F3164 (39%); F312 (39%); F315 (38%); F609 (23%)
F3189,Other bipolar disorder,154,F250 (66%); F3164 (45%); F312 (45%); F315 (44%); F609 (26%)
F319,"Bipolar disorder, unspecified",154,F250 (64%); F3164 (44%); F312 (43%); F315 (43%); F609 (32%)
F320,"Major depressive disorder, single episode, mild",,
F321,"Major depressive disorder, single episode, moderate",155,F323 (78%); F333 (45%); F251 (37%); F3162 (36%); F3132 (35%)
F322,"Major depressive disorder, single episode, severe without psychotic features",155,F323 (100%); F333 (56%); F3163 (51%); F3164 (51%); F3113 (51%)
F323,"Major depressive disorder, single episode, severe with psychotic features",152,F322 (100%); F321 (78%); F332 (73%); F3163 (51%); F3113 (51%)
F324,"Major depressive disorder, single episode, in partial remission",,
F325,"Major depressive disorder, single episode, in full remission",,
F3281,Premenstrual dysphoric disorder,,
F3289,Other specified depressive episodes,,
F329,"Major depressive disorder, single episode, unspecified",,
F32A,"Depression, unspecified",,
F330,"Major depressive disorder, recurrent, mild",,
F331,"Major depressive disorder, recurrent, moderate",155,F333 (75%); F323 (46%); F251 (40%); C089 (25%); F3162 (21%)
F332,"Major depressive disorder, recurrent severe without psychotic features",155,F333 (82%); F323 (73%); F3163 (41%); F3164 (41%); F3113 (40%)
F333,"Major depressive disorder, recurrent, severe with psychotic symptoms",152,F332 (82%); F331 (75%); F322 (56%); F321 (45%); F3013 (44%)
F3340,"Major depressive disorder, recurrent, in remission, unspecified",,
F3341,"Major depressive disorder, recurrent, in partial remission",,
F3342,"Major depressive disorder, recurrent, in full remission",,
F338,Other recurrent depressive disorders,,
F339,"Major depressive disorder, recurrent, unspecified",,
F340,Cyclothymic disorder,,
F341,Dysthymic disorder,,
F3481,Disruptive mood dysregulation disorder,,
F3489,Other specified persistent mood disorders,,
F349,"Persistent mood [affective] disorder, unspecified",,
F39,Unspecified mood [affective] disorder,,
F4000,"Agoraphobia, unspecified",,
F4001,Agoraphobia with panic disorder,,
F4002,Agoraphobia without panic disorder,,
F4010,"Social phobia, unspecified",,
F4011,"Social phobia, generalized",,
F40210,Arachnophobia,,
F40218,Other animal type phobia,,
F40220,Fear of thunderstorms,,
F40228,Other natural environment type phobia,,
F40230,Fear of blood,,
F40231,Fear of injections and transfusions,,
F40232,Fear of other medical care,,
F40233,Fear of injury,,
F40240,Claustrophobia,,
F40241,Acrophobia,,
F40242,Fear of bridges,,
F40243,Fear of flying,,
F40248,Other situational type phobia,,
F40290,Androphobia,,
F40291,Gynephobia,,
F40298,Other specified phobia,,
F408,Other phobic anxiety disorders,,
F409,"Phobic anxiety disorder, unspecified",,
F410,Panic disorder [episodic paroxysmal anxiety],,
F411,Generalized anxiety disorder,,
F422,Mixed obsessional thoughts and acts,,
F423,Hoarding disorder,,
F424,Excoriation (skin-picking) disorder,,
F428,Other obsessive-compulsive disorder,,
F429,"Obsessive-compulsive disorder, unspecified",,
F4310,"Post-traumatic stress disorder, unspecified",,
F4311,"Post-traumatic stress disorder, acute",,
F4312,"Post-traumatic stress disorder, chronic",,
F4320,"Adjustment disorder, unspecified",,
F4321,Adjustment disorder with depressed mood,,
F4322,Adjustment disorder with anxiety,,
F4323,Adjustment disorder with mixed anxiety and depressed mood,,
F4324,Adjustment disorder with disturbance of conduct,,
F4325,Adjustment disorder with mixed disturbance of emotions and conduct,,
F4329,Adjustment disorder with other symptoms,,
F440,Dissociative amnesia,153,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
F441,Dissociative fugue,153,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
F442,Dissociative stupor,,
F444,Conversion disorder with motor symptom or deficit,,
F445,Conversion disorder with seizures or convulsions,,
F446,Conversion disorder with sensory symptom or deficit,,
F447,Conversion disorder with mixed symptom presentation,,
F4481,Dissociative identity disorder,153,F3189 (18%); F319 (17%); F3181 (15%); F259 (15%); G709 (14%)
F4489,Other dissociative and conversion disorders,,
F449,"Dissociative and conversion disorder, unspecified",,
F450,Somatization disorder,,
F451,Undifferentiated somatoform disorder,,
F4520,"Hypochondriacal disorder, unspecified",,
F4521,Hypochondriasis,,
F4522,Body dysmorphic disorder,,
F4529,Other hypochondriacal disorders,,
F458,Other somatoform disorders,,
F459,"Somatoform disorder, unspecified",,
F481,Depersonalization-derealization syndrome,153,E340 (19%); G839 (18%); G8382 (17%); G8383 (17%); D469 (15%)
F5000,"Anorexia nervosa, unspecified",153,G8330 (9%); L97909 (8%); G8190 (8%); C8510 (8%); M08959 (8%)
F5001,"Anorexia nervosa, restricting type",153,E109 (8%); E119 (8%); E108 (8%); E118 (8%); E10621 (8%)
F5002,"Anorexia nervosa, binge eating/purging type",153,E109 (6%); E119 (6%); E108 (6%); E118 (6%); E10621 (6%)
F502,Bulimia nervosa,153,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
F5081,Binge eating disorder,,
F5082,Avoidant/restrictive food intake disorder,,
F5089,Other specified eating disorder,,
F509,"Eating disorder, unspecified",,
F530,Postpartum depression,,
F531,Puerperal psychosis,152,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
F600,Paranoid personality disorder,153,F200 (53%); F3189 (19%); F319 (18%); F3181 (16%); F259 (16%)
F601,Schizoid personality disorder,153,F3189 (19%); F319 (18%); F3181 (16%); F259 (15%); G709 (15%)
F602,Antisocial personality disorder,153,F3189 (19%); F319 (18%); F3181 (16%); F259 (15%); G709 (15%)
F603,Borderline personality disorder,153,F3189 (19%); F319 (18%); F3181 (16%); F259 (15%); G709 (15%)
F604,Histrionic personality disorder,153,F3189 (19%); F319 (18%); F3181 (16%); F259 (15%); G709 (15%)
F605,Obsessive-compulsive personality disorder,153,F3189 (15%); F319 (14%); F3181 (13%); F259 (12%); G709 (12%)
F606,Avoidant personality disorder,153,F3189 (19%); F319 (18%); F3181 (16%); F259 (15%); G709 (15%)
F607,Dependent personality disorder,153,G4042 (39%); E240 (38%); F3189 (19%); F319 (19%); F3181 (17%)
F6081,Narcissistic personality disorder,153,F3189 (19%); F319 (18%); F3181 (16%); F259 (15%); G709 (15%)
F6089,Other specific personality disorders,153,J84113 (35%); F258 (33%); F22 (31%); J668 (31%); G7089 (30%)
F609,"Personality disorder, unspecified",153,F319 (32%); F12959 (28%); F259 (27%); G709 (27%); F3189 (26%)
F630,Pathological gambling,,
F631,Pyromania,,
F632,Kleptomania,,
F633,Trichotillomania,,
F6381,Intermittent explosive disorder,,
F6389,Other impulse disorders,,
F639,"Impulse disorder, unspecified",,
F6810,"Factitious disorder imposed on self, unspecified",,
F6811,"Factitious disorder imposed on self, with predominantly psychological signs and symptoms",,
F6812,"Factitious disorder imposed on self, with predominantly physical signs and symptoms",,
F6813,"Factitious disorder imposed on self, with combined psychological and physical signs and symptoms",,
F68A,Factitious disorder imposed on another,,
F70,Mild intellectual disabilities,,
F71,Moderate intellectual disabilities,,
F72,Severe intellectual disabilities,,
F73,Profound intellectual disabilities,,
F78A1,SYNGAP1-related intellectual disability,,
F78A9,Other genetic related intellectual disability,,
F79,Unspecified intellectual disabilities,,
F840,Autistic disorder,,
F842,Rett's syndrome,,
F843,Other childhood disintegrative disorder,,
F845,Asperger's syndrome,,
F848,Other pervasive developmental disorders,,
F849,"Pervasive developmental disorder, unspecified",,
F900,"Attention-deficit hyperactivity disorder, predominantly inattentive type",,
F901,"Attention-deficit hyperactivity disorder, predominantly hyperactive type",,
F902,"Attention-deficit hyperactivity disorder, combined type",,
F908,"Attention-deficit hyperactivity disorder, other type",,
F909,"Attention-deficit hyperactivity disorder, unspecified type",,
F910,Conduct disorder confined to family context,,
F911,"Conduct disorder, childhood-onset type",,
F912,"Conduct disorder, adolescent-onset type",,
F913,Oppositional defiant disorder,,
F918,Other conduct disorders,,
F919,"Conduct disorder, unspecified",,
F930,Separation anxiety disorder of childhood,,
F950,Transient tic disorder,,
F951,Chronic motor or vocal tic disorder,,
F952,Tourette's disorder,,
F958,Other tic disorders,,
F959,"Tic disorder, unspecified",,
F9821,Rumination disorder of infancy,,
F9829,Other feeding disorders of infancy and early childhood,,
F983,Pica of infancy and childhood,,
F984,Stereotyped movement disorders,,
G041,Tropical spastic paraplegia,182,G114 (64%); G8220 (54%); G8221 (47%); G8222 (45%); G8110 (35%)
G0482,Acute flaccid myelitis,182,G8100 (46%); G8102 (42%); G8101 (42%); G8104 (38%); G8103 (38%)
G0489,Other myelitis,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
G0491,"Myelitis, unspecified",182,G8330 (14%); L97909 (13%); G8190 (13%); C8510 (13%); M08959 (13%)
G054,Myelitis in diseases classified elsewhere,182,G914 (50%); M9058 (50%); M9050 (48%); M90519 (48%); M90549 (48%)
G10,Huntington's disease,200,G959 (22%); I120 (21%); G20 (19%); G308 (19%); B259 (18%)
G110,Congenital nonprogressive ataxia,200,G3281 (34%); G7129 (33%); G7120 (32%); Q038 (31%); Q039 (31%)
G1110,"Early-onset cerebellar ataxia, unspecified",200,G3281 (56%); G300 (53%); I63449 (28%); I63349 (28%); I63549 (26%)
G1111,Friedreich ataxia,200,G3281 (39%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
G1119,Other early-onset cerebellar ataxia,200,G3281 (57%); G300 (53%); I63449 (26%); I63349 (26%); I63442 (26%)
G112,Late-onset cerebellar ataxia,200,G3281 (57%); G301 (53%); A5055 (32%); I63449 (26%); I63349 (26%)
G113,Cerebellar ataxia with defective DNA repair,200,G3281 (44%); I63449 (20%); I63349 (20%); I63442 (20%); I63441 (20%)
G114,Hereditary spastic paraplegia,200,G041 (64%); G8220 (58%); G8221 (51%); G8222 (48%); G8110 (38%)
G115,Hypomyelination - hypogonadotropic hypogonadism - hypodontia,200,G233 (22%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
G116,Leukodystrophy with vanishing white matter disease,200,G959 (12%); I120 (11%); G20 (10%); G308 (10%); B259 (10%)
G118,Other hereditary ataxias,200,D800 (38%); D640 (34%); D5932 (32%); E800 (32%); D66 (30%)
G119,"Hereditary ataxia, unspecified",200,G3281 (43%); D800 (42%); D640 (37%); D5932 (35%); E800 (34%)
G120,"Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]",190,G7100 (21%); G233 (17%); G7109 (17%); I82569 (16%); I82562 (16%)
G121,Other inherited spinal muscular atrophy,190,G7100 (28%); G233 (24%); G7109 (23%); I82569 (22%); I82562 (22%)
G1220,"Motor neuron disease, unspecified",190,X820XXA (34%); G6182 (32%); R402310 (26%); T448X2A (25%); X828XXA (25%)
G1221,Amyotrophic lateral sclerosis,190,G35 (40%); M3489 (38%); M349 (37%); M3482 (31%); M3483 (31%)
G1222,Progressive bulbar palsy,190,G808 (46%); G809 (44%); M340 (33%); G803 (32%); G804 (32%)
G1223,Primary lateral sclerosis,190,G35 (45%); C801 (45%); M3489 (43%); M349 (42%); D6949 (36%)
G1224,Familial motor neuron disease,190,E8331 (38%); A8183 (31%); X820XXA (28%); G6182 (27%); G901 (26%)
G1225,Progressive spinal muscle atrophy,190,M340 (35%); I673 (32%); A812 (32%); G233 (26%); L98423 (23%)
G1229,Other motor neuron disease,190,X820XXA (35%); G6182 (33%); T448X2A (26%); X828XXA (25%); R402310 (24%)
G128,Other spinal muscular atrophies and related syndromes,190,G8389 (28%); G7100 (27%); D763 (27%); D46Z (26%); M048 (25%)
G129,"Spinal muscular atrophy, unspecified",190,G7100 (40%); I82569 (31%); I82469 (31%); G233 (30%); G71039 (30%)
G130,Paraneoplastic neuromyopathy and neuropathy,,
G131,Other systemic atrophy primarily affecting central nervous system in neoplastic disease,,
G132,Systemic atrophy primarily affecting the central nervous system in myxedema,,
G138,Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere,,
G14,Postpolio syndrome,182,E340 (26%); G839 (25%); G8382 (23%); G8383 (23%); D469 (20%)
G20,Parkinson's disease,199,G959 (24%); I120 (23%); G308 (21%); B259 (21%); I279 (21%)
G20A1,"Parkinson's disease without dyskinesia, without mention of fluctuations",199,G959 (13%); I120 (12%); G308 (11%); B259 (11%); I279 (11%)
G20A2,"Parkinson's disease without dyskinesia, with fluctuations",199,G959 (15%); I120 (14%); G308 (13%); B259 (12%); I279 (12%)
G20B1,"Parkinson's disease with dyskinesia, without mention of fluctuations",199,G959 (13%); I120 (12%); G308 (11%); B259 (11%); I279 (11%)
G20B2,"Parkinson's disease with dyskinesia, with fluctuations",199,G959 (15%); I120 (14%); G308 (13%); B259 (12%); I279 (12%)
G20C,"Parkinsonism, unspecified",199,G8330 (13%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
G2111,Neuroleptic induced parkinsonism,,
G2119,Other drug induced secondary parkinsonism,,
G212,Secondary parkinsonism due to other external agents,,
G213,Postencephalitic parkinsonism,199,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
G214,Vascular parkinsonism,199,G9519 (35%); F01C4 (33%); F01B4 (33%); F01A4 (33%); F0154 (32%)
G218,Other secondary parkinsonism,199,M87353 (34%); M87352 (33%); M87351 (33%); M8738 (33%); M87373 (32%)
G219,"Secondary parkinsonism, unspecified",199,M87353 (39%); M87373 (37%); M87376 (37%); M87319 (36%); M87343 (36%)
G230,Hallervorden-Spatz disease,199,G959 (16%); I120 (15%); G308 (14%); B259 (14%); I279 (14%)
G231,Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski],199,M340 (21%); I673 (19%); A812 (19%); G1225 (19%); G1222 (17%)
G232,Striatonigral degeneration,199,I515 (43%); G320 (27%); H353230 (25%); H353220 (25%); H353210 (25%)
G233,Hypomyelination with atrophy of the basal ganglia and cerebellum,199,C716 (32%); G129 (30%); G1225 (26%); G121 (24%); I614 (24%)
G238,Other specified degenerative diseases of basal ganglia,199,G9589 (30%); I2789 (26%); J8489 (24%); J84178 (20%); G378 (20%)
G239,"Degenerative disease of basal ganglia, unspecified",199,G959 (18%); K50919 (16%); B259 (15%); I279 (15%); M02359 (15%)
G300,Alzheimer's disease with early onset,127,G1119 (53%); G1110 (53%); M061 (38%); M08259 (22%); M0820 (22%)
G301,Alzheimer's disease with late onset,127,G112 (53%); M061 (38%); A5055 (33%); M08259 (22%); M0820 (22%)
G308,Other Alzheimer's disease,127,G959 (24%); I120 (22%); G20 (21%); B259 (20%); I279 (20%)
G309,"Alzheimer's disease, unspecified",127,G959 (30%); K50919 (27%); B259 (25%); I279 (25%); M02359 (25%)
G3101,Pick's disease,127,G959 (22%); I120 (21%); G20 (19%); B259 (18%); I279 (18%)
G3109,Other frontotemporal neurocognitive disorder,127,F3189 (17%); F319 (17%); F609 (16%); F3181 (15%); F259 (14%)
G311,"Senile degeneration of brain, not elsewhere classified",,
G312,Degeneration of nervous system due to alcohol,,
G3180,"Leukodystrophy, unspecified",200,G8330 (12%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
G3181,Alpers disease,127,G959 (22%); I120 (21%); G20 (19%); B259 (18%); I279 (18%)
G3182,Leigh's disease,127,G959 (22%); I120 (21%); G20 (19%); B259 (18%); I279 (18%)
G3183,Neurocognitive disorder with Lewy bodies,127,F3189 (14%); F319 (14%); F609 (13%); F3181 (12%); F259 (12%)
G3185,Corticobasal degeneration,,
G3186,Alexander disease,127,G959 (22%); I120 (21%); G20 (19%); B259 (18%); I279 (18%)
G3189,Other specified degenerative diseases of nervous system,,
G319,"Degenerative disease of nervous system, unspecified",,
G320,Subacute combined degeneration of spinal cord in diseases classified elsewhere,182,G914 (35%); M9058 (35%); M9050 (34%); M90519 (34%); M90549 (34%)
G3281,Cerebellar ataxia in diseases classified elsewhere,182,G1119 (57%); G112 (57%); G1110 (56%); G113 (44%); G119 (43%)
G35,Multiple sclerosis,198,M3489 (58%); C8118 (56%); M349 (56%); M3482 (47%); M3483 (47%)
G360,Neuromyelitis optica [Devic],198,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
G361,Acute and subacute hemorrhagic leukoencephalitis [Hurst],198,D473 (28%); M86259 (26%); M86252 (25%); M86251 (25%); M8628 (25%)
G368,Other specified acute disseminated demyelination,198,C800 (46%); B447 (40%); B457 (40%); B464 (40%); B007 (35%)
G369,"Acute disseminated demyelination, unspecified",198,C800 (52%); B447 (42%); B457 (42%); B464 (42%); B007 (36%)
G370,Diffuse sclerosis of central nervous system,198,C729 (59%); D339 (53%); D439 (44%); D337 (44%); A819 (40%)
G371,Central demyelination of corpus callosum,198,Q040 (58%); C549 (33%); C548 (29%); C729 (20%); S73043A (19%)
G372,Central pontine myelinolysis,198,C729 (22%); S73043A (21%); S73046A (21%); S73042A (21%); S73045A (21%)
G373,Acute transverse myelitis in demyelinating disease of central nervous system,182,G379 (75%); G378 (62%); G3789 (62%); C729 (45%); D339 (40%)
G374,Subacute necrotizing myelitis of central nervous system,182,C729 (48%); D339 (43%); G370 (40%); G379 (39%); G378 (37%)
G375,Concentric sclerosis [Balo] of central nervous system,198,C729 (43%); D339 (39%); D439 (33%); D337 (32%); A819 (30%)
G378,Other specified demyelinating diseases of central nervous system,198,G373 (62%); C729 (54%); D337 (49%); D339 (48%); D438 (43%)
G3781,Myelin oligodendrocyte glycoprotein antibody disease,198,I7782 (21%); G959 (12%); I120 (11%); G20 (10%); G308 (10%)
G3789,Other specified demyelinating diseases of central nervous system,198,G373 (62%); C729 (54%); D337 (49%); D339 (48%); D438 (43%)
G379,"Demyelinating disease of central nervous system, unspecified",198,G373 (75%); C729 (61%); D339 (55%); D439 (46%); D337 (43%)
G40001,"Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus",201,G128 (22%); I616 (20%); S0630AA (19%); G8389 (17%); D763 (16%)
G40009,"Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus",201,G128 (22%); I616 (20%); S0630AA (19%); G8389 (17%); D763 (16%)
G40011,"Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status epilepticus",201,G128 (22%); I616 (20%); S0630AA (19%); G8389 (17%); D763 (16%)
G40019,"Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus",201,G128 (22%); I616 (20%); S0630AA (19%); G8389 (17%); D763 (16%)
G40101,"Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus",201,K56690 (22%); S98329A (20%); G128 (20%); S98322A (20%); S98321A (20%)
G40109,"Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus",201,K56690 (22%); S98329A (20%); G128 (20%); S98322A (20%); S98321A (20%)
G40111,"Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus",201,K56690 (22%); S98329A (20%); G128 (20%); S98322A (20%); S98321A (20%)
G40119,"Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus",201,K56690 (22%); S98329A (20%); G128 (20%); S98322A (20%); S98321A (20%)
G40201,"Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus",201,K56690 (22%); S98329A (20%); G128 (20%); S98322A (20%); S98321A (20%)
G40209,"Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus",201,K56690 (22%); S98329A (20%); G128 (20%); S98322A (20%); S98321A (20%)
G40211,"Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus",201,K56690 (22%); S98329A (20%); G128 (20%); S98322A (20%); S98321A (20%)
G40219,"Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus",201,K56690 (22%); S98329A (20%); G128 (20%); S98322A (20%); S98321A (20%)
G40301,"Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus",201,K650 (27%); G8389 (24%); D763 (23%); D46Z (22%); M048 (21%)
G40309,"Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus",201,K650 (27%); G8389 (24%); D763 (23%); D46Z (22%); M048 (21%)
G40311,"Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus",201,K650 (27%); G8389 (24%); D763 (23%); D46Z (22%); M048 (21%)
G40319,"Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus",201,K650 (27%); G8389 (24%); D763 (23%); D46Z (22%); M048 (21%)
G40401,"Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus",201,K650 (28%); G8389 (25%); D763 (24%); D46Z (24%); M048 (23%)
G40409,"Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus",201,K650 (28%); G8389 (25%); D763 (24%); D46Z (24%); M048 (23%)
G40411,"Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus",201,K650 (28%); G8389 (25%); D763 (24%); D46Z (24%); M048 (23%)
G40419,"Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus",201,K650 (28%); G8389 (25%); D763 (24%); D46Z (24%); M048 (23%)
G4042,Cyclin-Dependent Kinase-Like 5 Deficiency Disorder,201,F607 (39%); E240 (24%); C863 (21%); D8182 (19%); D8132 (18%)
G40501,"Epileptic seizures related to external causes, not intractable, with status epilepticus",201,D596 (38%); D612 (19%); T71192A (17%); C4320 (16%); D8984 (16%)
G40509,"Epileptic seizures related to external causes, not intractable, without status epilepticus",201,D596 (38%); D612 (19%); T71192A (17%); C4320 (16%); D8984 (16%)
G40801,"Other epilepsy, not intractable, with status epilepticus",201,Z930 (25%); Z931 (25%); Z933 (25%); Z941 (25%); Z942 (25%)
G40802,"Other epilepsy, not intractable, without status epilepticus",201,Z930 (25%); Z931 (25%); Z933 (25%); Z941 (25%); Z942 (25%)
G40803,"Other epilepsy, intractable, with status epilepticus",201,Z930 (25%); Z931 (25%); Z933 (25%); Z941 (25%); Z942 (25%)
G40804,"Other epilepsy, intractable, without status epilepticus",201,Z930 (25%); Z931 (25%); Z933 (25%); Z941 (25%); Z942 (25%)
G40811,"Lennox-Gastaut syndrome, not intractable, with status epilepticus",201,Z930 (19%); Z931 (18%); Z933 (18%); Z941 (18%); Z942 (18%)
G40812,"Lennox-Gastaut syndrome, not intractable, without status epilepticus",201,Z930 (19%); Z931 (18%); Z933 (18%); Z941 (18%); Z942 (18%)
G40813,"Lennox-Gastaut syndrome, intractable, with status epilepticus",201,Z930 (19%); Z931 (18%); Z933 (18%); Z941 (18%); Z942 (18%)
G40814,"Lennox-Gastaut syndrome, intractable, without status epilepticus",201,Z930 (19%); Z931 (18%); Z933 (18%); Z941 (18%); Z942 (18%)
G40821,"Epileptic spasms, not intractable, with status epilepticus",201,Z930 (21%); Z931 (20%); Z933 (20%); Z941 (20%); Z942 (20%)
G40822,"Epileptic spasms, not intractable, without status epilepticus",201,Z930 (21%); Z931 (20%); Z933 (20%); Z941 (20%); Z942 (20%)
G40823,"Epileptic spasms, intractable, with status epilepticus",201,Z930 (21%); Z931 (20%); Z933 (20%); Z941 (20%); Z942 (20%)
G40824,"Epileptic spasms, intractable, without status epilepticus",201,Z930 (21%); Z931 (20%); Z933 (20%); Z941 (20%); Z942 (20%)
G40833,"Dravet syndrome, intractable, with status epilepticus",201,Z930 (21%); Z931 (21%); Z933 (21%); Z941 (21%); Z942 (21%)
G40834,"Dravet syndrome, intractable, without status epilepticus",201,Z930 (21%); Z931 (21%); Z933 (21%); Z941 (21%); Z942 (21%)
G4089,Other seizures,201,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
G40901,"Epilepsy, unspecified, not intractable, with status epilepticus",201,Z9350 (27%); Z930 (25%); Z931 (25%); Z933 (25%); P919 (25%)
G40909,"Epilepsy, unspecified, not intractable, without status epilepticus",201,Z9350 (27%); Z930 (25%); Z931 (25%); Z933 (25%); P919 (25%)
G40911,"Epilepsy, unspecified, intractable, with status epilepticus",201,Z9350 (27%); Z930 (25%); Z931 (25%); Z933 (25%); P919 (25%)
G40919,"Epilepsy, unspecified, intractable, without status epilepticus",201,Z9350 (27%); Z930 (25%); Z931 (25%); Z933 (25%); P919 (25%)
G40A01,"Absence epileptic syndrome, not intractable, with status epilepticus",201,Z89449 (27%); Z89439 (27%); Z89442 (27%); Z89441 (27%); Z89432 (27%)
G40A09,"Absence epileptic syndrome, not intractable, without status epilepticus",201,Z89449 (27%); Z89439 (27%); Z89442 (27%); Z89441 (27%); Z89432 (27%)
G40A11,"Absence epileptic syndrome, intractable, with status epilepticus",201,Z89449 (27%); Z89439 (27%); Z89442 (27%); Z89441 (27%); Z89432 (27%)
G40A19,"Absence epileptic syndrome, intractable, without status epilepticus",201,Z89449 (27%); Z89439 (27%); Z89442 (27%); Z89441 (27%); Z89432 (27%)
G40B01,"Juvenile myoclonic epilepsy, not intractable, with status epilepticus",201,Z930 (19%); M08859 (19%); M0880 (19%); Z931 (19%); Z933 (19%)
G40B09,"Juvenile myoclonic epilepsy, not intractable, without status epilepticus",201,Z930 (19%); M08859 (19%); M0880 (19%); Z931 (19%); Z933 (19%)
G40B11,"Juvenile myoclonic epilepsy, intractable, with status epilepticus",201,Z930 (19%); M08859 (19%); M0880 (19%); Z931 (19%); Z933 (19%)
G40B19,"Juvenile myoclonic epilepsy, intractable, without status epilepticus",201,Z930 (19%); M08859 (19%); M0880 (19%); Z931 (19%); Z933 (19%)
G40C01,"Lafora progressive myoclonus epilepsy, not intractable, with status epilepticus",201,M340 (25%); I673 (23%); A812 (23%); G1225 (22%); G1222 (21%)
G40C09,"Lafora progressive myoclonus epilepsy, not intractable, without status epilepticus",201,M340 (25%); I673 (23%); A812 (23%); G1225 (22%); G1222 (21%)
G40C11,"Lafora progressive myoclonus epilepsy, intractable, with status epilepticus",201,M340 (25%); I673 (23%); A812 (23%); G1225 (22%); G1222 (21%)
G40C19,"Lafora progressive myoclonus epilepsy, intractable, without status epilepticus",201,M340 (25%); I673 (23%); A812 (23%); G1225 (22%); G1222 (21%)
G43001,"Migraine without aura, not intractable, with status migrainosus",,
G43009,"Migraine without aura, not intractable, without status migrainosus",,
G43011,"Migraine without aura, intractable, with status migrainosus",,
G43019,"Migraine without aura, intractable, without status migrainosus",,
G43101,"Migraine with aura, not intractable, with status migrainosus",,
G43109,"Migraine with aura, not intractable, without status migrainosus",,
G43111,"Migraine with aura, intractable, with status migrainosus",,
G43119,"Migraine with aura, intractable, without status migrainosus",,
G43401,"Hemiplegic migraine, not intractable, with status migrainosus",,
G43409,"Hemiplegic migraine, not intractable, without status migrainosus",,
G43411,"Hemiplegic migraine, intractable, with status migrainosus",,
G43419,"Hemiplegic migraine, intractable, without status migrainosus",,
G43501,"Persistent migraine aura without cerebral infarction, not intractable, with status migrainosus",,
G43509,"Persistent migraine aura without cerebral infarction, not intractable, without status migrainosus",,
G43511,"Persistent migraine aura without cerebral infarction, intractable, with status migrainosus",,
G43519,"Persistent migraine aura without cerebral infarction, intractable, without status migrainosus",,
G43601,"Persistent migraine aura with cerebral infarction, not intractable, with status migrainosus",,
G43609,"Persistent migraine aura with cerebral infarction, not intractable, without status migrainosus",,
G43611,"Persistent migraine aura with cerebral infarction, intractable, with status migrainosus",,
G43619,"Persistent migraine aura with cerebral infarction, intractable, without status migrainosus",,
G43701,"Chronic migraine without aura, not intractable, with status migrainosus",,
G43709,"Chronic migraine without aura, not intractable, without status migrainosus",,
G43711,"Chronic migraine without aura, intractable, with status migrainosus",,
G43719,"Chronic migraine without aura, intractable, without status migrainosus",,
G43801,"Other migraine, not intractable, with status migrainosus",,
G43809,"Other migraine, not intractable, without status migrainosus",,
G43811,"Other migraine, intractable, with status migrainosus",,
G43819,"Other migraine, intractable, without status migrainosus",,
G43821,"Menstrual migraine, not intractable, with status migrainosus",,
G43829,"Menstrual migraine, not intractable, without status migrainosus",,
G43831,"Menstrual migraine, intractable, with status migrainosus",,
G43839,"Menstrual migraine, intractable, without status migrainosus",,
G43901,"Migraine, unspecified, not intractable, with status migrainosus",,
G43909,"Migraine, unspecified, not intractable, without status migrainosus",,
G43911,"Migraine, unspecified, intractable, with status migrainosus",,
G43919,"Migraine, unspecified, intractable, without status migrainosus",,
G43A0,"Cyclical vomiting, in migraine, not intractable",,
G43A1,"Cyclical vomiting, in migraine, intractable",,
G43B0,"Ophthalmoplegic migraine, not intractable",,
G43B1,"Ophthalmoplegic migraine, intractable",,
G43C0,"Periodic headache syndromes in child or adult, not intractable",,
G43C1,"Periodic headache syndromes in child or adult, intractable",,
G43D0,"Abdominal migraine, not intractable",,
G43D1,"Abdominal migraine, intractable",,
G43E01,"Chronic migraine with aura, not intractable, with status migrainosus",,
G43E09,"Chronic migraine with aura, not intractable, without status migrainosus",,
G43E11,"Chronic migraine with aura, intractable, with status migrainosus",,
G43E19,"Chronic migraine with aura, intractable, without status migrainosus",,
G47411,Narcolepsy with cataplexy,,
G47419,Narcolepsy without cataplexy,,
G47421,Narcolepsy in conditions classified elsewhere with cataplexy,,
G47429,Narcolepsy in conditions classified elsewhere without cataplexy,,
G500,Trigeminal neuralgia,,
G501,Atypical facial pain,,
G508,Other disorders of trigeminal nerve,,
G509,"Disorder of trigeminal nerve, unspecified",,
G546,Phantom limb syndrome with pain,409,E340 (21%); I70728 (21%); I70722 (21%); I70721 (21%); I70328 (21%)
G547,Phantom limb syndrome without pain,409,E340 (21%); I70728 (21%); I70722 (21%); I70721 (21%); I70328 (21%)
G600,Hereditary motor and sensory neuropathy,,
G601,Refsum's disease,,
G602,Neuropathy in association with hereditary ataxia,,
G603,Idiopathic progressive neuropathy,,
G608,Other hereditary and idiopathic neuropathies,,
G609,"Hereditary and idiopathic neuropathy, unspecified",,
G610,Guillain-Barre syndrome,,
G611,Serum neuropathy,,
G6181,Chronic inflammatory demyelinating polyneuritis,193,G379 (34%); G378 (32%); G3789 (32%); M064 (29%); M3581 (27%)
G6182,Multifocal motor neuropathy,193,E1040 (43%); E1140 (43%); E1340 (42%); E0840 (37%); M86359 (35%)
G6189,Other inflammatory polyneuropathies,,
G619,"Inflammatory polyneuropathy, unspecified",,
G620,Drug-induced polyneuropathy,,
G621,Alcoholic polyneuropathy,,
G622,Polyneuropathy due to other toxic agents,,
G6281,Critical illness polyneuropathy,,
G6282,Radiation-induced polyneuropathy,,
G6289,Other specified polyneuropathies,,
G629,"Polyneuropathy, unspecified",,
G63,Polyneuropathy in diseases classified elsewhere,,
G64,Other disorders of peripheral nervous system,,
G650,Sequelae of Guillain-Barre syndrome,,
G651,Sequelae of other inflammatory polyneuropathy,,
G652,Sequelae of toxic polyneuropathy,,
G7000,Myasthenia gravis without (acute) exacerbation,196,G7001 (100%); J471 (44%); J441 (38%); J4551 (35%); M86159 (17%)
G7001,Myasthenia gravis with (acute) exacerbation,195,G7000 (100%); J471 (44%); J441 (38%); J4551 (35%); G702 (33%)
G701,Toxic myoneural disorders,196,F258 (36%); F22 (34%); J99 (33%); E8889 (32%); D5780 (31%)
G702,Congenital and developmental myasthenia,196,G7001 (33%); G7129 (32%); G7120 (31%); Q038 (30%); Q039 (30%)
G7080,"Lambert-Eaton syndrome, unspecified",196,G839 (24%); E340 (20%); D469 (20%); M05059 (20%); M0500 (19%)
G7081,Lambert-Eaton syndrome in disease classified elsewhere,196,C946 (27%); I96 (21%); I69865 (21%); I69965 (20%); I69869 (20%)
G7089,Other specified myoneural disorders,196,E8889 (45%); D57818 (38%); F258 (37%); F22 (35%); J99 (34%)
G709,"Myoneural disorder, unspecified",196,F319 (29%); F609 (27%); F12959 (25%); F259 (25%); F3189 (24%)
G7100,"Muscular dystrophy, unspecified",197,G129 (40%); I82569 (36%); I82469 (35%); I80259 (34%); I82562 (32%)
G7101,Duchenne or Becker muscular dystrophy,197,G129 (22%); I82569 (20%); I82562 (19%); I82561 (19%); I82469 (19%)
G7102,Facioscapulohumeral muscular dystrophy,197,G129 (27%); I82569 (24%); I82562 (24%); I82561 (24%); I82469 (23%)
G71031,Autosomal dominant limb girdle muscular dystrophy,197,G90B (35%); G8312 (26%); G8311 (26%); G8322 (25%); G8321 (25%)
G71032,Autosomal recessive limb girdle muscular dystrophy due to calpain-3 dysfunction,197,G90B (19%); E318 (18%); E319 (17%); G129 (17%); J4A8 (15%)
G71033,Limb girdle muscular dystrophy due to dysferlin dysfunction,197,E318 (22%); E319 (22%); G129 (21%); J4A8 (19%); I82569 (18%)
G710340,"Limb girdle muscular dystrophy due to sarcoglycan dysfunction, unspecified",197,E319 (25%); G129 (23%); E318 (23%); I82569 (21%); J4A9 (21%)
G710341,Limb girdle muscular dystrophy due to alpha sarcoglycan dysfunction,197,E8801 (25%); T446X2A (21%); E318 (20%); E319 (20%); G129 (19%)
G710342,Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction,197,D561 (26%); E318 (21%); E319 (21%); D562 (20%); G129 (20%)
G710349,Limb girdle muscular dystrophy due to other sarcoglycan dysfunction,197,E318 (23%); E319 (22%); G129 (21%); J4A8 (19%); I82569 (19%)
G71035,Limb girdle muscular dystrophy due to anoctamin-5 dysfunction,197,E318 (22%); E319 (22%); G129 (21%); J4A8 (19%); I82569 (18%)
G71038,Other limb girdle muscular dystrophy,197,G129 (27%); I82569 (24%); I82562 (24%); I82561 (24%); I82469 (24%)
G71039,"Limb girdle muscular dystrophy, unspecified",197,G129 (30%); I82569 (27%); I82469 (26%); I80259 (25%); I82562 (24%)
G7109,Other specified muscular dystrophies,197,G129 (30%); I82569 (27%); I82562 (26%); I82561 (26%); I82469 (26%)
G7111,Myotonic muscular dystrophy,197,G129 (27%); I82569 (24%); I82562 (24%); I82561 (24%); I82469 (23%)
G7112,Myotonia congenita,,
G7113,Myotonic chondrodystrophy,,
G7114,Drug induced myotonia,,
G7119,Other specified myotonic disorders,,
G7120,"Congenital myopathy, unspecified",197,Q039 (51%); Q038 (47%); M3392 (46%); M3393 (46%); M3312 (44%)
G7121,Nemaline myopathy,197,M3312 (36%); M3313 (36%); M3322 (34%); M3392 (34%); M3393 (34%)
G71220,X-linked myotubular myopathy,197,M3312 (28%); M3313 (28%); M3322 (26%); M3392 (26%); M3393 (26%)
G71228,Other centronuclear myopathy,197,M3312 (36%); M3313 (36%); M3322 (34%); M3392 (34%); M3393 (34%)
G7129,Other congenital myopathy,197,Q038 (48%); Q039 (47%); M3312 (45%); M3313 (45%); M3322 (43%)
G713,"Mitochondrial myopathy, not elsewhere classified",,
G718,Other primary disorders of muscles,,
G719,"Primary disorder of muscle, unspecified",,
G720,Drug-induced myopathy,,
G721,Alcoholic myopathy,,
G722,Myopathy due to other toxic agents,,
G723,Periodic paralysis,,
G7241,Inclusion body myositis [IBM],93,C754 (17%); C162 (15%); C251 (15%); C602 (14%); C6940 (14%)
G7249,"Other inflammatory and immune myopathies, not elsewhere classified",,
G7281,Critical illness myopathy,,
G7289,Other specified myopathies,,
G729,"Myopathy, unspecified",,
G731,Lambert-Eaton syndrome in neoplastic disease,196,M84553A (37%); M84552A (37%); M84551A (37%); M84559A (36%); M360 (29%)
G733,Myasthenic syndromes in other diseases classified elsewhere,196,G914 (39%); M9058 (39%); M9050 (38%); M90519 (38%); M90549 (38%)
G737,Myopathy in diseases classified elsewhere,,
G800,Spastic quadriplegic cerebral palsy,191,G801 (62%); G802 (62%); G808 (60%); G809 (59%); G803 (42%)
G801,Spastic diplegic cerebral palsy,192,G800 (62%); G8110 (34%); G8112 (30%); G8111 (30%); G114 (28%)
G802,Spastic hemiplegic cerebral palsy,192,G800 (62%); G8110 (34%); G8112 (30%); G8111 (30%); G114 (28%)
G803,Athetoid cerebral palsy,192,G800 (42%); G1222 (32%); I6349 (28%); I6339 (28%); G936 (28%)
G804,Ataxic cerebral palsy,192,G800 (42%); G1222 (32%); I6349 (28%); I6339 (28%); G936 (28%)
G808,Other cerebral palsy,192,G800 (60%); G1222 (46%); I6349 (40%); I6339 (39%); G936 (39%)
G809,"Cerebral palsy, unspecified",192,G800 (59%); G1222 (44%); I6340 (42%); I6330 (42%); I639 (41%)
G8100,Flaccid hemiplegia affecting unspecified side,253,G0482 (46%); G8330 (33%); G8332 (25%); G8331 (25%); G8310 (25%)
G8101,Flaccid hemiplegia affecting right dominant side,253,G8331 (48%); G0482 (42%); G8311 (41%); G8332 (41%); G8321 (40%)
G8102,Flaccid hemiplegia affecting left dominant side,253,G8332 (48%); G0482 (42%); G8312 (41%); G8331 (41%); G8322 (40%)
G8103,Flaccid hemiplegia affecting right nondominant side,253,G8333 (56%); G8334 (51%); G8313 (50%); G8323 (49%); G8314 (45%)
G8104,Flaccid hemiplegia affecting left nondominant side,253,G8334 (56%); G8333 (51%); G8314 (50%); G8324 (49%); G8313 (45%)
G8110,Spastic hemiplegia affecting unspecified side,253,G114 (38%); G041 (35%); G8330 (34%); G800 (34%); G801 (34%)
G8111,Spastic hemiplegia affecting right dominant side,253,G8331 (49%); G8311 (42%); G8332 (42%); G8321 (41%); G8312 (36%)
G8112,Spastic hemiplegia affecting left dominant side,253,G8332 (49%); G8312 (42%); G8331 (42%); G8322 (41%); G8311 (36%)
G8113,Spastic hemiplegia affecting right nondominant side,253,G8333 (58%); G8334 (52%); G8313 (51%); G8323 (50%); G8314 (46%)
G8114,Spastic hemiplegia affecting left nondominant side,253,G8334 (58%); G8333 (52%); G8314 (51%); G8324 (50%); G8313 (46%)
G8190,"Hemiplegia, unspecified affecting unspecified side",253,G8330 (55%); G8332 (38%); G8331 (38%); G8310 (37%); G8320 (36%)
G8191,"Hemiplegia, unspecified affecting right dominant side",253,G8331 (65%); G8332 (56%); G8311 (52%); G8321 (50%); G8312 (45%)
G8192,"Hemiplegia, unspecified affecting left dominant side",253,G8332 (65%); G8331 (56%); G8312 (52%); G8322 (50%); G8311 (45%)
G8193,"Hemiplegia, unspecified affecting right nondominant side",253,G8333 (72%); G8334 (65%); G8313 (61%); G8323 (60%); G8314 (55%)
G8194,"Hemiplegia, unspecified affecting left nondominant side",253,G8334 (72%); G8333 (65%); G8314 (61%); G8324 (60%); G8313 (55%)
G8220,"Paraplegia, unspecified",181,G114 (58%); G041 (54%); G8330 (13%); L97909 (12%); G8190 (12%)
G8221,"Paraplegia, complete",181,G114 (51%); G041 (47%); K56691 (26%); S98319A (24%); S98312A (24%)
G8222,"Paraplegia, incomplete",181,G114 (48%); G041 (45%); S14159A (29%); S34132A (28%); S24159A (28%)
G8250,"Quadriplegia, unspecified",180,G8330 (13%); L97909 (13%); G8190 (12%); C8510 (12%); M08959 (12%)
G8251,"Quadriplegia, C1-C4 complete",180,S14101A (28%); S14104A (28%); S14101D (26%); S14104D (26%); S14151A (25%)
G8252,"Quadriplegia, C1-C4 incomplete",180,S14151A (43%); S14154A (43%); S14151D (41%); S14154D (41%); S14101A (27%)
G8253,"Quadriplegia, C5-C7 complete",180,S14105A (28%); S14107A (28%); S14105D (26%); S14107D (26%); S14155A (25%)
G8254,"Quadriplegia, C5-C7 incomplete",180,S14155A (43%); S14157A (43%); S14155D (41%); S14157D (41%); S14105A (27%)
G830,Diplegia of upper limbs,254,C7640 (18%); C7642 (17%); C7641 (17%); M868X2 (16%); L89122 (16%)
G8310,Monoplegia of lower limb affecting unspecified side,254,C7650 (50%); C7652 (43%); C7651 (43%); G8190 (37%); C4370 (33%)
G8311,Monoplegia of lower limb affecting right dominant side,254,G8191 (52%); C7651 (46%); G8192 (45%); G8111 (42%); G8101 (41%)
G8312,Monoplegia of lower limb affecting left dominant side,254,G8192 (52%); C7652 (46%); G8191 (45%); G8112 (42%); G8102 (41%)
G8313,Monoplegia of lower limb affecting right nondominant side,254,G8193 (61%); G8194 (55%); G8113 (51%); G8103 (50%); G8114 (46%)
G8314,Monoplegia of lower limb affecting left nondominant side,254,G8194 (61%); G8193 (55%); G8114 (51%); G8104 (50%); G8113 (46%)
G8320,Monoplegia of upper limb affecting unspecified side,254,C7640 (54%); C7642 (47%); C7641 (47%); C4360 (37%); C8514 (36%)
G8321,Monoplegia of upper limb affecting right dominant side,254,G8191 (50%); C7641 (50%); G8192 (43%); C7640 (42%); C7642 (41%)
G8322,Monoplegia of upper limb affecting left dominant side,254,G8192 (50%); C7642 (50%); G8191 (43%); C7640 (42%); C7641 (41%)
G8323,Monoplegia of upper limb affecting right nondominant side,254,G8193 (60%); G8194 (54%); G8113 (50%); G8103 (49%); C7641 (45%)
G8324,Monoplegia of upper limb affecting left nondominant side,254,G8194 (60%); G8193 (54%); G8114 (50%); G8104 (49%); C7642 (45%)
G8330,"Monoplegia, unspecified affecting unspecified side",254,G8190 (55%); G8192 (38%); G8191 (38%); I69959 (34%); G8110 (34%)
G8331,"Monoplegia, unspecified affecting right dominant side",254,G8191 (65%); G8192 (56%); G8111 (49%); G8101 (48%); I69951 (43%)
G8332,"Monoplegia, unspecified affecting left dominant side",254,G8192 (65%); G8191 (56%); G8112 (49%); G8102 (48%); I69952 (43%)
G8333,"Monoplegia, unspecified affecting right nondominant side",254,G8193 (72%); G8194 (65%); G8113 (58%); G8103 (56%); G8114 (52%)
G8334,"Monoplegia, unspecified affecting left nondominant side",254,G8194 (72%); G8193 (65%); G8114 (58%); G8104 (56%); G8113 (52%)
G834,Cauda equina syndrome,182,C721 (85%); E340 (21%); G839 (20%); G8382 (19%); G8383 (19%)
G835,Locked-in state,254,R403 (40%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
G8381,Brown-Sequard syndrome,254,S14149A (72%); S24149A (71%); S14149D (69%); S24149D (68%); S14141A (65%)
G8382,Anterior cord syndrome,254,S14139A (75%); S24139A (74%); S14139D (71%); S24139D (70%); S14131A (68%)
G8383,Posterior cord syndrome,254,S14139A (49%); S14129A (49%); S24139A (49%); S14139D (47%); S14129D (46%)
G8384,Todd's paralysis (postepileptic),254,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
G8389,Other specified paralytic syndromes,254,D763 (40%); D46Z (40%); M048 (38%); K560 (37%); D6189 (33%)
G839,"Paralytic syndrome, unspecified",254,K560 (46%); E340 (34%); D469 (32%); M05059 (32%); M0500 (32%)
G9001,Carotid sinus syncope,,
G9009,Other idiopathic peripheral autonomic neuropathy,,
G901,Familial dysautonomia [Riley-Day],182,E8331 (30%); G1224 (26%); A8183 (24%); A0104 (0%); A0105 (0%)
G902,Horner's syndrome,,
G903,Multi-system degeneration of the autonomic nervous system,199,C479 (44%); C478 (40%); T44902A (38%); T44992A (36%); I515 (32%)
G904,Autonomic dysreflexia,,
G9050,"Complex regional pain syndrome I, unspecified",,
G90511,Complex regional pain syndrome I of right upper limb,,
G90512,Complex regional pain syndrome I of left upper limb,,
G90513,"Complex regional pain syndrome I of upper limb, bilateral",,
G90519,Complex regional pain syndrome I of unspecified upper limb,,
G90521,Complex regional pain syndrome I of right lower limb,,
G90522,Complex regional pain syndrome I of left lower limb,,
G90523,"Complex regional pain syndrome I of lower limb, bilateral",,
G90529,Complex regional pain syndrome I of unspecified lower limb,,
G9059,Complex regional pain syndrome I of other specified site,,
G908,Other disorders of autonomic nervous system,,
G909,"Disorder of the autonomic nervous system, unspecified",,
G90B,LMNB1-related autosomal dominant leukodystrophy,200,G71031 (35%); G71032 (19%); D8984 (18%); G8332 (16%); G8331 (16%)
G910,Communicating hydrocephalus,127,Q038 (47%); Q039 (45%); I602 (43%); I6030 (42%); I6032 (42%)
G911,Obstructive hydrocephalus,127,J449 (51%); J4489 (49%); Q038 (47%); Q039 (46%); I421 (43%)
G912,(Idiopathic) normal pressure hydrocephalus,127,Q038 (37%); Q039 (36%); Q054 (28%); D812 (27%); Q050 (26%)
G913,"Post-traumatic hydrocephalus, unspecified",127,R561 (64%); Q039 (44%); Q038 (41%); D47Z1 (35%); Q054 (34%)
G914,Hydrocephalus in diseases classified elsewhere,127,M9058 (52%); M9050 (51%); M90519 (51%); M90549 (51%); M90512 (50%)
G918,Other hydrocephalus,127,Q038 (73%); Q039 (71%); Q054 (54%); Q050 (52%); Q055 (52%)
G919,"Hydrocephalus, unspecified",127,Q039 (74%); Q038 (69%); Q054 (57%); Q050 (49%); Q055 (49%)
G931,"Anoxic brain damage, not elsewhere classified",202,P112 (52%); P111 (51%); C719 (29%); S068A0A (25%); C7931 (25%)
G9342,Megaloencephalic leukoencephalopathy with subcortical cysts,200,Q046 (34%); I673 (30%); A812 (30%); I610 (28%); P911 (25%)
G9343,Leukoencephalopathy with calcifications and cysts,200,Q046 (39%); I673 (35%); A812 (35%); P911 (30%); A0104 (0%)
G9344,Adult-onset leukodystrophy with axonal spheroids,200,M061 (48%); J8482 (19%); C9151 (18%); C9152 (18%); M08259 (17%)
G935,Compression of brain,202,S06A0XA (64%); S06A1XA (64%); G9529 (59%); G9520 (57%); C719 (49%)
G936,Cerebral edema,202,S061X0A (59%); P110 (58%); I6349 (55%); I6339 (55%); I6340 (55%)
G937,Reye's syndrome,127,E340 (26%); G839 (25%); G8382 (23%); G8383 (23%); D469 (20%)
G950,Syringomyelia and syringobulbia,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
G9511,Acute infarction of spinal cord (embolic) (nonembolic),182,C720 (30%); I219 (29%); D334 (25%); I6389 (22%); I639 (21%)
G9519,Other vascular myelopathies,182,G214 (35%); F01C4 (31%); F01B4 (30%); F01A4 (30%); F0154 (30%)
G9520,Unspecified cord compression,182,G935 (57%); S22000B (40%); S32000B (40%); S22000A (40%); S32000A (40%)
G9529,Other cord compression,182,G935 (59%); S22010B (38%); S22030B (38%); S06A0XA (38%); S06A1XA (38%)
G9581,Conus medullaris syndrome,182,E340 (19%); G839 (18%); G8382 (17%); G8383 (17%); D469 (15%)
G9589,Other specified diseases of spinal cord,182,C720 (52%); I2789 (47%); D334 (44%); J8489 (42%); J84178 (36%)
G959,"Disease of spinal cord, unspecified",182,C720 (61%); D334 (51%); S14119A (46%); S24119A (45%); S14119D (43%)
G990,Autonomic neuropathy in diseases classified elsewhere,,
G992,Myelopathy in diseases classified elsewhere,182,G914 (45%); M9058 (44%); M9050 (43%); M90519 (43%); M90549 (43%)
H01121,Discoid lupus erythematosus of right upper eyelid,,
H01122,Discoid lupus erythematosus of right lower eyelid,,
H01123,"Discoid lupus erythematosus of right eye, unspecified eyelid",,
H01124,Discoid lupus erythematosus of left upper eyelid,,
H01125,Discoid lupus erythematosus of left lower eyelid,,
H01126,"Discoid lupus erythematosus of left eye, unspecified eyelid",,
H01129,"Discoid lupus erythematosus of unspecified eye, unspecified eyelid",,
H348110,"Central retinal vein occlusion, right eye, with macular edema",298,E103511 (38%); E103591 (38%); E113511 (38%); E113591 (38%); E133511 (37%)
H348111,"Central retinal vein occlusion, right eye, with retinal neovascularization",298,E103541 (37%); E113541 (37%); E133541 (37%); E083541 (36%); E103549 (35%)
H348112,"Central retinal vein occlusion, right eye, stable",298,E103551 (35%); E113551 (35%); E133551 (34%); E083551 (31%); E103559 (30%)
H348120,"Central retinal vein occlusion, left eye, with macular edema",298,E103512 (37%); E103592 (37%); E113512 (37%); E113592 (37%); E133512 (37%)
H348121,"Central retinal vein occlusion, left eye, with retinal neovascularization",298,E103542 (37%); E113542 (37%); E133542 (37%); E083542 (36%); E103549 (35%)
H348122,"Central retinal vein occlusion, left eye, stable",298,E103552 (35%); E113552 (35%); E133552 (34%); E083552 (31%); E103559 (30%)
H348130,"Central retinal vein occlusion, bilateral, with macular edema",298,E103513 (36%); E103593 (36%); E113513 (36%); E113593 (36%); E133513 (35%)
H348131,"Central retinal vein occlusion, bilateral, with retinal neovascularization",298,E103543 (37%); E113543 (37%); E133543 (36%); E083543 (35%); E103549 (30%)
H348132,"Central retinal vein occlusion, bilateral, stable",298,E103553 (33%); E113553 (33%); E133553 (33%); E083553 (30%); I63233 (29%)
H348190,"Central retinal vein occlusion, unspecified eye, with macular edema",298,E103519 (36%); E103599 (36%); E113519 (36%); E113599 (36%); E133519 (35%)
H348191,"Central retinal vein occlusion, unspecified eye, with retinal neovascularization",298,E103549 (37%); E113549 (37%); E133549 (36%); E103542 (35%); E113542 (35%)
H348192,"Central retinal vein occlusion, unspecified eye, stable",298,E103559 (33%); E113559 (33%); E133559 (33%); E103552 (30%); E113552 (30%)
H348310,"Tributary (branch) retinal vein occlusion, right eye, with macular edema",298,E103511 (32%); E103591 (32%); E113511 (32%); E113591 (32%); E133511 (31%)
H348311,"Tributary (branch) retinal vein occlusion, right eye, with retinal neovascularization",298,E103541 (33%); E113541 (33%); E133541 (33%); E083541 (32%); E103549 (31%)
H348312,"Tributary (branch) retinal vein occlusion, right eye, stable",298,E103551 (29%); E113551 (29%); E133551 (29%); E083551 (26%); E103559 (25%)
H348320,"Tributary (branch) retinal vein occlusion, left eye, with macular edema",298,E103512 (32%); E103592 (32%); E113512 (32%); E113592 (32%); E133512 (31%)
H348321,"Tributary (branch) retinal vein occlusion, left eye, with retinal neovascularization",298,E103542 (33%); E113542 (33%); E133542 (33%); E083542 (32%); E103549 (31%)
H348322,"Tributary (branch) retinal vein occlusion, left eye, stable",298,E103552 (29%); E113552 (29%); E133552 (29%); E083552 (26%); E103559 (25%)
H348330,"Tributary (branch) retinal vein occlusion, bilateral, with macular edema",298,E103513 (30%); E103593 (30%); E113513 (30%); E113593 (30%); E133513 (30%)
H348331,"Tributary (branch) retinal vein occlusion, bilateral, with retinal neovascularization",298,E103543 (32%); E113543 (32%); E133543 (32%); E083543 (31%); E103549 (27%)
H348332,"Tributary (branch) retinal vein occlusion, bilateral, stable",298,E103553 (28%); E113553 (28%); E133553 (27%); E083553 (25%); I63233 (24%)
H348390,"Tributary (branch) retinal vein occlusion, unspecified eye, with macular edema",298,E103519 (30%); E103599 (30%); E113519 (30%); E113599 (30%); E133519 (30%)
H348391,"Tributary (branch) retinal vein occlusion, unspecified eye, with retinal neovascularization",298,E103549 (32%); E113549 (32%); E133549 (32%); E103542 (31%); E113542 (31%)
H348392,"Tributary (branch) retinal vein occlusion, unspecified eye, stable",298,E103559 (28%); E113559 (28%); E133559 (27%); E103552 (25%); E113552 (25%)
H353210,"Exudative age-related macular degeneration, right eye, stage unspecified",300,M80051A (33%); M80059A (32%); I515 (30%); M8008XA (30%); M80052A (30%)
H353211,"Exudative age-related macular degeneration, right eye, with active choroidal neovascularization",300,M80051A (27%); K732 (25%); I515 (24%); M8008XA (24%); M80059A (24%)
H353212,"Exudative age-related macular degeneration, right eye, with inactive choroidal neovascularization",300,M80051A (27%); I515 (24%); M8008XA (24%); M80059A (24%); M80052A (24%)
H353213,"Exudative age-related macular degeneration, right eye, with inactive scar",300,M80051A (28%); I515 (26%); M8008XA (26%); M80059A (26%); M80052A (26%)
H353220,"Exudative age-related macular degeneration, left eye, stage unspecified",300,M80052A (33%); M80059A (32%); I515 (30%); M8008XA (30%); M80051A (30%)
H353221,"Exudative age-related macular degeneration, left eye, with active choroidal neovascularization",300,M80052A (27%); K732 (25%); I515 (24%); M8008XA (24%); M80059A (24%)
H353222,"Exudative age-related macular degeneration, left eye, with inactive choroidal neovascularization",300,M80052A (27%); I515 (24%); M8008XA (24%); M80059A (24%); M80051A (24%)
H353223,"Exudative age-related macular degeneration, left eye, with inactive scar",300,M80052A (28%); I515 (26%); M8008XA (26%); M80059A (26%); M80051A (26%)
H353230,"Exudative age-related macular degeneration, bilateral, stage unspecified",300,M80059A (32%); I515 (30%); M8008XA (30%); M80052A (30%); M80051A (30%)
H353231,"Exudative age-related macular degeneration, bilateral, with active choroidal neovascularization",300,K732 (25%); I515 (25%); M8008XA (24%); M80059A (24%); M80052A (24%)
H353232,"Exudative age-related macular degeneration, bilateral, with inactive choroidal neovascularization",300,I515 (25%); M8008XA (24%); M80059A (24%); M80052A (24%); M80051A (24%)
H353233,"Exudative age-related macular degeneration, bilateral, with inactive scar",300,I515 (26%); M8008XA (26%); M80059A (26%); M80052A (26%); M80051A (26%)
H353290,"Exudative age-related macular degeneration, unspecified eye, stage unspecified",300,M80059A (33%); I515 (30%); M8008XA (30%); M80052A (30%); M80051A (30%)
H353291,"Exudative age-related macular degeneration, unspecified eye, with active choroidal neovascularization",300,M80059A (26%); K732 (25%); I515 (25%); M8008XA (24%); M80052A (24%)
H353292,"Exudative age-related macular degeneration, unspecified eye, with inactive choroidal neovascularization",300,M80059A (26%); I515 (25%); M8008XA (24%); M80052A (24%); M80051A (24%)
H353293,"Exudative age-related macular degeneration, unspecified eye, with inactive scar",300,M80059A (27%); I515 (26%); M8008XA (26%); M80052A (26%); M80051A (26%)
H36811,"Nonproliferative sickle-cell retinopathy, right eye",108,H36821 (81%); H36829 (75%); H36822 (74%); H36823 (60%); D571 (45%)
H36811,"Nonproliferative sickle-cell retinopathy, right eye",,
H36812,"Nonproliferative sickle-cell retinopathy, left eye",108,H36822 (81%); H36829 (75%); H36821 (74%); H36823 (60%); D571 (45%)
H36812,"Nonproliferative sickle-cell retinopathy, left eye",,
H36813,"Nonproliferative sickle-cell retinopathy, bilateral",108,H36823 (80%); H36829 (61%); H36822 (60%); H36821 (60%); D571 (46%)
H36813,"Nonproliferative sickle-cell retinopathy, bilateral",,
H36819,"Nonproliferative sickle-cell retinopathy, unspecified eye",108,H36829 (80%); H36822 (75%); H36821 (75%); H36823 (61%); D571 (46%)
H36819,"Nonproliferative sickle-cell retinopathy, unspecified eye",,
H36821,"Proliferative sickle-cell retinopathy, right eye",108,H36821 (100%); H36829 (94%); H36822 (93%); H36823 (79%); E103551 (47%)
H36821,"Proliferative sickle-cell retinopathy, right eye",298,H36821 (100%); H36829 (94%); H36822 (93%); H36811 (81%); H36823 (79%)
H36822,"Proliferative sickle-cell retinopathy, left eye",108,H36822 (100%); H36829 (94%); H36821 (93%); H36823 (79%); E103552 (47%)
H36822,"Proliferative sickle-cell retinopathy, left eye",298,H36822 (100%); H36829 (94%); H36821 (93%); H36812 (81%); H36823 (79%)
H36823,"Proliferative sickle-cell retinopathy, bilateral",108,H36823 (100%); H36829 (80%); H36822 (79%); H36821 (79%); D571 (46%)
H36823,"Proliferative sickle-cell retinopathy, bilateral",298,H36823 (100%); H36829 (80%); H36813 (80%); H36822 (79%); H36821 (79%)
H36829,"Proliferative sickle-cell retinopathy, unspecified eye",108,H36829 (100%); H36822 (94%); H36821 (94%); H36823 (80%); D571 (46%)
H36829,"Proliferative sickle-cell retinopathy, unspecified eye",298,H36829 (100%); H36822 (94%); H36821 (94%); H36823 (80%); H36819 (80%)
H4010X0,"Unspecified open-angle glaucoma, stage unspecified",,
H4010X0,"Unspecified open-angle glaucoma, stage unspecified",,
H4010X1,"Unspecified open-angle glaucoma, mild stage",,
H4010X1,"Unspecified open-angle glaucoma, mild stage",,
H4010X2,"Unspecified open-angle glaucoma, moderate stage",,
H4010X3,"Unspecified open-angle glaucoma, severe stage",,
H4010X4,"Unspecified open-angle glaucoma, indeterminate stage",,
H4010X4,"Unspecified open-angle glaucoma, indeterminate stage",,
H401110,"Primary open-angle glaucoma, right eye, stage unspecified",,
H401110,"Primary open-angle glaucoma, right eye, stage unspecified",,
H401111,"Primary open-angle glaucoma, right eye, mild stage",,
H401111,"Primary open-angle glaucoma, right eye, mild stage",,
H401112,"Primary open-angle glaucoma, right eye, moderate stage",,
H401113,"Primary open-angle glaucoma, right eye, severe stage",,
H401114,"Primary open-angle glaucoma, right eye, indeterminate stage",,
H401114,"Primary open-angle glaucoma, right eye, indeterminate stage",,
H401120,"Primary open-angle glaucoma, left eye, stage unspecified",,
H401120,"Primary open-angle glaucoma, left eye, stage unspecified",,
H401121,"Primary open-angle glaucoma, left eye, mild stage",,
H401121,"Primary open-angle glaucoma, left eye, mild stage",,
H401122,"Primary open-angle glaucoma, left eye, moderate stage",,
H401123,"Primary open-angle glaucoma, left eye, severe stage",,
H401124,"Primary open-angle glaucoma, left eye, indeterminate stage",,
H401124,"Primary open-angle glaucoma, left eye, indeterminate stage",,
H401130,"Primary open-angle glaucoma, bilateral, stage unspecified",,
H401130,"Primary open-angle glaucoma, bilateral, stage unspecified",,
H401131,"Primary open-angle glaucoma, bilateral, mild stage",,
H401131,"Primary open-angle glaucoma, bilateral, mild stage",,
H401132,"Primary open-angle glaucoma, bilateral, moderate stage",,
H401133,"Primary open-angle glaucoma, bilateral, severe stage",,
H401134,"Primary open-angle glaucoma, bilateral, indeterminate stage",,
H401134,"Primary open-angle glaucoma, bilateral, indeterminate stage",,
H401190,"Primary open-angle glaucoma, unspecified eye, stage unspecified",,
H401190,"Primary open-angle glaucoma, unspecified eye, stage unspecified",,
H401191,"Primary open-angle glaucoma, unspecified eye, mild stage",,
H401191,"Primary open-angle glaucoma, unspecified eye, mild stage",,
H401192,"Primary open-angle glaucoma, unspecified eye, moderate stage",,
H401193,"Primary open-angle glaucoma, unspecified eye, severe stage",,
H401194,"Primary open-angle glaucoma, unspecified eye, indeterminate stage",,
H401194,"Primary open-angle glaucoma, unspecified eye, indeterminate stage",,
H401210,"Low-tension glaucoma, right eye, stage unspecified",,
H401210,"Low-tension glaucoma, right eye, stage unspecified",,
H401211,"Low-tension glaucoma, right eye, mild stage",,
H401211,"Low-tension glaucoma, right eye, mild stage",,
H401212,"Low-tension glaucoma, right eye, moderate stage",,
H401213,"Low-tension glaucoma, right eye, severe stage",,
H401214,"Low-tension glaucoma, right eye, indeterminate stage",,
H401214,"Low-tension glaucoma, right eye, indeterminate stage",,
H401220,"Low-tension glaucoma, left eye, stage unspecified",,
H401220,"Low-tension glaucoma, left eye, stage unspecified",,
H401221,"Low-tension glaucoma, left eye, mild stage",,
H401221,"Low-tension glaucoma, left eye, mild stage",,
H401222,"Low-tension glaucoma, left eye, moderate stage",,
H401223,"Low-tension glaucoma, left eye, severe stage",,
H401224,"Low-tension glaucoma, left eye, indeterminate stage",,
H401224,"Low-tension glaucoma, left eye, indeterminate stage",,
H401230,"Low-tension glaucoma, bilateral, stage unspecified",,
H401230,"Low-tension glaucoma, bilateral, stage unspecified",,
H401231,"Low-tension glaucoma, bilateral, mild stage",,
H401231,"Low-tension glaucoma, bilateral, mild stage",,
H401232,"Low-tension glaucoma, bilateral, moderate stage",,
H401233,"Low-tension glaucoma, bilateral, severe stage",,
H401234,"Low-tension glaucoma, bilateral, indeterminate stage",,
H401234,"Low-tension glaucoma, bilateral, indeterminate stage",,
H401290,"Low-tension glaucoma, unspecified eye, stage unspecified",,
H401290,"Low-tension glaucoma, unspecified eye, stage unspecified",,
H401291,"Low-tension glaucoma, unspecified eye, mild stage",,
H401291,"Low-tension glaucoma, unspecified eye, mild stage",,
H401292,"Low-tension glaucoma, unspecified eye, moderate stage",,
H401293,"Low-tension glaucoma, unspecified eye, severe stage",,
H401294,"Low-tension glaucoma, unspecified eye, indeterminate stage",,
H401294,"Low-tension glaucoma, unspecified eye, indeterminate stage",,
H401310,"Pigmentary glaucoma, right eye, stage unspecified",,
H401310,"Pigmentary glaucoma, right eye, stage unspecified",,
H401311,"Pigmentary glaucoma, right eye, mild stage",,
H401311,"Pigmentary glaucoma, right eye, mild stage",,
H401312,"Pigmentary glaucoma, right eye, moderate stage",,
H401313,"Pigmentary glaucoma, right eye, severe stage",,
H401314,"Pigmentary glaucoma, right eye, indeterminate stage",,
H401314,"Pigmentary glaucoma, right eye, indeterminate stage",,
H401320,"Pigmentary glaucoma, left eye, stage unspecified",,
H401320,"Pigmentary glaucoma, left eye, stage unspecified",,
H401321,"Pigmentary glaucoma, left eye, mild stage",,
H401321,"Pigmentary glaucoma, left eye, mild stage",,
H401322,"Pigmentary glaucoma, left eye, moderate stage",,
H401323,"Pigmentary glaucoma, left eye, severe stage",,
H401324,"Pigmentary glaucoma, left eye, indeterminate stage",,
H401324,"Pigmentary glaucoma, left eye, indeterminate stage",,
H401330,"Pigmentary glaucoma, bilateral, stage unspecified",,
H401330,"Pigmentary glaucoma, bilateral, stage unspecified",,
H401331,"Pigmentary glaucoma, bilateral, mild stage",,
H401331,"Pigmentary glaucoma, bilateral, mild stage",,
H401332,"Pigmentary glaucoma, bilateral, moderate stage",,
H401333,"Pigmentary glaucoma, bilateral, severe stage",,
H401334,"Pigmentary glaucoma, bilateral, indeterminate stage",,
H401334,"Pigmentary glaucoma, bilateral, indeterminate stage",,
H401390,"Pigmentary glaucoma, unspecified eye, stage unspecified",,
H401390,"Pigmentary glaucoma, unspecified eye, stage unspecified",,
H401391,"Pigmentary glaucoma, unspecified eye, mild stage",,
H401391,"Pigmentary glaucoma, unspecified eye, mild stage",,
H401392,"Pigmentary glaucoma, unspecified eye, moderate stage",,
H401393,"Pigmentary glaucoma, unspecified eye, severe stage",,
H401394,"Pigmentary glaucoma, unspecified eye, indeterminate stage",,
H401394,"Pigmentary glaucoma, unspecified eye, indeterminate stage",,
H401410,"Capsular glaucoma with pseudoexfoliation of lens, right eye, stage unspecified",,
H401410,"Capsular glaucoma with pseudoexfoliation of lens, right eye, stage unspecified",,
H401411,"Capsular glaucoma with pseudoexfoliation of lens, right eye, mild stage",,
H401411,"Capsular glaucoma with pseudoexfoliation of lens, right eye, mild stage",,
H401412,"Capsular glaucoma with pseudoexfoliation of lens, right eye, moderate stage",,
H401413,"Capsular glaucoma with pseudoexfoliation of lens, right eye, severe stage",,
H401414,"Capsular glaucoma with pseudoexfoliation of lens, right eye, indeterminate stage",,
H401414,"Capsular glaucoma with pseudoexfoliation of lens, right eye, indeterminate stage",,
H401420,"Capsular glaucoma with pseudoexfoliation of lens, left eye, stage unspecified",,
H401420,"Capsular glaucoma with pseudoexfoliation of lens, left eye, stage unspecified",,
H401421,"Capsular glaucoma with pseudoexfoliation of lens, left eye, mild stage",,
H401421,"Capsular glaucoma with pseudoexfoliation of lens, left eye, mild stage",,
H401422,"Capsular glaucoma with pseudoexfoliation of lens, left eye, moderate stage",,
H401423,"Capsular glaucoma with pseudoexfoliation of lens, left eye, severe stage",,
H401424,"Capsular glaucoma with pseudoexfoliation of lens, left eye, indeterminate stage",,
H401424,"Capsular glaucoma with pseudoexfoliation of lens, left eye, indeterminate stage",,
H401430,"Capsular glaucoma with pseudoexfoliation of lens, bilateral, stage unspecified",,
H401430,"Capsular glaucoma with pseudoexfoliation of lens, bilateral, stage unspecified",,
H401431,"Capsular glaucoma with pseudoexfoliation of lens, bilateral, mild stage",,
H401431,"Capsular glaucoma with pseudoexfoliation of lens, bilateral, mild stage",,
H401432,"Capsular glaucoma with pseudoexfoliation of lens, bilateral, moderate stage",,
H401433,"Capsular glaucoma with pseudoexfoliation of lens, bilateral, severe stage",,
H401434,"Capsular glaucoma with pseudoexfoliation of lens, bilateral, indeterminate stage",,
H401434,"Capsular glaucoma with pseudoexfoliation of lens, bilateral, indeterminate stage",,
H401490,"Capsular glaucoma with pseudoexfoliation of lens, unspecified eye, stage unspecified",,
H401490,"Capsular glaucoma with pseudoexfoliation of lens, unspecified eye, stage unspecified",,
H401491,"Capsular glaucoma with pseudoexfoliation of lens, unspecified eye, mild stage",,
H401491,"Capsular glaucoma with pseudoexfoliation of lens, unspecified eye, mild stage",,
H401492,"Capsular glaucoma with pseudoexfoliation of lens, unspecified eye, moderate stage",,
H401493,"Capsular glaucoma with pseudoexfoliation of lens, unspecified eye, severe stage",,
H401494,"Capsular glaucoma with pseudoexfoliation of lens, unspecified eye, indeterminate stage",,
H401494,"Capsular glaucoma with pseudoexfoliation of lens, unspecified eye, indeterminate stage",,
H40151,"Residual stage of open-angle glaucoma, right eye",,
H40152,"Residual stage of open-angle glaucoma, left eye",,
H40153,"Residual stage of open-angle glaucoma, bilateral",,
H40159,"Residual stage of open-angle glaucoma, unspecified eye",,
H4020X0,"Unspecified primary angle-closure glaucoma, stage unspecified",,
H4020X1,"Unspecified primary angle-closure glaucoma, mild stage",,
H4020X2,"Unspecified primary angle-closure glaucoma, moderate stage",,
H4020X2,"Unspecified primary angle-closure glaucoma, moderate stage",,
H4020X3,"Unspecified primary angle-closure glaucoma, severe stage",,
H4020X3,"Unspecified primary angle-closure glaucoma, severe stage",,
H4020X4,"Unspecified primary angle-closure glaucoma, indeterminate stage",,
H402210,"Chronic angle-closure glaucoma, right eye, stage unspecified",,
H402211,"Chronic angle-closure glaucoma, right eye, mild stage",,
H402212,"Chronic angle-closure glaucoma, right eye, moderate stage",,
H402212,"Chronic angle-closure glaucoma, right eye, moderate stage",,
H402213,"Chronic angle-closure glaucoma, right eye, severe stage",,
H402213,"Chronic angle-closure glaucoma, right eye, severe stage",,
H402214,"Chronic angle-closure glaucoma, right eye, indeterminate stage",,
H402220,"Chronic angle-closure glaucoma, left eye, stage unspecified",,
H402221,"Chronic angle-closure glaucoma, left eye, mild stage",,
H402222,"Chronic angle-closure glaucoma, left eye, moderate stage",,
H402222,"Chronic angle-closure glaucoma, left eye, moderate stage",,
H402223,"Chronic angle-closure glaucoma, left eye, severe stage",,
H402223,"Chronic angle-closure glaucoma, left eye, severe stage",,
H402224,"Chronic angle-closure glaucoma, left eye, indeterminate stage",,
H402230,"Chronic angle-closure glaucoma, bilateral, stage unspecified",,
H402231,"Chronic angle-closure glaucoma, bilateral, mild stage",,
H402232,"Chronic angle-closure glaucoma, bilateral, moderate stage",,
H402232,"Chronic angle-closure glaucoma, bilateral, moderate stage",,
H402233,"Chronic angle-closure glaucoma, bilateral, severe stage",,
H402233,"Chronic angle-closure glaucoma, bilateral, severe stage",,
H402234,"Chronic angle-closure glaucoma, bilateral, indeterminate stage",,
H402290,"Chronic angle-closure glaucoma, unspecified eye, stage unspecified",,
H402291,"Chronic angle-closure glaucoma, unspecified eye, mild stage",,
H402292,"Chronic angle-closure glaucoma, unspecified eye, moderate stage",,
H402292,"Chronic angle-closure glaucoma, unspecified eye, moderate stage",,
H402293,"Chronic angle-closure glaucoma, unspecified eye, severe stage",,
H402293,"Chronic angle-closure glaucoma, unspecified eye, severe stage",,
H402294,"Chronic angle-closure glaucoma, unspecified eye, indeterminate stage",,
H40231,"Intermittent angle-closure glaucoma, right eye",,
H40232,"Intermittent angle-closure glaucoma, left eye",,
H40233,"Intermittent angle-closure glaucoma, bilateral",,
H40239,"Intermittent angle-closure glaucoma, unspecified eye",,
H40241,"Residual stage of angle-closure glaucoma, right eye",,
H40242,"Residual stage of angle-closure glaucoma, left eye",,
H40243,"Residual stage of angle-closure glaucoma, bilateral",,
H40249,"Residual stage of angle-closure glaucoma, unspecified eye",,
H4030X0,"Glaucoma secondary to eye trauma, unspecified eye, stage unspecified",,
H4030X1,"Glaucoma secondary to eye trauma, unspecified eye, mild stage",,
H4030X2,"Glaucoma secondary to eye trauma, unspecified eye, moderate stage",,
H4030X2,"Glaucoma secondary to eye trauma, unspecified eye, moderate stage",,
H4030X3,"Glaucoma secondary to eye trauma, unspecified eye, severe stage",,
H4030X3,"Glaucoma secondary to eye trauma, unspecified eye, severe stage",,
H4030X4,"Glaucoma secondary to eye trauma, unspecified eye, indeterminate stage",,
H4031X0,"Glaucoma secondary to eye trauma, right eye, stage unspecified",,
H4031X1,"Glaucoma secondary to eye trauma, right eye, mild stage",,
H4031X2,"Glaucoma secondary to eye trauma, right eye, moderate stage",,
H4031X2,"Glaucoma secondary to eye trauma, right eye, moderate stage",,
H4031X3,"Glaucoma secondary to eye trauma, right eye, severe stage",,
H4031X3,"Glaucoma secondary to eye trauma, right eye, severe stage",,
H4031X4,"Glaucoma secondary to eye trauma, right eye, indeterminate stage",,
H4032X0,"Glaucoma secondary to eye trauma, left eye, stage unspecified",,
H4032X1,"Glaucoma secondary to eye trauma, left eye, mild stage",,
H4032X2,"Glaucoma secondary to eye trauma, left eye, moderate stage",,
H4032X2,"Glaucoma secondary to eye trauma, left eye, moderate stage",,
H4032X3,"Glaucoma secondary to eye trauma, left eye, severe stage",,
H4032X3,"Glaucoma secondary to eye trauma, left eye, severe stage",,
H4032X4,"Glaucoma secondary to eye trauma, left eye, indeterminate stage",,
H4033X0,"Glaucoma secondary to eye trauma, bilateral, stage unspecified",,
H4033X1,"Glaucoma secondary to eye trauma, bilateral, mild stage",,
H4033X2,"Glaucoma secondary to eye trauma, bilateral, moderate stage",,
H4033X2,"Glaucoma secondary to eye trauma, bilateral, moderate stage",,
H4033X3,"Glaucoma secondary to eye trauma, bilateral, severe stage",,
H4033X3,"Glaucoma secondary to eye trauma, bilateral, severe stage",,
H4033X4,"Glaucoma secondary to eye trauma, bilateral, indeterminate stage",,
H4040X0,"Glaucoma secondary to eye inflammation, unspecified eye, stage unspecified",,
H4040X1,"Glaucoma secondary to eye inflammation, unspecified eye, mild stage",,
H4040X2,"Glaucoma secondary to eye inflammation, unspecified eye, moderate stage",,
H4040X2,"Glaucoma secondary to eye inflammation, unspecified eye, moderate stage",,
H4040X3,"Glaucoma secondary to eye inflammation, unspecified eye, severe stage",,
H4040X3,"Glaucoma secondary to eye inflammation, unspecified eye, severe stage",,
H4040X4,"Glaucoma secondary to eye inflammation, unspecified eye, indeterminate stage",,
H4041X0,"Glaucoma secondary to eye inflammation, right eye, stage unspecified",,
H4041X1,"Glaucoma secondary to eye inflammation, right eye, mild stage",,
H4041X2,"Glaucoma secondary to eye inflammation, right eye, moderate stage",,
H4041X2,"Glaucoma secondary to eye inflammation, right eye, moderate stage",,
H4041X3,"Glaucoma secondary to eye inflammation, right eye, severe stage",,
H4041X3,"Glaucoma secondary to eye inflammation, right eye, severe stage",,
H4041X4,"Glaucoma secondary to eye inflammation, right eye, indeterminate stage",,
H4042X0,"Glaucoma secondary to eye inflammation, left eye, stage unspecified",,
H4042X1,"Glaucoma secondary to eye inflammation, left eye, mild stage",,
H4042X2,"Glaucoma secondary to eye inflammation, left eye, moderate stage",,
H4042X2,"Glaucoma secondary to eye inflammation, left eye, moderate stage",,
H4042X3,"Glaucoma secondary to eye inflammation, left eye, severe stage",,
H4042X3,"Glaucoma secondary to eye inflammation, left eye, severe stage",,
H4042X4,"Glaucoma secondary to eye inflammation, left eye, indeterminate stage",,
H4043X0,"Glaucoma secondary to eye inflammation, bilateral, stage unspecified",,
H4043X1,"Glaucoma secondary to eye inflammation, bilateral, mild stage",,
H4043X2,"Glaucoma secondary to eye inflammation, bilateral, moderate stage",,
H4043X2,"Glaucoma secondary to eye inflammation, bilateral, moderate stage",,
H4043X3,"Glaucoma secondary to eye inflammation, bilateral, severe stage",,
H4043X3,"Glaucoma secondary to eye inflammation, bilateral, severe stage",,
H4043X4,"Glaucoma secondary to eye inflammation, bilateral, indeterminate stage",,
H4050X0,"Glaucoma secondary to other eye disorders, unspecified eye, stage unspecified",,
H4050X1,"Glaucoma secondary to other eye disorders, unspecified eye, mild stage",,
H4050X2,"Glaucoma secondary to other eye disorders, unspecified eye, moderate stage",,
H4050X2,"Glaucoma secondary to other eye disorders, unspecified eye, moderate stage",,
H4050X3,"Glaucoma secondary to other eye disorders, unspecified eye, severe stage",,
H4050X3,"Glaucoma secondary to other eye disorders, unspecified eye, severe stage",,
H4050X4,"Glaucoma secondary to other eye disorders, unspecified eye, indeterminate stage",,
H4051X0,"Glaucoma secondary to other eye disorders, right eye, stage unspecified",,
H4051X1,"Glaucoma secondary to other eye disorders, right eye, mild stage",,
H4051X2,"Glaucoma secondary to other eye disorders, right eye, moderate stage",,
H4051X2,"Glaucoma secondary to other eye disorders, right eye, moderate stage",,
H4051X3,"Glaucoma secondary to other eye disorders, right eye, severe stage",,
H4051X3,"Glaucoma secondary to other eye disorders, right eye, severe stage",,
H4051X4,"Glaucoma secondary to other eye disorders, right eye, indeterminate stage",,
H4052X0,"Glaucoma secondary to other eye disorders, left eye, stage unspecified",,
H4052X1,"Glaucoma secondary to other eye disorders, left eye, mild stage",,
H4052X2,"Glaucoma secondary to other eye disorders, left eye, moderate stage",,
H4052X2,"Glaucoma secondary to other eye disorders, left eye, moderate stage",,
H4052X3,"Glaucoma secondary to other eye disorders, left eye, severe stage",,
H4052X3,"Glaucoma secondary to other eye disorders, left eye, severe stage",,
H4052X4,"Glaucoma secondary to other eye disorders, left eye, indeterminate stage",,
H4053X0,"Glaucoma secondary to other eye disorders, bilateral, stage unspecified",,
H4053X1,"Glaucoma secondary to other eye disorders, bilateral, mild stage",,
H4053X2,"Glaucoma secondary to other eye disorders, bilateral, moderate stage",,
H4053X2,"Glaucoma secondary to other eye disorders, bilateral, moderate stage",,
H4053X3,"Glaucoma secondary to other eye disorders, bilateral, severe stage",,
H4053X3,"Glaucoma secondary to other eye disorders, bilateral, severe stage",,
H4053X4,"Glaucoma secondary to other eye disorders, bilateral, indeterminate stage",,
H4060X0,"Glaucoma secondary to drugs, unspecified eye, stage unspecified",,
H4060X1,"Glaucoma secondary to drugs, unspecified eye, mild stage",,
H4060X2,"Glaucoma secondary to drugs, unspecified eye, moderate stage",,
H4060X2,"Glaucoma secondary to drugs, unspecified eye, moderate stage",,
H4060X3,"Glaucoma secondary to drugs, unspecified eye, severe stage",,
H4060X3,"Glaucoma secondary to drugs, unspecified eye, severe stage",,
H4060X4,"Glaucoma secondary to drugs, unspecified eye, indeterminate stage",,
H4061X0,"Glaucoma secondary to drugs, right eye, stage unspecified",,
H4061X1,"Glaucoma secondary to drugs, right eye, mild stage",,
H4061X2,"Glaucoma secondary to drugs, right eye, moderate stage",,
H4061X2,"Glaucoma secondary to drugs, right eye, moderate stage",,
H4061X3,"Glaucoma secondary to drugs, right eye, severe stage",,
H4061X3,"Glaucoma secondary to drugs, right eye, severe stage",,
H4061X4,"Glaucoma secondary to drugs, right eye, indeterminate stage",,
H4062X0,"Glaucoma secondary to drugs, left eye, stage unspecified",,
H4062X1,"Glaucoma secondary to drugs, left eye, mild stage",,
H4062X2,"Glaucoma secondary to drugs, left eye, moderate stage",,
H4062X2,"Glaucoma secondary to drugs, left eye, moderate stage",,
H4062X3,"Glaucoma secondary to drugs, left eye, severe stage",,
H4062X3,"Glaucoma secondary to drugs, left eye, severe stage",,
H4062X4,"Glaucoma secondary to drugs, left eye, indeterminate stage",,
H4063X0,"Glaucoma secondary to drugs, bilateral, stage unspecified",,
H4063X1,"Glaucoma secondary to drugs, bilateral, mild stage",,
H4063X2,"Glaucoma secondary to drugs, bilateral, moderate stage",,
H4063X2,"Glaucoma secondary to drugs, bilateral, moderate stage",,
H4063X3,"Glaucoma secondary to drugs, bilateral, severe stage",,
H4063X3,"Glaucoma secondary to drugs, bilateral, severe stage",,
H4063X4,"Glaucoma secondary to drugs, bilateral, indeterminate stage",,
H40811,"Glaucoma with increased episcleral venous pressure, right eye",,
H40812,"Glaucoma with increased episcleral venous pressure, left eye",,
H40813,"Glaucoma with increased episcleral venous pressure, bilateral",,
H40819,"Glaucoma with increased episcleral venous pressure, unspecified eye",,
H40821,"Hypersecretion glaucoma, right eye",,
H40822,"Hypersecretion glaucoma, left eye",,
H40823,"Hypersecretion glaucoma, bilateral",,
H40829,"Hypersecretion glaucoma, unspecified eye",,
H40831,"Aqueous misdirection, right eye",,
H40832,"Aqueous misdirection, left eye",,
H40833,"Aqueous misdirection, bilateral",,
H40839,"Aqueous misdirection, unspecified eye",,
H4089,Other specified glaucoma,,
H409,Unspecified glaucoma,,
H42,Glaucoma in diseases classified elsewhere,,
H4310,"Vitreous hemorrhage, unspecified eye",298,C6990 (27%); I629 (26%); I609 (26%); I619 (25%); I6200 (24%)
H4311,"Vitreous hemorrhage, right eye",298,C6991 (26%); S06340A (23%); H36821 (22%); K9401 (21%); K9421 (21%)
H4312,"Vitreous hemorrhage, left eye",298,C6992 (26%); S06350A (23%); H36822 (22%); K9401 (21%); K9421 (21%)
H4313,"Vitreous hemorrhage, bilateral",298,I69265 (30%); I69065 (29%); I69165 (29%); K9401 (22%); K9421 (22%)
H49811,"Kearns-Sayre syndrome, right eye",,
H49812,"Kearns-Sayre syndrome, left eye",,
H49813,"Kearns-Sayre syndrome, bilateral",,
H49819,"Kearns-Sayre syndrome, unspecified eye",,
I0981,Rheumatic heart failure,226,I50811 (54%); T8622 (52%); I50813 (50%); I5084 (47%); T8632 (45%)
I10,Essential (primary) hypertension,,
I110,Hypertensive heart disease with heart failure,226,I50811 (63%); I1311 (62%); I132 (62%); T8622 (61%); I50813 (58%)
I119,Hypertensive heart disease without heart failure,,
I120,Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease,326,I132 (90%); N1830 (85%); I130 (84%); N184 (77%); N1831 (64%)
I120,Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease,,
I129,"Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease",,
I130,"Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease",226,I1311 (92%); I132 (92%); N185 (87%); N1830 (86%); I120 (84%)
I130,"Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease",,
I1310,"Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease",,
I1311,"Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease",326,I132 (100%); I130 (92%); N1830 (76%); N184 (69%); I110 (62%)
I1311,"Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease",,
I132,"Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease",226,I1311 (100%); I132 (100%); I120 (90%); N185 (78%); N1830 (76%)
I132,"Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease",326,I132 (100%); I130 (92%); N1830 (76%); N184 (69%); I110 (62%)
I150,Renovascular hypertension,,
I151,Hypertension secondary to other renal disorders,,
I152,Hypertension secondary to endocrine disorders,,
I158,Other secondary hypertension,,
I159,"Secondary hypertension, unspecified",,
I160,Hypertensive urgency,,
I161,Hypertensive emergency,,
I169,"Hypertensive crisis, unspecified",,
I1A0,Resistant hypertension,,
I200,Unstable angina,229,S1202XB (30%); S1202XA (30%); S22012B (29%); S22032B (29%); S32012B (29%)
I201,Angina pectoris with documented spasm,,
I202,Refractory angina pectoris,,
I208,Other forms of angina pectoris,,
I2081,Angina pectoris with coronary microvascular dysfunction,,
I2089,Other forms of angina pectoris,,
I209,"Angina pectoris, unspecified",,
I2101,ST elevation (STEMI) myocardial infarction involving left main coronary artery,228,I240 (37%); C3402 (31%); C3400 (28%); C3401 (27%); I25720 (25%)
I2102,ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery,228,I240 (35%); I63422 (30%); I63322 (30%); I63429 (27%); I63329 (27%)
I2109,ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall,228,I240 (37%); I63429 (28%); I63329 (28%); I63422 (28%); I63421 (28%)
I2111,ST elevation (STEMI) myocardial infarction involving right coronary artery,228,I240 (40%); I25720 (27%); I238 (27%); I63131 (27%); I63031 (27%)
I2119,ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall,228,I240 (35%); I25720 (24%); I238 (24%); I233 (23%); I515 (21%)
I2121,ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery,228,I240 (36%); I25720 (24%); I238 (24%); I63132 (24%); I63032 (24%)
I2129,ST elevation (STEMI) myocardial infarction involving other sites,228,I238 (30%); I515 (27%); I240 (26%); I230 (25%); M341 (24%)
I213,ST elevation (STEMI) myocardial infarction of unspecified site,228,I238 (31%); I515 (28%); I240 (27%); I230 (26%); M341 (25%)
I214,Non-ST elevation (NSTEMI) myocardial infarction,228,I238 (30%); I515 (27%); I240 (26%); I230 (25%); M341 (25%)
I219,"Acute myocardial infarction, unspecified",228,I238 (67%); I240 (58%); I230 (56%); I235 (47%); I515 (46%)
I21A1,Myocardial infarction type 2,228,I238 (55%); I515 (50%); I240 (48%); I230 (46%); I6389 (39%)
I21A9,Other myocardial infarction type,228,I238 (55%); I515 (50%); I240 (48%); I230 (46%); I6389 (39%)
I21B,Myocardial infarction with coronary microvascular dysfunction,228,I2481 (79%); I240 (48%); I238 (32%); I515 (29%); I230 (27%)
I220,Subsequent ST elevation (STEMI) myocardial infarction of anterior wall,228,C673 (29%); C113 (28%); I238 (27%); I233 (27%); S32413B (27%)
I221,Subsequent ST elevation (STEMI) myocardial infarction of inferior wall,228,I238 (26%); I233 (26%); I515 (24%); I240 (22%); I82221 (22%)
I222,Subsequent non-ST elevation (NSTEMI) myocardial infarction,228,I238 (28%); I515 (26%); I240 (25%); I230 (24%); M341 (23%)
I228,Subsequent ST elevation (STEMI) myocardial infarction of other sites,228,I238 (29%); I515 (27%); I240 (26%); I230 (25%); M341 (24%)
I229,Subsequent ST elevation (STEMI) myocardial infarction of unspecified site,228,I238 (29%); I515 (27%); I240 (25%); I230 (24%); M341 (24%)
I230,Hemopericardium as current complication following acute myocardial infarction,229,I219 (56%); I21A1 (46%); I21A9 (46%); I515 (27%); I21B (27%)
I231,Atrial septal defect as current complication following acute myocardial infarction,229,I219 (45%); I21A1 (38%); I21A9 (38%); I4891 (25%); I4892 (24%)
I232,Ventricular septal defect as current complication following acute myocardial infarction,229,I219 (45%); I21A1 (37%); I21A9 (37%); I501 (29%); I4901 (27%)
I233,Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction,229,I219 (44%); I21A1 (36%); I21A9 (36%); I462 (30%); I220 (27%)
I234,Rupture of chordae tendineae as current complication following acute myocardial infarction,229,I219 (45%); I21A1 (37%); I21A9 (37%); I515 (22%); I21B (21%)
I235,Rupture of papillary muscle as current complication following acute myocardial infarction,229,I219 (47%); I21A1 (39%); I21A9 (39%); I515 (23%); I21B (23%)
I236,"Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction",229,I219 (40%); I21A1 (33%); I21A9 (33%); C715 (30%); I515 (19%)
I237,Postinfarction angina,229,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
I238,Other current complications following acute myocardial infarction,229,I219 (67%); I21A1 (55%); I21A9 (55%); I515 (33%); I21B (32%)
I240,Acute coronary thrombosis not resulting in myocardial infarction,229,I219 (58%); I21A1 (48%); I21A9 (48%); I21B (48%); I2111 (40%)
I241,Dressler's syndrome,229,E340 (26%); G839 (25%); G8382 (23%); G8383 (23%); D469 (20%)
I248,Other forms of acute ischemic heart disease,229,B4489 (41%); B458 (41%); I50811 (37%); I279 (36%); I110 (36%)
I2481,Acute coronary microvascular dysfunction,229,I21B (79%); E318 (28%); E319 (27%); T463X2A (24%); J4A8 (24%)
I2489,Other forms of acute ischemic heart disease,229,B4489 (41%); B458 (41%); I50811 (37%); I279 (36%); I110 (36%)
I249,"Acute ischemic heart disease, unspecified",229,I279 (47%); I50811 (45%); I110 (43%); I50813 (41%); M05359 (36%)
I2510,Atherosclerotic heart disease of native coronary artery without angina pectoris,,
I25110,Atherosclerotic heart disease of native coronary artery with unstable angina pectoris,229,I279 (25%); I110 (25%); I2111 (20%); I271 (20%); I1311 (19%)
I25111,Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm,,
I25112,Atherosclerotic heart disease of native coronary artery with refractory angina pectoris,,
I25118,Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris,,
I25119,Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris,,
I252,Old myocardial infarction,,
I253,Aneurysm of heart,,
I2541,Coronary artery aneurysm,,
I2542,Coronary artery dissection,,
I255,Ischemic cardiomyopathy,,
I256,Silent myocardial ischemia,,
I25700,"Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris",229,I7035 (34%); I7035 (34%); I7075 (32%); I7075 (32%); I70349 (32%)
I25701,"Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm",,
I25702,"Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris",,
I25708,"Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris",,
I25709,"Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris",,
I25710,Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris,229,I7045 (50%); I7045 (50%); I70443 (46%); I70443 (46%); I70433 (46%)
I25711,Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm,,
I25712,Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris,,
I25718,Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris,,
I25719,Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris,,
I25720,Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris,229,I7045 (37%); I7045 (37%); I70443 (35%); I70443 (35%); I70433 (35%)
I25721,Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm,,
I25722,Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris,,
I25728,Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris,,
I25729,Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris,,
I25730,Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris,229,I7055 (52%); I7055 (52%); I70543 (49%); I70543 (49%); I70533 (49%)
I25731,Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm,,
I25732,Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris,,
I25738,Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris,,
I25739,Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris,,
I25750,Atherosclerosis of native coronary artery of transplanted heart with unstable angina,229,C802 (30%); I7025 (26%); I7025 (26%); I70243 (25%); I70243 (25%)
I25751,Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm,,
I25752,Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris,,
I25758,Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris,,
I25759,Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris,,
I25760,Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina,229,I7075 (31%); I7075 (31%); I7035 (30%); I7035 (30%); C802 (29%)
I25761,Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm,,
I25762,Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris,,
I25768,Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris,,
I25769,Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris,,
I25790,Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris,229,I7075 (33%); I7075 (33%); I7035 (32%); I7035 (32%); I70743 (30%)
I25791,Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm,,
I25792,Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris,,
I25798,Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris,,
I25799,Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris,,
I25810,Atherosclerosis of coronary artery bypass graft(s) without angina pectoris,,
I25811,Atherosclerosis of native coronary artery of transplanted heart without angina pectoris,,
I25812,Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris,,
I2582,Chronic total occlusion of coronary artery,,
I2583,Coronary atherosclerosis due to lipid rich plaque,,
I2584,Coronary atherosclerosis due to calcified coronary lesion,,
I2585,Chronic coronary microvascular dysfunction,,
I2589,Other forms of chronic ischemic heart disease,,
I259,"Chronic ischemic heart disease, unspecified",,
I2601,Septic pulmonary embolism with acute cor pulmonale,267,I2781 (62%); I76 (43%); J810 (40%); R6520 (29%); R6521 (29%)
I2601,Septic pulmonary embolism with acute cor pulmonale,,
I2602,Saddle embolus of pulmonary artery with acute cor pulmonale,267,I2781 (54%); I7401 (51%); J810 (35%); I281 (31%); J441 (20%)
I2602,Saddle embolus of pulmonary artery with acute cor pulmonale,,
I2609,Other pulmonary embolism with acute cor pulmonale,267,I2781 (72%); J810 (46%); J441 (27%); I279 (27%); I2720 (27%)
I2609,Other pulmonary embolism with acute cor pulmonale,,
I2690,Septic pulmonary embolism without acute cor pulmonale,267,I2781 (62%); I76 (43%); J810 (40%); R6520 (29%); R6521 (29%)
I2692,Saddle embolus of pulmonary artery without acute cor pulmonale,267,I2781 (54%); I7401 (51%); J810 (35%); I281 (31%); J441 (20%)
I2693,Single subsegmental pulmonary embolism without acute cor pulmonale,267,I2781 (54%); J810 (35%); F321 (22%); J441 (20%); I279 (20%)
I2694,Multiple subsegmental pulmonary emboli without acute cor pulmonale,267,I2781 (53%); J810 (34%); M8619 (27%); M8609 (22%); J441 (20%)
I2699,Other pulmonary embolism without acute cor pulmonale,267,I2781 (72%); J810 (46%); J441 (27%); I279 (27%); I2720 (27%)
I270,Primary pulmonary hypertension,226,C801 (45%); K766 (37%); I2782 (36%); D6949 (36%); J810 (36%)
I271,Kyphoscoliotic heart disease,226,I249 (35%); I1311 (34%); I132 (34%); C380 (33%); M05359 (33%)
I2720,"Pulmonary hypertension, unspecified",226,K766 (45%); I2782 (44%); J8410 (43%); J810 (43%); J849 (40%)
I2721,Secondary pulmonary arterial hypertension,226,I76 (41%); I7409 (36%); K766 (31%); I2782 (31%); J810 (30%)
I2722,Pulmonary hypertension due to left heart disease,226,J849 (42%); J449 (39%); J4489 (37%); M05352 (37%); M05312 (36%)
I2723,Pulmonary hypertension due to lung diseases and hypoxia,226,J8489 (38%); J84178 (38%); J9691 (35%); J9611 (33%); J9601 (33%)
I2724,Chronic thromboembolic pulmonary hypertension,226,I2782 (43%); I87319 (32%); I87312 (31%); I87311 (31%); K766 (31%)
I2729,Other secondary pulmonary hypertension,226,K766 (40%); I2782 (39%); J810 (38%); J8410 (34%); B441 (34%)
I2781,Cor pulmonale (chronic),226,I2609 (72%); I2699 (72%); I2601 (62%); I2690 (62%); I2693 (54%)
I2782,Chronic pulmonary embolism,267,J449 (50%); J810 (48%); J4489 (48%); I279 (45%); I2720 (44%)
I2783,Eisenmenger's syndrome,226,E340 (26%); G839 (25%); G8382 (23%); G8383 (23%); D469 (20%)
I2789,Other specified pulmonary heart diseases,226,J8489 (66%); J84178 (52%); G9589 (47%); J4489 (41%); I2782 (40%)
I279,"Pulmonary heart disease, unspecified",226,J849 (59%); J449 (53%); I249 (47%); J4489 (47%); I2782 (45%)
I280,Arteriovenous fistula of pulmonary vessels,226,K50913 (30%); J860 (28%); J869 (28%); I2782 (28%); K51813 (27%)
I281,Aneurysm of pulmonary artery,226,I2782 (39%); J810 (38%); I718 (35%); I7110 (35%); J8410 (34%)
I288,Other diseases of pulmonary vessels,226,J8489 (50%); J84178 (50%); I2782 (38%); J810 (38%); I80299 (34%)
I289,"Disease of pulmonary vessels, unspecified",226,J849 (52%); J449 (47%); J4489 (41%); I80209 (39%); I2782 (39%)
I3131,Malignant pericardial effusion in diseases classified elsewhere,17,G914 (35%); M9058 (34%); M9050 (34%); M90519 (34%); M90549 (33%)
I420,Dilated cardiomyopathy,227,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
I421,Obstructive hypertrophic cardiomyopathy,227,G911 (43%); J449 (38%); J4489 (37%); Q400 (34%); J441 (30%)
I422,Other hypertrophic cardiomyopathy,227,Q400 (42%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
I423,Endomyocardial (eosinophilic) disease,227,J8281 (48%); G959 (17%); I120 (15%); G20 (14%); G308 (14%)
I424,Endocardial fibroelastosis,227,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
I425,Other restrictive cardiomyopathy,227,J4A0 (51%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
I426,Alcoholic cardiomyopathy,227,K7010 (42%); K7011 (42%); K7040 (41%); K7041 (41%); K7030 (37%)
I427,Cardiomyopathy due to drug and external agent,,
I428,Other cardiomyopathies,227,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
I429,"Cardiomyopathy, unspecified",227,G8330 (14%); L97909 (13%); G8190 (13%); C8510 (13%); M08959 (13%)
I43,Cardiomyopathy in diseases classified elsewhere,227,G914 (50%); M9058 (50%); M9050 (48%); M90519 (48%); M90549 (48%)
I442,"Atrioventricular block, complete",238,G8221 (19%); K56691 (17%); S98319A (16%); S98312A (16%); S98311A (16%)
I462,Cardiac arrest due to underlying cardiac condition,213,P290 (52%); T86290 (44%); R092 (33%); I233 (30%); T460X2A (29%)
I468,Cardiac arrest due to other underlying condition,213,R092 (47%); P2881 (41%); P290 (37%); R402A (36%); E089 (36%)
I469,"Cardiac arrest, cause unspecified",213,R092 (44%); K56601 (39%); P2881 (39%); K56600 (38%); P290 (35%)
I470,Re-entry ventricular arrhythmia,238,I501 (38%); I4901 (36%); I4902 (35%); I232 (20%); A0104 (0%)
I471,Supraventricular tachycardia,,
I4710,"Supraventricular tachycardia, unspecified",,
I4711,"Inappropriate sinus tachycardia, so stated",,
I4719,Other supraventricular tachycardia,,
I4720,"Ventricular tachycardia, unspecified",238,I501 (53%); I4901 (47%); I4902 (45%); I232 (25%); G8330 (9%)
I4721,Torsades de pointes,238,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
I4729,Other ventricular tachycardia,238,I501 (50%); I4901 (47%); I4902 (46%); I232 (26%); A0104 (0%)
I479,"Paroxysmal tachycardia, unspecified",238,D595 (29%); G8330 (9%); L97909 (8%); G8190 (8%); C8510 (8%)
I480,Paroxysmal atrial fibrillation,238,I4901 (40%); D595 (26%); I231 (20%); A0104 (0%); A0105 (0%)
I4811,Longstanding persistent atrial fibrillation,238,I4901 (34%); K730 (30%); J4550 (26%); K713 (25%); R403 (24%)
I4819,Other persistent atrial fibrillation,238,I4901 (41%); K730 (36%); J4550 (31%); K713 (30%); R403 (30%)
I4820,"Chronic atrial fibrillation, unspecified",238,I4901 (47%); I231 (24%); M8660 (20%); M86619 (20%); M86649 (19%)
I4821,Permanent atrial fibrillation,238,I4901 (38%); I231 (19%); A0104 (0%); A0105 (0%); A021 (0%)
I483,Typical atrial flutter,238,I4902 (41%); I231 (19%); A0104 (0%); A0105 (0%); A021 (0%)
I484,Atypical atrial flutter,238,I4902 (45%); M84756A (26%); M84755A (26%); M84754A (26%); A819 (26%)
I4891,Unspecified atrial fibrillation,238,I4901 (50%); I231 (25%); G8330 (10%); L97909 (9%); G8190 (9%)
I4892,Unspecified atrial flutter,238,I4902 (52%); I231 (24%); G8330 (9%); L97909 (9%); G8190 (9%)
I4901,Ventricular fibrillation,213,I501 (53%); I4891 (50%); I4729 (47%); I4820 (47%); I4720 (47%)
I4902,Ventricular flutter,213,I4892 (52%); I501 (51%); I4729 (46%); I4720 (45%); I484 (45%)
I492,Junctional premature depolarization,238,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
I495,Sick sinus syndrome,238,C310 (30%); M86459 (28%); C312 (28%); M86452 (28%); M86451 (28%)
I501,"Left ventricular failure, unspecified",226,I4720 (53%); I4901 (53%); I4902 (51%); I4729 (50%); I470 (38%)
I5020,Unspecified systolic (congestive) heart failure,226,I5021 (93%); I5023 (90%); I5041 (80%); I5043 (78%); I5031 (61%)
I5021,Acute systolic (congestive) heart failure,225,I5023 (96%); I5020 (93%); I5022 (91%); I5043 (82%); I5040 (78%)
I5022,Chronic systolic (congestive) heart failure,226,I5023 (94%); I5021 (91%); I5043 (81%); I5041 (78%); I5033 (65%)
I5023,Acute on chronic systolic (congestive) heart failure,224,I5021 (96%); I5022 (94%); I5020 (90%); I5041 (80%); I5042 (79%)
I5030,Unspecified diastolic (congestive) heart failure,226,I5031 (93%); I5033 (90%); I5041 (80%); I5043 (78%); I5021 (61%)
I5031,Acute diastolic (congestive) heart failure,225,I5033 (96%); I5030 (93%); I5032 (91%); I5043 (82%); I5040 (78%)
I5032,Chronic diastolic (congestive) heart failure,226,I5033 (94%); I5031 (91%); I5043 (81%); I5041 (78%); I5023 (65%)
I5033,Acute on chronic diastolic (congestive) heart failure,224,I5031 (96%); I5032 (94%); I5030 (90%); I5041 (80%); I5042 (79%)
I5040,Unspecified combined systolic (congestive) and diastolic (congestive) heart failure,226,I5041 (97%); I5043 (95%); I5021 (78%); I5031 (78%); I5023 (75%)
I5041,Acute combined systolic (congestive) and diastolic (congestive) heart failure,225,I5043 (98%); I5040 (97%); I5042 (96%); I5023 (80%); I5033 (80%)
I5042,Chronic combined systolic (congestive) and diastolic (congestive) heart failure,226,I5043 (97%); I5041 (96%); I5023 (79%); I5033 (79%); I5021 (77%)
I5043,Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure,224,I5041 (98%); I5042 (97%); I5040 (95%); I5021 (82%); I5031 (82%)
I50810,"Right heart failure, unspecified",226,I50811 (85%); I50813 (79%); T8622 (72%); I5084 (66%); T8632 (63%)
I50811,Acute right heart failure,225,I50814 (85%); I50810 (85%); I5089 (82%); I50812 (80%); I509 (79%)
I50812,Chronic right heart failure,226,I50813 (89%); I50811 (80%); T8622 (68%); I5084 (62%); T8632 (60%)
I50813,Acute on chronic right heart failure,225,I50812 (89%); I50814 (79%); I50810 (79%); I5089 (77%); I509 (74%)
I50814,Right heart failure due to left heart failure,226,I50811 (85%); I50813 (79%); T8622 (77%); I5084 (70%); T8632 (68%)
I5082,Biventricular heart failure,226,I50811 (54%); T8622 (52%); I50813 (50%); I5084 (47%); T8632 (45%)
I5083,High output heart failure,226,I50811 (44%); T8622 (42%); I50813 (41%); I5084 (39%); T8632 (37%)
I5084,End stage heart failure,222,I5089 (72%); I50814 (70%); I509 (70%); I50810 (66%); I50812 (62%)
I5089,Other heart failure,226,I50811 (82%); T8622 (80%); I50813 (77%); I5084 (72%); T8632 (70%)
I509,"Heart failure, unspecified",226,I50811 (79%); T8622 (77%); I50813 (74%); I5084 (70%); T8632 (67%)
I511,"Rupture of chordae tendineae, not elsewhere classified",229,I96 (19%); K738 (16%); G914 (15%); M9058 (15%); M9050 (15%)
I512,"Rupture of papillary muscle, not elsewhere classified",229,L98423 (21%); I96 (21%); L97303 (19%); L97503 (19%); L97323 (19%)
I514,"Myocarditis, unspecified",227,G8330 (11%); L97909 (11%); G8190 (11%); C8510 (11%); M08959 (11%)
I515,Myocardial degeneration,227,I21A1 (50%); I21A9 (50%); I219 (46%); G232 (43%); G320 (33%)
I6000,Nontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation,248,I69069 (38%); I69049 (37%); I69039 (37%); I69065 (37%); I69059 (36%)
I6001,Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation,248,I69061 (37%); I69065 (36%); I69041 (36%); I69069 (36%); I69031 (35%)
I6002,Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation,248,I69062 (37%); I69065 (36%); I69042 (36%); I69069 (36%); I69032 (35%)
I6010,Nontraumatic subarachnoid hemorrhage from unspecified middle cerebral artery,248,I63419 (62%); I63319 (62%); I63412 (59%); I63411 (59%); I63312 (59%)
I6011,Nontraumatic subarachnoid hemorrhage from right middle cerebral artery,248,I63411 (62%); I63311 (62%); I63419 (59%); I63319 (59%); I63412 (58%)
I6012,Nontraumatic subarachnoid hemorrhage from left middle cerebral artery,248,I63412 (62%); I63312 (62%); I63419 (59%); I63319 (59%); I63411 (58%)
I602,Nontraumatic subarachnoid hemorrhage from anterior communicating artery,248,G910 (43%); I69065 (42%); I69069 (42%); I69049 (41%); I69039 (40%)
I6030,Nontraumatic subarachnoid hemorrhage from unspecified posterior communicating artery,248,I69069 (43%); I69049 (42%); G910 (42%); I69039 (42%); I69065 (42%)
I6031,Nontraumatic subarachnoid hemorrhage from right posterior communicating artery,248,G910 (42%); I69061 (41%); I69065 (41%); I69041 (41%); I69069 (41%)
I6032,Nontraumatic subarachnoid hemorrhage from left posterior communicating artery,248,G910 (42%); I69062 (41%); I69065 (41%); I69042 (41%); I69069 (41%)
I604,Nontraumatic subarachnoid hemorrhage from basilar artery,248,I6312 (55%); I6302 (54%); I6322 (47%); I69065 (45%); I69069 (45%)
I6050,Nontraumatic subarachnoid hemorrhage from unspecified vertebral artery,248,I63119 (51%); I63019 (51%); I69069 (49%); I69049 (48%); I69039 (47%)
I6051,Nontraumatic subarachnoid hemorrhage from right vertebral artery,248,I63111 (52%); I63011 (52%); I63119 (47%); I63019 (47%); I69061 (47%)
I6052,Nontraumatic subarachnoid hemorrhage from left vertebral artery,248,I63112 (52%); I63012 (52%); I63119 (47%); I63019 (47%); I69062 (47%)
I606,Nontraumatic subarachnoid hemorrhage from other intracranial arteries,248,I69065 (50%); I69069 (49%); I69265 (48%); I69049 (48%); I69269 (47%)
I607,Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery,248,I69069 (52%); I69049 (51%); I69269 (50%); I69039 (50%); I69065 (50%)
I608,Other nontraumatic subarachnoid hemorrhage,248,I69065 (66%); I69069 (65%); I69049 (64%); I69039 (63%); I69059 (62%)
I609,"Nontraumatic subarachnoid hemorrhage, unspecified",248,I69069 (67%); I69049 (66%); I69039 (65%); I69065 (64%); I69059 (64%)
I610,"Nontraumatic intracerebral hemorrhage in hemisphere, subcortical",248,I69165 (41%); I69169 (41%); I69149 (40%); I69139 (39%); I69159 (39%)
I611,"Nontraumatic intracerebral hemorrhage in hemisphere, cortical",248,I69165 (41%); I69169 (40%); I69149 (39%); I69139 (39%); I69159 (38%)
I612,"Nontraumatic intracerebral hemorrhage in hemisphere, unspecified",248,I69169 (51%); I69149 (50%); I69139 (49%); I69165 (49%); I69159 (49%)
I613,Nontraumatic intracerebral hemorrhage in brain stem,248,C717 (64%); I69165 (46%); I69169 (45%); I69149 (45%); I69139 (44%)
I614,Nontraumatic intracerebral hemorrhage in cerebellum,248,I69165 (53%); I69169 (52%); I69149 (51%); I69139 (51%); I69159 (50%)
I615,"Nontraumatic intracerebral hemorrhage, intraventricular",248,I69165 (52%); I69169 (51%); I69149 (50%); I69139 (49%); I69159 (49%)
I616,"Nontraumatic intracerebral hemorrhage, multiple localized",248,I69165 (47%); I69169 (46%); I69149 (45%); I69139 (45%); I69159 (44%)
I618,Other nontraumatic intracerebral hemorrhage,248,I69165 (67%); I69169 (66%); I69149 (65%); I69139 (64%); I69159 (63%)
I619,"Nontraumatic intracerebral hemorrhage, unspecified",248,I69169 (68%); I69149 (67%); I69139 (66%); I69165 (66%); I69159 (65%)
I6200,"Nontraumatic subdural hemorrhage, unspecified",248,S065X0A (58%); S065X9A (53%); S065X1A (47%); S065XAA (47%); S065X3A (41%)
I6201,Nontraumatic acute subdural hemorrhage,248,S065X0A (54%); S065X9A (46%); S065X1A (44%); S065XAA (44%); S065X3A (38%)
I6202,Nontraumatic subacute subdural hemorrhage,248,S065X0A (50%); S065X9A (43%); S065X1A (40%); S065XAA (40%); M86259 (38%)
I6203,Nontraumatic chronic subdural hemorrhage,248,S065X0A (55%); S065X9A (48%); S065X1A (45%); S065XAA (45%); S065X3A (39%)
I621,Nontraumatic extradural hemorrhage,248,I69265 (30%); I69065 (30%); I69269 (30%); I69165 (30%); I69069 (30%)
I629,"Nontraumatic intracranial hemorrhage, unspecified",248,I69269 (66%); I69249 (65%); I69239 (64%); I69265 (64%); I69259 (63%)
I6300,Cerebral infarction due to thrombosis of unspecified precerebral artery,249,I749 (48%); I745 (34%); I69369 (32%); I69349 (31%); I6010 (31%)
I63011,Cerebral infarction due to thrombosis of right vertebral artery,249,I6051 (52%); I6050 (47%); I6052 (47%); I749 (45%); C412 (36%)
I63012,Cerebral infarction due to thrombosis of left vertebral artery,249,I6052 (52%); I6050 (47%); I6051 (47%); I749 (45%); C412 (36%)
I63013,Cerebral infarction due to thrombosis of bilateral vertebral arteries,249,I748 (47%); I69365 (42%); I744 (39%); I743 (37%); I742 (36%)
I63019,Cerebral infarction due to thrombosis of unspecified vertebral artery,249,I6050 (51%); I749 (50%); I6052 (47%); I6051 (47%); C412 (36%)
I6302,Cerebral infarction due to thrombosis of basilar artery,249,I604 (54%); I749 (43%); I745 (34%); I69365 (30%); I69369 (29%)
I63031,Cerebral infarction due to thrombosis of right carotid artery,249,I749 (46%); I745 (36%); S06810A (35%); I6011 (35%); C754 (33%)
I63032,Cerebral infarction due to thrombosis of left carotid artery,249,I749 (46%); I745 (36%); S06820A (35%); I6012 (35%); C754 (34%)
I63033,Cerebral infarction due to thrombosis of bilateral carotid arteries,249,I748 (48%); I69365 (44%); I744 (40%); I743 (38%); I742 (37%)
I63039,Cerebral infarction due to thrombosis of unspecified carotid artery,249,I749 (51%); I745 (37%); I69369 (35%); C754 (34%); I69349 (34%)
I6309,Cerebral infarction due to thrombosis of other precerebral artery,249,I749 (44%); I745 (35%); I69365 (30%); I69369 (30%); I69349 (29%)
I6310,Cerebral infarction due to embolism of unspecified precerebral artery,249,I749 (47%); I745 (34%); I69369 (32%); I69349 (31%); I6010 (31%)
I63111,Cerebral infarction due to embolism of right vertebral artery,249,I6051 (52%); I6050 (47%); I6052 (47%); I749 (45%); C412 (36%)
I63112,Cerebral infarction due to embolism of left vertebral artery,249,I6052 (52%); I6050 (47%); I6051 (47%); I749 (45%); C412 (36%)
I63113,Cerebral infarction due to embolism of bilateral vertebral arteries,249,I748 (47%); I69365 (42%); I744 (38%); I743 (37%); I742 (36%)
I63119,Cerebral infarction due to embolism of unspecified vertebral artery,249,I6050 (51%); I749 (50%); I6052 (47%); I6051 (47%); C412 (36%)
I6312,Cerebral infarction due to embolism of basilar artery,249,I604 (55%); I749 (43%); I745 (34%); I69365 (30%); I69369 (29%)
I63131,Cerebral infarction due to embolism of right carotid artery,249,I749 (46%); I745 (36%); S06810A (35%); I6011 (35%); C754 (34%)
I63132,Cerebral infarction due to embolism of left carotid artery,249,I749 (46%); I745 (36%); S06820A (35%); I6012 (35%); C754 (34%)
I63133,Cerebral infarction due to embolism of bilateral carotid arteries,249,I748 (48%); I69365 (44%); I744 (40%); I743 (38%); I742 (37%)
I63139,Cerebral infarction due to embolism of unspecified carotid artery,249,I749 (51%); I745 (37%); I69369 (35%); C754 (34%); I69349 (34%)
I6319,Cerebral infarction due to embolism of other precerebral artery,249,I749 (44%); I745 (34%); I69365 (30%); I69369 (30%); I69349 (29%)
I6320,Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries,249,I69369 (29%); I69349 (29%); I69339 (28%); I69359 (28%); I744 (25%)
I63211,Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery,249,I6051 (45%); I6050 (43%); I6052 (40%); C412 (31%); I6011 (29%)
I63212,Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery,249,I6052 (45%); I6050 (43%); I6051 (40%); C412 (31%); I6012 (29%)
I63213,Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries,249,I69365 (37%); C412 (29%); H348132 (28%); H348130 (28%); I6050 (27%)
I63219,Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery,249,I6050 (45%); I6052 (40%); I6051 (40%); I69369 (31%); C412 (30%)
I6322,Cerebral infarction due to unspecified occlusion or stenosis of basilar artery,249,I604 (47%); I69369 (28%); I69349 (27%); I6010 (27%); I69339 (27%)
I63231,Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries,249,I69369 (29%); C754 (28%); I69361 (28%); I69349 (28%); I69341 (27%)
I63232,Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries,249,I69369 (29%); C754 (28%); I69362 (28%); I69349 (28%); I69342 (27%)
I63233,Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries,249,I69365 (38%); H348132 (29%); H348130 (28%); I69369 (28%); C754 (27%)
I63239,Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery,249,I69369 (31%); I69349 (31%); I6010 (30%); I69339 (30%); I69359 (30%)
I6329,Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries,249,I69369 (28%); I69349 (27%); I69339 (26%); I69359 (26%); I69365 (26%)
I6330,Cerebral infarction due to thrombosis of unspecified cerebral artery,249,G936 (54%); I749 (47%); I69369 (46%); I69349 (44%); I69365 (43%)
I63311,Cerebral infarction due to thrombosis of right middle cerebral artery,249,I6011 (62%); I6010 (59%); I6012 (58%); G936 (48%); I69361 (38%)
I63312,Cerebral infarction due to thrombosis of left middle cerebral artery,249,I6012 (62%); I6010 (59%); I6011 (58%); G936 (48%); I69362 (38%)
I63313,Cerebral infarction due to thrombosis of bilateral middle cerebral arteries,249,I69365 (48%); G936 (46%); I6010 (44%); I6012 (44%); I6011 (44%)
I63319,Cerebral infarction due to thrombosis of unspecified middle cerebral artery,249,I6010 (62%); I6012 (59%); I6011 (59%); G936 (48%); I749 (41%)
I63321,Cerebral infarction due to thrombosis of right anterior cerebral artery,249,G936 (50%); I6011 (41%); I69361 (40%); I69365 (40%); I69341 (39%)
I63322,Cerebral infarction due to thrombosis of left anterior cerebral artery,249,G936 (50%); I6012 (41%); I69362 (40%); I69365 (40%); I69342 (39%)
I63323,Cerebral infarction due to thrombosis of bilateral anterior cerebral arteries,249,I69365 (50%); G936 (48%); I748 (41%); I69369 (37%); I69349 (36%)
I63329,Cerebral infarction due to thrombosis of unspecified anterior cerebral artery,249,G936 (50%); I749 (43%); I69369 (42%); I69349 (41%); I69365 (40%)
I63331,Cerebral infarction due to thrombosis of right posterior cerebral artery,249,G936 (50%); I6011 (41%); I69361 (40%); I69365 (40%); I69341 (39%)
I63332,Cerebral infarction due to thrombosis of left posterior cerebral artery,249,G936 (50%); I6012 (41%); I69362 (40%); I69365 (40%); I69342 (39%)
I63333,Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries,249,I69365 (50%); G936 (47%); I748 (41%); I69369 (37%); I69349 (36%)
I63339,Cerebral infarction due to thrombosis of unspecified posterior cerebral artery,249,G936 (50%); I749 (43%); I69369 (42%); I69349 (41%); I69365 (40%)
I63341,Cerebral infarction due to thrombosis of right cerebellar artery,249,I749 (45%); I745 (35%); I6011 (34%); I69361 (32%); I69341 (32%)
I63342,Cerebral infarction due to thrombosis of left cerebellar artery,249,I749 (45%); I745 (35%); I6012 (34%); I69362 (32%); I69342 (32%)
I63343,Cerebral infarction due to thrombosis of bilateral cerebellar arteries,249,I748 (47%); I69365 (43%); I744 (39%); I743 (37%); I742 (36%)
I63349,Cerebral infarction due to thrombosis of unspecified cerebellar artery,249,I749 (50%); I745 (36%); I69369 (34%); I69349 (33%); I6010 (32%)
I6339,Cerebral infarction due to thrombosis of other cerebral artery,249,G936 (55%); I69365 (44%); I69369 (43%); I749 (43%); I69349 (42%)
I6340,Cerebral infarction due to embolism of unspecified cerebral artery,249,G936 (55%); I749 (46%); I69369 (46%); I69349 (44%); I69365 (44%)
I63411,Cerebral infarction due to embolism of right middle cerebral artery,249,I6011 (62%); I6010 (59%); I6012 (58%); G936 (48%); I69361 (38%)
I63412,Cerebral infarction due to embolism of left middle cerebral artery,249,I6012 (62%); I6010 (59%); I6011 (58%); G936 (48%); I69362 (38%)
I63413,Cerebral infarction due to embolism of bilateral middle cerebral arteries,249,I69365 (48%); G936 (46%); I6010 (44%); I6012 (44%); I6011 (44%)
I63419,Cerebral infarction due to embolism of unspecified middle cerebral artery,249,I6010 (62%); I6012 (59%); I6011 (59%); G936 (48%); I749 (41%)
I63421,Cerebral infarction due to embolism of right anterior cerebral artery,249,G936 (50%); I6011 (41%); I69361 (40%); I69365 (40%); I69341 (39%)
I63422,Cerebral infarction due to embolism of left anterior cerebral artery,249,G936 (50%); I6012 (41%); I69362 (40%); I69365 (40%); I69342 (39%)
I63423,Cerebral infarction due to embolism of bilateral anterior cerebral arteries,249,I69365 (50%); G936 (48%); I748 (41%); I69369 (37%); I69349 (36%)
I63429,Cerebral infarction due to embolism of unspecified anterior cerebral artery,249,G936 (50%); I749 (43%); I69369 (42%); I69349 (41%); I69365 (40%)
I63431,Cerebral infarction due to embolism of right posterior cerebral artery,249,G936 (50%); I6011 (41%); I69361 (40%); I69365 (40%); I69341 (39%)
I63432,Cerebral infarction due to embolism of left posterior cerebral artery,249,G936 (50%); I6012 (41%); I69362 (40%); I69365 (40%); I69342 (39%)
I63433,Cerebral infarction due to embolism of bilateral posterior cerebral arteries,249,I69365 (50%); G936 (47%); I748 (41%); I69369 (37%); I69349 (36%)
I63439,Cerebral infarction due to embolism of unspecified posterior cerebral artery,249,G936 (50%); I749 (43%); I69369 (42%); I69349 (41%); I69365 (40%)
I63441,Cerebral infarction due to embolism of right cerebellar artery,249,I749 (45%); I745 (35%); I6011 (34%); I69361 (32%); I69341 (32%)
I63442,Cerebral infarction due to embolism of left cerebellar artery,249,I749 (45%); I745 (35%); I6012 (34%); I69362 (32%); I69342 (32%)
I63443,Cerebral infarction due to embolism of bilateral cerebellar arteries,249,I748 (47%); I69365 (43%); I744 (39%); I743 (37%); I742 (36%)
I63449,Cerebral infarction due to embolism of unspecified cerebellar artery,249,I749 (50%); I745 (36%); I69369 (34%); I69349 (33%); I6010 (32%)
I6349,Cerebral infarction due to embolism of other cerebral artery,249,G936 (55%); I69365 (44%); I69369 (43%); I749 (43%); I69349 (42%)
I6350,Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery,249,G936 (47%); I69369 (41%); I69349 (40%); I69339 (40%); I6010 (39%)
I63511,Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery,249,I6011 (56%); I6010 (55%); I6012 (52%); G936 (43%); I69369 (36%)
I63512,Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery,249,I6012 (56%); I6010 (55%); I6011 (52%); G936 (43%); I69369 (36%)
I63513,Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries,249,I69365 (43%); I6010 (42%); G936 (41%); I6012 (39%); I6011 (39%)
I63519,Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery,249,I6010 (56%); I6012 (52%); I6011 (52%); G936 (42%); I69369 (38%)
I63521,Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery,249,G936 (44%); I69369 (37%); I6011 (36%); I69349 (36%); I69361 (35%)
I63522,Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery,249,G936 (44%); I69369 (37%); I6012 (36%); I69349 (36%); I69362 (35%)
I63523,Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries,249,I69365 (45%); G936 (43%); I69369 (36%); I69349 (35%); I69339 (34%)
I63529,Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery,249,G936 (44%); I69369 (39%); I69349 (38%); I69339 (37%); I6010 (37%)
I63531,Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery,249,G936 (44%); I69369 (37%); I6011 (36%); I69349 (36%); I69361 (35%)
I63532,Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery,249,G936 (44%); I69369 (37%); I6012 (36%); I69349 (36%); I69362 (35%)
I63533,Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries,249,I69365 (45%); G936 (43%); I69369 (36%); I69349 (35%); I69339 (34%)
I63539,Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery,249,G936 (44%); I69369 (39%); I69349 (38%); I69339 (37%); I6010 (37%)
I63541,Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery,249,I6011 (29%); I69369 (29%); I69361 (28%); I69349 (28%); I6010 (27%)
I63542,Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery,249,I6012 (29%); I69369 (29%); I69362 (28%); I69349 (28%); I6010 (27%)
I63543,Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries,249,I69365 (37%); H348132 (28%); H348130 (28%); I69369 (27%); I69349 (27%)
I63549,Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery,249,I69369 (31%); I69349 (30%); I6010 (29%); I69339 (29%); I69359 (29%)
I6359,Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery,249,G936 (48%); I69369 (40%); I69349 (39%); I69365 (38%); I69339 (38%)
I636,"Cerebral infarction due to cerebral venous thrombosis, nonpyogenic",249,G936 (43%); I69365 (34%); I69369 (33%); I69349 (32%); I69339 (32%)
I6381,Other cerebral infarction due to occlusion or stenosis of small artery,249,Q419 (35%); Q418 (31%); I69365 (28%); I69369 (27%); C179 (27%)
I6389,Other cerebral infarction,249,I69365 (56%); I69369 (54%); I69349 (53%); I69339 (52%); G936 (52%)
I639,"Cerebral infarction, unspecified",249,I69369 (57%); I69349 (56%); I69339 (55%); I69359 (54%); I69365 (53%)
I670,"Dissection of cerebral arteries, nonruptured",,
I673,Progressive vascular leukoencephalopathy,127,M340 (36%); G9343 (35%); G1225 (32%); G9342 (30%); G214 (30%)
I674,Hypertensive encephalopathy,,
I69031,Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right dominant side,254,I69051 (68%); I69053 (66%); I69052 (65%); I69054 (62%); I608 (59%)
I69032,Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left dominant side,254,I69052 (68%); I69054 (66%); I69051 (65%); I69053 (62%); I608 (59%)
I69033,Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side,254,I69053 (70%); I69054 (67%); I69051 (66%); I69052 (62%); I69253 (57%)
I69034,Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side,254,I69054 (70%); I69053 (67%); I69052 (66%); I69051 (62%); I69254 (57%)
I69039,Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting unspecified side,254,I609 (65%); I69059 (64%); I608 (63%); I69052 (57%); I69051 (57%)
I69041,Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right dominant side,254,I69051 (69%); I69053 (67%); I69052 (66%); I69054 (63%); I608 (60%)
I69042,Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left dominant side,254,I69052 (69%); I69054 (67%); I69051 (66%); I69053 (63%); I608 (60%)
I69043,Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side,254,I69053 (71%); I69054 (68%); I69051 (67%); I69052 (63%); I69253 (58%)
I69044,Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side,254,I69054 (71%); I69053 (68%); I69052 (67%); I69051 (63%); I69254 (58%)
I69049,Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting unspecified side,254,I609 (66%); I69059 (65%); I608 (64%); I69052 (58%); I69051 (58%)
I69051,Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right dominant side,253,I69061 (70%); I69041 (69%); I69031 (68%); I69063 (68%); I69062 (67%)
I69052,Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant side,253,I69062 (70%); I69042 (69%); I69032 (68%); I69064 (68%); I69061 (67%)
I69053,Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant side,253,I69063 (72%); I69043 (71%); I69033 (70%); I69064 (69%); I69044 (68%)
I69054,Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant side,253,I69064 (72%); I69044 (71%); I69034 (70%); I69063 (69%); I69043 (68%)
I69059,Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting unspecified side,253,I69069 (66%); I69049 (65%); I609 (64%); I69039 (64%); I608 (62%)
I69061,Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right dominant side,254,I69051 (70%); I69053 (68%); I69052 (67%); I69054 (64%); I608 (61%)
I69062,Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left dominant side,254,I69052 (70%); I69054 (68%); I69051 (67%); I69053 (64%); I608 (61%)
I69063,Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right non-dominant side,254,I69053 (72%); I69054 (69%); I69051 (68%); I69052 (64%); I69253 (59%)
I69064,Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left non-dominant side,254,I69054 (72%); I69053 (69%); I69052 (68%); I69051 (64%); I69254 (59%)
I69065,"Other paralytic syndrome following nontraumatic subarachnoid hemorrhage, bilateral",254,I608 (66%); I609 (64%); P525 (56%); I69059 (53%); I607 (50%)
I69069,Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting unspecified side,254,I609 (67%); I69059 (66%); I608 (65%); I69052 (60%); I69051 (60%)
I69131,Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right dominant side,254,I69151 (69%); I69153 (66%); I69152 (65%); I69154 (63%); I618 (60%)
I69132,Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left dominant side,254,I69152 (69%); I69154 (66%); I69151 (65%); I69153 (63%); I618 (60%)
I69133,Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side,254,I69153 (71%); I69154 (68%); I69151 (66%); I69152 (63%); I618 (58%)
I69134,Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side,254,I69154 (71%); I69153 (68%); I69152 (66%); I69151 (63%); I618 (58%)
I69139,Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting unspecified side,254,I619 (66%); I69159 (65%); I618 (64%); I69152 (58%); I69151 (58%)
I69141,Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right dominant side,254,I69151 (70%); I69153 (67%); I69152 (66%); I69154 (64%); I618 (61%)
I69142,Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left dominant side,254,I69152 (70%); I69154 (67%); I69151 (66%); I69153 (64%); I618 (61%)
I69143,Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side,254,I69153 (72%); I69154 (69%); I69151 (67%); I69152 (64%); I618 (59%)
I69144,Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side,254,I69154 (72%); I69153 (69%); I69152 (67%); I69151 (64%); I618 (59%)
I69149,Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting unspecified side,254,I619 (67%); I69159 (66%); I618 (65%); I69152 (59%); I69151 (59%)
I69151,Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side,253,I69161 (71%); I69141 (70%); I69131 (69%); I69163 (68%); I69162 (68%)
I69152,Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant side,253,I69162 (71%); I69142 (70%); I69132 (69%); I69164 (68%); I69161 (68%)
I69153,Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant side,253,I69163 (73%); I69143 (72%); I69133 (71%); I69164 (70%); I69144 (69%)
I69154,Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant side,253,I69164 (73%); I69144 (72%); I69134 (71%); I69163 (70%); I69143 (69%)
I69159,Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting unspecified side,253,I69169 (67%); I69149 (66%); I619 (65%); I69139 (65%); I618 (63%)
I69161,Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right dominant side,254,I69151 (71%); I69153 (69%); I69152 (68%); I69154 (65%); I618 (62%)
I69162,Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left dominant side,254,I69152 (71%); I69154 (69%); I69151 (68%); I69153 (65%); I618 (62%)
I69163,Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right non-dominant side,254,I69153 (73%); I69154 (70%); I69151 (68%); I69152 (65%); I618 (60%)
I69164,Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left non-dominant side,254,I69154 (73%); I69153 (70%); I69152 (68%); I69151 (65%); I618 (60%)
I69165,"Other paralytic syndrome following nontraumatic intracerebral hemorrhage, bilateral",254,I618 (67%); I619 (66%); P524 (58%); I69159 (54%); I614 (53%)
I69169,Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting unspecified side,254,I619 (68%); I69159 (67%); I618 (66%); I69152 (61%); I69151 (61%)
I69231,Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right dominant side,254,I69251 (68%); I69253 (65%); I69252 (64%); I69254 (62%); I69259 (57%)
I69232,Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left dominant side,254,I69252 (68%); I69254 (65%); I69251 (64%); I69253 (62%); I69259 (57%)
I69233,Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side,254,I69253 (70%); I69254 (67%); I69251 (65%); I69252 (62%); I69053 (57%)
I69234,Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side,254,I69254 (70%); I69253 (67%); I69252 (65%); I69251 (62%); I69054 (57%)
I69239,Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting unspecified side,254,I629 (64%); I69259 (63%); I69252 (57%); I69251 (57%); I69254 (55%)
I69241,Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right dominant side,254,I69251 (69%); I69253 (66%); I69252 (65%); I69254 (63%); I69259 (58%)
I69242,Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left dominant side,254,I69252 (69%); I69254 (66%); I69251 (65%); I69253 (63%); I69259 (58%)
I69243,Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side,254,I69253 (71%); I69254 (68%); I69251 (66%); I69252 (63%); I69053 (58%)
I69244,Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side,254,I69254 (71%); I69253 (68%); I69252 (66%); I69251 (63%); I69054 (58%)
I69249,Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting unspecified side,254,I629 (65%); I69259 (64%); I69252 (58%); I69251 (58%); I69254 (56%)
I69251,Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right dominant side,253,I69261 (70%); I69241 (69%); I69231 (68%); I69263 (67%); I69262 (66%)
I69252,Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant side,253,I69262 (70%); I69242 (69%); I69232 (68%); I69264 (67%); I69261 (66%)
I69253,Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant side,253,I69263 (72%); I69243 (71%); I69233 (70%); I69264 (69%); I69244 (68%)
I69254,Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side,253,I69264 (72%); I69244 (71%); I69234 (70%); I69263 (69%); I69243 (68%)
I69259,Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting unspecified side,253,I69269 (65%); I69249 (64%); I629 (63%); I69239 (63%); I69262 (59%)
I69261,Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right dominant side,254,I69251 (70%); I69253 (68%); I69252 (66%); I69254 (64%); I69259 (59%)
I69262,Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left dominant side,254,I69252 (70%); I69254 (67%); I69251 (66%); I69253 (64%); I69259 (59%)
I69263,Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right non-dominant side,254,I69253 (72%); I69254 (69%); I69251 (67%); I69252 (64%); I69053 (59%)
I69264,Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left non-dominant side,254,I69254 (72%); I69253 (69%); I69252 (67%); I69251 (64%); I69054 (59%)
I69265,"Other paralytic syndrome following other nontraumatic intracranial hemorrhage, bilateral",254,I629 (64%); P529 (54%); I69259 (52%); I69252 (49%); I69251 (49%)
I69269,Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting unspecified side,254,I629 (66%); I69259 (65%); I69252 (59%); I69251 (59%); I69254 (57%)
I69331,Monoplegia of upper limb following cerebral infarction affecting right dominant side,254,I69351 (63%); I69353 (60%); I69352 (59%); I69354 (56%); I69359 (49%)
I69332,Monoplegia of upper limb following cerebral infarction affecting left dominant side,254,I69352 (63%); I69354 (60%); I69351 (59%); I69353 (56%); I69359 (49%)
I69333,Monoplegia of upper limb following cerebral infarction affecting right non-dominant side,254,I69353 (66%); I69354 (62%); I69351 (60%); I69352 (56%); I69359 (47%)
I69334,Monoplegia of upper limb following cerebral infarction affecting left non-dominant side,254,I69354 (66%); I69353 (62%); I69352 (60%); I69351 (56%); I69359 (47%)
I69339,Monoplegia of upper limb following cerebral infarction affecting unspecified side,254,I69359 (56%); I639 (55%); I6389 (52%); I69352 (49%); I69351 (49%)
I69341,Monoplegia of lower limb following cerebral infarction affecting right dominant side,254,I69351 (64%); I69353 (61%); I69352 (60%); I69354 (57%); I69359 (50%)
I69342,Monoplegia of lower limb following cerebral infarction affecting left dominant side,254,I69352 (64%); I69354 (61%); I69351 (60%); I69353 (57%); I69359 (50%)
I69343,Monoplegia of lower limb following cerebral infarction affecting right non-dominant side,254,I69353 (67%); I69354 (63%); I69351 (61%); I69352 (57%); I69359 (48%)
I69344,Monoplegia of lower limb following cerebral infarction affecting left non-dominant side,254,I69354 (67%); I69353 (63%); I69352 (61%); I69351 (57%); I69359 (48%)
I69349,Monoplegia of lower limb following cerebral infarction affecting unspecified side,254,I69359 (57%); I639 (56%); I6389 (53%); I69352 (50%); I69351 (50%)
I69351,Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side,253,I69361 (65%); I69341 (64%); I69331 (63%); I69363 (62%); I69343 (61%)
I69352,Hemiplegia and hemiparesis following cerebral infarction affecting left dominant side,253,I69362 (65%); I69342 (64%); I69332 (63%); I69364 (62%); I69344 (61%)
I69353,Hemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side,253,I69363 (68%); I69343 (67%); I69333 (66%); I69364 (64%); I69344 (63%)
I69354,Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side,253,I69364 (68%); I69344 (67%); I69334 (66%); I69363 (64%); I69343 (63%)
I69359,Hemiplegia and hemiparesis following cerebral infarction affecting unspecified side,253,I69369 (59%); I69349 (57%); I69339 (56%); I639 (54%); I6389 (51%)
I69361,Other paralytic syndrome following cerebral infarction affecting right dominant side,254,I69351 (65%); I69353 (62%); I69352 (61%); I69354 (58%); I69359 (51%)
I69362,Other paralytic syndrome following cerebral infarction affecting left dominant side,254,I69352 (65%); I69354 (62%); I69351 (61%); I69353 (58%); I69359 (51%)
I69363,Other paralytic syndrome following cerebral infarction affecting right non-dominant side,254,I69353 (68%); I69354 (64%); I69351 (62%); I69352 (58%); I69359 (49%)
I69364,Other paralytic syndrome following cerebral infarction affecting left non-dominant side,254,I69354 (68%); I69353 (64%); I69352 (62%); I69351 (58%); I69359 (49%)
I69365,"Other paralytic syndrome following cerebral infarction, bilateral",254,I6389 (56%); I639 (53%); P91823 (51%); I63423 (50%); I63323 (50%)
I69369,Other paralytic syndrome following cerebral infarction affecting unspecified side,254,I69359 (59%); I639 (57%); I6389 (54%); I69352 (52%); I69351 (52%)
I69831,Monoplegia of upper limb following other cerebrovascular disease affecting right dominant side,254,I69851 (64%); I69951 (63%); I69853 (61%); I69953 (61%); I69852 (60%)
I69832,Monoplegia of upper limb following other cerebrovascular disease affecting left dominant side,254,I69852 (64%); I69952 (63%); I69854 (61%); I69954 (61%); I69851 (60%)
I69833,Monoplegia of upper limb following other cerebrovascular disease affecting right non-dominant side,254,I69853 (67%); I69953 (66%); I69854 (63%); I69954 (62%); I69851 (61%)
I69834,Monoplegia of upper limb following other cerebrovascular disease affecting left non-dominant side,254,I69854 (67%); I69954 (66%); I69853 (63%); I69953 (62%); I69852 (61%)
I69839,Monoplegia of upper limb following other cerebrovascular disease affecting unspecified side,254,I69959 (58%); I69859 (58%); I69952 (53%); I69951 (53%); I69852 (51%)
I69841,Monoplegia of lower limb following other cerebrovascular disease affecting right dominant side,254,I69851 (65%); I69951 (64%); I69853 (62%); I69953 (62%); I69852 (61%)
I69842,Monoplegia of lower limb following other cerebrovascular disease affecting left dominant side,254,I69852 (65%); I69952 (64%); I69854 (62%); I69954 (62%); I69851 (61%)
I69843,Monoplegia of lower limb following other cerebrovascular disease affecting right non-dominant side,254,I69853 (68%); I69953 (67%); I69854 (64%); I69954 (63%); I69851 (62%)
I69844,Monoplegia of lower limb following other cerebrovascular disease affecting left non-dominant side,254,I69854 (68%); I69954 (67%); I69853 (64%); I69953 (63%); I69852 (62%)
I69849,Monoplegia of lower limb following other cerebrovascular disease affecting unspecified side,254,I69959 (60%); I69859 (59%); I69952 (54%); I69951 (54%); I69852 (52%)
I69851,Hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side,253,I69861 (66%); I69961 (66%); I69841 (65%); I69941 (64%); I69831 (64%)
I69852,Hemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant side,253,I69862 (66%); I69962 (66%); I69842 (65%); I69942 (64%); I69832 (64%)
I69853,Hemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant side,253,I69863 (69%); I69963 (68%); I69843 (68%); I69943 (67%); I69833 (67%)
I69854,Hemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant side,253,I69864 (69%); I69964 (68%); I69844 (68%); I69944 (67%); I69834 (67%)
I69859,Hemiplegia and hemiparesis following other cerebrovascular disease affecting unspecified side,253,I69969 (61%); I69869 (61%); I69949 (59%); I69849 (59%); I69939 (58%)
I69861,Other paralytic syndrome following other cerebrovascular disease affecting right dominant side,254,I69851 (66%); I69951 (66%); I69853 (64%); I69953 (63%); I69852 (62%)
I69862,Other paralytic syndrome following other cerebrovascular disease affecting left dominant side,254,I69852 (66%); I69952 (66%); I69854 (64%); I69954 (63%); I69851 (62%)
I69863,Other paralytic syndrome following other cerebrovascular disease affecting right non-dominant side,254,I69853 (69%); I69953 (68%); I69854 (65%); I69954 (65%); I69851 (63%)
I69864,Other paralytic syndrome following other cerebrovascular disease affecting left non-dominant side,254,I69854 (69%); I69954 (68%); I69853 (65%); I69953 (65%); I69852 (63%)
I69865,"Other paralytic syndrome following other cerebrovascular disease, bilateral",254,I69859 (45%); I69959 (44%); I69852 (42%); I69851 (42%); I69952 (42%)
I69869,Other paralytic syndrome following other cerebrovascular disease affecting unspecified side,254,I69959 (61%); I69859 (61%); I69952 (55%); I69951 (55%); I69852 (54%)
I69931,Monoplegia of upper limb following unspecified cerebrovascular disease affecting right dominant side,254,I69951 (65%); I69851 (63%); I69953 (62%); I69952 (61%); I69853 (61%)
I69932,Monoplegia of upper limb following unspecified cerebrovascular disease affecting left dominant side,254,I69952 (65%); I69852 (63%); I69954 (62%); I69951 (61%); I69854 (61%)
I69933,Monoplegia of upper limb following unspecified cerebrovascular disease affecting right non-dominant side,254,I69953 (67%); I69853 (66%); I69954 (64%); I69854 (62%); I69951 (62%)
I69934,Monoplegia of upper limb following unspecified cerebrovascular disease affecting left non-dominant side,254,I69954 (67%); I69854 (66%); I69953 (64%); I69853 (62%); I69952 (62%)
I69939,Monoplegia of upper limb following unspecified cerebrovascular disease affecting unspecified side,254,I69959 (61%); I69859 (58%); I69952 (53%); I69951 (53%); I69954 (51%)
I69941,Monoplegia of lower limb following unspecified cerebrovascular disease affecting right dominant side,254,I69951 (66%); I69851 (64%); I69953 (63%); I69952 (62%); I69853 (62%)
I69942,Monoplegia of lower limb following unspecified cerebrovascular disease affecting left dominant side,254,I69952 (66%); I69852 (64%); I69954 (63%); I69951 (62%); I69854 (62%)
I69943,Monoplegia of lower limb following unspecified cerebrovascular disease affecting right non-dominant side,254,I69953 (68%); I69853 (67%); I69954 (65%); I69854 (63%); I69951 (63%)
I69944,Monoplegia of lower limb following unspecified cerebrovascular disease affecting left non-dominant side,254,I69954 (68%); I69854 (67%); I69953 (65%); I69853 (63%); I69952 (63%)
I69949,Monoplegia of lower limb following unspecified cerebrovascular disease affecting unspecified side,254,I69959 (62%); I69859 (59%); I69952 (54%); I69951 (54%); I69954 (52%)
I69951,Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right dominant side,253,I69961 (67%); I69941 (66%); I69861 (66%); I69931 (65%); I69841 (64%)
I69952,Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left dominant side,253,I69962 (67%); I69942 (66%); I69862 (66%); I69932 (65%); I69842 (64%)
I69953,Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right non-dominant side,253,I69963 (70%); I69943 (68%); I69863 (68%); I69933 (67%); I69843 (67%)
I69954,Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side,253,I69964 (70%); I69944 (68%); I69864 (68%); I69934 (67%); I69844 (67%)
I69959,Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified side,253,I69969 (63%); I69949 (62%); I69939 (61%); I69869 (61%); I69849 (60%)
I69961,Other paralytic syndrome following unspecified cerebrovascular disease affecting right dominant side,254,I69951 (67%); I69851 (66%); I69953 (65%); I69952 (63%); I69853 (63%)
I69962,Other paralytic syndrome following unspecified cerebrovascular disease affecting left dominant side,254,I69952 (67%); I69852 (66%); I69954 (64%); I69951 (63%); I69854 (63%)
I69963,Other paralytic syndrome following unspecified cerebrovascular disease affecting right non-dominant side,254,I69953 (70%); I69853 (68%); I69954 (66%); I69854 (65%); I69951 (64%)
I69964,Other paralytic syndrome following unspecified cerebrovascular disease affecting left non-dominant side,254,I69954 (70%); I69854 (68%); I69953 (66%); I69853 (65%); I69952 (64%)
I69965,"Other paralytic syndrome following unspecified cerebrovascular disease, bilateral",254,I69959 (48%); I69859 (47%); I69952 (43%); I69951 (43%); I69954 (42%)
I69969,Other paralytic syndrome following unspecified cerebrovascular disease affecting unspecified side,254,I69959 (63%); I69859 (61%); I69952 (56%); I69951 (56%); I69954 (53%)
I700,Atherosclerosis of aorta,,
I701,Atherosclerosis of renal artery,,
I70201,"Unspecified atherosclerosis of native arteries of extremities, right leg",,
I70202,"Unspecified atherosclerosis of native arteries of extremities, left leg",,
I70203,"Unspecified atherosclerosis of native arteries of extremities, bilateral legs",,
I70208,"Unspecified atherosclerosis of native arteries of extremities, other extremity",,
I70209,"Unspecified atherosclerosis of native arteries of extremities, unspecified extremity",,
I70211,"Atherosclerosis of native arteries of extremities with intermittent claudication, right leg",,
I70212,"Atherosclerosis of native arteries of extremities with intermittent claudication, left leg",,
I70213,"Atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs",,
I70218,"Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity",,
I70219,"Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity",,
I70221,"Atherosclerosis of native arteries of extremities with rest pain, right leg",264,I70261 (72%); I70262 (68%); I7025 (67%); I7025 (67%); I70238 (61%)
I70222,"Atherosclerosis of native arteries of extremities with rest pain, left leg",264,I70262 (72%); I70261 (68%); I7025 (67%); I7025 (67%); I70248 (61%)
I70223,"Atherosclerosis of native arteries of extremities with rest pain, bilateral legs",264,I70263 (77%); I7025 (60%); I7025 (60%); I70268 (54%); I70262 (53%)
I70228,"Atherosclerosis of native arteries of extremities with rest pain, other extremity",264,I70268 (71%); I70269 (70%); I7025 (67%); I7025 (67%); I70262 (59%)
I70229,"Atherosclerosis of native arteries of extremities with rest pain, unspecified extremity",264,I70269 (72%); I70268 (70%); I7025 (66%); I7025 (66%); I70262 (59%)
I70231,Atherosclerosis of native arteries of right leg with ulceration of thigh,263,I70231 (100%); I70241 (95%); I70233 (83%); I70235 (83%); I70238 (83%)
I70231,Atherosclerosis of native arteries of right leg with ulceration of thigh,383,I70231 (100%); I70241 (95%); I70233 (83%); I70235 (83%); I70238 (83%)
I70232,Atherosclerosis of native arteries of right leg with ulceration of calf,263,I70232 (99%); I70242 (95%); I70233 (83%); I70235 (83%); I70238 (83%)
I70232,Atherosclerosis of native arteries of right leg with ulceration of calf,383,I70232 (99%); I70242 (95%); I70233 (83%); I70235 (83%); I70238 (83%)
I70233,Atherosclerosis of native arteries of right leg with ulceration of ankle,263,I70233 (100%); I70243 (94%); I70235 (86%); I70238 (86%); I70239 (84%)
I70233,Atherosclerosis of native arteries of right leg with ulceration of ankle,383,I70233 (100%); I70243 (94%); I70235 (86%); I70238 (86%); I70239 (84%)
I70234,Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot,263,I70234 (100%); I70244 (95%); I70233 (76%); I70235 (76%); I70238 (75%)
I70234,Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot,383,I70234 (100%); I70244 (95%); I70233 (76%); I70235 (76%); I70238 (75%)
I70235,Atherosclerosis of native arteries of right leg with ulceration of other part of foot,263,I70235 (100%); I70245 (94%); I70233 (86%); I70238 (85%); I70239 (84%)
I70235,Atherosclerosis of native arteries of right leg with ulceration of other part of foot,383,I70235 (100%); I70245 (94%); I70233 (86%); I70238 (85%); I70239 (84%)
I70238,Atherosclerosis of native arteries of right leg with ulceration of other part of lower leg,263,I70238 (100%); I70248 (95%); I70233 (86%); I70235 (85%); I70239 (84%)
I70238,Atherosclerosis of native arteries of right leg with ulceration of other part of lower leg,383,I70238 (100%); I70248 (95%); I70233 (86%); I70235 (85%); I70239 (84%)
I70239,Atherosclerosis of native arteries of right leg with ulceration of unspecified site,263,I70239 (100%); I70249 (95%); I70233 (84%); I70235 (84%); I70238 (84%)
I70239,Atherosclerosis of native arteries of right leg with ulceration of unspecified site,383,I70239 (100%); I70249 (95%); I70233 (84%); I70235 (84%); I70238 (84%)
I70241,Atherosclerosis of native arteries of left leg with ulceration of thigh,263,I70241 (100%); I70231 (95%); I70243 (83%); I70245 (83%); I70248 (83%)
I70241,Atherosclerosis of native arteries of left leg with ulceration of thigh,383,I70241 (100%); I70231 (95%); I70243 (83%); I70245 (83%); I70248 (83%)
I70242,Atherosclerosis of native arteries of left leg with ulceration of calf,263,I70242 (99%); I70232 (95%); I70243 (83%); I70245 (83%); I70248 (83%)
I70242,Atherosclerosis of native arteries of left leg with ulceration of calf,383,I70242 (99%); I70232 (95%); I70243 (83%); I70245 (83%); I70248 (83%)
I70243,Atherosclerosis of native arteries of left leg with ulceration of ankle,263,I70243 (100%); I70233 (94%); I70245 (86%); I70248 (85%); I70249 (84%)
I70243,Atherosclerosis of native arteries of left leg with ulceration of ankle,383,I70243 (100%); I70233 (94%); I70245 (86%); I70248 (85%); I70249 (84%)
I70244,Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot,263,I70244 (99%); I70234 (95%); I70243 (76%); I70245 (76%); I70248 (75%)
I70244,Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot,383,I70244 (99%); I70234 (95%); I70243 (76%); I70245 (76%); I70248 (75%)
I70245,Atherosclerosis of native arteries of left leg with ulceration of other part of foot,263,I70245 (100%); I70235 (94%); I70243 (86%); I70248 (85%); I70249 (84%)
I70245,Atherosclerosis of native arteries of left leg with ulceration of other part of foot,383,I70245 (100%); I70235 (94%); I70243 (86%); I70248 (85%); I70249 (84%)
I70248,Atherosclerosis of native arteries of left leg with ulceration of other part of lower leg,263,I70248 (100%); I70238 (95%); I70243 (85%); I70245 (85%); I70249 (84%)
I70248,Atherosclerosis of native arteries of left leg with ulceration of other part of lower leg,383,I70248 (100%); I70238 (95%); I70243 (85%); I70245 (85%); I70249 (84%)
I70249,Atherosclerosis of native arteries of left leg with ulceration of unspecified site,263,I70249 (100%); I70239 (95%); I70243 (84%); I70245 (84%); I70248 (84%)
I70249,Atherosclerosis of native arteries of left leg with ulceration of unspecified site,383,I70249 (100%); I70239 (95%); I70243 (84%); I70245 (84%); I70248 (84%)
I7025,Atherosclerosis of native arteries of other extremities with ulceration,263,I7025 (100%); I70243 (73%); I70233 (73%); I70245 (73%); I70235 (73%)
I7025,Atherosclerosis of native arteries of other extremities with ulceration,383,I7025 (100%); I70268 (75%); I70262 (74%); I70261 (74%); I70269 (74%)
I70261,"Atherosclerosis of native arteries of extremities with gangrene, right leg",263,I7025 (74%); I70221 (72%); I70238 (68%); I70222 (68%); I70233 (67%)
I70262,"Atherosclerosis of native arteries of extremities with gangrene, left leg",263,I7025 (74%); I70222 (72%); I70248 (68%); I70221 (68%); I70243 (67%)
I70263,"Atherosclerosis of native arteries of extremities with gangrene, bilateral legs",263,I70223 (77%); I7025 (66%); I70228 (53%); I70222 (52%); I70221 (52%)
I70268,"Atherosclerosis of native arteries of extremities with gangrene, other extremity",263,I7025 (75%); I70228 (71%); I70229 (70%); I70222 (59%); I70221 (59%)
I70269,"Atherosclerosis of native arteries of extremities with gangrene, unspecified extremity",263,I7025 (74%); I70229 (72%); I70228 (70%); I70222 (58%); I70221 (58%)
I70291,"Other atherosclerosis of native arteries of extremities, right leg",,
I70292,"Other atherosclerosis of native arteries of extremities, left leg",,
I70293,"Other atherosclerosis of native arteries of extremities, bilateral legs",,
I70298,"Other atherosclerosis of native arteries of extremities, other extremity",,
I70299,"Other atherosclerosis of native arteries of extremities, unspecified extremity",,
I70301,"Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, right leg",,
I70302,"Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, left leg",,
I70303,"Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, bilateral legs",,
I70308,"Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, other extremity",,
I70309,"Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, unspecified extremity",,
I70311,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, right leg",,
I70312,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, left leg",,
I70313,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, bilateral legs",,
I70318,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, other extremity",,
I70319,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, unspecified extremity",,
I70321,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, right leg",264,I70361 (70%); I70761 (68%); I70362 (66%); I70762 (64%); I70338 (59%)
I70322,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, left leg",264,I70362 (70%); I70762 (68%); I70361 (66%); I70761 (64%); I70348 (59%)
I70323,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, bilateral legs",264,I70363 (76%); I70763 (75%); I70663 (66%); I70463 (63%); I70563 (61%)
I70328,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, other extremity",264,I70368 (69%); I70769 (69%); I70369 (69%); I70768 (68%); I7035 (62%)
I70329,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, unspecified extremity",264,I70369 (71%); I70368 (70%); I70769 (70%); I70768 (66%); I7035 (62%)
I70331,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of thigh,263,I70331 (100%); I70731 (98%); I70341 (94%); I70741 (93%); I70631 (84%)
I70331,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of thigh,383,I70331 (100%); I70731 (98%); I70341 (94%); I70741 (93%); I70631 (84%)
I70332,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of calf,263,I70332 (100%); I70732 (98%); I70342 (94%); I70742 (93%); I70632 (84%)
I70332,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of calf,383,I70332 (100%); I70732 (98%); I70342 (94%); I70742 (93%); I70632 (84%)
I70333,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of ankle,263,I70333 (100%); I70733 (98%); I70343 (94%); I70743 (92%); I70335 (85%)
I70333,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of ankle,383,I70333 (100%); I70733 (98%); I70343 (94%); I70743 (92%); I70335 (85%)
I70334,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of heel and midfoot,263,I70334 (100%); I70734 (98%); I70344 (95%); I70744 (94%); I70634 (86%)
I70334,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of heel and midfoot,383,I70334 (100%); I70734 (98%); I70344 (95%); I70744 (94%); I70634 (86%)
I70335,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of other part of foot,263,I70335 (100%); I70735 (98%); I70345 (94%); I70745 (92%); I70333 (85%)
I70335,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of other part of foot,383,I70335 (100%); I70735 (98%); I70345 (94%); I70745 (92%); I70333 (85%)
I70338,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of other part of lower leg,263,I70338 (100%); I70738 (98%); I70348 (95%); I70748 (94%); I70638 (86%)
I70338,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of other part of lower leg,383,I70338 (100%); I70738 (98%); I70348 (95%); I70748 (94%); I70638 (86%)
I70339,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of unspecified site,263,I70339 (100%); I70739 (98%); I70349 (94%); I70749 (93%); I70333 (84%)
I70339,Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of unspecified site,383,I70339 (100%); I70739 (98%); I70349 (94%); I70749 (93%); I70333 (84%)
I70341,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of thigh,263,I70341 (100%); I70741 (98%); I70331 (94%); I70731 (93%); I70641 (84%)
I70341,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of thigh,383,I70341 (100%); I70741 (98%); I70331 (94%); I70731 (93%); I70641 (84%)
I70342,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of calf,263,I70342 (99%); I70742 (98%); I70332 (94%); I70732 (93%); I70642 (84%)
I70342,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of calf,383,I70342 (99%); I70742 (98%); I70332 (94%); I70732 (93%); I70642 (84%)
I70343,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of ankle,263,I70343 (100%); I70743 (98%); I70333 (94%); I70733 (92%); I70345 (85%)
I70343,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of ankle,383,I70343 (100%); I70743 (98%); I70333 (94%); I70733 (92%); I70345 (85%)
I70344,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of heel and midfoot,263,I70344 (100%); I70744 (98%); I70334 (95%); I70734 (94%); I70644 (86%)
I70344,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of heel and midfoot,383,I70344 (100%); I70744 (98%); I70334 (95%); I70734 (94%); I70644 (86%)
I70345,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of other part of foot,263,I70345 (100%); I70745 (98%); I70335 (94%); I70735 (92%); I70343 (85%)
I70345,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of other part of foot,383,I70345 (100%); I70745 (98%); I70335 (94%); I70735 (92%); I70343 (85%)
I70348,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of other part of lower leg,263,I70348 (100%); I70748 (98%); I70338 (95%); I70738 (94%); I70648 (86%)
I70348,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of other part of lower leg,383,I70348 (100%); I70748 (98%); I70338 (95%); I70738 (94%); I70648 (86%)
I70349,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of unspecified site,263,I70349 (100%); I70749 (98%); I70339 (94%); I70739 (93%); I70343 (84%)
I70349,Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of unspecified site,383,I70349 (100%); I70749 (98%); I70339 (94%); I70739 (93%); I70343 (84%)
I7035,Atherosclerosis of unspecified type of bypass graft(s) of other extremity with ulceration,263,I7035 (100%); I7075 (98%); I7065 (80%); I7045 (74%); I70343 (74%)
I7035,Atherosclerosis of unspecified type of bypass graft(s) of other extremity with ulceration,383,I7035 (100%); I7075 (98%); I7065 (80%); I7045 (74%); I70343 (74%)
I70361,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, right leg",263,I70321 (70%); I70721 (68%); I70338 (66%); I70322 (66%); I70333 (65%)
I70362,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, left leg",263,I70322 (70%); I70722 (68%); I70348 (66%); I70321 (66%); I70343 (65%)
I70363,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, bilateral legs",263,I70323 (76%); I70723 (74%); I70623 (66%); I70423 (64%); I70523 (62%)
I70368,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, other extremity",263,I70329 (70%); I70328 (69%); I70729 (69%); I7035 (69%); I70728 (68%)
I70369,"Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, unspecified extremity",263,I70329 (71%); I7035 (70%); I70328 (69%); I70729 (69%); I70728 (65%)
I70391,"Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, right leg",,
I70392,"Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, left leg",,
I70393,"Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, bilateral legs",,
I70398,"Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, other extremity",,
I70399,"Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, unspecified extremity",,
I70401,"Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, right leg",,
I70402,"Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, left leg",,
I70403,"Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, bilateral legs",,
I70408,"Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, other extremity",,
I70409,"Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, unspecified extremity",,
I70411,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, right leg",,
I70412,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, left leg",,
I70413,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, bilateral legs",,
I70418,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, other extremity",,
I70419,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, unspecified extremity",,
I70421,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, right leg",264,I70461 (75%); I70462 (72%); I70438 (66%); I70438 (66%); I70433 (66%)
I70422,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, left leg",264,I70462 (75%); I70461 (72%); I70448 (66%); I70448 (66%); I70443 (66%)
I70423,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, bilateral legs",264,I70463 (79%); I70763 (65%); I70363 (64%); I70663 (61%); I70468 (59%)
I70428,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, other extremity",264,I70468 (75%); I70469 (74%); I7045 (69%); I7045 (69%); I70462 (65%)
I70429,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, unspecified extremity",264,I70469 (75%); I70468 (74%); I7045 (69%); I7045 (69%); I70462 (64%)
I70431,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of thigh,263,I70431 (100%); I70441 (95%); I70433 (86%); I70435 (86%); I70438 (85%)
I70431,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of thigh,383,I70431 (100%); I70441 (95%); I70433 (86%); I70435 (86%); I70438 (85%)
I70432,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of calf,263,I70432 (100%); I70442 (95%); I70433 (86%); I70435 (86%); I70438 (85%)
I70432,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of calf,383,I70432 (100%); I70442 (95%); I70433 (86%); I70435 (86%); I70438 (85%)
I70433,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of ankle,263,I70433 (100%); I70443 (95%); I70435 (88%); I70438 (88%); I70439 (87%)
I70433,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of ankle,383,I70433 (100%); I70443 (95%); I70435 (88%); I70438 (88%); I70439 (87%)
I70434,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of heel and midfoot,263,I70434 (100%); I70444 (96%); I70734 (83%); I70334 (82%); I70433 (80%)
I70434,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of heel and midfoot,383,I70434 (100%); I70444 (96%); I70734 (83%); I70334 (82%); I70433 (80%)
I70435,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of foot,263,I70435 (100%); I70445 (95%); I70433 (88%); I70438 (87%); I70439 (87%)
I70435,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of foot,383,I70435 (100%); I70445 (95%); I70433 (88%); I70438 (87%); I70439 (87%)
I70438,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of lower leg,263,I70438 (100%); I70448 (96%); I70433 (88%); I70435 (87%); I70439 (86%)
I70438,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of lower leg,383,I70438 (100%); I70448 (96%); I70433 (88%); I70435 (87%); I70439 (86%)
I70439,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of unspecified site,263,I70439 (100%); I70449 (95%); I70433 (87%); I70435 (87%); I70438 (86%)
I70439,Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of unspecified site,383,I70439 (100%); I70449 (95%); I70433 (87%); I70435 (87%); I70438 (86%)
I70441,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of thigh,263,I70441 (100%); I70431 (95%); I70443 (86%); I70445 (86%); I70448 (85%)
I70441,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of thigh,383,I70441 (100%); I70431 (95%); I70443 (86%); I70445 (86%); I70448 (85%)
I70442,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of calf,263,I70442 (100%); I70432 (95%); I70443 (86%); I70445 (86%); I70448 (85%)
I70442,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of calf,383,I70442 (100%); I70432 (95%); I70443 (86%); I70445 (86%); I70448 (85%)
I70443,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of ankle,263,I70443 (100%); I70433 (95%); I70445 (88%); I70448 (88%); I70449 (87%)
I70443,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of ankle,383,I70443 (100%); I70433 (95%); I70445 (88%); I70448 (88%); I70449 (87%)
I70444,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of heel and midfoot,263,I70444 (100%); I70434 (96%); I70744 (83%); I70344 (82%); I70443 (80%)
I70444,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of heel and midfoot,383,I70444 (100%); I70434 (96%); I70744 (83%); I70344 (82%); I70443 (80%)
I70445,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of other part of foot,263,I70445 (100%); I70435 (95%); I70443 (88%); I70448 (87%); I70449 (87%)
I70445,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of other part of foot,383,I70445 (100%); I70435 (95%); I70443 (88%); I70448 (87%); I70449 (87%)
I70448,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of other part of lower leg,263,I70448 (100%); I70438 (96%); I70443 (88%); I70445 (87%); I70449 (86%)
I70448,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of other part of lower leg,383,I70448 (100%); I70438 (96%); I70443 (88%); I70445 (87%); I70449 (86%)
I70449,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of unspecified site,263,I70449 (100%); I70439 (95%); I70443 (87%); I70445 (87%); I70448 (86%)
I70449,Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of unspecified site,383,I70449 (100%); I70439 (95%); I70443 (87%); I70445 (87%); I70448 (86%)
I7045,Atherosclerosis of autologous vein bypass graft(s) of other extremity with ulceration,263,I7045 (100%); I70443 (80%); I70433 (80%); I70445 (80%); I70435 (80%)
I7045,Atherosclerosis of autologous vein bypass graft(s) of other extremity with ulceration,383,I7045 (100%); I70443 (80%); I70433 (80%); I70445 (80%); I70435 (80%)
I70461,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, right leg",263,I70421 (75%); I70438 (73%); I70433 (72%); I70435 (72%); I70422 (72%)
I70462,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, left leg",263,I70422 (75%); I70448 (73%); I70443 (72%); I70445 (72%); I70421 (72%)
I70463,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, bilateral legs",263,I70423 (79%); I70723 (64%); I70323 (63%); I70623 (60%); I70428 (58%)
I70468,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, other extremity",263,I7045 (76%); I70428 (75%); I70429 (74%); I70422 (65%); I70421 (65%)
I70469,"Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, unspecified extremity",263,I70429 (75%); I7045 (75%); I70428 (74%); I70422 (64%); I70421 (64%)
I70491,"Other atherosclerosis of autologous vein bypass graft(s) of the extremities, right leg",,
I70492,"Other atherosclerosis of autologous vein bypass graft(s) of the extremities, left leg",,
I70493,"Other atherosclerosis of autologous vein bypass graft(s) of the extremities, bilateral legs",,
I70498,"Other atherosclerosis of autologous vein bypass graft(s) of the extremities, other extremity",,
I70499,"Other atherosclerosis of autologous vein bypass graft(s) of the extremities, unspecified extremity",,
I70501,"Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, right leg",,
I70502,"Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, left leg",,
I70503,"Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, bilateral legs",,
I70508,"Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, other extremity",,
I70509,"Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, unspecified extremity",,
I70511,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, right leg",,
I70512,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, left leg",,
I70513,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, bilateral legs",,
I70518,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, other extremity",,
I70519,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, unspecified extremity",,
I70521,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, right leg",264,I70561 (77%); I70562 (73%); I70538 (68%); I70538 (68%); I70533 (68%)
I70522,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, left leg",264,I70562 (77%); I70561 (73%); I70548 (68%); I70548 (68%); I70543 (68%)
I70523,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, bilateral legs",264,I70563 (80%); I70763 (63%); I70363 (62%); I70568 (62%); I70562 (61%)
I70528,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, other extremity",264,I70568 (76%); I70569 (76%); I7055 (71%); I7055 (71%); I70562 (67%)
I70529,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, unspecified extremity",264,I70569 (77%); I70568 (76%); I7055 (71%); I7055 (71%); I70562 (66%)
I70531,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of thigh,263,I70531 (100%); I70541 (96%); I70533 (87%); I70535 (87%); I70538 (86%)
I70531,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of thigh,383,I70531 (100%); I70541 (96%); I70533 (87%); I70535 (87%); I70538 (86%)
I70532,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of calf,263,I70532 (100%); I70542 (96%); I70533 (87%); I70535 (87%); I70538 (86%)
I70532,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of calf,383,I70532 (100%); I70542 (96%); I70533 (87%); I70535 (87%); I70538 (86%)
I70533,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of ankle,263,I70533 (100%); I70543 (95%); I70535 (89%); I70538 (88%); I70539 (88%)
I70533,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of ankle,383,I70533 (100%); I70543 (95%); I70535 (89%); I70538 (88%); I70539 (88%)
I70534,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of heel and midfoot,263,I70534 (100%); I70544 (96%); I70533 (81%); I70535 (81%); I70734 (81%)
I70534,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of heel and midfoot,383,I70534 (100%); I70544 (96%); I70533 (81%); I70535 (81%); I70734 (81%)
I70535,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of other part of foot,263,I70535 (100%); I70545 (95%); I70533 (89%); I70538 (88%); I70539 (88%)
I70535,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of other part of foot,383,I70535 (100%); I70545 (95%); I70533 (89%); I70538 (88%); I70539 (88%)
I70538,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of other part of lower leg,263,I70538 (100%); I70548 (96%); I70533 (88%); I70535 (88%); I70539 (87%)
I70538,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of other part of lower leg,383,I70538 (100%); I70548 (96%); I70533 (88%); I70535 (88%); I70539 (87%)
I70539,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of unspecified site,263,I70539 (100%); I70549 (96%); I70533 (88%); I70535 (88%); I70538 (87%)
I70539,Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of unspecified site,383,I70539 (100%); I70549 (96%); I70533 (88%); I70535 (88%); I70538 (87%)
I70541,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of thigh,263,I70541 (100%); I70531 (96%); I70543 (87%); I70545 (87%); I70548 (86%)
I70541,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of thigh,383,I70541 (100%); I70531 (96%); I70543 (87%); I70545 (87%); I70548 (86%)
I70542,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of calf,263,I70542 (100%); I70532 (96%); I70543 (87%); I70545 (87%); I70548 (86%)
I70542,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of calf,383,I70542 (100%); I70532 (96%); I70543 (87%); I70545 (87%); I70548 (86%)
I70543,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of ankle,263,I70543 (100%); I70533 (95%); I70545 (89%); I70548 (88%); I70549 (88%)
I70543,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of ankle,383,I70543 (100%); I70533 (95%); I70545 (89%); I70548 (88%); I70549 (88%)
I70544,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of heel and midfoot,263,I70544 (100%); I70534 (96%); I70543 (81%); I70545 (81%); I70744 (81%)
I70544,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of heel and midfoot,383,I70544 (100%); I70534 (96%); I70543 (81%); I70545 (81%); I70744 (81%)
I70545,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of other part of foot,263,I70545 (100%); I70535 (95%); I70543 (89%); I70548 (88%); I70549 (88%)
I70545,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of other part of foot,383,I70545 (100%); I70535 (95%); I70543 (89%); I70548 (88%); I70549 (88%)
I70548,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of other part of lower leg,263,I70548 (100%); I70538 (96%); I70543 (88%); I70545 (88%); I70549 (87%)
I70548,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of other part of lower leg,383,I70548 (100%); I70538 (96%); I70543 (88%); I70545 (88%); I70549 (87%)
I70549,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of unspecified site,263,I70549 (100%); I70539 (96%); I70543 (88%); I70545 (88%); I70548 (87%)
I70549,Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of unspecified site,383,I70549 (100%); I70539 (96%); I70543 (88%); I70545 (88%); I70548 (87%)
I7055,Atherosclerosis of nonautologous biological bypass graft(s) of other extremity with ulceration,263,I7055 (100%); I70543 (81%); I70533 (81%); I70545 (81%); I70535 (81%)
I7055,Atherosclerosis of nonautologous biological bypass graft(s) of other extremity with ulceration,383,I7055 (100%); I70543 (81%); I70533 (81%); I70545 (81%); I70535 (81%)
I70561,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, right leg",263,I70521 (77%); I70538 (74%); I70533 (74%); I70535 (74%); I70522 (73%)
I70562,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, left leg",263,I70522 (77%); I70548 (74%); I70543 (74%); I70545 (74%); I70521 (73%)
I70563,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, bilateral legs",263,I70523 (80%); I70723 (62%); I70323 (61%); I70528 (61%); I70522 (60%)
I70568,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, other extremity",263,I7055 (78%); I70528 (76%); I70529 (76%); I70522 (67%); I70521 (67%)
I70569,"Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, unspecified extremity",263,I7055 (77%); I70529 (77%); I70528 (76%); I70522 (66%); I70521 (66%)
I70591,"Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, right leg",,
I70592,"Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, left leg",,
I70593,"Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, bilateral legs",,
I70598,"Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, other extremity",,
I70599,"Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, unspecified extremity",,
I70601,"Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, right leg",,
I70602,"Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, left leg",,
I70603,"Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, bilateral legs",,
I70608,"Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, other extremity",,
I70609,"Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, unspecified extremity",,
I70611,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, right leg",,
I70612,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, left leg",,
I70613,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, bilateral legs",,
I70618,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, other extremity",,
I70619,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, unspecified extremity",,
I70621,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, right leg",264,I70661 (73%); I70662 (69%); I70638 (63%); I70638 (63%); I70633 (62%)
I70622,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, left leg",264,I70662 (73%); I70661 (69%); I70648 (63%); I70648 (63%); I70643 (62%)
I70623,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, bilateral legs",264,I70663 (78%); I70763 (67%); I70363 (66%); I70463 (60%); I70563 (59%)
I70628,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, other extremity",264,I70668 (72%); I70669 (72%); I7065 (66%); I7065 (66%); I70662 (61%)
I70629,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, unspecified extremity",264,I70669 (73%); I70668 (72%); I7065 (65%); I7065 (65%); I70662 (60%)
I70631,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of thigh,263,I70631 (100%); I70641 (95%); I70731 (85%); I70633 (84%); I70635 (84%)
I70631,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of thigh,383,I70631 (100%); I70641 (95%); I70731 (85%); I70633 (84%); I70635 (84%)
I70632,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of calf,263,I70632 (100%); I70642 (95%); I70732 (85%); I70633 (84%); I70635 (84%)
I70632,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of calf,383,I70632 (100%); I70642 (95%); I70732 (85%); I70633 (84%); I70635 (84%)
I70633,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of ankle,263,I70633 (100%); I70643 (95%); I70635 (87%); I70638 (86%); I70639 (85%)
I70633,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of ankle,383,I70633 (100%); I70643 (95%); I70635 (87%); I70638 (86%); I70639 (85%)
I70634,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of heel and midfoot,263,I70634 (100%); I70644 (96%); I70734 (87%); I70334 (86%); I70744 (83%)
I70634,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of heel and midfoot,383,I70634 (100%); I70644 (96%); I70734 (87%); I70334 (86%); I70744 (83%)
I70635,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of other part of foot,263,I70635 (100%); I70645 (95%); I70633 (87%); I70638 (86%); I70639 (85%)
I70635,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of other part of foot,383,I70635 (100%); I70645 (95%); I70633 (87%); I70638 (86%); I70639 (85%)
I70638,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of other part of lower leg,263,I70638 (100%); I70648 (96%); I70738 (88%); I70338 (86%); I70633 (86%)
I70638,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of other part of lower leg,383,I70638 (100%); I70648 (96%); I70738 (88%); I70338 (86%); I70633 (86%)
I70639,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of unspecified site,263,I70639 (100%); I70649 (95%); I70633 (85%); I70635 (85%); I70739 (85%)
I70639,Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of unspecified site,383,I70639 (100%); I70649 (95%); I70633 (85%); I70635 (85%); I70739 (85%)
I70641,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of thigh,263,I70641 (100%); I70631 (95%); I70741 (85%); I70643 (84%); I70645 (84%)
I70641,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of thigh,383,I70641 (100%); I70631 (95%); I70741 (85%); I70643 (84%); I70645 (84%)
I70642,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of calf,263,I70642 (100%); I70632 (95%); I70742 (85%); I70643 (84%); I70645 (84%)
I70642,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of calf,383,I70642 (100%); I70632 (95%); I70742 (85%); I70643 (84%); I70645 (84%)
I70643,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of ankle,263,I70643 (100%); I70633 (95%); I70645 (87%); I70648 (86%); I70649 (85%)
I70643,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of ankle,383,I70643 (100%); I70633 (95%); I70645 (87%); I70648 (86%); I70649 (85%)
I70644,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of heel and midfoot,263,I70644 (99%); I70634 (96%); I70744 (87%); I70344 (86%); I70734 (83%)
I70644,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of heel and midfoot,383,I70644 (99%); I70634 (96%); I70744 (87%); I70344 (86%); I70734 (83%)
I70645,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of other part of foot,263,I70645 (100%); I70635 (95%); I70643 (87%); I70648 (86%); I70649 (85%)
I70645,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of other part of foot,383,I70645 (100%); I70635 (95%); I70643 (87%); I70648 (86%); I70649 (85%)
I70648,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of other part of lower leg,263,I70648 (100%); I70638 (96%); I70748 (88%); I70348 (86%); I70643 (86%)
I70648,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of other part of lower leg,383,I70648 (100%); I70638 (96%); I70748 (88%); I70348 (86%); I70643 (86%)
I70649,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of unspecified site,263,I70649 (100%); I70639 (95%); I70643 (85%); I70645 (85%); I70749 (85%)
I70649,Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of unspecified site,383,I70649 (100%); I70639 (95%); I70643 (85%); I70645 (85%); I70749 (85%)
I7065,Atherosclerosis of nonbiological bypass graft(s) of other extremity with ulceration,263,I7065 (100%); I7075 (81%); I7035 (80%); I70643 (77%); I70633 (77%)
I7065,Atherosclerosis of nonbiological bypass graft(s) of other extremity with ulceration,383,I7065 (100%); I7075 (81%); I7035 (80%); I70643 (77%); I70633 (77%)
I70661,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, right leg",263,I70621 (73%); I70638 (70%); I70622 (69%); I70633 (69%); I70635 (69%)
I70662,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, left leg",263,I70622 (73%); I70648 (70%); I70621 (69%); I70643 (69%); I70645 (69%)
I70663,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, bilateral legs",263,I70623 (78%); I70723 (66%); I70323 (66%); I70423 (61%); I70523 (59%)
I70668,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, other extremity",263,I7065 (73%); I70628 (72%); I70629 (72%); I70622 (61%); I70621 (61%)
I70669,"Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, unspecified extremity",263,I70629 (73%); I7065 (72%); I70628 (72%); I70622 (60%); I70621 (60%)
I70691,"Other atherosclerosis of nonbiological bypass graft(s) of the extremities, right leg",,
I70692,"Other atherosclerosis of nonbiological bypass graft(s) of the extremities, left leg",,
I70693,"Other atherosclerosis of nonbiological bypass graft(s) of the extremities, bilateral legs",,
I70698,"Other atherosclerosis of nonbiological bypass graft(s) of the extremities, other extremity",,
I70699,"Other atherosclerosis of nonbiological bypass graft(s) of the extremities, unspecified extremity",,
I70701,"Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, right leg",,
I70702,"Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, left leg",,
I70703,"Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, bilateral legs",,
I70708,"Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, other extremity",,
I70709,"Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, unspecified extremity",,
I70711,"Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, right leg",,
I70712,"Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, left leg",,
I70713,"Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, bilateral legs",,
I70718,"Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, other extremity",,
I70719,"Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, unspecified extremity",,
I70721,"Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, right leg",264,I70761 (69%); I70361 (68%); I70762 (65%); I70362 (64%); I70661 (59%)
I70722,"Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, left leg",264,I70762 (69%); I70362 (68%); I70761 (65%); I70361 (64%); I70662 (59%)
I70723,"Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, bilateral legs",264,I70763 (75%); I70363 (74%); I70663 (66%); I70463 (64%); I70563 (62%)
I70728,"Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, other extremity",264,I70768 (69%); I70368 (68%); I70769 (68%); I70369 (65%); I7075 (60%)
I70729,"Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, unspecified extremity",264,I70368 (69%); I70769 (69%); I70369 (69%); I70768 (68%); I7035 (62%)
I70731,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of thigh,263,I70731 (100%); I70331 (98%); I70741 (94%); I70341 (93%); I70631 (85%)
I70731,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of thigh,383,I70731 (100%); I70331 (98%); I70741 (94%); I70341 (93%); I70631 (85%)
I70732,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of calf,263,I70732 (100%); I70332 (98%); I70742 (94%); I70342 (93%); I70632 (85%)
I70732,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of calf,383,I70732 (100%); I70332 (98%); I70742 (94%); I70342 (93%); I70632 (85%)
I70733,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of ankle,263,I70733 (100%); I70333 (98%); I70743 (94%); I70343 (92%); I70735 (85%)
I70733,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of ankle,383,I70733 (100%); I70333 (98%); I70743 (94%); I70343 (92%); I70735 (85%)
I70734,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of heel and midfoot,263,I70734 (100%); I70334 (98%); I70744 (95%); I70344 (94%); I70634 (87%)
I70734,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of heel and midfoot,383,I70734 (100%); I70334 (98%); I70744 (95%); I70344 (94%); I70634 (87%)
I70735,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of other part of foot,263,I70735 (100%); I70335 (98%); I70745 (94%); I70345 (92%); I70733 (85%)
I70735,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of other part of foot,383,I70735 (100%); I70335 (98%); I70745 (94%); I70345 (92%); I70733 (85%)
I70738,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of other part of lower leg,263,I70738 (100%); I70338 (98%); I70748 (95%); I70348 (94%); I70638 (88%)
I70738,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of other part of lower leg,383,I70738 (100%); I70338 (98%); I70748 (95%); I70348 (94%); I70638 (88%)
I70739,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of unspecified site,263,I70739 (100%); I70339 (98%); I70749 (94%); I70349 (93%); I70639 (85%)
I70739,Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of unspecified site,383,I70739 (100%); I70339 (98%); I70749 (94%); I70349 (93%); I70639 (85%)
I70741,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of thigh,263,I70741 (100%); I70341 (98%); I70731 (94%); I70331 (93%); I70641 (85%)
I70741,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of thigh,383,I70741 (100%); I70341 (98%); I70731 (94%); I70331 (93%); I70641 (85%)
I70742,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of calf,263,I70742 (100%); I70342 (98%); I70732 (94%); I70332 (93%); I70642 (85%)
I70742,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of calf,383,I70742 (100%); I70342 (98%); I70732 (94%); I70332 (93%); I70642 (85%)
I70743,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of ankle,263,I70743 (100%); I70343 (98%); I70733 (94%); I70333 (92%); I70745 (85%)
I70743,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of ankle,383,I70743 (100%); I70343 (98%); I70733 (94%); I70333 (92%); I70745 (85%)
I70744,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of heel and midfoot,263,I70744 (100%); I70344 (98%); I70734 (95%); I70334 (94%); I70644 (87%)
I70744,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of heel and midfoot,383,I70744 (100%); I70344 (98%); I70734 (95%); I70334 (94%); I70644 (87%)
I70745,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of other part of foot,263,I70745 (100%); I70345 (98%); I70735 (94%); I70335 (92%); I70743 (85%)
I70745,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of other part of foot,383,I70745 (100%); I70345 (98%); I70735 (94%); I70335 (92%); I70743 (85%)
I70748,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of other part of lower leg,263,I70748 (100%); I70348 (98%); I70738 (95%); I70338 (94%); I70648 (88%)
I70748,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of other part of lower leg,383,I70748 (100%); I70348 (98%); I70738 (95%); I70338 (94%); I70648 (88%)
I70749,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of unspecified site,263,I70749 (100%); I70349 (98%); I70739 (94%); I70339 (93%); I70649 (85%)
I70749,Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of unspecified site,383,I70749 (100%); I70349 (98%); I70739 (94%); I70339 (93%); I70649 (85%)
I7075,Atherosclerosis of other type of bypass graft(s) of other extremity with ulceration,263,I7075 (100%); I7035 (98%); I7065 (81%); I7045 (76%); I70743 (73%)
I7075,Atherosclerosis of other type of bypass graft(s) of other extremity with ulceration,383,I7075 (100%); I7035 (98%); I7065 (81%); I7045 (76%); I70743 (73%)
I70761,"Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, right leg",263,I70721 (69%); I70321 (68%); I70738 (65%); I70722 (65%); I70338 (64%)
I70762,"Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, left leg",263,I70722 (69%); I70322 (68%); I70748 (65%); I70721 (65%); I70348 (64%)
I70763,"Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, bilateral legs",263,I70723 (75%); I70323 (75%); I70623 (67%); I70423 (65%); I70523 (63%)
I70768,"Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, other extremity",263,I70728 (69%); I7075 (68%); I70328 (68%); I70729 (68%); I7035 (67%)
I70769,"Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, unspecified extremity",263,I70329 (70%); I70328 (69%); I70729 (69%); I7035 (69%); I70728 (68%)
I70791,"Other atherosclerosis of other type of bypass graft(s) of the extremities, right leg",,
I70792,"Other atherosclerosis of other type of bypass graft(s) of the extremities, left leg",,
I70793,"Other atherosclerosis of other type of bypass graft(s) of the extremities, bilateral legs",,
I70798,"Other atherosclerosis of other type of bypass graft(s) of the extremities, other extremity",,
I70799,"Other atherosclerosis of other type of bypass graft(s) of the extremities, unspecified extremity",,
I7092,Chronic total occlusion of artery of the extremities,,
I7100,Dissection of unspecified site of aorta,264,C8510 (31%); M0890 (30%); C6990 (29%); M8660 (29%); C8190 (29%)
I71010,Dissection of ascending aorta,264,C182 (41%); C7A022 (35%); D3A022 (32%); A0104 (0%); A0105 (0%)
I71011,Dissection of aortic arch,264,M314 (58%); S12030B (32%); S12031B (32%); S12030A (32%); S12031A (32%)
I71012,Dissection of descending thoracic aorta,264,C186 (38%); C7A024 (31%); D3A024 (29%); I2102 (21%); M4624 (18%)
I71019,"Dissection of thoracic aorta, unspecified",264,S22009B (27%); S22009A (27%); S24109A (25%); S22008B (25%); S22019B (25%)
I7102,Dissection of abdominal aorta,264,C8513 (24%); C8173 (24%); C8193 (23%); C8293 (23%); C772 (23%)
I7103,Dissection of thoracoabdominal aorta,264,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
I7110,"Thoracic aortic aneurysm, ruptured, unspecified",264,I281 (35%); C755 (28%); M314 (26%); D447 (23%); S22009B (23%)
I7111,"Aneurysm of the ascending aorta, ruptured",264,C182 (37%); I281 (32%); C7A022 (31%); D3A022 (29%); A0104 (0%)
I7112,"Aneurysm of the aortic arch, ruptured",264,M314 (52%); I281 (32%); S12030B (28%); S12031B (28%); S12030A (28%)
I7113,"Aneurysm of the descending thoracic aorta, ruptured",264,C186 (34%); I281 (31%); C7A024 (28%); D3A024 (27%); I2102 (19%)
I7120,"Thoracic aortic aneurysm, without rupture, unspecified",,
I7121,"Aneurysm of the ascending aorta, without rupture",,
I7122,"Aneurysm of the aortic arch, without rupture",,
I7123,"Aneurysm of the descending thoracic aorta, without rupture",,
I7130,"Abdominal aortic aneurysm, ruptured, unspecified",264,I281 (34%); C755 (27%); M314 (25%); C8513 (23%); D447 (23%)
I7131,"Pararenal abdominal aortic aneurysm, ruptured",264,I281 (29%); C755 (23%); M314 (21%); D447 (19%); C8513 (17%)
I7132,"Juxtarenal abdominal aortic aneurysm, ruptured",264,I281 (29%); C755 (23%); M314 (21%); D447 (19%); C8513 (17%)
I7133,"Infrarenal abdominal aortic aneurysm, ruptured",264,I281 (29%); C755 (23%); M314 (21%); D447 (19%); C8513 (17%)
I7140,"Abdominal aortic aneurysm, without rupture, unspecified",,
I7141,"Pararenal abdominal aortic aneurysm, without rupture",,
I7142,"Juxtarenal abdominal aortic aneurysm, without rupture",,
I7143,"Infrarenal abdominal aortic aneurysm, without rupture",,
I7150,"Thoracoabdominal aortic aneurysm, ruptured, unspecified",264,I281 (32%); C755 (25%); M314 (23%); D447 (21%); G8330 (7%)
I7151,"Supraceliac aneurysm of the thoracoabdominal aorta, ruptured",264,I281 (27%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
I7152,"Paravisceral aneurysm of the thoracoabdominal aorta, ruptured",264,I281 (27%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
I7160,"Thoracoabdominal aortic aneurysm, without rupture, unspecified",,
I7161,"Supraceliac aneurysm of the thoracoabdominal aorta, without rupture",,
I7162,"Paravisceral aneurysm of the thoracoabdominal aorta, without rupture",,
I718,"Aortic aneurysm of unspecified site, ruptured",264,I281 (35%); C755 (28%); C8510 (26%); M0890 (26%); M314 (26%)
I719,"Aortic aneurysm of unspecified site, without rupture",,
I720,Aneurysm of carotid artery,,
I721,Aneurysm of artery of upper extremity,,
I722,Aneurysm of renal artery,,
I723,Aneurysm of iliac artery,,
I724,Aneurysm of artery of lower extremity,,
I725,Aneurysm of other precerebral arteries,,
I726,Aneurysm of vertebral artery,,
I728,Aneurysm of other specified arteries,,
I729,Aneurysm of unspecified site,,
I7301,Raynaud's syndrome with gangrene,263,J850 (32%); N493 (28%); E340 (22%); E1051 (22%); E1052 (22%)
I731,Thromboangiitis obliterans [Buerger's disease],,
I7381,Erythromelalgia,,
I7389,Other specified peripheral vascular diseases,,
I739,"Peripheral vascular disease, unspecified",,
I7401,Saddle embolus of abdominal aorta,264,I2602 (51%); I2692 (51%); C8513 (19%); C8173 (19%); C8193 (19%)
I7409,Other arterial embolism and thrombosis of abdominal aorta,264,I2721 (36%); I82291 (29%); I823 (29%); I82290 (29%); I82519 (27%)
I7410,Embolism and thrombosis of unspecified parts of aorta,264,S128XXA (39%); I82519 (35%); I82A29 (35%); I82529 (35%); I82539 (35%)
I7411,Embolism and thrombosis of thoracic aorta,264,I82291 (60%); I82290 (58%); I823 (38%); I82519 (35%); I82A29 (35%)
I7419,Embolism and thrombosis of other parts of aorta,264,S128XXA (39%); I82291 (35%); I823 (35%); I82290 (34%); C257 (33%)
I742,Embolism and thrombosis of arteries of the upper extremities,264,I7025 (46%); I7025 (46%); I82729 (44%); I82722 (44%); I82721 (44%)
I743,Embolism and thrombosis of arteries of the lower extremities,264,I7025 (47%); I7025 (47%); I70268 (42%); I70262 (42%); I70261 (42%)
I744,"Embolism and thrombosis of arteries of extremities, unspecified",264,I7025 (50%); I7025 (50%); I70269 (47%); I70268 (44%); I70262 (44%)
I745,Embolism and thrombosis of iliac artery,264,I82529 (74%); I82522 (73%); I82521 (73%); I82429 (72%); I82422 (71%)
I748,Embolism and thrombosis of other arteries,264,I63033 (48%); I63133 (48%); I82291 (48%); I823 (48%); I63343 (47%)
I749,Embolism and thrombosis of unspecified artery,264,I63039 (51%); I63139 (51%); I63349 (50%); I63019 (50%); I63449 (50%)
I75011,Atheroembolism of right upper extremity,264,T870X1 (41%); T8751 (41%); T8741 (40%); I82721 (37%); I82621 (37%)
I75012,Atheroembolism of left upper extremity,264,T870X2 (41%); T8752 (41%); T8742 (40%); I82722 (37%); I82622 (37%)
I75013,Atheroembolism of bilateral upper extremities,264,I70763 (32%); I70363 (31%); I70263 (30%); I70663 (30%); I80203 (30%)
I75019,Atheroembolism of unspecified upper extremity,264,T870X9 (40%); I82729 (36%); T870X2 (35%); T870X1 (35%); I82629 (35%)
I75021,Atheroembolism of right lower extremity,264,I83218 (49%); I83208 (44%); I83228 (44%); I83018 (43%); I87011 (38%)
I75022,Atheroembolism of left lower extremity,264,I83228 (49%); I83208 (44%); I83218 (44%); I83028 (43%); I87012 (38%)
I75023,Atheroembolism of bilateral lower extremities,264,I80203 (39%); I70763 (33%); I70363 (32%); I70263 (31%); I70663 (31%)
I75029,Atheroembolism of unspecified lower extremity,264,I83208 (48%); I83228 (45%); I83218 (45%); I83008 (41%); I83028 (38%)
I7581,Atheroembolism of kidney,264,N185 (42%); N1830 (41%); I130 (40%); C7A093 (38%); E1022 (38%)
I7589,Atheroembolism of other site,264,M868X8 (39%); M8788 (38%); M8668 (34%); M8660 (32%); M8618 (32%)
I76,Septic arterial embolism,264,I2601 (43%); I2690 (43%); I2721 (41%); R6520 (37%); R6521 (37%)
I770,"Arteriovenous fistula, acquired",,
I771,Stricture of artery,,
I772,Rupture of artery,,
I773,Arterial fibromuscular dysplasia,,
I774,Celiac artery compression syndrome,,
I775,Necrosis of artery,,
I776,"Arteritis, unspecified",,
I7770,Dissection of unspecified artery,,
I7771,Dissection of carotid artery,,
I7772,Dissection of iliac artery,,
I7773,Dissection of renal artery,,
I7774,Dissection of vertebral artery,,
I7775,Dissection of other precerebral arteries,,
I7776,Dissection of artery of upper extremity,,
I7777,Dissection of artery of lower extremity,,
I7779,Dissection of other specified artery,,
I77810,Thoracic aortic ectasia,,
I77811,Abdominal aortic ectasia,,
I77812,Thoracoabdominal aortic ectasia,,
I77819,"Aortic ectasia, unspecified site",,
I7782,Antineutrophilic cytoplasmic antibody [ANCA] vasculitis,93,G3781 (21%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
I7789,Other specified disorders of arteries and arterioles,,
I779,"Disorder of arteries and arterioles, unspecified",,
I780,Hereditary hemorrhagic telangiectasia,,
I790,Aneurysm of aorta in diseases classified elsewhere,,
I791,Aortitis in diseases classified elsewhere,,
I798,"Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere",,
I8010,Phlebitis and thrombophlebitis of unspecified femoral vein,267,M84756A (27%); M84759A (27%); M84755A (25%); M84754A (25%); M84758A (24%)
I8011,Phlebitis and thrombophlebitis of right femoral vein,267,M84754A (29%); M84757A (28%); M84756A (25%); M84755A (24%); M84759A (24%)
I8012,Phlebitis and thrombophlebitis of left femoral vein,267,M84755A (29%); M84758A (28%); M84756A (25%); M84754A (24%); M84759A (24%)
I8013,"Phlebitis and thrombophlebitis of femoral vein, bilateral",267,H348132 (25%); H348130 (25%); M84756A (24%); M84755A (23%); M84754A (23%)
I80201,Phlebitis and thrombophlebitis of unspecified deep vessels of right lower extremity,267,I289 (37%); I288 (33%); I83218 (33%); I83208 (31%); I75021 (30%)
I80202,Phlebitis and thrombophlebitis of unspecified deep vessels of left lower extremity,267,I289 (37%); I288 (33%); I83228 (33%); I83208 (31%); I75022 (30%)
I80203,"Phlebitis and thrombophlebitis of unspecified deep vessels of lower extremities, bilateral",267,I75023 (39%); I289 (35%); I288 (31%); I75013 (30%); I743 (26%)
I80209,Phlebitis and thrombophlebitis of unspecified deep vessels of unspecified lower extremity,267,I289 (39%); I83208 (33%); I288 (33%); I75029 (31%); I83008 (29%)
I80211,Phlebitis and thrombophlebitis of right iliac vein,267,I745 (36%); H348112 (18%); H348110 (17%); I70433 (17%); I70433 (17%)
I80212,Phlebitis and thrombophlebitis of left iliac vein,267,I745 (36%); H348122 (18%); H348120 (17%); I70443 (17%); I70443 (17%)
I80213,"Phlebitis and thrombophlebitis of iliac vein, bilateral",267,I745 (34%); H348132 (25%); H348130 (25%); H348332 (21%); H348330 (21%)
I80219,Phlebitis and thrombophlebitis of unspecified iliac vein,267,I745 (36%); H348192 (16%); H348190 (16%); I70449 (15%); I70449 (15%)
I80221,Phlebitis and thrombophlebitis of right popliteal vein,267,H348112 (18%); H348110 (17%); I70433 (17%); I70433 (17%); I70435 (17%)
I80222,Phlebitis and thrombophlebitis of left popliteal vein,267,H348122 (18%); H348120 (17%); I70443 (17%); I70443 (17%); I70445 (17%)
I80223,"Phlebitis and thrombophlebitis of popliteal vein, bilateral",267,H348132 (25%); H348130 (25%); H348332 (21%); H348330 (21%); I70463 (20%)
I80229,Phlebitis and thrombophlebitis of unspecified popliteal vein,267,H348192 (16%); H348190 (16%); I70449 (15%); I70449 (15%); I70439 (15%)
I80231,Phlebitis and thrombophlebitis of right tibial vein,267,H348112 (18%); H348110 (17%); I70433 (17%); I70433 (17%); I70435 (17%)
I80232,Phlebitis and thrombophlebitis of left tibial vein,267,H348122 (18%); H348120 (17%); I70443 (17%); I70443 (17%); I70445 (17%)
I80233,"Phlebitis and thrombophlebitis of tibial vein, bilateral",267,H348132 (25%); H348130 (25%); H348332 (21%); H348330 (21%); I70463 (20%)
I80239,Phlebitis and thrombophlebitis of unspecified tibial vein,267,H348192 (16%); H348190 (16%); I70449 (15%); I70449 (15%); I70439 (15%)
I80241,Phlebitis and thrombophlebitis of right peroneal vein,267,H348112 (18%); H348110 (17%); I70433 (17%); I70433 (17%); I70435 (17%)
I80242,Phlebitis and thrombophlebitis of left peroneal vein,267,H348122 (18%); H348120 (17%); I70443 (17%); I70443 (17%); I70445 (17%)
I80243,"Phlebitis and thrombophlebitis of peroneal vein, bilateral",267,H348132 (25%); H348130 (25%); H348332 (21%); H348330 (21%); I70463 (20%)
I80249,Phlebitis and thrombophlebitis of unspecified peroneal vein,267,H348192 (16%); H348190 (16%); I70449 (15%); I70449 (15%); I70439 (15%)
I80251,Phlebitis and thrombophlebitis of right calf muscular vein,267,I70432 (32%); I70432 (32%); G7100 (30%); I70442 (28%); I70442 (28%)
I80252,Phlebitis and thrombophlebitis of left calf muscular vein,267,I70442 (32%); I70442 (32%); G7100 (30%); I70432 (28%); I70432 (28%)
I80253,"Phlebitis and thrombophlebitis of calf muscular vein, bilateral",267,G7100 (29%); I70442 (27%); I70442 (27%); I70432 (27%); I70432 (27%)
I80259,Phlebitis and thrombophlebitis of unspecified calf muscular vein,267,G7100 (34%); G129 (29%); I70442 (28%); I70442 (28%); I70432 (28%)
I80291,Phlebitis and thrombophlebitis of other deep vessels of right lower extremity,267,I289 (34%); I288 (33%); I83218 (33%); I75021 (30%); I83208 (30%)
I80292,Phlebitis and thrombophlebitis of other deep vessels of left lower extremity,267,I289 (34%); I288 (33%); I83228 (33%); I75022 (30%); I83208 (30%)
I80293,"Phlebitis and thrombophlebitis of other deep vessels of lower extremity, bilateral",267,I289 (33%); I288 (32%); I87013 (31%); I83208 (29%); I83228 (29%)
I80299,Phlebitis and thrombophlebitis of other deep vessels of unspecified lower extremity,267,I289 (38%); I288 (34%); I83208 (32%); I83228 (30%); I83218 (30%)
I820,Budd-Chiari syndrome,267,Q0702 (46%); Q0701 (40%); Q0700 (37%); Q0703 (37%); E340 (20%)
I82210,Acute embolism and thrombosis of superior vena cava,267,I749 (32%); I748 (32%); I744 (26%); C110 (26%); I7411 (25%)
I82211,Chronic embolism and thrombosis of superior vena cava,267,I749 (32%); I748 (32%); I744 (27%); C110 (26%); I7411 (26%)
I82220,Acute embolism and thrombosis of inferior vena cava,267,I749 (31%); I748 (31%); I744 (26%); I7411 (25%); I745 (25%)
I82221,Chronic embolism and thrombosis of inferior vena cava,267,I749 (32%); I748 (32%); I744 (26%); I7411 (25%); I745 (25%)
I82290,Acute embolism and thrombosis of other thoracic veins,267,I7411 (58%); I749 (47%); I748 (46%); I744 (38%); I745 (37%)
I82291,Chronic embolism and thrombosis of other thoracic veins,267,I7411 (60%); I749 (48%); I748 (48%); I744 (39%); I745 (38%)
I823,Embolism and thrombosis of renal vein,267,I749 (48%); I748 (48%); N186 (40%); C659 (40%); C652 (39%)
I82401,Acute embolism and thrombosis of unspecified deep veins of right lower extremity,267,I83218 (49%); I83208 (48%); I83018 (48%); I83019 (47%); I83008 (47%)
I82402,Acute embolism and thrombosis of unspecified deep veins of left lower extremity,267,I83228 (49%); I83208 (48%); I83028 (48%); I83029 (47%); I83008 (47%)
I82403,"Acute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral",267,I83208 (46%); I83008 (45%); I83228 (44%); I83218 (44%); I83009 (43%)
I82409,Acute embolism and thrombosis of unspecified deep veins of unspecified lower extremity,267,I83208 (49%); I83009 (49%); I83008 (48%); I83003 (46%); I83005 (46%)
I82411,Acute embolism and thrombosis of right femoral vein,267,I749 (43%); I748 (43%); I744 (35%); I7411 (34%); I745 (34%)
I82412,Acute embolism and thrombosis of left femoral vein,267,I749 (43%); I748 (43%); I744 (35%); I7411 (34%); I745 (34%)
I82413,"Acute embolism and thrombosis of femoral vein, bilateral",267,I749 (41%); I748 (41%); I744 (34%); I7411 (33%); I745 (32%)
I82419,Acute embolism and thrombosis of unspecified femoral vein,267,I749 (48%); I748 (43%); I744 (39%); I7410 (35%); I7411 (35%)
I82421,Acute embolism and thrombosis of right iliac vein,267,I745 (71%); I749 (42%); I748 (42%); I744 (35%); I7411 (34%)
I82422,Acute embolism and thrombosis of left iliac vein,267,I745 (71%); I749 (42%); I748 (42%); I744 (35%); I7411 (34%)
I82423,"Acute embolism and thrombosis of iliac vein, bilateral",267,I745 (68%); I749 (41%); I748 (40%); I744 (33%); I7411 (32%)
I82429,Acute embolism and thrombosis of unspecified iliac vein,267,I745 (72%); I749 (47%); I748 (43%); I744 (39%); I7410 (34%)
I82431,Acute embolism and thrombosis of right popliteal vein,267,I749 (42%); I748 (42%); I744 (35%); I7411 (33%); I745 (33%)
I82432,Acute embolism and thrombosis of left popliteal vein,267,I749 (42%); I748 (42%); I744 (35%); I7411 (33%); I745 (33%)
I82433,"Acute embolism and thrombosis of popliteal vein, bilateral",267,I749 (40%); I748 (40%); I744 (33%); I7411 (32%); I745 (32%)
I82439,Acute embolism and thrombosis of unspecified popliteal vein,267,I749 (47%); I748 (42%); I744 (39%); I7410 (34%); I7411 (34%)
I82441,Acute embolism and thrombosis of right tibial vein,267,I749 (42%); I748 (42%); I744 (35%); I7411 (33%); I745 (33%)
I82442,Acute embolism and thrombosis of left tibial vein,267,I749 (42%); I748 (42%); I744 (35%); I7411 (33%); I745 (33%)
I82443,"Acute embolism and thrombosis of tibial vein, bilateral",267,I749 (40%); I748 (40%); I744 (33%); I7411 (32%); I745 (32%)
I82449,Acute embolism and thrombosis of unspecified tibial vein,267,I749 (47%); I748 (42%); I744 (39%); I7410 (34%); I7411 (34%)
I82451,Acute embolism and thrombosis of right peroneal vein,267,I749 (42%); I748 (42%); I744 (35%); I7411 (33%); I745 (33%)
I82452,Acute embolism and thrombosis of left peroneal vein,267,I749 (42%); I748 (42%); I744 (35%); I7411 (33%); I745 (33%)
I82453,"Acute embolism and thrombosis of peroneal vein, bilateral",267,I749 (40%); I748 (40%); I744 (33%); I7411 (32%); I745 (32%)
I82459,Acute embolism and thrombosis of unspecified peroneal vein,267,I749 (47%); I748 (42%); I744 (39%); I7410 (34%); I7411 (34%)
I82461,Acute embolism and thrombosis of right calf muscular vein,267,I749 (40%); I748 (39%); I70432 (34%); I70432 (34%); I744 (32%)
I82462,Acute embolism and thrombosis of left calf muscular vein,267,I749 (40%); I748 (39%); I70442 (34%); I70442 (34%); I744 (32%)
I82463,"Acute embolism and thrombosis of calf muscular vein, bilateral",267,I749 (38%); I748 (38%); I744 (31%); G7100 (30%); I7411 (30%)
I82469,Acute embolism and thrombosis of unspecified calf muscular vein,267,I749 (44%); I748 (40%); I744 (36%); G7100 (35%); I7410 (32%)
I82491,Acute embolism and thrombosis of other specified deep vein of right lower extremity,267,I743 (39%); I749 (38%); I748 (37%); I83218 (35%); I75021 (33%)
I82492,Acute embolism and thrombosis of other specified deep vein of left lower extremity,267,I743 (39%); I749 (38%); I748 (37%); I83228 (35%); I75022 (33%)
I82493,"Acute embolism and thrombosis of other specified deep vein of lower extremity, bilateral",267,I743 (38%); I749 (36%); I748 (36%); I87013 (33%); I83208 (31%)
I82499,Acute embolism and thrombosis of other specified deep vein of unspecified lower extremity,267,I749 (42%); I743 (39%); I748 (38%); I83208 (34%); I744 (34%)
I824Y1,Acute embolism and thrombosis of unspecified deep veins of right proximal lower extremity,267,I83218 (43%); I83208 (42%); I83018 (42%); I83019 (41%); I83008 (41%)
I824Y2,Acute embolism and thrombosis of unspecified deep veins of left proximal lower extremity,267,I83228 (43%); I83208 (42%); I83028 (42%); I83029 (41%); I83008 (41%)
I824Y3,"Acute embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral",267,I83208 (41%); I83008 (39%); I83228 (39%); I83218 (39%); I83009 (37%)
I824Y9,Acute embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity,267,I83208 (43%); I83009 (43%); I83008 (42%); I83003 (40%); I83005 (40%)
I824Z1,Acute embolism and thrombosis of unspecified deep veins of right distal lower extremity,267,I83218 (43%); I83208 (42%); I83018 (42%); I83019 (41%); I83008 (41%)
I824Z2,Acute embolism and thrombosis of unspecified deep veins of left distal lower extremity,267,I83228 (43%); I83208 (42%); I83028 (42%); I83029 (41%); I83008 (41%)
I824Z3,"Acute embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral",267,I83208 (41%); I83008 (40%); I83228 (39%); I83218 (39%); I83009 (38%)
I824Z9,Acute embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity,267,I83208 (43%); I83009 (43%); I83008 (42%); I83003 (40%); I83005 (40%)
I82501,Chronic embolism and thrombosis of unspecified deep veins of right lower extremity,267,I83218 (50%); I83208 (49%); I83018 (49%); I83019 (48%); I83008 (47%)
I82502,Chronic embolism and thrombosis of unspecified deep veins of left lower extremity,267,I83228 (50%); I83208 (49%); I83028 (49%); I83029 (48%); I83008 (48%)
I82503,"Chronic embolism and thrombosis of unspecified deep veins of lower extremity, bilateral",267,I83208 (47%); I83008 (46%); I83228 (45%); I83218 (45%); I83009 (43%)
I82509,Chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity,267,I83208 (50%); I83009 (50%); I83008 (49%); I83003 (47%); I83005 (47%)
I82511,Chronic embolism and thrombosis of right femoral vein,267,I749 (44%); I748 (44%); I744 (36%); I7411 (35%); I745 (35%)
I82512,Chronic embolism and thrombosis of left femoral vein,267,I749 (44%); I748 (44%); I744 (36%); I7411 (35%); I745 (35%)
I82513,"Chronic embolism and thrombosis of femoral vein, bilateral",267,I749 (42%); I748 (42%); I744 (34%); I7411 (33%); I745 (33%)
I82519,Chronic embolism and thrombosis of unspecified femoral vein,267,I749 (49%); I748 (44%); I744 (40%); I7410 (35%); I7411 (35%)
I82521,Chronic embolism and thrombosis of right iliac vein,267,I745 (73%); I749 (43%); I748 (43%); I744 (35%); I7411 (34%)
I82522,Chronic embolism and thrombosis of left iliac vein,267,I745 (73%); I749 (43%); I748 (43%); I744 (35%); I7411 (34%)
I82523,"Chronic embolism and thrombosis of iliac vein, bilateral",267,I745 (70%); I749 (41%); I748 (41%); I744 (34%); I7411 (33%)
I82529,Chronic embolism and thrombosis of unspecified iliac vein,267,I745 (74%); I749 (48%); I748 (44%); I744 (40%); I7410 (35%)
I82531,Chronic embolism and thrombosis of right popliteal vein,267,I749 (43%); I748 (43%); I744 (35%); I7411 (34%); I745 (34%)
I82532,Chronic embolism and thrombosis of left popliteal vein,267,I749 (43%); I748 (43%); I744 (35%); I7411 (34%); I745 (34%)
I82533,"Chronic embolism and thrombosis of popliteal vein, bilateral",267,I749 (41%); I748 (41%); I744 (34%); I7411 (33%); I745 (32%)
I82539,Chronic embolism and thrombosis of unspecified popliteal vein,267,I749 (48%); I748 (43%); I744 (39%); I7410 (35%); I7411 (35%)
I82541,Chronic embolism and thrombosis of right tibial vein,267,I749 (43%); I748 (43%); I744 (35%); I7411 (34%); I745 (34%)
I82542,Chronic embolism and thrombosis of left tibial vein,267,I749 (43%); I748 (43%); I744 (35%); I7411 (34%); I745 (34%)
I82543,"Chronic embolism and thrombosis of tibial vein, bilateral",267,I749 (41%); I748 (41%); I744 (34%); I7411 (33%); I745 (32%)
I82549,Chronic embolism and thrombosis of unspecified tibial vein,267,I749 (48%); I748 (43%); I744 (39%); I7410 (35%); I7411 (35%)
I82551,Chronic embolism and thrombosis of right peroneal vein,267,I749 (43%); I748 (43%); I744 (35%); I7411 (34%); I745 (34%)
I82552,Chronic embolism and thrombosis of left peroneal vein,267,I749 (43%); I748 (43%); I744 (35%); I7411 (34%); I745 (34%)
I82553,"Chronic embolism and thrombosis of peroneal vein, bilateral",267,I749 (41%); I748 (41%); I744 (34%); I7411 (33%); I745 (32%)
I82559,Chronic embolism and thrombosis of unspecified peroneal vein,267,I749 (48%); I748 (43%); I744 (39%); I7410 (35%); I7411 (35%)
I82561,Chronic embolism and thrombosis of right calf muscular vein,267,I749 (40%); I748 (40%); L97219 (35%); I70432 (34%); I70432 (34%)
I82562,Chronic embolism and thrombosis of left calf muscular vein,267,I749 (40%); I748 (40%); L97229 (35%); I70442 (34%); I70442 (34%)
I82563,"Chronic embolism and thrombosis of calf muscular vein, bilateral",267,I749 (39%); I748 (39%); I744 (32%); G7100 (31%); I7411 (31%)
I82569,Chronic embolism and thrombosis of unspecified calf muscular vein,267,I749 (45%); I748 (41%); I744 (37%); G7100 (36%); L97209 (35%)
I82591,Chronic embolism and thrombosis of other specified deep vein of right lower extremity,267,I743 (40%); I749 (38%); I748 (38%); I83218 (36%); I75021 (33%)
I82592,Chronic embolism and thrombosis of other specified deep vein of left lower extremity,267,I743 (40%); I749 (38%); I748 (38%); I83228 (36%); I75022 (33%)
I82593,"Chronic embolism and thrombosis of other specified deep vein of lower extremity, bilateral",267,I743 (38%); I749 (37%); I748 (37%); I87313 (34%); I87013 (34%)
I82599,Chronic embolism and thrombosis of other specified deep vein of unspecified lower extremity,267,I749 (43%); I743 (40%); I748 (39%); I83208 (35%); I744 (35%)
I825Y1,Chronic embolism and thrombosis of unspecified deep veins of right proximal lower extremity,267,I83218 (44%); I83208 (42%); I83018 (42%); I83019 (42%); I83008 (41%)
I825Y2,Chronic embolism and thrombosis of unspecified deep veins of left proximal lower extremity,267,I83228 (44%); I83208 (42%); I83028 (42%); I83029 (42%); I83008 (41%)
I825Y3,"Chronic embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral",267,I83208 (41%); I83008 (40%); I83228 (39%); I83218 (39%); I83009 (38%)
I825Y9,Chronic embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity,267,I83208 (44%); I83009 (43%); I83008 (43%); I83003 (41%); I83005 (41%)
I825Z1,Chronic embolism and thrombosis of unspecified deep veins of right distal lower extremity,267,I83218 (44%); I83208 (43%); I83018 (43%); I83019 (42%); I83008 (41%)
I825Z2,Chronic embolism and thrombosis of unspecified deep veins of left distal lower extremity,267,I83228 (44%); I83208 (43%); I83028 (43%); I83029 (42%); I83008 (41%)
I825Z3,"Chronic embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral",267,I83208 (41%); I83008 (40%); I83228 (39%); I83218 (39%); I83009 (38%)
I825Z9,Chronic embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity,267,I83208 (44%); I83009 (43%); I83008 (43%); I83003 (41%); I83005 (41%)
I82621,Acute embolism and thrombosis of deep veins of right upper extremity,267,I742 (43%); I749 (38%); I748 (38%); I75011 (37%); I83013 (36%)
I82622,Acute embolism and thrombosis of deep veins of left upper extremity,267,I742 (43%); I749 (38%); I748 (38%); I75012 (37%); I83023 (36%)
I82623,"Acute embolism and thrombosis of deep veins of upper extremity, bilateral",267,I742 (41%); I749 (37%); I748 (36%); I83208 (32%); I83228 (32%)
I82629,Acute embolism and thrombosis of deep veins of unspecified upper extremity,267,I742 (43%); I749 (42%); I748 (38%); I83009 (36%); I83208 (35%)
I82721,Chronic embolism and thrombosis of deep veins of right upper extremity,267,I742 (44%); I749 (39%); I748 (38%); I75011 (37%); I83013 (37%)
I82722,Chronic embolism and thrombosis of deep veins of left upper extremity,267,I742 (44%); I749 (39%); I748 (38%); I75012 (37%); I83023 (37%)
I82723,"Chronic embolism and thrombosis of deep veins of upper extremity, bilateral",267,I742 (42%); I749 (37%); I748 (37%); I83208 (32%); I83228 (32%)
I82729,Chronic embolism and thrombosis of deep veins of unspecified upper extremity,267,I742 (44%); I749 (43%); I748 (39%); I83009 (37%); I83208 (36%)
I82A11,Acute embolism and thrombosis of right axillary vein,267,I749 (42%); I748 (42%); I744 (35%); I7411 (34%); I745 (33%)
I82A12,Acute embolism and thrombosis of left axillary vein,267,I749 (42%); I748 (42%); I744 (35%); I7411 (34%); I745 (33%)
I82A13,"Acute embolism and thrombosis of axillary vein, bilateral",267,I749 (41%); I748 (40%); I744 (33%); I7411 (32%); I745 (32%)
I82A19,Acute embolism and thrombosis of unspecified axillary vein,267,I749 (47%); I748 (43%); I744 (39%); I7410 (34%); I7411 (34%)
I82A21,Chronic embolism and thrombosis of right axillary vein,267,I749 (43%); I748 (43%); I744 (36%); I7411 (34%); I745 (34%)
I82A22,Chronic embolism and thrombosis of left axillary vein,267,I749 (43%); I748 (43%); I744 (36%); I7411 (35%); I745 (34%)
I82A23,"Chronic embolism and thrombosis of axillary vein, bilateral",267,I749 (42%); I748 (41%); I744 (34%); I7411 (33%); I745 (33%)
I82A29,Chronic embolism and thrombosis of unspecified axillary vein,267,I749 (49%); I748 (44%); I744 (40%); I7410 (35%); I7411 (35%)
I82B11,Acute embolism and thrombosis of right subclavian vein,267,I749 (41%); I748 (41%); I744 (34%); I7411 (33%); I745 (33%)
I82B12,Acute embolism and thrombosis of left subclavian vein,267,I749 (41%); I748 (41%); I744 (34%); I7411 (33%); I745 (33%)
I82B13,"Acute embolism and thrombosis of subclavian vein, bilateral",267,I749 (40%); I748 (39%); I744 (32%); I7411 (31%); I745 (31%)
I82B19,Acute embolism and thrombosis of unspecified subclavian vein,267,I749 (46%); I748 (42%); I744 (38%); I7410 (33%); I7411 (33%)
I82B21,Chronic embolism and thrombosis of right subclavian vein,267,I749 (42%); I748 (42%); I744 (35%); I7411 (34%); I745 (33%)
I82B22,Chronic embolism and thrombosis of left subclavian vein,267,I749 (42%); I748 (42%); I744 (35%); I7411 (34%); I745 (33%)
I82B23,"Chronic embolism and thrombosis of subclavian vein, bilateral",267,I749 (41%); I748 (40%); I744 (33%); I7411 (32%); I745 (32%)
I82B29,Chronic embolism and thrombosis of unspecified subclavian vein,267,I749 (47%); I748 (43%); I744 (39%); I7410 (34%); I7411 (34%)
I82C11,Acute embolism and thrombosis of right internal jugular vein,267,I749 (37%); I748 (36%); I744 (30%); I7411 (29%); I745 (29%)
I82C12,Acute embolism and thrombosis of left internal jugular vein,267,I749 (37%); I748 (36%); I744 (30%); I7411 (29%); I745 (29%)
I82C13,"Acute embolism and thrombosis of internal jugular vein, bilateral",267,I749 (35%); I748 (35%); I744 (29%); I7411 (28%); I745 (28%)
I82C19,Acute embolism and thrombosis of unspecified internal jugular vein,267,I749 (41%); I748 (37%); I744 (33%); I7410 (29%); I7411 (29%)
I82C21,Chronic embolism and thrombosis of right internal jugular vein,267,I749 (37%); I748 (37%); I744 (31%); I7411 (30%); I745 (29%)
I82C22,Chronic embolism and thrombosis of left internal jugular vein,267,I749 (37%); I748 (37%); I744 (31%); I7411 (30%); I745 (29%)
I82C23,"Chronic embolism and thrombosis of internal jugular vein, bilateral",267,I749 (36%); I748 (36%); I744 (29%); I7411 (29%); I745 (28%)
I82C29,Chronic embolism and thrombosis of unspecified internal jugular vein,267,I749 (42%); I748 (37%); I744 (34%); I7410 (30%); I7411 (30%)
I83001,Varicose veins of unspecified lower extremity with ulcer of thigh,383,I82509 (45%); I82409 (44%); I82502 (43%); I82501 (43%); I82402 (42%)
I83002,Varicose veins of unspecified lower extremity with ulcer of calf,383,I82509 (45%); I82409 (44%); I82502 (43%); I82501 (43%); I82402 (42%)
I83003,Varicose veins of unspecified lower extremity with ulcer of ankle,383,I82509 (47%); I82409 (46%); I82502 (45%); I82501 (45%); I82402 (44%)
I83004,Varicose veins of unspecified lower extremity with ulcer of heel and midfoot,383,L97404 (44%); L97403 (44%); L97424 (42%); L97414 (42%); L97423 (41%)
I83005,Varicose veins of unspecified lower extremity with ulcer other part of foot,383,I82509 (47%); I82409 (46%); I82502 (45%); I82501 (45%); I82402 (44%)
I83008,Varicose veins of unspecified lower extremity with ulcer other part of lower leg,383,I82509 (49%); I82409 (48%); I82502 (48%); I82501 (47%); I82402 (47%)
I83009,Varicose veins of unspecified lower extremity with ulcer of unspecified site,383,I82509 (50%); I82409 (49%); I82502 (45%); I82501 (45%); I82402 (44%)
I83011,Varicose veins of right lower extremity with ulcer of thigh,383,I82501 (45%); I82401 (44%); I82502 (40%); I82509 (39%); I82402 (39%)
I83012,Varicose veins of right lower extremity with ulcer of calf,383,I82501 (45%); I82401 (44%); I82502 (40%); I82509 (39%); I82402 (39%)
I83013,Varicose veins of right lower extremity with ulcer of ankle,383,I82501 (46%); I82401 (45%); I82502 (41%); I82509 (41%); I82402 (40%)
I83014,Varicose veins of right lower extremity with ulcer of heel and midfoot,383,L97414 (45%); L97413 (45%); L97404 (42%); L97403 (41%); L97424 (41%)
I83015,Varicose veins of right lower extremity with ulcer other part of foot,383,I82501 (46%); I82401 (45%); I82502 (41%); I82509 (41%); I82402 (40%)
I83018,Varicose veins of right lower extremity with ulcer other part of lower leg,383,I82501 (49%); I82401 (48%); M868X6 (46%); I82502 (44%); I82509 (44%)
I83019,Varicose veins of right lower extremity with ulcer of unspecified site,383,I82501 (48%); I82401 (47%); I82509 (45%); I82409 (44%); I82502 (43%)
I83021,Varicose veins of left lower extremity with ulcer of thigh,383,I82502 (45%); I82402 (44%); I82501 (40%); I82509 (39%); I82401 (39%)
I83022,Varicose veins of left lower extremity with ulcer of calf,383,I82502 (45%); I82402 (44%); I82501 (40%); I82509 (39%); I82401 (39%)
I83023,Varicose veins of left lower extremity with ulcer of ankle,383,I82502 (46%); I82402 (45%); I82501 (41%); I82509 (41%); I82401 (40%)
I83024,Varicose veins of left lower extremity with ulcer of heel and midfoot,383,L97424 (45%); L97423 (45%); L97404 (42%); L97403 (41%); L97414 (41%)
I83025,Varicose veins of left lower extremity with ulcer other part of foot,383,I82502 (46%); I82402 (45%); I82501 (41%); I82509 (41%); I82401 (40%)
I83028,Varicose veins of left lower extremity with ulcer other part of lower leg,383,I82502 (49%); I82402 (48%); M868X6 (46%); I82501 (44%); I82509 (44%)
I83029,Varicose veins of left lower extremity with ulcer of unspecified site,383,I82502 (48%); I82402 (47%); I82509 (45%); I82409 (44%); I82501 (43%)
I83201,Varicose veins of unspecified lower extremity with both ulcer of thigh and inflammation,383,I82509 (40%); I82409 (39%); I82502 (38%); I82501 (38%); I82402 (38%)
I83202,Varicose veins of unspecified lower extremity with both ulcer of calf and inflammation,383,I82509 (40%); I82409 (39%); I82502 (38%); I82501 (38%); I82402 (38%)
I83203,Varicose veins of unspecified lower extremity with both ulcer of ankle and inflammation,383,I82509 (41%); I82409 (41%); I82502 (39%); I82501 (39%); I82402 (39%)
I83204,Varicose veins of unspecified lower extremity with both ulcer of heel and midfoot and inflammation,383,L97404 (40%); L97403 (40%); L97424 (38%); L97414 (38%); L97423 (37%)
I83205,Varicose veins of unspecified lower extremity with both ulcer other part of foot and inflammation,383,I82509 (41%); I82409 (41%); I82502 (39%); I82501 (39%); I82402 (39%)
I83208,Varicose veins of unspecified lower extremity with both ulcer of other part of lower extremity and inflammation,383,I82509 (50%); I82409 (49%); I82502 (49%); I82501 (49%); I82402 (48%)
I83209,Varicose veins of unspecified lower extremity with both ulcer of unspecified site and inflammation,383,I82509 (44%); I82409 (44%); I82502 (40%); I82501 (40%); I82402 (40%)
I83211,Varicose veins of right lower extremity with both ulcer of thigh and inflammation,383,I82501 (40%); I82401 (39%); I82502 (36%); I82509 (35%); I82402 (35%)
I83212,Varicose veins of right lower extremity with both ulcer of calf and inflammation,383,I82501 (40%); I82401 (39%); I82502 (35%); I82509 (35%); I82402 (35%)
I83213,Varicose veins of right lower extremity with both ulcer of ankle and inflammation,383,I82501 (41%); I82401 (40%); I82502 (36%); I82509 (36%); I82402 (36%)
I83214,Varicose veins of right lower extremity with both ulcer of heel and midfoot and inflammation,383,L97414 (41%); L97413 (41%); L97404 (38%); L97403 (37%); L97424 (37%)
I83215,Varicose veins of right lower extremity with both ulcer other part of foot and inflammation,383,I82501 (41%); I82401 (40%); I82502 (36%); I82509 (36%); I82402 (36%)
I83218,Varicose veins of right lower extremity with both ulcer of other part of lower extremity and inflammation,383,I82501 (50%); I82401 (49%); I75021 (49%); I82502 (47%); I82509 (46%)
I83219,Varicose veins of right lower extremity with both ulcer of unspecified site and inflammation,383,I82501 (43%); I82401 (42%); I82509 (40%); I82409 (39%); I82502 (38%)
I83221,Varicose veins of left lower extremity with both ulcer of thigh and inflammation,383,I82502 (40%); I82402 (39%); I82501 (36%); I82509 (35%); I82401 (35%)
I83222,Varicose veins of left lower extremity with both ulcer of calf and inflammation,383,I82502 (40%); I82402 (39%); I82501 (35%); I82509 (35%); I82401 (35%)
I83223,Varicose veins of left lower extremity with both ulcer of ankle and inflammation,383,I82502 (41%); I82402 (40%); I82501 (36%); I82509 (36%); I82401 (36%)
I83224,Varicose veins of left lower extremity with both ulcer of heel and midfoot and inflammation,383,L97424 (41%); L97423 (41%); L97404 (38%); L97403 (37%); L97414 (37%)
I83225,Varicose veins of left lower extremity with both ulcer other part of foot and inflammation,383,I82502 (41%); I82402 (40%); I82501 (36%); I82509 (36%); I82401 (36%)
I83228,Varicose veins of left lower extremity with both ulcer of other part of lower extremity and inflammation,383,I82502 (50%); I82402 (49%); I75022 (49%); I82501 (47%); I82509 (46%)
I83229,Varicose veins of left lower extremity with both ulcer of unspecified site and inflammation,383,I82502 (43%); I82402 (42%); I82509 (40%); I82409 (39%); I82501 (38%)
I8500,Esophageal varices without bleeding,63,J9504 (28%); K50911 (28%); K51811 (27%); K51911 (26%); K51011 (25%)
I8501,Esophageal varices with bleeding,63,J9504 (28%); K50911 (28%); K51811 (27%); K51911 (26%); K51011 (25%)
I8510,Secondary esophageal varices without bleeding,63,J9504 (26%); K50911 (26%); K51811 (25%); K51911 (25%); K51011 (23%)
I8511,Secondary esophageal varices with bleeding,63,J9504 (26%); K50911 (26%); K51811 (25%); K51911 (25%); K51011 (23%)
I87011,Postthrombotic syndrome with ulcer of right lower extremity,383,I75021 (38%); L89132 (35%); L89133 (35%); L89134 (35%); T871X1 (32%)
I87012,Postthrombotic syndrome with ulcer of left lower extremity,383,I75022 (38%); L89142 (35%); L89143 (35%); L89144 (35%); T871X2 (32%)
I87013,Postthrombotic syndrome with ulcer of bilateral lower extremity,383,I82503 (34%); I82593 (34%); I82403 (34%); I82493 (33%); I80293 (31%)
I87019,Postthrombotic syndrome with ulcer of unspecified lower extremity,383,I75029 (36%); I75022 (31%); I75021 (31%); T871X9 (30%); I82509 (29%)
I87031,Postthrombotic syndrome with ulcer and inflammation of right lower extremity,383,I75021 (33%); L89132 (31%); L89133 (31%); L89134 (31%); T871X1 (28%)
I87032,Postthrombotic syndrome with ulcer and inflammation of left lower extremity,383,I75022 (33%); L89142 (31%); L89143 (31%); L89144 (31%); T871X2 (28%)
I87033,Postthrombotic syndrome with ulcer and inflammation of bilateral lower extremity,383,I82503 (30%); I82593 (30%); I82403 (30%); I82493 (29%); I80293 (27%)
I87039,Postthrombotic syndrome with ulcer and inflammation of unspecified lower extremity,383,I75029 (31%); I75022 (27%); I75021 (27%); T871X9 (27%); I82509 (25%)
I87311,Chronic venous hypertension (idiopathic) with ulcer of right lower extremity,383,I2720 (35%); I2724 (31%); I2729 (31%); I75021 (31%); I82501 (30%)
I87312,Chronic venous hypertension (idiopathic) with ulcer of left lower extremity,383,I2720 (35%); I2722 (33%); I2724 (31%); I2729 (31%); I75022 (31%)
I87313,Chronic venous hypertension (idiopathic) with ulcer of bilateral lower extremity,383,I82503 (35%); I82593 (34%); I2720 (34%); I2724 (31%); I2729 (30%)
I87319,Chronic venous hypertension (idiopathic) with ulcer of unspecified lower extremity,383,I2720 (39%); I2724 (32%); I2729 (32%); I82509 (30%); I270 (29%)
I87331,Chronic venous hypertension (idiopathic) with ulcer and inflammation of right lower extremity,383,I2720 (32%); I2724 (29%); I2729 (29%); I75021 (28%); I82501 (27%)
I87332,Chronic venous hypertension (idiopathic) with ulcer and inflammation of left lower extremity,383,I2720 (32%); I2722 (30%); I2724 (29%); I2729 (29%); I75022 (28%)
I87333,Chronic venous hypertension (idiopathic) with ulcer and inflammation of bilateral lower extremity,383,I82503 (32%); I82593 (31%); I2720 (31%); I2724 (28%); I2729 (28%)
I87339,Chronic venous hypertension (idiopathic) with ulcer and inflammation of unspecified lower extremity,383,I2720 (35%); I2724 (29%); I2729 (29%); I82509 (28%); I270 (27%)
I96,"Gangrene, not elsewhere classified",263,J850 (49%); N493 (43%); E1051 (34%); E1052 (34%); E1151 (34%)
I97810,Intraoperative cerebrovascular infarction during cardiac surgery,,
I97811,Intraoperative cerebrovascular infarction during other surgery,,
I97820,Postprocedural cerebrovascular infarction following cardiac surgery,,
I97821,Postprocedural cerebrovascular infarction following other surgery,,
J13,Pneumonia due to Streptococcus pneumoniae,,
J14,Pneumonia due to Hemophilus influenzae,,
J150,Pneumonia due to Klebsiella pneumoniae,282,A403 (39%); J851 (29%); J852 (29%); J8281 (28%); J84111 (26%)
J151,Pneumonia due to Pseudomonas,282,A4152 (64%); J851 (38%); J852 (38%); J8281 (36%); J84111 (34%)
J1520,"Pneumonia due to staphylococcus, unspecified",282,A412 (59%); A411 (51%); J851 (40%); J852 (40%); P362 (39%)
J15211,Pneumonia due to Methicillin susceptible Staphylococcus aureus,282,A4101 (86%); A4102 (61%); P362 (49%); A412 (32%); A411 (30%)
J15212,Pneumonia due to Methicillin resistant Staphylococcus aureus,282,A4102 (86%); A4101 (61%); P362 (49%); A412 (32%); A411 (30%)
J1529,Pneumonia due to other staphylococcus,282,A412 (55%); A411 (52%); J851 (41%); J852 (41%); P362 (40%)
J153,"Pneumonia due to streptococcus, group B",,
J154,Pneumonia due to other streptococci,,
J155,Pneumonia due to Escherichia coli,282,A4151 (78%); P364 (70%); J851 (30%); J852 (30%); J8281 (29%)
J156,Pneumonia due to other Gram-negative bacteria,282,A4159 (65%); A4150 (64%); M00859 (32%); M00819 (32%); M00849 (32%)
J1561,Pneumonia due to Acinetobacter baumannii,282,A4154 (78%); J851 (29%); J852 (29%); J8281 (28%); J84111 (27%)
J1569,Pneumonia due to other Gram-negative bacteria,282,A4159 (65%); A4150 (64%); M00859 (32%); M00819 (32%); M00849 (32%)
J158,Pneumonia due to other specified bacteria,282,J84111 (50%); M00859 (44%); M00819 (44%); M00849 (44%); M00852 (43%)
J181,"Lobar pneumonia, unspecified organism",,
J410,Simple chronic bronchitis,280,R5600 (35%); G40101 (20%); G40109 (20%); G40111 (20%); G40119 (20%)
J411,Mucopurulent chronic bronchitis,280,M8668 (14%); M8660 (13%); M86619 (13%); M86649 (13%); K739 (13%)
J418,Mixed simple and mucopurulent chronic bronchitis,280,R5600 (26%); C8120 (21%); C8127 (21%); F3160 (20%); T425X2A (19%)
J42,Unspecified chronic bronchitis,280,M8660 (25%); M86619 (25%); M86649 (25%); K739 (24%); M86659 (23%)
J430,Unilateral pulmonary emphysema [MacLeod's syndrome],280,I2782 (25%); J810 (24%); I279 (22%); I2720 (22%); B441 (21%)
J431,Panlobular emphysema,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J432,Centrilobular emphysema,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J438,Other emphysema,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J439,"Emphysema, unspecified",280,G8330 (13%); L97909 (13%); G8190 (13%); C8510 (13%); M08959 (13%)
J440,Chronic obstructive pulmonary disease with (acute) lower respiratory infection,280,J810 (42%); G911 (39%); I2782 (37%); I279 (37%); J9621 (36%)
J441,Chronic obstructive pulmonary disease with (acute) exacerbation,280,J810 (44%); G911 (40%); I2782 (39%); I279 (39%); G7000 (38%)
J4481,Bronchiolitis obliterans and bronchiolitis obliterans syndrome,280,E340 (10%); G839 (9%); G8382 (9%); G8383 (9%); D469 (8%)
J4489,Other specified chronic obstructive pulmonary disease,280,G911 (49%); I2782 (48%); I279 (47%); I2789 (41%); I289 (41%)
J449,"Chronic obstructive pulmonary disease, unspecified",280,I279 (53%); G911 (51%); I2782 (50%); I289 (47%); I2722 (39%)
J4520,"Mild intermittent asthma, uncomplicated",,
J4521,Mild intermittent asthma with (acute) exacerbation,,
J4522,Mild intermittent asthma with status asthmaticus,,
J4530,"Mild persistent asthma, uncomplicated",,
J4531,Mild persistent asthma with (acute) exacerbation,,
J4532,Mild persistent asthma with status asthmaticus,,
J4540,"Moderate persistent asthma, uncomplicated",,
J4541,Moderate persistent asthma with (acute) exacerbation,,
J4542,Moderate persistent asthma with status asthmaticus,,
J4550,"Severe persistent asthma, uncomplicated",279,K730 (34%); I4819 (31%); K713 (29%); R403 (28%); I4811 (26%)
J4551,Severe persistent asthma with (acute) exacerbation,279,J471 (43%); J441 (37%); G7000 (35%); G7001 (35%); K730 (31%)
J4552,Severe persistent asthma with status asthmaticus,279,K730 (29%); I4819 (26%); K713 (24%); R403 (24%); I4811 (22%)
J45901,Unspecified asthma with (acute) exacerbation,,
J45902,Unspecified asthma with status asthmaticus,,
J45909,"Unspecified asthma, uncomplicated",,
J45990,Exercise induced bronchospasm,,
J45991,Cough variant asthma,,
J45998,Other asthma,,
J470,Bronchiectasis with acute lower respiratory infection,280,J9601 (35%); J80 (35%); J9602 (35%); J9621 (34%); J9622 (33%)
J471,Bronchiectasis with (acute) exacerbation,280,G7000 (44%); G7001 (44%); J4551 (43%); M86159 (21%); M86152 (20%)
J479,"Bronchiectasis, uncomplicated",280,F1420 (35%); F1020 (35%); F1520 (35%); F1410 (34%); F1120 (34%)
J4A0,Restrictive allograft syndrome,276,I425 (51%); T86290 (37%); E340 (21%); G839 (19%); G8382 (18%)
J4A8,Other chronic lung allograft dysfunction,276,T86290 (38%); E318 (31%); E319 (30%); C7800 (25%); J850 (25%)
J4A9,"Chronic lung allograft dysfunction, unspecified",276,T86290 (38%); E319 (33%); E318 (31%); C7800 (29%); C3490 (27%)
J60,Coalworker's pneumoconiosis,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J61,Pneumoconiosis due to asbestos and other mineral fibers,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J620,Pneumoconiosis due to talc dust,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J628,Pneumoconiosis due to other dust containing silica,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J630,Aluminosis (of lung),280,C7800 (29%); J850 (29%); C7802 (28%); C7801 (28%); Z942 (28%)
J631,Bauxite fibrosis (of lung),280,J84112 (37%); E849 (37%); E848 (30%); E840 (27%); E8419 (27%)
J632,Berylliosis,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J633,Graphite fibrosis (of lung),280,J84112 (37%); E849 (37%); E848 (30%); E840 (27%); E8419 (27%)
J634,Siderosis,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J635,Stannosis,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J636,Pneumoconiosis due to other specified inorganic dusts,280,T578X2A (37%); T5792XA (32%); M068A (21%); E1369 (20%); A4189 (15%)
J64,Unspecified pneumoconiosis,280,G8330 (13%); L97909 (13%); G8190 (13%); C8510 (13%); M08959 (13%)
J65,Pneumoconiosis associated with tuberculosis,280,J95851 (25%); C802 (24%); D5931 (22%); S32463B (22%); S32466B (22%)
J660,Byssinosis,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J661,Flax-dressers' disease,280,G959 (16%); I120 (15%); G20 (14%); G308 (14%); B259 (14%)
J662,Cannabinosis,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J668,Airway disease due to other specific organic dusts,280,F6089 (31%); T528X2A (22%); T5292XA (22%); T541X2A (20%); G959 (12%)
J670,Farmer's lung,280,C7800 (29%); J850 (29%); C7802 (28%); C7801 (28%); Z942 (28%)
J671,Bagassosis,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J672,Bird fancier's lung,280,C7800 (22%); J850 (22%); C7802 (21%); C7801 (21%); Z942 (21%)
J673,Suberosis,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J674,Maltworker's lung,280,C7800 (29%); J850 (29%); C7802 (28%); C7801 (28%); Z942 (28%)
J675,Mushroom-worker's lung,280,C7800 (22%); J850 (22%); C7802 (21%); C7801 (21%); Z942 (21%)
J676,Maple-bark-stripper's lung,280,C7800 (18%); J850 (18%); C7802 (18%); C7801 (18%); Z942 (18%)
J677,Air conditioner and humidifier lung,280,T790XXA (39%); X7409XA (21%); C7800 (19%); J850 (18%); C7802 (18%)
J678,Hypersensitivity pneumonitis due to other organic dusts,280,M310 (35%); B250 (31%); T528X2A (24%); T5292XA (23%); T541X2A (22%)
J679,Hypersensitivity pneumonitis due to unspecified organic dust,280,M310 (35%); B250 (31%); T5292XA (25%); T528X2A (23%); T541X2A (22%)
J680,"Bronchitis and pneumonitis due to chemicals, gases, fumes and vapors",280,T5992XA (53%); T59892A (52%); B250 (27%); T415X2A (20%); X770XXA (18%)
J681,"Pulmonary edema due to chemicals, gases, fumes and vapors",280,T5992XA (59%); T59892A (58%); J810 (37%); I2782 (25%); I279 (22%)
J682,"Upper respiratory inflammation due to chemicals, gases, fumes and vapors, not elsewhere classified",280,T5992XA (53%); T59892A (52%); C390 (25%); T415X2A (20%); M90529 (20%)
J683,"Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapors",280,T5992XA (50%); T59892A (49%); J9601 (23%); J80 (23%); J9602 (23%)
J684,"Chronic respiratory conditions due to chemicals, gases, fumes and vapors",280,T5992XA (53%); T59892A (52%); J9611 (23%); J9612 (22%); M308 (22%)
J688,"Other respiratory conditions due to chemicals, gases, fumes and vapors",280,T5992XA (55%); T59892A (53%); M308 (22%); T415X2A (21%); R092 (20%)
J689,"Unspecified respiratory condition due to chemicals, gases, fumes and vapors",280,T5992XA (59%); T59892A (56%); T415X2A (22%); R092 (21%); C7830 (21%)
J690,Pneumonitis due to inhalation of food and vomit,282,B250 (30%); J84114 (29%); J84113 (22%); T6482XA (21%); T6292XA (21%)
J691,Pneumonitis due to inhalation of oils and essences,282,B250 (30%); J84114 (29%); J84113 (21%); J678 (20%); J679 (20%)
J698,Pneumonitis due to inhalation of other solids and liquids,282,B250 (30%); J84114 (29%); J84113 (21%); J678 (20%); J679 (20%)
J700,Acute pulmonary manifestations due to radiation,,
J701,Chronic and other pulmonary manifestations due to radiation,,
J702,Acute drug-induced interstitial lung disorders,,
J703,Chronic drug-induced interstitial lung disorders,,
J704,"Drug-induced interstitial lung disorders, unspecified",,
J705,Respiratory conditions due to smoke inhalation,,
J708,Respiratory conditions due to other specified external agents,,
J709,Respiratory conditions due to unspecified external agent,,
J80,Acute respiratory distress syndrome,213,J470 (35%); J440 (30%); R092 (30%); M3311 (28%); M3311 (28%)
J810,Acute pulmonary edema,213,I2782 (48%); I2609 (46%); I2699 (46%); J441 (44%); I279 (44%)
J8281,Chronic eosinophilic pneumonia,280,I423 (48%); J1529 (39%); J158 (38%); J1520 (38%); J151 (36%)
J8283,Eosinophilic asthma,,
J8289,"Other pulmonary eosinophilia, not elsewhere classified",,
J8401,Alveolar proteinosis,280,E662 (30%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
J8402,Pulmonary alveolar microlithiasis,280,I2782 (30%); J810 (30%); I279 (28%); I2720 (27%); E662 (27%)
J8403,Idiopathic pulmonary hemosiderosis,280,J84112 (50%); I2782 (34%); J810 (33%); I279 (31%); I2720 (30%)
J8409,Other alveolar and parieto-alveolar conditions,280,E662 (36%); M308 (20%); A0104 (0%); A0105 (0%); A021 (0%)
J8410,"Pulmonary fibrosis, unspecified",280,J84112 (83%); E840 (61%); E849 (54%); I279 (44%); I2720 (43%)
J84111,"Idiopathic interstitial pneumonia, not otherwise specified",280,J158 (50%); J1529 (37%); J1520 (36%); J151 (34%); J851 (34%)
J84112,Idiopathic pulmonary fibrosis,278,J8410 (83%); E840 (54%); J8403 (50%); J84178 (48%); E849 (44%)
J84113,Idiopathic non-specific interstitial pneumonitis,280,F6089 (35%); B250 (33%); J690 (22%); J691 (21%); J698 (21%)
J84114,Acute interstitial pneumonitis,280,B250 (45%); J690 (29%); J691 (29%); J698 (29%); M3215 (24%)
J84115,Respiratory bronchiolitis interstitial lung disease,280,J84170 (35%); M05159 (26%); M0510 (25%); M05119 (25%); M05149 (25%)
J84116,Cryptogenic organizing pneumonia,280,J1529 (31%); J158 (31%); J1520 (30%); J151 (29%); J851 (28%)
J84117,Desquamative interstitial pneumonia,280,J1529 (34%); J158 (33%); J1520 (33%); J151 (31%); J851 (31%)
J84170,Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere,278,J84178 (41%); J8489 (36%); J84115 (35%); J849 (34%); G914 (27%)
J84178,Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere,280,I2789 (52%); I288 (50%); J84112 (48%); G914 (48%); M9058 (48%)
J842,Lymphoid interstitial pneumonia,280,C91Z1 (40%); C9191 (39%); C91Z2 (38%); C9192 (38%); J1529 (37%)
J8481,Lymphangioleiomyomatosis,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J8482,Adult pulmonary Langerhans cell histiocytosis,280,C966 (63%); C965 (58%); C960 (53%); D763 (40%); M061 (33%)
J8483,Surfactant mutations of the lung,,
J84841,Neuroendocrine cell hyperplasia of infancy,,
J84842,Pulmonary interstitial glycogenosis,,
J84843,Alveolar capillary dysplasia with vein misalignment,,
J84848,Other interstitial lung diseases of childhood,,
J8489,Other specified interstitial pulmonary diseases,280,I2789 (66%); I288 (50%); G9589 (42%); I2723 (38%); I2782 (36%)
J849,"Interstitial pulmonary disease, unspecified",280,I279 (59%); I289 (52%); I2722 (42%); I2720 (40%); I2782 (39%)
J850,Gangrene and necrosis of lung,283,I96 (49%); A480 (38%); N493 (35%); C7800 (32%); C7802 (32%)
J851,Abscess of lung with pneumonia,283,J1529 (41%); J158 (40%); K50914 (40%); J1520 (40%); J151 (38%)
J852,Abscess of lung without pneumonia,283,J1529 (41%); J158 (40%); K50914 (40%); J1520 (40%); J151 (38%)
J853,Abscess of mediastinum,283,C383 (61%); C781 (54%); C381 (54%); C382 (54%); K50914 (43%)
J860,Pyothorax with fistula,283,K50913 (40%); K51813 (37%); K51913 (36%); K51013 (33%); K51213 (33%)
J869,Pyothorax without fistula,283,K50913 (40%); K51813 (37%); K51913 (36%); K51013 (33%); K51213 (33%)
J910,Malignant pleural effusion,17,C380 (13%); C411 (12%); C720 (12%); C261 (12%); C719 (12%)
J9500,Unspecified tracheostomy complication,211,K50918 (40%); K9400 (39%); K9420 (39%); T8620 (39%); T86819 (39%)
J9501,Hemorrhage from tracheostomy stoma,211,K9401 (19%); K9421 (19%); I608 (18%); I629 (18%); K9411 (18%)
J9502,Infection of tracheostomy stoma,211,K9402 (27%); K9422 (27%); T8623 (26%); T86812 (26%); K9412 (26%)
J9503,Malfunction of tracheostomy stoma,211,K9403 (41%); K9423 (41%); K9413 (40%); K9433 (40%); A0104 (0%)
J9504,Tracheo-esophageal fistula following tracheostomy,211,I8500 (28%); I8501 (28%); K50913 (26%); I8510 (26%); I8511 (26%)
J9509,Other tracheostomy complication,211,E1069 (37%); E1169 (37%); K50918 (36%); K9400 (35%); K9420 (35%)
J951,Acute pulmonary insufficiency following thoracic surgery,,
J952,Acute pulmonary insufficiency following nonthoracic surgery,,
J953,Chronic pulmonary insufficiency following surgery,,
J95821,Acute postprocedural respiratory failure,,
J95822,Acute and chronic postprocedural respiratory failure,,
J95850,Mechanical complication of respirator,211,T82592A (57%); T82512A (37%); E1069 (27%); E1169 (27%); K50918 (26%)
J95851,Ventilator associated pneumonia,211,J1529 (36%); J158 (35%); J1520 (35%); J151 (33%); J851 (33%)
J95859,Other complication of respirator [ventilator],211,E1069 (27%); E1169 (27%); K50918 (26%); K9400 (26%); K9420 (26%)
J9600,"Acute respiratory failure, unspecified whether with hypoxia or hypercapnia",213,I50811 (38%); I50813 (36%); I509 (32%); I50810 (30%); J470 (29%)
J9601,Acute respiratory failure with hypoxia,213,I50811 (46%); I50813 (43%); J470 (35%); I5089 (34%); I50814 (33%)
J9602,Acute respiratory failure with hypercapnia,213,I50811 (46%); I50813 (43%); J470 (35%); I5089 (34%); I50814 (33%)
J9610,"Chronic respiratory failure, unspecified whether with hypoxia or hypercapnia",213,I50812 (35%); I509 (32%); I50813 (32%); I50810 (30%); I5089 (29%)
J9611,Chronic respiratory failure with hypoxia,213,I50812 (43%); I50813 (38%); I5089 (35%); I50814 (34%); I509 (34%)
J9612,Chronic respiratory failure with hypercapnia,213,I50812 (43%); I50813 (38%); I5089 (35%); I50814 (34%); I509 (34%)
J9620,"Acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia",213,I50813 (44%); I50811 (37%); I50812 (34%); I5023 (31%); I5033 (31%)
J9621,Acute and chronic respiratory failure with hypoxia,213,I50813 (52%); I50811 (44%); I50812 (40%); I5023 (36%); I5033 (36%)
J9622,Acute and chronic respiratory failure with hypercapnia,213,I50813 (51%); I50811 (44%); I50812 (40%); I5023 (36%); I5033 (36%)
J9690,"Respiratory failure, unspecified, unspecified whether with hypoxia or hypercapnia",213,I509 (36%); I50810 (34%); I5089 (29%); I501 (29%); C7830 (28%)
J9691,"Respiratory failure, unspecified with hypoxia",213,I509 (40%); I50810 (38%); I5089 (36%); I50814 (35%); I2723 (35%)
J9692,"Respiratory failure, unspecified with hypercapnia",213,I509 (40%); I50810 (38%); I5089 (36%); I50814 (35%); R092 (32%)
J982,Interstitial emphysema,280,M3215 (26%); J84170 (25%); A0104 (0%); A0105 (0%); A021 (0%)
J983,Compensatory emphysema,280,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
J99,Respiratory disorders in diseases classified elsewhere,280,K67 (59%); G914 (45%); M9058 (44%); M9050 (43%); M90519 (43%)
K251,Acute gastric ulcer with perforation,78,T471X2A (26%); M86159 (21%); M86152 (21%); M86151 (21%); M8618 (20%)
K252,Acute gastric ulcer with both hemorrhage and perforation,78,I6201 (29%); T471X2A (24%); M86159 (20%); M86152 (19%); M86151 (19%)
K255,Chronic or unspecified gastric ulcer with perforation,78,L98429 (27%); L97909 (27%); L97309 (27%); L97509 (27%); L97109 (26%)
K256,Chronic or unspecified gastric ulcer with both hemorrhage and perforation,78,L98429 (26%); L97909 (25%); L97309 (25%); L97509 (25%); I6203 (25%)
K261,Acute duodenal ulcer with perforation,78,M86159 (21%); M86152 (20%); M86151 (20%); M8618 (20%); M8610 (19%)
K262,Acute duodenal ulcer with both hemorrhage and perforation,78,I6201 (28%); M86159 (20%); M86152 (19%); M86151 (19%); M8618 (19%)
K265,Chronic or unspecified duodenal ulcer with perforation,78,L98429 (27%); L97909 (27%); L97309 (27%); L97509 (27%); L97109 (26%)
K266,Chronic or unspecified duodenal ulcer with both hemorrhage and perforation,78,L98429 (25%); L97909 (25%); L97309 (25%); L97509 (25%); I6203 (25%)
K271,"Acute peptic ulcer, site unspecified, with perforation",78,M8610 (43%); M8618 (40%); M8600 (35%); L8992 (34%); L8993 (34%)
K272,"Acute peptic ulcer, site unspecified, with both hemorrhage and perforation",78,M8610 (40%); M8618 (38%); M8600 (33%); L8992 (32%); L8993 (32%)
K275,"Chronic or unspecified peptic ulcer, site unspecified, with perforation",78,M8660 (42%); L8992 (37%); L8993 (37%); L8994 (37%); M8668 (35%)
K276,"Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation",78,M8660 (40%); L8992 (35%); L8993 (35%); L8994 (35%); M8668 (33%)
K281,Acute gastrojejunal ulcer with perforation,78,M86159 (21%); M86152 (20%); M86151 (20%); M8618 (20%); M8610 (19%)
K282,Acute gastrojejunal ulcer with both hemorrhage and perforation,78,I6201 (28%); M86159 (20%); M86152 (19%); M86151 (19%); M8618 (19%)
K285,Chronic or unspecified gastrojejunal ulcer with perforation,78,L98429 (27%); L97909 (27%); L97309 (27%); L97509 (27%); L97109 (26%)
K286,Chronic or unspecified gastrojejunal ulcer with both hemorrhage and perforation,78,L98429 (25%); L97909 (25%); L97309 (25%); L97509 (25%); I6203 (25%)
K5000,Crohn's disease of small intestine without complications,80,K50012 (71%); K50812 (66%); C179 (56%); T86858 (52%); C784 (51%)
K50011,Crohn's disease of small intestine with rectal bleeding,80,K50012 (59%); K50812 (55%); K51811 (49%); K51911 (48%); C179 (47%)
K50012,Crohn's disease of small intestine with intestinal obstruction,78,K50012 (100%); K50812 (93%); K50112 (82%); K50912 (79%); K5000 (71%)
K50012,Crohn's disease of small intestine with intestinal obstruction,80,K50012 (100%); K50812 (93%); K50112 (82%); K50912 (79%); K56691 (53%)
K50013,Crohn's disease of small intestine with fistula,80,K50012 (68%); K50812 (63%); C179 (54%); C784 (49%); K50112 (48%)
K50014,Crohn's disease of small intestine with abscess,80,K50012 (68%); K50812 (63%); C179 (54%); C784 (49%); K50112 (48%)
K50018,Crohn's disease of small intestine with other complication,80,K50012 (70%); K50812 (65%); C179 (56%); T86859 (51%); C784 (51%)
K50019,Crohn's disease of small intestine with unspecified complications,80,K50012 (70%); K50812 (65%); C179 (59%); T86858 (51%); C784 (50%)
K5010,Crohn's disease of large intestine without complications,80,K50112 (70%); K50812 (64%); T86858 (53%); K50012 (51%); C785 (40%)
K50111,Crohn's disease of large intestine with rectal bleeding,80,K50112 (58%); K50812 (53%); K51811 (50%); K51911 (49%); K51011 (46%)
K50112,Crohn's disease of large intestine with intestinal obstruction,78,K50112 (100%); K50812 (91%); K50012 (82%); K50912 (80%); K5010 (70%)
K50112,Crohn's disease of large intestine with intestinal obstruction,80,K50112 (100%); K50812 (91%); K50012 (82%); K50912 (80%); K56691 (53%)
K50113,Crohn's disease of large intestine with fistula,80,K50112 (67%); K50812 (61%); K50012 (49%); C785 (38%); K50912 (37%)
K50114,Crohn's disease of large intestine with abscess,80,K50112 (66%); K50812 (61%); K50012 (49%); C785 (38%); K50912 (36%)
K50118,Crohn's disease of large intestine with other complication,80,K50112 (69%); K50812 (63%); T86859 (52%); K50012 (50%); C785 (40%)
K50119,Crohn's disease of large intestine with unspecified complications,80,K50112 (69%); K50812 (63%); T86858 (52%); K50012 (50%); K50912 (41%)
K5080,Crohn's disease of both small and large intestine without complications,80,K50812 (75%); K50012 (65%); K50112 (62%); C179 (51%); T86858 (47%)
K50811,Crohn's disease of both small and large intestine with rectal bleeding,80,K50812 (64%); K50012 (55%); K50112 (53%); K51811 (46%); K51911 (45%)
K50812,Crohn's disease of both small and large intestine with intestinal obstruction,78,K50812 (100%); K50012 (93%); K50112 (91%); K5080 (75%); K50818 (74%)
K50812,Crohn's disease of both small and large intestine with intestinal obstruction,80,K50812 (100%); K50012 (93%); K50112 (91%); K50912 (73%); K56691 (49%)
K50813,Crohn's disease of both small and large intestine with fistula,80,K50812 (72%); K50012 (62%); K50112 (60%); C179 (49%); C784 (45%)
K50814,Crohn's disease of both small and large intestine with abscess,80,K50812 (72%); K50012 (62%); K50112 (60%); C179 (49%); C784 (45%)
K50818,Crohn's disease of both small and large intestine with other complication,80,K50812 (74%); K50012 (64%); K50112 (62%); C179 (51%); T86859 (47%)
K50819,Crohn's disease of both small and large intestine with unspecified complications,80,K50812 (74%); K50012 (64%); K50112 (62%); C179 (54%); T86858 (47%)
K5090,"Crohn's disease, unspecified, without complications",80,K50912 (54%); E108 (43%); E118 (43%); E138 (41%); K50112 (41%)
K50911,"Crohn's disease, unspecified, with rectal bleeding",80,K51911 (60%); K51811 (59%); K51011 (55%); K51211 (55%); K51311 (55%)
K50912,"Crohn's disease, unspecified, with intestinal obstruction",78,K50912 (100%); K50112 (80%); K50012 (79%); K50812 (73%); K51912 (54%)
K50912,"Crohn's disease, unspecified, with intestinal obstruction",80,K50912 (100%); K50112 (80%); K50012 (79%); K50812 (73%); K56691 (64%)
K50913,"Crohn's disease, unspecified, with fistula",80,K50912 (50%); K51913 (42%); J860 (40%); J869 (40%); K51813 (39%)
K50914,"Crohn's disease, unspecified, with abscess",80,K50912 (50%); J853 (43%); K51914 (42%); J851 (40%); J852 (40%)
K50918,"Crohn's disease, unspecified, with other complication",80,K50912 (53%); K50112 (41%); K50012 (40%); J9500 (40%); K9400 (39%)
K50919,"Crohn's disease, unspecified, with unspecified complications",80,K50912 (54%); E108 (45%); E118 (45%); E138 (43%); K51919 (42%)
K5100,Ulcerative (chronic) pancolitis without complications,81,K51012 (67%); E109 (32%); E119 (32%); K51212 (31%); K51312 (31%)
K51011,Ulcerative (chronic) pancolitis with rectal bleeding,81,K50911 (55%); K51012 (54%); K50111 (46%); K50011 (46%); K50811 (43%)
K51012,Ulcerative (chronic) pancolitis with intestinal obstruction,78,K51012 (100%); K51212 (69%); K51312 (69%); K5100 (67%); K51812 (67%)
K51012,Ulcerative (chronic) pancolitis with intestinal obstruction,81,K51012 (100%); K51212 (69%); K51312 (69%); K51812 (67%); K51912 (66%)
K51013,Ulcerative (chronic) pancolitis with fistula,81,K51012 (63%); K50913 (35%); J860 (33%); J869 (33%); K51212 (29%)
K51014,Ulcerative (chronic) pancolitis with abscess,81,K51012 (63%); J853 (36%); K50914 (36%); J851 (34%); J852 (34%)
K51018,Ulcerative (chronic) pancolitis with other complication,81,K51012 (66%); K51212 (31%); K51312 (31%); E1069 (30%); E1169 (30%)
K51019,Ulcerative (chronic) pancolitis with unspecified complications,81,K51012 (66%); E108 (35%); E118 (35%); E138 (33%); K50919 (32%)
K5120,Ulcerative (chronic) proctitis without complications,81,K51212 (67%); E109 (32%); E119 (32%); K51012 (31%); K51312 (31%)
K51211,Ulcerative (chronic) proctitis with rectal bleeding,81,K50911 (55%); K51212 (54%); K50111 (46%); K50011 (46%); K50811 (43%)
K51212,Ulcerative (chronic) proctitis with intestinal obstruction,78,K51212 (100%); K51012 (69%); K51312 (69%); K5120 (67%); K51812 (67%)
K51212,Ulcerative (chronic) proctitis with intestinal obstruction,81,K51212 (100%); K51012 (69%); K51312 (69%); K51812 (67%); K51912 (66%)
K51213,Ulcerative (chronic) proctitis with fistula,81,K51212 (63%); K50913 (35%); J860 (33%); J869 (33%); K51012 (29%)
K51214,Ulcerative (chronic) proctitis with abscess,81,K51212 (63%); J853 (36%); K50914 (36%); J851 (34%); J852 (34%)
K51218,Ulcerative (chronic) proctitis with other complication,81,K51212 (66%); K51012 (31%); K51312 (31%); E1069 (30%); E1169 (30%)
K51219,Ulcerative (chronic) proctitis with unspecified complications,81,K51212 (66%); E108 (35%); E118 (35%); E138 (33%); K50919 (32%)
K5130,Ulcerative (chronic) rectosigmoiditis without complications,81,K51312 (67%); E109 (32%); E119 (32%); K51012 (31%); K51212 (31%)
K51311,Ulcerative (chronic) rectosigmoiditis with rectal bleeding,81,K50911 (55%); K51312 (54%); K50111 (46%); K50011 (46%); K50811 (43%)
K51312,Ulcerative (chronic) rectosigmoiditis with intestinal obstruction,78,K51312 (100%); K51012 (69%); K51212 (69%); K5130 (67%); K51812 (67%)
K51312,Ulcerative (chronic) rectosigmoiditis with intestinal obstruction,81,K51312 (100%); K51012 (69%); K51212 (69%); K51812 (67%); K51912 (66%)
K51313,Ulcerative (chronic) rectosigmoiditis with fistula,81,K51312 (63%); K50913 (35%); J860 (33%); J869 (33%); K51012 (29%)
K51314,Ulcerative (chronic) rectosigmoiditis with abscess,81,K51312 (63%); J853 (36%); K50914 (36%); J851 (34%); J852 (34%)
K51318,Ulcerative (chronic) rectosigmoiditis with other complication,81,K51312 (66%); K51012 (31%); K51212 (31%); E1069 (30%); E1169 (30%)
K51319,Ulcerative (chronic) rectosigmoiditis with unspecified complications,81,K51312 (66%); E108 (35%); E118 (35%); E138 (33%); K50919 (32%)
K5140,Inflammatory polyps of colon without complications,81,K51412 (73%); C189 (37%); C184 (31%); M064 (31%); M3581 (29%)
K51411,Inflammatory polyps of colon with rectal bleeding,81,K51412 (62%); K50911 (50%); K50111 (42%); K50011 (42%); K50811 (39%)
K51412,Inflammatory polyps of colon with intestinal obstruction,78,K51412 (99%); K5140 (73%); K51418 (73%); K51419 (72%); K51413 (70%)
K51412,Inflammatory polyps of colon with intestinal obstruction,81,K51412 (99%); K56691 (50%); K56690 (49%); K56699 (43%); K50912 (43%)
K51413,Inflammatory polyps of colon with fistula,81,K51412 (70%); C189 (36%); K50913 (31%); C184 (30%); M064 (30%)
K51414,Inflammatory polyps of colon with abscess,81,K51412 (70%); C189 (36%); J853 (32%); K50914 (32%); C184 (30%)
K51418,Inflammatory polyps of colon with other complication,81,K51412 (73%); C189 (37%); C184 (31%); M064 (31%); M3581 (29%)
K51419,Inflammatory polyps of colon with unspecified complications,81,K51412 (72%); C189 (41%); C184 (31%); M064 (31%); E108 (30%)
K5150,Left sided colitis without complications,81,K51512 (67%); E109 (32%); E119 (32%); E108 (31%); E118 (31%)
K51511,Left sided colitis with rectal bleeding,81,K50911 (54%); K51512 (54%); K50111 (46%); K50011 (46%); K50811 (43%)
K51512,Left sided colitis with intestinal obstruction,78,K51512 (100%); K51812 (70%); K51912 (69%); K5150 (67%); K51518 (66%)
K51512,Left sided colitis with intestinal obstruction,81,K51512 (100%); K51812 (70%); K51912 (69%); K56691 (56%); K56690 (55%)
K51513,Left sided colitis with fistula,81,K51512 (63%); K50913 (35%); J860 (33%); J869 (33%); K50113 (28%)
K51514,Left sided colitis with abscess,81,K51512 (63%); J853 (36%); K50914 (36%); J851 (34%); J852 (34%)
K51518,Left sided colitis with other complication,81,K51512 (66%); E1069 (30%); E1169 (30%); J9509 (29%); K50918 (28%)
K51519,Left sided colitis with unspecified complications,81,K51512 (66%); E108 (34%); E118 (34%); E138 (33%); K50919 (32%)
K5180,Other ulcerative colitis without complications,81,K51812 (60%); K51912 (59%); E109 (35%); E119 (35%); E108 (34%)
K51811,Other ulcerative colitis with rectal bleeding,81,K50911 (59%); K50111 (50%); K50011 (49%); K51812 (47%); K51912 (46%)
K51812,Other ulcerative colitis with intestinal obstruction,78,K51812 (100%); K51912 (98%); K51512 (70%); K51012 (67%); K51212 (67%)
K51812,Other ulcerative colitis with intestinal obstruction,81,K51812 (100%); K51912 (98%); K51512 (70%); K51012 (67%); K51212 (67%)
K51813,Other ulcerative colitis with fistula,81,K51812 (56%); K51912 (56%); K50913 (39%); J860 (37%); J869 (37%)
K51814,Other ulcerative colitis with abscess,81,K51812 (56%); K51912 (55%); J853 (39%); K50914 (39%); J851 (37%)
K51818,Other ulcerative colitis with other complication,81,K51812 (59%); K51912 (59%); E1069 (33%); E1169 (33%); J9509 (33%)
K51819,Other ulcerative colitis with unspecified complications,81,K51912 (61%); K51812 (59%); E108 (38%); E118 (38%); E138 (37%)
K5190,"Ulcerative colitis, unspecified, without complications",81,K51912 (61%); K51812 (59%); E108 (38%); E118 (38%); E138 (37%)
K51911,"Ulcerative colitis, unspecified with rectal bleeding",81,K50911 (60%); K50111 (49%); K50011 (48%); K51912 (48%); K51812 (46%)
K51912,"Ulcerative colitis, unspecified with intestinal obstruction",78,K51912 (100%); K51812 (98%); K51512 (69%); K51012 (66%); K51212 (66%)
K51912,"Ulcerative colitis, unspecified with intestinal obstruction",81,K51912 (100%); K51812 (98%); K51512 (69%); K51012 (66%); K51212 (66%)
K51913,"Ulcerative colitis, unspecified with fistula",81,K51912 (58%); K51812 (55%); K50913 (42%); J860 (36%); J869 (36%)
K51914,"Ulcerative colitis, unspecified with abscess",81,K51912 (58%); K51812 (55%); K50914 (42%); J853 (39%); J851 (36%)
K51918,"Ulcerative colitis, unspecified with other complication",81,K51912 (61%); K51812 (58%); K50918 (36%); J9500 (36%); K9400 (35%)
K51919,"Ulcerative colitis, unspecified with unspecified complications",81,K51912 (61%); K51812 (56%); K50919 (42%); E108 (41%); E118 (41%)
K52831,Collagenous colitis,,
K52832,Lymphocytic colitis,,
K52838,Other microscopic colitis,,
K52839,"Microscopic colitis, unspecified",,
K55011,Focal (segmental) acute (reversible) ischemia of small intestine,,
K55012,Diffuse acute (reversible) ischemia of small intestine,,
K55019,"Acute (reversible) ischemia of small intestine, extent unspecified",,
K55021,Focal (segmental) acute infarction of small intestine,,
K55022,Diffuse acute infarction of small intestine,,
K55029,"Acute infarction of small intestine, extent unspecified",,
K55031,Focal (segmental) acute (reversible) ischemia of large intestine,,
K55032,Diffuse acute (reversible) ischemia of large intestine,,
K55039,"Acute (reversible) ischemia of large intestine, extent unspecified",,
K55041,Focal (segmental) acute infarction of large intestine,,
K55042,Diffuse acute infarction of large intestine,,
K55049,"Acute infarction of large intestine, extent unspecified",,
K55051,"Focal (segmental) acute (reversible) ischemia of intestine, part unspecified",,
K55052,"Diffuse acute (reversible) ischemia of intestine, part unspecified",,
K55059,"Acute (reversible) ischemia of intestine, part and extent unspecified",,
K55061,"Focal (segmental) acute infarction of intestine, part unspecified",,
K55062,"Diffuse acute infarction of intestine, part unspecified",,
K55069,"Acute infarction of intestine, part and extent unspecified",,
K551,Chronic vascular disorders of intestine,,
K5530,"Necrotizing enterocolitis, unspecified",,
K5531,Stage 1 necrotizing enterocolitis,,
K5532,Stage 2 necrotizing enterocolitis,,
K5533,Stage 3 necrotizing enterocolitis,,
K558,Other vascular disorders of intestine,,
K559,"Vascular disorder of intestine, unspecified",,
K560,Paralytic ileus,78,G839 (46%); E8411 (40%); G8389 (37%); I69365 (30%); I69369 (29%)
K561,Intussusception,78,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
K562,Volvulus,78,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
K563,Gallstone ileus,78,E8411 (33%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
K5641,Fecal impaction,78,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
K5649,Other impaction of intestine,78,Z9482 (34%); T86858 (33%); T86852 (33%); T86851 (33%); C179 (33%)
K5650,"Intestinal adhesions [bands], unspecified as to partial versus complete obstruction",78,K50912 (38%); K51912 (35%); K51812 (33%); K51012 (31%); K51212 (31%)
K5651,"Intestinal adhesions [bands], with partial obstruction",78,K50912 (41%); K51812 (39%); K51912 (38%); K51012 (36%); K51212 (36%)
K5652,Intestinal adhesions [bands] with complete obstruction,78,K50912 (42%); K51812 (39%); K51912 (39%); K51012 (36%); K51212 (36%)
K56600,"Partial intestinal obstruction, unspecified as to cause",78,K50912 (52%); K51912 (48%); K51812 (46%); K51012 (42%); K51212 (42%)
K56601,"Complete intestinal obstruction, unspecified as to cause",78,K50912 (52%); K51912 (48%); K51812 (46%); K51012 (43%); K51212 (43%)
K56609,"Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction",78,K50912 (59%); K51912 (54%); K51812 (51%); K51012 (47%); K51212 (47%)
K56690,Other partial intestinal obstruction,78,K50912 (63%); K51812 (59%); K51912 (58%); K51012 (55%); K51212 (55%)
K56691,Other complete intestinal obstruction,78,K50912 (64%); K51812 (60%); K51912 (60%); K51012 (56%); K51212 (56%)
K56699,Other intestinal obstruction unspecified as to partial versus complete obstruction,78,K50912 (58%); K51912 (53%); K51812 (52%); K51012 (48%); K51212 (48%)
K567,"Ileus, unspecified",78,E8411 (48%); G8330 (12%); L97909 (12%); G8190 (12%); C8510 (12%)
K5931,Toxic megacolon,78,A483 (23%); G701 (19%); T6592XA (19%); T5192XA (19%); T65892A (17%)
K631,Perforation of intestine (nontraumatic),78,Z9482 (34%); T86858 (33%); T86852 (33%); T86851 (33%); C179 (33%)
K650,Generalized (acute) peritonitis,78,G40401 (28%); G40409 (28%); G40411 (28%); G40419 (28%); G40301 (27%)
K651,Peritoneal abscess,78,J853 (39%); K50914 (39%); J851 (37%); J852 (37%); K51814 (36%)
K652,Spontaneous bacterial peritonitis,78,P368 (38%); P369 (37%); T50A92A (30%); T50A22A (21%); A0104 (0%)
K653,Choleperitonitis,78,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
K654,Sclerosing mesenteritis,78,K8301 (39%); A811 (39%); T468X2A (29%); A0104 (0%); A0105 (0%)
K658,Other peritonitis,78,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
K659,"Peritonitis, unspecified",78,G8330 (13%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
K67,Disorders of peritoneum in infectious diseases classified elsewhere,78,J99 (59%); C482 (44%); M01X59 (42%); M01X19 (42%); M01X49 (42%)
K6812,Psoas muscle abscess,78,J853 (35%); K50914 (35%); J851 (33%); J852 (33%); K51814 (32%)
K6819,Other retroperitoneal abscess,78,J853 (39%); K50914 (39%); J851 (37%); J852 (37%); K51814 (36%)
K7010,Alcoholic hepatitis without ascites,65,K7030 (62%); K7031 (62%); R180 (54%); I426 (42%); B251 (34%)
K7011,Alcoholic hepatitis with ascites,65,K7030 (62%); K7031 (62%); R180 (54%); I426 (42%); B251 (34%)
K7030,Alcoholic cirrhosis of liver without ascites,64,K7010 (62%); K7011 (62%); R180 (47%); K7150 (42%); K7151 (42%)
K7031,Alcoholic cirrhosis of liver with ascites,64,K7010 (62%); K7011 (62%); R180 (47%); K7150 (42%); K7151 (42%)
K7040,Alcoholic hepatic failure without coma,63,I426 (41%); R4020 (38%); K7010 (34%); K7011 (34%); C183 (33%)
K7041,Alcoholic hepatic failure with coma,63,I426 (41%); R4020 (38%); K7010 (34%); K7011 (34%); C183 (33%)
K7041,Alcoholic hepatic failure with coma,,
K709,"Alcoholic liver disease, unspecified",,
K7111,"Toxic liver disease with hepatic necrosis, with coma",,
K713,Toxic liver disease with chronic persistent hepatitis,65,K717 (49%); B251 (31%); I4819 (30%); K7469 (30%); C220 (29%)
K714,Toxic liver disease with chronic lobular hepatitis,65,K717 (47%); B251 (30%); K7469 (29%); C220 (28%); Z944 (28%)
K7150,Toxic liver disease with chronic active hepatitis without ascites,65,K717 (43%); R180 (42%); K7030 (42%); K7031 (42%); B251 (27%)
K7151,Toxic liver disease with chronic active hepatitis with ascites,65,K717 (43%); R180 (42%); K7030 (42%); K7031 (42%); B251 (27%)
K717,Toxic liver disease with fibrosis and cirrhosis of liver,64,K713 (49%); K714 (47%); C220 (47%); Z944 (46%); T8649 (45%)
K7201,Acute and subacute hepatic failure with coma,,
K7210,Chronic hepatic failure without coma,63,R4020 (44%); I50812 (44%); I50813 (39%); C183 (38%); I5089 (36%)
K7211,Chronic hepatic failure with coma,63,R4020 (44%); I50812 (44%); I50813 (39%); C183 (38%); I5089 (36%)
K7290,"Hepatic failure, unspecified without coma",63,R4020 (53%); I509 (41%); C183 (40%); I50810 (39%); I5089 (37%)
K7291,"Hepatic failure, unspecified with coma",63,R4020 (53%); I509 (41%); C183 (40%); I50810 (39%); I5089 (37%)
K730,"Chronic persistent hepatitis, not elsewhere classified",65,B251 (37%); I4819 (36%); J4550 (34%); R403 (33%); J4551 (31%)
K731,"Chronic lobular hepatitis, not elsewhere classified",65,B251 (35%); I96 (24%); G914 (19%); M9058 (18%); M9050 (18%)
K732,"Chronic active hepatitis, not elsewhere classified",65,B251 (37%); I96 (25%); H353231 (25%); H353291 (25%); H353221 (25%)
K738,"Other chronic hepatitis, not elsewhere classified",65,B251 (48%); I96 (33%); G914 (26%); M9058 (26%); M9050 (25%)
K739,"Chronic hepatitis, unspecified",65,B251 (55%); M8660 (28%); M86619 (28%); M86649 (28%); M86659 (26%)
K743,Primary biliary cirrhosis,68,K744 (77%); K7469 (44%); K7460 (43%); C249 (40%); C801 (40%)
K744,Secondary biliary cirrhosis,64,K745 (88%); K743 (77%); C249 (42%); C248 (36%); M87353 (26%)
K745,"Biliary cirrhosis, unspecified",68,K744 (88%); K7460 (53%); K7469 (51%); C249 (49%); C248 (39%)
K7460,Unspecified cirrhosis of liver,64,K745 (53%); K743 (43%); T8640 (43%); C220 (41%); Z944 (41%)
K7469,Other cirrhosis of liver,64,K745 (51%); K743 (44%); C220 (42%); Z944 (42%); T8649 (41%)
K754,Autoimmune hepatitis,65,D5919 (46%); E310 (45%); D5910 (45%); B251 (43%); D5913 (39%)
K766,Portal hypertension,63,I2720 (45%); I2729 (40%); I270 (37%); I2722 (36%); I2724 (31%)
K767,Hepatorenal syndrome,63,E340 (26%); G839 (25%); G8382 (23%); G8383 (23%); D469 (20%)
K7681,Hepatopulmonary syndrome,63,E340 (26%); G839 (25%); G8382 (23%); G8383 (23%); D469 (20%)
K7682,Hepatic encephalopathy,63,P91819 (51%); P91811 (43%); C183 (41%); E8021 (35%); P9160 (34%)
K8301,Primary sclerosing cholangitis,68,K654 (39%); C801 (37%); A811 (35%); D6949 (30%); E7253 (29%)
K8309,Other cholangitis,68,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
K831,Obstruction of bile duct,68,C240 (61%); C221 (60%); C787 (54%); K56699 (36%); K56609 (35%)
K860,Alcohol-induced chronic pancreatitis,79,F10288 (53%); F10188 (53%); F1029 (53%); F10988 (53%); B252 (51%)
K861,Other chronic pancreatitis,79,B252 (66%); M8668 (19%); M8660 (18%); M86619 (18%); M86649 (18%)
K862,Cyst of pancreas,,
K863,Pseudocyst of pancreas,,
K8681,Exocrine pancreatic insufficiency,,
K8689,Other specified diseases of pancreas,,
K869,"Disease of pancreas, unspecified",,
K87,"Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere",,
K900,Celiac disease,,
K901,Tropical sprue,,
K902,"Blind loop syndrome, not elsewhere classified",,
K903,Pancreatic steatorrhea,,
K9049,"Malabsorption due to intolerance, not elsewhere classified",,
K9081,Whipple's disease,,
K90821,Short bowel syndrome with colon in continuity,,
K90822,Short bowel syndrome without colon in continuity,,
K90829,"Short bowel syndrome, unspecified",,
K9083,Intestinal failure,,
K9089,Other intestinal malabsorption,,
K909,"Intestinal malabsorption, unspecified",,
K912,"Postsurgical malabsorption, not elsewhere classified",,
K91850,Pouchitis,463,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
K91858,Other complications of intestinal pouch,463,E109 (30%); E119 (30%); K56691 (30%); E108 (29%); E118 (29%)
K9400,"Colostomy complication, unspecified",463,K50918 (39%); J9500 (39%); T8620 (38%); T86819 (38%); T86859 (37%)
K9401,Colostomy hemorrhage,463,I608 (25%); I629 (25%); I609 (24%); I618 (24%); I619 (24%)
K9402,Colostomy infection,463,T8623 (35%); T86812 (34%); T86852 (33%); T8643 (32%); T8633 (30%)
K9403,Colostomy malfunction,463,J9503 (41%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
K9409,Other complications of colostomy,463,E109 (39%); E119 (39%); E108 (38%); E118 (38%); E139 (38%)
K9410,"Enterostomy complication, unspecified",463,K50918 (38%); J9500 (38%); T8620 (37%); T86819 (37%); T86859 (36%)
K9411,Enterostomy hemorrhage,463,I608 (24%); I629 (24%); I609 (24%); I618 (24%); I619 (23%)
K9412,Enterostomy infection,463,T8623 (34%); T86812 (34%); T86852 (33%); T8643 (31%); T8633 (30%)
K9413,Enterostomy malfunction,463,J9503 (40%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
K9419,Other complications of enterostomy,463,E109 (38%); E119 (38%); E108 (37%); E118 (37%); E139 (37%)
K9420,"Gastrostomy complication, unspecified",463,K50918 (39%); J9500 (39%); T8620 (38%); T86819 (38%); T86859 (37%)
K9421,Gastrostomy hemorrhage,463,I608 (25%); I629 (25%); I609 (24%); I618 (24%); I619 (24%)
K9422,Gastrostomy infection,463,T8623 (35%); T86812 (34%); T86852 (33%); T8643 (32%); T8633 (30%)
K9423,Gastrostomy malfunction,463,J9503 (41%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
K9429,Other complications of gastrostomy,463,E109 (39%); E119 (39%); E108 (38%); E118 (38%); E139 (38%)
K9430,"Esophagostomy complications, unspecified",463,E108 (42%); E118 (42%); E138 (40%); K50919 (39%); E109 (38%)
K9431,Esophagostomy hemorrhage,463,I608 (24%); I629 (24%); I609 (24%); I618 (24%); I619 (23%)
K9432,Esophagostomy infection,463,T8623 (34%); T86812 (34%); T86852 (33%); T8643 (31%); T8633 (30%)
K9433,Esophagostomy malfunction,463,J9503 (40%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
K9439,Other complications of esophagostomy,463,E109 (38%); E119 (38%); E108 (37%); E118 (37%); E139 (37%)
L100,Pemphigus vulgaris,387,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L101,Pemphigus vegetans,387,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L102,Pemphigus foliaceous,387,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L103,Brazilian pemphigus [fogo selvagem],387,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L104,Pemphigus erythematosus,387,M329 (41%); M3213 (36%); M3213 (36%); M3219 (36%); M3210 (35%)
L105,Drug-induced pemphigus,,
L1081,Paraneoplastic pemphigus,387,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L1089,Other pemphigus,387,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L109,"Pemphigus, unspecified",387,G8330 (13%); L97909 (13%); G8190 (13%); C8510 (13%); M08959 (13%)
L120,Bullous pemphigoid,387,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L121,Cicatricial pemphigoid,387,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L122,Chronic bullous disease of childhood,,
L1230,"Acquired epidermolysis bullosa, unspecified",,
L1231,Epidermolysis bullosa due to drug,,
L1235,Other acquired epidermolysis bullosa,,
L128,Other pemphigoid,387,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L129,"Pemphigoid, unspecified",387,G8330 (12%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
L130,Dermatitis herpetiformis,,
L131,Subcorneal pustular dermatitis,,
L138,Other specified bullous disorders,,
L139,"Bullous disorder, unspecified",,
L14,Bullous disorders in diseases classified elsewhere,,
L400,Psoriasis vulgaris,,
L401,Generalized pustular psoriasis,,
L402,Acrodermatitis continua,,
L403,Pustulosis palmaris et plantaris,,
L404,Guttate psoriasis,,
L4050,"Arthropathic psoriasis, unspecified",93,G8330 (8%); L97909 (8%); G8190 (8%); C8510 (8%); C6990 (7%)
L4051,Distal interphalangeal psoriatic arthropathy,93,I825Z2 (24%); I825Z1 (24%); I825Z9 (23%); I824Z2 (23%); I824Z1 (23%)
L4052,Psoriatic arthritis mutilans,93,M009 (13%); A5442 (12%); M00859 (12%); M00259 (12%); M00819 (12%)
L4053,Psoriatic spondylitis,93,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L4054,Psoriatic juvenile arthropathy,93,M029 (33%); E10618 (32%); E11618 (32%); E13618 (30%); M02159 (29%)
L4059,Other psoriatic arthropathy,93,M029 (36%); E10618 (35%); E11618 (35%); E13618 (34%); M02159 (32%)
L408,Other psoriasis,,
L409,"Psoriasis, unspecified",,
L410,Pityriasis lichenoides et varioliformis acuta,,
L411,Pityriasis lichenoides chronica,,
L413,Small plaque parapsoriasis,,
L414,Large plaque parapsoriasis,,
L415,Retiform parapsoriasis,,
L418,Other parapsoriasis,,
L419,"Parapsoriasis, unspecified",,
L511,Stevens-Johnson syndrome,,
L512,Toxic epidermal necrolysis [Lyell],,
L513,Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome,,
L88,Pyoderma gangrenosum,387,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
L89000,"Pressure ulcer of unspecified elbow, unstageable",381,L89002 (64%); L89004 (64%); L89022 (58%); L89024 (58%); L89012 (58%)
L89001,"Pressure ulcer of unspecified elbow, stage 1",,
L89002,"Pressure ulcer of unspecified elbow, stage 2",382,L89003 (100%); L89004 (100%); L89023 (93%); L89024 (93%); L89013 (93%)
L89003,"Pressure ulcer of unspecified elbow, stage 3",381,L89002 (100%); L89004 (100%); L89022 (93%); L89024 (93%); L89012 (93%)
L89004,"Pressure ulcer of unspecified elbow, stage 4",379,L89002 (100%); L89003 (100%); L89022 (93%); L89023 (93%); L89012 (93%)
L89006,Pressure-induced deep tissue damage of unspecified elbow,,
L89009,"Pressure ulcer of unspecified elbow, unspecified stage",,
L89010,"Pressure ulcer of right elbow, unstageable",381,L89012 (65%); L89014 (65%); L89002 (58%); L89004 (58%); L89022 (57%)
L89011,"Pressure ulcer of right elbow, stage 1",,
L89012,"Pressure ulcer of right elbow, stage 2",382,L89013 (100%); L89014 (100%); L89003 (93%); L89004 (93%); L89023 (91%)
L89013,"Pressure ulcer of right elbow, stage 3",381,L89012 (100%); L89014 (100%); L89002 (93%); L89004 (93%); L89022 (91%)
L89014,"Pressure ulcer of right elbow, stage 4",379,L89012 (100%); L89013 (100%); L89002 (93%); L89003 (93%); L89022 (91%)
L89016,Pressure-induced deep tissue damage of right elbow,,
L89019,"Pressure ulcer of right elbow, unspecified stage",,
L89020,"Pressure ulcer of left elbow, unstageable",381,L89022 (65%); L89024 (65%); L89002 (58%); L89004 (58%); L89012 (57%)
L89021,"Pressure ulcer of left elbow, stage 1",,
L89022,"Pressure ulcer of left elbow, stage 2",382,L89023 (100%); L89024 (100%); L89003 (93%); L89004 (93%); L89013 (91%)
L89023,"Pressure ulcer of left elbow, stage 3",381,L89022 (100%); L89024 (100%); L89002 (93%); L89004 (93%); L89012 (91%)
L89024,"Pressure ulcer of left elbow, stage 4",379,L89022 (100%); L89023 (100%); L89002 (93%); L89003 (93%); L89012 (91%)
L89026,Pressure-induced deep tissue damage of left elbow,,
L89029,"Pressure ulcer of left elbow, unspecified stage",,
L89100,"Pressure ulcer of unspecified part of back, unstageable",381,L89102 (51%); L89104 (51%); L89502 (45%); L89504 (45%); L89202 (44%)
L89101,"Pressure ulcer of unspecified part of back, stage 1",,
L89102,"Pressure ulcer of unspecified part of back, stage 2",382,L89103 (100%); L89104 (100%); L89503 (87%); L89504 (87%); L89203 (86%)
L89103,"Pressure ulcer of unspecified part of back, stage 3",381,L89102 (100%); L89104 (100%); L89502 (87%); L89504 (87%); L89202 (86%)
L89104,"Pressure ulcer of unspecified part of back, stage 4",379,L89102 (100%); L89103 (100%); L89502 (87%); L89503 (87%); L89202 (86%)
L89106,Pressure-induced deep tissue damage of unspecified part of back,,
L89109,"Pressure ulcer of unspecified part of back, unspecified stage",,
L89110,"Pressure ulcer of right upper back, unstageable",381,L89112 (63%); L89114 (63%); L89122 (55%); L89124 (55%); L89132 (43%)
L89111,"Pressure ulcer of right upper back, stage 1",,
L89112,"Pressure ulcer of right upper back, stage 2",382,L89113 (100%); L89114 (100%); L89123 (91%); L89124 (91%); L89133 (79%)
L89113,"Pressure ulcer of right upper back, stage 3",381,L89112 (100%); L89114 (100%); L89122 (91%); L89124 (91%); L89132 (79%)
L89114,"Pressure ulcer of right upper back, stage 4",379,L89112 (100%); L89113 (100%); L89122 (91%); L89123 (91%); L89132 (79%)
L89116,Pressure-induced deep tissue damage of right upper back,,
L89119,"Pressure ulcer of right upper back, unspecified stage",,
L89120,"Pressure ulcer of left upper back, unstageable",381,L89122 (63%); L89124 (63%); L89112 (55%); L89114 (55%); L89142 (43%)
L89121,"Pressure ulcer of left upper back, stage 1",,
L89122,"Pressure ulcer of left upper back, stage 2",382,L89123 (100%); L89124 (100%); L89113 (91%); L89114 (91%); L89143 (79%)
L89123,"Pressure ulcer of left upper back, stage 3",381,L89122 (100%); L89124 (100%); L89112 (91%); L89114 (91%); L89142 (79%)
L89124,"Pressure ulcer of left upper back, stage 4",379,L89122 (100%); L89123 (100%); L89112 (91%); L89113 (91%); L89142 (79%)
L89126,Pressure-induced deep tissue damage of left upper back,,
L89129,"Pressure ulcer of left upper back, unspecified stage",,
L89130,"Pressure ulcer of right lower back, unstageable",381,L89132 (61%); L89134 (61%); L89142 (52%); L89144 (52%); L97819 (47%)
L89131,"Pressure ulcer of right lower back, stage 1",,
L89132,"Pressure ulcer of right lower back, stage 2",382,L89133 (100%); L89134 (100%); L89143 (90%); L89144 (90%); L89103 (82%)
L89133,"Pressure ulcer of right lower back, stage 3",381,L89132 (100%); L89134 (100%); L89142 (90%); L89144 (90%); L89102 (82%)
L89134,"Pressure ulcer of right lower back, stage 4",379,L89132 (100%); L89133 (100%); L89142 (90%); L89143 (90%); L89102 (82%)
L89136,Pressure-induced deep tissue damage of right lower back,,
L89139,"Pressure ulcer of right lower back, unspecified stage",,
L89140,"Pressure ulcer of left lower back, unstageable",381,L89142 (61%); L89144 (61%); L89132 (52%); L89134 (52%); L97829 (47%)
L89141,"Pressure ulcer of left lower back, stage 1",,
L89142,"Pressure ulcer of left lower back, stage 2",382,L89143 (100%); L89144 (100%); L89133 (90%); L89134 (90%); L89103 (82%)
L89143,"Pressure ulcer of left lower back, stage 3",381,L89142 (100%); L89144 (100%); L89132 (90%); L89134 (90%); L89102 (82%)
L89144,"Pressure ulcer of left lower back, stage 4",379,L89142 (100%); L89143 (100%); L89132 (90%); L89133 (90%); L89102 (82%)
L89146,Pressure-induced deep tissue damage of left lower back,,
L89149,"Pressure ulcer of left lower back, unspecified stage",,
L89150,"Pressure ulcer of sacral region, unstageable",381,L89152 (75%); L89154 (75%); M4628 (45%); M488X8 (41%); M458 (39%)
L89151,"Pressure ulcer of sacral region, stage 1",,
L89152,"Pressure ulcer of sacral region, stage 2",382,L89153 (100%); L89154 (100%); L89150 (75%); L89103 (64%); L89104 (64%)
L89153,"Pressure ulcer of sacral region, stage 3",381,L89152 (100%); L89154 (100%); L89102 (64%); L89104 (64%); L89142 (57%)
L89154,"Pressure ulcer of sacral region, stage 4",379,L89152 (100%); L89153 (100%); L89150 (75%); L89102 (64%); L89103 (64%)
L89156,Pressure-induced deep tissue damage of sacral region,,
L89159,"Pressure ulcer of sacral region, unspecified stage",,
L89200,"Pressure ulcer of unspecified hip, unstageable",381,L89202 (63%); L89204 (63%); L89222 (57%); L89224 (57%); L89212 (57%)
L89201,"Pressure ulcer of unspecified hip, stage 1",,
L89202,"Pressure ulcer of unspecified hip, stage 2",382,L89203 (100%); L89204 (100%); L89223 (92%); L89224 (92%); L89213 (92%)
L89203,"Pressure ulcer of unspecified hip, stage 3",381,L89202 (100%); L89204 (100%); L89222 (92%); L89224 (92%); L89212 (92%)
L89204,"Pressure ulcer of unspecified hip, stage 4",379,L89202 (100%); L89203 (100%); L89222 (92%); L89223 (92%); L89212 (92%)
L89206,Pressure-induced deep tissue damage of unspecified hip,,
L89209,"Pressure ulcer of unspecified hip, unspecified stage",,
L89210,"Pressure ulcer of right hip, unstageable",381,L89212 (64%); L89214 (64%); L89202 (57%); L89204 (57%); L89222 (56%)
L89211,"Pressure ulcer of right hip, stage 1",,
L89212,"Pressure ulcer of right hip, stage 2",382,L89213 (100%); L89214 (100%); L89203 (92%); L89204 (92%); L89223 (91%)
L89213,"Pressure ulcer of right hip, stage 3",381,L89212 (100%); L89214 (100%); L89202 (92%); L89204 (92%); L89222 (91%)
L89214,"Pressure ulcer of right hip, stage 4",379,L89212 (100%); L89213 (100%); L89202 (92%); L89203 (92%); L89222 (91%)
L89216,Pressure-induced deep tissue damage of right hip,,
L89219,"Pressure ulcer of right hip, unspecified stage",,
L89220,"Pressure ulcer of left hip, unstageable",381,L89222 (64%); L89224 (64%); L89202 (57%); L89204 (57%); L89212 (56%)
L89221,"Pressure ulcer of left hip, stage 1",,
L89222,"Pressure ulcer of left hip, stage 2",382,L89223 (100%); L89224 (100%); L89203 (92%); L89204 (92%); L89213 (91%)
L89223,"Pressure ulcer of left hip, stage 3",381,L89222 (100%); L89224 (100%); L89202 (92%); L89204 (92%); L89212 (91%)
L89224,"Pressure ulcer of left hip, stage 4",379,L89222 (100%); L89223 (100%); L89202 (92%); L89203 (92%); L89212 (91%)
L89226,Pressure-induced deep tissue damage of left hip,,
L89229,"Pressure ulcer of left hip, unspecified stage",,
L89300,"Pressure ulcer of unspecified buttock, unstageable",381,L89302 (69%); L89304 (69%); L89322 (64%); L89324 (64%); L89312 (64%)
L89301,"Pressure ulcer of unspecified buttock, stage 1",,
L89302,"Pressure ulcer of unspecified buttock, stage 2",382,L89303 (100%); L89304 (100%); L89323 (94%); L89324 (94%); L89313 (94%)
L89303,"Pressure ulcer of unspecified buttock, stage 3",381,L89302 (100%); L89304 (100%); L89322 (94%); L89324 (94%); L89312 (94%)
L89304,"Pressure ulcer of unspecified buttock, stage 4",379,L89302 (100%); L89303 (100%); L89322 (94%); L89323 (94%); L89312 (94%)
L89306,Pressure-induced deep tissue damage of unspecified buttock,,
L89309,"Pressure ulcer of unspecified buttock, unspecified stage",,
L89310,"Pressure ulcer of right buttock, unstageable",381,L89312 (70%); L89314 (70%); L89302 (64%); L89304 (64%); L89322 (63%)
L89311,"Pressure ulcer of right buttock, stage 1",,
L89312,"Pressure ulcer of right buttock, stage 2",382,L89313 (100%); L89314 (100%); L89303 (94%); L89304 (94%); L89323 (92%)
L89313,"Pressure ulcer of right buttock, stage 3",381,L89312 (100%); L89314 (100%); L89302 (94%); L89304 (94%); L89322 (92%)
L89314,"Pressure ulcer of right buttock, stage 4",379,L89312 (100%); L89313 (100%); L89302 (94%); L89303 (94%); L89322 (92%)
L89316,Pressure-induced deep tissue damage of right buttock,,
L89319,"Pressure ulcer of right buttock, unspecified stage",,
L89320,"Pressure ulcer of left buttock, unstageable",381,L89322 (70%); L89324 (70%); L89302 (64%); L89304 (64%); L89312 (63%)
L89321,"Pressure ulcer of left buttock, stage 1",,
L89322,"Pressure ulcer of left buttock, stage 2",382,L89323 (99%); L89324 (99%); L89303 (94%); L89304 (94%); L89313 (92%)
L89323,"Pressure ulcer of left buttock, stage 3",381,L89322 (99%); L89324 (99%); L89302 (94%); L89304 (94%); L89312 (92%)
L89324,"Pressure ulcer of left buttock, stage 4",379,L89322 (99%); L89323 (99%); L89302 (94%); L89303 (94%); L89312 (92%)
L89326,Pressure-induced deep tissue damage of left buttock,,
L89329,"Pressure ulcer of left buttock, unspecified stage",,
L8940,"Pressure ulcer of contiguous site of back, buttock and hip, unspecified stage",,
L8941,"Pressure ulcer of contiguous site of back, buttock and hip, stage 1",,
L8942,"Pressure ulcer of contiguous site of back, buttock and hip, stage 2",382,L8943 (100%); L8944 (100%); L8945 (84%); L89303 (68%); L89304 (68%)
L8943,"Pressure ulcer of contiguous site of back, buttock and hip, stage 3",381,L8942 (100%); L8944 (100%); L89302 (68%); L89304 (68%); L89322 (66%)
L8944,"Pressure ulcer of contiguous site of back, buttock and hip, stage 4",379,L8942 (100%); L8943 (100%); L8945 (84%); L89302 (68%); L89303 (68%)
L8945,"Pressure ulcer of contiguous site of back, buttock and hip, unstageable",381,L8942 (84%); L8944 (84%); L89302 (48%); L89304 (48%); L89322 (47%)
L8946,"Pressure-induced deep tissue damage of contiguous site of back, buttock and hip",,
L89500,"Pressure ulcer of unspecified ankle, unstageable",381,L89502 (62%); L89504 (62%); L89522 (56%); L89524 (56%); L89512 (56%)
L89501,"Pressure ulcer of unspecified ankle, stage 1",,
L89502,"Pressure ulcer of unspecified ankle, stage 2",382,L89503 (100%); L89504 (100%); L89523 (92%); L89524 (92%); L89513 (92%)
L89503,"Pressure ulcer of unspecified ankle, stage 3",381,L89502 (100%); L89504 (100%); L89522 (92%); L89524 (92%); L89512 (92%)
L89504,"Pressure ulcer of unspecified ankle, stage 4",379,L89502 (100%); L89503 (100%); L89522 (92%); L89523 (92%); L89512 (92%)
L89506,Pressure-induced deep tissue damage of unspecified ankle,,
L89509,"Pressure ulcer of unspecified ankle, unspecified stage",,
L89510,"Pressure ulcer of right ankle, unstageable",381,L89512 (63%); L89514 (63%); L89502 (56%); L89504 (56%); L89522 (55%)
L89511,"Pressure ulcer of right ankle, stage 1",,
L89512,"Pressure ulcer of right ankle, stage 2",382,L89513 (100%); L89514 (100%); L89503 (92%); L89504 (92%); L89523 (90%)
L89513,"Pressure ulcer of right ankle, stage 3",381,L89512 (100%); L89514 (100%); L89502 (92%); L89504 (92%); L89522 (90%)
L89514,"Pressure ulcer of right ankle, stage 4",379,L89512 (100%); L89513 (100%); L89502 (92%); L89503 (92%); L89522 (90%)
L89516,Pressure-induced deep tissue damage of right ankle,,
L89519,"Pressure ulcer of right ankle, unspecified stage",,
L89520,"Pressure ulcer of left ankle, unstageable",381,L89522 (63%); L89524 (63%); L89502 (56%); L89504 (56%); L89512 (55%)
L89521,"Pressure ulcer of left ankle, stage 1",,
L89522,"Pressure ulcer of left ankle, stage 2",382,L89523 (100%); L89524 (100%); L89503 (92%); L89504 (92%); L89513 (90%)
L89523,"Pressure ulcer of left ankle, stage 3",381,L89522 (100%); L89524 (100%); L89502 (92%); L89504 (92%); L89512 (90%)
L89524,"Pressure ulcer of left ankle, stage 4",379,L89522 (100%); L89523 (100%); L89502 (92%); L89503 (92%); L89512 (90%)
L89526,Pressure-induced deep tissue damage of left ankle,,
L89529,"Pressure ulcer of left ankle, unspecified stage",,
L89600,"Pressure ulcer of unspecified heel, unstageable",381,L89602 (66%); L89604 (66%); L89622 (60%); L89624 (60%); L89612 (60%)
L89601,"Pressure ulcer of unspecified heel, stage 1",,
L89602,"Pressure ulcer of unspecified heel, stage 2",382,L89603 (100%); L89604 (100%); L89623 (93%); L89624 (93%); L89613 (93%)
L89603,"Pressure ulcer of unspecified heel, stage 3",381,L89602 (100%); L89604 (100%); L89622 (93%); L89624 (93%); L89612 (93%)
L89604,"Pressure ulcer of unspecified heel, stage 4",379,L89602 (100%); L89603 (100%); L89622 (93%); L89623 (93%); L89612 (93%)
L89606,Pressure-induced deep tissue damage of unspecified heel,,
L89609,"Pressure ulcer of unspecified heel, unspecified stage",,
L89610,"Pressure ulcer of right heel, unstageable",381,L89612 (67%); L89614 (67%); L89602 (60%); L89604 (60%); L89622 (59%)
L89611,"Pressure ulcer of right heel, stage 1",,
L89612,"Pressure ulcer of right heel, stage 2",382,L89613 (100%); L89614 (100%); L89603 (93%); L89604 (93%); L89623 (91%)
L89613,"Pressure ulcer of right heel, stage 3",381,L89612 (100%); L89614 (100%); L89602 (93%); L89604 (93%); L89622 (91%)
L89614,"Pressure ulcer of right heel, stage 4",379,L89612 (100%); L89613 (100%); L89602 (93%); L89603 (93%); L89622 (91%)
L89616,Pressure-induced deep tissue damage of right heel,,
L89619,"Pressure ulcer of right heel, unspecified stage",,
L89620,"Pressure ulcer of left heel, unstageable",381,L89622 (67%); L89624 (67%); L89602 (61%); L89604 (61%); L89612 (59%)
L89621,"Pressure ulcer of left heel, stage 1",,
L89622,"Pressure ulcer of left heel, stage 2",382,L89623 (100%); L89624 (100%); L89603 (93%); L89604 (93%); L89613 (91%)
L89623,"Pressure ulcer of left heel, stage 3",381,L89622 (100%); L89624 (100%); L89602 (93%); L89604 (93%); L89612 (91%)
L89624,"Pressure ulcer of left heel, stage 4",379,L89622 (100%); L89623 (100%); L89602 (93%); L89603 (93%); L89612 (91%)
L89626,Pressure-induced deep tissue damage of left heel,,
L89629,"Pressure ulcer of left heel, unspecified stage",,
L89810,"Pressure ulcer of head, unstageable",381,L89812 (64%); L89814 (64%); L89102 (39%); L89104 (39%); L89142 (35%)
L89811,"Pressure ulcer of head, stage 1",,
L89812,"Pressure ulcer of head, stage 2",382,L89813 (100%); L89814 (100%); L89103 (79%); L89104 (79%); L89143 (70%)
L89813,"Pressure ulcer of head, stage 3",381,L89812 (100%); L89814 (100%); L89102 (79%); L89104 (79%); L89142 (70%)
L89814,"Pressure ulcer of head, stage 4",379,L89812 (100%); L89813 (100%); L89102 (79%); L89103 (79%); L89142 (70%)
L89816,Pressure-induced deep tissue damage of head,,
L89819,"Pressure ulcer of head, unspecified stage",,
L89890,"Pressure ulcer of other site, unstageable",381,L89892 (61%); L89894 (61%); L8992 (59%); L8994 (59%); L89102 (41%)
L89891,"Pressure ulcer of other site, stage 1",,
L89892,"Pressure ulcer of other site, stage 2",382,L89893 (100%); L89894 (100%); L8993 (97%); L8994 (97%); L89103 (82%)
L89893,"Pressure ulcer of other site, stage 3",381,L89892 (100%); L89894 (100%); L8992 (97%); L8994 (97%); L89102 (82%)
L89894,"Pressure ulcer of other site, stage 4",379,L89892 (100%); L89893 (100%); L8992 (97%); L8993 (97%); L89102 (82%)
L89896,Pressure-induced deep tissue damage of other site,,
L89899,"Pressure ulcer of other site, unspecified stage",,
L8990,"Pressure ulcer of unspecified site, unspecified stage",,
L8991,"Pressure ulcer of unspecified site, stage 1",,
L8992,"Pressure ulcer of unspecified site, stage 2",382,L8993 (100%); L8994 (100%); L89893 (97%); L89894 (97%); L89103 (86%)
L8993,"Pressure ulcer of unspecified site, stage 3",381,L8992 (100%); L8994 (100%); L89892 (97%); L89894 (97%); L89102 (86%)
L8994,"Pressure ulcer of unspecified site, stage 4",379,L8992 (100%); L8993 (100%); L89892 (97%); L89893 (97%); L89102 (86%)
L8995,"Pressure ulcer of unspecified site, unstageable",381,L8992 (63%); L8994 (63%); L89892 (60%); L89894 (60%); L89102 (45%)
L8996,Pressure-induced deep tissue damage of unspecified site,,
L930,Discoid lupus erythematosus,,
L931,Subacute cutaneous lupus erythematosus,,
L932,Other local lupus erythematosus,,
L945,Poikiloderma vasculare atrophicans,,
L97101,Non-pressure chronic ulcer of unspecified thigh limited to breakdown of skin,383,L97104 (54%); L97103 (53%); L97124 (51%); L97114 (51%); L97123 (50%)
L97102,Non-pressure chronic ulcer of unspecified thigh with fat layer exposed,383,L97104 (52%); L97103 (52%); L97124 (49%); L97114 (49%); L97123 (49%)
L97103,Non-pressure chronic ulcer of unspecified thigh with necrosis of muscle,380,L97109 (69%); L97129 (67%); L97119 (67%); L97108 (65%); L97128 (61%)
L97104,Non-pressure chronic ulcer of unspecified thigh with necrosis of bone,380,L97109 (69%); L97129 (67%); L97119 (67%); L97108 (65%); L97128 (62%)
L97105,Non-pressure chronic ulcer of unspecified thigh with muscle involvement without evidence of necrosis,380,L97109 (58%); L97129 (57%); L97119 (57%); L97108 (55%); L97128 (52%)
L97106,Non-pressure chronic ulcer of unspecified thigh with bone involvement without evidence of necrosis,380,L97109 (59%); L97129 (57%); L97119 (57%); L97108 (55%); L97128 (52%)
L97108,Non-pressure chronic ulcer of unspecified thigh with other specified severity,383,L97104 (65%); L97103 (65%); L97124 (62%); L97114 (62%); L97123 (61%)
L97109,Non-pressure chronic ulcer of unspecified thigh with unspecified severity,383,L97104 (69%); L97103 (69%); L97124 (62%); L97114 (62%); L97123 (62%)
L97111,Non-pressure chronic ulcer of right thigh limited to breakdown of skin,383,L97114 (55%); L97113 (54%); L97104 (51%); L97103 (50%); L97124 (50%)
L97112,Non-pressure chronic ulcer of right thigh with fat layer exposed,383,L97114 (53%); L97113 (53%); L97104 (50%); L97103 (49%); L97124 (49%)
L97113,Non-pressure chronic ulcer of right thigh with necrosis of muscle,380,L97119 (68%); L97118 (66%); L97129 (63%); L97109 (62%); L97108 (61%)
L97114,Non-pressure chronic ulcer of right thigh with necrosis of bone,380,L97119 (69%); L97118 (66%); L97129 (64%); L97109 (62%); L97108 (62%)
L97115,Non-pressure chronic ulcer of right thigh with muscle involvement without evidence of necrosis,380,L97119 (58%); L97118 (56%); L97129 (54%); L97109 (53%); L97108 (52%)
L97116,Non-pressure chronic ulcer of right thigh with bone involvement without evidence of necrosis,380,L97119 (59%); L97118 (56%); L97129 (54%); L97109 (53%); L97108 (52%)
L97118,Non-pressure chronic ulcer of right thigh with other specified severity,383,L97114 (66%); L97113 (66%); L97104 (62%); L97103 (61%); L97124 (61%)
L97119,Non-pressure chronic ulcer of right thigh with unspecified severity,383,L97114 (69%); L97113 (68%); L97104 (67%); L97103 (67%); L97124 (64%)
L97121,Non-pressure chronic ulcer of left thigh limited to breakdown of skin,383,L97124 (55%); L97123 (54%); L97104 (51%); L97103 (50%); L97114 (50%)
L97122,Non-pressure chronic ulcer of left thigh with fat layer exposed,383,L97124 (53%); L97123 (53%); L97104 (50%); L97103 (49%); L97114 (49%)
L97123,Non-pressure chronic ulcer of left thigh with necrosis of muscle,380,L97129 (68%); L97128 (66%); L97119 (63%); L97109 (62%); L97108 (61%)
L97124,Non-pressure chronic ulcer of left thigh with necrosis of bone,380,L97129 (69%); L97128 (66%); L97119 (64%); L97109 (62%); L97108 (62%)
L97125,Non-pressure chronic ulcer of left thigh with muscle involvement without evidence of necrosis,380,L97129 (58%); L97128 (56%); L97119 (54%); L97109 (53%); L97108 (52%)
L97126,Non-pressure chronic ulcer of left thigh with bone involvement without evidence of necrosis,380,L97129 (59%); L97128 (56%); L97119 (54%); L97109 (53%); L97108 (52%)
L97128,Non-pressure chronic ulcer of left thigh with other specified severity,383,L97124 (66%); L97123 (66%); L97104 (62%); L97103 (61%); L97114 (61%)
L97129,Non-pressure chronic ulcer of left thigh with unspecified severity,383,L97124 (69%); L97123 (68%); L97104 (67%); L97103 (67%); L97114 (64%)
L97201,Non-pressure chronic ulcer of unspecified calf limited to breakdown of skin,383,L97204 (54%); L97203 (53%); L97224 (51%); L97214 (51%); L97223 (50%)
L97202,Non-pressure chronic ulcer of unspecified calf with fat layer exposed,383,L97204 (53%); L97203 (52%); L97224 (50%); L97214 (50%); L97223 (49%)
L97203,Non-pressure chronic ulcer of unspecified calf with necrosis of muscle,380,L97209 (69%); L97229 (67%); L97219 (67%); L97208 (65%); L97228 (61%)
L97204,Non-pressure chronic ulcer of unspecified calf with necrosis of bone,380,L97209 (69%); L97229 (68%); L97219 (68%); L97208 (65%); L97228 (62%)
L97205,Non-pressure chronic ulcer of unspecified calf with muscle involvement without evidence of necrosis,380,L97209 (58%); L97229 (57%); L97219 (57%); L97208 (55%); L97228 (52%)
L97206,Non-pressure chronic ulcer of unspecified calf with bone involvement without evidence of necrosis,380,L97209 (59%); L97229 (57%); L97219 (57%); L97208 (56%); L97228 (52%)
L97208,Non-pressure chronic ulcer of unspecified calf with other specified severity,383,L97204 (65%); L97203 (65%); L97224 (62%); L97214 (62%); L97223 (61%)
L97209,Non-pressure chronic ulcer of unspecified calf with unspecified severity,383,L97204 (69%); L97203 (69%); L97224 (62%); L97214 (62%); L97223 (62%)
L97211,Non-pressure chronic ulcer of right calf limited to breakdown of skin,383,L97214 (55%); L97213 (54%); L97204 (51%); L97203 (50%); L97224 (50%)
L97212,Non-pressure chronic ulcer of right calf with fat layer exposed,383,L97214 (53%); L97213 (53%); L97204 (50%); L97203 (49%); L97224 (49%)
L97213,Non-pressure chronic ulcer of right calf with necrosis of muscle,380,L97219 (69%); L97218 (66%); L97229 (63%); L97209 (62%); L97208 (61%)
L97214,Non-pressure chronic ulcer of right calf with necrosis of bone,380,L97219 (69%); L97218 (66%); L97229 (64%); L97209 (62%); L97208 (62%)
L97215,Non-pressure chronic ulcer of right calf with muscle involvement without evidence of necrosis,380,L97219 (58%); L97218 (56%); L97229 (54%); L97209 (53%); L97208 (52%)
L97216,Non-pressure chronic ulcer of right calf with bone involvement without evidence of necrosis,380,L97219 (59%); L97218 (56%); L97229 (54%); L97209 (53%); L97208 (52%)
L97218,Non-pressure chronic ulcer of right calf with other specified severity,383,L97214 (66%); L97213 (66%); L97204 (62%); L97203 (61%); L97224 (61%)
L97219,Non-pressure chronic ulcer of right calf with unspecified severity,383,L97214 (69%); L97213 (69%); L97204 (68%); L97203 (67%); L97224 (64%)
L97221,Non-pressure chronic ulcer of left calf limited to breakdown of skin,383,L97224 (55%); L97223 (54%); L97204 (51%); L97203 (50%); L97214 (50%)
L97222,Non-pressure chronic ulcer of left calf with fat layer exposed,383,L97224 (53%); L97223 (53%); L97204 (50%); L97203 (49%); L97214 (49%)
L97223,Non-pressure chronic ulcer of left calf with necrosis of muscle,380,L97229 (69%); L97228 (66%); L97219 (63%); L97209 (62%); L97208 (61%)
L97224,Non-pressure chronic ulcer of left calf with necrosis of bone,380,L97229 (69%); L97228 (66%); L97219 (64%); L97209 (62%); L97208 (62%)
L97225,Non-pressure chronic ulcer of left calf with muscle involvement without evidence of necrosis,380,L97229 (58%); L97228 (56%); L97219 (54%); L97209 (53%); L97208 (52%)
L97226,Non-pressure chronic ulcer of left calf with bone involvement without evidence of necrosis,380,L97229 (59%); L97228 (56%); L97219 (54%); L97209 (53%); L97208 (53%)
L97228,Non-pressure chronic ulcer of left calf with other specified severity,383,L97224 (66%); L97223 (66%); L97204 (62%); L97203 (61%); L97214 (61%)
L97229,Non-pressure chronic ulcer of left calf with unspecified severity,383,L97224 (69%); L97223 (69%); L97204 (68%); L97203 (67%); L97214 (64%)
L97301,Non-pressure chronic ulcer of unspecified ankle limited to breakdown of skin,383,L97304 (51%); L98494 (51%); L97303 (51%); L98493 (50%); L97324 (48%)
L97302,Non-pressure chronic ulcer of unspecified ankle with fat layer exposed,383,L97304 (50%); L97303 (49%); L97324 (47%); L97314 (47%); L97323 (46%)
L97303,Non-pressure chronic ulcer of unspecified ankle with necrosis of muscle,380,L97309 (66%); L97329 (64%); L97319 (64%); L97308 (62%); L97328 (58%)
L97304,Non-pressure chronic ulcer of unspecified ankle with necrosis of bone,380,L97309 (67%); L97329 (65%); L97319 (65%); L97308 (63%); L97328 (59%)
L97305,Non-pressure chronic ulcer of unspecified ankle with muscle involvement without evidence of necrosis,380,L97309 (56%); L97329 (54%); L97319 (54%); L97308 (52%); L97328 (49%)
L97306,Non-pressure chronic ulcer of unspecified ankle with bone involvement without evidence of necrosis,380,L97309 (56%); L97329 (55%); L97319 (55%); L97308 (53%); L97328 (49%)
L97308,Non-pressure chronic ulcer of unspecified ankle with other specified severity,383,L97304 (63%); L97303 (62%); L97324 (59%); L97314 (59%); L97323 (58%)
L97309,Non-pressure chronic ulcer of unspecified ankle with unspecified severity,383,L97304 (67%); L97303 (66%); L97324 (60%); L97314 (60%); L97323 (59%)
L97311,Non-pressure chronic ulcer of right ankle limited to breakdown of skin,383,L97314 (52%); L97313 (51%); L98494 (50%); L98493 (50%); L97304 (48%)
L97312,Non-pressure chronic ulcer of right ankle with fat layer exposed,383,L97314 (51%); L97313 (50%); L97304 (47%); L97303 (46%); L97324 (46%)
L97313,Non-pressure chronic ulcer of right ankle with necrosis of muscle,380,L97319 (66%); L97318 (63%); L97329 (60%); L97309 (59%); L97308 (58%)
L97314,Non-pressure chronic ulcer of right ankle with necrosis of bone,380,L97319 (67%); L97318 (64%); L97329 (61%); L97309 (60%); L97308 (59%)
L97315,Non-pressure chronic ulcer of right ankle with muscle involvement without evidence of necrosis,380,L97319 (56%); L97318 (53%); L97329 (51%); L97309 (50%); L97308 (49%)
L97316,Non-pressure chronic ulcer of right ankle with bone involvement without evidence of necrosis,380,L97319 (56%); L97318 (54%); L97329 (51%); L97309 (50%); L97308 (50%)
L97318,Non-pressure chronic ulcer of right ankle with other specified severity,383,L97314 (64%); L97313 (63%); L97304 (59%); L97303 (58%); L97324 (58%)
L97319,Non-pressure chronic ulcer of right ankle with unspecified severity,383,L97314 (67%); L97313 (66%); L97304 (65%); L97303 (64%); L97324 (61%)
L97321,Non-pressure chronic ulcer of left ankle limited to breakdown of skin,383,L97324 (52%); L97323 (51%); L98494 (50%); L98493 (50%); L97304 (48%)
L97322,Non-pressure chronic ulcer of left ankle with fat layer exposed,383,L97324 (51%); L97323 (50%); L97304 (47%); L97303 (46%); L97314 (46%)
L97323,Non-pressure chronic ulcer of left ankle with necrosis of muscle,380,L97329 (66%); L97328 (63%); L97319 (60%); L97309 (59%); L97308 (58%)
L97324,Non-pressure chronic ulcer of left ankle with necrosis of bone,380,L97329 (67%); L97328 (64%); L97319 (61%); L97309 (60%); L97308 (59%)
L97325,Non-pressure chronic ulcer of left ankle with muscle involvement without evidence of necrosis,380,L97329 (56%); L97328 (53%); L97319 (51%); L97309 (50%); L97308 (49%)
L97326,Non-pressure chronic ulcer of left ankle with bone involvement without evidence of necrosis,380,L97329 (56%); L97328 (54%); L97319 (51%); L97309 (50%); L97308 (50%)
L97328,Non-pressure chronic ulcer of left ankle with other specified severity,383,L97324 (64%); L97323 (63%); L97304 (59%); L97303 (58%); L97314 (58%)
L97329,Non-pressure chronic ulcer of left ankle with unspecified severity,383,L97324 (67%); L97323 (66%); L97304 (65%); L97303 (64%); L97314 (61%)
L97401,Non-pressure chronic ulcer of unspecified heel and midfoot limited to breakdown of skin,383,L97404 (61%); L97403 (60%); L97424 (58%); L97414 (58%); L97423 (57%)
L97402,Non-pressure chronic ulcer of unspecified heel and midfoot with fat layer exposed,383,L97404 (59%); L97403 (59%); L97424 (57%); L97414 (57%); L97423 (56%)
L97403,Non-pressure chronic ulcer of unspecified heel and midfoot with necrosis of muscle,380,L97409 (74%); L97429 (73%); L97419 (73%); L97408 (71%); L97428 (68%)
L97404,Non-pressure chronic ulcer of unspecified heel and midfoot with necrosis of bone,380,L97409 (75%); L97429 (73%); L97419 (73%); L97408 (71%); L97428 (68%)
L97405,Non-pressure chronic ulcer of unspecified heel and midfoot with muscle involvement without evidence of necrosis,380,L97409 (65%); L97429 (63%); L97419 (63%); L97408 (62%); L97428 (59%)
L97406,Non-pressure chronic ulcer of unspecified heel and midfoot with bone involvement without evidence of necrosis,380,L97409 (65%); L97429 (64%); L97419 (64%); L97408 (62%); L97428 (59%)
L97408,Non-pressure chronic ulcer of unspecified heel and midfoot with other specified severity,383,L97404 (71%); L97403 (71%); L97424 (68%); L97414 (68%); L97423 (68%)
L97409,Non-pressure chronic ulcer of unspecified heel and midfoot with unspecified severity,383,L97404 (75%); L97403 (74%); L97424 (69%); L97414 (69%); L97423 (69%)
L97411,Non-pressure chronic ulcer of right heel and midfoot limited to breakdown of skin,383,L97414 (61%); L97413 (61%); L97404 (58%); L97403 (58%); L97424 (58%)
L97412,Non-pressure chronic ulcer of right heel and midfoot with fat layer exposed,383,L97414 (60%); L97413 (60%); L97404 (57%); L97403 (57%); L97424 (56%)
L97413,Non-pressure chronic ulcer of right heel and midfoot with necrosis of muscle,380,L97419 (74%); L97418 (71%); L97429 (70%); L97409 (69%); L97408 (68%)
L97414,Non-pressure chronic ulcer of right heel and midfoot with necrosis of bone,380,L97419 (75%); L97418 (72%); L97429 (70%); L97409 (69%); L97408 (68%)
L97415,Non-pressure chronic ulcer of right heel and midfoot with muscle involvement without evidence of necrosis,380,L97419 (65%); L97418 (62%); L97429 (61%); L97409 (60%); L97408 (59%)
L97416,Non-pressure chronic ulcer of right heel and midfoot with bone involvement without evidence of necrosis,380,L97419 (65%); L97418 (63%); L97429 (61%); L97409 (60%); L97408 (60%)
L97418,Non-pressure chronic ulcer of right heel and midfoot with other specified severity,383,L97414 (72%); L97413 (71%); L97404 (68%); L97403 (68%); L97424 (68%)
L97419,Non-pressure chronic ulcer of right heel and midfoot with unspecified severity,383,L97414 (75%); L97413 (74%); L97404 (73%); L97403 (73%); L97424 (70%)
L97421,Non-pressure chronic ulcer of left heel and midfoot limited to breakdown of skin,383,L97424 (61%); L97423 (61%); L97404 (58%); L97403 (58%); L97414 (58%)
L97422,Non-pressure chronic ulcer of left heel and midfoot with fat layer exposed,383,L97424 (60%); L97423 (60%); L97404 (57%); L97403 (57%); L97414 (56%)
L97423,Non-pressure chronic ulcer of left heel and midfoot with necrosis of muscle,380,L97429 (74%); L97428 (71%); L97419 (70%); L97409 (69%); L97408 (68%)
L97424,Non-pressure chronic ulcer of left heel and midfoot with necrosis of bone,380,L97429 (75%); L97428 (72%); L97419 (70%); L97409 (69%); L97408 (68%)
L97425,Non-pressure chronic ulcer of left heel and midfoot with muscle involvement without evidence of necrosis,380,L97429 (65%); L97428 (62%); L97419 (61%); L97409 (60%); L97408 (59%)
L97426,Non-pressure chronic ulcer of left heel and midfoot with bone involvement without evidence of necrosis,380,L97429 (65%); L97428 (63%); L97419 (61%); L97409 (60%); L97408 (60%)
L97428,Non-pressure chronic ulcer of left heel and midfoot with other specified severity,383,L97424 (72%); L97423 (71%); L97404 (68%); L97403 (68%); L97414 (68%)
L97429,Non-pressure chronic ulcer of left heel and midfoot with unspecified severity,383,L97424 (75%); L97423 (74%); L97404 (73%); L97403 (73%); L97414 (70%)
L97501,Non-pressure chronic ulcer of other part of unspecified foot limited to breakdown of skin,383,L97504 (51%); L98494 (51%); L97503 (51%); L98493 (50%); L97524 (48%)
L97502,Non-pressure chronic ulcer of other part of unspecified foot with fat layer exposed,383,L97504 (50%); L97503 (49%); L97524 (47%); L97514 (47%); L97523 (46%)
L97503,Non-pressure chronic ulcer of other part of unspecified foot with necrosis of muscle,380,L97509 (66%); L97529 (64%); L97519 (64%); L97508 (62%); L97528 (58%)
L97504,Non-pressure chronic ulcer of other part of unspecified foot with necrosis of bone,380,L97509 (67%); L97529 (65%); L97519 (65%); L97508 (63%); L97528 (59%)
L97505,Non-pressure chronic ulcer of other part of unspecified foot with muscle involvement without evidence of necrosis,380,L97509 (56%); L97529 (54%); L97519 (54%); L97508 (52%); L97528 (49%)
L97506,Non-pressure chronic ulcer of other part of unspecified foot with bone involvement without evidence of necrosis,380,L97509 (56%); L97529 (55%); L97519 (55%); L97508 (53%); L97528 (49%)
L97508,Non-pressure chronic ulcer of other part of unspecified foot with other specified severity,383,L97504 (63%); L97503 (62%); L97524 (59%); L97514 (59%); L97523 (58%)
L97509,Non-pressure chronic ulcer of other part of unspecified foot with unspecified severity,383,L97504 (67%); L97503 (66%); L97524 (60%); L97514 (60%); L97523 (59%)
L97511,Non-pressure chronic ulcer of other part of right foot limited to breakdown of skin,383,L97514 (52%); L97513 (51%); L98494 (50%); L98493 (50%); L97504 (48%)
L97512,Non-pressure chronic ulcer of other part of right foot with fat layer exposed,383,L97514 (51%); L97513 (50%); L97504 (47%); L97503 (46%); L97524 (46%)
L97513,Non-pressure chronic ulcer of other part of right foot with necrosis of muscle,380,L97519 (66%); L97518 (63%); L97529 (60%); L97509 (59%); L97508 (58%)
L97514,Non-pressure chronic ulcer of other part of right foot with necrosis of bone,380,L97519 (67%); L97518 (64%); L97529 (61%); L97509 (60%); L97508 (59%)
L97515,Non-pressure chronic ulcer of other part of right foot with muscle involvement without evidence of necrosis,380,L97519 (56%); L97518 (53%); L97529 (51%); L97509 (50%); L97508 (49%)
L97516,Non-pressure chronic ulcer of other part of right foot with bone involvement without evidence of necrosis,380,L97519 (56%); L97518 (54%); L97529 (51%); L97509 (50%); L97508 (50%)
L97518,Non-pressure chronic ulcer of other part of right foot with other specified severity,383,L97514 (64%); L97513 (63%); L97504 (59%); L97503 (58%); L97524 (58%)
L97519,Non-pressure chronic ulcer of other part of right foot with unspecified severity,383,L97514 (67%); L97513 (66%); L97504 (65%); L97503 (64%); L97524 (61%)
L97521,Non-pressure chronic ulcer of other part of left foot limited to breakdown of skin,383,L97524 (52%); L97523 (51%); L98494 (50%); L98493 (50%); L97504 (48%)
L97522,Non-pressure chronic ulcer of other part of left foot with fat layer exposed,383,L97524 (51%); L97523 (50%); L97504 (47%); L97503 (46%); L97514 (46%)
L97523,Non-pressure chronic ulcer of other part of left foot with necrosis of muscle,380,L97529 (66%); L97528 (63%); L97519 (60%); L97509 (59%); L97508 (58%)
L97524,Non-pressure chronic ulcer of other part of left foot with necrosis of bone,380,L97529 (67%); L97528 (64%); L97519 (61%); L97509 (60%); L97508 (59%)
L97525,Non-pressure chronic ulcer of other part of left foot with muscle involvement without evidence of necrosis,380,L97529 (56%); L97528 (53%); L97519 (51%); L97509 (50%); L97508 (49%)
L97526,Non-pressure chronic ulcer of other part of left foot with bone involvement without evidence of necrosis,380,L97529 (56%); L97528 (54%); L97519 (51%); L97509 (50%); L97508 (50%)
L97528,Non-pressure chronic ulcer of other part of left foot with other specified severity,383,L97524 (64%); L97523 (63%); L97504 (59%); L97503 (58%); L97514 (58%)
L97529,Non-pressure chronic ulcer of other part of left foot with unspecified severity,383,L97524 (67%); L97523 (66%); L97504 (65%); L97503 (64%); L97514 (61%)
L97801,Non-pressure chronic ulcer of other part of unspecified lower leg limited to breakdown of skin,383,L97904 (54%); L97804 (54%); L97903 (54%); L97803 (53%); L97924 (53%)
L97802,Non-pressure chronic ulcer of other part of unspecified lower leg with fat layer exposed,383,L97904 (53%); L97804 (53%); L97903 (52%); L97803 (52%); L97924 (51%)
L97803,Non-pressure chronic ulcer of other part of unspecified lower leg with necrosis of muscle,380,L97809 (69%); L97829 (67%); L97819 (67%); L97929 (67%); L97919 (67%)
L97804,Non-pressure chronic ulcer of other part of unspecified lower leg with necrosis of bone,380,L97809 (69%); L97829 (68%); L97819 (68%); L97929 (68%); L97919 (67%)
L97805,Non-pressure chronic ulcer of other part of unspecified lower leg with muscle involvement without evidence of necrosis,380,L97809 (58%); L97829 (57%); L97819 (57%); L97929 (57%); L97919 (57%)
L97806,Non-pressure chronic ulcer of other part of unspecified lower leg with bone involvement without evidence of necrosis,380,L97809 (59%); L97829 (57%); L97819 (57%); L97929 (57%); L97919 (57%)
L97808,Non-pressure chronic ulcer of other part of unspecified lower leg with other specified severity,383,L97904 (66%); L97804 (66%); L97903 (65%); L97803 (65%); L97924 (64%)
L97809,Non-pressure chronic ulcer of other part of unspecified lower leg with unspecified severity,383,L97904 (72%); L97903 (72%); L97804 (69%); L97803 (69%); L97924 (68%)
L97811,Non-pressure chronic ulcer of other part of right lower leg limited to breakdown of skin,383,L97814 (55%); L97813 (54%); L97914 (54%); L97913 (53%); L97804 (51%)
L97812,Non-pressure chronic ulcer of other part of right lower leg with fat layer exposed,383,L97814 (54%); L97813 (53%); L97914 (53%); L97913 (52%); L97804 (50%)
L97813,Non-pressure chronic ulcer of other part of right lower leg with necrosis of muscle,380,L97819 (69%); L97818 (66%); L97919 (65%); L97918 (65%); L97829 (63%)
L97814,Non-pressure chronic ulcer of other part of right lower leg with necrosis of bone,380,L97819 (69%); L97818 (66%); L97919 (66%); L97918 (65%); L97829 (64%)
L97815,Non-pressure chronic ulcer of other part of right lower leg with muscle involvement without evidence of necrosis,380,L97819 (59%); L97818 (56%); L97919 (56%); L97918 (55%); L97829 (54%)
L97816,Non-pressure chronic ulcer of other part of right lower leg with bone involvement without evidence of necrosis,380,L97819 (59%); L97818 (56%); L97919 (56%); L97918 (56%); L97829 (54%)
L97818,Non-pressure chronic ulcer of other part of right lower leg with other specified severity,383,L97814 (66%); L97813 (66%); L97914 (65%); L97913 (65%); L97804 (62%)
L97819,Non-pressure chronic ulcer of other part of right lower leg with unspecified severity,383,L97914 (71%); L97913 (71%); L97814 (69%); L97813 (69%); L97904 (68%)
L97821,Non-pressure chronic ulcer of other part of left lower leg limited to breakdown of skin,383,L97824 (55%); L97823 (54%); L97924 (54%); L97923 (53%); L97804 (51%)
L97822,Non-pressure chronic ulcer of other part of left lower leg with fat layer exposed,383,L97824 (54%); L97823 (53%); L97924 (53%); L97923 (52%); L97804 (50%)
L97823,Non-pressure chronic ulcer of other part of left lower leg with necrosis of muscle,380,L97829 (69%); L97828 (66%); L97929 (65%); L97928 (65%); L97819 (63%)
L97824,Non-pressure chronic ulcer of other part of left lower leg with necrosis of bone,380,L97829 (69%); L97828 (66%); L97929 (66%); L97928 (65%); L97819 (64%)
L97825,Non-pressure chronic ulcer of other part of left lower leg with muscle involvement without evidence of necrosis,380,L97829 (59%); L97828 (56%); L97929 (56%); L97928 (55%); L97819 (54%)
L97826,Non-pressure chronic ulcer of other part of left lower leg with bone involvement without evidence of necrosis,380,L97829 (59%); L97828 (56%); L97929 (56%); L97928 (56%); L97819 (54%)
L97828,Non-pressure chronic ulcer of other part of left lower leg with other specified severity,383,L97824 (66%); L97823 (66%); L97924 (65%); L97923 (65%); L97804 (62%)
L97829,Non-pressure chronic ulcer of other part of left lower leg with unspecified severity,383,L97924 (71%); L97923 (71%); L97824 (69%); L97823 (69%); L97904 (68%)
L97901,Non-pressure chronic ulcer of unspecified part of unspecified lower leg limited to breakdown of skin,383,L97904 (57%); L97903 (57%); L97804 (55%); L97803 (54%); L97924 (53%)
L97902,Non-pressure chronic ulcer of unspecified part of unspecified lower leg with fat layer exposed,383,L97904 (56%); L97903 (55%); L97804 (54%); L97803 (53%); L97924 (52%)
L97903,Non-pressure chronic ulcer of unspecified part of unspecified lower leg with necrosis of muscle,380,L97909 (72%); L97809 (72%); L97929 (70%); L97919 (70%); L97908 (68%)
L97904,Non-pressure chronic ulcer of unspecified part of unspecified lower leg with necrosis of bone,380,L97909 (73%); L97809 (72%); L97929 (70%); L97919 (70%); L97908 (68%)
L97905,Non-pressure chronic ulcer of unspecified part of unspecified lower leg with muscle involvement without evidence of necrosis,380,L97909 (62%); L97809 (62%); L97929 (60%); L97919 (60%); L97908 (58%)
L97906,Non-pressure chronic ulcer of unspecified part of unspecified lower leg with bone involvement without evidence of necrosis,380,L97909 (62%); L97809 (62%); L97929 (60%); L97919 (60%); L97908 (59%)
L97908,Non-pressure chronic ulcer of unspecified part of unspecified lower leg with other specified severity,383,L97904 (68%); L97903 (68%); L97804 (66%); L97803 (65%); L97924 (64%)
L97909,Non-pressure chronic ulcer of unspecified part of unspecified lower leg with unspecified severity,383,L97904 (73%); L97903 (72%); L97804 (67%); L97803 (67%); L97924 (66%)
L97911,Non-pressure chronic ulcer of unspecified part of right lower leg limited to breakdown of skin,383,L97914 (56%); L97913 (55%); L97814 (54%); L97813 (54%); L97904 (53%)
L97912,Non-pressure chronic ulcer of unspecified part of right lower leg with fat layer exposed,383,L97914 (55%); L97913 (54%); L97814 (53%); L97813 (53%); L97904 (52%)
L97913,Non-pressure chronic ulcer of unspecified part of right lower leg with necrosis of muscle,380,L97819 (71%); L97919 (70%); L97809 (67%); L97918 (67%); L97829 (65%)
L97914,Non-pressure chronic ulcer of unspecified part of right lower leg with necrosis of bone,380,L97819 (71%); L97919 (71%); L97809 (68%); L97918 (67%); L97829 (66%)
L97915,Non-pressure chronic ulcer of unspecified part of right lower leg with muscle involvement without evidence of necrosis,380,L97819 (61%); L97919 (60%); L97809 (57%); L97918 (57%); L97829 (56%)
L97916,Non-pressure chronic ulcer of unspecified part of right lower leg with bone involvement without evidence of necrosis,380,L97819 (61%); L97919 (61%); L97809 (58%); L97918 (57%); L97829 (56%)
L97918,Non-pressure chronic ulcer of unspecified part of right lower leg with other specified severity,383,L97914 (67%); L97913 (67%); L97814 (65%); L97813 (65%); L97904 (64%)
L97919,Non-pressure chronic ulcer of unspecified part of right lower leg with unspecified severity,383,L97914 (71%); L97904 (70%); L97913 (70%); L97903 (70%); L97804 (67%)
L97921,Non-pressure chronic ulcer of unspecified part of left lower leg limited to breakdown of skin,383,L97924 (56%); L97923 (55%); L97824 (54%); L97823 (54%); L97904 (53%)
L97922,Non-pressure chronic ulcer of unspecified part of left lower leg with fat layer exposed,383,L97924 (55%); L97923 (54%); L97824 (53%); L97823 (53%); L97904 (52%)
L97923,Non-pressure chronic ulcer of unspecified part of left lower leg with necrosis of muscle,380,L97829 (71%); L97929 (70%); L97809 (67%); L97928 (67%); L97819 (65%)
L97924,Non-pressure chronic ulcer of unspecified part of left lower leg with necrosis of bone,380,L97829 (71%); L97929 (71%); L97809 (68%); L97928 (67%); L97819 (66%)
L97925,Non-pressure chronic ulcer of unspecified part of left lower leg with muscle involvement without evidence of necrosis,380,L97829 (61%); L97929 (60%); L97809 (57%); L97928 (57%); L97819 (56%)
L97926,Non-pressure chronic ulcer of unspecified part of left lower leg with bone involvement without evidence of necrosis,380,L97829 (61%); L97929 (61%); L97809 (58%); L97928 (57%); L97819 (56%)
L97928,Non-pressure chronic ulcer of unspecified part of left lower leg with other specified severity,383,L97924 (67%); L97923 (67%); L97824 (65%); L97823 (65%); L97904 (64%)
L97929,Non-pressure chronic ulcer of unspecified part of left lower leg with unspecified severity,383,L97924 (71%); L97904 (70%); L97923 (70%); L97903 (70%); L97804 (68%)
L98411,Non-pressure chronic ulcer of buttock limited to breakdown of skin,383,L98414 (55%); L98413 (55%); L98494 (49%); L98493 (48%); L89302 (48%)
L98412,Non-pressure chronic ulcer of buttock with fat layer exposed,383,L98414 (54%); L98413 (54%); L89302 (47%); L89303 (47%); L89304 (47%)
L98413,Non-pressure chronic ulcer of buttock with necrosis of muscle,380,L98419 (69%); L98418 (66%); L89302 (56%); L89303 (56%); L89304 (56%)
L98414,Non-pressure chronic ulcer of buttock with necrosis of bone,380,L98419 (70%); L98418 (67%); L89302 (57%); L89303 (57%); L89304 (57%)
L98415,Non-pressure chronic ulcer of buttock with muscle involvement without evidence of necrosis,380,L98419 (59%); L98418 (57%); L89302 (48%); L89303 (48%); L89304 (48%)
L98416,Non-pressure chronic ulcer of buttock with bone involvement without evidence of necrosis,380,L98419 (60%); L98418 (57%); L89302 (49%); L89303 (49%); L89304 (49%)
L98418,Non-pressure chronic ulcer of buttock with other specified severity,383,L98414 (67%); L98413 (66%); L89302 (58%); L89303 (58%); L89304 (58%)
L98419,Non-pressure chronic ulcer of buttock with unspecified severity,383,L98414 (70%); L98413 (69%); L89302 (64%); L89303 (64%); L89304 (64%)
L98421,Non-pressure chronic ulcer of back limited to breakdown of skin,383,L98494 (54%); L98493 (54%); L98496 (47%); L98495 (46%); L98424 (43%)
L98422,Non-pressure chronic ulcer of back with fat layer exposed,383,L98424 (42%); L98423 (41%); L97304 (38%); L97504 (38%); L97303 (37%)
L98423,Non-pressure chronic ulcer of back with necrosis of muscle,380,L98429 (58%); L98428 (54%); L97329 (51%); L97319 (51%); L97529 (51%)
L98424,Non-pressure chronic ulcer of back with necrosis of bone,380,L98429 (58%); L98428 (55%); L97329 (51%); L97319 (51%); L97529 (51%)
L98425,Non-pressure chronic ulcer of back with muscle involvement without evidence of necrosis,380,L98429 (47%); L98428 (44%); L97329 (41%); L97319 (41%); L97529 (41%)
L98426,Non-pressure chronic ulcer of back with bone involvement without evidence of necrosis,380,L98429 (47%); L98428 (45%); L97329 (42%); L97319 (42%); L97529 (42%)
L98428,Non-pressure chronic ulcer of back with other specified severity,383,L98424 (55%); L98423 (54%); L97304 (50%); L97504 (50%); L97303 (49%)
L98429,Non-pressure chronic ulcer of back with unspecified severity,383,L98424 (58%); L98423 (58%); L97304 (57%); L97504 (57%); L97303 (56%)
L98491,Non-pressure chronic ulcer of skin of other sites limited to breakdown of skin,383,L98494 (66%); L98493 (65%); L98496 (57%); L98495 (56%); E10622 (50%)
L98492,Non-pressure chronic ulcer of skin of other sites with fat layer exposed,383,L98494 (57%); L98493 (56%); L98496 (49%); L98495 (49%); L98424 (37%)
L98493,Non-pressure chronic ulcer of skin of other sites with necrosis of muscle,380,L98499 (71%); L98498 (69%); L98491 (65%); L98492 (56%); L98421 (54%)
L98494,Non-pressure chronic ulcer of skin of other sites with necrosis of bone,380,L98499 (72%); L98498 (69%); L98491 (66%); L98492 (57%); L98421 (54%)
L98495,Non-pressure chronic ulcer of skin of other sites with muscle involvement without evidence of necrosis,380,L98499 (62%); L98498 (59%); L98491 (56%); L98492 (49%); L98421 (46%)
L98496,Non-pressure chronic ulcer of skin of other sites with bone involvement without evidence of necrosis,380,L98499 (62%); L98498 (60%); L98491 (57%); L98492 (49%); L98421 (47%)
L98498,Non-pressure chronic ulcer of skin of other sites with other specified severity,383,L98494 (69%); L98493 (69%); L98496 (60%); L98495 (59%); E13622 (53%)
L98499,Non-pressure chronic ulcer of skin of other sites with unspecified severity,383,L98494 (72%); L98493 (71%); L98496 (62%); L98495 (62%); L98424 (47%)
M0000,"Staphylococcal arthritis, unspecified joint",92,S78019A (39%); S48019A (39%); S78029A (38%); S48029A (38%); S78012A (35%)
M00011,"Staphylococcal arthritis, right shoulder",92,M08811 (57%); M08911 (55%); M06811 (54%); M08011 (50%); M08819 (48%)
M00012,"Staphylococcal arthritis, left shoulder",92,M08812 (57%); M08912 (55%); M06812 (54%); M08012 (50%); M08819 (48%)
M00019,"Staphylococcal arthritis, unspecified shoulder",92,M08919 (56%); M08819 (55%); M08912 (52%); M08911 (52%); M06819 (52%)
M00021,"Staphylococcal arthritis, right elbow",92,M08821 (59%); M08921 (57%); M06821 (55%); M08021 (52%); M08829 (50%)
M00022,"Staphylococcal arthritis, left elbow",92,M08822 (59%); M08922 (57%); M06822 (55%); M08022 (52%); M08829 (50%)
M00029,"Staphylococcal arthritis, unspecified elbow",92,M08929 (57%); M08829 (57%); M08922 (54%); M08921 (54%); M06829 (54%)
M00031,"Staphylococcal arthritis, right wrist",92,M08831 (60%); M08931 (58%); M06831 (56%); M08031 (53%); M08839 (51%)
M00032,"Staphylococcal arthritis, left wrist",92,M08832 (60%); M08932 (58%); M06832 (56%); M08032 (53%); M08839 (51%)
M00039,"Staphylococcal arthritis, unspecified wrist",92,M08939 (58%); M08839 (58%); M08932 (55%); M08931 (55%); M06839 (55%)
M00041,"Staphylococcal arthritis, right hand",92,M08841 (58%); M08941 (56%); M06841 (55%); M08041 (51%); M08849 (49%)
M00042,"Staphylococcal arthritis, left hand",92,M08842 (58%); M08942 (56%); M06842 (55%); M08042 (51%); M08849 (49%)
M00049,"Staphylococcal arthritis, unspecified hand",92,M08949 (57%); M08849 (56%); M08942 (53%); M08941 (53%); M06849 (53%)
M00051,"Staphylococcal arthritis, right hip",92,M08851 (57%); M08951 (55%); M06851 (53%); M08051 (50%); M08859 (48%)
M00052,"Staphylococcal arthritis, left hip",92,M08852 (57%); M08952 (55%); M06852 (53%); M08052 (50%); M08859 (48%)
M00059,"Staphylococcal arthritis, unspecified hip",92,M08959 (56%); M08859 (55%); M08952 (52%); M08951 (52%); M06859 (51%)
M00061,"Staphylococcal arthritis, right knee",92,M08861 (59%); M08961 (57%); M06861 (56%); M08061 (52%); M08869 (51%)
M00062,"Staphylococcal arthritis, left knee",92,M08862 (59%); M08962 (57%); M06862 (56%); M08062 (52%); M08869 (51%)
M00069,"Staphylococcal arthritis, unspecified knee",92,M08969 (58%); M08869 (57%); M08962 (54%); M08961 (54%); M06869 (54%)
M00071,"Staphylococcal arthritis, right ankle and foot",92,M08871 (65%); M08971 (64%); M06871 (62%); M08071 (59%); M08879 (58%)
M00072,"Staphylococcal arthritis, left ankle and foot",92,M08872 (65%); M08972 (64%); M06872 (62%); M08072 (59%); M08879 (58%)
M00079,"Staphylococcal arthritis, unspecified ankle and foot",92,M08879 (64%); M08979 (64%); M08972 (61%); M08971 (61%); M06879 (61%)
M0008,"Staphylococcal arthritis, vertebrae",92,M0898 (63%); M0688 (62%); M0808 (58%); M0848 (50%); M0608 (48%)
M0009,Staphylococcal polyarthritis,92,M083 (45%); A021 (0%); A065 (0%); A072 (0%); A207 (0%)
M0010,"Pneumococcal arthritis, unspecified joint",92,S78019A (39%); S48019A (39%); S78029A (38%); S48029A (38%); S78012A (35%)
M00111,"Pneumococcal arthritis, right shoulder",92,M08811 (57%); M08911 (55%); M06811 (54%); M08011 (50%); M08819 (48%)
M00112,"Pneumococcal arthritis, left shoulder",92,M08812 (57%); M08912 (55%); M06812 (54%); M08012 (50%); M08819 (48%)
M00119,"Pneumococcal arthritis, unspecified shoulder",92,M08919 (56%); M08819 (55%); M08912 (52%); M08911 (52%); M06819 (52%)
M00121,"Pneumococcal arthritis, right elbow",92,M08821 (59%); M08921 (57%); M06821 (55%); M08021 (52%); M08829 (50%)
M00122,"Pneumococcal arthritis, left elbow",92,M08822 (59%); M08922 (57%); M06822 (55%); M08022 (52%); M08829 (50%)
M00129,"Pneumococcal arthritis, unspecified elbow",92,M08929 (57%); M08829 (57%); M08922 (54%); M08921 (54%); M06829 (54%)
M00131,"Pneumococcal arthritis, right wrist",92,M08831 (60%); M08931 (58%); M06831 (56%); M08031 (53%); M08839 (51%)
M00132,"Pneumococcal arthritis, left wrist",92,M08832 (60%); M08932 (58%); M06832 (56%); M08032 (53%); M08839 (51%)
M00139,"Pneumococcal arthritis, unspecified wrist",92,M08939 (58%); M08839 (58%); M08932 (55%); M08931 (55%); M06839 (55%)
M00141,"Pneumococcal arthritis, right hand",92,M08841 (58%); M08941 (56%); M06841 (55%); M08041 (51%); M08849 (49%)
M00142,"Pneumococcal arthritis, left hand",92,M08842 (58%); M08942 (56%); M06842 (55%); M08042 (51%); M08849 (49%)
M00149,"Pneumococcal arthritis, unspecified hand",92,M08949 (57%); M08849 (56%); M08942 (53%); M08941 (53%); M06849 (53%)
M00151,"Pneumococcal arthritis, right hip",92,M08851 (57%); M08951 (55%); M06851 (53%); M08051 (50%); M08859 (48%)
M00152,"Pneumococcal arthritis, left hip",92,M08852 (57%); M08952 (55%); M06852 (53%); M08052 (50%); M08859 (48%)
M00159,"Pneumococcal arthritis, unspecified hip",92,M08959 (56%); M08859 (55%); M08952 (52%); M08951 (52%); M06859 (51%)
M00161,"Pneumococcal arthritis, right knee",92,M08861 (59%); M08961 (57%); M06861 (56%); M08061 (52%); M08869 (51%)
M00162,"Pneumococcal arthritis, left knee",92,M08862 (59%); M08962 (57%); M06862 (56%); M08062 (52%); M08869 (51%)
M00169,"Pneumococcal arthritis, unspecified knee",92,M08969 (58%); M08869 (57%); M08962 (54%); M08961 (54%); M06869 (54%)
M00171,"Pneumococcal arthritis, right ankle and foot",92,M08871 (65%); M08971 (64%); M06871 (62%); M08071 (59%); M08879 (58%)
M00172,"Pneumococcal arthritis, left ankle and foot",92,M08872 (65%); M08972 (64%); M06872 (62%); M08072 (59%); M08879 (58%)
M00179,"Pneumococcal arthritis, unspecified ankle and foot",92,M08879 (64%); M08979 (64%); M08972 (61%); M08971 (61%); M06879 (61%)
M0018,"Pneumococcal arthritis, vertebrae",92,M0898 (63%); M0688 (62%); M0808 (58%); M0848 (50%); M0608 (48%)
M0019,Pneumococcal polyarthritis,92,M083 (45%); A021 (0%); A065 (0%); A072 (0%); A207 (0%)
M0020,"Other streptococcal arthritis, unspecified joint",92,A409 (49%); A408 (45%); S78019A (39%); S48019A (39%); S78029A (38%)
M00211,"Other streptococcal arthritis, right shoulder",92,M08811 (58%); M08911 (56%); M06811 (54%); M08011 (51%); A408 (50%)
M00212,"Other streptococcal arthritis, left shoulder",92,M08812 (58%); M08912 (56%); M06812 (54%); M08012 (51%); A408 (50%)
M00219,"Other streptococcal arthritis, unspecified shoulder",92,M08919 (56%); M08819 (56%); A409 (55%); M08912 (52%); M08911 (52%)
M00221,"Other streptococcal arthritis, right elbow",92,M08821 (59%); M08921 (57%); M06821 (56%); M08021 (52%); M08829 (50%)
M00222,"Other streptococcal arthritis, left elbow",92,M08822 (59%); M08922 (57%); M06822 (56%); M08022 (52%); M08829 (50%)
M00229,"Other streptococcal arthritis, unspecified elbow",92,M08929 (58%); M08829 (57%); A409 (54%); M08922 (54%); M08921 (54%)
M00231,"Other streptococcal arthritis, right wrist",92,M08831 (60%); M08931 (58%); M06831 (57%); M08031 (53%); M08839 (52%)
M00232,"Other streptococcal arthritis, left wrist",92,M08832 (60%); M08932 (58%); M06832 (57%); M08032 (53%); M08839 (52%)
M00239,"Other streptococcal arthritis, unspecified wrist",92,M08939 (59%); M08839 (58%); M08932 (55%); M08931 (55%); M06839 (55%)
M00241,"Other streptococcal arthritis, right hand",92,M08841 (58%); M08941 (56%); M06841 (55%); M08041 (51%); A408 (50%)
M00242,"Other streptococcal arthritis, left hand",92,M08842 (58%); M08942 (56%); M06842 (55%); M08042 (51%); A408 (50%)
M00249,"Other streptococcal arthritis, unspecified hand",92,M08949 (57%); M08849 (56%); A409 (55%); M08942 (53%); M08941 (53%)
M00251,"Other streptococcal arthritis, right hip",92,M08851 (57%); M08951 (55%); M06851 (54%); A408 (50%); M08051 (50%)
M00252,"Other streptococcal arthritis, left hip",92,M08852 (57%); M08952 (55%); M06852 (54%); A408 (50%); M08052 (50%)
M00259,"Other streptococcal arthritis, unspecified hip",92,M08959 (56%); A409 (56%); M08859 (55%); M08952 (52%); M08951 (52%)
M00261,"Other streptococcal arthritis, right knee",92,M08861 (59%); M08961 (58%); M06861 (56%); M08061 (52%); M08869 (51%)
M00262,"Other streptococcal arthritis, left knee",92,M08862 (59%); M08962 (58%); M06862 (56%); M08062 (52%); M08869 (51%)
M00269,"Other streptococcal arthritis, unspecified knee",92,M08969 (58%); M08869 (58%); M08962 (55%); M08961 (55%); M06869 (54%)
M00271,"Other streptococcal arthritis, right ankle and foot",92,M08871 (66%); M08971 (64%); M06871 (62%); M08071 (59%); M08879 (58%)
M00272,"Other streptococcal arthritis, left ankle and foot",92,M08872 (66%); M08972 (64%); M06872 (62%); M08072 (59%); M08879 (58%)
M00279,"Other streptococcal arthritis, unspecified ankle and foot",92,M08879 (64%); M08979 (64%); M08972 (61%); M08971 (61%); M06879 (61%)
M0028,"Other streptococcal arthritis, vertebrae",92,M0898 (63%); M0688 (62%); M0808 (58%); M0848 (50%); M0608 (48%)
M0029,Other streptococcal polyarthritis,92,A408 (46%); M083 (45%); A409 (44%); A021 (0%); A065 (0%)
M0080,"Arthritis due to other bacteria, unspecified joint",92,J158 (39%); S78019A (39%); S48019A (39%); S78029A (38%); S48029A (38%)
M00811,"Arthritis due to other bacteria, right shoulder",92,M08811 (58%); M08911 (56%); M06811 (54%); M08011 (51%); M08819 (49%)
M00812,"Arthritis due to other bacteria, left shoulder",92,M08812 (58%); M08912 (56%); M06812 (54%); M08012 (51%); M08819 (49%)
M00819,"Arthritis due to other bacteria, unspecified shoulder",92,M08919 (56%); M08819 (56%); M08912 (53%); M08911 (53%); M06819 (52%)
M00821,"Arthritis due to other bacteria, right elbow",92,M08821 (59%); M08921 (58%); M06821 (56%); M08021 (52%); M08829 (51%)
M00822,"Arthritis due to other bacteria, left elbow",92,M08822 (59%); M08922 (58%); M06822 (56%); M08022 (52%); M08829 (51%)
M00829,"Arthritis due to other bacteria, unspecified elbow",92,M08929 (58%); M08829 (58%); M08922 (54%); M08921 (54%); M06829 (54%)
M00831,"Arthritis due to other bacteria, right wrist",92,M08831 (60%); M08931 (58%); M06831 (57%); M08031 (53%); M08839 (52%)
M00832,"Arthritis due to other bacteria, left wrist",92,M08832 (60%); M08932 (58%); M06832 (57%); M08032 (53%); M08839 (52%)
M00839,"Arthritis due to other bacteria, unspecified wrist",92,M08939 (59%); M08839 (58%); M08932 (55%); M08931 (55%); M06839 (55%)
M00841,"Arthritis due to other bacteria, right hand",92,M08841 (58%); M08941 (57%); M06841 (55%); M08041 (51%); M08849 (49%)
M00842,"Arthritis due to other bacteria, left hand",92,M08842 (58%); M08942 (57%); M06842 (55%); M08042 (51%); M08849 (49%)
M00849,"Arthritis due to other bacteria, unspecified hand",92,M08949 (57%); M08849 (57%); M08942 (53%); M08941 (53%); M06849 (53%)
M00851,"Arthritis due to other bacteria, right hip",92,M08851 (57%); M08951 (56%); M06851 (54%); M08051 (50%); M08859 (48%)
M00852,"Arthritis due to other bacteria, left hip",92,M08852 (57%); M08952 (56%); M06852 (54%); M08052 (50%); M08859 (48%)
M00859,"Arthritis due to other bacteria, unspecified hip",92,M08959 (56%); M08859 (55%); M08952 (52%); M08951 (52%); M06859 (52%)
M00861,"Arthritis due to other bacteria, right knee",92,M08861 (60%); M08961 (58%); M06861 (56%); M08061 (53%); M08869 (51%)
M00862,"Arthritis due to other bacteria, left knee",92,M08862 (60%); M08962 (58%); M06862 (56%); M08062 (53%); M08869 (51%)
M00869,"Arthritis due to other bacteria, unspecified knee",92,M08969 (58%); M08869 (58%); M08962 (55%); M08961 (55%); M06869 (54%)
M00871,"Arthritis due to other bacteria, right ankle and foot",92,M08871 (66%); M08971 (64%); M06871 (62%); M08071 (59%); M08879 (58%)
M00872,"Arthritis due to other bacteria, left ankle and foot",92,M08872 (66%); M08972 (64%); M06872 (62%); M08072 (59%); M08879 (58%)
M00879,"Arthritis due to other bacteria, unspecified ankle and foot",92,M08879 (64%); M08979 (64%); M08972 (62%); M08971 (61%); M06879 (61%)
M0088,"Arthritis due to other bacteria, vertebrae",92,M0898 (64%); M0688 (62%); M0808 (59%); M0848 (50%); M0608 (48%)
M0089,Polyarthritis due to other bacteria,92,M083 (45%); J158 (39%); J156 (28%); J1569 (28%); A021 (0%)
M009,"Pyogenic arthritis, unspecified",92,M069 (37%); M08959 (30%); M0890 (30%); M08919 (30%); M08949 (30%)
M01X0,Direct infection of unspecified joint in infectious and parasitic diseases classified elsewhere,92,K67 (40%); G914 (32%); G054 (30%); I43 (30%); J84178 (29%)
M01X11,Direct infection of right shoulder in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X12,Direct infection of left shoulder in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X19,Direct infection of unspecified shoulder in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X21,Direct infection of right elbow in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X22,Direct infection of left elbow in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X29,Direct infection of unspecified elbow in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X31,Direct infection of right wrist in infectious and parasitic diseases classified elsewhere,92,K67 (41%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X32,Direct infection of left wrist in infectious and parasitic diseases classified elsewhere,92,K67 (41%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X39,Direct infection of unspecified wrist in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X41,Direct infection of right hand in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X42,Direct infection of left hand in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X49,Direct infection of unspecified hand in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X51,Direct infection of right hip in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X52,Direct infection of left hip in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X59,Direct infection of unspecified hip in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X61,Direct infection of right knee in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X62,Direct infection of left knee in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X69,Direct infection of unspecified knee in infectious and parasitic diseases classified elsewhere,92,K67 (42%); G914 (33%); G054 (31%); I43 (31%); J84178 (30%)
M01X71,Direct infection of right ankle and foot in infectious and parasitic diseases classified elsewhere,92,K67 (40%); M08871 (32%); G914 (32%); M08971 (31%); M06871 (31%)
M01X72,Direct infection of left ankle and foot in infectious and parasitic diseases classified elsewhere,92,K67 (40%); M08872 (32%); G914 (32%); M08972 (31%); M06872 (31%)
M01X79,Direct infection of unspecified ankle and foot in infectious and parasitic diseases classified elsewhere,92,K67 (41%); G914 (32%); M08979 (31%); M08879 (31%); G054 (30%)
M01X8,Direct infection of vertebrae in infectious and parasitic diseases classified elsewhere,92,K67 (40%); G914 (32%); M0898 (31%); M0688 (30%); G054 (30%)
M01X9,Direct infection of multiple joints in infectious and parasitic diseases classified elsewhere,92,K67 (36%); G914 (29%); G054 (27%); I43 (27%); J84178 (26%)
M0210,"Postdysenteric arthropathy, unspecified site",92,M1200 (46%); M1208 (41%); C8510 (35%); M0890 (35%); E10618 (34%)
M02111,"Postdysenteric arthropathy, right shoulder",92,M12011 (48%); M12019 (42%); M12012 (41%); M08811 (36%); M08911 (35%)
M02112,"Postdysenteric arthropathy, left shoulder",92,M12012 (48%); M12019 (42%); M12011 (41%); M08812 (36%); M08912 (35%)
M02119,"Postdysenteric arthropathy, unspecified shoulder",92,M12019 (46%); M12012 (42%); M12011 (42%); M08919 (35%); E10618 (34%)
M02121,"Postdysenteric arthropathy, right elbow",92,M12021 (49%); M12029 (43%); M12022 (43%); M08821 (38%); M08921 (37%)
M02122,"Postdysenteric arthropathy, left elbow",92,M12022 (49%); M12029 (43%); M12021 (43%); M08822 (38%); M08922 (37%)
M02129,"Postdysenteric arthropathy, unspecified elbow",92,M12029 (47%); M12022 (43%); M12021 (43%); M08929 (37%); M08829 (36%)
M02131,"Postdysenteric arthropathy, right wrist",92,M12031 (49%); M12039 (44%); M12032 (43%); M08831 (39%); M08931 (38%)
M02132,"Postdysenteric arthropathy, left wrist",92,M12032 (49%); M12039 (44%); M12031 (43%); M08832 (39%); M08932 (38%)
M02139,"Postdysenteric arthropathy, unspecified wrist",92,M12039 (48%); M12032 (44%); M12031 (44%); M08939 (38%); M08839 (37%)
M02141,"Postdysenteric arthropathy, right hand",92,M12041 (48%); M12049 (42%); M12042 (42%); M08841 (37%); M08941 (36%)
M02142,"Postdysenteric arthropathy, left hand",92,M12042 (48%); M12049 (42%); M12041 (42%); M08842 (37%); M08942 (36%)
M02149,"Postdysenteric arthropathy, unspecified hand",92,M12049 (47%); M12042 (43%); M12041 (43%); M08949 (36%); M08849 (34%)
M02151,"Postdysenteric arthropathy, right hip",92,M12051 (47%); M12059 (42%); M12052 (41%); M08851 (35%); M08951 (34%)
M02152,"Postdysenteric arthropathy, left hip",92,M12052 (47%); M12059 (42%); M12051 (41%); M08852 (35%); M08952 (34%)
M02159,"Postdysenteric arthropathy, unspecified hip",92,M12059 (46%); M12052 (42%); M12051 (42%); M08959 (35%); E10618 (34%)
M02161,"Postdysenteric arthropathy, right knee",92,M12061 (49%); M12069 (43%); M12062 (43%); M08861 (38%); M08961 (37%)
M02162,"Postdysenteric arthropathy, left knee",92,M12062 (49%); M12069 (43%); M12061 (43%); M08862 (38%); M08962 (37%)
M02169,"Postdysenteric arthropathy, unspecified knee",92,M12069 (48%); M12062 (44%); M12061 (44%); M08969 (38%); M08869 (36%)
M02171,"Postdysenteric arthropathy, right ankle and foot",92,M12071 (54%); M12079 (49%); M12072 (48%); M08871 (47%); M08971 (46%)
M02172,"Postdysenteric arthropathy, left ankle and foot",92,M12072 (54%); M12079 (49%); M12071 (48%); M08872 (47%); M08972 (46%)
M02179,"Postdysenteric arthropathy, unspecified ankle and foot",92,M12079 (53%); M12072 (49%); M12071 (49%); M08979 (46%); M08879 (45%)
M0218,"Postdysenteric arthropathy, vertebrae",92,M0898 (45%); M0688 (44%); M0808 (42%); M0628 (41%); M0638 (41%)
M0219,"Postdysenteric arthropathy, multiple sites",92,M1209 (54%); M0889 (47%); M0899 (46%); M0689 (45%); M0809 (42%)
M0230,"Reiter's disease, unspecified site",94,C8410 (47%); M0530 (38%); M0510 (38%); C8510 (38%); M0890 (38%)
M02311,"Reiter's disease, right shoulder",94,M87811 (44%); M05311 (40%); M05111 (40%); M86611 (40%); M08811 (39%)
M02312,"Reiter's disease, left shoulder",94,M87812 (44%); M05312 (40%); M05112 (40%); M86612 (40%); M08812 (39%)
M02319,"Reiter's disease, unspecified shoulder",94,M87819 (41%); M05319 (39%); M05119 (39%); M08919 (38%); M86619 (37%)
M02321,"Reiter's disease, right elbow",94,M05321 (42%); M05121 (42%); M08821 (41%); M08921 (40%); M06821 (39%)
M02322,"Reiter's disease, left elbow",94,M05322 (42%); M05122 (42%); M08822 (41%); M08922 (40%); M06822 (38%)
M02329,"Reiter's disease, unspecified elbow",94,M08929 (40%); M05329 (40%); M05129 (40%); M08829 (38%); M08029 (37%)
M02331,"Reiter's disease, right wrist",94,M05331 (43%); M05131 (43%); M08831 (42%); M08931 (41%); M06831 (40%)
M02332,"Reiter's disease, left wrist",94,M05332 (43%); M05132 (43%); M08832 (42%); M08932 (41%); M06832 (40%)
M02339,"Reiter's disease, unspecified wrist",94,M08939 (41%); M05339 (41%); M05139 (41%); M08839 (40%); M08039 (38%)
M02341,"Reiter's disease, right hand",94,M87841 (45%); M05341 (41%); M05141 (41%); M86641 (41%); M08841 (40%)
M02342,"Reiter's disease, left hand",94,M87842 (45%); M05342 (41%); M05142 (41%); M86642 (41%); M08842 (40%)
M02349,"Reiter's disease, unspecified hand",94,M87843 (42%); M05349 (39%); M05149 (39%); M08949 (39%); M86649 (38%)
M02351,"Reiter's disease, right hip",94,M05351 (40%); M05151 (40%); M08851 (38%); M08951 (37%); M06851 (36%)
M02352,"Reiter's disease, left hip",94,M05352 (40%); M05152 (40%); M08852 (38%); M08952 (37%); M84659A (36%)
M02359,"Reiter's disease, unspecified hip",94,M84659A (41%); M05359 (38%); M05159 (38%); M08959 (38%); M08859 (35%)
M02361,"Reiter's disease, right knee",94,M05361 (42%); M05161 (42%); M08861 (41%); M08961 (40%); M06861 (39%)
M02362,"Reiter's disease, left knee",94,M05362 (42%); M05162 (42%); M08862 (41%); M08962 (40%); M06862 (39%)
M02369,"Reiter's disease, unspecified knee",94,M08969 (41%); M05369 (40%); M05169 (40%); M08869 (39%); M08069 (37%)
M02371,"Reiter's disease, right ankle and foot",94,M86671 (51%); M08871 (50%); M868X7 (49%); M86171 (49%); M08971 (49%)
M02372,"Reiter's disease, left ankle and foot",94,M86672 (51%); M08872 (50%); M868X7 (49%); M86172 (49%); M08972 (49%)
M02379,"Reiter's disease, unspecified ankle and foot",94,M868X7 (50%); M86679 (49%); M08979 (49%); M08879 (48%); M86179 (47%)
M0238,"Reiter's disease, vertebrae",94,M0898 (48%); M0688 (47%); M0088 (45%); M0028 (45%); M0008 (45%)
M0239,"Reiter's disease, multiple sites",94,M868X0 (56%); M8789 (55%); M8669 (51%); C8418 (50%); M0889 (50%)
M0280,"Other reactive arthropathies, unspecified site",92,C8510 (34%); M0890 (33%); C6990 (32%); C8190 (32%); C8290 (32%)
M02811,"Other reactive arthropathies, right shoulder",92,M08811 (34%); M08911 (33%); M06811 (32%); M08011 (30%); M06211 (30%)
M02812,"Other reactive arthropathies, left shoulder",92,M08812 (34%); M08912 (33%); M06812 (32%); M08012 (30%); M06212 (30%)
M02819,"Other reactive arthropathies, unspecified shoulder",92,M08919 (33%); M08819 (32%); M08019 (31%); M08912 (30%); M08911 (30%)
M02821,"Other reactive arthropathies, right elbow",92,M08821 (36%); M08921 (35%); M06821 (34%); M08021 (32%); M06221 (32%)
M02822,"Other reactive arthropathies, left elbow",92,M08822 (36%); M08922 (35%); M06822 (34%); M08022 (32%); M06222 (32%)
M02829,"Other reactive arthropathies, unspecified elbow",92,M08929 (36%); M08829 (34%); M08029 (33%); M08922 (32%); M08921 (32%)
M02831,"Other reactive arthropathies, right wrist",92,M08831 (37%); M08931 (36%); M06831 (35%); M08031 (33%); M06231 (33%)
M02832,"Other reactive arthropathies, left wrist",92,M08832 (37%); M08932 (36%); M06832 (35%); M08032 (33%); M06232 (33%)
M02839,"Other reactive arthropathies, unspecified wrist",92,M08939 (37%); M08839 (35%); M08039 (34%); M08932 (33%); M08931 (33%)
M02841,"Other reactive arthropathies, right hand",92,M08841 (35%); M08941 (34%); M06841 (33%); M08041 (31%); M06241 (31%)
M02842,"Other reactive arthropathies, left hand",92,M08842 (35%); M08942 (34%); M06842 (33%); M08042 (31%); M06242 (31%)
M02849,"Other reactive arthropathies, unspecified hand",92,M08949 (34%); M08849 (33%); M08049 (31%); M08942 (31%); M08941 (31%)
M02851,"Other reactive arthropathies, right hip",92,M08851 (34%); M08951 (33%); M06851 (32%); M08051 (30%); M06251 (29%)
M02852,"Other reactive arthropathies, left hip",92,M08852 (34%); M08952 (33%); M06852 (32%); M08052 (29%); M06252 (29%)
M02859,"Other reactive arthropathies, unspecified hip",92,M08959 (33%); M08859 (31%); M08059 (30%); M08952 (29%); M08951 (29%)
M02861,"Other reactive arthropathies, right knee",92,M08861 (37%); M08961 (36%); M06861 (35%); M08061 (32%); M06261 (32%)
M02862,"Other reactive arthropathies, left knee",92,M08862 (37%); M08962 (36%); M06862 (35%); M08062 (32%); M06262 (32%)
M02869,"Other reactive arthropathies, unspecified knee",92,M08969 (36%); M08869 (34%); M08069 (33%); M08962 (32%); M08961 (32%)
M02871,"Other reactive arthropathies, right ankle and foot",92,M08871 (45%); M08971 (44%); M06871 (43%); M08071 (40%); M06271 (40%)
M02872,"Other reactive arthropathies, left ankle and foot",92,M08872 (45%); M08972 (44%); M06872 (43%); M08072 (40%); M06272 (40%)
M02879,"Other reactive arthropathies, unspecified ankle and foot",92,M08979 (44%); M08879 (43%); M08972 (41%); M08971 (41%); M06879 (41%)
M0288,"Other reactive arthropathies, vertebrae",92,M0898 (43%); M0688 (42%); M0808 (40%); M0628 (40%); M0638 (40%)
M0289,"Other reactive arthropathies, multiple sites",92,M0889 (45%); M0899 (44%); M0689 (43%); M0809 (40%); M0629 (40%)
M029,"Reactive arthropathy, unspecified",92,E10618 (39%); E11618 (39%); E13618 (37%); L4059 (36%); D8686 (34%)
M041,Periodic fever syndromes,94,G8389 (29%); D763 (28%); D46Z (28%); G733 (22%); G128 (19%)
M042,Cryopyrin-associated periodic syndromes,94,G8389 (26%); D763 (25%); D46Z (25%); J95851 (22%); C802 (21%)
M048,Other autoinflammatory syndromes,94,G8389 (38%); D763 (37%); D46Z (36%); G733 (28%); G128 (25%)
M049,"Autoinflammatory syndrome, unspecified",94,G839 (31%); E340 (26%); D469 (25%); M05059 (25%); M0500 (25%)
M0500,"Felty's syndrome, unspecified site",93,C8510 (38%); C6990 (36%); M8660 (36%); C8190 (36%); C8290 (36%)
M05011,"Felty's syndrome, right shoulder",93,M87811 (43%); M86611 (39%); M86111 (37%); M868X1 (35%); M87311 (35%)
M05012,"Felty's syndrome, left shoulder",93,M87812 (43%); M86612 (39%); M86112 (37%); M868X1 (35%); M87312 (35%)
M05019,"Felty's syndrome, unspecified shoulder",93,M87819 (40%); M86619 (36%); M868X1 (36%); M86119 (34%); M87319 (32%)
M05021,"Felty's syndrome, right elbow",93,M00821 (36%); M00221 (36%); M00021 (36%); M00121 (36%); M02321 (35%)
M05022,"Felty's syndrome, left elbow",93,M00822 (36%); M00222 (36%); M00022 (36%); M00122 (36%); M02322 (35%)
M05029,"Felty's syndrome, unspecified elbow",93,M00829 (34%); M00229 (34%); M00029 (33%); M00129 (33%); M02329 (33%)
M05031,"Felty's syndrome, right wrist",93,M00831 (37%); M00231 (37%); M00031 (37%); M00131 (37%); M02331 (36%)
M05032,"Felty's syndrome, left wrist",93,M00832 (37%); M00232 (37%); M00032 (37%); M00132 (37%); M02332 (36%)
M05039,"Felty's syndrome, unspecified wrist",93,M00839 (35%); M00239 (35%); M00039 (35%); M00139 (35%); M02339 (34%)
M05041,"Felty's syndrome, right hand",93,M87841 (44%); M86641 (40%); M86141 (38%); M868X4 (36%); M87341 (36%)
M05042,"Felty's syndrome, left hand",93,M87842 (44%); M86642 (40%); M86142 (38%); M868X4 (36%); M87342 (36%)
M05049,"Felty's syndrome, unspecified hand",93,M87843 (41%); M86649 (37%); M868X4 (37%); M86149 (36%); M87842 (34%)
M05051,"Felty's syndrome, right hip",93,M00851 (33%); M00251 (33%); M00051 (33%); M00151 (33%); M02351 (32%)
M05052,"Felty's syndrome, left hip",93,M00852 (33%); M00252 (33%); M00052 (33%); M00152 (33%); M02352 (32%)
M05059,"Felty's syndrome, unspecified hip",93,S73003A (33%); S73006A (33%); G839 (32%); M00859 (31%); M00259 (31%)
M05061,"Felty's syndrome, right knee",93,M00861 (36%); M00261 (36%); M00061 (36%); M00161 (36%); M02361 (35%)
M05062,"Felty's syndrome, left knee",93,M00862 (36%); M00262 (36%); M00062 (36%); M00162 (36%); M02362 (35%)
M05069,"Felty's syndrome, unspecified knee",93,M00869 (34%); M00269 (34%); M00069 (34%); M00169 (34%); M02369 (33%)
M05071,"Felty's syndrome, right ankle and foot",93,M86671 (50%); M868X7 (49%); M86171 (48%); M00871 (45%); M00271 (45%)
M05072,"Felty's syndrome, left ankle and foot",93,M86672 (50%); M868X7 (49%); M86172 (48%); M00872 (45%); M00272 (45%)
M05079,"Felty's syndrome, unspecified ankle and foot",93,M868X7 (50%); M86679 (48%); M86179 (47%); M00879 (43%); M00279 (43%)
M0509,"Felty's syndrome, multiple sites",93,M868X0 (55%); M8789 (54%); M8669 (50%); M8619 (48%); M8739 (46%)
M0510,Rheumatoid lung disease with rheumatoid arthritis of unspecified site,93,M0230 (38%); C8410 (36%); C8510 (29%); C7800 (29%); C6990 (28%)
M05111,Rheumatoid lung disease with rheumatoid arthritis of right shoulder,93,M02311 (40%); M00811 (38%); M00211 (38%); M00011 (38%); M00111 (38%)
M05112,Rheumatoid lung disease with rheumatoid arthritis of left shoulder,93,M02312 (40%); M00812 (38%); M00212 (38%); M00012 (38%); M00112 (38%)
M05119,Rheumatoid lung disease with rheumatoid arthritis of unspecified shoulder,93,M02319 (39%); M00819 (37%); M00219 (36%); M00019 (36%); M00119 (36%)
M05121,Rheumatoid lung disease with rheumatoid arthritis of right elbow,93,M02321 (42%); M00821 (40%); M00221 (40%); M00021 (40%); M00121 (40%)
M05122,Rheumatoid lung disease with rheumatoid arthritis of left elbow,93,M02322 (42%); M00822 (40%); M00222 (40%); M00022 (40%); M00122 (40%)
M05129,Rheumatoid lung disease with rheumatoid arthritis of unspecified elbow,93,M02329 (40%); M00829 (38%); M00229 (38%); M00029 (38%); M00129 (38%)
M05131,Rheumatoid lung disease with rheumatoid arthritis of right wrist,93,M02331 (43%); M00831 (41%); M00231 (41%); M00031 (41%); M00131 (41%)
M05132,Rheumatoid lung disease with rheumatoid arthritis of left wrist,93,M02332 (43%); M00832 (41%); M00232 (41%); M00032 (41%); M00132 (41%)
M05139,Rheumatoid lung disease with rheumatoid arthritis of unspecified wrist,93,M02339 (41%); M00839 (39%); M00239 (39%); M00039 (39%); M00139 (39%)
M05141,Rheumatoid lung disease with rheumatoid arthritis of right hand,93,M02341 (41%); M00841 (39%); M00241 (39%); M00041 (39%); M00141 (39%)
M05142,Rheumatoid lung disease with rheumatoid arthritis of left hand,93,M02342 (41%); M00842 (39%); M00242 (39%); M00042 (39%); M00142 (39%)
M05149,Rheumatoid lung disease with rheumatoid arthritis of unspecified hand,93,M02349 (39%); M00849 (37%); M00249 (37%); M00049 (37%); M00149 (37%)
M05151,Rheumatoid lung disease with rheumatoid arthritis of right hip,93,M02351 (40%); M00851 (38%); M00251 (38%); M00051 (38%); M00151 (38%)
M05152,Rheumatoid lung disease with rheumatoid arthritis of left hip,93,M02352 (40%); M00852 (38%); M00252 (38%); M00052 (38%); M00152 (38%)
M05159,Rheumatoid lung disease with rheumatoid arthritis of unspecified hip,93,M02359 (38%); M00859 (36%); M00259 (36%); M00059 (36%); M00159 (36%)
M05161,Rheumatoid lung disease with rheumatoid arthritis of right knee,93,M02361 (42%); M00861 (40%); M00261 (40%); M00061 (40%); M00161 (40%)
M05162,Rheumatoid lung disease with rheumatoid arthritis of left knee,93,M02362 (42%); M00862 (40%); M00262 (40%); M00062 (40%); M00162 (40%)
M05169,Rheumatoid lung disease with rheumatoid arthritis of unspecified knee,93,M02369 (40%); M00869 (39%); M00269 (38%); M00069 (38%); M00169 (38%)
M05171,Rheumatoid lung disease with rheumatoid arthritis of right ankle and foot,93,M02371 (48%); M00871 (47%); M00271 (46%); M00071 (46%); M00171 (46%)
M05172,Rheumatoid lung disease with rheumatoid arthritis of left ankle and foot,93,M02372 (48%); M00872 (47%); M00272 (46%); M00072 (46%); M00172 (46%)
M05179,Rheumatoid lung disease with rheumatoid arthritis of unspecified ankle and foot,93,M02379 (47%); M00879 (45%); M00279 (45%); M00079 (45%); M00179 (45%)
M0519,Rheumatoid lung disease with rheumatoid arthritis of multiple sites,93,M0239 (48%); M868X0 (44%); M8789 (44%); M8669 (41%); C8418 (40%)
M0520,Rheumatoid vasculitis with rheumatoid arthritis of unspecified site,93,C8510 (29%); C6990 (28%); M8660 (28%); C8190 (28%); C8290 (28%)
M05211,Rheumatoid vasculitis with rheumatoid arthritis of right shoulder,93,M00811 (39%); M00211 (39%); M00011 (38%); M00111 (38%); M87811 (34%)
M05212,Rheumatoid vasculitis with rheumatoid arthritis of left shoulder,93,M00812 (39%); M00212 (39%); M00012 (38%); M00112 (38%); M87812 (34%)
M05219,Rheumatoid vasculitis with rheumatoid arthritis of unspecified shoulder,93,M00819 (37%); M00219 (37%); M00019 (37%); M00119 (37%); M00812 (32%)
M05221,Rheumatoid vasculitis with rheumatoid arthritis of right elbow,93,M00821 (40%); M00221 (40%); M00021 (40%); M00121 (40%); M00829 (34%)
M05222,Rheumatoid vasculitis with rheumatoid arthritis of left elbow,93,M00822 (40%); M00222 (40%); M00022 (40%); M00122 (40%); M00829 (34%)
M05229,Rheumatoid vasculitis with rheumatoid arthritis of unspecified elbow,93,M00829 (39%); M00229 (39%); M00029 (38%); M00129 (38%); M00822 (34%)
M05231,Rheumatoid vasculitis with rheumatoid arthritis of right wrist,93,M00831 (41%); M00231 (41%); M00031 (41%); M00131 (41%); M00839 (35%)
M05232,Rheumatoid vasculitis with rheumatoid arthritis of left wrist,93,M00832 (41%); M00232 (41%); M00032 (41%); M00132 (41%); M00839 (35%)
M05239,Rheumatoid vasculitis with rheumatoid arthritis of unspecified wrist,93,M00839 (40%); M00239 (39%); M00039 (39%); M00139 (39%); M00832 (35%)
M05241,Rheumatoid vasculitis with rheumatoid arthritis of right hand,93,M00841 (40%); M00241 (39%); M00041 (39%); M00141 (39%); M87841 (35%)
M05242,Rheumatoid vasculitis with rheumatoid arthritis of left hand,93,M00842 (39%); M00242 (39%); M00042 (39%); M00142 (39%); M87842 (35%)
M05249,Rheumatoid vasculitis with rheumatoid arthritis of unspecified hand,93,M00849 (38%); M00249 (38%); M00049 (37%); M00149 (37%); M00842 (33%)
M05251,Rheumatoid vasculitis with rheumatoid arthritis of right hip,93,M00851 (38%); M00251 (38%); M00051 (38%); M00151 (38%); M00859 (32%)
M05252,Rheumatoid vasculitis with rheumatoid arthritis of left hip,93,M00852 (38%); M00252 (38%); M00052 (38%); M00152 (38%); M00859 (32%)
M05259,Rheumatoid vasculitis with rheumatoid arthritis of unspecified hip,93,M00859 (37%); M00259 (37%); M00059 (36%); M00159 (36%); M00852 (32%)
M05261,Rheumatoid vasculitis with rheumatoid arthritis of right knee,93,M00861 (41%); M00261 (41%); M00061 (40%); M00161 (40%); M00869 (35%)
M05262,Rheumatoid vasculitis with rheumatoid arthritis of left knee,93,M00862 (41%); M00262 (41%); M00062 (40%); M00162 (40%); M00869 (35%)
M05269,Rheumatoid vasculitis with rheumatoid arthritis of unspecified knee,93,M00869 (39%); M00269 (39%); M00069 (39%); M00169 (39%); M00862 (34%)
M05271,Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot,93,M00871 (47%); M00271 (47%); M00071 (47%); M00171 (47%); M00879 (42%)
M05272,Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot,93,M00872 (47%); M00272 (47%); M00072 (47%); M00172 (47%); M00879 (42%)
M05279,Rheumatoid vasculitis with rheumatoid arthritis of unspecified ankle and foot,93,M00879 (46%); M00279 (45%); M00079 (45%); M00179 (45%); M00872 (41%)
M0529,Rheumatoid vasculitis with rheumatoid arthritis of multiple sites,93,M868X0 (45%); M8789 (44%); M8669 (41%); M8619 (39%); M8739 (38%)
M0530,Rheumatoid heart disease with rheumatoid arthritis of unspecified site,93,I279 (44%); I110 (40%); M0230 (38%); C8410 (36%); I249 (36%)
M05311,Rheumatoid heart disease with rheumatoid arthritis of right shoulder,93,M02311 (40%); I279 (39%); I110 (39%); M00811 (38%); M00211 (38%)
M05312,Rheumatoid heart disease with rheumatoid arthritis of left shoulder,93,M02312 (40%); I279 (39%); I110 (39%); M00812 (38%); M00212 (38%)
M05319,Rheumatoid heart disease with rheumatoid arthritis of unspecified shoulder,93,I279 (44%); I110 (40%); M02319 (39%); M00819 (37%); M00219 (37%)
M05321,Rheumatoid heart disease with rheumatoid arthritis of right elbow,93,M02321 (42%); M00821 (40%); M00221 (40%); M00021 (40%); M00121 (40%)
M05322,Rheumatoid heart disease with rheumatoid arthritis of left elbow,93,M02322 (42%); M00822 (40%); M00222 (40%); M00022 (40%); M00122 (40%)
M05329,Rheumatoid heart disease with rheumatoid arthritis of unspecified elbow,93,I279 (43%); M02329 (40%); I110 (39%); M00829 (38%); M00229 (38%)
M05331,Rheumatoid heart disease with rheumatoid arthritis of right wrist,93,M02331 (43%); M00831 (41%); M00231 (41%); M00031 (41%); M00131 (41%)
M05332,Rheumatoid heart disease with rheumatoid arthritis of left wrist,93,M02332 (43%); M00832 (41%); M00232 (41%); M00032 (41%); M00132 (41%)
M05339,Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist,93,I279 (43%); M02339 (41%); M00839 (39%); I110 (39%); M00239 (39%)
M05341,Rheumatoid heart disease with rheumatoid arthritis of right hand,93,M02341 (41%); M00841 (39%); I279 (39%); I110 (39%); M00241 (39%)
M05342,Rheumatoid heart disease with rheumatoid arthritis of left hand,93,M02342 (41%); I279 (39%); M00842 (39%); I110 (39%); M00242 (39%)
M05349,Rheumatoid heart disease with rheumatoid arthritis of unspecified hand,93,I279 (44%); I110 (40%); M02349 (39%); M00849 (37%); M00249 (37%)
M05351,Rheumatoid heart disease with rheumatoid arthritis of right hip,93,M02351 (40%); I279 (39%); I110 (39%); M00851 (38%); M00251 (38%)
M05352,Rheumatoid heart disease with rheumatoid arthritis of left hip,93,M02352 (40%); I279 (39%); I110 (39%); M00852 (38%); M00252 (38%)
M05359,Rheumatoid heart disease with rheumatoid arthritis of unspecified hip,93,I279 (44%); I110 (40%); M02359 (38%); M00859 (36%); M00259 (36%)
M05361,Rheumatoid heart disease with rheumatoid arthritis of right knee,93,M02361 (42%); M00861 (40%); M00261 (40%); M00061 (40%); M00161 (40%)
M05362,Rheumatoid heart disease with rheumatoid arthritis of left knee,93,M02362 (42%); M00862 (40%); M00262 (40%); M00062 (40%); M00162 (40%)
M05369,Rheumatoid heart disease with rheumatoid arthritis of unspecified knee,93,I279 (43%); M02369 (40%); I110 (39%); M00869 (39%); M00269 (38%)
M05371,Rheumatoid heart disease with rheumatoid arthritis of right ankle and foot,93,M02371 (48%); M00871 (47%); M00271 (47%); M00071 (46%); M00171 (46%)
M05372,Rheumatoid heart disease with rheumatoid arthritis of left ankle and foot,93,M02372 (48%); M00872 (47%); M00272 (46%); M00072 (46%); M00172 (46%)
M05379,Rheumatoid heart disease with rheumatoid arthritis of unspecified ankle and foot,93,M02379 (47%); M00879 (45%); M00279 (45%); M00079 (45%); M00179 (45%)
M0539,Rheumatoid heart disease with rheumatoid arthritis of multiple sites,93,M0239 (48%); M868X0 (44%); M8789 (44%); M8669 (41%); C8418 (40%)
M0540,Rheumatoid myopathy with rheumatoid arthritis of unspecified site,93,G7120 (39%); G7129 (36%); C8510 (30%); G7121 (29%); G71228 (29%)
M0540,Rheumatoid myopathy with rheumatoid arthritis of unspecified site,,
M05411,Rheumatoid myopathy with rheumatoid arthritis of right shoulder,93,M00811 (39%); M00211 (39%); M00011 (39%); M00111 (39%); G7129 (35%)
M05411,Rheumatoid myopathy with rheumatoid arthritis of right shoulder,,
M05412,Rheumatoid myopathy with rheumatoid arthritis of left shoulder,93,M00812 (39%); M00212 (39%); M00012 (39%); M00112 (39%); G7129 (35%)
M05412,Rheumatoid myopathy with rheumatoid arthritis of left shoulder,,
M05419,Rheumatoid myopathy with rheumatoid arthritis of unspecified shoulder,93,G7120 (39%); M00819 (38%); M00219 (37%); M00019 (37%); M00119 (37%)
M05419,Rheumatoid myopathy with rheumatoid arthritis of unspecified shoulder,,
M05421,Rheumatoid myopathy with rheumatoid arthritis of right elbow,93,M00821 (41%); M00221 (41%); M00021 (41%); M00121 (41%); G7129 (35%)
M05421,Rheumatoid myopathy with rheumatoid arthritis of right elbow,,
M05422,Rheumatoid myopathy with rheumatoid arthritis of left elbow,93,M00822 (41%); M00222 (41%); M00022 (41%); M00122 (41%); G7129 (35%)
M05422,Rheumatoid myopathy with rheumatoid arthritis of left elbow,,
M05429,Rheumatoid myopathy with rheumatoid arthritis of unspecified elbow,93,M00829 (39%); M00229 (39%); M00029 (39%); M00129 (39%); G7120 (39%)
M05429,Rheumatoid myopathy with rheumatoid arthritis of unspecified elbow,,
M05431,Rheumatoid myopathy with rheumatoid arthritis of right wrist,93,M00831 (42%); M00231 (42%); M00031 (42%); M00131 (42%); M00839 (36%)
M05431,Rheumatoid myopathy with rheumatoid arthritis of right wrist,,
M05432,Rheumatoid myopathy with rheumatoid arthritis of left wrist,93,M00832 (42%); M00232 (42%); M00032 (42%); M00132 (42%); M00839 (36%)
M05432,Rheumatoid myopathy with rheumatoid arthritis of left wrist,,
M05439,Rheumatoid myopathy with rheumatoid arthritis of unspecified wrist,93,M00839 (40%); M00239 (40%); M00039 (40%); M00139 (40%); G7120 (38%)
M05439,Rheumatoid myopathy with rheumatoid arthritis of unspecified wrist,,
M05441,Rheumatoid myopathy with rheumatoid arthritis of right hand,93,M00841 (40%); M00241 (40%); M00041 (40%); M00141 (40%); M87841 (35%)
M05441,Rheumatoid myopathy with rheumatoid arthritis of right hand,,
M05442,Rheumatoid myopathy with rheumatoid arthritis of left hand,93,M00842 (40%); M00242 (40%); M00042 (40%); M00142 (40%); M87842 (35%)
M05442,Rheumatoid myopathy with rheumatoid arthritis of left hand,,
M05449,Rheumatoid myopathy with rheumatoid arthritis of unspecified hand,93,G7120 (39%); M00849 (38%); M00249 (38%); M00049 (38%); M00149 (38%)
M05449,Rheumatoid myopathy with rheumatoid arthritis of unspecified hand,,
M05451,Rheumatoid myopathy with rheumatoid arthritis of right hip,93,M00851 (39%); M00251 (39%); M00051 (39%); M00151 (39%); G7129 (36%)
M05451,Rheumatoid myopathy with rheumatoid arthritis of right hip,,
M05452,Rheumatoid myopathy with rheumatoid arthritis of left hip,93,M00852 (39%); M00252 (39%); M00052 (39%); M00152 (39%); G7129 (36%)
M05452,Rheumatoid myopathy with rheumatoid arthritis of left hip,,
M05459,Rheumatoid myopathy with rheumatoid arthritis of unspecified hip,93,G7120 (39%); M00859 (37%); M00259 (37%); M00059 (37%); M00159 (37%)
M05459,Rheumatoid myopathy with rheumatoid arthritis of unspecified hip,,
M05461,Rheumatoid myopathy with rheumatoid arthritis of right knee,93,M00861 (41%); M00261 (41%); M00061 (41%); M00161 (41%); M00869 (35%)
M05461,Rheumatoid myopathy with rheumatoid arthritis of right knee,,
M05462,Rheumatoid myopathy with rheumatoid arthritis of left knee,93,M00862 (41%); M00262 (41%); M00062 (41%); M00162 (41%); M00869 (35%)
M05462,Rheumatoid myopathy with rheumatoid arthritis of left knee,,
M05469,Rheumatoid myopathy with rheumatoid arthritis of unspecified knee,93,M00869 (40%); M00269 (39%); M00069 (39%); M00169 (39%); G7120 (39%)
M05469,Rheumatoid myopathy with rheumatoid arthritis of unspecified knee,,
M05471,Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot,93,M00871 (48%); M00271 (48%); M00071 (47%); M00171 (47%); M00879 (42%)
M05471,Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot,,
M05472,Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot,93,M00872 (48%); M00272 (48%); M00072 (47%); M00172 (47%); M00879 (42%)
M05472,Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot,,
M05479,Rheumatoid myopathy with rheumatoid arthritis of unspecified ankle and foot,93,M00879 (46%); M00279 (46%); M00079 (46%); M00179 (46%); M00872 (42%)
M05479,Rheumatoid myopathy with rheumatoid arthritis of unspecified ankle and foot,,
M0549,Rheumatoid myopathy with rheumatoid arthritis of multiple sites,93,M868X0 (45%); M8789 (45%); M8669 (42%); M8619 (40%); M8739 (38%)
M0549,Rheumatoid myopathy with rheumatoid arthritis of multiple sites,,
M0550,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site,93,E1042 (35%); E1142 (35%); E1342 (34%); C8510 (30%); E0842 (29%)
M0550,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site,,
M05511,Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder,93,M00811 (39%); M00211 (39%); M00011 (39%); M00111 (39%); E1042 (34%)
M05511,Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder,,
M05512,Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder,93,M00812 (39%); M00212 (39%); M00012 (39%); M00112 (39%); E1042 (34%)
M05512,Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder,,
M05519,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified shoulder,93,M00819 (37%); M00219 (37%); M00019 (37%); M00119 (37%); E1042 (35%)
M05519,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified shoulder,,
M05521,Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow,93,M00821 (41%); M00221 (41%); M00021 (40%); M00121 (40%); M00829 (34%)
M05521,Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow,,
M05522,Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow,93,M00822 (41%); M00222 (41%); M00022 (40%); M00122 (40%); M00829 (34%)
M05522,Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow,,
M05529,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified elbow,93,M00829 (39%); M00229 (39%); M00029 (39%); M00129 (39%); E1042 (34%)
M05529,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified elbow,,
M05531,Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist,93,M00831 (41%); M00231 (41%); M00031 (41%); M00131 (41%); M00839 (35%)
M05531,Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist,,
M05532,Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist,93,M00832 (41%); M00232 (41%); M00032 (41%); M00132 (41%); M00839 (35%)
M05532,Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist,,
M05539,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified wrist,93,M00839 (40%); M00239 (40%); M00039 (39%); M00139 (39%); M00832 (35%)
M05539,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified wrist,,
M05541,Rheumatoid polyneuropathy with rheumatoid arthritis of right hand,93,M00841 (40%); M00241 (40%); M00041 (39%); M00141 (39%); M87841 (35%)
M05541,Rheumatoid polyneuropathy with rheumatoid arthritis of right hand,,
M05542,Rheumatoid polyneuropathy with rheumatoid arthritis of left hand,93,M00842 (40%); M00242 (40%); M00042 (39%); M00142 (39%); M87842 (35%)
M05542,Rheumatoid polyneuropathy with rheumatoid arthritis of left hand,,
M05549,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hand,93,M00849 (38%); M00249 (38%); M00049 (38%); M00149 (38%); E1042 (35%)
M05549,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hand,,
M05551,Rheumatoid polyneuropathy with rheumatoid arthritis of right hip,93,M00851 (39%); M00251 (39%); M00051 (38%); M00151 (38%); E1042 (34%)
M05551,Rheumatoid polyneuropathy with rheumatoid arthritis of right hip,,
M05552,Rheumatoid polyneuropathy with rheumatoid arthritis of left hip,93,M00852 (39%); M00252 (39%); M00052 (38%); M00152 (38%); E1042 (34%)
M05552,Rheumatoid polyneuropathy with rheumatoid arthritis of left hip,,
M05559,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip,93,M00859 (37%); M00259 (37%); M00059 (37%); M00159 (37%); E1042 (35%)
M05559,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip,,
M05561,Rheumatoid polyneuropathy with rheumatoid arthritis of right knee,93,M00861 (41%); M00261 (41%); M00061 (41%); M00161 (41%); M00869 (35%)
M05561,Rheumatoid polyneuropathy with rheumatoid arthritis of right knee,,
M05562,Rheumatoid polyneuropathy with rheumatoid arthritis of left knee,93,M00862 (41%); M00262 (41%); M00062 (41%); M00162 (41%); M00869 (35%)
M05562,Rheumatoid polyneuropathy with rheumatoid arthritis of left knee,,
M05569,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee,93,M00869 (39%); M00269 (39%); M00069 (39%); M00169 (39%); M00862 (34%)
M05569,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee,,
M05571,Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot,93,M00871 (47%); M00271 (47%); M00071 (47%); M00171 (47%); M00879 (42%)
M05571,Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot,,
M05572,Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot,93,M00872 (47%); M00272 (47%); M00072 (47%); M00172 (47%); M00879 (42%)
M05572,Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot,,
M05579,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot,93,M00879 (46%); M00279 (46%); M00079 (46%); M00179 (46%); M00872 (42%)
M05579,Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot,,
M0559,Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites,93,M868X0 (45%); M8789 (44%); M8669 (41%); M8619 (40%); M8739 (38%)
M0559,Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites,,
M0560,Rheumatoid arthritis of unspecified site with involvement of other organs and systems,93,C8510 (29%); C7910 (27%); C6990 (27%); M8660 (27%); C7839 (27%)
M05611,Rheumatoid arthritis of right shoulder with involvement of other organs and systems,93,M00811 (38%); M00211 (38%); M00011 (37%); M00111 (37%); M87811 (33%)
M05612,Rheumatoid arthritis of left shoulder with involvement of other organs and systems,93,M00812 (38%); M00212 (38%); M00012 (37%); M00112 (37%); M87812 (33%)
M05619,Rheumatoid arthritis of unspecified shoulder with involvement of other organs and systems,93,M00819 (36%); M00219 (36%); M00019 (36%); M00119 (36%); M00812 (31%)
M05621,Rheumatoid arthritis of right elbow with involvement of other organs and systems,93,M00821 (39%); M00221 (39%); M00021 (39%); M00121 (39%); M00829 (33%)
M05622,Rheumatoid arthritis of left elbow with involvement of other organs and systems,93,M00822 (39%); M00222 (39%); M00022 (39%); M00122 (39%); M00829 (33%)
M05629,Rheumatoid arthritis of unspecified elbow with involvement of other organs and systems,93,M00829 (38%); M00229 (37%); M00029 (37%); M00129 (37%); M00822 (33%)
M05631,Rheumatoid arthritis of right wrist with involvement of other organs and systems,93,M00831 (40%); M00231 (40%); M00031 (40%); M00131 (40%); M00839 (34%)
M05632,Rheumatoid arthritis of left wrist with involvement of other organs and systems,93,M00832 (40%); M00232 (40%); M00032 (40%); M00132 (40%); M00839 (34%)
M05639,Rheumatoid arthritis of unspecified wrist with involvement of other organs and systems,93,M00839 (38%); M00239 (38%); M00039 (38%); M00139 (38%); M00832 (34%)
M05641,Rheumatoid arthritis of right hand with involvement of other organs and systems,93,M00841 (38%); M00241 (38%); M00041 (38%); M00141 (38%); M87841 (34%)
M05642,Rheumatoid arthritis of left hand with involvement of other organs and systems,93,M00842 (38%); M00242 (38%); M00042 (38%); M00142 (38%); M87842 (34%)
M05649,Rheumatoid arthritis of unspecified hand with involvement of other organs and systems,93,M00849 (37%); M00249 (37%); M00049 (36%); M00149 (36%); M00842 (32%)
M05651,Rheumatoid arthritis of right hip with involvement of other organs and systems,93,M00851 (37%); M00251 (37%); M00051 (37%); M00151 (37%); M00859 (31%)
M05652,Rheumatoid arthritis of left hip with involvement of other organs and systems,93,M00852 (37%); M00252 (37%); M00052 (37%); M00152 (37%); M00859 (31%)
M05659,Rheumatoid arthritis of unspecified hip with involvement of other organs and systems,93,M00859 (36%); M00259 (35%); M00059 (35%); M00159 (35%); M00852 (31%)
M05661,Rheumatoid arthritis of right knee with involvement of other organs and systems,93,M00861 (40%); M00261 (39%); M00061 (39%); M00161 (39%); M00869 (34%)
M05662,Rheumatoid arthritis of left knee with involvement of other organs and systems,93,M00862 (40%); M00262 (39%); M00062 (39%); M00162 (39%); M00869 (34%)
M05669,Rheumatoid arthritis of unspecified knee with involvement of other organs and systems,93,M00869 (38%); M00269 (38%); M00069 (38%); M00169 (38%); M00862 (33%)
M05671,Rheumatoid arthritis of right ankle and foot with involvement of other organs and systems,93,M00871 (46%); M00271 (46%); M00071 (45%); M00171 (45%); M00879 (41%)
M05672,Rheumatoid arthritis of left ankle and foot with involvement of other organs and systems,93,M00872 (46%); M00272 (46%); M00072 (45%); M00172 (45%); M00879 (41%)
M05679,Rheumatoid arthritis of unspecified ankle and foot with involvement of other organs and systems,93,M00879 (44%); M00279 (44%); M00079 (44%); M00179 (44%); M00872 (40%)
M0569,Rheumatoid arthritis of multiple sites with involvement of other organs and systems,93,M868X0 (44%); M8789 (43%); M8669 (40%); M8619 (38%); M8739 (37%)
M0570,Rheumatoid arthritis with rheumatoid factor of unspecified site without organ or systems involvement,93,M3210 (27%); M3219 (26%); C8510 (24%); C6990 (23%); M8660 (23%)
M05711,Rheumatoid arthritis with rheumatoid factor of right shoulder without organ or systems involvement,93,M00811 (32%); M00211 (31%); M00011 (31%); M00111 (31%); M87811 (28%)
M05712,Rheumatoid arthritis with rheumatoid factor of left shoulder without organ or systems involvement,93,M00812 (32%); M00212 (31%); M00012 (31%); M00112 (31%); M87812 (27%)
M05719,Rheumatoid arthritis with rheumatoid factor of unspecified shoulder without organ or systems involvement,93,M00819 (30%); M00219 (30%); M00019 (30%); M00119 (30%); M3210 (27%)
M05721,Rheumatoid arthritis with rheumatoid factor of right elbow without organ or systems involvement,93,M00821 (33%); M00221 (33%); M00021 (33%); M00121 (33%); M00829 (28%)
M05722,Rheumatoid arthritis with rheumatoid factor of left elbow without organ or systems involvement,93,M00822 (33%); M00222 (33%); M00022 (33%); M00122 (33%); M00829 (28%)
M05729,Rheumatoid arthritis with rheumatoid factor of unspecified elbow without organ or systems involvement,93,M00829 (31%); M00229 (31%); M00029 (31%); M00129 (31%); M00822 (28%)
M05731,Rheumatoid arthritis with rheumatoid factor of right wrist without organ or systems involvement,93,M00831 (34%); M00231 (34%); M00031 (33%); M00131 (33%); M00839 (29%)
M05732,Rheumatoid arthritis with rheumatoid factor of left wrist without organ or systems involvement,93,M00832 (34%); M00232 (34%); M00032 (33%); M00132 (33%); M00839 (29%)
M05739,Rheumatoid arthritis with rheumatoid factor of unspecified wrist without organ or systems involvement,93,M00839 (32%); M00239 (32%); M00039 (32%); M00139 (32%); M00832 (28%)
M05741,Rheumatoid arthritis with rheumatoid factor of right hand without organ or systems involvement,93,M00841 (32%); M00241 (32%); M00041 (32%); M00141 (32%); M87841 (28%)
M05742,Rheumatoid arthritis with rheumatoid factor of left hand without organ or systems involvement,93,M00842 (32%); M00242 (32%); M00042 (32%); M00142 (32%); M87842 (28%)
M05749,Rheumatoid arthritis with rheumatoid factor of unspecified hand without organ or systems involvement,93,M00849 (31%); M00249 (30%); M00049 (30%); M00149 (30%); M3210 (27%)
M05751,Rheumatoid arthritis with rheumatoid factor of right hip without organ or systems involvement,93,M00851 (31%); M00251 (31%); M00051 (31%); M00151 (31%); M00859 (26%)
M05752,Rheumatoid arthritis with rheumatoid factor of left hip without organ or systems involvement,93,M00852 (31%); M00252 (31%); M00052 (31%); M00152 (31%); M00859 (26%)
M05759,Rheumatoid arthritis with rheumatoid factor of unspecified hip without organ or systems involvement,93,M00859 (30%); M00259 (30%); M00059 (29%); M00159 (29%); M3210 (27%)
M05761,Rheumatoid arthritis with rheumatoid factor of right knee without organ or systems involvement,93,M00861 (33%); M00261 (33%); M00061 (33%); M00161 (33%); M00869 (28%)
M05762,Rheumatoid arthritis with rheumatoid factor of left knee without organ or systems involvement,93,M00862 (33%); M00262 (33%); M00062 (33%); M00162 (33%); M00869 (28%)
M05769,Rheumatoid arthritis with rheumatoid factor of unspecified knee without organ or systems involvement,93,M00869 (32%); M00269 (32%); M00069 (31%); M00169 (31%); M00862 (28%)
M05771,Rheumatoid arthritis with rheumatoid factor of right ankle and foot without organ or systems involvement,93,M00871 (39%); M00271 (39%); M00071 (39%); M00171 (39%); M00879 (34%)
M05772,Rheumatoid arthritis with rheumatoid factor of left ankle and foot without organ or systems involvement,93,M00872 (39%); M00272 (39%); M00072 (39%); M00172 (39%); M00879 (34%)
M05779,Rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot without organ or systems involvement,93,M00879 (38%); M00279 (38%); M00079 (37%); M00179 (37%); M00872 (34%)
M0579,Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement,93,M868X0 (37%); M8789 (37%); M8669 (34%); M8619 (33%); M8739 (31%)
M057A,Rheumatoid arthritis with rheumatoid factor of other specified site without organ or systems involvement,93,M3219 (25%); M3210 (25%); S0269XB (22%); S0269XA (22%); M868X8 (22%)
M0580,Other rheumatoid arthritis with rheumatoid factor of unspecified site,93,C8510 (31%); C6990 (29%); M8660 (29%); C8190 (29%); C8290 (29%)
M05811,Other rheumatoid arthritis with rheumatoid factor of right shoulder,93,M00811 (41%); M00211 (41%); M00011 (40%); M00111 (40%); M87811 (35%)
M05812,Other rheumatoid arthritis with rheumatoid factor of left shoulder,93,M00812 (41%); M00212 (41%); M00012 (40%); M00112 (40%); M87812 (35%)
M05819,Other rheumatoid arthritis with rheumatoid factor of unspecified shoulder,93,M00819 (39%); M00219 (39%); M00019 (38%); M00119 (38%); M00812 (34%)
M05821,Other rheumatoid arthritis with rheumatoid factor of right elbow,93,M00821 (42%); M00221 (42%); M00021 (42%); M00121 (42%); M00829 (36%)
M05822,Other rheumatoid arthritis with rheumatoid factor of left elbow,93,M00822 (42%); M00222 (42%); M00022 (42%); M00122 (42%); M00829 (36%)
M05829,Other rheumatoid arthritis with rheumatoid factor of unspecified elbow,93,M00829 (40%); M00229 (40%); M00029 (40%); M00129 (40%); M00822 (36%)
M05831,Other rheumatoid arthritis with rheumatoid factor of right wrist,93,M00831 (43%); M00231 (43%); M00031 (43%); M00131 (43%); M00839 (37%)
M05832,Other rheumatoid arthritis with rheumatoid factor of left wrist,93,M00832 (43%); M00232 (43%); M00032 (43%); M00132 (43%); M00839 (37%)
M05839,Other rheumatoid arthritis with rheumatoid factor of unspecified wrist,93,M00839 (41%); M00239 (41%); M00039 (41%); M00139 (41%); M00832 (37%)
M05841,Other rheumatoid arthritis with rheumatoid factor of right hand,93,M00841 (41%); M00241 (41%); M00041 (41%); M00141 (41%); M87841 (36%)
M05842,Other rheumatoid arthritis with rheumatoid factor of left hand,93,M00842 (41%); M00242 (41%); M00042 (41%); M00142 (41%); M87842 (36%)
M05849,Other rheumatoid arthritis with rheumatoid factor of unspecified hand,93,M00849 (40%); M00249 (39%); M00049 (39%); M00149 (39%); M00842 (35%)
M05851,Other rheumatoid arthritis with rheumatoid factor of right hip,93,M00851 (40%); M00251 (40%); M00051 (40%); M00151 (40%); M00859 (34%)
M05852,Other rheumatoid arthritis with rheumatoid factor of left hip,93,M00852 (40%); M00252 (40%); M00052 (40%); M00152 (40%); M00859 (34%)
M05859,Other rheumatoid arthritis with rheumatoid factor of unspecified hip,93,M00859 (38%); M00259 (38%); M00059 (38%); M00159 (38%); M00852 (33%)
M05861,Other rheumatoid arthritis with rheumatoid factor of right knee,93,M00861 (43%); M00261 (42%); M00061 (42%); M00161 (42%); M00869 (36%)
M05862,Other rheumatoid arthritis with rheumatoid factor of left knee,93,M00862 (43%); M00262 (42%); M00062 (42%); M00162 (42%); M00869 (36%)
M05869,Other rheumatoid arthritis with rheumatoid factor of unspecified knee,93,M00869 (41%); M00269 (41%); M00069 (40%); M00169 (40%); M00862 (36%)
M05871,Other rheumatoid arthritis with rheumatoid factor of right ankle and foot,93,M00871 (49%); M00271 (49%); M00071 (49%); M00171 (49%); M00879 (43%)
M05872,Other rheumatoid arthritis with rheumatoid factor of left ankle and foot,93,M00872 (49%); M00272 (49%); M00072 (49%); M00172 (49%); M00879 (43%)
M05879,Other rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot,93,M00879 (48%); M00279 (47%); M00079 (47%); M00179 (47%); M00872 (43%)
M0589,Other rheumatoid arthritis with rheumatoid factor of multiple sites,93,M868X0 (47%); M8789 (46%); M8669 (43%); M8619 (41%); M8739 (39%)
M058A,Other rheumatoid arthritis with rheumatoid factor of other specified site,93,S0269XB (29%); S0269XA (28%); M868X8 (28%); M8788 (27%); C8580 (26%)
M059,"Rheumatoid arthritis with rheumatoid factor, unspecified",93,M009 (20%); D66 (19%); D67 (19%); D681 (19%); M00859 (19%)
M0600,"Rheumatoid arthritis without rheumatoid factor, unspecified site",93,C8510 (31%); C6990 (29%); M8660 (29%); C8190 (29%); C8290 (29%)
M06011,"Rheumatoid arthritis without rheumatoid factor, right shoulder",93,M00811 (41%); M00211 (41%); M00011 (40%); M00111 (40%); M87811 (35%)
M06012,"Rheumatoid arthritis without rheumatoid factor, left shoulder",93,M00812 (41%); M00212 (41%); M00012 (40%); M00112 (40%); M87812 (35%)
M06019,"Rheumatoid arthritis without rheumatoid factor, unspecified shoulder",93,M00819 (39%); M00219 (39%); M00019 (38%); M00119 (38%); M00812 (34%)
M06021,"Rheumatoid arthritis without rheumatoid factor, right elbow",93,M00821 (42%); M00221 (42%); M00021 (42%); M00121 (42%); M00829 (36%)
M06022,"Rheumatoid arthritis without rheumatoid factor, left elbow",93,M00822 (42%); M00222 (42%); M00022 (42%); M00122 (42%); M00829 (36%)
M06029,"Rheumatoid arthritis without rheumatoid factor, unspecified elbow",93,M00829 (40%); M00229 (40%); M00029 (40%); M00129 (40%); M00822 (36%)
M06031,"Rheumatoid arthritis without rheumatoid factor, right wrist",93,M00831 (43%); M00231 (43%); M00031 (43%); M00131 (43%); M00839 (37%)
M06032,"Rheumatoid arthritis without rheumatoid factor, left wrist",93,M00832 (43%); M00232 (43%); M00032 (43%); M00132 (43%); M00839 (37%)
M06039,"Rheumatoid arthritis without rheumatoid factor, unspecified wrist",93,M00839 (41%); M00239 (41%); M00039 (41%); M00139 (41%); M00832 (37%)
M06041,"Rheumatoid arthritis without rheumatoid factor, right hand",93,M00841 (41%); M00241 (41%); M00041 (41%); M00141 (41%); M87841 (36%)
M06042,"Rheumatoid arthritis without rheumatoid factor, left hand",93,M00842 (41%); M00242 (41%); M00042 (41%); M00142 (41%); M87842 (36%)
M06049,"Rheumatoid arthritis without rheumatoid factor, unspecified hand",93,M00849 (40%); M00249 (39%); M00049 (39%); M00149 (39%); M00842 (35%)
M06051,"Rheumatoid arthritis without rheumatoid factor, right hip",93,M00851 (40%); M00251 (40%); M00051 (40%); M00151 (40%); M00859 (34%)
M06052,"Rheumatoid arthritis without rheumatoid factor, left hip",93,M00852 (40%); M00252 (40%); M00052 (40%); M00152 (40%); M00859 (34%)
M06059,"Rheumatoid arthritis without rheumatoid factor, unspecified hip",93,M00859 (38%); M00259 (38%); M00059 (38%); M00159 (38%); M00852 (33%)
M06061,"Rheumatoid arthritis without rheumatoid factor, right knee",93,M00861 (43%); M00261 (42%); M00061 (42%); M00161 (42%); M00869 (36%)
M06062,"Rheumatoid arthritis without rheumatoid factor, left knee",93,M00862 (43%); M00262 (42%); M00062 (42%); M00162 (42%); M00869 (36%)
M06069,"Rheumatoid arthritis without rheumatoid factor, unspecified knee",93,M00869 (41%); M00269 (41%); M00069 (40%); M00169 (40%); M00862 (36%)
M06071,"Rheumatoid arthritis without rheumatoid factor, right ankle and foot",93,M00871 (49%); M00271 (49%); M00071 (49%); M00171 (49%); M00879 (43%)
M06072,"Rheumatoid arthritis without rheumatoid factor, left ankle and foot",93,M00872 (49%); M00272 (49%); M00072 (49%); M00172 (49%); M00879 (43%)
M06079,"Rheumatoid arthritis without rheumatoid factor, unspecified ankle and foot",93,M00879 (48%); M00279 (47%); M00079 (47%); M00179 (47%); M00872 (43%)
M0608,"Rheumatoid arthritis without rheumatoid factor, vertebrae",93,M0088 (48%); M0028 (48%); M0008 (48%); M0018 (48%); M0238 (37%)
M0609,"Rheumatoid arthritis without rheumatoid factor, multiple sites",93,M868X0 (47%); M8789 (46%); M8669 (43%); M8619 (41%); M8739 (39%)
M060A,"Rheumatoid arthritis without rheumatoid factor, other specified site",93,S0269XB (29%); S0269XA (28%); M868X8 (28%); M8788 (27%); C8580 (26%)
M061,Adult-onset Still's disease,93,G9344 (48%); G300 (38%); G301 (38%); J8482 (33%); C9151 (31%)
M0620,"Rheumatoid bursitis, unspecified site",93,C8510 (39%); C6990 (37%); M8660 (37%); C8190 (37%); C8290 (37%)
M06211,"Rheumatoid bursitis, right shoulder",93,M87811 (44%); M86611 (40%); M86111 (38%); M868X1 (36%); M87311 (36%)
M06212,"Rheumatoid bursitis, left shoulder",93,M87812 (44%); M86612 (40%); M86112 (38%); M868X1 (36%); M87312 (36%)
M06219,"Rheumatoid bursitis, unspecified shoulder",93,M87819 (41%); M86619 (37%); M868X1 (37%); M86119 (35%); M87319 (33%)
M06221,"Rheumatoid bursitis, right elbow",93,M00821 (37%); M00221 (37%); M00021 (37%); M00121 (37%); M02321 (36%)
M06222,"Rheumatoid bursitis, left elbow",93,M00822 (37%); M00222 (37%); M00022 (37%); M00122 (37%); M02322 (36%)
M06229,"Rheumatoid bursitis, unspecified elbow",93,M00829 (34%); M00229 (34%); M00029 (34%); M00129 (34%); M02329 (33%)
M06231,"Rheumatoid bursitis, right wrist",93,M00831 (38%); M00231 (38%); M00031 (38%); M00131 (38%); M02331 (37%)
M06232,"Rheumatoid bursitis, left wrist",93,M00832 (38%); M00232 (38%); M00032 (38%); M00132 (38%); M02332 (37%)
M06239,"Rheumatoid bursitis, unspecified wrist",93,M00839 (36%); M00239 (36%); M00039 (35%); M00139 (35%); M02339 (35%)
M06241,"Rheumatoid bursitis, right hand",93,M87841 (45%); M86641 (41%); M86141 (39%); M868X4 (37%); M87341 (37%)
M06242,"Rheumatoid bursitis, left hand",93,M87842 (45%); M86642 (41%); M86142 (39%); M868X4 (37%); M87342 (37%)
M06249,"Rheumatoid bursitis, unspecified hand",93,M87843 (42%); M86649 (38%); M868X4 (38%); M86149 (36%); M87842 (34%)
M06251,"Rheumatoid bursitis, right hip",93,M00851 (34%); M00251 (34%); M00051 (34%); M00151 (34%); M02351 (33%)
M06252,"Rheumatoid bursitis, left hip",93,M00852 (34%); M00252 (34%); M00052 (34%); M00152 (34%); M02352 (33%)
M06259,"Rheumatoid bursitis, unspecified hip",93,S73003A (34%); S73006A (34%); M00859 (32%); M00259 (31%); M00059 (31%)
M06261,"Rheumatoid bursitis, right knee",93,M00861 (37%); M00261 (37%); M00061 (37%); M00161 (37%); M02361 (36%)
M06262,"Rheumatoid bursitis, left knee",93,M00862 (37%); M00262 (37%); M00062 (37%); M00162 (37%); M02362 (36%)
M06269,"Rheumatoid bursitis, unspecified knee",93,M00869 (35%); M00269 (35%); M00069 (35%); M00169 (35%); M02369 (34%)
M06271,"Rheumatoid bursitis, right ankle and foot",93,M86671 (51%); M868X7 (50%); M86171 (49%); M00871 (46%); M00271 (46%)
M06272,"Rheumatoid bursitis, left ankle and foot",93,M86672 (51%); M868X7 (50%); M86172 (49%); M00872 (46%); M00272 (46%)
M06279,"Rheumatoid bursitis, unspecified ankle and foot",93,M868X7 (51%); M86679 (50%); M86179 (48%); M00879 (44%); M00279 (44%)
M0628,"Rheumatoid bursitis, vertebrae",93,M0088 (45%); M0028 (45%); M0008 (45%); M0018 (45%); M0238 (44%)
M0629,"Rheumatoid bursitis, multiple sites",93,M868X0 (56%); M8789 (55%); M8669 (51%); M8619 (49%); M8739 (47%)
M0630,"Rheumatoid nodule, unspecified site",93,C8510 (39%); C6990 (37%); M8660 (37%); C8190 (37%); C8290 (37%)
M06311,"Rheumatoid nodule, right shoulder",93,M87811 (44%); M86611 (40%); M86111 (38%); M868X1 (36%); M87311 (36%)
M06312,"Rheumatoid nodule, left shoulder",93,M87812 (44%); M86612 (40%); M86112 (38%); M868X1 (36%); M87312 (36%)
M06319,"Rheumatoid nodule, unspecified shoulder",93,M87819 (41%); M86619 (37%); M868X1 (37%); M86119 (35%); M87319 (33%)
M06321,"Rheumatoid nodule, right elbow",93,M00821 (37%); M00221 (37%); M00021 (37%); M00121 (37%); M02321 (36%)
M06322,"Rheumatoid nodule, left elbow",93,M00822 (37%); M00222 (37%); M00022 (37%); M00122 (37%); M02322 (36%)
M06329,"Rheumatoid nodule, unspecified elbow",93,M00829 (34%); M00229 (34%); M00029 (34%); M00129 (34%); M02329 (33%)
M06331,"Rheumatoid nodule, right wrist",93,M00831 (38%); M00231 (38%); M00031 (38%); M00131 (38%); M02331 (37%)
M06332,"Rheumatoid nodule, left wrist",93,M00832 (38%); M00232 (38%); M00032 (38%); M00132 (38%); M02332 (37%)
M06339,"Rheumatoid nodule, unspecified wrist",93,M00839 (36%); M00239 (36%); M00039 (35%); M00139 (35%); M02339 (35%)
M06341,"Rheumatoid nodule, right hand",93,M87841 (45%); M86641 (41%); M86141 (39%); M868X4 (37%); M87341 (37%)
M06342,"Rheumatoid nodule, left hand",93,M87842 (45%); M86642 (41%); M86142 (39%); M868X4 (37%); M87342 (37%)
M06349,"Rheumatoid nodule, unspecified hand",93,M87843 (42%); M86649 (38%); M868X4 (38%); M86149 (36%); M87842 (34%)
M06351,"Rheumatoid nodule, right hip",93,M00851 (34%); M00251 (34%); M00051 (34%); M00151 (34%); M02351 (33%)
M06352,"Rheumatoid nodule, left hip",93,M00852 (34%); M00252 (34%); M00052 (34%); M00152 (34%); M02352 (33%)
M06359,"Rheumatoid nodule, unspecified hip",93,S73003A (34%); S73006A (34%); M00859 (32%); M00259 (31%); M00059 (31%)
M06361,"Rheumatoid nodule, right knee",93,M00861 (37%); M00261 (37%); M00061 (37%); M00161 (37%); M02361 (36%)
M06362,"Rheumatoid nodule, left knee",93,M00862 (37%); M00262 (37%); M00062 (37%); M00162 (37%); M02362 (36%)
M06369,"Rheumatoid nodule, unspecified knee",93,M00869 (35%); M00269 (35%); M00069 (35%); M00169 (35%); M02369 (34%)
M06371,"Rheumatoid nodule, right ankle and foot",93,M86671 (51%); M868X7 (50%); M86171 (49%); M00871 (46%); M00271 (46%)
M06372,"Rheumatoid nodule, left ankle and foot",93,M86672 (51%); M868X7 (50%); M86172 (49%); M00872 (46%); M00272 (46%)
M06379,"Rheumatoid nodule, unspecified ankle and foot",93,M868X7 (51%); M86679 (50%); M86179 (48%); M00879 (44%); M00279 (44%)
M0638,"Rheumatoid nodule, vertebrae",93,M0088 (45%); M0028 (45%); M0008 (45%); M0018 (45%); M0238 (44%)
M0639,"Rheumatoid nodule, multiple sites",93,M868X0 (56%); M8789 (55%); M8669 (51%); M8619 (49%); M8739 (47%)
M064,Inflammatory polyarthropathy,94,M3581 (34%); K5140 (31%); K51418 (31%); K51419 (31%); K51413 (30%)
M0680,"Other specified rheumatoid arthritis, unspecified site",93,C8510 (42%); C8580 (41%); S0269XB (40%); S0269XA (40%); C6990 (40%)
M06811,"Other specified rheumatoid arthritis, right shoulder",93,M00811 (54%); M00211 (54%); M00011 (54%); M00111 (54%); M87811 (47%)
M06812,"Other specified rheumatoid arthritis, left shoulder",93,M00812 (54%); M00212 (54%); M00012 (54%); M00112 (54%); M87812 (47%)
M06819,"Other specified rheumatoid arthritis, unspecified shoulder",93,M00819 (52%); M00219 (52%); M00019 (52%); M00119 (52%); M00812 (45%)
M06821,"Other specified rheumatoid arthritis, right elbow",93,M00821 (56%); M00221 (56%); M00021 (55%); M00121 (55%); M00829 (47%)
M06822,"Other specified rheumatoid arthritis, left elbow",93,M00822 (56%); M00222 (56%); M00022 (55%); M00122 (55%); M00829 (47%)
M06829,"Other specified rheumatoid arthritis, unspecified elbow",93,M00829 (54%); M00229 (54%); M00029 (54%); M00129 (54%); M00822 (47%)
M06831,"Other specified rheumatoid arthritis, right wrist",93,M00831 (57%); M00231 (57%); M00031 (56%); M00131 (56%); M00839 (48%)
M06832,"Other specified rheumatoid arthritis, left wrist",93,M00832 (57%); M00232 (57%); M00032 (56%); M00132 (56%); M00839 (48%)
M06839,"Other specified rheumatoid arthritis, unspecified wrist",93,M00839 (55%); M00239 (55%); M00039 (55%); M00139 (55%); M00832 (49%)
M06841,"Other specified rheumatoid arthritis, right hand",93,M00841 (55%); M00241 (55%); M00041 (55%); M00141 (55%); M87841 (48%)
M06842,"Other specified rheumatoid arthritis, left hand",93,M00842 (55%); M00242 (55%); M00042 (55%); M00142 (55%); M87842 (48%)
M06849,"Other specified rheumatoid arthritis, unspecified hand",93,M00849 (53%); M00249 (53%); M00049 (53%); M00149 (53%); M00842 (46%)
M06851,"Other specified rheumatoid arthritis, right hip",93,M00851 (54%); M00251 (54%); M00051 (53%); M00151 (53%); M00859 (45%)
M06852,"Other specified rheumatoid arthritis, left hip",93,M00852 (54%); M00252 (54%); M00052 (53%); M00152 (53%); M00859 (45%)
M06859,"Other specified rheumatoid arthritis, unspecified hip",93,M00859 (52%); M00259 (52%); M00059 (51%); M00159 (51%); M00852 (45%)
M06861,"Other specified rheumatoid arthritis, right knee",93,M00861 (56%); M00261 (56%); M00061 (56%); M00161 (56%); M00869 (48%)
M06862,"Other specified rheumatoid arthritis, left knee",93,M00862 (56%); M00262 (56%); M00062 (56%); M00162 (56%); M00869 (48%)
M06869,"Other specified rheumatoid arthritis, unspecified knee",93,M00869 (54%); M00269 (54%); M00069 (54%); M00169 (54%); M00862 (48%)
M06871,"Other specified rheumatoid arthritis, right ankle and foot",93,M00871 (62%); M00271 (62%); M00071 (62%); M00171 (62%); M00879 (55%)
M06872,"Other specified rheumatoid arthritis, left ankle and foot",93,M00872 (62%); M00272 (62%); M00072 (62%); M00172 (62%); M00879 (55%)
M06879,"Other specified rheumatoid arthritis, unspecified ankle and foot",93,M00879 (61%); M00279 (61%); M00079 (61%); M00179 (61%); M00872 (55%)
M0688,"Other specified rheumatoid arthritis, vertebrae",93,M0088 (62%); M0028 (62%); M0008 (62%); M0018 (62%); M0238 (47%)
M0689,"Other specified rheumatoid arthritis, multiple sites",93,M868X0 (59%); M8789 (59%); M8669 (54%); M8619 (52%); M8739 (50%)
M068A,"Other specified rheumatoid arthritis, other specified site",93,E1369 (54%); S0269XB (45%); S0269XA (45%); A4189 (42%); C8580 (42%)
M069,"Rheumatoid arthritis, unspecified",93,M009 (37%); M00859 (34%); M00259 (34%); M00819 (34%); M00219 (34%)
M0800,Unspecified juvenile rheumatoid arthritis of unspecified site,93,C8510 (48%); C6990 (45%); C8190 (45%); C8290 (45%); M8660 (41%)
M08011,"Unspecified juvenile rheumatoid arthritis, right shoulder",93,M00811 (51%); M00211 (51%); M00011 (50%); M00111 (50%); M00819 (48%)
M08012,"Unspecified juvenile rheumatoid arthritis, left shoulder",93,M00812 (51%); M00212 (51%); M00012 (50%); M00112 (50%); M00819 (48%)
M08019,"Unspecified juvenile rheumatoid arthritis, unspecified shoulder",93,M00819 (51%); M00219 (51%); M00019 (51%); M00119 (51%); M87819 (46%)
M08021,"Unspecified juvenile rheumatoid arthritis, right elbow",93,M00821 (52%); M00221 (52%); M00021 (52%); M00121 (52%); M00829 (49%)
M08022,"Unspecified juvenile rheumatoid arthritis, left elbow",93,M00822 (52%); M00222 (52%); M00022 (52%); M00122 (52%); M00829 (50%)
M08029,"Unspecified juvenile rheumatoid arthritis, unspecified elbow",93,M00829 (53%); M00229 (53%); M00029 (53%); M00129 (53%); M00822 (42%)
M08031,"Unspecified juvenile rheumatoid arthritis, right wrist",93,M00831 (53%); M00231 (53%); M00031 (53%); M00131 (53%); M00839 (50%)
M08032,"Unspecified juvenile rheumatoid arthritis, left wrist",93,M00832 (53%); M00232 (53%); M00032 (53%); M00132 (53%); M00839 (50%)
M08039,"Unspecified juvenile rheumatoid arthritis, unspecified wrist",93,M00839 (54%); M00239 (54%); M00039 (53%); M00139 (53%); M00832 (43%)
M08041,"Unspecified juvenile rheumatoid arthritis, right hand",93,M00841 (51%); M00241 (51%); M00041 (51%); M00141 (51%); M00849 (49%)
M08042,"Unspecified juvenile rheumatoid arthritis, left hand",93,M00842 (51%); M00242 (51%); M00042 (51%); M00142 (51%); M00849 (49%)
M08049,"Unspecified juvenile rheumatoid arthritis, unspecified hand",93,M00849 (52%); M00249 (52%); M00049 (52%); M00149 (52%); M87843 (47%)
M08051,"Unspecified juvenile rheumatoid arthritis, right hip",93,M00851 (50%); M00251 (50%); M00051 (50%); M00151 (50%); M00859 (47%)
M08052,"Unspecified juvenile rheumatoid arthritis, left hip",93,M00852 (50%); M00252 (50%); M00052 (50%); M00152 (50%); M00859 (47%)
M08059,"Unspecified juvenile rheumatoid arthritis, unspecified hip",93,M00859 (51%); M00259 (51%); M00059 (51%); M00159 (51%); S73003A (41%)
M08061,"Unspecified juvenile rheumatoid arthritis, right knee",93,M00861 (53%); M00261 (52%); M00061 (52%); M00161 (52%); M00869 (50%)
M08062,"Unspecified juvenile rheumatoid arthritis, left knee",93,M00862 (53%); M00262 (52%); M00062 (52%); M00162 (52%); M00869 (50%)
M08069,"Unspecified juvenile rheumatoid arthritis, unspecified knee",93,M00869 (53%); M00269 (53%); M00069 (53%); M00169 (53%); M00862 (43%)
M08071,"Unspecified juvenile rheumatoid arthritis, right ankle and foot",93,M00871 (59%); M00271 (59%); M00071 (59%); M00171 (59%); M00879 (57%)
M08072,"Unspecified juvenile rheumatoid arthritis, left ankle and foot",93,M00872 (59%); M00272 (59%); M00072 (59%); M00172 (59%); M00879 (57%)
M08079,"Unspecified juvenile rheumatoid arthritis, unspecified ankle and foot",93,M00879 (60%); M00279 (59%); M00079 (59%); M00179 (59%); M86679 (52%)
M0808,"Unspecified juvenile rheumatoid arthritis, vertebrae",93,M0088 (59%); M0028 (58%); M0008 (58%); M0018 (58%); M0238 (44%)
M0809,"Unspecified juvenile rheumatoid arthritis, multiple sites",93,M868X0 (56%); M8789 (55%); M8669 (52%); M8619 (50%); M8739 (47%)
M080A,"Unspecified juvenile rheumatoid arthritis, other specified site",93,C8510 (36%); C8580 (36%); S0269XB (35%); S0269XA (35%); C6990 (35%)
M081,Juvenile ankylosing spondylitis,93,M302 (22%); C9331 (18%); M3301 (18%); C9332 (17%); C9330 (14%)
M0820,"Juvenile rheumatoid arthritis with systemic onset, unspecified site",93,C8510 (29%); C6990 (28%); M8660 (28%); C8190 (27%); C8290 (27%)
M08211,"Juvenile rheumatoid arthritis with systemic onset, right shoulder",93,M00811 (38%); M00211 (38%); M00011 (38%); M00111 (38%); M87811 (33%)
M08212,"Juvenile rheumatoid arthritis with systemic onset, left shoulder",93,M00812 (38%); M00212 (38%); M00012 (38%); M00112 (38%); M87812 (33%)
M08219,"Juvenile rheumatoid arthritis with systemic onset, unspecified shoulder",93,M00819 (36%); M00219 (36%); M00019 (36%); M00119 (36%); M00812 (32%)
M08221,"Juvenile rheumatoid arthritis with systemic onset, right elbow",93,M00821 (40%); M00221 (40%); M00021 (39%); M00121 (39%); M00829 (34%)
M08222,"Juvenile rheumatoid arthritis with systemic onset, left elbow",93,M00822 (40%); M00222 (40%); M00022 (39%); M00122 (39%); M00829 (34%)
M08229,"Juvenile rheumatoid arthritis with systemic onset, unspecified elbow",93,M00829 (38%); M00229 (38%); M00029 (38%); M00129 (38%); M00822 (33%)
M08231,"Juvenile rheumatoid arthritis with systemic onset, right wrist",93,M00831 (40%); M00231 (40%); M00031 (40%); M00131 (40%); M00839 (35%)
M08232,"Juvenile rheumatoid arthritis with systemic onset, left wrist",93,M00832 (40%); M00232 (40%); M00032 (40%); M00132 (40%); M00839 (35%)
M08239,"Juvenile rheumatoid arthritis with systemic onset, unspecified wrist",93,M00839 (39%); M00239 (39%); M00039 (38%); M00139 (38%); M00832 (34%)
M08241,"Juvenile rheumatoid arthritis with systemic onset, right hand",93,M00841 (39%); M00241 (39%); M00041 (38%); M00141 (38%); M87841 (34%)
M08242,"Juvenile rheumatoid arthritis with systemic onset, left hand",93,M00842 (39%); M00242 (39%); M00042 (38%); M00142 (38%); M87842 (34%)
M08249,"Juvenile rheumatoid arthritis with systemic onset, unspecified hand",93,M00849 (37%); M00249 (37%); M00049 (37%); M00149 (37%); M00842 (32%)
M08251,"Juvenile rheumatoid arthritis with systemic onset, right hip",93,M00851 (38%); M00251 (38%); M00051 (37%); M00151 (37%); M00859 (31%)
M08252,"Juvenile rheumatoid arthritis with systemic onset, left hip",93,M00852 (38%); M00252 (38%); M00052 (37%); M00152 (37%); M00859 (31%)
M08259,"Juvenile rheumatoid arthritis with systemic onset, unspecified hip",93,M00859 (36%); M00259 (36%); M00059 (36%); M00159 (36%); M00852 (31%)
M08261,"Juvenile rheumatoid arthritis with systemic onset, right knee",93,M00861 (40%); M00261 (40%); M00061 (40%); M00161 (40%); M00869 (34%)
M08262,"Juvenile rheumatoid arthritis with systemic onset, left knee",93,M00862 (40%); M00262 (40%); M00062 (40%); M00162 (40%); M00869 (34%)
M08269,"Juvenile rheumatoid arthritis with systemic onset, unspecified knee",93,M00869 (38%); M00269 (38%); M00069 (38%); M00169 (38%); M00862 (34%)
M08271,"Juvenile rheumatoid arthritis with systemic onset, right ankle and foot",93,M00871 (46%); M00271 (46%); M00071 (46%); M00171 (46%); M00879 (41%)
M08272,"Juvenile rheumatoid arthritis with systemic onset, left ankle and foot",93,M00872 (46%); M00272 (46%); M00072 (46%); M00172 (46%); M00879 (41%)
M08279,"Juvenile rheumatoid arthritis with systemic onset, unspecified ankle and foot",93,M00879 (45%); M00279 (45%); M00079 (45%); M00179 (45%); M00872 (41%)
M0828,"Juvenile rheumatoid arthritis with systemic onset, vertebrae",93,M0088 (46%); M0028 (46%); M0008 (45%); M0018 (45%); M0238 (34%)
M0829,"Juvenile rheumatoid arthritis with systemic onset, multiple sites",93,M868X0 (44%); M8789 (43%); M8669 (40%); M8619 (39%); M8739 (37%)
M082A,"Juvenile rheumatoid arthritis with systemic onset, other specified site",93,S0269XB (27%); S0269XA (27%); M868X8 (26%); M8788 (26%); C8580 (25%)
M083,Juvenile rheumatoid polyarthritis (seronegative),93,M0089 (45%); M0029 (45%); M0009 (45%); M0019 (45%); M302 (18%)
M0840,"Pauciarticular juvenile rheumatoid arthritis, unspecified site",93,C8510 (32%); C6990 (31%); M8660 (31%); C8190 (30%); C8290 (30%)
M08411,"Pauciarticular juvenile rheumatoid arthritis, right shoulder",93,M00811 (42%); M00211 (42%); M00011 (42%); M00111 (42%); M87811 (37%)
M08412,"Pauciarticular juvenile rheumatoid arthritis, left shoulder",93,M00812 (42%); M00212 (42%); M00012 (42%); M00112 (42%); M87812 (37%)
M08419,"Pauciarticular juvenile rheumatoid arthritis, unspecified shoulder",93,M00819 (40%); M00219 (40%); M00019 (40%); M00119 (40%); M00812 (35%)
M08421,"Pauciarticular juvenile rheumatoid arthritis, right elbow",93,M00821 (44%); M00221 (44%); M00021 (44%); M00121 (44%); M00829 (37%)
M08422,"Pauciarticular juvenile rheumatoid arthritis, left elbow",93,M00822 (44%); M00222 (44%); M00022 (44%); M00122 (44%); M00829 (37%)
M08429,"Pauciarticular juvenile rheumatoid arthritis, unspecified elbow",93,M00829 (42%); M00229 (42%); M00029 (42%); M00129 (42%); M00822 (37%)
M08431,"Pauciarticular juvenile rheumatoid arthritis, right wrist",93,M00831 (45%); M00231 (45%); M00031 (44%); M00131 (44%); M00839 (38%)
M08432,"Pauciarticular juvenile rheumatoid arthritis, left wrist",93,M00832 (45%); M00232 (45%); M00032 (44%); M00132 (44%); M00839 (38%)
M08439,"Pauciarticular juvenile rheumatoid arthritis, unspecified wrist",93,M00839 (43%); M00239 (43%); M00039 (43%); M00139 (43%); M00832 (38%)
M08441,"Pauciarticular juvenile rheumatoid arthritis, right hand",93,M00841 (43%); M00241 (43%); M00041 (43%); M00141 (43%); M87841 (38%)
M08442,"Pauciarticular juvenile rheumatoid arthritis, left hand",93,M00842 (43%); M00242 (43%); M00042 (43%); M00142 (43%); M87842 (38%)
M08449,"Pauciarticular juvenile rheumatoid arthritis, unspecified hand",93,M00849 (41%); M00249 (41%); M00049 (41%); M00149 (41%); M00842 (36%)
M08451,"Pauciarticular juvenile rheumatoid arthritis, right hip",93,M00851 (42%); M00251 (42%); M00051 (42%); M00151 (42%); M00859 (35%)
M08452,"Pauciarticular juvenile rheumatoid arthritis, left hip",93,M00852 (42%); M00252 (42%); M00052 (42%); M00152 (42%); M00859 (35%)
M08459,"Pauciarticular juvenile rheumatoid arthritis, unspecified hip",93,M00859 (40%); M00259 (40%); M00059 (40%); M00159 (40%); M00852 (35%)
M08461,"Pauciarticular juvenile rheumatoid arthritis, right knee",93,M00861 (44%); M00261 (44%); M00061 (44%); M00161 (44%); M00869 (38%)
M08462,"Pauciarticular juvenile rheumatoid arthritis, left knee",93,M00862 (44%); M00262 (44%); M00062 (44%); M00162 (44%); M00869 (38%)
M08469,"Pauciarticular juvenile rheumatoid arthritis, unspecified knee",93,M00869 (42%); M00269 (42%); M00069 (42%); M00169 (42%); M00862 (37%)
M08471,"Pauciarticular juvenile rheumatoid arthritis, right ankle and foot",93,M00871 (51%); M00271 (51%); M00071 (50%); M00171 (50%); M00879 (45%)
M08472,"Pauciarticular juvenile rheumatoid arthritis, left ankle and foot",93,M00872 (51%); M00272 (51%); M00072 (50%); M00172 (50%); M00879 (45%)
M08479,"Pauciarticular juvenile rheumatoid arthritis, unspecified ankle and foot",93,M00879 (49%); M00279 (49%); M00079 (49%); M00179 (49%); M00872 (45%)
M0848,"Pauciarticular juvenile rheumatoid arthritis, vertebrae",93,M0088 (50%); M0028 (50%); M0008 (50%); M0018 (50%); M0238 (38%)
M084A,"Pauciarticular juvenile rheumatoid arthritis, other specified site",93,S0269XB (30%); S0269XA (29%); M868X8 (29%); M8788 (28%); C8580 (27%)
M0880,"Other juvenile arthritis, unspecified site",93,C8510 (45%); C6990 (42%); M8660 (42%); C8190 (42%); C8290 (42%)
M08811,"Other juvenile arthritis, right shoulder",93,M00811 (58%); M00211 (58%); M00011 (57%); M00111 (57%); M87811 (50%)
M08812,"Other juvenile arthritis, left shoulder",93,M00812 (58%); M00212 (58%); M00012 (57%); M00112 (57%); M87812 (50%)
M08819,"Other juvenile arthritis, unspecified shoulder",93,M00819 (56%); M00219 (56%); M00019 (55%); M00119 (55%); M00812 (49%)
M08821,"Other juvenile arthritis, right elbow",93,M00821 (59%); M00221 (59%); M00021 (59%); M00121 (59%); M00829 (50%)
M08822,"Other juvenile arthritis, left elbow",93,M00822 (59%); M00222 (59%); M00022 (59%); M00122 (59%); M00829 (50%)
M08829,"Other juvenile arthritis, unspecified elbow",93,M00829 (58%); M00229 (57%); M00029 (57%); M00129 (57%); M00822 (51%)
M08831,"Other juvenile arthritis, right wrist",93,M00831 (60%); M00231 (60%); M00031 (60%); M00131 (60%); M00839 (51%)
M08832,"Other juvenile arthritis, left wrist",93,M00832 (60%); M00232 (60%); M00032 (60%); M00132 (60%); M00839 (51%)
M08839,"Other juvenile arthritis, unspecified wrist",93,M00839 (58%); M00239 (58%); M00039 (58%); M00139 (58%); M00832 (52%)
M08841,"Other juvenile arthritis, right hand",93,M00841 (58%); M00241 (58%); M00041 (58%); M00141 (58%); M87841 (51%)
M08842,"Other juvenile arthritis, left hand",93,M00842 (58%); M00242 (58%); M00042 (58%); M00142 (58%); M87842 (51%)
M08849,"Other juvenile arthritis, unspecified hand",93,M00849 (57%); M00249 (56%); M00049 (56%); M00149 (56%); M00842 (49%)
M08851,"Other juvenile arthritis, right hip",93,M00851 (57%); M00251 (57%); M00051 (57%); M00151 (57%); M00859 (48%)
M08852,"Other juvenile arthritis, left hip",93,M00852 (57%); M00252 (57%); M00052 (57%); M00152 (57%); M00859 (48%)
M08859,"Other juvenile arthritis, unspecified hip",93,M00859 (55%); M00259 (55%); M00059 (55%); M00159 (55%); M00852 (48%)
M08861,"Other juvenile arthritis, right knee",93,M00861 (60%); M00261 (59%); M00061 (59%); M00161 (59%); M00869 (51%)
M08862,"Other juvenile arthritis, left knee",93,M00862 (60%); M00262 (59%); M00062 (59%); M00162 (59%); M00869 (51%)
M08869,"Other juvenile arthritis, unspecified knee",93,M00869 (58%); M00269 (58%); M00069 (57%); M00169 (57%); M00862 (51%)
M08871,"Other juvenile arthritis, right ankle and foot",93,M00871 (66%); M00271 (66%); M00071 (65%); M00171 (65%); M00879 (58%)
M08872,"Other juvenile arthritis, left ankle and foot",93,M00872 (66%); M00272 (66%); M00072 (65%); M00172 (65%); M00879 (58%)
M08879,"Other juvenile arthritis, unspecified ankle and foot",93,M00879 (64%); M00279 (64%); M00079 (64%); M00179 (64%); M00872 (58%)
M0888,"Other juvenile arthritis, other specified site",93,S0269XB (39%); S0269XA (39%); M868X8 (38%); M8788 (38%); C8580 (36%)
M0889,"Other juvenile arthritis, multiple sites",93,M868X0 (63%); M8789 (62%); M8669 (57%); M8619 (55%); M8739 (53%)
M0890,"Juvenile arthritis, unspecified, unspecified site",93,C8510 (52%); C6990 (50%); C8190 (49%); C8290 (49%); M8660 (45%)
M08911,"Juvenile arthritis, unspecified, right shoulder",93,M00811 (56%); M00211 (56%); M00011 (55%); M00111 (55%); M00819 (53%)
M08912,"Juvenile arthritis, unspecified, left shoulder",93,M00812 (56%); M00212 (56%); M00012 (55%); M00112 (55%); M00819 (53%)
M08919,"Juvenile arthritis, unspecified, unspecified shoulder",93,M00819 (56%); M00219 (56%); M00019 (56%); M00119 (56%); M87819 (50%)
M08921,"Juvenile arthritis, unspecified, right elbow",93,M00821 (58%); M00221 (57%); M00021 (57%); M00121 (57%); M00829 (54%)
M08922,"Juvenile arthritis, unspecified, left elbow",93,M00822 (58%); M00222 (57%); M00022 (57%); M00122 (57%); M00829 (54%)
M08929,"Juvenile arthritis, unspecified, unspecified elbow",93,M00829 (58%); M00229 (58%); M00029 (57%); M00129 (57%); M00822 (46%)
M08931,"Juvenile arthritis, unspecified, right wrist",93,M00831 (58%); M00231 (58%); M00031 (58%); M00131 (58%); M00839 (55%)
M08932,"Juvenile arthritis, unspecified, left wrist",93,M00832 (58%); M00232 (58%); M00032 (58%); M00132 (58%); M00839 (55%)
M08939,"Juvenile arthritis, unspecified, unspecified wrist",93,M00839 (59%); M00239 (59%); M00039 (58%); M00139 (58%); M00832 (47%)
M08941,"Juvenile arthritis, unspecified, right hand",93,M00841 (57%); M00241 (56%); M00041 (56%); M00141 (56%); M00849 (53%)
M08942,"Juvenile arthritis, unspecified, left hand",93,M00842 (57%); M00242 (56%); M00042 (56%); M00142 (56%); M00849 (53%)
M08949,"Juvenile arthritis, unspecified, unspecified hand",93,M00849 (57%); M00249 (57%); M00049 (57%); M00149 (57%); M87843 (51%)
M08951,"Juvenile arthritis, unspecified, right hip",93,M00851 (56%); M00251 (55%); M00051 (55%); M00151 (55%); M00859 (52%)
M08952,"Juvenile arthritis, unspecified, left hip",93,M00852 (56%); M00252 (55%); M00052 (55%); M00152 (55%); M00859 (52%)
M08959,"Juvenile arthritis, unspecified, unspecified hip",93,M00859 (56%); M00259 (56%); M00059 (56%); M00159 (56%); S73003A (45%)
M08961,"Juvenile arthritis, unspecified, right knee",93,M00861 (58%); M00261 (58%); M00061 (57%); M00161 (57%); M00869 (55%)
M08962,"Juvenile arthritis, unspecified, left knee",93,M00862 (58%); M00262 (58%); M00062 (57%); M00162 (57%); M00869 (55%)
M08969,"Juvenile arthritis, unspecified, unspecified knee",93,M00869 (58%); M00269 (58%); M00069 (58%); M00169 (58%); M00862 (46%)
M08971,"Juvenile arthritis, unspecified, right ankle and foot",93,M00871 (64%); M00271 (64%); M00071 (64%); M00171 (64%); M00879 (61%)
M08972,"Juvenile arthritis, unspecified, left ankle and foot",93,M00872 (64%); M00272 (64%); M00072 (64%); M00172 (64%); M00879 (62%)
M08979,"Juvenile arthritis, unspecified, unspecified ankle and foot",93,M00879 (64%); M00279 (64%); M00079 (64%); M00179 (64%); M86679 (57%)
M0898,"Juvenile arthritis, unspecified, vertebrae",93,M0088 (64%); M0028 (63%); M0008 (63%); M0018 (63%); M0238 (48%)
M0899,"Juvenile arthritis, unspecified, multiple sites",93,M868X0 (61%); M8789 (60%); M8669 (56%); M8619 (54%); M8739 (51%)
M089A,"Juvenile arthritis, unspecified, other specified site",93,C8510 (40%); C8580 (39%); S0269XB (38%); S0269XA (38%); C6990 (38%)
M1200,"Chronic postrheumatic arthropathy [Jaccoud], unspecified site",94,M0210 (46%); M8660 (41%); M8668 (37%); M8650 (32%); M029 (32%)
M12011,"Chronic postrheumatic arthropathy [Jaccoud], right shoulder",94,M02111 (48%); M86611 (43%); M02119 (42%); M02112 (41%); M86619 (36%)
M12012,"Chronic postrheumatic arthropathy [Jaccoud], left shoulder",94,M02112 (48%); M86612 (43%); M02119 (42%); M02111 (41%); M86619 (36%)
M12019,"Chronic postrheumatic arthropathy [Jaccoud], unspecified shoulder",94,M02119 (46%); M02112 (42%); M02111 (42%); M86619 (41%); M86612 (35%)
M12021,"Chronic postrheumatic arthropathy [Jaccoud], right elbow",94,M02121 (49%); M02129 (43%); M02122 (43%); M08821 (31%); M02151 (30%)
M12022,"Chronic postrheumatic arthropathy [Jaccoud], left elbow",94,M02122 (49%); M02129 (43%); M02121 (43%); M08822 (31%); M02152 (30%)
M12029,"Chronic postrheumatic arthropathy [Jaccoud], unspecified elbow",94,M02129 (47%); M02122 (43%); M02121 (43%); M029 (32%); M08929 (30%)
M12031,"Chronic postrheumatic arthropathy [Jaccoud], right wrist",94,M02131 (49%); M02139 (44%); M02132 (43%); M08831 (32%); M08931 (31%)
M12032,"Chronic postrheumatic arthropathy [Jaccoud], left wrist",94,M02132 (49%); M02139 (44%); M02131 (43%); M08832 (32%); M08932 (31%)
M12039,"Chronic postrheumatic arthropathy [Jaccoud], unspecified wrist",94,M02139 (48%); M02132 (44%); M02131 (44%); M029 (32%); M08939 (31%)
M12041,"Chronic postrheumatic arthropathy [Jaccoud], right hand",94,M02141 (48%); M86641 (43%); M02149 (43%); M02142 (42%); M86649 (37%)
M12042,"Chronic postrheumatic arthropathy [Jaccoud], left hand",94,M02142 (48%); M86642 (43%); M02149 (43%); M02141 (42%); M86649 (37%)
M12049,"Chronic postrheumatic arthropathy [Jaccoud], unspecified hand",94,M02149 (47%); M02142 (42%); M02141 (42%); M86649 (41%); M86642 (36%)
M12051,"Chronic postrheumatic arthropathy [Jaccoud], right hip",94,M02151 (47%); M02159 (42%); M02152 (41%); M02111 (30%); M02141 (30%)
M12052,"Chronic postrheumatic arthropathy [Jaccoud], left hip",94,M02152 (47%); M02159 (42%); M02151 (41%); M02112 (30%); M02142 (30%)
M12059,"Chronic postrheumatic arthropathy [Jaccoud], unspecified hip",94,M02159 (46%); M02152 (42%); M02151 (42%); M029 (32%); M0210 (28%)
M12061,"Chronic postrheumatic arthropathy [Jaccoud], right knee",94,M02161 (49%); M02169 (44%); M02162 (43%); M08861 (31%); M08961 (30%)
M12062,"Chronic postrheumatic arthropathy [Jaccoud], left knee",94,M02162 (49%); M02169 (44%); M02161 (43%); M08862 (31%); M08962 (30%)
M12069,"Chronic postrheumatic arthropathy [Jaccoud], unspecified knee",94,M02169 (48%); M02162 (43%); M02161 (43%); M029 (32%); M08969 (30%)
M12071,"Chronic postrheumatic arthropathy [Jaccoud], right ankle and foot",94,M02171 (54%); M86671 (50%); M02179 (49%); M02172 (48%); M86679 (45%)
M12072,"Chronic postrheumatic arthropathy [Jaccoud], left ankle and foot",94,M02172 (54%); M86672 (50%); M02179 (49%); M02171 (48%); M86679 (45%)
M12079,"Chronic postrheumatic arthropathy [Jaccoud], unspecified ankle and foot",94,M02179 (53%); M86679 (49%); M02172 (49%); M02171 (49%); M86672 (44%)
M1208,"Chronic postrheumatic arthropathy [Jaccoud], other specified site",94,M0210 (41%); E13618 (39%); M068A (39%); M8668 (36%); M0680 (35%)
M1209,"Chronic postrheumatic arthropathy [Jaccoud], multiple sites",94,M0219 (54%); M8669 (50%); M868X0 (43%); M8789 (43%); M8659 (42%)
M300,Polyarteritis nodosa,94,M301 (33%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
M301,Polyarteritis with lung involvement [Churg-Strauss],278,M302 (41%); M300 (33%); M3481 (27%); M3502 (25%); M308 (25%)
M302,Juvenile polyarteritis,94,M301 (41%); M08859 (31%); M0880 (31%); M08819 (31%); M08849 (30%)
M303,Mucocutaneous lymph node syndrome [Kawasaki],93,C779 (43%); E340 (16%); G839 (15%); G8382 (14%); G8383 (14%)
M308,Other conditions related to polyarteritis nodosa,94,M301 (25%); J688 (22%); J684 (22%); J683 (20%); J8409 (20%)
M310,Hypersensitivity angiitis,93,J678 (35%); J679 (35%); A0104 (0%); A0105 (0%); A021 (0%)
M3110,"Thrombotic microangiopathy, unspecified",112,M3111 (48%); G8330 (9%); L97909 (8%); G8190 (8%); C8510 (8%)
M3111,Hematopoietic stem cell transplantation-associated thrombotic microangiopathy [HSCT-TMA],454,M3119 (49%); M3110 (48%); C717 (23%); I613 (19%); C969 (17%)
M3119,Other thrombotic microangiopathy,112,M3111 (49%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
M312,Lethal midline granuloma,93,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
M3130,Wegener's granulomatosis without renal involvement,93,I823 (29%); N186 (29%); C659 (29%); C652 (28%); C651 (28%)
M3131,Wegener's granulomatosis with renal involvement,93,I823 (29%); N186 (29%); C659 (29%); C652 (28%); C651 (28%)
M314,Aortic arch syndrome [Takayasu],93,I71011 (58%); I7112 (52%); S12030B (28%); S12031B (28%); S12030A (28%)
M315,Giant cell arteritis with polymyalgia rheumatica,94,C8300 (16%); C8307 (16%); C8302 (14%); C8306 (14%); C8308 (14%)
M316,Other giant cell arteritis,94,C8300 (23%); C8307 (22%); C8302 (20%); C8306 (20%); C8308 (19%)
M317,Microscopic polyangiitis,94,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
M318,Other specified necrotizing vasculopathies,94,M726 (38%); P779 (36%); P771 (33%); P772 (33%); P773 (33%)
M319,"Necrotizing vasculopathy, unspecified",94,T86290 (45%); P779 (41%); M726 (41%); P771 (36%); P772 (36%)
M320,Drug-induced systemic lupus erythematosus,,
M3210,"Systemic lupus erythematosus, organ or system involvement unspecified",94,M3213 (84%); M3310 (39%); M3390 (38%); M3399 (38%); M3320 (37%)
M3211,Endocarditis in systemic lupus erythematosus,94,M3213 (67%); L104 (33%); M3489 (25%); M349 (25%); M3482 (21%)
M3212,Pericarditis in systemic lupus erythematosus,94,M3213 (67%); L104 (33%); M3489 (25%); M349 (25%); M3482 (21%)
M3213,Lung involvement in systemic lupus erythematosus,94,M3213 (100%); M3481 (54%); M3481 (54%); L104 (36%); M3502 (30%)
M3213,Lung involvement in systemic lupus erythematosus,280,M3213 (100%); M3219 (85%); M3210 (84%); M329 (83%); M328 (70%)
M3214,Glomerular disease in systemic lupus erythematosus,94,M3213 (65%); L104 (32%); M3489 (24%); M349 (24%); M3482 (20%)
M3214,Glomerular disease in systemic lupus erythematosus,,
M3215,Tubulo-interstitial nephropathy in systemic lupus erythematosus,94,M3213 (55%); E1021 (32%); E1121 (32%); E1321 (31%); E0821 (27%)
M3215,Tubulo-interstitial nephropathy in systemic lupus erythematosus,,
M3219,Other organ or system involvement in systemic lupus erythematosus,94,M3213 (85%); M3319 (37%); M3310 (36%); M3481 (36%); M3481 (36%)
M328,Other forms of systemic lupus erythematosus,94,M3213 (70%); B4489 (40%); B458 (40%); L104 (35%); I248 (32%)
M329,"Systemic lupus erythematosus, unspecified",94,M3213 (83%); L104 (41%); M349 (35%); M3489 (32%); M3482 (26%)
M3300,"Juvenile dermatomyositis, organ involvement unspecified",93,M3301 (74%); M3311 (62%); M3210 (35%); M3219 (33%); C689 (26%)
M3301,Juvenile dermatomyositis with respiratory involvement,93,M3301 (100%); M3311 (90%); M3321 (46%); M3391 (46%); R092 (31%)
M3301,Juvenile dermatomyositis with respiratory involvement,280,M3301 (100%); M3311 (90%); M3309 (75%); M3300 (74%); M3319 (63%)
M3302,Juvenile dermatomyositis with myopathy,93,M3301 (60%); M3311 (45%); G7129 (40%); G7120 (39%); G7121 (32%)
M3302,Juvenile dermatomyositis with myopathy,,
M3303,Juvenile dermatomyositis without myopathy,93,M3301 (60%); M3311 (45%); G7129 (40%); G7120 (39%); G7121 (32%)
M3309,Juvenile dermatomyositis with other organ involvement,93,M3301 (75%); M3311 (63%); M3219 (34%); M3210 (33%); C689 (23%)
M3310,"Other dermatomyositis, organ involvement unspecified",93,M3311 (68%); M3301 (62%); M3210 (39%); M3219 (36%); C689 (29%)
M3311,Other dermatomyositis with respiratory involvement,93,M3311 (100%); M3301 (90%); M3321 (51%); M3391 (51%); R092 (34%)
M3311,Other dermatomyositis with respiratory involvement,280,M3311 (100%); M3301 (90%); M3319 (69%); M3310 (68%); M3309 (63%)
M3312,Other dermatomyositis with myopathy,93,M3311 (51%); M3301 (46%); G7129 (45%); G7120 (44%); G7121 (36%)
M3312,Other dermatomyositis with myopathy,,
M3313,Other dermatomyositis without myopathy,93,M3311 (51%); M3301 (46%); G7129 (45%); G7120 (44%); G7121 (36%)
M3319,Other dermatomyositis with other organ involvement,93,M3311 (69%); M3301 (63%); M3219 (37%); M3210 (37%); C689 (26%)
M3320,"Polymyositis, organ involvement unspecified",93,M3321 (71%); M3210 (37%); M3219 (35%); C689 (28%); C7830 (27%)
M3321,Polymyositis with respiratory involvement,93,M3321 (100%); M3311 (51%); M3391 (48%); M3301 (46%); R092 (32%)
M3321,Polymyositis with respiratory involvement,280,M3321 (100%); M3329 (72%); M3320 (71%); M3322 (56%); M3311 (51%)
M3322,Polymyositis with myopathy,93,M3321 (56%); G7129 (43%); G7120 (42%); G7121 (34%); G71228 (34%)
M3322,Polymyositis with myopathy,,
M3329,Polymyositis with other organ involvement,93,M3321 (72%); M3219 (35%); M3210 (35%); C689 (24%); C7830 (24%)
M3390,"Dermatopolymyositis, unspecified, organ involvement unspecified",93,M3391 (72%); M3210 (38%); M3219 (33%); C689 (30%); C7830 (30%)
M3391,"Dermatopolymyositis, unspecified with respiratory involvement",93,M3391 (100%); M3311 (51%); M3321 (48%); M3301 (46%); R092 (32%)
M3391,"Dermatopolymyositis, unspecified with respiratory involvement",280,M3391 (100%); M3399 (73%); M3390 (72%); M3392 (57%); M3393 (57%)
M3392,"Dermatopolymyositis, unspecified with myopathy",93,M3391 (57%); G7120 (46%); G7129 (42%); G7121 (34%); G71228 (34%)
M3392,"Dermatopolymyositis, unspecified with myopathy",,
M3393,"Dermatopolymyositis, unspecified without myopathy",93,M3391 (57%); G7120 (46%); G7129 (42%); G7121 (34%); G71228 (34%)
M3399,"Dermatopolymyositis, unspecified with other organ involvement",93,M3391 (73%); M3210 (38%); M3219 (35%); C689 (28%); C7830 (28%)
M340,Progressive systemic sclerosis,93,M3481 (59%); G35 (45%); I673 (36%); A812 (36%); G1225 (35%)
M341,CR(E)ST syndrome,93,I213 (25%); I214 (25%); I2129 (24%); I228 (24%); I229 (24%)
M342,Systemic sclerosis induced by drug and chemical,,
M3481,Systemic sclerosis with lung involvement,93,M3481 (100%); M3213 (54%); M3213 (54%); G35 (45%); M3502 (37%)
M3481,Systemic sclerosis with lung involvement,278,M3481 (100%); M3489 (77%); M349 (74%); M3482 (63%); M3483 (62%)
M3482,Systemic sclerosis with myopathy,93,M3481 (63%); G35 (47%); G7129 (40%); G7120 (39%); Q851 (36%)
M3482,Systemic sclerosis with myopathy,,
M3483,Systemic sclerosis with polyneuropathy,93,M3481 (62%); G35 (47%); E1042 (39%); E1142 (39%); E1342 (37%)
M3483,Systemic sclerosis with polyneuropathy,,
M3489,Other systemic sclerosis,93,M3481 (77%); G35 (58%); Q851 (44%); G1223 (43%); G370 (39%)
M349,"Systemic sclerosis, unspecified",93,M3481 (74%); G35 (56%); Q851 (43%); G1223 (42%); C8110 (41%)
M3500,"Sjogren syndrome, unspecified",,
M3501,Sjogren syndrome with keratoconjunctivitis,,
M3502,Sjogren syndrome with lung involvement,280,M3481 (37%); M3481 (37%); M3213 (30%); M301 (25%); C7800 (24%)
M3502,Sjogren syndrome with lung involvement,,
M3503,Sjogren syndrome with myopathy,,
M3503,Sjogren syndrome with myopathy,,
M3504,Sjogren syndrome with tubulo-interstitial nephropathy,,
M3504,Sjogren syndrome with tubulo-interstitial nephropathy,,
M3505,Sjogren syndrome with inflammatory arthritis,,
M3506,Sjogren syndrome with peripheral nervous system involvement,,
M3506,Sjogren syndrome with peripheral nervous system involvement,,
M3507,Sjogren syndrome with central nervous system involvement,,
M3508,Sjogren syndrome with gastrointestinal involvement,,
M3509,Sjogren syndrome with other organ involvement,,
M350A,Sjogren syndrome with glomerular disease,,
M350A,Sjogren syndrome with glomerular disease,,
M350B,Sjogren syndrome with vasculitis,,
M350C,Sjogren syndrome with dental involvement,,
M351,Other overlap syndromes,,
M352,Behcet's disease,94,G959 (22%); I120 (21%); G20 (19%); G308 (19%); B259 (18%)
M353,Polymyalgia rheumatica,,
M355,Multifocal fibrosclerosis,,
M3581,Multisystem inflammatory syndrome,2,M064 (34%); K5140 (29%); K51418 (29%); K51419 (28%); K51413 (28%)
M3589,Other specified systemic involvement of connective tissue,,
M359,"Systemic involvement of connective tissue, unspecified",,
M360,Dermato(poly)myositis in neoplastic disease,93,M84553A (33%); M84552A (33%); M84551A (33%); M84559A (32%); G731 (29%)
M368,Systemic disorders of connective tissue in other diseases classified elsewhere,,
M450,Ankylosing spondylitis of multiple sites in spine,93,M4639 (42%); M868X0 (40%); M8789 (39%); M8669 (37%); M8619 (35%)
M451,Ankylosing spondylitis of occipito-atlanto-axial region,93,M4621 (74%); M4851XA (64%); M4631 (57%); M4622 (17%); M4624 (17%)
M452,Ankylosing spondylitis of cervical region,93,M4622 (41%); M4852XA (30%); M4632 (24%); M4624 (24%); M4626 (23%)
M453,Ankylosing spondylitis of cervicothoracic region,93,M4623 (56%); M4853XA (44%); M4633 (38%); M4622 (22%); M4624 (21%)
M454,Ankylosing spondylitis of thoracic region,93,M4624 (44%); M4854XA (32%); M4634 (27%); M4622 (24%); M4626 (23%)
M455,Ankylosing spondylitis of thoracolumbar region,93,M4625 (56%); M4855XA (44%); M4635 (38%); M4622 (22%); M4624 (21%)
M456,Ankylosing spondylitis lumbar region,93,M4626 (45%); M4856XA (33%); M4636 (27%); M4622 (24%); M4624 (23%)
M457,Ankylosing spondylitis of lumbosacral region,93,M4627 (55%); M4857XA (43%); M4637 (37%); S329XXB (25%); S329XXA (25%)
M458,Ankylosing spondylitis sacral and sacrococcygeal region,93,M4628 (66%); M4858XA (55%); M4638 (48%); L89152 (41%); L89153 (41%)
M459,Ankylosing spondylitis of unspecified sites in spine,93,M4639 (33%); P115 (31%); S329XXB (27%); S329XXA (27%); M868X9 (27%)
M45A0,Non-radiographic axial spondyloarthritis of unspecified sites in spine,93,M4639 (28%); P115 (27%); S329XXB (23%); S329XXA (23%); M868X9 (23%)
M45A1,Non-radiographic axial spondyloarthritis of occipito-atlanto-axial region,93,M4621 (74%); M4851XA (64%); M4631 (57%); C8385 (14%); C8595 (14%)
M45A2,Non-radiographic axial spondyloarthritis of cervical region,93,M4622 (34%); M4621 (33%); M4851XA (29%); M4631 (26%); M4852XA (24%)
M45A3,Non-radiographic axial spondyloarthritis of cervicothoracic region,93,M4623 (48%); M4853XA (38%); M4633 (32%); M4621 (30%); M4851XA (26%)
M45A4,Non-radiographic axial spondyloarthritis of thoracic region,93,M4624 (36%); M4621 (33%); M4851XA (28%); M4854XA (27%); M4631 (25%)
M45A5,Non-radiographic axial spondyloarthritis of thoracolumbar region,93,M4625 (48%); M4855XA (38%); M4635 (32%); M4621 (30%); M4851XA (26%)
M45A6,Non-radiographic axial spondyloarthritis of lumbar region,93,M4626 (37%); M4621 (33%); M4851XA (28%); M4856XA (27%); M4631 (25%)
M45A7,Non-radiographic axial spondyloarthritis of lumbosacral region,93,M4627 (47%); M4857XA (37%); M4637 (31%); M4621 (31%); M4851XA (27%)
M45A8,Non-radiographic axial spondyloarthritis of sacral and sacrococcygeal region,93,M4628 (58%); M4858XA (48%); M4638 (42%); L89152 (36%); L89153 (36%)
M45AB,Non-radiographic axial spondyloarthritis of multiple sites in spine,93,M4639 (36%); M868X0 (35%); M8789 (34%); C8388 (32%); M8669 (32%)
M4600,"Spinal enthesopathy, site unspecified",,
M4601,"Spinal enthesopathy, occipito-atlanto-axial region",,
M4602,"Spinal enthesopathy, cervical region",,
M4603,"Spinal enthesopathy, cervicothoracic region",,
M4604,"Spinal enthesopathy, thoracic region",,
M4605,"Spinal enthesopathy, thoracolumbar region",,
M4606,"Spinal enthesopathy, lumbar region",,
M4607,"Spinal enthesopathy, lumbosacral region",,
M4608,"Spinal enthesopathy, sacral and sacrococcygeal region",,
M4609,"Spinal enthesopathy, multiple sites in spine",,
M461,"Sacroiliitis, not elsewhere classified",,
M4620,"Osteomyelitis of vertebra, site unspecified",92,M4850XA (46%); C8510 (44%); M0890 (44%); C6990 (42%); C8190 (42%)
M4621,"Osteomyelitis of vertebra, occipito-atlanto-axial region",92,M4851XA (79%); M488X1 (78%); M451 (74%); M45A1 (74%); M45A2 (33%)
M4622,"Osteomyelitis of vertebra, cervical region",92,M4852XA (54%); M488X2 (46%); M452 (41%); M4854XA (38%); M4856XA (38%)
M4623,"Osteomyelitis of vertebra, cervicothoracic region",92,M4853XA (66%); M488X3 (62%); M453 (56%); M45A3 (48%); M4852XA (31%)
M4624,"Osteomyelitis of vertebra, thoracic region",92,M4854XA (56%); M488X4 (49%); S22018B (45%); S22038B (45%); S22018A (44%)
M4625,"Osteomyelitis of vertebra, thoracolumbar region",92,M4855XA (66%); M488X5 (62%); M455 (56%); M45A5 (48%); M4852XA (31%)
M4626,"Osteomyelitis of vertebra, lumbar region",92,M4856XA (57%); M488X6 (50%); S32018B (45%); S32038B (45%); S32018A (45%)
M4627,"Osteomyelitis of vertebra, lumbosacral region",92,M4857XA (65%); M488X7 (61%); M457 (55%); M45A7 (47%); M4852XA (32%)
M4628,"Osteomyelitis of vertebra, sacral and sacrococcygeal region",92,M4858XA (73%); M488X8 (71%); M458 (66%); M45A8 (58%); L89152 (48%)
M4630,"Infection of intervertebral disc (pyogenic), site unspecified",92,C8510 (24%); M0890 (24%); C6990 (23%); C8190 (23%); C8290 (23%)
M4631,"Infection of intervertebral disc (pyogenic), occipito-atlanto-axial region",92,M488X1 (60%); M451 (57%); M45A1 (57%); M4851XA (56%); M45A2 (26%)
M4632,"Infection of intervertebral disc (pyogenic), cervical region",92,M488X2 (27%); M452 (24%); M4852XA (23%); K9402 (22%); K9422 (22%)
M4633,"Infection of intervertebral disc (pyogenic), cervicothoracic region",92,M488X3 (41%); M453 (38%); M4853XA (37%); M45A3 (32%); K9402 (20%)
M4634,"Infection of intervertebral disc (pyogenic), thoracic region",92,M488X4 (30%); M454 (27%); M4854XA (26%); M45A4 (22%); K9402 (21%)
M4635,"Infection of intervertebral disc (pyogenic), thoracolumbar region",92,M488X5 (41%); M455 (38%); M4855XA (37%); M45A5 (32%); K9402 (20%)
M4636,"Infection of intervertebral disc (pyogenic), lumbar region",92,M488X6 (30%); M456 (27%); M4856XA (26%); M45A6 (23%); K9402 (21%)
M4637,"Infection of intervertebral disc (pyogenic), lumbosacral region",92,M488X7 (40%); M457 (37%); M4857XA (36%); M45A7 (31%); S329XXB (21%)
M4638,"Infection of intervertebral disc (pyogenic), sacral and sacrococcygeal region",92,M488X8 (51%); M458 (48%); M4858XA (47%); M45A8 (42%); L89152 (35%)
M4639,"Infection of intervertebral disc (pyogenic), multiple sites in spine",92,M450 (42%); M45AB (36%); M459 (33%); M0889 (30%); M0899 (29%)
M4650,"Other infective spondylopathies, site unspecified",,
M4651,"Other infective spondylopathies, occipito-atlanto-axial region",,
M4652,"Other infective spondylopathies, cervical region",,
M4653,"Other infective spondylopathies, cervicothoracic region",,
M4654,"Other infective spondylopathies, thoracic region",,
M4655,"Other infective spondylopathies, thoracolumbar region",,
M4656,"Other infective spondylopathies, lumbar region",,
M4657,"Other infective spondylopathies, lumbosacral region",,
M4658,"Other infective spondylopathies, sacral and sacrococcygeal region",,
M4659,"Other infective spondylopathies, multiple sites in spine",,
M4680,"Other specified inflammatory spondylopathies, site unspecified",,
M4681,"Other specified inflammatory spondylopathies, occipito-atlanto-axial region",,
M4682,"Other specified inflammatory spondylopathies, cervical region",,
M4683,"Other specified inflammatory spondylopathies, cervicothoracic region",,
M4684,"Other specified inflammatory spondylopathies, thoracic region",,
M4685,"Other specified inflammatory spondylopathies, thoracolumbar region",,
M4686,"Other specified inflammatory spondylopathies, lumbar region",,
M4687,"Other specified inflammatory spondylopathies, lumbosacral region",,
M4688,"Other specified inflammatory spondylopathies, sacral and sacrococcygeal region",,
M4689,"Other specified inflammatory spondylopathies, multiple sites in spine",,
M4690,"Unspecified inflammatory spondylopathy, site unspecified",,
M4691,"Unspecified inflammatory spondylopathy, occipito-atlanto-axial region",,
M4692,"Unspecified inflammatory spondylopathy, cervical region",,
M4693,"Unspecified inflammatory spondylopathy, cervicothoracic region",,
M4694,"Unspecified inflammatory spondylopathy, thoracic region",,
M4695,"Unspecified inflammatory spondylopathy, thoracolumbar region",,
M4696,"Unspecified inflammatory spondylopathy, lumbar region",,
M4697,"Unspecified inflammatory spondylopathy, lumbosacral region",,
M4698,"Unspecified inflammatory spondylopathy, sacral and sacrococcygeal region",,
M4699,"Unspecified inflammatory spondylopathy, multiple sites in spine",,
M4850XA,"Collapsed vertebra, not elsewhere classified, site unspecified, initial encounter for fracture",401,M4620 (46%); M9050 (42%); M9058 (39%); C8440 (38%); S0269XB (36%)
M4851XA,"Collapsed vertebra, not elsewhere classified, occipito-atlanto-axial region, initial encounter for fracture",401,M4621 (79%); M488X1 (68%); M451 (64%); M45A1 (64%); M4631 (56%)
M4852XA,"Collapsed vertebra, not elsewhere classified, cervical region, initial encounter for fracture",401,M4622 (54%); M4624 (37%); M4626 (37%); M488X2 (33%); M4627 (32%)
M4853XA,"Collapsed vertebra, not elsewhere classified, cervicothoracic region, initial encounter for fracture",401,M4623 (66%); M488X3 (49%); M453 (44%); M45A3 (38%); M4633 (37%)
M4854XA,"Collapsed vertebra, not elsewhere classified, thoracic region, initial encounter for fracture",401,M4624 (56%); M4622 (38%); M488X4 (36%); M4626 (36%); M454 (32%)
M4855XA,"Collapsed vertebra, not elsewhere classified, thoracolumbar region, initial encounter for fracture",401,M4625 (66%); M488X5 (49%); M455 (44%); M45A5 (38%); M4635 (37%)
M4856XA,"Collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture",401,M4626 (57%); M4622 (38%); M488X6 (37%); M4624 (36%); M456 (33%)
M4857XA,"Collapsed vertebra, not elsewhere classified, lumbosacral region, initial encounter for fracture",401,M4627 (65%); M488X7 (48%); M457 (43%); M45A7 (37%); S329XXB (36%)
M4858XA,"Collapsed vertebra, not elsewhere classified, sacral and sacrococcygeal region, initial encounter for fracture",401,M4628 (73%); M488X8 (59%); M458 (55%); M45A8 (48%); M4638 (47%)
M488X1,"Other specified spondylopathies, occipito-atlanto-axial region",93,M4621 (78%); M4851XA (68%); M4631 (60%); M4622 (18%); E1369 (18%)
M488X2,"Other specified spondylopathies, cervical region",93,M4622 (46%); M4852XA (33%); M4632 (27%); E1369 (27%); M4624 (27%)
M488X3,"Other specified spondylopathies, cervicothoracic region",93,M4623 (62%); M4853XA (49%); M4633 (41%); M4622 (24%); E1369 (23%)
M488X4,"Other specified spondylopathies, thoracic region",93,M4624 (49%); M4854XA (36%); M4634 (30%); M4622 (27%); E1369 (26%)
M488X5,"Other specified spondylopathies, thoracolumbar region",93,M4625 (62%); M4855XA (49%); M4635 (41%); M4622 (24%); E1369 (23%)
M488X6,"Other specified spondylopathies, lumbar region",93,M4626 (50%); M4856XA (37%); M4636 (30%); M4622 (27%); E1369 (26%)
M488X7,"Other specified spondylopathies, lumbosacral region",93,M4627 (61%); M4857XA (48%); M4637 (40%); S329XXB (28%); S329XXA (28%)
M488X8,"Other specified spondylopathies, sacral and sacrococcygeal region",93,M4628 (71%); M4858XA (59%); M4638 (51%); L89152 (44%); L89153 (44%)
M488X9,"Other specified spondylopathies, site unspecified",93,C8510 (36%); C8580 (36%); S0269XB (35%); S0269XA (34%); C6990 (34%)
M4980,"Spondylopathy in diseases classified elsewhere, site unspecified",,
M4981,"Spondylopathy in diseases classified elsewhere, occipito-atlanto-axial region",,
M4982,"Spondylopathy in diseases classified elsewhere, cervical region",,
M4983,"Spondylopathy in diseases classified elsewhere, cervicothoracic region",,
M4984,"Spondylopathy in diseases classified elsewhere, thoracic region",,
M4985,"Spondylopathy in diseases classified elsewhere, thoracolumbar region",,
M4986,"Spondylopathy in diseases classified elsewhere, lumbar region",,
M4987,"Spondylopathy in diseases classified elsewhere, lumbosacral region",,
M4988,"Spondylopathy in diseases classified elsewhere, sacral and sacrococcygeal region",,
M4989,"Spondylopathy in diseases classified elsewhere, multiple sites in spine",,
M726,Necrotizing fasciitis,92,M319 (41%); M318 (38%); P779 (38%); P771 (35%); P772 (35%)
M8000XA,"Age-related osteoporosis with current pathological fracture, unspecified site, initial encounter for fracture",,
M80011A,"Age-related osteoporosis with current pathological fracture, right shoulder, initial encounter for fracture",,
M80012A,"Age-related osteoporosis with current pathological fracture, left shoulder, initial encounter for fracture",,
M80019A,"Age-related osteoporosis with current pathological fracture, unspecified shoulder, initial encounter for fracture",,
M80021A,"Age-related osteoporosis with current pathological fracture, right humerus, initial encounter for fracture",,
M80022A,"Age-related osteoporosis with current pathological fracture, left humerus, initial encounter for fracture",,
M80029A,"Age-related osteoporosis with current pathological fracture, unspecified humerus, initial encounter for fracture",,
M80031A,"Age-related osteoporosis with current pathological fracture, right forearm, initial encounter for fracture",,
M80032A,"Age-related osteoporosis with current pathological fracture, left forearm, initial encounter for fracture",,
M80039A,"Age-related osteoporosis with current pathological fracture, unspecified forearm, initial encounter for fracture",,
M80041A,"Age-related osteoporosis with current pathological fracture, right hand, initial encounter for fracture",,
M80042A,"Age-related osteoporosis with current pathological fracture, left hand, initial encounter for fracture",,
M80049A,"Age-related osteoporosis with current pathological fracture, unspecified hand, initial encounter for fracture",,
M80051A,"Age-related osteoporosis with current pathological fracture, right femur, initial encounter for fracture",402,M8008XA (93%); M8088XA (76%); H353210 (33%); H353230 (30%); H353220 (30%)
M80052A,"Age-related osteoporosis with current pathological fracture, left femur, initial encounter for fracture",402,M8008XA (93%); M8088XA (76%); H353220 (33%); H353230 (30%); H353210 (30%)
M80059A,"Age-related osteoporosis with current pathological fracture, unspecified femur, initial encounter for fracture",402,M8008XA (93%); M8088XA (77%); H353290 (33%); H353230 (32%); H353220 (32%)
M80061A,"Age-related osteoporosis with current pathological fracture, right lower leg, initial encounter for fracture",,
M80062A,"Age-related osteoporosis with current pathological fracture, left lower leg, initial encounter for fracture",,
M80069A,"Age-related osteoporosis with current pathological fracture, unspecified lower leg, initial encounter for fracture",,
M80071A,"Age-related osteoporosis with current pathological fracture, right ankle and foot, initial encounter for fracture",,
M80072A,"Age-related osteoporosis with current pathological fracture, left ankle and foot, initial encounter for fracture",,
M80079A,"Age-related osteoporosis with current pathological fracture, unspecified ankle and foot, initial encounter for fracture",,
M8008XA,"Age-related osteoporosis with current pathological fracture, vertebra(e), initial encounter for fracture",401,M80059A (93%); M80052A (93%); M80051A (93%); M80859A (77%); M80852A (76%)
M800AXA,"Age-related osteoporosis with current pathological fracture, other site, initial encounter for fracture",,
M800B1A,"Age-related osteoporosis with current pathological fracture, right pelvis, initial encounter for fracture",,
M800B2A,"Age-related osteoporosis with current pathological fracture, left pelvis, initial encounter for fracture",,
M800B9A,"Age-related osteoporosis with current pathological fracture, unspecified pelvis, initial encounter for fracture",,
M8080XA,"Other osteoporosis with current pathological fracture, unspecified site, initial encounter for fracture",,
M80811A,"Other osteoporosis with current pathological fracture, right shoulder, initial encounter for fracture",,
M80812A,"Other osteoporosis with current pathological fracture, left shoulder, initial encounter for fracture",,
M80819A,"Other osteoporosis with current pathological fracture, unspecified shoulder, initial encounter for fracture",,
M80821A,"Other osteoporosis with current pathological fracture, right humerus, initial encounter for fracture",,
M80822A,"Other osteoporosis with current pathological fracture, left humerus, initial encounter for fracture",,
M80829A,"Other osteoporosis with current pathological fracture, unspecified humerus, initial encounter for fracture",,
M80831A,"Other osteoporosis with current pathological fracture, right forearm, initial encounter for fracture",,
M80832A,"Other osteoporosis with current pathological fracture, left forearm, initial encounter for fracture",,
M80839A,"Other osteoporosis with current pathological fracture, unspecified forearm, initial encounter for fracture",,
M80841A,"Other osteoporosis with current pathological fracture, right hand, initial encounter for fracture",,
M80842A,"Other osteoporosis with current pathological fracture, left hand, initial encounter for fracture",,
M80849A,"Other osteoporosis with current pathological fracture, unspecified hand, initial encounter for fracture",,
M80851A,"Other osteoporosis with current pathological fracture, right femur, initial encounter for fracture",402,M8088XA (90%); M8008XA (76%); S0211GB (32%); S0211GA (32%); S0240CB (32%)
M80852A,"Other osteoporosis with current pathological fracture, left femur, initial encounter for fracture",402,M8088XA (90%); M8008XA (76%); S0211HB (32%); S0211HA (32%); S0240DB (32%)
M80859A,"Other osteoporosis with current pathological fracture, unspecified femur, initial encounter for fracture",402,M8088XA (91%); M8008XA (77%); S02609B (34%); S02609A (33%); S22009B (33%)
M80861A,"Other osteoporosis with current pathological fracture, right lower leg, initial encounter for fracture",,
M80862A,"Other osteoporosis with current pathological fracture, left lower leg, initial encounter for fracture",,
M80869A,"Other osteoporosis with current pathological fracture, unspecified lower leg, initial encounter for fracture",,
M80871A,"Other osteoporosis with current pathological fracture, right ankle and foot, initial encounter for fracture",,
M80872A,"Other osteoporosis with current pathological fracture, left ankle and foot, initial encounter for fracture",,
M80879A,"Other osteoporosis with current pathological fracture, unspecified ankle and foot, initial encounter for fracture",,
M8088XA,"Other osteoporosis with current pathological fracture, vertebra(e), initial encounter for fracture",401,M80859A (91%); M80852A (90%); M80851A (90%); M80059A (77%); M80052A (76%)
M808AXA,"Other osteoporosis with current pathological fracture, other site, initial encounter for fracture",,
M808B1A,"Other osteoporosis with current pathological fracture, right pelvis, initial encounter for fracture",,
M808B2A,"Other osteoporosis with current pathological fracture, left pelvis, initial encounter for fracture",,
M808B9A,"Other osteoporosis with current pathological fracture, unspecified pelvis, initial encounter for fracture",,
M810,Age-related osteoporosis without current pathological fracture,,
M816,Localized osteoporosis [Lequesne],,
M818,Other osteoporosis without current pathological fracture,,
M830,Puerperal osteomalacia,,
M831,Senile osteomalacia,,
M832,Adult osteomalacia due to malabsorption,,
M833,Adult osteomalacia due to malnutrition,,
M834,Aluminum bone disease,,
M835,Other drug-induced osteomalacia in adults,,
M838,Other adult osteomalacia,,
M839,"Adult osteomalacia, unspecified",,
M8440XA,"Pathological fracture, unspecified site, initial encounter for fracture",,
M84411A,"Pathological fracture, right shoulder, initial encounter for fracture",,
M84412A,"Pathological fracture, left shoulder, initial encounter for fracture",,
M84419A,"Pathological fracture, unspecified shoulder, initial encounter for fracture",,
M84421A,"Pathological fracture, right humerus, initial encounter for fracture",,
M84422A,"Pathological fracture, left humerus, initial encounter for fracture",,
M84429A,"Pathological fracture, unspecified humerus, initial encounter for fracture",,
M84431A,"Pathological fracture, right ulna, initial encounter for fracture",,
M84432A,"Pathological fracture, left ulna, initial encounter for fracture",,
M84433A,"Pathological fracture, right radius, initial encounter for fracture",,
M84434A,"Pathological fracture, left radius, initial encounter for fracture",,
M84439A,"Pathological fracture, unspecified ulna and radius, initial encounter for fracture",,
M84441A,"Pathological fracture, right hand, initial encounter for fracture",,
M84442A,"Pathological fracture, left hand, initial encounter for fracture",,
M84443A,"Pathological fracture, unspecified hand, initial encounter for fracture",,
M84444A,"Pathological fracture, right finger(s), initial encounter for fracture",,
M84445A,"Pathological fracture, left finger(s), initial encounter for fracture",,
M84446A,"Pathological fracture, unspecified finger(s), initial encounter for fracture",,
M84451A,"Pathological fracture, right femur, initial encounter for fracture",402,M8088XA (59%); M8008XA (50%); S0211GB (44%); S0211GA (44%); S0240CB (44%)
M84452A,"Pathological fracture, left femur, initial encounter for fracture",402,M8088XA (59%); M8008XA (50%); S0211HB (44%); S0211HA (44%); S0240DB (44%)
M84453A,"Pathological fracture, unspecified femur, initial encounter for fracture",402,M8088XA (60%); M8008XA (50%); S02609B (47%); S02609A (47%); S22009B (46%)
M84454A,"Pathological fracture, pelvis, initial encounter for fracture",,
M84459A,"Pathological fracture, hip, unspecified, initial encounter for fracture",402,M8088XA (57%); M8008XA (48%); S02609B (45%); S02609A (45%); S22009B (44%)
M84461A,"Pathological fracture, right tibia, initial encounter for fracture",,
M84462A,"Pathological fracture, left tibia, initial encounter for fracture",,
M84463A,"Pathological fracture, right fibula, initial encounter for fracture",,
M84464A,"Pathological fracture, left fibula, initial encounter for fracture",,
M84469A,"Pathological fracture, unspecified tibia and fibula, initial encounter for fracture",,
M84471A,"Pathological fracture, right ankle, initial encounter for fracture",,
M84472A,"Pathological fracture, left ankle, initial encounter for fracture",,
M84473A,"Pathological fracture, unspecified ankle, initial encounter for fracture",,
M84474A,"Pathological fracture, right foot, initial encounter for fracture",,
M84475A,"Pathological fracture, left foot, initial encounter for fracture",,
M84476A,"Pathological fracture, unspecified foot, initial encounter for fracture",,
M84477A,"Pathological fracture, right toe(s), initial encounter for fracture",,
M84478A,"Pathological fracture, left toe(s), initial encounter for fracture",,
M84479A,"Pathological fracture, unspecified toe(s), initial encounter for fracture",,
M8448XA,"Pathological fracture, other site, initial encounter for fracture",,
M8450XA,"Pathological fracture in neoplastic disease, unspecified site, initial encounter for fracture",,
M84511A,"Pathological fracture in neoplastic disease, right shoulder, initial encounter for fracture",,
M84512A,"Pathological fracture in neoplastic disease, left shoulder, initial encounter for fracture",,
M84519A,"Pathological fracture in neoplastic disease, unspecified shoulder, initial encounter for fracture",,
M84521A,"Pathological fracture in neoplastic disease, right humerus, initial encounter for fracture",,
M84522A,"Pathological fracture in neoplastic disease, left humerus, initial encounter for fracture",,
M84529A,"Pathological fracture in neoplastic disease, unspecified humerus, initial encounter for fracture",,
M84531A,"Pathological fracture in neoplastic disease, right ulna, initial encounter for fracture",,
M84532A,"Pathological fracture in neoplastic disease, left ulna, initial encounter for fracture",,
M84533A,"Pathological fracture in neoplastic disease, right radius, initial encounter for fracture",,
M84534A,"Pathological fracture in neoplastic disease, left radius, initial encounter for fracture",,
M84539A,"Pathological fracture in neoplastic disease, unspecified ulna and radius, initial encounter for fracture",,
M84541A,"Pathological fracture in neoplastic disease, right hand, initial encounter for fracture",,
M84542A,"Pathological fracture in neoplastic disease, left hand, initial encounter for fracture",,
M84549A,"Pathological fracture in neoplastic disease, unspecified hand, initial encounter for fracture",,
M84550A,"Pathological fracture in neoplastic disease, pelvis, initial encounter for fracture",,
M84551A,"Pathological fracture in neoplastic disease, right femur, initial encounter for fracture",402,M8088XA (45%); M8008XA (38%); G731 (37%); S0211GB (33%); S0211GA (33%)
M84552A,"Pathological fracture in neoplastic disease, left femur, initial encounter for fracture",402,M8088XA (45%); M8008XA (38%); G731 (37%); S0211HB (33%); S0211HA (33%)
M84553A,"Pathological fracture in neoplastic disease, unspecified femur, initial encounter for fracture",402,M8088XA (45%); M8008XA (38%); G731 (37%); S02609B (35%); S02609A (35%)
M84559A,"Pathological fracture in neoplastic disease, hip, unspecified, initial encounter for fracture",402,M8088XA (44%); M8008XA (37%); G731 (36%); S02609B (35%); S02609A (34%)
M84561A,"Pathological fracture in neoplastic disease, right tibia, initial encounter for fracture",,
M84562A,"Pathological fracture in neoplastic disease, left tibia, initial encounter for fracture",,
M84563A,"Pathological fracture in neoplastic disease, right fibula, initial encounter for fracture",,
M84564A,"Pathological fracture in neoplastic disease, left fibula, initial encounter for fracture",,
M84569A,"Pathological fracture in neoplastic disease, unspecified tibia and fibula, initial encounter for fracture",,
M84571A,"Pathological fracture in neoplastic disease, right ankle, initial encounter for fracture",,
M84572A,"Pathological fracture in neoplastic disease, left ankle, initial encounter for fracture",,
M84573A,"Pathological fracture in neoplastic disease, unspecified ankle, initial encounter for fracture",,
M84574A,"Pathological fracture in neoplastic disease, right foot, initial encounter for fracture",,
M84575A,"Pathological fracture in neoplastic disease, left foot, initial encounter for fracture",,
M84576A,"Pathological fracture in neoplastic disease, unspecified foot, initial encounter for fracture",,
M8458XA,"Pathological fracture in neoplastic disease, other specified site, initial encounter for fracture",,
M8460XA,"Pathological fracture in other disease, unspecified site, initial encounter for fracture",,
M84611A,"Pathological fracture in other disease, right shoulder, initial encounter for fracture",,
M84612A,"Pathological fracture in other disease, left shoulder, initial encounter for fracture",,
M84619A,"Pathological fracture in other disease, unspecified shoulder, initial encounter for fracture",,
M84621A,"Pathological fracture in other disease, right humerus, initial encounter for fracture",,
M84622A,"Pathological fracture in other disease, left humerus, initial encounter for fracture",,
M84629A,"Pathological fracture in other disease, unspecified humerus, initial encounter for fracture",,
M84631A,"Pathological fracture in other disease, right ulna, initial encounter for fracture",,
M84632A,"Pathological fracture in other disease, left ulna, initial encounter for fracture",,
M84633A,"Pathological fracture in other disease, right radius, initial encounter for fracture",,
M84634A,"Pathological fracture in other disease, left radius, initial encounter for fracture",,
M84639A,"Pathological fracture in other disease, unspecified ulna and radius, initial encounter for fracture",,
M84641A,"Pathological fracture in other disease, right hand, initial encounter for fracture",,
M84642A,"Pathological fracture in other disease, left hand, initial encounter for fracture",,
M84649A,"Pathological fracture in other disease, unspecified hand, initial encounter for fracture",,
M84650A,"Pathological fracture in other disease, pelvis, initial encounter for fracture",,
M84651A,"Pathological fracture in other disease, right femur, initial encounter for fracture",402,M8088XA (55%); M8008XA (46%); S0211GB (41%); S0211GA (40%); S0240CB (40%)
M84652A,"Pathological fracture in other disease, left femur, initial encounter for fracture",402,M8088XA (55%); M8008XA (46%); S0211HB (41%); S0211HA (40%); S0240DB (40%)
M84653A,"Pathological fracture in other disease, unspecified femur, initial encounter for fracture",402,M8088XA (55%); M8008XA (47%); S02609B (43%); S02609A (43%); S22009B (43%)
M84659A,"Pathological fracture in other disease, hip, unspecified, initial encounter for fracture",402,M8088XA (53%); M8008XA (45%); S02609B (42%); S02609A (41%); S22009B (41%)
M84661A,"Pathological fracture in other disease, right tibia, initial encounter for fracture",,
M84662A,"Pathological fracture in other disease, left tibia, initial encounter for fracture",,
M84663A,"Pathological fracture in other disease, right fibula, initial encounter for fracture",,
M84664A,"Pathological fracture in other disease, left fibula, initial encounter for fracture",,
M84669A,"Pathological fracture in other disease, unspecified tibia and fibula, initial encounter for fracture",,
M84671A,"Pathological fracture in other disease, right ankle, initial encounter for fracture",,
M84672A,"Pathological fracture in other disease, left ankle, initial encounter for fracture",,
M84673A,"Pathological fracture in other disease, unspecified ankle, initial encounter for fracture",,
M84674A,"Pathological fracture in other disease, right foot, initial encounter for fracture",,
M84675A,"Pathological fracture in other disease, left foot, initial encounter for fracture",,
M84676A,"Pathological fracture in other disease, unspecified foot, initial encounter for fracture",,
M8468XA,"Pathological fracture in other disease, other site, initial encounter for fracture",,
M84754A,"Complete transverse atypical femoral fracture, right leg, initial encounter for fracture",402,S88911A (34%); S88011A (31%); I82511 (31%); S0211GB (30%); I82411 (30%)
M84755A,"Complete transverse atypical femoral fracture, left leg, initial encounter for fracture",402,S88912A (34%); S88012A (31%); I82512 (31%); S0211HB (30%); I82412 (30%)
M84756A,"Complete transverse atypical femoral fracture, unspecified leg, initial encounter for fracture",402,S88919A (34%); S02609B (32%); S88912A (32%); S88911A (32%); S02609A (32%)
M84757A,"Complete oblique atypical femoral fracture, right leg, initial encounter for fracture",402,S88911A (33%); S88011A (30%); I82511 (30%); S0211GB (30%); I82411 (29%)
M84758A,"Complete oblique atypical femoral fracture, left leg, initial encounter for fracture",402,S88912A (33%); S88012A (30%); I82512 (30%); S0211HB (30%); I82412 (29%)
M84759A,"Complete oblique atypical femoral fracture, unspecified leg, initial encounter for fracture",402,S88919A (33%); S02609B (31%); S88912A (31%); S88911A (31%); S02609A (31%)
M8600,"Acute hematogenous osteomyelitis, unspecified site",92,C8510 (35%); M0890 (35%); K271 (35%); C6990 (34%); C8190 (33%)
M86011,"Acute hematogenous osteomyelitis, right shoulder",92,M08811 (36%); M08911 (35%); M06811 (33%); M08011 (31%); M06211 (31%)
M86012,"Acute hematogenous osteomyelitis, left shoulder",92,M08812 (36%); M08912 (34%); M06812 (33%); M08012 (31%); M06212 (31%)
M86019,"Acute hematogenous osteomyelitis, unspecified shoulder",92,M08919 (35%); M08819 (33%); M08019 (32%); M08912 (31%); M08911 (31%)
M86021,"Acute hematogenous osteomyelitis, right humerus",92,I50811 (26%); I50813 (24%); I82411 (21%); J810 (21%); I82A11 (21%)
M86022,"Acute hematogenous osteomyelitis, left humerus",92,I82412 (21%); J810 (21%); I82A12 (20%); I82422 (20%); I82432 (20%)
M86029,"Acute hematogenous osteomyelitis, unspecified humerus",92,I219 (23%); C9501 (21%); J810 (21%); C9502 (20%); I249 (19%)
M86031,"Acute hematogenous osteomyelitis, right radius and ulna",92,I50811 (23%); I50813 (21%); I82411 (18%); J810 (18%); I82A11 (18%)
M86032,"Acute hematogenous osteomyelitis, left radius and ulna",92,I82412 (18%); J810 (18%); I82A12 (18%); I82422 (18%); I82432 (18%)
M86039,"Acute hematogenous osteomyelitis, unspecified radius and ulna",92,I219 (20%); C9501 (18%); J810 (18%); C9502 (17%); I249 (17%)
M86041,"Acute hematogenous osteomyelitis, right hand",92,M08841 (37%); M08941 (36%); M06841 (34%); M08041 (32%); M06241 (32%)
M86042,"Acute hematogenous osteomyelitis, left hand",92,M08842 (37%); M08942 (35%); M06842 (34%); M08042 (32%); M06242 (32%)
M86049,"Acute hematogenous osteomyelitis, unspecified hand",92,M08949 (36%); M08849 (34%); M08049 (33%); M08942 (32%); M08941 (32%)
M86051,"Acute hematogenous osteomyelitis, right femur",92,I50811 (30%); I50813 (28%); S728X1A (24%); I82411 (23%); J810 (23%)
M86052,"Acute hematogenous osteomyelitis, left femur",92,S728X2A (24%); I82412 (23%); J810 (23%); I82A12 (23%); S7292XA (23%)
M86059,"Acute hematogenous osteomyelitis, unspecified femur",92,I219 (26%); S7290XA (24%); C9501 (24%); J810 (24%); C9502 (23%)
M86061,"Acute hematogenous osteomyelitis, right tibia and fibula",92,I50811 (23%); I50813 (21%); I82411 (18%); J810 (18%); I82A11 (18%)
M86062,"Acute hematogenous osteomyelitis, left tibia and fibula",92,I82412 (18%); J810 (18%); I82A12 (18%); I82422 (18%); I82432 (18%)
M86069,"Acute hematogenous osteomyelitis, unspecified tibia and fibula",92,I219 (20%); C9501 (18%); J810 (18%); C9502 (17%); I249 (17%)
M86071,"Acute hematogenous osteomyelitis, right ankle and foot",92,M08871 (47%); M08971 (46%); M06871 (44%); M08071 (42%); M06271 (42%)
M86072,"Acute hematogenous osteomyelitis, left ankle and foot",92,M08872 (47%); M08972 (46%); M06872 (44%); M08072 (42%); M06272 (42%)
M86079,"Acute hematogenous osteomyelitis, unspecified ankle and foot",92,M08979 (46%); M08879 (45%); M08972 (43%); M08971 (43%); M06879 (43%)
M8608,"Acute hematogenous osteomyelitis, other sites",92,J810 (23%); C457 (23%); Q018 (23%); M0889 (23%); C7989 (22%)
M8609,"Acute hematogenous osteomyelitis, multiple sites",92,M0889 (47%); M0899 (46%); M0689 (44%); M0809 (42%); M0629 (42%)
M8610,"Other acute osteomyelitis, unspecified site",92,C8510 (43%); M0890 (43%); K271 (43%); C6990 (41%); C8190 (41%)
M86111,"Other acute osteomyelitis, right shoulder",92,M08811 (44%); M08911 (42%); M06811 (41%); M08011 (38%); M06211 (38%)
M86112,"Other acute osteomyelitis, left shoulder",92,M08812 (44%); M08912 (42%); M06812 (41%); M08012 (38%); M06212 (38%)
M86119,"Other acute osteomyelitis, unspecified shoulder",92,M08919 (43%); M08819 (41%); M08019 (39%); M08912 (38%); M08911 (38%)
M86121,"Other acute osteomyelitis, right humerus",92,I50811 (31%); I50813 (29%); I82411 (25%); J810 (24%); I82A11 (24%)
M86122,"Other acute osteomyelitis, left humerus",92,I82412 (25%); J810 (24%); I82A12 (24%); I82422 (24%); I82432 (24%)
M86129,"Other acute osteomyelitis, unspecified humerus",92,I219 (28%); C9501 (25%); J810 (25%); C9502 (24%); I249 (23%)
M86131,"Other acute osteomyelitis, right radius and ulna",92,I50811 (26%); I50813 (24%); I82411 (20%); J810 (20%); I82A11 (20%)
M86132,"Other acute osteomyelitis, left radius and ulna",92,I82412 (20%); J810 (20%); I82A12 (20%); I82422 (20%); I82432 (20%)
M86139,"Other acute osteomyelitis, unspecified radius and ulna",92,I219 (23%); C9501 (21%); J810 (21%); C9502 (20%); I249 (19%)
M86141,"Other acute osteomyelitis, right hand",92,M08841 (45%); M08941 (43%); M06841 (42%); M08041 (39%); M06241 (39%)
M86142,"Other acute osteomyelitis, left hand",92,M08842 (45%); M08942 (43%); M06842 (42%); M08042 (39%); M06242 (39%)
M86149,"Other acute osteomyelitis, unspecified hand",92,M08949 (44%); M08849 (42%); M08049 (40%); M08942 (40%); M08941 (39%)
M86151,"Other acute osteomyelitis, right femur",92,I50811 (37%); I50813 (35%); S728X1A (30%); I82411 (29%); J810 (29%)
M86152,"Other acute osteomyelitis, left femur",92,S728X2A (30%); I82412 (29%); J810 (29%); I82A12 (29%); S7292XA (29%)
M86159,"Other acute osteomyelitis, unspecified femur",92,I219 (33%); S7290XA (30%); C9501 (30%); J810 (30%); C9502 (29%)
M86161,"Other acute osteomyelitis, right tibia and fibula",92,I50811 (26%); I50813 (24%); I82411 (20%); J810 (20%); I82A11 (20%)
M86162,"Other acute osteomyelitis, left tibia and fibula",92,I82412 (20%); J810 (20%); I82A12 (20%); I82422 (20%); I82432 (20%)
M86169,"Other acute osteomyelitis, unspecified tibia and fibula",92,I219 (23%); C9501 (21%); J810 (21%); C9502 (20%); I249 (19%)
M86171,"Other acute osteomyelitis, right ankle and foot",92,M08871 (55%); M08971 (54%); M06871 (52%); M08071 (50%); M06271 (49%)
M86172,"Other acute osteomyelitis, left ankle and foot",92,M08872 (55%); M08972 (54%); M06872 (52%); M08072 (50%); M06272 (49%)
M86179,"Other acute osteomyelitis, unspecified ankle and foot",92,M08979 (54%); M08879 (53%); M08972 (51%); M08971 (51%); M06879 (51%)
M8618,"Other acute osteomyelitis, other site",92,K271 (40%); K272 (38%); M0880 (35%); C8170 (33%); M0680 (32%)
M8619,"Other acute osteomyelitis, multiple sites",92,M0889 (55%); M0899 (54%); M0689 (52%); M0809 (50%); M0629 (49%)
M8620,"Subacute osteomyelitis, unspecified site",92,C8510 (38%); M0890 (38%); C6990 (36%); I6202 (36%); C8190 (36%)
M86211,"Subacute osteomyelitis, right shoulder",92,M08811 (38%); M08911 (37%); M06811 (36%); I6202 (35%); M08011 (34%)
M86212,"Subacute osteomyelitis, left shoulder",92,M08812 (38%); M08912 (37%); M06812 (36%); I6202 (35%); M08012 (34%)
M86219,"Subacute osteomyelitis, unspecified shoulder",92,M08919 (38%); I6202 (36%); M08819 (36%); M08019 (34%); M08912 (34%)
M86221,"Subacute osteomyelitis, right humerus",92,I6202 (33%); A811 (28%); G320 (26%); G374 (25%); G361 (22%)
M86222,"Subacute osteomyelitis, left humerus",92,I6202 (33%); A811 (28%); G320 (26%); G374 (25%); G361 (22%)
M86229,"Subacute osteomyelitis, unspecified humerus",92,I6202 (33%); A811 (28%); G320 (27%); G374 (25%); G361 (22%)
M86231,"Subacute osteomyelitis, right radius and ulna",92,I6202 (28%); A811 (24%); G320 (22%); G374 (21%); G361 (19%)
M86232,"Subacute osteomyelitis, left radius and ulna",92,I6202 (28%); A811 (24%); G320 (22%); G374 (21%); G361 (19%)
M86239,"Subacute osteomyelitis, unspecified radius and ulna",92,I6202 (28%); A811 (24%); G320 (23%); G374 (22%); G361 (19%)
M86241,"Subacute osteomyelitis, right hand",92,M08841 (39%); M08941 (38%); M06841 (37%); I6202 (35%); M08041 (35%)
M86242,"Subacute osteomyelitis, left hand",92,M08842 (39%); M08942 (38%); M06842 (37%); I6202 (35%); M08042 (35%)
M86249,"Subacute osteomyelitis, unspecified hand",92,M08949 (39%); M08849 (37%); I6202 (36%); M08049 (35%); M08942 (35%)
M86251,"Subacute osteomyelitis, right femur",92,I6202 (37%); A811 (32%); G320 (30%); G374 (29%); S728X1A (26%)
M86252,"Subacute osteomyelitis, left femur",92,I6202 (37%); A811 (32%); G320 (30%); G374 (29%); S728X2A (26%)
M86259,"Subacute osteomyelitis, unspecified femur",92,I6202 (38%); A811 (33%); G320 (31%); G374 (30%); S7290XA (26%)
M86261,"Subacute osteomyelitis, right tibia and fibula",92,I6202 (28%); A811 (24%); G320 (22%); G374 (21%); G361 (19%)
M86262,"Subacute osteomyelitis, left tibia and fibula",92,I6202 (28%); A811 (24%); G320 (22%); G374 (21%); G361 (19%)
M86269,"Subacute osteomyelitis, unspecified tibia and fibula",92,I6202 (28%); A811 (24%); G320 (23%); G374 (22%); G361 (19%)
M86271,"Subacute osteomyelitis, right ankle and foot",92,M08871 (50%); M08971 (48%); M06871 (47%); M08071 (45%); M06271 (45%)
M86272,"Subacute osteomyelitis, left ankle and foot",92,M08872 (50%); M08972 (48%); M06872 (47%); M08072 (45%); M06272 (45%)
M86279,"Subacute osteomyelitis, unspecified ankle and foot",92,M08979 (49%); M08879 (48%); M08972 (46%); M08971 (46%); M06879 (45%)
M8628,"Subacute osteomyelitis, other site",92,I6202 (37%); A811 (32%); M0880 (30%); G320 (30%); G374 (29%)
M8629,"Subacute osteomyelitis, multiple sites",92,M0889 (50%); M0899 (48%); M0689 (47%); M0809 (45%); M0629 (45%)
M8630,"Chronic multifocal osteomyelitis, unspecified site",92,C8510 (35%); M0890 (35%); C6990 (34%); G6182 (34%); C8190 (33%)
M86311,"Chronic multifocal osteomyelitis, right shoulder",92,M08811 (36%); M08911 (35%); M06811 (34%); M12011 (33%); G6182 (33%)
M86312,"Chronic multifocal osteomyelitis, left shoulder",92,M08812 (36%); M08912 (35%); M06812 (34%); M12012 (33%); G6182 (33%)
M86319,"Chronic multifocal osteomyelitis, unspecified shoulder",92,M08919 (35%); G6182 (34%); M08819 (33%); M08019 (32%); A812 (32%)
M86321,"Chronic multifocal osteomyelitis, right humerus",92,G6182 (31%); A812 (29%); C965 (22%); I50812 (21%); C960 (20%)
M86322,"Chronic multifocal osteomyelitis, left humerus",92,G6182 (31%); A812 (29%); C965 (22%); C960 (20%); L97329 (17%)
M86329,"Chronic multifocal osteomyelitis, unspecified humerus",92,G6182 (31%); A812 (29%); C965 (22%); C960 (20%); K739 (20%)
M86331,"Chronic multifocal osteomyelitis, right radius and ulna",92,G6182 (27%); A812 (25%); C965 (19%); I50812 (18%); C960 (17%)
M86332,"Chronic multifocal osteomyelitis, left radius and ulna",92,G6182 (27%); A812 (25%); C965 (19%); C960 (17%); L97329 (14%)
M86339,"Chronic multifocal osteomyelitis, unspecified radius and ulna",92,G6182 (27%); A812 (25%); C965 (19%); C960 (18%); K739 (17%)
M86341,"Chronic multifocal osteomyelitis, right hand",92,M08841 (37%); M08941 (36%); M06841 (35%); M12041 (34%); G6182 (33%)
M86342,"Chronic multifocal osteomyelitis, left hand",92,M08842 (37%); M08942 (36%); M06842 (34%); M12042 (34%); G6182 (33%)
M86349,"Chronic multifocal osteomyelitis, unspecified hand",92,M08949 (36%); M08849 (34%); G6182 (33%); M08049 (33%); M08942 (32%)
M86351,"Chronic multifocal osteomyelitis, right femur",92,G6182 (35%); A812 (33%); C965 (25%); S728X1A (24%); I50812 (24%)
M86352,"Chronic multifocal osteomyelitis, left femur",92,G6182 (35%); A812 (33%); C965 (25%); S728X2A (24%); S7292XA (23%)
M86359,"Chronic multifocal osteomyelitis, unspecified femur",92,G6182 (35%); A812 (33%); C965 (25%); S7290XA (24%); C960 (23%)
M86361,"Chronic multifocal osteomyelitis, right tibia and fibula",92,G6182 (27%); A812 (25%); C965 (19%); I50812 (18%); C960 (17%)
M86362,"Chronic multifocal osteomyelitis, left tibia and fibula",92,G6182 (27%); A812 (25%); C965 (19%); C960 (17%); L97329 (14%)
M86369,"Chronic multifocal osteomyelitis, unspecified tibia and fibula",92,G6182 (27%); A812 (25%); C965 (19%); C960 (18%); K739 (17%)
M86371,"Chronic multifocal osteomyelitis, right ankle and foot",92,M08871 (47%); M08971 (46%); M06871 (44%); M08071 (42%); M06271 (42%)
M86372,"Chronic multifocal osteomyelitis, left ankle and foot",92,M08872 (47%); M08972 (46%); M06872 (44%); M08072 (42%); M06272 (42%)
M86379,"Chronic multifocal osteomyelitis, unspecified ankle and foot",92,M08979 (46%); M08879 (45%); M08972 (43%); M08971 (43%); M06879 (43%)
M8638,"Chronic multifocal osteomyelitis, other site",92,G6182 (34%); A812 (32%); M1200 (28%); M0880 (28%); M1208 (27%)
M8639,"Chronic multifocal osteomyelitis, multiple sites",92,M0889 (47%); M0899 (46%); M0689 (45%); M0809 (42%); M0629 (42%)
M8640,"Chronic osteomyelitis with draining sinus, unspecified site",92,C319 (31%); C8510 (30%); M0890 (29%); C310 (29%); C6990 (28%)
M86411,"Chronic osteomyelitis with draining sinus, right shoulder",92,M08811 (30%); M08911 (29%); C310 (29%); M06811 (28%); M12011 (28%)
M86412,"Chronic osteomyelitis with draining sinus, left shoulder",92,M08812 (30%); M08912 (29%); C310 (29%); M06812 (28%); M12012 (28%)
M86419,"Chronic osteomyelitis with draining sinus, unspecified shoulder",92,C319 (31%); M08919 (30%); C310 (29%); C312 (28%); M08819 (28%)
M86421,"Chronic osteomyelitis with draining sinus, right humerus",92,C310 (27%); C312 (26%); C319 (26%); I495 (26%); C12 (25%)
M86422,"Chronic osteomyelitis with draining sinus, left humerus",92,C310 (27%); C312 (26%); C319 (26%); I495 (26%); C12 (25%)
M86429,"Chronic osteomyelitis with draining sinus, unspecified humerus",92,C319 (29%); C310 (28%); C312 (27%); I495 (26%); C12 (25%)
M86431,"Chronic osteomyelitis with draining sinus, right radius and ulna",92,C310 (25%); C312 (24%); C319 (23%); I495 (23%); C12 (23%)
M86432,"Chronic osteomyelitis with draining sinus, left radius and ulna",92,C310 (25%); C312 (24%); C319 (23%); I495 (23%); C12 (23%)
M86439,"Chronic osteomyelitis with draining sinus, unspecified radius and ulna",92,C319 (26%); C310 (25%); C312 (24%); I495 (23%); C12 (23%)
M86441,"Chronic osteomyelitis with draining sinus, right hand",92,M08841 (31%); M08941 (30%); M06841 (29%); M12041 (29%); C310 (29%)
M86442,"Chronic osteomyelitis with draining sinus, left hand",92,M08842 (31%); M08942 (30%); M06842 (29%); M12042 (29%); C310 (29%)
M86449,"Chronic osteomyelitis with draining sinus, unspecified hand",92,C319 (31%); M08949 (30%); C310 (29%); M08849 (29%); C312 (28%)
M86451,"Chronic osteomyelitis with draining sinus, right femur",92,C310 (30%); C312 (29%); C319 (28%); I495 (28%); C12 (27%)
M86452,"Chronic osteomyelitis with draining sinus, left femur",92,C310 (30%); C312 (29%); C319 (28%); I495 (28%); C12 (27%)
M86459,"Chronic osteomyelitis with draining sinus, unspecified femur",92,C319 (32%); C310 (30%); C312 (29%); I495 (28%); C12 (28%)
M86461,"Chronic osteomyelitis with draining sinus, right tibia and fibula",92,C310 (25%); C312 (24%); C319 (23%); I495 (23%); C12 (23%)
M86462,"Chronic osteomyelitis with draining sinus, left tibia and fibula",92,C310 (25%); C312 (24%); C319 (23%); I495 (23%); C12 (23%)
M86469,"Chronic osteomyelitis with draining sinus, unspecified tibia and fibula",92,C319 (26%); C310 (25%); C312 (24%); I495 (23%); C12 (23%)
M86471,"Chronic osteomyelitis with draining sinus, right ankle and foot",92,M08871 (40%); M08971 (39%); M06871 (38%); M08071 (36%); M06271 (36%)
M86472,"Chronic osteomyelitis with draining sinus, left ankle and foot",92,M08872 (40%); M08972 (39%); M06872 (38%); M08072 (36%); M06272 (36%)
M86479,"Chronic osteomyelitis with draining sinus, unspecified ankle and foot",92,M08979 (39%); M08879 (39%); M08972 (37%); M08971 (37%); M06879 (37%)
M8648,"Chronic osteomyelitis with draining sinus, other site",92,C310 (30%); C312 (28%); C319 (28%); I495 (28%); C12 (27%)
M8649,"Chronic osteomyelitis with draining sinus, multiple sites",92,M0889 (40%); M0899 (39%); M0689 (38%); M0809 (36%); M0629 (36%)
M8650,"Other chronic hematogenous osteomyelitis, unspecified site",92,C8510 (36%); M0890 (36%); C6990 (35%); C8190 (34%); C8290 (34%)
M86511,"Other chronic hematogenous osteomyelitis, right shoulder",92,M08811 (37%); M08911 (36%); M06811 (35%); M12011 (34%); M08011 (32%)
M86512,"Other chronic hematogenous osteomyelitis, left shoulder",92,M08812 (37%); M08912 (36%); M06812 (35%); M12012 (34%); M08012 (32%)
M86519,"Other chronic hematogenous osteomyelitis, unspecified shoulder",92,M08919 (36%); M08819 (34%); M08019 (33%); M12019 (33%); M08912 (32%)
M86521,"Other chronic hematogenous osteomyelitis, right humerus",92,I50812 (21%); I50813 (19%); L97319 (17%); L97519 (17%); I82511 (17%)
M86522,"Other chronic hematogenous osteomyelitis, left humerus",92,L97329 (17%); L97529 (17%); I82512 (17%); I82A22 (16%); L97129 (16%)
M86529,"Other chronic hematogenous osteomyelitis, unspecified humerus",92,K739 (21%); L97909 (19%); J42 (18%); L97309 (18%); L97509 (18%)
M86531,"Other chronic hematogenous osteomyelitis, right radius and ulna",92,I50812 (18%); I50813 (17%); L97319 (15%); L97519 (15%); I82511 (14%)
M86532,"Other chronic hematogenous osteomyelitis, left radius and ulna",92,L97329 (15%); L97529 (15%); I82512 (14%); I82A22 (14%); L97129 (14%)
M86539,"Other chronic hematogenous osteomyelitis, unspecified radius and ulna",92,K739 (18%); L97909 (17%); J42 (16%); L97309 (15%); L97509 (15%)
M86541,"Other chronic hematogenous osteomyelitis, right hand",92,M08841 (38%); M08941 (37%); M06841 (36%); M12041 (35%); M08041 (33%)
M86542,"Other chronic hematogenous osteomyelitis, left hand",92,M08842 (38%); M08942 (37%); M06842 (36%); M12042 (35%); M08042 (33%)
M86549,"Other chronic hematogenous osteomyelitis, unspecified hand",92,M08949 (37%); M08849 (35%); M08049 (34%); M08942 (33%); M08941 (33%)
M86551,"Other chronic hematogenous osteomyelitis, right femur",92,S728X1A (25%); I50812 (24%); S7291XA (24%); I50813 (22%); S72391A (21%)
M86552,"Other chronic hematogenous osteomyelitis, left femur",92,S728X2A (25%); S7292XA (24%); S72392A (21%); S728X2B (21%); S72302A (21%)
M86559,"Other chronic hematogenous osteomyelitis, unspecified femur",92,S7290XA (25%); K739 (24%); L97909 (22%); S72309A (22%); S72009A (21%)
M86561,"Other chronic hematogenous osteomyelitis, right tibia and fibula",92,I50812 (18%); I50813 (17%); L97319 (15%); L97519 (15%); I82511 (14%)
M86562,"Other chronic hematogenous osteomyelitis, left tibia and fibula",92,L97329 (15%); L97529 (15%); I82512 (14%); I82A22 (14%); L97129 (14%)
M86569,"Other chronic hematogenous osteomyelitis, unspecified tibia and fibula",92,K739 (18%); L97909 (17%); J42 (16%); L97309 (15%); L97509 (15%)
M86571,"Other chronic hematogenous osteomyelitis, right ankle and foot",92,M08871 (48%); M08971 (47%); M06871 (46%); M08071 (43%); M06271 (43%)
M86572,"Other chronic hematogenous osteomyelitis, left ankle and foot",92,M08872 (48%); M08972 (47%); M06872 (46%); M08072 (43%); M06272 (43%)
M86579,"Other chronic hematogenous osteomyelitis, unspecified ankle and foot",92,M08979 (47%); M08879 (46%); M08972 (44%); M08971 (44%); M06879 (44%)
M8658,"Other chronic hematogenous osteomyelitis, other site",92,M1200 (29%); M0880 (29%); M1208 (28%); K275 (27%); C8170 (27%)
M8659,"Other chronic hematogenous osteomyelitis, multiple sites",92,M0889 (48%); M0899 (47%); M0689 (46%); M0809 (43%); M0629 (43%)
M8660,"Other chronic osteomyelitis, unspecified site",92,C8510 (46%); M0890 (45%); C6990 (44%); C8190 (43%); C8290 (43%)
M86611,"Other chronic osteomyelitis, right shoulder",92,M08811 (46%); M08911 (44%); M06811 (43%); M12011 (43%); M08011 (40%)
M86612,"Other chronic osteomyelitis, left shoulder",92,M08812 (46%); M08912 (44%); M06812 (43%); M12012 (43%); M08012 (40%)
M86619,"Other chronic osteomyelitis, unspecified shoulder",92,M08919 (45%); M08819 (43%); M08019 (41%); M12019 (41%); M08912 (40%)
M86621,"Other chronic osteomyelitis, right humerus",92,I50812 (26%); I50813 (23%); L97319 (21%); L97519 (20%); I82511 (20%)
M86622,"Other chronic osteomyelitis, left humerus",92,L97329 (20%); L97529 (20%); I82512 (20%); I82A22 (20%); L97129 (20%)
M86629,"Other chronic osteomyelitis, unspecified humerus",92,K739 (25%); L97909 (23%); J42 (22%); L97309 (22%); L97509 (22%)
M86631,"Other chronic osteomyelitis, right radius and ulna",92,I50812 (21%); I50813 (19%); L97319 (17%); L97519 (17%); I82511 (16%)
M86632,"Other chronic osteomyelitis, left radius and ulna",92,L97329 (17%); L97529 (17%); I82512 (16%); I82A22 (16%); L97129 (16%)
M86639,"Other chronic osteomyelitis, unspecified radius and ulna",92,K739 (20%); L97909 (19%); J42 (18%); L97309 (18%); L97509 (18%)
M86641,"Other chronic osteomyelitis, right hand",92,M08841 (47%); M08941 (45%); M06841 (44%); M12041 (43%); M08041 (41%)
M86642,"Other chronic osteomyelitis, left hand",92,M08842 (47%); M08942 (45%); M06842 (44%); M12042 (43%); M08042 (41%)
M86649,"Other chronic osteomyelitis, unspecified hand",92,M08949 (46%); M08849 (44%); M08049 (42%); M08942 (42%); M08941 (42%)
M86651,"Other chronic osteomyelitis, right thigh",92,L97119 (51%); L97118 (49%); L97114 (48%); L97113 (48%); L97129 (43%)
M86652,"Other chronic osteomyelitis, left thigh",92,L97129 (51%); L97128 (49%); L97124 (48%); L97123 (48%); L97119 (43%)
M86659,"Other chronic osteomyelitis, unspecified thigh",92,L97109 (53%); L97129 (49%); L97119 (49%); L97108 (48%); L97104 (47%)
M86661,"Other chronic osteomyelitis, right tibia and fibula",92,I50812 (21%); I50813 (19%); L97319 (17%); L97519 (17%); I82511 (16%)
M86662,"Other chronic osteomyelitis, left tibia and fibula",92,L97329 (17%); L97529 (17%); I82512 (16%); I82A22 (16%); L97129 (16%)
M86669,"Other chronic osteomyelitis, unspecified tibia and fibula",92,K739 (20%); L97909 (19%); J42 (18%); L97309 (18%); L97509 (18%)
M86671,"Other chronic osteomyelitis, right ankle and foot",92,M08871 (57%); M08971 (56%); M06871 (54%); M08071 (51%); M06271 (51%)
M86672,"Other chronic osteomyelitis, left ankle and foot",92,M08872 (57%); M08972 (56%); M06872 (54%); M08072 (51%); M06272 (51%)
M86679,"Other chronic osteomyelitis, unspecified ankle and foot",92,M08979 (57%); M08879 (55%); M08972 (53%); M08971 (53%); M06879 (53%)
M8668,"Other chronic osteomyelitis, other site",92,M1200 (37%); M0880 (37%); M1208 (36%); K275 (35%); C8170 (35%)
M8669,"Other chronic osteomyelitis, multiple sites",92,M0889 (57%); M0899 (56%); M0689 (54%); M0809 (52%); M0629 (51%)
M868X0,"Other osteomyelitis, multiple sites",92,M0889 (63%); M0899 (61%); M0689 (59%); M0809 (56%); M0629 (56%)
M868X1,"Other osteomyelitis, shoulder",92,M08819 (42%); M08812 (41%); M08811 (41%); M08912 (40%); M08911 (40%)
M868X2,"Other osteomyelitis, upper arm",92,S48912A (49%); S48911A (49%); S48922A (48%); S48921A (48%); S48919A (48%)
M868X3,"Other osteomyelitis, forearm",92,S58912A (47%); S58911A (47%); S58922A (46%); S58921A (46%); S58919A (46%)
M868X4,"Other osteomyelitis, hand",92,M08849 (44%); M08842 (43%); M08841 (43%); M08942 (41%); M08941 (41%)
M868X5,"Other osteomyelitis, thigh",92,L97129 (36%); L97119 (36%); L97109 (35%); L97108 (35%); I70741 (35%)
M868X6,"Other osteomyelitis, lower leg",92,I70748 (49%); I70748 (49%); I70738 (49%); I70738 (49%); I70348 (49%)
M868X7,"Other osteomyelitis, ankle and foot",92,M08879 (57%); M08872 (56%); M08871 (56%); M08972 (54%); M08971 (54%)
M868X8,"Other osteomyelitis, other site",92,M0880 (42%); C8170 (40%); M0680 (39%); C8510 (39%); I7589 (39%)
M868X9,"Other osteomyelitis, unspecified sites",92,M0899 (39%); M0809 (36%); C457 (33%); Q018 (33%); C8518 (33%)
M869,"Osteomyelitis, unspecified",92,G8330 (21%); L97909 (20%); G8190 (20%); C8510 (20%); M08959 (20%)
M8700,Idiopathic aseptic necrosis of unspecified bone,92,L98424 (44%); L97304 (43%); L97504 (43%); L97904 (43%); L97104 (42%)
M87011,Idiopathic aseptic necrosis of right shoulder,92,M08811 (33%); M08911 (32%); M06811 (31%); M08011 (29%); M06211 (29%)
M87012,Idiopathic aseptic necrosis of left shoulder,92,M08812 (33%); M08912 (32%); M06812 (31%); M08012 (29%); M06212 (29%)
M87019,Idiopathic aseptic necrosis of unspecified shoulder,92,M08919 (33%); M08819 (31%); M08019 (30%); M08912 (29%); M08911 (29%)
M87021,Idiopathic aseptic necrosis of right humerus,92,J84112 (24%); I87311 (23%); T8753 (22%); D613 (22%); L97314 (22%)
M87022,Idiopathic aseptic necrosis of left humerus,92,J84112 (24%); I87312 (23%); T8754 (22%); D613 (22%); J84111 (22%)
M87029,Idiopathic aseptic necrosis of unspecified humerus,92,J84112 (24%); D613 (22%); J84111 (22%); J8403 (22%); T8750 (21%)
M87031,Idiopathic aseptic necrosis of right radius,92,J84112 (24%); I87311 (23%); T8753 (22%); D613 (22%); L97314 (22%)
M87032,Idiopathic aseptic necrosis of left radius,92,J84112 (24%); I87312 (23%); T8754 (22%); D613 (22%); J84111 (22%)
M87033,Idiopathic aseptic necrosis of unspecified radius,92,J84112 (24%); D613 (22%); J84111 (22%); J8403 (22%); T8750 (21%)
M87034,Idiopathic aseptic necrosis of right ulna,92,J84112 (24%); I87311 (23%); T8753 (22%); D613 (22%); L97314 (22%)
M87035,Idiopathic aseptic necrosis of left ulna,92,J84112 (24%); I87312 (23%); T8754 (22%); D613 (22%); J84111 (22%)
M87036,Idiopathic aseptic necrosis of unspecified ulna,92,J84112 (24%); D613 (22%); J84111 (22%); J8403 (22%); T8750 (21%)
M87037,Idiopathic aseptic necrosis of right carpus,92,J84112 (23%); I87311 (22%); T8753 (21%); D613 (21%); L97314 (21%)
M87038,Idiopathic aseptic necrosis of left carpus,92,J84112 (23%); I87312 (22%); T8754 (21%); D613 (21%); J84111 (21%)
M87039,Idiopathic aseptic necrosis of unspecified carpus,92,J84112 (23%); D613 (21%); J84111 (21%); J8403 (21%); T8750 (20%)
M87041,Idiopathic aseptic necrosis of right hand,92,M08841 (34%); M08941 (33%); M06841 (32%); M08041 (30%); M06241 (30%)
M87042,Idiopathic aseptic necrosis of left hand,92,M08842 (34%); M08942 (33%); M06842 (32%); M08042 (30%); M06242 (30%)
M87043,Idiopathic aseptic necrosis of unspecified hand,92,M08949 (34%); M08849 (32%); M08049 (31%); M08942 (30%); M08941 (30%)
M87044,Idiopathic aseptic necrosis of right finger(s),92,J84112 (23%); I87311 (22%); T8753 (21%); D613 (21%); L97314 (21%)
M87045,Idiopathic aseptic necrosis of left finger(s),92,J84112 (23%); I87312 (22%); T8754 (21%); D613 (21%); J84111 (21%)
M87046,Idiopathic aseptic necrosis of unspecified finger(s),92,J84112 (23%); D613 (21%); J84111 (21%); J8403 (21%); T8750 (20%)
M87050,Idiopathic aseptic necrosis of pelvis,92,C763 (44%); C659 (33%); C652 (32%); C651 (32%); S3289XB (30%)
M87051,Idiopathic aseptic necrosis of right femur,92,J84112 (27%); I87311 (25%); T8753 (25%); D613 (24%); L97314 (24%)
M87052,Idiopathic aseptic necrosis of left femur,92,J84112 (27%); I87312 (25%); T8754 (25%); D613 (24%); J84111 (24%)
M87059,Idiopathic aseptic necrosis of unspecified femur,92,J84112 (27%); D613 (25%); J84111 (25%); J8403 (24%); T8750 (24%)
M87061,Idiopathic aseptic necrosis of right tibia,92,J84112 (24%); I87311 (23%); T8753 (22%); D613 (22%); L97314 (22%)
M87062,Idiopathic aseptic necrosis of left tibia,92,J84112 (24%); I87312 (23%); T8754 (22%); D613 (22%); J84111 (22%)
M87063,Idiopathic aseptic necrosis of unspecified tibia,92,J84112 (24%); D613 (22%); J84111 (22%); J8403 (22%); T8750 (21%)
M87064,Idiopathic aseptic necrosis of right fibula,92,J84112 (24%); I87311 (23%); T8753 (22%); D613 (22%); L97314 (22%)
M87065,Idiopathic aseptic necrosis of left fibula,92,J84112 (24%); I87312 (23%); T8754 (22%); D613 (22%); J84111 (22%)
M87066,Idiopathic aseptic necrosis of unspecified fibula,92,J84112 (24%); D613 (22%); J84111 (22%); J8403 (22%); T8750 (21%)
M87071,Idiopathic aseptic necrosis of right ankle,92,L97314 (39%); L97313 (38%); L97304 (33%); L97303 (33%); L97324 (33%)
M87072,Idiopathic aseptic necrosis of left ankle,92,L97324 (39%); L97323 (38%); L97304 (33%); L97303 (33%); L97314 (33%)
M87073,Idiopathic aseptic necrosis of unspecified ankle,92,L97304 (37%); L97303 (37%); L97324 (33%); L97314 (33%); L97323 (33%)
M87074,Idiopathic aseptic necrosis of right foot,92,L97514 (39%); L97513 (39%); L97504 (33%); L97503 (33%); L97524 (33%)
M87075,Idiopathic aseptic necrosis of left foot,92,L97524 (39%); L97523 (39%); L97504 (33%); L97503 (33%); L97514 (33%)
M87076,Idiopathic aseptic necrosis of unspecified foot,92,L97504 (37%); L97503 (37%); L97524 (33%); L97514 (33%); L97523 (33%)
M87077,Idiopathic aseptic necrosis of right toe(s),92,J84112 (23%); I87311 (22%); T8753 (21%); D613 (21%); L97314 (21%)
M87078,Idiopathic aseptic necrosis of left toe(s),92,J84112 (23%); I87312 (22%); T8754 (21%); D613 (21%); J84111 (21%)
M87079,Idiopathic aseptic necrosis of unspecified toe(s),92,J84112 (23%); D613 (21%); J84111 (21%); J8403 (21%); T8750 (20%)
M8708,"Idiopathic aseptic necrosis of bone, other site",92,L98424 (41%); L97304 (37%); L97504 (37%); L97324 (37%); L97314 (37%)
M8709,"Idiopathic aseptic necrosis of bone, multiple sites",92,L98494 (43%); M0889 (40%); M0899 (39%); M0689 (38%); L98424 (38%)
M8710,"Osteonecrosis due to drugs, unspecified bone",,
M87111,"Osteonecrosis due to drugs, right shoulder",,
M87112,"Osteonecrosis due to drugs, left shoulder",,
M87119,"Osteonecrosis due to drugs, unspecified shoulder",,
M87121,"Osteonecrosis due to drugs, right humerus",,
M87122,"Osteonecrosis due to drugs, left humerus",,
M87129,"Osteonecrosis due to drugs, unspecified humerus",,
M87131,Osteonecrosis due to drugs of right radius,,
M87132,Osteonecrosis due to drugs of left radius,,
M87133,Osteonecrosis due to drugs of unspecified radius,,
M87134,Osteonecrosis due to drugs of right ulna,,
M87135,Osteonecrosis due to drugs of left ulna,,
M87136,Osteonecrosis due to drugs of unspecified ulna,,
M87137,Osteonecrosis due to drugs of right carpus,,
M87138,Osteonecrosis due to drugs of left carpus,,
M87139,Osteonecrosis due to drugs of unspecified carpus,,
M87141,"Osteonecrosis due to drugs, right hand",,
M87142,"Osteonecrosis due to drugs, left hand",,
M87143,"Osteonecrosis due to drugs, unspecified hand",,
M87144,"Osteonecrosis due to drugs, right finger(s)",,
M87145,"Osteonecrosis due to drugs, left finger(s)",,
M87146,"Osteonecrosis due to drugs, unspecified finger(s)",,
M87150,"Osteonecrosis due to drugs, pelvis",,
M87151,"Osteonecrosis due to drugs, right femur",,
M87152,"Osteonecrosis due to drugs, left femur",,
M87159,"Osteonecrosis due to drugs, unspecified femur",,
M87161,"Osteonecrosis due to drugs, right tibia",,
M87162,"Osteonecrosis due to drugs, left tibia",,
M87163,"Osteonecrosis due to drugs, unspecified tibia",,
M87164,"Osteonecrosis due to drugs, right fibula",,
M87165,"Osteonecrosis due to drugs, left fibula",,
M87166,"Osteonecrosis due to drugs, unspecified fibula",,
M87171,"Osteonecrosis due to drugs, right ankle",,
M87172,"Osteonecrosis due to drugs, left ankle",,
M87173,"Osteonecrosis due to drugs, unspecified ankle",,
M87174,"Osteonecrosis due to drugs, right foot",,
M87175,"Osteonecrosis due to drugs, left foot",,
M87176,"Osteonecrosis due to drugs, unspecified foot",,
M87177,"Osteonecrosis due to drugs, right toe(s)",,
M87178,"Osteonecrosis due to drugs, left toe(s)",,
M87179,"Osteonecrosis due to drugs, unspecified toe(s)",,
M87180,"Osteonecrosis due to drugs, jaw",,
M87188,"Osteonecrosis due to drugs, other site",,
M8719,"Osteonecrosis due to drugs, multiple sites",,
M8720,"Osteonecrosis due to previous trauma, unspecified bone",92,C7951 (29%); L97904 (26%); L97304 (25%); L97504 (25%); L97104 (25%)
M87211,"Osteonecrosis due to previous trauma, right shoulder",92,M08811 (33%); M08911 (32%); M06811 (31%); M08011 (29%); M06211 (29%)
M87212,"Osteonecrosis due to previous trauma, left shoulder",92,M08812 (33%); M08912 (32%); M06812 (31%); M08012 (29%); M06212 (29%)
M87219,"Osteonecrosis due to previous trauma, unspecified shoulder",92,M08919 (32%); M08819 (30%); M08019 (29%); M08912 (29%); M08911 (29%)
M87221,"Osteonecrosis due to previous trauma, right humerus",92,M08851 (8%); C7651 (8%); M08811 (8%); M08841 (8%); M08821 (7%)
M87222,"Osteonecrosis due to previous trauma, left humerus",92,M08852 (8%); C7652 (8%); M08812 (8%); M08842 (8%); M08822 (7%)
M87229,"Osteonecrosis due to previous trauma, unspecified humerus",92,G8330 (9%); L97909 (9%); G8190 (8%); C8510 (8%); M08959 (8%)
M87231,Osteonecrosis due to previous trauma of right radius,92,M08851 (8%); C7651 (8%); M08811 (8%); M08841 (8%); M08821 (7%)
M87232,Osteonecrosis due to previous trauma of left radius,92,M08852 (8%); C7652 (8%); M08812 (8%); M08842 (8%); M08822 (7%)
M87233,Osteonecrosis due to previous trauma of unspecified radius,92,G8330 (9%); L97909 (9%); G8190 (8%); C8510 (8%); M08959 (8%)
M87234,Osteonecrosis due to previous trauma of right ulna,92,M08851 (8%); C7651 (8%); M08811 (8%); M08841 (8%); M08821 (7%)
M87235,Osteonecrosis due to previous trauma of left ulna,92,M08852 (8%); C7652 (8%); M08812 (8%); M08842 (8%); M08822 (7%)
M87236,Osteonecrosis due to previous trauma of unspecified ulna,92,G8330 (9%); L97909 (9%); G8190 (8%); C8510 (8%); M08959 (8%)
M87237,Osteonecrosis due to previous trauma of right carpus,92,M08851 (7%); C7651 (7%); M08811 (7%); M08841 (7%); M08821 (7%)
M87238,Osteonecrosis due to previous trauma of left carpus,92,M08852 (7%); C7652 (7%); M08812 (7%); M08842 (7%); M08822 (7%)
M87239,Osteonecrosis due to previous trauma of unspecified carpus,92,G8330 (8%); L97909 (8%); G8190 (8%); C8510 (8%); M08959 (8%)
M87241,"Osteonecrosis due to previous trauma, right hand",92,M08841 (34%); M08941 (33%); M06841 (32%); M08041 (30%); M06241 (30%)
M87242,"Osteonecrosis due to previous trauma, left hand",92,M08842 (34%); M08942 (33%); M06842 (32%); M08042 (30%); M06242 (30%)
M87243,"Osteonecrosis due to previous trauma, unspecified hand",92,M08949 (33%); M08849 (31%); M08049 (30%); M08942 (30%); M08941 (30%)
M87244,"Osteonecrosis due to previous trauma, right finger(s)",92,M08851 (7%); C7651 (7%); M08811 (7%); M08841 (7%); M08821 (7%)
M87245,"Osteonecrosis due to previous trauma, left finger(s)",92,M08852 (7%); C7652 (7%); M08812 (7%); M08842 (7%); M08822 (7%)
M87246,"Osteonecrosis due to previous trauma, unspecified finger(s)",92,G8330 (8%); L97909 (8%); G8190 (8%); C8510 (8%); M08959 (8%)
M87250,"Osteonecrosis due to previous trauma, pelvis",92,C763 (43%); C659 (32%); C652 (32%); C651 (32%); S3289XB (30%)
M87251,"Osteonecrosis due to previous trauma, right femur",92,S728X1A (22%); S7291XA (21%); S72391A (19%); S728X1B (18%); S72301A (18%)
M87252,"Osteonecrosis due to previous trauma, left femur",92,S728X2A (22%); S7292XA (21%); S72392A (19%); S728X2B (18%); S72302A (18%)
M87256,"Osteonecrosis due to previous trauma, unspecified femur",92,S7290XA (22%); S72309A (19%); S72009A (19%); S72059A (19%); S728X9A (19%)
M87261,"Osteonecrosis due to previous trauma, right tibia",92,M08851 (8%); C7651 (8%); M08811 (8%); M08841 (8%); M08821 (7%)
M87262,"Osteonecrosis due to previous trauma, left tibia",92,M08852 (8%); C7652 (8%); M08812 (8%); M08842 (8%); M08822 (7%)
M87263,"Osteonecrosis due to previous trauma, unspecified tibia",92,G8330 (9%); L97909 (9%); G8190 (8%); C8510 (8%); M08959 (8%)
M87264,"Osteonecrosis due to previous trauma, right fibula",92,M08851 (8%); C7651 (8%); M08811 (8%); M08841 (8%); M08821 (7%)
M87265,"Osteonecrosis due to previous trauma, left fibula",92,M08852 (8%); C7652 (8%); M08812 (8%); M08842 (8%); M08822 (7%)
M87266,"Osteonecrosis due to previous trauma, unspecified fibula",92,G8330 (9%); L97909 (9%); G8190 (8%); C8510 (8%); M08959 (8%)
M87271,"Osteonecrosis due to previous trauma, right ankle",92,M08871 (27%); L89512 (27%); L89513 (27%); L89514 (27%); M08971 (26%)
M87272,"Osteonecrosis due to previous trauma, left ankle",92,M08872 (27%); L89522 (27%); L89523 (27%); L89524 (27%); M08972 (26%)
M87273,"Osteonecrosis due to previous trauma, unspecified ankle",92,M08979 (27%); M08079 (25%); M08879 (25%); L89502 (24%); L89503 (24%)
M87274,"Osteonecrosis due to previous trauma, right foot",92,M08871 (27%); M08971 (26%); M06871 (26%); M08071 (24%); M06271 (24%)
M87275,"Osteonecrosis due to previous trauma, left foot",92,M08872 (27%); M08972 (26%); M06872 (26%); M08072 (24%); M06272 (24%)
M87276,"Osteonecrosis due to previous trauma, unspecified foot",92,M08979 (27%); M08079 (25%); M08879 (25%); M08972 (24%); M08971 (24%)
M87277,"Osteonecrosis due to previous trauma, right toe(s)",92,M08851 (7%); C7651 (7%); M08811 (7%); M08841 (7%); M08821 (7%)
M87278,"Osteonecrosis due to previous trauma, left toe(s)",92,M08852 (7%); C7652 (7%); M08812 (7%); M08842 (7%); M08822 (7%)
M87279,"Osteonecrosis due to previous trauma, unspecified toe(s)",92,G8330 (8%); L97909 (8%); G8190 (8%); C8510 (8%); M08959 (8%)
M8728,"Osteonecrosis due to previous trauma, other site",92,M0880 (25%); C8170 (24%); M0680 (24%); C8510 (23%); I7589 (23%)
M8729,"Osteonecrosis due to previous trauma, multiple sites",92,M0889 (43%); M0899 (42%); M0689 (41%); M0809 (39%); M0629 (39%)
M8730,"Other secondary osteonecrosis, unspecified bone",92,C7951 (68%); C7952 (52%); C7B03 (51%); C799 (37%); C7800 (36%)
M87311,"Other secondary osteonecrosis, right shoulder",92,M08811 (41%); C7801 (40%); M08911 (40%); M06811 (39%); M08011 (36%)
M87312,"Other secondary osteonecrosis, left shoulder",92,M08812 (41%); C7802 (40%); M08912 (40%); M06812 (39%); M08012 (36%)
M87319,"Other secondary osteonecrosis, unspecified shoulder",92,M08919 (41%); C799 (39%); M08819 (38%); C7800 (38%); M08019 (37%)
M87321,"Other secondary osteonecrosis, right humerus",92,C7801 (37%); C7961 (31%); C799 (30%); C7951 (29%); C7981 (29%)
M87322,"Other secondary osteonecrosis, left humerus",92,C7802 (37%); C7962 (31%); C799 (30%); C7951 (29%); C7981 (29%)
M87329,"Other secondary osteonecrosis, unspecified humerus",92,C799 (36%); C7800 (34%); G219 (33%); C7940 (32%); C7951 (30%)
M87331,Other secondary osteonecrosis of right radius,92,C7801 (37%); C7961 (31%); C799 (30%); C7951 (29%); C7981 (29%)
M87332,Other secondary osteonecrosis of left radius,92,C7802 (37%); C7962 (31%); C799 (30%); C7951 (29%); C7981 (29%)
M87333,Other secondary osteonecrosis of unspecified radius,92,C799 (36%); C7800 (34%); G219 (33%); C7940 (32%); C7951 (30%)
M87334,Other secondary osteonecrosis of right ulna,92,C7801 (37%); C7961 (31%); C799 (30%); C7951 (29%); C7981 (29%)
M87335,Other secondary osteonecrosis of left ulna,92,C7802 (37%); C7962 (31%); C799 (30%); C7951 (29%); C7981 (29%)
M87336,Other secondary osteonecrosis of unspecified ulna,92,C799 (36%); C7800 (34%); G219 (33%); C7940 (32%); C7951 (30%)
M87337,Other secondary osteonecrosis of right carpus,92,C7801 (34%); C7961 (30%); C799 (28%); C7951 (27%); C7981 (27%)
M87338,Other secondary osteonecrosis of left carpus,92,C7802 (34%); C7962 (29%); C799 (28%); C7951 (27%); C7981 (27%)
M87339,Other secondary osteonecrosis of unspecified carpus,92,C799 (33%); C7800 (32%); G219 (31%); C7940 (30%); C7951 (28%)
M87341,"Other secondary osteonecrosis, right hand",92,M08841 (42%); M08941 (41%); C7801 (40%); M06841 (40%); M08041 (37%)
M87342,"Other secondary osteonecrosis, left hand",92,M08842 (42%); M08942 (41%); C7802 (40%); M06842 (40%); M08042 (37%)
M87343,"Other secondary osteonecrosis, unspecified hand",92,M08949 (42%); M08849 (39%); C799 (39%); M08049 (38%); C7800 (37%)
M87344,"Other secondary osteonecrosis, right finger(s)",92,C7801 (34%); C7961 (30%); C799 (28%); C7951 (27%); C7981 (27%)
M87345,"Other secondary osteonecrosis, left finger(s)",92,C7802 (34%); C7962 (29%); C799 (28%); C7951 (27%); C7981 (27%)
M87346,"Other secondary osteonecrosis, unspecified finger(s)",92,C799 (33%); C7800 (32%); G219 (31%); C7940 (30%); C7951 (28%)
M87350,"Other secondary osteonecrosis, pelvis",92,C763 (53%); C7900 (52%); C7902 (51%); C7901 (51%); C659 (40%)
M87351,"Other secondary osteonecrosis, right femur",92,C7801 (43%); C7961 (37%); C799 (35%); C7951 (34%); C7981 (34%)
M87352,"Other secondary osteonecrosis, left femur",92,C7802 (43%); C7962 (37%); C799 (35%); C7951 (34%); C7981 (34%)
M87353,"Other secondary osteonecrosis, unspecified femur",92,C799 (42%); C7800 (41%); G219 (39%); C7940 (37%); C7951 (35%)
M87361,"Other secondary osteonecrosis, right tibia",92,C7801 (37%); C7961 (31%); C799 (30%); C7951 (29%); C7981 (29%)
M87362,"Other secondary osteonecrosis, left tibia",92,C7802 (37%); C7962 (31%); C799 (30%); C7951 (29%); C7981 (29%)
M87363,"Other secondary osteonecrosis, unspecified tibia",92,C799 (36%); C7800 (34%); G219 (33%); C7940 (32%); C7951 (30%)
M87364,"Other secondary osteonecrosis, right fibula",92,C7801 (37%); C7961 (31%); C799 (30%); C7951 (29%); C7981 (29%)
M87365,"Other secondary osteonecrosis, left fibula",92,C7802 (37%); C7962 (31%); C799 (30%); C7951 (29%); C7981 (29%)
M87366,"Other secondary osteonecrosis, unspecified fibula",92,C799 (36%); C7800 (34%); G219 (33%); C7940 (32%); C7951 (30%)
M87371,"Other secondary osteonecrosis, right ankle",92,C7801 (41%); C7961 (35%); M08871 (34%); L89512 (34%); L89513 (34%)
M87372,"Other secondary osteonecrosis, left ankle",92,C7802 (41%); C7962 (35%); M08872 (34%); L89522 (34%); L89523 (34%)
M87373,"Other secondary osteonecrosis, unspecified ankle",92,C799 (40%); C7800 (38%); G219 (37%); C7940 (35%); M08979 (34%)
M87374,"Other secondary osteonecrosis, right foot",92,C7801 (41%); C7961 (35%); M08871 (34%); M08971 (33%); C799 (33%)
M87375,"Other secondary osteonecrosis, left foot",92,C7802 (41%); C7962 (35%); M08872 (34%); M08972 (33%); C799 (33%)
M87376,"Other secondary osteonecrosis, unspecified foot",92,C799 (40%); C7800 (38%); G219 (37%); C7940 (35%); M08979 (35%)
M87377,"Other secondary osteonecrosis, right toe(s)",92,C7801 (34%); C7961 (30%); C799 (28%); C7951 (27%); C7981 (27%)
M87378,"Other secondary osteonecrosis, left toe(s)",92,C7802 (34%); C7962 (29%); C799 (28%); C7951 (27%); C7981 (27%)
M87379,"Other secondary osteonecrosis, unspecified toe(s)",92,C799 (33%); C7800 (32%); G219 (31%); C7940 (30%); C7951 (28%)
M8738,"Other secondary osteonecrosis, other site",92,C799 (64%); C7B00 (48%); C7951 (34%); C7981 (33%); C7800 (33%)
M8739,"Other secondary osteonecrosis, multiple sites",92,M0889 (53%); M0899 (51%); M0689 (50%); C7989 (50%); M0809 (47%)
M8780,"Other osteonecrosis, unspecified bone",92,C7951 (44%); L97904 (40%); L97304 (38%); L97504 (38%); L97104 (37%)
M87811,"Other osteonecrosis, right shoulder",92,M08811 (50%); M08911 (49%); M06811 (47%); M08011 (44%); M06211 (44%)
M87812,"Other osteonecrosis, left shoulder",92,M08812 (50%); M08912 (49%); M06812 (47%); M08012 (44%); M06212 (44%)
M87819,"Other osteonecrosis, unspecified shoulder",92,M08919 (50%); M08819 (47%); M08019 (46%); M08912 (45%); M08911 (45%)
M87821,"Other osteonecrosis, right humerus",92,M08851 (11%); C7651 (11%); M08811 (11%); M08841 (11%); M08821 (11%)
M87822,"Other osteonecrosis, left humerus",92,M08852 (11%); C7652 (11%); M08812 (11%); M08842 (11%); M08822 (11%)
M87829,"Other osteonecrosis, unspecified humerus",92,G8330 (13%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
M87831,Other osteonecrosis of right radius,92,M08851 (11%); C7651 (11%); M08811 (11%); M08841 (11%); M08821 (11%)
M87832,Other osteonecrosis of left radius,92,M08852 (11%); C7652 (11%); M08812 (11%); M08842 (11%); M08822 (11%)
M87833,Other osteonecrosis of unspecified radius,92,G8330 (13%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
M87834,Other osteonecrosis of right ulna,92,M08851 (11%); C7651 (11%); M08811 (11%); M08841 (11%); M08821 (11%)
M87835,Other osteonecrosis of left ulna,92,M08852 (11%); C7652 (11%); M08812 (11%); M08842 (11%); M08822 (11%)
M87836,Other osteonecrosis of unspecified ulna,92,G8330 (13%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
M87837,Other osteonecrosis of right carpus,92,M08851 (10%); C7651 (10%); M08811 (10%); M08841 (10%); M08821 (10%)
M87838,Other osteonecrosis of left carpus,92,M08852 (10%); C7652 (10%); M08812 (10%); M08842 (10%); M08822 (10%)
M87839,Other osteonecrosis of unspecified carpus,92,G8330 (12%); L97909 (11%); G8190 (11%); C8510 (11%); M08959 (11%)
M87841,"Other osteonecrosis, right hand",92,M08841 (51%); M08941 (50%); M06841 (48%); M08041 (45%); M06241 (45%)
M87842,"Other osteonecrosis, left hand",92,M08842 (51%); M08942 (50%); M06842 (48%); M08042 (45%); M06242 (45%)
M87843,"Other osteonecrosis, unspecified hand",92,M08949 (51%); M08849 (49%); M08049 (47%); M08942 (46%); M08941 (46%)
M87844,"Other osteonecrosis, right finger(s)",92,M08851 (10%); C7651 (10%); M08811 (10%); M08841 (10%); M08821 (10%)
M87845,"Other osteonecrosis, left finger(s)",92,M08852 (10%); C7652 (10%); M08812 (10%); M08842 (10%); M08822 (10%)
M87849,"Other osteonecrosis, unspecified finger(s)",92,G8330 (12%); L97909 (11%); G8190 (11%); C8510 (11%); M08959 (11%)
M87850,"Other osteonecrosis, pelvis",92,C763 (63%); C659 (47%); C652 (46%); C651 (46%); S3289XB (43%)
M87851,"Other osteonecrosis, right femur",92,S728X1A (36%); S7291XA (35%); S72391A (31%); S728X1B (30%); S72301A (30%)
M87852,"Other osteonecrosis, left femur",92,S728X2A (36%); S7292XA (35%); S72392A (31%); S728X2B (30%); S72302A (30%)
M87859,"Other osteonecrosis, unspecified femur",92,S7290XA (37%); S72309A (32%); S72009A (32%); S72059A (32%); S728X9A (32%)
M87861,"Other osteonecrosis, right tibia",92,M08851 (11%); C7651 (11%); M08811 (11%); M08841 (11%); M08821 (11%)
M87862,"Other osteonecrosis, left tibia",92,M08852 (11%); C7652 (11%); M08812 (11%); M08842 (11%); M08822 (11%)
M87863,"Other osteonecrosis, unspecified tibia",92,G8330 (13%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
M87864,"Other osteonecrosis, right fibula",92,M08851 (11%); C7651 (11%); M08811 (11%); M08841 (11%); M08821 (11%)
M87865,"Other osteonecrosis, left fibula",92,M08852 (11%); C7652 (11%); M08812 (11%); M08842 (11%); M08822 (11%)
M87869,"Other osteonecrosis, unspecified fibula",92,G8330 (13%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
M87871,"Other osteonecrosis, right ankle",92,M08871 (42%); L89512 (42%); L89513 (42%); L89514 (42%); M08971 (41%)
M87872,"Other osteonecrosis, left ankle",92,M08872 (42%); L89522 (42%); L89523 (42%); L89524 (42%); M08972 (41%)
M87873,"Other osteonecrosis, unspecified ankle",92,M08979 (43%); M08079 (40%); M08879 (39%); L89502 (39%); L89503 (39%)
M87874,"Other osteonecrosis, right foot",92,M08871 (42%); M08971 (41%); M06871 (40%); M08071 (38%); M06271 (38%)
M87875,"Other osteonecrosis, left foot",92,M08872 (42%); M08972 (41%); M06872 (40%); M08072 (38%); M06272 (38%)
M87876,"Other osteonecrosis, unspecified foot",92,M08979 (43%); M08079 (40%); M08879 (39%); M08972 (38%); M08971 (38%)
M87877,"Other osteonecrosis, right toe(s)",92,M08851 (10%); C7651 (10%); M08811 (10%); M08841 (10%); M08821 (10%)
M87878,"Other osteonecrosis, left toe(s)",92,M08852 (10%); C7652 (10%); M08812 (10%); M08842 (10%); M08822 (10%)
M87879,"Other osteonecrosis, unspecified toe(s)",92,G8330 (12%); L97909 (11%); G8190 (11%); C8510 (11%); M08959 (11%)
M8788,"Other osteonecrosis, other site",92,M0880 (41%); C8170 (39%); M0680 (38%); C8510 (38%); I7589 (38%)
M8789,"Other osteonecrosis, multiple sites",92,M0889 (62%); M0899 (60%); M0689 (59%); M0809 (55%); M0629 (55%)
M879,"Osteonecrosis, unspecified",92,G8330 (20%); L97909 (20%); G8190 (19%); C8510 (19%); M08959 (19%)
M8960,"Osteopathy after poliomyelitis, unspecified site",92,C8510 (34%); M0890 (33%); C6990 (32%); C8190 (32%); C8290 (32%)
M89611,"Osteopathy after poliomyelitis, right shoulder",92,M08811 (34%); M08911 (33%); M06811 (32%); M08011 (30%); M06211 (30%)
M89612,"Osteopathy after poliomyelitis, left shoulder",92,M08812 (34%); M08912 (33%); M06812 (32%); M08012 (30%); M06212 (30%)
M89619,"Osteopathy after poliomyelitis, unspecified shoulder",92,M08919 (33%); M08819 (31%); M08019 (30%); M08912 (30%); M08911 (30%)
M89621,"Osteopathy after poliomyelitis, right upper arm",92,S48911A (40%); S48921A (40%); S48912A (36%); S48922A (35%); S48919A (35%)
M89622,"Osteopathy after poliomyelitis, left upper arm",92,S48912A (40%); S48922A (40%); S48911A (36%); S48921A (35%); S48919A (35%)
M89629,"Osteopathy after poliomyelitis, unspecified upper arm",92,S48919A (41%); S48929A (40%); S48912A (39%); S48911A (39%); S48922A (38%)
M89631,"Osteopathy after poliomyelitis, right forearm",92,S58911A (38%); S58921A (38%); S58912A (33%); S58922A (32%); S58919A (32%)
M89632,"Osteopathy after poliomyelitis, left forearm",92,S58912A (38%); S58922A (38%); S58911A (33%); S58921A (32%); S58919A (32%)
M89639,"Osteopathy after poliomyelitis, unspecified forearm",92,S58919A (39%); S58929A (38%); S58912A (36%); S58911A (36%); S58922A (36%)
M89641,"Osteopathy after poliomyelitis, right hand",92,M08841 (35%); M08941 (34%); M06841 (33%); M08041 (31%); M06241 (31%)
M89642,"Osteopathy after poliomyelitis, left hand",92,M08842 (35%); M08942 (34%); M06842 (33%); M08042 (31%); M06242 (31%)
M89649,"Osteopathy after poliomyelitis, unspecified hand",92,M08949 (34%); M08849 (33%); M08049 (31%); M08942 (31%); M08941 (31%)
M89651,"Osteopathy after poliomyelitis, right thigh",92,L97119 (29%); I70731 (28%); I70731 (28%); L97118 (28%); I70331 (28%)
M89652,"Osteopathy after poliomyelitis, left thigh",92,L97129 (29%); I70741 (28%); I70741 (28%); L97128 (28%); I70341 (28%)
M89659,"Osteopathy after poliomyelitis, unspecified thigh",92,L97109 (30%); S78919A (28%); S78929A (27%); L97129 (27%); L97119 (27%)
M89661,"Osteopathy after poliomyelitis, right lower leg",92,I70738 (37%); I70738 (37%); I70338 (37%); I70338 (37%); I70238 (36%)
M89662,"Osteopathy after poliomyelitis, left lower leg",92,I70748 (37%); I70748 (37%); I70348 (37%); I70348 (37%); I70248 (36%)
M89669,"Osteopathy after poliomyelitis, unspecified lower leg",92,I70348 (35%); I70348 (35%); I70338 (35%); I70338 (35%); I83008 (33%)
M89671,"Osteopathy after poliomyelitis, right ankle and foot",92,M08871 (45%); M08971 (44%); M06871 (43%); M08071 (40%); M06271 (40%)
M89672,"Osteopathy after poliomyelitis, left ankle and foot",92,M08872 (45%); M08972 (44%); M06872 (43%); M08072 (40%); M06272 (40%)
M89679,"Osteopathy after poliomyelitis, unspecified ankle and foot",92,M08979 (44%); M08879 (43%); M08972 (41%); M08971 (41%); M06879 (41%)
M8968,"Osteopathy after poliomyelitis, other site",92,M0880 (26%); C8170 (25%); M0680 (25%); C8510 (24%); I7589 (24%)
M8969,"Osteopathy after poliomyelitis, multiple sites",92,M0889 (45%); M0899 (44%); M0689 (43%); M0809 (40%); M0629 (40%)
M9050,"Osteonecrosis in diseases classified elsewhere, unspecified site",92,G914 (51%); G054 (48%); I43 (48%); J84178 (47%); C8440 (45%)
M90511,"Osteonecrosis in diseases classified elsewhere, right shoulder",92,G914 (50%); G054 (48%); I43 (48%); J84178 (46%); G992 (43%)
M90512,"Osteonecrosis in diseases classified elsewhere, left shoulder",92,G914 (50%); G054 (48%); I43 (48%); J84178 (46%); G992 (43%)
M90519,"Osteonecrosis in diseases classified elsewhere, unspecified shoulder",92,G914 (51%); G054 (48%); I43 (48%); J84178 (46%); F0284 (44%)
M90521,"Osteonecrosis in diseases classified elsewhere, right upper arm",92,G914 (43%); S48911A (42%); S48921A (42%); G054 (40%); I43 (40%)
M90522,"Osteonecrosis in diseases classified elsewhere, left upper arm",92,G914 (43%); S48912A (42%); S48922A (42%); G054 (40%); I43 (40%)
M90529,"Osteonecrosis in diseases classified elsewhere, unspecified upper arm",92,G914 (43%); S48919A (43%); S48929A (42%); G054 (41%); I43 (41%)
M90531,"Osteonecrosis in diseases classified elsewhere, right forearm",92,G914 (45%); G054 (42%); I43 (42%); J84178 (41%); S58911A (40%)
M90532,"Osteonecrosis in diseases classified elsewhere, left forearm",92,G914 (45%); G054 (42%); I43 (42%); J84178 (41%); S58912A (40%)
M90539,"Osteonecrosis in diseases classified elsewhere, unspecified forearm",92,G914 (45%); G054 (43%); I43 (43%); J84178 (41%); S58919A (41%)
M90541,"Osteonecrosis in diseases classified elsewhere, right hand",92,G914 (50%); G054 (47%); I43 (47%); J84178 (45%); G992 (42%)
M90542,"Osteonecrosis in diseases classified elsewhere, left hand",92,G914 (50%); G054 (47%); I43 (47%); J84178 (45%); G992 (42%)
M90549,"Osteonecrosis in diseases classified elsewhere, unspecified hand",92,G914 (51%); G054 (48%); I43 (48%); J84178 (46%); F0284 (44%)
M90551,"Osteonecrosis in diseases classified elsewhere, right thigh",92,G914 (48%); G054 (46%); I43 (46%); J84178 (44%); G992 (41%)
M90552,"Osteonecrosis in diseases classified elsewhere, left thigh",92,G914 (48%); G054 (46%); I43 (46%); J84178 (44%); G992 (41%)
M90559,"Osteonecrosis in diseases classified elsewhere, unspecified thigh",92,G914 (49%); G054 (47%); I43 (47%); J84178 (45%); F0284 (43%)
M90561,"Osteonecrosis in diseases classified elsewhere, right lower leg",92,G914 (48%); G054 (46%); I43 (46%); J84178 (44%); G992 (41%)
M90562,"Osteonecrosis in diseases classified elsewhere, left lower leg",92,G914 (48%); G054 (46%); I43 (46%); J84178 (44%); G992 (41%)
M90569,"Osteonecrosis in diseases classified elsewhere, unspecified lower leg",92,G914 (49%); G054 (46%); I43 (46%); J84178 (45%); F0284 (42%)
M90571,"Osteonecrosis in diseases classified elsewhere, right ankle and foot",92,M08871 (47%); G914 (46%); M08971 (46%); M06871 (45%); G054 (44%)
M90572,"Osteonecrosis in diseases classified elsewhere, left ankle and foot",92,M08872 (47%); G914 (46%); M08972 (46%); M06872 (45%); G054 (44%)
M90579,"Osteonecrosis in diseases classified elsewhere, unspecified ankle and foot",92,G914 (47%); M08979 (46%); M08879 (45%); G054 (45%); I43 (45%)
M9058,"Osteonecrosis in diseases classified elsewhere, other site",92,G914 (52%); G054 (50%); I43 (50%); J84178 (48%); G992 (44%)
M9059,"Osteonecrosis in diseases classified elsewhere, multiple sites",92,C8448 (48%); M0889 (47%); G914 (46%); M0899 (46%); M0689 (45%)
M96621,"Fracture of humerus following insertion of orthopedic implant, joint prosthesis, or bone plate, right arm",,
M96622,"Fracture of humerus following insertion of orthopedic implant, joint prosthesis, or bone plate, left arm",,
M96629,"Fracture of humerus following insertion of orthopedic implant, joint prosthesis, or bone plate, unspecified arm",,
M96631,"Fracture of radius or ulna following insertion of orthopedic implant, joint prosthesis, or bone plate, right arm",,
M96632,"Fracture of radius or ulna following insertion of orthopedic implant, joint prosthesis, or bone plate, left arm",,
M96639,"Fracture of radius or ulna following insertion of orthopedic implant, joint prosthesis, or bone plate, unspecified arm",,
M9665,"Fracture of pelvis following insertion of orthopedic implant, joint prosthesis, or bone plate",,
M96661,"Fracture of femur following insertion of orthopedic implant, joint prosthesis, or bone plate, right leg",,
M96662,"Fracture of femur following insertion of orthopedic implant, joint prosthesis, or bone plate, left leg",,
M96669,"Fracture of femur following insertion of orthopedic implant, joint prosthesis, or bone plate, unspecified leg",,
M96671,"Fracture of tibia or fibula following insertion of orthopedic implant, joint prosthesis, or bone plate, right leg",,
M96672,"Fracture of tibia or fibula following insertion of orthopedic implant, joint prosthesis, or bone plate, left leg",,
M96679,"Fracture of tibia or fibula following insertion of orthopedic implant, joint prosthesis, or bone plate, unspecified leg",,
M9669,"Fracture of other bone following insertion of orthopedic implant, joint prosthesis, or bone plate",,
M9701XA,"Periprosthetic fracture around internal prosthetic right hip joint, initial encounter",402,S78011A (41%); S78021A (40%); S78019A (37%); S78012A (37%); S78029A (37%)
M9702XA,"Periprosthetic fracture around internal prosthetic left hip joint, initial encounter",402,S78012A (41%); S78022A (40%); S78019A (37%); S78011A (37%); S78029A (37%)
N000,Acute nephritic syndrome with minor glomerular abnormality,,
N001,Acute nephritic syndrome with focal and segmental glomerular lesions,,
N002,Acute nephritic syndrome with diffuse membranous glomerulonephritis,,
N003,Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis,,
N004,Acute nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis,,
N005,Acute nephritic syndrome with diffuse mesangiocapillary glomerulonephritis,,
N006,Acute nephritic syndrome with dense deposit disease,,
N007,Acute nephritic syndrome with diffuse crescentic glomerulonephritis,,
N008,Acute nephritic syndrome with other morphologic changes,,
N009,Acute nephritic syndrome with unspecified morphologic changes,,
N00A,Acute nephritic syndrome with C3 glomerulonephritis,,
N010,Rapidly progressive nephritic syndrome with minor glomerular abnormality,,
N011,Rapidly progressive nephritic syndrome with focal and segmental glomerular lesions,,
N012,Rapidly progressive nephritic syndrome with diffuse membranous glomerulonephritis,,
N013,Rapidly progressive nephritic syndrome with diffuse mesangial proliferative glomerulonephritis,,
N014,Rapidly progressive nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis,,
N015,Rapidly progressive nephritic syndrome with diffuse mesangiocapillary glomerulonephritis,,
N016,Rapidly progressive nephritic syndrome with dense deposit disease,,
N017,Rapidly progressive nephritic syndrome with diffuse crescentic glomerulonephritis,,
N018,Rapidly progressive nephritic syndrome with other morphologic changes,,
N019,Rapidly progressive nephritic syndrome with unspecified morphologic changes,,
N01A,Rapidly progressive nephritic syndrome with C3 glomerulonephritis,,
N020,Recurrent and persistent hematuria with minor glomerular abnormality,,
N021,Recurrent and persistent hematuria with focal and segmental glomerular lesions,,
N022,Recurrent and persistent hematuria with diffuse membranous glomerulonephritis,,
N023,Recurrent and persistent hematuria with diffuse mesangial proliferative glomerulonephritis,,
N024,Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis,,
N025,Recurrent and persistent hematuria with diffuse mesangiocapillary glomerulonephritis,,
N026,Recurrent and persistent hematuria with dense deposit disease,,
N027,Recurrent and persistent hematuria with diffuse crescentic glomerulonephritis,,
N028,Recurrent and persistent hematuria with other morphologic changes,,
N029,Recurrent and persistent hematuria with unspecified morphologic changes,,
N02A,Recurrent and persistent hematuria with C3 glomerulonephritis,,
N02B1,Recurrent and persistent immunoglobulin A nephropathy with glomerular lesion,,
N02B2,Recurrent and persistent immunoglobulin A nephropathy with focal and segmental glomerular lesion,,
N02B3,Recurrent and persistent immunoglobulin A nephropathy with diffuse membranoproliferative glomerulonephritis,,
N02B4,Recurrent and persistent immunoglobulin A nephropathy with diffuse membranous glomerulonephritis,,
N02B5,Recurrent and persistent immunoglobulin A nephropathy with diffuse mesangial proliferative glomerulonephritis,,
N02B6,Recurrent and persistent immunoglobulin A nephropathy with diffuse mesangiocapillary glomerulonephritis,,
N02B9,Other recurrent and persistent immunoglobulin A nephropathy,,
N030,Chronic nephritic syndrome with minor glomerular abnormality,,
N031,Chronic nephritic syndrome with focal and segmental glomerular lesions,,
N032,Chronic nephritic syndrome with diffuse membranous glomerulonephritis,,
N033,Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis,,
N034,Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis,,
N035,Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis,,
N036,Chronic nephritic syndrome with dense deposit disease,,
N037,Chronic nephritic syndrome with diffuse crescentic glomerulonephritis,,
N038,Chronic nephritic syndrome with other morphologic changes,,
N039,Chronic nephritic syndrome with unspecified morphologic changes,,
N03A,Chronic nephritic syndrome with C3 glomerulonephritis,,
N040,Nephrotic syndrome with minor glomerular abnormality,,
N041,Nephrotic syndrome with focal and segmental glomerular lesions,,
N042,Nephrotic syndrome with diffuse membranous glomerulonephritis,,
N0420,"Nephrotic syndrome with diffuse membranous glomerulonephritis, unspecified",,
N0421,Primary membranous nephropathy with nephrotic syndrome,,
N0422,Secondary membranous nephropathy with nephrotic syndrome,,
N0429,Other nephrotic syndrome with diffuse membranous glomerulonephritis,,
N043,Nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis,,
N044,Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis,,
N045,Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis,,
N046,Nephrotic syndrome with dense deposit disease,,
N047,Nephrotic syndrome with diffuse crescentic glomerulonephritis,,
N048,Nephrotic syndrome with other morphologic changes,,
N049,Nephrotic syndrome with unspecified morphologic changes,,
N04A,Nephrotic syndrome with C3 glomerulonephritis,,
N050,Unspecified nephritic syndrome with minor glomerular abnormality,,
N051,Unspecified nephritic syndrome with focal and segmental glomerular lesions,,
N052,Unspecified nephritic syndrome with diffuse membranous glomerulonephritis,,
N053,Unspecified nephritic syndrome with diffuse mesangial proliferative glomerulonephritis,,
N054,Unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis,,
N055,Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis,,
N056,Unspecified nephritic syndrome with dense deposit disease,,
N057,Unspecified nephritic syndrome with diffuse crescentic glomerulonephritis,,
N058,Unspecified nephritic syndrome with other morphologic changes,,
N059,Unspecified nephritic syndrome with unspecified morphologic changes,,
N05A,Unspecified nephritic syndrome with C3 glomerulonephritis,,
N060,Isolated proteinuria with minor glomerular abnormality,,
N061,Isolated proteinuria with focal and segmental glomerular lesions,,
N062,Isolated proteinuria with diffuse membranous glomerulonephritis,,
N0620,"Isolated proteinuria with diffuse membranous glomerulonephritis, unspecified",,
N0621,Primary membranous nephropathy with isolated proteinuria,,
N0622,Secondary membranous nephropathy with isolated proteinuria,,
N0629,Other isolated proteinuria with diffuse membranous glomerulonephritis,,
N063,Isolated proteinuria with diffuse mesangial proliferative glomerulonephritis,,
N064,Isolated proteinuria with diffuse endocapillary proliferative glomerulonephritis,,
N065,Isolated proteinuria with diffuse mesangiocapillary glomerulonephritis,,
N066,Isolated proteinuria with dense deposit disease,,
N067,Isolated proteinuria with diffuse crescentic glomerulonephritis,,
N068,Isolated proteinuria with other morphologic lesion,,
N069,Isolated proteinuria with unspecified morphologic lesion,,
N06A,Isolated proteinuria with C3 glomerulonephritis,,
N070,"Hereditary nephropathy, not elsewhere classified with minor glomerular abnormality",,
N071,"Hereditary nephropathy, not elsewhere classified with focal and segmental glomerular lesions",,
N072,"Hereditary nephropathy, not elsewhere classified with diffuse membranous glomerulonephritis",,
N073,"Hereditary nephropathy, not elsewhere classified with diffuse mesangial proliferative glomerulonephritis",,
N074,"Hereditary nephropathy, not elsewhere classified with diffuse endocapillary proliferative glomerulonephritis",,
N075,"Hereditary nephropathy, not elsewhere classified with diffuse mesangiocapillary glomerulonephritis",,
N076,"Hereditary nephropathy, not elsewhere classified with dense deposit disease",,
N077,"Hereditary nephropathy, not elsewhere classified with diffuse crescentic glomerulonephritis",,
N078,"Hereditary nephropathy, not elsewhere classified with other morphologic lesions",,
N079,"Hereditary nephropathy, not elsewhere classified with unspecified morphologic lesions",,
N07A,"Hereditary nephropathy, not elsewhere classified with C3 glomerulonephritis",,
N08,Glomerular disorders in diseases classified elsewhere,,
N140,Analgesic nephropathy,,
N1411,Contrast-induced nephropathy,,
N1419,"Nephropathy induced by other drugs, medicaments and biological substances",,
N142,"Nephropathy induced by unspecified drug, medicament or biological substance",,
N143,Nephropathy induced by heavy metals,,
N144,"Toxic nephropathy, not elsewhere classified",,
N150,Balkan nephropathy,,
N158,Other specified renal tubulo-interstitial diseases,,
N170,Acute kidney failure with tubular necrosis,,
N171,Acute kidney failure with acute cortical necrosis,,
N172,Acute kidney failure with medullary necrosis,,
N178,Other acute kidney failure,,
N179,"Acute kidney failure, unspecified",,
N181,"Chronic kidney disease, stage 1",,
N182,"Chronic kidney disease, stage 2 (mild)",,
N1830,"Chronic kidney disease, stage 3 unspecified",329,N185 (97%); I130 (86%); N184 (86%); I120 (85%); I1311 (76%)
N1831,"Chronic kidney disease, stage 3a",329,N185 (74%); N184 (65%); I130 (64%); I120 (64%); I1311 (58%)
N1832,"Chronic kidney disease, stage 3b",328,N185 (74%); N1830 (72%); N184 (65%); I130 (64%); I120 (64%)
N184,"Chronic kidney disease, stage 4 (severe)",327,N185 (88%); N1830 (86%); I130 (77%); I120 (77%); I1311 (69%)
N185,"Chronic kidney disease, stage 5",326,N1830 (97%); N184 (88%); I130 (87%); I132 (78%); N1831 (74%)
N186,End stage renal disease,326,I132 (60%); I5084 (46%); I823 (40%); N1830 (40%); C659 (39%)
N189,"Chronic kidney disease, unspecified",,
N19,Unspecified kidney failure,,
N250,Renal osteodystrophy,,
N251,Nephrogenic diabetes insipidus,,
N2581,Secondary hyperparathyroidism of renal origin,,
N262,Page kidney,,
N280,Ischemia and infarction of kidney,,
N493,Fournier gangrene,92,I96 (43%); J850 (35%); A480 (34%); I7301 (28%); I70768 (26%)
N7682,Fournier disease of vagina and vulva,92,C52 (48%); C519 (45%); C518 (36%); G959 (14%); I120 (13%)
N99510,Cystostomy hemorrhage,,
N99511,Cystostomy infection,,
N99512,Cystostomy malfunction,,
N99518,Other cystostomy complication,,
N99520,Hemorrhage of incontinent external stoma of urinary tract,,
N99521,Infection of incontinent external stoma of urinary tract,,
N99522,Malfunction of incontinent external stoma of urinary tract,,
N99523,Herniation of incontinent stoma of urinary tract,,
N99524,Stenosis of incontinent stoma of urinary tract,,
N99528,Other complication of incontinent external stoma of urinary tract,,
N99530,Hemorrhage of continent stoma of urinary tract,,
N99531,Infection of continent stoma of urinary tract,,
N99532,Malfunction of continent stoma of urinary tract,,
N99533,Herniation of continent stoma of urinary tract,,
N99534,Stenosis of continent stoma of urinary tract,,
N99538,Other complication of continent stoma of urinary tract,,
P0270,Newborn affected by fetal inflammatory response syndrome,2,P0441 (34%); P043 (34%); P0481 (33%); P0418 (33%); P0442 (32%)
P040,"Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery",137,P0270 (20%); P2819 (14%); P90 (14%); P285 (13%); P559 (13%)
P0411,Newborn affected by maternal antineoplastic chemotherapy,137,P0270 (27%); T451X2A (27%); P2819 (19%); P90 (19%); P285 (19%)
P0412,Newborn affected by maternal cytotoxic drugs,137,P0270 (29%); P2819 (20%); P90 (20%); P285 (20%); P559 (20%)
P0413,Newborn affected by maternal use of anticonvulsants,137,P0270 (30%); P2819 (21%); P90 (21%); P285 (21%); P559 (21%)
P0414,Newborn affected by maternal use of opiates,137,P0270 (30%); P2819 (21%); P90 (21%); P285 (21%); P559 (21%)
P0415,Newborn affected by maternal use of antidepressants,137,T43292A (36%); T43202A (35%); P0270 (32%); T43012A (28%); T43022A (28%)
P0416,Newborn affected by maternal use of amphetamines,137,T43622A (38%); P0270 (31%); P2819 (22%); P90 (22%); P285 (21%)
P0417,Newborn affected by maternal use of sedative-hypnotics,137,P0270 (28%); F13959 (24%); F13931 (24%); F1397 (24%); F13950 (24%)
P0418,Newborn affected by other maternal medication,137,P0270 (33%); P2819 (23%); P90 (23%); P285 (22%); P559 (22%)
P0419,Newborn affected by maternal use of unspecified medication,137,P0270 (30%); P559 (24%); P2810 (24%); P529 (22%); P919 (22%)
P041A,Newborn affected by maternal use of anxiolytics,137,P0270 (30%); P2819 (21%); P90 (21%); P285 (21%); P559 (21%)
P042,Newborn affected by maternal use of tobacco,137,P0270 (31%); T65212A (28%); T65222A (28%); T65292A (28%); P2819 (22%)
P043,Newborn affected by maternal use of alcohol,137,F10988 (48%); F1094 (45%); F10980 (45%); F10959 (44%); F10982 (44%)
P0440,Newborn affected by maternal use of unspecified drugs of addiction,137,P0270 (28%); P559 (22%); P2810 (22%); P529 (21%); P919 (21%)
P0441,Newborn affected by maternal use of cocaine,137,F14959 (44%); F14950 (42%); F14951 (42%); P0270 (34%); F14259 (34%)
P0442,Newborn affected by maternal use of hallucinogens,137,P0270 (32%); T40992A (29%); T40902A (29%); P2819 (22%); P90 (22%)
P0449,Newborn affected by maternal use of other drugs of addiction,137,P0270 (29%); P2819 (20%); P90 (20%); P285 (20%); P559 (19%)
P045,Newborn affected by maternal use of nutritional chemical substances,137,P0270 (24%); T65892A (20%); T50Z92A (18%); T578X2A (17%); P2819 (17%)
P046,Newborn affected by maternal exposure to environmental chemical substances,137,P0270 (23%); X832XXA (22%); T65892A (19%); T50Z92A (17%); T578X2A (16%)
P0481,Newborn affected by maternal use of cannabis,137,F12959 (42%); F12950 (38%); F12951 (38%); P0270 (33%); F12259 (28%)
P0489,Newborn affected by other maternal noxious substances,137,T628X2A (39%); P0270 (29%); T65892A (25%); T6292XA (22%); T50Z92A (22%)
P049,"Newborn affected by maternal noxious substance, unspecified",137,T6292XA (36%); P0270 (31%); F19959 (25%); P559 (24%); F19259 (24%)
P100,Subdural hemorrhage due to birth injury,248,P122 (49%); P115 (48%); S065X0A (48%); S065X9A (41%); S065X1A (39%)
P101,Cerebral hemorrhage due to birth injury,248,P122 (55%); P115 (53%); I6349 (32%); I6339 (32%); G936 (32%)
P102,Intraventricular hemorrhage due to birth injury,248,P122 (48%); P115 (47%); S069X0A (18%); K9401 (18%); K9421 (18%)
P103,Subarachnoid hemorrhage due to birth injury,248,P122 (52%); P115 (51%); S066X0A (42%); S066X9A (35%); I69065 (35%)
P104,Tentorial tear due to birth injury,248,P115 (38%); P122 (30%); S069X0A (15%); S34139A (14%); S14109A (14%)
P108,Other intracranial lacerations and hemorrhages due to birth injury,248,P115 (36%); S069X0A (32%); S06890A (31%); P122 (29%); S069X9A (26%)
P109,Unspecified intracranial laceration and hemorrhage due to birth injury,248,P122 (46%); P115 (45%); S069X0A (43%); S06890A (38%); S069X9A (38%)
P110,Cerebral edema due to birth injury,248,G936 (58%); P115 (54%); P122 (44%); S061X0A (35%); I6349 (32%)
P111,Other specified brain damage due to birth injury,248,G931 (51%); P115 (41%); P122 (34%); S062X0A (32%); S06300A (31%)
P112,Unspecified brain damage due to birth injury,248,G931 (52%); P115 (43%); C719 (35%); P122 (35%); S06300A (34%)
P115,Birth injury to spine and spinal cord,182,P110 (54%); P101 (53%); P103 (51%); P100 (48%); P102 (47%)
P122,Epicranial subaponeurotic hemorrhage due to birth injury,399,P101 (55%); P103 (52%); P100 (49%); P102 (48%); P109 (46%)
P220,Respiratory distress syndrome of newborn,213,P2881 (47%); R092 (29%); M3311 (27%); M3311 (27%); C7830 (25%)
P260,Tracheobronchial hemorrhage originating in the perinatal period,213,P780 (28%); K9401 (13%); K9421 (13%); I608 (13%); I629 (13%)
P261,Massive pulmonary hemorrhage originating in the perinatal period,213,P780 (27%); I2782 (23%); I279 (21%); I2720 (21%); J8410 (20%)
P268,Other pulmonary hemorrhages originating in the perinatal period,213,P528 (32%); P780 (28%); P108 (25%); I2782 (24%); I279 (22%)
P269,Unspecified pulmonary hemorrhage originating in the perinatal period,213,P780 (31%); I279 (27%); I2720 (27%); I2782 (27%); J8410 (26%)
P270,Wilson-Mikity syndrome,213,E8301 (58%); E340 (20%); G839 (18%); G8382 (18%); G8383 (17%)
P271,Bronchopulmonary dysplasia originating in the perinatal period,213,B4481 (29%); P780 (27%); Q061 (24%); Q044 (21%); C92A1 (21%)
P278,Other chronic respiratory diseases originating in the perinatal period,213,J99 (34%); P780 (30%); R092 (23%); M3311 (21%); M3311 (21%)
P279,Unspecified chronic respiratory disease originating in the perinatal period,213,P780 (30%); J440 (28%); J84115 (23%); R092 (23%); C7830 (23%)
P280,Primary atelectasis of newborn,213,C801 (43%); D6949 (34%); E7253 (33%); G1223 (33%); I270 (33%)
P2810,Unspecified atelectasis of newborn,213,P559 (35%); P529 (33%); P919 (33%); P90 (31%); P369 (30%)
P2811,Resorption atelectasis without respiratory distress syndrome,213,R092 (22%); M3311 (20%); M3311 (20%); C7830 (19%); M3321 (19%)
P2819,Other atelectasis of newborn,213,P90 (32%); P559 (31%); P558 (31%); P525 (30%); P529 (29%)
P285,Respiratory failure of newborn,213,P2881 (59%); I5089 (41%); I50814 (40%); I509 (40%); I50810 (37%)
P2881,Respiratory arrest of newborn,212,P2981 (66%); P285 (59%); P220 (47%); I468 (41%); I469 (39%)
P290,Neonatal cardiac failure,225,I462 (52%); P915 (47%); P91829 (42%); P91819 (40%); P2981 (39%)
P2981,Cardiac arrest of newborn,213,P2881 (66%); R092 (50%); P290 (39%); T86290 (33%); P90 (26%)
P360,"Sepsis of newborn due to streptococcus, group B",2,T362X2A (31%); B377 (25%); P2819 (22%); P90 (22%); P285 (22%)
P3610,Sepsis of newborn due to unspecified streptococci,2,P559 (29%); P2810 (29%); B377 (29%); P529 (27%); P919 (27%)
P3619,Sepsis of newborn due to other streptococci,2,B377 (29%); P2819 (26%); P90 (26%); P285 (26%); P559 (26%)
P362,Sepsis of newborn due to Staphylococcus aureus,2,J15211 (49%); J15212 (49%); J1529 (40%); J1520 (39%); B377 (26%)
P3630,Sepsis of newborn due to unspecified staphylococci,2,P559 (29%); P2810 (29%); B377 (29%); P529 (27%); P919 (27%)
P3639,Sepsis of newborn due to other staphylococci,2,B377 (29%); P2819 (26%); P90 (26%); P285 (26%); P559 (26%)
P364,Sepsis of newborn due to Escherichia coli,2,J155 (70%); B377 (24%); P2819 (22%); P90 (22%); P285 (21%)
P365,Sepsis of newborn due to anaerobes,2,B377 (29%); P2819 (26%); P90 (26%); P285 (26%); P559 (26%)
P368,Other bacterial sepsis of newborn,2,T50A92A (38%); K652 (38%); B377 (31%); P2819 (27%); P90 (27%)
P369,"Bacterial sepsis of newborn, unspecified",2,T50A92A (37%); K652 (37%); P559 (30%); P2810 (30%); B377 (30%)
P520,"Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn",248,I69265 (26%); I69065 (26%); I69269 (26%); I69165 (26%); I69069 (26%)
P521,"Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn",248,I69265 (26%); I69065 (26%); I69269 (26%); I69165 (26%); I69069 (26%)
P5221,"Intraventricular (nontraumatic) hemorrhage, grade 3, of newborn",248,I69265 (26%); I69065 (26%); I69269 (26%); I69165 (26%); I69069 (26%)
P5222,"Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn",248,I69265 (26%); I69065 (26%); I69269 (26%); I69165 (26%); I69069 (26%)
P523,Unspecified intraventricular (nontraumatic) hemorrhage of newborn,248,I69269 (31%); I69069 (31%); I69249 (31%); I69169 (31%); I69049 (30%)
P524,Intracerebral (nontraumatic) hemorrhage of newborn,248,I69165 (58%); I69169 (57%); I69149 (56%); I69139 (55%); I69159 (54%)
P525,Subarachnoid (nontraumatic) hemorrhage of newborn,248,I69065 (56%); I69069 (55%); I69049 (54%); I69039 (53%); I69059 (53%)
P526,Cerebellar (nontraumatic) and posterior fossa hemorrhage of newborn,248,C090 (37%); I63449 (25%); I63349 (25%); I63442 (25%); I63441 (25%)
P528,Other intracranial (nontraumatic) hemorrhages of newborn,248,I69265 (34%); I69269 (33%); I69249 (33%); P268 (32%); I69239 (32%)
P529,"Intracranial (nontraumatic) hemorrhage of newborn, unspecified",248,I69269 (56%); I69249 (55%); I69239 (54%); I69265 (54%); I69259 (54%)
P550,Rh isoimmunization of newborn,109,P570 (42%); P2819 (24%); P90 (24%); P285 (23%); P2810 (23%)
P551,ABO isoimmunization of newborn,109,P570 (42%); P2819 (24%); P90 (24%); P285 (23%); P2810 (23%)
P558,Other hemolytic diseases of newborn,109,J84178 (32%); P2819 (31%); P90 (31%); P285 (30%); P2810 (30%)
P559,"Hemolytic disease of newborn, unspecified",109,P2810 (35%); P529 (33%); P919 (33%); P2819 (31%); P90 (31%)
P560,Hydrops fetalis due to isoimmunization,109,P570 (39%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
P5690,Hydrops fetalis due to unspecified hemolytic disease,109,G959 (19%); K50919 (17%); B259 (16%); I279 (16%); M02359 (16%)
P5699,Hydrops fetalis due to other hemolytic disease,109,G959 (15%); I120 (14%); G20 (13%); G308 (13%); B259 (13%)
P570,Kernicterus due to isoimmunization,192,P550 (42%); P551 (42%); P560 (39%); A0104 (0%); A0105 (0%)
P578,Other specified kernicterus,192,M068A (33%); E1369 (32%); A4189 (25%); M06859 (21%); M0680 (21%)
P579,"Kernicterus, unspecified",192,G8330 (12%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
P771,Stage 1 necrotizing enterocolitis in newborn,78,M319 (36%); M726 (35%); M318 (33%); G374 (27%); L89102 (25%)
P772,Stage 2 necrotizing enterocolitis in newborn,78,M319 (36%); M726 (35%); M318 (33%); G374 (27%); L89102 (25%)
P773,Stage 3 necrotizing enterocolitis in newborn,78,M319 (36%); M726 (35%); M318 (33%); G374 (27%); L89102 (25%)
P779,"Necrotizing enterocolitis in newborn, unspecified",78,M319 (41%); M726 (38%); M318 (36%); G374 (29%); P559 (28%)
P780,Perinatal intestinal perforation,78,P269 (31%); P279 (30%); P278 (30%); P260 (28%); P268 (28%)
P90,Convulsions of newborn,201,P2819 (32%); P285 (32%); P559 (31%); P2810 (31%); P558 (31%)
P910,Neonatal cerebral ischemia,202,P91829 (58%); P91823 (54%); P91822 (50%); P91821 (50%); P290 (34%)
P911,Acquired periventricular cysts of newborn,202,Q046 (38%); G9343 (30%); Z89449 (28%); Z89439 (28%); Z89442 (28%)
P912,Neonatal cerebral leukomalacia,202,P91829 (58%); P91823 (54%); P91822 (50%); P91821 (50%); P290 (34%)
P913,Neonatal cerebral irritability,202,P91829 (58%); P91823 (54%); P91822 (50%); P91821 (50%); P290 (34%)
P914,Neonatal cerebral depression,202,P91829 (58%); P91823 (54%); P91822 (50%); P91821 (50%); P290 (34%)
P915,Neonatal coma,202,P91829 (55%); P91823 (51%); P91822 (47%); P91821 (47%); P290 (47%)
P9160,"Hypoxic ischemic encephalopathy [HIE], unspecified",202,I249 (34%); K7682 (34%); I248 (26%); I2489 (26%); G8330 (6%)
P9161,Mild hypoxic ischemic encephalopathy [HIE],202,K7682 (32%); I249 (30%); I248 (25%); I2489 (25%); F03A4 (18%)
P9162,Moderate hypoxic ischemic encephalopathy [HIE],202,K7682 (32%); I249 (30%); I248 (25%); I2489 (25%); F03B4 (18%)
P9163,Severe hypoxic ischemic encephalopathy [HIE],202,K7682 (32%); I249 (31%); I248 (25%); I2489 (25%); F03C4 (17%)
P91811,Neonatal encephalopathy in diseases classified elsewhere,202,K7682 (43%); G914 (41%); M9058 (40%); M9050 (39%); M90519 (39%)
P91819,"Neonatal encephalopathy, unspecified",202,K7682 (51%); P91829 (51%); P91823 (43%); P91822 (40%); P91821 (40%)
P91821,"Neonatal cerebral infarction, right side of brain",249,P910 (50%); P912 (50%); P913 (50%); P914 (50%); P915 (47%)
P91822,"Neonatal cerebral infarction, left side of brain",249,P910 (50%); P912 (50%); P913 (50%); P914 (50%); P915 (47%)
P91823,"Neonatal cerebral infarction, bilateral",249,P910 (54%); P912 (54%); P913 (54%); P914 (54%); P915 (51%)
P91829,"Neonatal cerebral infarction, unspecified side",249,P910 (58%); P912 (58%); P913 (58%); P914 (58%); P915 (55%)
P9188,Other specified disturbances of cerebral status of newborn,202,F19122 (35%); F13932 (32%); S061XAA (28%); I6349 (27%); I6339 (27%)
P919,"Disturbance of cerebral status of newborn, unspecified",202,F0390 (42%); F03C0 (40%); F03B0 (40%); F03A0 (40%); F0150 (39%)
P930,Grey baby syndrome,137,E340 (19%); G839 (18%); G8382 (17%); G8383 (17%); D469 (15%)
P938,Other reactions and intoxications due to drugs administered to newborn,137,P2819 (18%); P90 (18%); P285 (17%); P559 (17%); P2810 (17%)
P961,Neonatal withdrawal symptoms from maternal use of drugs of addiction,137,P915 (31%); F10939 (31%); F10930 (28%); P91829 (28%); F10931 (28%)
P962,Withdrawal symptoms from therapeutic use of drugs in newborn,137,F10939 (34%); T415X2A (32%); F10930 (31%); F10931 (31%); F19931 (28%)
Q000,Anencephaly,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q001,Craniorachischisis,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q002,Iniencephaly,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q010,Frontal encephalocele,182,C312 (51%); C711 (49%); A0104 (0%); A0105 (0%); A021 (0%)
Q011,Nasofrontal encephalocele,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q012,Occipital encephalocele,182,C714 (38%); S02113B (36%); S02113A (36%); S02110B (35%); S02110A (35%)
Q018,Encephalocele of other sites,182,M868X9 (33%); M868X0 (27%); M8789 (27%); M8669 (25%); C457 (25%)
Q019,"Encephalocele, unspecified",182,G8330 (13%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
Q02,Microcephaly,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q030,Malformations of aqueduct of Sylvius,182,Q433 (26%); A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%)
Q031,Atresia of foramina of Magendie and Luschka,182,Q442 (21%); Q410 (19%); Q411 (19%); Q412 (19%); Q429 (19%)
Q038,Other congenital hydrocephalus,182,G918 (73%); G919 (69%); G914 (50%); G7129 (48%); G911 (47%)
Q039,"Congenital hydrocephalus, unspecified",182,G919 (74%); G918 (71%); G7120 (51%); G914 (48%); G7129 (47%)
Q040,Congenital malformations of corpus callosum,182,G371 (58%); Q433 (43%); C549 (34%); C548 (29%); G7129 (28%)
Q041,Arhinencephaly,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q042,Holoprosencephaly,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q043,Other reduction deformities of brain,182,C719 (30%); G935 (28%); C7931 (26%); D332 (25%); D496 (24%)
Q044,Septo-optic dysplasia of brain,182,C7230 (34%); C7232 (34%); C7231 (34%); C719 (27%); G935 (26%)
Q045,Megalencephaly,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q046,Congenital cerebral cysts,182,G9343 (39%); G7129 (39%); P911 (38%); G7120 (38%); G9342 (34%)
Q048,Other specified congenital malformations of brain,182,Q433 (54%); G7129 (36%); G7120 (35%); C719 (34%); G935 (32%)
Q049,"Congenital malformation of brain, unspecified",182,C719 (39%); G7120 (39%); G7129 (36%); D332 (33%); G935 (33%)
Q050,Cervical spina bifida with hydrocephalus,182,G918 (52%); G919 (49%); G914 (35%); G911 (33%); G910 (33%)
Q051,Thoracic spina bifida with hydrocephalus,182,G918 (51%); G919 (48%); G914 (34%); G911 (33%); G910 (32%)
Q052,Lumbar spina bifida with hydrocephalus,182,G918 (50%); G919 (48%); G914 (34%); G911 (33%); G910 (32%)
Q053,Sacral spina bifida with hydrocephalus,182,G918 (48%); G919 (46%); G914 (33%); G911 (31%); G910 (31%)
Q054,Unspecified spina bifida with hydrocephalus,182,G919 (57%); G918 (54%); G914 (37%); G911 (35%); G910 (35%)
Q055,Cervical spina bifida without hydrocephalus,182,G918 (52%); G919 (49%); G914 (35%); G911 (33%); G910 (33%)
Q056,Thoracic spina bifida without hydrocephalus,182,G918 (51%); G919 (48%); G914 (34%); G911 (33%); G910 (32%)
Q057,Lumbar spina bifida without hydrocephalus,182,G918 (50%); G919 (48%); G914 (34%); G911 (33%); G910 (32%)
Q058,Sacral spina bifida without hydrocephalus,182,G918 (48%); G919 (46%); G914 (33%); G911 (31%); G910 (31%)
Q059,"Spina bifida, unspecified",182,G8330 (10%); L97909 (10%); G8190 (10%); C8510 (10%); M08959 (10%)
Q060,Amyelia,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q061,Hypoplasia and dysplasia of spinal cord,182,C720 (35%); D334 (30%); C92A1 (27%); C92A2 (27%); D46A (27%)
Q062,Diastematomyelia,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q063,Other congenital cauda equina malformations,182,C721 (69%); Q433 (43%); G7129 (29%); G7120 (28%); D700 (23%)
Q064,Hydromyelia,182,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q068,Other specified congenital malformations of spinal cord,182,Q433 (53%); C720 (38%); G7129 (35%); G7120 (34%); D334 (32%)
Q069,"Congenital malformation of spinal cord, unspecified",182,G7120 (39%); C720 (38%); G7129 (36%); D334 (32%); S14119A (29%)
Q0700,Arnold-Chiari syndrome without spina bifida or hydrocephalus,182,G918 (38%); I820 (37%); G919 (37%); G914 (26%); G911 (25%)
Q0701,Arnold-Chiari syndrome with spina bifida,182,I820 (40%); E340 (16%); G839 (15%); G8382 (15%); G8383 (14%)
Q0702,Arnold-Chiari syndrome with hydrocephalus,182,G918 (48%); I820 (46%); G919 (45%); G914 (32%); G911 (31%)
Q0703,Arnold-Chiari syndrome with spina bifida and hydrocephalus,182,G918 (38%); I820 (37%); G919 (37%); G914 (26%); G911 (25%)
Q078,Other specified congenital malformations of nervous system,182,Q433 (52%); G378 (35%); G3789 (35%); G7129 (35%); D337 (34%)
Q079,"Congenital malformation of nervous system, unspecified",182,G7120 (38%); C7940 (38%); C729 (37%); G7129 (35%); D339 (33%)
Q200,Common arterial trunk,,
Q201,Double outlet right ventricle,,
Q202,Double outlet left ventricle,,
Q203,Discordant ventriculoarterial connection,,
Q204,Double inlet ventricle,,
Q205,Discordant atrioventricular connection,,
Q208,Other congenital malformations of cardiac chambers and connections,,
Q210,Ventricular septal defect,,
Q2120,"Atrioventricular septal defect, unspecified as to partial or complete",,
Q2121,Partial atrioventricular septal defect,,
Q2122,Transitional atrioventricular septal defect,,
Q2123,Complete atrioventricular septal defect,,
Q213,Tetralogy of Fallot,,
Q220,Pulmonary valve atresia,,
Q234,Hypoplastic left heart syndrome,,
Q245,Malformation of coronary vessels,,
Q250,Patent ductus arteriosus,,
Q255,Atresia of pulmonary artery,,
Q2571,Coarctation of pulmonary artery,,
Q260,Congenital stenosis of vena cava,,
Q261,Persistent left superior vena cava,,
Q262,Total anomalous pulmonary venous connection,,
Q263,Partial anomalous pulmonary venous connection,,
Q264,"Anomalous pulmonary venous connection, unspecified",,
Q268,Other congenital malformations of great veins,,
Q269,"Congenital malformation of great vein, unspecified",,
Q400,Congenital hypertrophic pyloric stenosis,78,I422 (42%); C163 (37%); I421 (34%); G7129 (29%); Q443 (29%)
Q410,"Congenital absence, atresia and stenosis of duodenum",78,C170 (44%); C7A010 (35%); D3A010 (32%); G7129 (28%); Q443 (28%)
Q411,"Congenital absence, atresia and stenosis of jejunum",78,C171 (44%); C7A011 (35%); D3A011 (32%); G7129 (28%); Q443 (28%)
Q412,"Congenital absence, atresia and stenosis of ileum",78,C172 (44%); C7A012 (35%); D3A012 (32%); G7129 (28%); Q443 (28%)
Q418,"Congenital absence, atresia and stenosis of other specified parts of small intestine",78,C179 (41%); C784 (37%); C178 (33%); K5000 (33%); K50018 (32%)
Q419,"Congenital absence, atresia and stenosis of small intestine, part unspecified",78,C179 (48%); C784 (41%); K50019 (38%); C178 (37%); K5000 (36%)
Q420,"Congenital absence, atresia and stenosis of rectum with fistula",78,C20 (37%); C7A026 (29%); D3A026 (26%); K50913 (26%); G7129 (26%)
Q421,"Congenital absence, atresia and stenosis of rectum without fistula",78,C20 (37%); C7A026 (29%); D3A026 (26%); K50913 (26%); G7129 (26%)
Q422,"Congenital absence, atresia and stenosis of anus with fistula",78,C210 (40%); K50913 (26%); G7129 (26%); Q443 (26%); G7120 (25%)
Q423,"Congenital absence, atresia and stenosis of anus without fistula",78,C210 (40%); K50913 (26%); G7129 (26%); Q443 (26%); G7120 (25%)
Q428,"Congenital absence, atresia and stenosis of other parts of large intestine",78,K5010 (32%); K50118 (32%); K50119 (31%); K50113 (30%); K50114 (30%)
Q429,"Congenital absence, atresia and stenosis of large intestine, part unspecified",78,K50119 (36%); K5010 (34%); K50118 (34%); K50113 (33%); K50114 (33%)
Q431,Hirschsprung's disease,78,G959 (22%); I120 (21%); G20 (19%); G308 (19%); B259 (18%)
Q432,Other congenital functional disorders of colon,78,D71 (49%); R532 (43%); C189 (35%); G7129 (31%); G7120 (30%)
Q433,Congenital malformations of intestinal fixation,78,Q048 (54%); Q068 (53%); Q078 (52%); Q063 (43%); Q040 (43%)
Q442,Atresia of bile ducts,68,C240 (29%); C221 (29%); C787 (26%); Q410 (24%); Q411 (24%)
Q443,Congenital stenosis and stricture of bile ducts,68,Q400 (29%); Q410 (28%); Q411 (28%); Q412 (28%); Q429 (28%)
Q4471,Alagille syndrome,68,E340 (26%); G839 (25%); G8382 (23%); G8383 (23%); D469 (20%)
Q6111,Cystic dilatation of collecting ducts,,
Q6119,"Other polycystic kidney, infantile type",,
Q7960,"Ehlers-Danlos syndrome, unspecified",,
Q7961,Classical Ehlers-Danlos syndrome,,
Q7962,Hypermobile Ehlers-Danlos syndrome,,
Q7963,Vascular Ehlers-Danlos syndrome,,
Q7969,Other Ehlers-Danlos syndromes,,
Q8500,"Neurofibromatosis, unspecified",23,G8330 (12%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
Q8501,"Neurofibromatosis, type 1",23,E109 (14%); E119 (14%); E108 (14%); E118 (14%); E10621 (14%)
Q8502,"Neurofibromatosis, type 2",23,E109 (14%); E119 (14%); E108 (14%); E118 (14%); E10621 (14%)
Q8503,Schwannomatosis,23,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q8509,Other neurofibromatosis,23,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
Q851,Tuberous sclerosis,23,G35 (46%); M3489 (44%); M349 (43%); M3482 (36%); M3483 (35%)
Q8581,PTEN hamartoma tumor syndrome,23,C7A00 (22%); C7A093 (21%); D3A00 (20%); C7A092 (20%); C7A026 (20%)
Q8582,Other Cowden syndrome,23,E340 (26%); G839 (25%); G8382 (23%); G8383 (23%); D469 (20%)
Q8583,Von Hippel-Lindau syndrome,23,D6809 (30%); D6800 (29%); D6801 (29%); D6803 (29%); D68029 (28%)
Q8589,"Other phakomatoses, not elsewhere classified",23,I96 (29%); K738 (25%); G914 (23%); M9058 (23%); M9050 (22%)
Q859,"Phakomatosis, unspecified",23,G8330 (11%); L97909 (11%); G8190 (11%); C8510 (11%); M08959 (11%)
Q8711,Prader-Willi syndrome,,
Q8740,"Marfan syndrome, unspecified",,
Q87410,Marfan syndrome with aortic dilation,,
Q87418,Marfan syndrome with other cardiovascular manifestations,,
Q8742,Marfan syndrome with ocular manifestations,,
Q8743,Marfan syndrome with skeletal manifestation,,
Q8782,Arterial tortuosity syndrome,,
Q910,"Trisomy 18, nonmosaicism (meiotic nondisjunction)",,
Q911,"Trisomy 18, mosaicism (mitotic nondisjunction)",,
Q912,"Trisomy 18, translocation",,
Q913,"Trisomy 18, unspecified",,
Q914,"Trisomy 13, nonmosaicism (meiotic nondisjunction)",,
Q915,"Trisomy 13, mosaicism (mitotic nondisjunction)",,
Q916,"Trisomy 13, translocation",,
Q917,"Trisomy 13, unspecified",,
Q920,"Whole chromosome trisomy, nonmosaicism (meiotic nondisjunction)",,
Q921,"Whole chromosome trisomy, mosaicism (mitotic nondisjunction)",,
Q922,Partial trisomy,,
Q925,Duplications with other complex rearrangements,,
Q9261,Marker chromosomes in normal individual,,
Q9262,Marker chromosomes in abnormal individual,,
Q927,Triploidy and polyploidy,,
Q928,Other specified trisomies and partial trisomies of autosomes,,
Q929,"Trisomy and partial trisomy of autosomes, unspecified",,
Q930,"Whole chromosome monosomy, nonmosaicism (meiotic nondisjunction)",,
Q931,"Whole chromosome monosomy, mosaicism (mitotic nondisjunction)",,
Q932,"Chromosome replaced with ring, dicentric or isochromosome",,
Q933,Deletion of short arm of chromosome 4,,
Q934,Deletion of short arm of chromosome 5,,
Q9351,Angelman syndrome,,
Q9352,Phelan-McDermid syndrome,,
Q9359,Other deletions of part of a chromosome,,
Q937,Deletions with other complex rearrangements,,
Q9381,Velo-cardio-facial syndrome,,
Q9382,Williams syndrome,,
Q9388,Other microdeletions,,
Q9389,Other deletions from the autosomes,,
Q939,"Deletion from autosomes, unspecified",,
Q952,Balanced autosomal rearrangement in abnormal individual,,
Q953,Balanced sex/autosomal rearrangement in abnormal individual,,
Q992,Fragile X chromosome,,
R092,Respiratory arrest,212,P2981 (50%); I468 (47%); I469 (44%); P285 (36%); M3311 (34%)
R180,Malignant ascites,17,K7010 (54%); K7011 (54%); K7030 (47%); K7031 (47%); K7150 (42%)
R4020,Unspecified coma,202,K7290 (53%); K7291 (53%); E1010 (46%); E1011 (46%); E10641 (46%)
R402110,"Coma scale, eyes open, never, unspecified time",202,K7290 (22%); K7291 (22%); E1010 (19%); E1011 (19%); E10641 (19%)
R402111,"Coma scale, eyes open, never, in the field [EMT or ambulance]",202,K7290 (15%); K7291 (15%); E1010 (15%); E1011 (15%); E10641 (15%)
R402112,"Coma scale, eyes open, never, at arrival to emergency department",202,K7290 (15%); K7291 (15%); E1010 (15%); E1011 (15%); E10641 (15%)
R402113,"Coma scale, eyes open, never, at hospital admission",202,K7290 (18%); K7291 (18%); E1010 (18%); E1011 (18%); E10641 (18%)
R402114,"Coma scale, eyes open, never, 24 hours or more after hospital admission",202,S061X4A (32%); S069X4A (32%); S066X4A (31%); S06894A (31%); S064X4A (31%)
R402120,"Coma scale, eyes open, to pain, unspecified time",202,I70329 (20%); K7290 (20%); K7291 (20%); G546 (20%); G547 (20%)
R402121,"Coma scale, eyes open, to pain, in the field [EMT or ambulance]",202,G546 (16%); G547 (16%); K7290 (14%); K7291 (14%); E1010 (14%)
R402122,"Coma scale, eyes open, to pain, at arrival to emergency department",202,G546 (16%); G547 (16%); K7290 (14%); K7291 (14%); E1010 (14%)
R402123,"Coma scale, eyes open, to pain, at hospital admission",202,G546 (18%); G547 (18%); K7290 (16%); K7291 (16%); E1010 (16%)
R402124,"Coma scale, eyes open, to pain, 24 hours or more after hospital admission",202,S061X4A (30%); S069X4A (30%); S066X4A (29%); S06894A (29%); S064X4A (29%)
R402210,"Coma scale, best verbal response, none, unspecified time",202,K7290 (19%); K7291 (19%); E1010 (16%); E1011 (16%); E10641 (16%)
R402211,"Coma scale, best verbal response, none, in the field [EMT or ambulance]",202,K7290 (14%); K7291 (14%); E1010 (13%); E1011 (13%); E10641 (13%)
R402212,"Coma scale, best verbal response, none, at arrival to emergency department",202,K7290 (14%); K7291 (14%); E1010 (13%); E1011 (13%); E10641 (13%)
R402213,"Coma scale, best verbal response, none, at hospital admission",202,K7290 (15%); K7291 (15%); E1010 (15%); E1011 (15%); E10641 (15%)
R402214,"Coma scale, best verbal response, none, 24 hours or more after hospital admission",202,S061X4A (28%); S069X4A (28%); S066X4A (28%); S06894A (28%); S064X4A (28%)
R402220,"Coma scale, best verbal response, incomprehensible words, unspecified time",202,K7290 (15%); K7291 (15%); E1010 (13%); E1011 (13%); E10641 (13%)
R402221,"Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance]",202,K7290 (12%); K7291 (12%); E1010 (12%); E1011 (12%); E10641 (12%)
R402222,"Coma scale, best verbal response, incomprehensible words, at arrival to emergency department",202,K7290 (12%); K7291 (12%); E1010 (12%); E1011 (12%); E10641 (12%)
R402223,"Coma scale, best verbal response, incomprehensible words, at hospital admission",202,K7290 (13%); K7291 (13%); E1010 (13%); E1011 (13%); E10641 (13%)
R402224,"Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission",202,S061X4A (24%); S069X4A (24%); S066X4A (24%); S06894A (24%); S064X4A (24%)
R402310,"Coma scale, best motor response, none, unspecified time",202,G1220 (26%); G1229 (24%); X820XXA (24%); G6182 (23%); G1224 (20%)
R402311,"Coma scale, best motor response, none, in the field [EMT or ambulance]",202,G1229 (20%); X820XXA (20%); G1220 (20%); G6182 (19%); G1224 (16%)
R402312,"Coma scale, best motor response, none, at arrival to emergency department",202,G1229 (20%); X820XXA (20%); G1220 (20%); G6182 (19%); G1224 (16%)
R402313,"Coma scale, best motor response, none, at hospital admission",202,G1229 (23%); X820XXA (23%); G1220 (22%); G6182 (22%); G1224 (18%)
R402314,"Coma scale, best motor response, none, 24 hours or more after hospital admission",202,S061X4A (29%); S069X4A (29%); S066X4A (28%); S06894A (28%); S064X4A (28%)
R402320,"Coma scale, best motor response, extension, unspecified time",202,G1220 (24%); G1229 (23%); X820XXA (22%); G6182 (21%); G1224 (18%)
R402321,"Coma scale, best motor response, extension, in the field [EMT or ambulance]",202,G1229 (19%); X820XXA (19%); G1220 (19%); G6182 (18%); G1224 (16%)
R402322,"Coma scale, best motor response, extension, at arrival to emergency department",202,G1229 (19%); X820XXA (19%); G1220 (19%); G6182 (18%); G1224 (16%)
R402323,"Coma scale, best motor response, extension, at hospital admission",202,G1229 (21%); X820XXA (21%); G1220 (21%); G6182 (20%); G1224 (17%)
R402324,"Coma scale, best motor response, extension, 24 hours or more after hospital admission",202,S061X4A (27%); S069X4A (27%); S066X4A (27%); S06894A (27%); S064X4A (26%)
R402340,"Coma scale, best motor response, flexion withdrawal, unspecified time",,
R402341,"Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance]",,
R402342,"Coma scale, best motor response, flexion withdrawal, at arrival to emergency department",,
R402343,"Coma scale, best motor response, flexion withdrawal, at hospital admission",,
R402344,"Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission",,
R402430,"Glasgow coma scale score 3-8, unspecified time",202,K7290 (20%); K7291 (20%); E1010 (17%); E1011 (17%); E10641 (17%)
R402431,"Glasgow coma scale score 3-8, in the field [EMT or ambulance]",202,K7290 (14%); K7291 (14%); E1010 (14%); E1011 (14%); E10641 (14%)
R402432,"Glasgow coma scale score 3-8, at arrival to emergency department",202,K7290 (14%); K7291 (14%); E1010 (14%); E1011 (14%); E10641 (14%)
R402433,"Glasgow coma scale score 3-8, at hospital admission",202,K7290 (16%); K7291 (16%); E1010 (16%); E1011 (16%); E10641 (16%)
R402434,"Glasgow coma scale score 3-8, 24 hours or more after hospital admission",202,S061X4A (30%); S069X4A (30%); S066X4A (29%); S06894A (29%); S064X4A (29%)
R402440,"Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified time",202,K7290 (23%); K7291 (23%); E1010 (21%); E1011 (21%); E10641 (21%)
R402441,"Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance]",202,K7290 (20%); K7291 (20%); E1010 (19%); E1011 (19%); E10641 (19%)
R402442,"Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency department",202,K7290 (20%); K7291 (20%); E1010 (19%); E1011 (19%); E10641 (19%)
R402443,"Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission",202,K7290 (21%); K7291 (21%); E1010 (20%); E1011 (20%); E10641 (20%)
R402444,"Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission",202,S061X4A (20%); S069X4A (20%); K7290 (20%); K7291 (20%); E1010 (20%)
R402A,Nontraumatic coma due to underlying condition,202,E0810 (60%); E0811 (60%); E08641 (60%); E08649 (60%); E0801 (59%)
R403,Persistent vegetative state,202,G835 (40%); K730 (33%); I4819 (30%); J4550 (28%); K713 (27%)
R4588,Nonsuicidal self-harm,155,A0104 (0%); A0105 (0%); A021 (0%); A0223 (0%); A0224 (0%)
R532,Functional quadriplegia,180,Q432 (43%); D71 (36%); A0104 (0%); A0105 (0%); A021 (0%)
R5600,Simple febrile convulsions,201,J410 (35%); J418 (26%); A0104 (0%); A0105 (0%); A021 (0%)
R5601,Complex febrile convulsions,201,D816 (23%); D817 (22%); A312 (19%); A0104 (0%); A0105 (0%)
R561,Post traumatic seizures,201,G913 (64%); D47Z1 (35%); T794XXA (17%); T791XXA (16%); S061X0A (15%)
R569,Unspecified convulsions,201,G8330 (12%); L97909 (12%); G8190 (12%); C8510 (12%); M08959 (12%)
R570,Cardiogenic shock,213,R578 (64%); T794XXA (52%); A483 (48%); R571 (41%); R6520 (35%)
R571,Hypovolemic shock,2,R579 (61%); R570 (41%); A0104 (0%); A0105 (0%); A0223 (0%)
R578,Other shock,2,R579 (96%); R570 (64%); A0104 (0%); A0105 (0%); A0223 (0%)
R579,"Shock, unspecified",213,R578 (96%); T794XXA (78%); A483 (72%); R571 (61%); R6520 (53%)
R64,Cachexia,,
R6510,Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction,2,M3219 (21%); M3210 (21%); I2481 (21%); M064 (20%); M3489 (18%)
R6511,Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunction,2,M3219 (21%); M3210 (21%); I2481 (21%); M064 (20%); M3489 (18%)
R6520,Severe sepsis without septic shock,2,R579 (53%); I76 (37%); R570 (35%); I2601 (29%); I2690 (29%)
R6521,Severe sepsis with septic shock,2,R579 (53%); I76 (37%); R570 (35%); I2601 (29%); I2690 (29%)
S020XXA,"Fracture of vault of skull, initial encounter for closed fracture",399,S728X9A (49%); S728X2A (47%); S728X1A (47%); S7292XA (46%); S7291XA (46%)
S020XXB,"Fracture of vault of skull, initial encounter for open fracture",399,S3219XB (42%); S32402B (42%); S32401B (42%); S22018B (41%); S22038B (41%)
S020XXS,"Fracture of vault of skull, sequela",,
S02101A,"Fracture of base of skull, right side, initial encounter for closed fracture",399,S72041A (66%); S72044A (66%); S72043A (62%); S72046A (62%); S72042A (61%)
S02101B,"Fracture of base of skull, right side, initial encounter for open fracture",399,S72041B (60%); S72044B (60%); S72041A (58%); S72044A (58%); S72043B (56%)
S02101S,"Fracture of base of skull, right side, sequela",,
S02102A,"Fracture of base of skull, left side, initial encounter for closed fracture",399,S72042A (66%); S72045A (66%); S72043A (62%); S72046A (62%); S72041A (61%)
S02102B,"Fracture of base of skull, left side, initial encounter for open fracture",399,S72042B (60%); S72045B (60%); S72042A (58%); S72045A (58%); S72043B (56%)
S02102S,"Fracture of base of skull, left side, sequela",,
S02109A,"Fracture of base of skull, unspecified side, initial encounter for closed fracture",399,S72043A (66%); S72046A (65%); S72042A (62%); S72041A (62%); S72045A (62%)
S02109B,"Fracture of base of skull, unspecified side, initial encounter for open fracture",399,S72043B (59%); S72046B (59%); S72043A (57%); S72046A (57%); S72042B (56%)
S02109S,"Fracture of base of skull, unspecified side, sequela",,
S02110A,"Type I occipital condyle fracture, unspecified side, initial encounter for closed fracture",399,S72413A (59%); S72416A (59%); S72433A (59%); S72436A (59%); S72423A (59%)
S02110B,"Type I occipital condyle fracture, unspecified side, initial encounter for open fracture",399,S72413B (60%); S72416B (60%); S72433B (60%); S72436B (60%); S72423B (60%)
S02110S,"Type I occipital condyle fracture, unspecified side, sequela",,
S02111A,"Type II occipital condyle fracture, unspecified side, initial encounter for closed fracture",399,S72413B (61%); S72433B (61%); S72416B (61%); S72436B (61%); S72423B (61%)
S02111B,"Type II occipital condyle fracture, unspecified side, initial encounter for open fracture",399,S728X9B (69%); S72433B (68%); S7290XB (68%); S72436B (68%); S72423B (68%)
S02111S,"Type II occipital condyle fracture, unspecified side, sequela",,
S02112A,"Type III occipital condyle fracture, unspecified side, initial encounter for closed fracture",399,S32139A (54%); S72413A (53%); S72416A (53%); S72433A (53%); S72436A (53%)
S02112B,"Type III occipital condyle fracture, unspecified side, initial encounter for open fracture",399,S72413B (54%); S72416B (54%); S72433B (53%); S72436B (53%); S72423B (53%)
S02112S,"Type III occipital condyle fracture, unspecified side, sequela",,
S02113A,"Unspecified occipital condyle fracture, initial encounter for closed fracture",399,S72413A (62%); S72416A (61%); S72433A (61%); S72436A (61%); S72423A (61%)
S02113B,"Unspecified occipital condyle fracture, initial encounter for open fracture",399,S72413B (56%); S72416B (56%); S72433B (56%); S72436B (56%); S72423B (55%)
S02113S,"Unspecified occipital condyle fracture, sequela",,
S02118A,"Other fracture of occiput, unspecified side, initial encounter for closed fracture",399,S728X9A (65%); S7290XA (64%); S7292XA (61%); S7291XA (61%); S32409A (59%)
S02118B,"Other fracture of occiput, unspecified side, initial encounter for open fracture",399,S32409B (59%); S32402B (56%); S32401B (56%); S3210XB (55%); S22009B (54%)
S02118S,"Other fracture of occiput, unspecified side, sequela",,
S02119A,"Unspecified fracture of occiput, initial encounter for closed fracture",399,S728X9A (65%); S7290XA (64%); S7292XA (61%); S7291XA (61%); S32409A (59%)
S02119B,"Unspecified fracture of occiput, initial encounter for open fracture",399,S32409B (59%); S32402B (56%); S32401B (56%); S3210XB (55%); S22009B (54%)
S02119S,"Unspecified fracture of occiput, sequela",,
S0211AA,"Type I occipital condyle fracture, right side, initial encounter for closed fracture",399,S72431A (60%); S72434A (60%); S72421A (60%); S72424A (60%); S728X1A (59%)
S0211AB,"Type I occipital condyle fracture, right side, initial encounter for open fracture",399,S72431B (61%); S72434B (61%); S72421B (61%); S72424B (61%); S72411B (60%)
S0211AS,"Type I occipital condyle fracture, right side, sequela",,
S0211BA,"Type I occipital condyle fracture, left side, initial encounter for closed fracture",399,S72432A (60%); S72435A (60%); S72422A (60%); S72425A (60%); S728X2A (59%)
S0211BB,"Type I occipital condyle fracture, left side, initial encounter for open fracture",399,S72432B (61%); S72435B (61%); S72422B (61%); S72425B (61%); S72412B (60%)
S0211BS,"Type I occipital condyle fracture, left side, sequela",,
S0211CA,"Type II occipital condyle fracture, right side, initial encounter for closed fracture",399,S72431B (62%); S72434B (62%); S72421B (62%); S72424B (62%); S72411B (61%)
S0211CB,"Type II occipital condyle fracture, right side, initial encounter for open fracture",399,S728X1B (70%); S72431B (69%); S72434B (69%); S72421B (68%); S72424B (68%)
S0211CS,"Type II occipital condyle fracture, right side, sequela",,
S0211DA,"Type II occipital condyle fracture, left side, initial encounter for closed fracture",399,S72432B (62%); S72435B (62%); S72422B (62%); S72425B (62%); S72412B (61%)
S0211DB,"Type II occipital condyle fracture, left side, initial encounter for open fracture",399,S728X2B (70%); S72432B (69%); S72435B (68%); S72422B (68%); S72425B (68%)
S0211DS,"Type II occipital condyle fracture, left side, sequela",,
S0211EA,"Type III occipital condyle fracture, right side, initial encounter for closed fracture",399,S72431A (54%); S72434A (54%); S72421A (54%); S72424A (54%); S728X1A (53%)
S0211EB,"Type III occipital condyle fracture, right side, initial encounter for open fracture",399,S72431B (54%); S72434B (54%); S72421B (54%); S72424B (54%); S72411B (53%)
S0211ES,"Type III occipital condyle fracture, right side, sequela",,
S0211FA,"Type III occipital condyle fracture, left side, initial encounter for closed fracture",399,S72432A (54%); S72435A (54%); S72422A (54%); S72425A (54%); S728X2A (53%)
S0211FB,"Type III occipital condyle fracture, left side, initial encounter for open fracture",399,S72432B (54%); S72435B (54%); S72422B (54%); S72425B (54%); S72412B (53%)
S0211FS,"Type III occipital condyle fracture, left side, sequela",,
S0211GA,"Other fracture of occiput, right side, initial encounter for closed fracture",399,S728X1A (66%); S7291XA (64%); S32401A (59%); S728X9A (59%); S728X2A (57%)
S0211GB,"Other fracture of occiput, right side, initial encounter for open fracture",399,S32401B (58%); S32391B (55%); S32491B (55%); S728X1B (55%); S32301B (54%)
S0211GS,"Other fracture of occiput, right side, sequela",,
S0211HA,"Other fracture of occiput, left side, initial encounter for closed fracture",399,S728X2A (66%); S7292XA (64%); S32402A (59%); S728X9A (59%); S728X1A (57%)
S0211HB,"Other fracture of occiput, left side, initial encounter for open fracture",399,S32402B (58%); S32392B (55%); S32492B (55%); S728X2B (55%); S32302B (54%)
S0211HS,"Other fracture of occiput, left side, sequela",,
S02121A,"Fracture of orbital roof, right side, initial encounter for closed fracture",399,S728X1A (56%); S7291XA (54%); S32401A (50%); S728X9A (50%); S728X2A (49%)
S02121B,"Fracture of orbital roof, right side, initial encounter for open fracture",399,S32401B (49%); S32391B (47%); S32491B (46%); S728X1B (46%); S32301B (46%)
S02121S,"Fracture of orbital roof, right side, sequela",,
S02122A,"Fracture of orbital roof, left side, initial encounter for closed fracture",399,S728X2A (56%); S7292XA (54%); S32402A (50%); S728X9A (50%); S728X1A (49%)
S02122B,"Fracture of orbital roof, left side, initial encounter for open fracture",399,S32402B (49%); S32392B (47%); S32492B (46%); S728X2B (46%); S32302B (46%)
S02122S,"Fracture of orbital roof, left side, sequela",,
S02129A,"Fracture of orbital roof, unspecified side, initial encounter for closed fracture",399,S728X9A (54%); S7290XA (54%); S7292XA (52%); S7291XA (52%); S32409A (50%)
S02129B,"Fracture of orbital roof, unspecified side, initial encounter for open fracture",399,S32409B (49%); S32402B (47%); S32401B (47%); S3210XB (46%); S22009B (46%)
S02129S,"Fracture of orbital roof, unspecified side, sequela",,
S0219XA,"Other fracture of base of skull, initial encounter for closed fracture",399,S72043A (64%); S72046A (64%); S72042A (63%); S72041A (63%); S72045A (63%)
S0219XB,"Other fracture of base of skull, initial encounter for open fracture",399,S72043B (58%); S72046B (58%); S72042B (57%); S72041B (57%); S72045B (57%)
S0219XS,"Other fracture of base of skull, sequela",,
S0230XA,"Fracture of orbital floor, unspecified side, initial encounter for closed fracture",399,S728X9A (56%); S7290XA (55%); S7292XA (53%); S7291XA (53%); S32409A (51%)
S0230XB,"Fracture of orbital floor, unspecified side, initial encounter for open fracture",399,S32409B (50%); S32402B (48%); S32401B (48%); S3210XB (47%); S22009B (47%)
S0230XS,"Fracture of orbital floor, unspecified side, sequela",,
S0231XA,"Fracture of orbital floor, right side, initial encounter for closed fracture",399,S728X1A (57%); S7291XA (55%); S32401A (51%); S728X9A (51%); S728X2A (50%)
S0231XB,"Fracture of orbital floor, right side, initial encounter for open fracture",399,S32401B (51%); S32391B (47%); S32491B (47%); S728X1B (47%); S32301B (46%)
S0231XS,"Fracture of orbital floor, right side, sequela",,
S0232XA,"Fracture of orbital floor, left side, initial encounter for closed fracture",399,S728X2A (57%); S7292XA (55%); S32402A (51%); S728X9A (51%); S728X1A (50%)
S0232XB,"Fracture of orbital floor, left side, initial encounter for open fracture",399,S32402B (50%); S32392B (47%); S32492B (47%); S728X2B (47%); S32302B (46%)
S0232XS,"Fracture of orbital floor, left side, sequela",,
S02400A,"Malar fracture, unspecified side, initial encounter for closed fracture",399,S728X9A (64%); S7290XA (63%); S7292XA (60%); S7291XA (60%); S32409A (58%)
S02400B,"Malar fracture, unspecified side, initial encounter for open fracture",399,S32409B (58%); S32402B (55%); S32401B (55%); S3210XB (54%); S22009B (54%)
S02400S,"Malar fracture, unspecified side, sequela",,
S02401A,"Maxillary fracture, unspecified side, initial encounter for closed fracture",399,S728X9A (64%); S7290XA (63%); S7292XA (61%); S7291XA (61%); S32409A (59%)
S02401B,"Maxillary fracture, unspecified side, initial encounter for open fracture",399,S32409B (58%); S32402B (56%); S32401B (56%); S3210XB (55%); S22009B (54%)
S02401S,"Maxillary fracture, unspecified side, sequela",,
S02402A,"Zygomatic fracture, unspecified side, initial encounter for closed fracture",399,S728X9A (64%); S7290XA (63%); S7292XA (60%); S7291XA (60%); S32409A (58%)
S02402B,"Zygomatic fracture, unspecified side, initial encounter for open fracture",399,S32409B (58%); S32402B (55%); S32401B (55%); S3210XB (54%); S22009B (54%)
S02402S,"Zygomatic fracture, unspecified side, sequela",,
S0240AA,"Malar fracture, right side, initial encounter for closed fracture",399,S728X1A (65%); S7291XA (63%); S32401A (58%); S728X9A (58%); S728X2A (56%)
S0240AB,"Malar fracture, right side, initial encounter for open fracture",399,S32401B (58%); S32391B (54%); S32491B (54%); S728X1B (54%); S32301B (53%)
S0240AS,"Malar fracture, right side, sequela",,
S0240BA,"Malar fracture, left side, initial encounter for closed fracture",399,S728X2A (65%); S7292XA (63%); S32402A (58%); S728X9A (58%); S728X1A (56%)
S0240BB,"Malar fracture, left side, initial encounter for open fracture",399,S32402B (58%); S32392B (54%); S32492B (54%); S728X2B (54%); S32302B (53%)
S0240BS,"Malar fracture, left side, sequela",,
S0240CA,"Maxillary fracture, right side, initial encounter for closed fracture",399,S728X1A (65%); S7291XA (63%); S32401A (59%); S728X9A (58%); S728X2A (57%)
S0240CB,"Maxillary fracture, right side, initial encounter for open fracture",399,S32401B (58%); S32391B (55%); S32491B (54%); S728X1B (54%); S32301B (53%)
S0240CS,"Maxillary fracture, right side, sequela",,
S0240DA,"Maxillary fracture, left side, initial encounter for closed fracture",399,S728X2A (65%); S7292XA (63%); S32402A (59%); S728X9A (58%); S728X1A (57%)
S0240DB,"Maxillary fracture, left side, initial encounter for open fracture",399,S32402B (58%); S32392B (55%); S32492B (54%); S728X2B (54%); S32302B (53%)
S0240DS,"Maxillary fracture, left side, sequela",,
S0240EA,"Zygomatic fracture, right side, initial encounter for closed fracture",399,S728X1A (65%); S7291XA (63%); S32401A (58%); S728X9A (58%); S728X2A (56%)
S0240EB,"Zygomatic fracture, right side, initial encounter for open fracture",399,S32401B (58%); S32391B (54%); S32491B (54%); S728X1B (54%); S32301B (53%)
S0240ES,"Zygomatic fracture, right side, sequela",,
S0240FA,"Zygomatic fracture, left side, initial encounter for closed fracture",399,S728X2A (65%); S7292XA (63%); S32402A (58%); S728X9A (58%); S728X1A (56%)
S0240FB,"Zygomatic fracture, left side, initial encounter for open fracture",399,S32402B (58%); S32392B (54%); S32492B (54%); S728X2B (54%); S32302B (53%)
S0240FS,"Zygomatic fracture, left side, sequela",,
S02411A,"LeFort I fracture, initial encounter for closed fracture",399,S728X9A (60%); S728X2A (58%); S728X1A (58%); S7292XA (57%); S7291XA (57%)
S02411B,"LeFort I fracture, initial encounter for open fracture",399,S3219XB (52%); S32402B (52%); S32401B (52%); S22018B (51%); S22038B (51%)
S02411S,"LeFort I fracture, sequela",,
S02412A,"LeFort II fracture, initial encounter for closed fracture",399,S728X9A (55%); S728X2A (54%); S728X1A (54%); S728X9B (53%); S7292XA (52%)
S02412B,"LeFort II fracture, initial encounter for open fracture",399,S728X9B (63%); S728X2B (62%); S728X1B (62%); S7292XB (61%); S7291XB (61%)
S02412S,"LeFort II fracture, sequela",,
S02413A,"LeFort III fracture, initial encounter for closed fracture",399,S32139A (56%); S32130A (54%); S728X9A (52%); S728X2A (51%); S728X1A (51%)
S02413B,"LeFort III fracture, initial encounter for open fracture",399,S32139B (55%); S32130B (53%); S32139A (48%); S1224XB (47%); S32131B (46%)
S02413S,"LeFort III fracture, sequela",,
S0242XA,"Fracture of alveolus of maxilla, initial encounter for closed fracture",399,S728X9A (47%); S728X2A (46%); S728X1A (46%); S7292XA (45%); S7291XA (45%)
S0242XB,"Fracture of alveolus of maxilla, initial encounter for open fracture",399,S3219XB (41%); S32402B (41%); S32401B (41%); S22018B (40%); S22038B (40%)
S0242XS,"Fracture of alveolus of maxilla, sequela",,
S02600A,"Fracture of unspecified part of body of mandible, unspecified side, initial encounter for closed fracture",399,S7290XA (68%); S728X9A (65%); S32409A (63%); S7292XA (61%); S7291XA (61%)
S02600B,"Fracture of unspecified part of body of mandible, unspecified side, initial encounter for open fracture",399,S32409B (63%); S22009B (58%); S32309B (58%); S32609B (58%); S32009B (58%)
S02600S,"Fracture of unspecified part of body of mandible, unspecified side, sequela",,
S02601A,"Fracture of unspecified part of body of right mandible, initial encounter for closed fracture",399,S7291XA (66%); S728X1A (64%); S728X9A (61%); S32401A (61%); S7290XA (61%)
S02601B,"Fracture of unspecified part of body of right mandible, initial encounter for open fracture",399,S32401B (61%); S32301B (56%); S32601B (56%); S32409B (56%); S7291XB (55%)
S02601S,"Fracture of unspecified part of body of right mandible, sequela",,
S02602A,"Fracture of unspecified part of body of left mandible, initial encounter for closed fracture",399,S7292XA (66%); S728X2A (64%); S728X9A (61%); S32402A (61%); S7290XA (61%)
S02602B,"Fracture of unspecified part of body of left mandible, initial encounter for open fracture",399,S32402B (61%); S32302B (56%); S32602B (56%); S32409B (56%); S7292XB (55%)
S02602S,"Fracture of unspecified part of body of left mandible, sequela",,
S02609A,"Fracture of mandible, unspecified, initial encounter for closed fracture",399,S728X9A (72%); S7290XA (71%); S7292XA (68%); S7291XA (68%); S32409A (66%)
S02609B,"Fracture of mandible, unspecified, initial encounter for open fracture",399,S32409B (65%); S32402B (62%); S32401B (62%); S3210XB (61%); S22009B (61%)
S02609S,"Fracture of mandible, unspecified, sequela",,
S02610A,"Fracture of condylar process of mandible, unspecified side, initial encounter for closed fracture",399,S728X9A (49%); S7290XA (48%); S7292XA (46%); S7291XA (46%); S32409A (45%)
S02610B,"Fracture of condylar process of mandible, unspecified side, initial encounter for open fracture",399,S32409B (44%); S32402B (42%); S32401B (42%); S3210XB (42%); S22009B (41%)
S02610S,"Fracture of condylar process of mandible, unspecified side, sequela",,
S02611A,"Fracture of condylar process of right mandible, initial encounter for closed fracture",399,S728X1A (50%); S7291XA (49%); S32401A (45%); S728X9A (45%); S728X2A (44%)
S02611B,"Fracture of condylar process of right mandible, initial encounter for open fracture",399,S32401B (45%); S32391B (42%); S32491B (42%); S728X1B (42%); S32301B (41%)
S02611S,"Fracture of condylar process of right mandible, sequela",,
S02612A,"Fracture of condylar process of left mandible, initial encounter for closed fracture",399,S728X2A (50%); S7292XA (49%); S32402A (45%); S728X9A (45%); S728X1A (44%)
S02612B,"Fracture of condylar process of left mandible, initial encounter for open fracture",399,S32402B (45%); S32392B (42%); S32492B (42%); S728X2B (42%); S32302B (41%)
S02612S,"Fracture of condylar process of left mandible, sequela",,
S02620A,"Fracture of subcondylar process of mandible, unspecified side, initial encounter for closed fracture",399,S728X9A (49%); S7290XA (48%); S7292XA (46%); S7291XA (46%); S32409A (45%)
S02620B,"Fracture of subcondylar process of mandible, unspecified side, initial encounter for open fracture",399,S32409B (44%); S32402B (42%); S32401B (42%); S3210XB (42%); S22009B (41%)
S02620S,"Fracture of subcondylar process of mandible, unspecified side, sequela",,
S02621A,"Fracture of subcondylar process of right mandible, initial encounter for closed fracture",399,S728X1A (50%); S7291XA (49%); S32401A (45%); S728X9A (45%); S728X2A (44%)
S02621B,"Fracture of subcondylar process of right mandible, initial encounter for open fracture",399,S32401B (45%); S32391B (42%); S32491B (42%); S728X1B (42%); S32301B (41%)
S02621S,"Fracture of subcondylar process of right mandible, sequela",,
S02622A,"Fracture of subcondylar process of left mandible, initial encounter for closed fracture",399,S728X2A (50%); S7292XA (49%); S32402A (45%); S728X9A (45%); S728X1A (44%)
S02622B,"Fracture of subcondylar process of left mandible, initial encounter for open fracture",399,S32402B (45%); S32392B (42%); S32492B (42%); S728X2B (42%); S32302B (41%)
S02622S,"Fracture of subcondylar process of left mandible, sequela",,
S02630A,"Fracture of coronoid process of mandible, unspecified side, initial encounter for closed fracture",399,S728X9A (49%); S7290XA (48%); S7292XA (46%); S7291XA (46%); S32409A (45%)
S02630B,"Fracture of coronoid process of mandible, unspecified side, initial encounter for open fracture",399,S32409B (44%); S32402B (42%); S32401B (42%); S3210XB (42%); S22009B (41%)
S02630S,"Fracture of coronoid process of mandible, unspecified side, sequela",,
S02631A,"Fracture of coronoid process of right mandible, initial encounter for closed fracture",399,S728X1A (50%); S7291XA (49%); S32401A (45%); S728X9A (45%); S728X2A (44%)
S02631B,"Fracture of coronoid process of right mandible, initial encounter for open fracture",399,S32401B (45%); S32391B (42%); S32491B (42%); S728X1B (42%); S32301B (41%)
S02631S,"Fracture of coronoid process of right mandible, sequela",,
S02632A,"Fracture of coronoid process of left mandible, initial encounter for closed fracture",399,S728X2A (50%); S7292XA (49%); S32402A (45%); S728X9A (45%); S728X1A (44%)
S02632B,"Fracture of coronoid process of left mandible, initial encounter for open fracture",399,S32402B (45%); S32392B (42%); S32492B (42%); S728X2B (42%); S32302B (41%)
S02632S,"Fracture of coronoid process of left mandible, sequela",,
S02640A,"Fracture of ramus of mandible, unspecified side, initial encounter for closed fracture",399,S728X9A (56%); S7290XA (55%); S7292XA (53%); S7291XA (53%); S32409A (51%)
S02640B,"Fracture of ramus of mandible, unspecified side, initial encounter for open fracture",399,S32409B (51%); S32402B (48%); S32401B (48%); S3210XB (48%); S22009B (47%)
S02640S,"Fracture of ramus of mandible, unspecified side, sequela",,
S02641A,"Fracture of ramus of right mandible, initial encounter for closed fracture",399,S728X1A (57%); S7291XA (56%); S32401A (51%); S728X9A (51%); S728X2A (50%)
S02641B,"Fracture of ramus of right mandible, initial encounter for open fracture",399,S32401B (51%); S32391B (48%); S32491B (48%); S728X1B (47%); S32301B (47%)
S02641S,"Fracture of ramus of right mandible, sequela",,
S02642A,"Fracture of ramus of left mandible, initial encounter for closed fracture",399,S728X2A (57%); S7292XA (56%); S32402A (51%); S728X9A (51%); S728X1A (50%)
S02642B,"Fracture of ramus of left mandible, initial encounter for open fracture",399,S32402B (51%); S32392B (48%); S32492B (48%); S728X2B (47%); S32302B (47%)
S02642S,"Fracture of ramus of left mandible, sequela",,
S02650A,"Fracture of angle of mandible, unspecified side, initial encounter for closed fracture",399,S728X9A (56%); S7290XA (55%); S7292XA (53%); S7291XA (53%); S32409A (51%)
S02650B,"Fracture of angle of mandible, unspecified side, initial encounter for open fracture",399,S32409B (51%); S32402B (48%); S32401B (48%); S3210XB (48%); S22009B (47%)
S02650S,"Fracture of angle of mandible, unspecified side, sequela",,
S02651A,"Fracture of angle of right mandible, initial encounter for closed fracture",399,S728X1A (57%); S7291XA (56%); S32401A (51%); S728X9A (51%); S728X2A (50%)
S02651B,"Fracture of angle of right mandible, initial encounter for open fracture",399,S32401B (51%); S32391B (48%); S32491B (48%); S728X1B (47%); S32301B (47%)
S02651S,"Fracture of angle of right mandible, sequela",,
S02652A,"Fracture of angle of left mandible, initial encounter for closed fracture",399,S728X2A (57%); S7292XA (56%); S32402A (51%); S728X9A (51%); S728X1A (50%)
S02652B,"Fracture of angle of left mandible, initial encounter for open fracture",399,S32402B (51%); S32392B (48%); S32492B (48%); S728X2B (47%); S32302B (47%)
S02652S,"Fracture of angle of left mandible, sequela",,
S0266XA,"Fracture of symphysis of mandible, initial encounter for closed fracture",399,S728X9A (50%); S728X2A (49%); S728X1A (49%); S7292XA (48%); S7291XA (48%)
S0266XB,"Fracture of symphysis of mandible, initial encounter for open fracture",399,S3219XB (44%); S32402B (43%); S32401B (43%); S22018B (43%); S22038B (43%)
S0266XS,"Fracture of symphysis of mandible, sequela",,
S02670A,"Fracture of alveolus of mandible, unspecified side, initial encounter for closed fracture",399,S728X9A (57%); S7290XA (56%); S7292XA (54%); S7291XA (54%); S32409A (52%)
S02670B,"Fracture of alveolus of mandible, unspecified side, initial encounter for open fracture",399,S32409B (51%); S32402B (49%); S32401B (49%); S3210XB (48%); S22009B (48%)
S02670S,"Fracture of alveolus of mandible, unspecified side, sequela",,
S02671A,"Fracture of alveolus of right mandible, initial encounter for closed fracture",399,S728X1A (58%); S7291XA (56%); S32401A (52%); S728X9A (52%); S728X2A (50%)
S02671B,"Fracture of alveolus of right mandible, initial encounter for open fracture",399,S32401B (51%); S32391B (48%); S32491B (48%); S728X1B (48%); S32301B (47%)
S02671S,"Fracture of alveolus of right mandible, sequela",,
S02672A,"Fracture of alveolus of left mandible, initial encounter for closed fracture",399,S728X2A (58%); S7292XA (56%); S32402A (52%); S728X9A (52%); S728X1A (50%)
S02672B,"Fracture of alveolus of left mandible, initial encounter for open fracture",399,S32402B (51%); S32392B (48%); S32492B (48%); S728X2B (48%); S32302B (47%)
S02672S,"Fracture of alveolus of left mandible, sequela",,
S0269XA,"Fracture of mandible of other specified site, initial encounter for closed fracture",399,S32499A (62%); S32492A (61%); S32491A (61%); S32699A (58%); S32692A (57%)
S0269XB,"Fracture of mandible of other specified site, initial encounter for open fracture",399,S32499B (62%); S32492B (61%); S32491B (61%); S32699B (57%); S32692B (56%)
S0269XS,"Fracture of mandible of other specified site, sequela",,
S0280XA,"Fracture of other specified skull and facial bones, unspecified side, initial encounter for closed fracture",399,S32499A (50%); C410 (48%); S32699A (47%); S728X9A (47%); S32492A (47%)
S0280XB,"Fracture of other specified skull and facial bones, unspecified side, initial encounter for open fracture",399,S32499B (50%); C410 (48%); S32699B (46%); S32492B (46%); S32491B (46%)
S0280XS,"Fracture of other specified skull and facial bones, unspecified side, sequela",,
S0281XA,"Fracture of other specified skull and facial bones, right side, initial encounter for closed fracture",399,S32491A (51%); S728X1A (48%); S32691A (48%); C410 (47%); S32591A (47%)
S0281XB,"Fracture of other specified skull and facial bones, right side, initial encounter for open fracture",399,S32491B (51%); C410 (48%); S32691B (47%); S32591B (47%); S32499B (47%)
S0281XS,"Fracture of other specified skull and facial bones, right side, sequela",,
S0282XA,"Fracture of other specified skull and facial bones, left side, initial encounter for closed fracture",399,S32492A (51%); S728X2A (48%); S32692A (48%); C410 (47%); S32592A (47%)
S0282XB,"Fracture of other specified skull and facial bones, left side, initial encounter for open fracture",399,S32492B (51%); C410 (48%); S32692B (47%); S32592B (47%); S32499B (47%)
S0282XS,"Fracture of other specified skull and facial bones, left side, sequela",,
S02831A,"Fracture of medial orbital wall, right side, initial encounter for closed fracture",399,S32471A (75%); S32474A (75%); S32473A (71%); S32476A (71%); S32472A (71%)
S02831B,"Fracture of medial orbital wall, right side, initial encounter for open fracture",399,S32471B (75%); S32474B (75%); S32473B (71%); S32476B (71%); S32472B (70%)
S02831S,"Fracture of medial orbital wall, right side, sequela",,
S02832A,"Fracture of medial orbital wall, left side, initial encounter for closed fracture",399,S32472A (75%); S32475A (75%); S32473A (71%); S32476A (71%); S32471A (71%)
S02832B,"Fracture of medial orbital wall, left side, initial encounter for open fracture",399,S32472B (75%); S32475B (75%); S32473B (71%); S32476B (71%); S32471B (70%)
S02832S,"Fracture of medial orbital wall, left side, sequela",,
S02839A,"Fracture of medial orbital wall, unspecified side, initial encounter for closed fracture",399,S32473A (75%); S32476A (75%); S32472A (71%); S32471A (71%); S32475A (71%)
S02839B,"Fracture of medial orbital wall, unspecified side, initial encounter for open fracture",399,S32473B (74%); S32476B (74%); S32472B (71%); S32471B (71%); S32475B (71%)
S02839S,"Fracture of medial orbital wall, unspecified side, sequela",,
S02841A,"Fracture of lateral orbital wall, right side, initial encounter for closed fracture",399,S72421A (60%); S72424A (60%); S72423A (56%); S72426A (56%); S72422A (55%)
S02841B,"Fracture of lateral orbital wall, right side, initial encounter for open fracture",399,S32411B (55%); S32414B (54%); S72421B (54%); S72424B (54%); S32421B (54%)
S02841S,"Fracture of lateral orbital wall, right side, sequela",,
S02842A,"Fracture of lateral orbital wall, left side, initial encounter for closed fracture",399,S72422A (60%); S72425A (60%); S72423A (56%); S72426A (56%); S72421A (55%)
S02842B,"Fracture of lateral orbital wall, left side, initial encounter for open fracture",399,S32412B (54%); S32415B (54%); S72422B (54%); S72425B (54%); S32422B (54%)
S02842S,"Fracture of lateral orbital wall, left side, sequela",,
S02849A,"Fracture of lateral orbital wall, unspecified side, initial encounter for closed fracture",399,S72423A (59%); S72426A (59%); S72422A (56%); S72421A (56%); S72425A (56%)
S02849B,"Fracture of lateral orbital wall, unspecified side, initial encounter for open fracture",399,S32413B (54%); S32416B (54%); S72423B (53%); S72426B (53%); S32423B (53%)
S02849S,"Fracture of lateral orbital wall, unspecified side, sequela",,
S0285XA,"Fracture of orbit, unspecified, initial encounter for closed fracture",399,S728X9A (63%); C6960 (62%); S7290XA (62%); S7292XA (60%); S7291XA (60%)
S0285XB,"Fracture of orbit, unspecified, initial encounter for open fracture",399,C6960 (63%); C6962 (57%); C6961 (57%); S32409B (57%); S32402B (55%)
S0285XS,"Fracture of orbit, unspecified, sequela",,
S0291XA,"Unspecified fracture of skull, initial encounter for closed fracture",399,S728X9A (68%); S7290XA (67%); S7292XA (64%); S7291XA (64%); S32409A (62%)
S0291XB,"Unspecified fracture of skull, initial encounter for open fracture",399,S32409B (62%); S32402B (59%); S32401B (59%); S3210XB (58%); S22009B (57%)
S0291XS,"Unspecified fracture of skull, sequela",,
S0292XA,"Unspecified fracture of facial bones, initial encounter for closed fracture",399,S728X9A (55%); S7290XA (54%); S7292XA (52%); S7291XA (52%); S32409A (51%)
S0292XB,"Unspecified fracture of facial bones, initial encounter for open fracture",399,S32409B (50%); S32402B (48%); S32401B (48%); S3210XB (47%); S22009B (46%)
S0292XS,"Unspecified fracture of facial bones, sequela",,
S060X0S,"Concussion without loss of consciousness, sequela",,
S060X1S,"Concussion with loss of consciousness of 30 minutes or less, sequela",,
S060X9S,"Concussion with loss of consciousness of unspecified duration, sequela",,
S060XAS,"Concussion with loss of consciousness status unknown, sequela",,
S061X0A,"Traumatic cerebral edema without loss of consciousness, initial encounter",399,S061X9A (83%); S061X1A (78%); S061X3A (66%); S061X4A (66%); G936 (59%)
S061X0S,"Traumatic cerebral edema without loss of consciousness, sequela",,
S061X1A,"Traumatic cerebral edema with loss of consciousness of 30 minutes or less, initial encounter",398,S061X0A (78%); S061X3A (67%); S061XAA (61%); S061X4A (52%); S066X0A (47%)
S061X1S,"Traumatic cerebral edema with loss of consciousness of 30 minutes or less, sequela",,
S061X2A,"Traumatic cerebral edema with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S061X3A (73%); S061X0A (59%); S066X3A (58%); S065X3A (56%); S062X3A (54%)
S061X2S,"Traumatic cerebral edema with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S061X3A,"Traumatic cerebral edema with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S061X2A (73%); S061X1A (67%); S061X0A (66%); S066X2A (58%); S06362A (58%)
S061X3S,"Traumatic cerebral edema with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S061X4A,"Traumatic cerebral edema with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S061X0A (66%); S061X9A (55%); S061X1A (52%); S061XAA (51%); S066X0A (40%)
S061X4S,"Traumatic cerebral edema with loss of consciousness of 6 hours to 24 hours, sequela",,
S061X5A,"Traumatic cerebral edema with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S061X0A (55%); S061X9A (46%); S061X1A (43%); S061XAA (43%); S066X0A (33%)
S061X5S,"Traumatic cerebral edema with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S061X6A,"Traumatic cerebral edema with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S061X0A (49%); S061X9A (41%); S061X1A (38%); S061XAA (38%); S066X0A (30%)
S061X6S,"Traumatic cerebral edema with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S061X9A,"Traumatic cerebral edema with loss of consciousness of unspecified duration, initial encounter",398,S061X0A (83%); S061XAA (65%); S061X3A (55%); S061X4A (55%); S06360A (52%)
S061X9S,"Traumatic cerebral edema with loss of consciousness of unspecified duration, sequela",,
S061XAA,"Traumatic cerebral edema with loss of consciousness status unknown, initial encounter",399,S061X9A (65%); S061X1A (61%); S061X3A (52%); S061X4A (51%); G936 (46%)
S061XAS,"Traumatic cerebral edema with loss of consciousness status unknown, sequela",,
S062X0A,"Diffuse traumatic brain injury without loss of consciousness, initial encounter",399,S062X9A (87%); S062X1A (83%); S062X3A (73%); S062X4A (72%); S062X2A (66%)
S062X0S,"Diffuse traumatic brain injury without loss of consciousness, sequela",,
S062X1A,"Diffuse traumatic brain injury with loss of consciousness of 30 minutes or less, initial encounter",398,S062X0A (83%); S062X3A (73%); S062XAA (69%); S06300A (63%); S062X4A (61%)
S062X1S,"Diffuse traumatic brain injury with loss of consciousness of 30 minutes or less, sequela",,
S062X2A,"Diffuse traumatic brain injury with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S062X3A (77%); S062X0A (66%); S06303A (66%); S069X3A (57%); S068A3A (56%)
S062X2S,"Diffuse traumatic brain injury with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S062X3A,"Diffuse traumatic brain injury with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S062X2A (77%); S062X1A (73%); S062X0A (73%); S06302A (66%); S062X9A (64%)
S062X3S,"Diffuse traumatic brain injury with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S062X4A,"Diffuse traumatic brain injury with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S062X0A (72%); S062X9A (63%); S062X1A (61%); S062XAA (60%); S06300A (55%)
S062X4S,"Diffuse traumatic brain injury with loss of consciousness of 6 hours to 24 hours, sequela",,
S062X5A,"Diffuse traumatic brain injury with loss of consciousness greater than 24 hours with return to pre-existing conscious levels, initial encounter",397,S062X0A (58%); S062X9A (51%); S062X1A (48%); S062XAA (48%); S06300A (44%)
S062X5S,"Diffuse traumatic brain injury with loss of consciousness greater than 24 hours with return to pre-existing conscious levels, sequela",,
S062X6A,"Diffuse traumatic brain injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S062X0A (56%); S062X9A (49%); S062X1A (47%); S062XAA (47%); S06300A (43%)
S062X6S,"Diffuse traumatic brain injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S062X9A,"Diffuse traumatic brain injury with loss of consciousness of unspecified duration, initial encounter",398,S062X0A (87%); S062XAA (73%); S06300A (69%); S062X3A (64%); S062X4A (63%)
S062X9S,"Diffuse traumatic brain injury with loss of consciousness of unspecified duration, sequela",,
S062XAA,"Diffuse traumatic brain injury with loss of consciousness status unknown, initial encounter",399,S062X9A (73%); S062X1A (69%); S062X3A (61%); S062X4A (60%); S062X2A (55%)
S062XAS,"Diffuse traumatic brain injury with loss of consciousness status unknown, sequela",,
S06300A,"Unspecified focal traumatic brain injury without loss of consciousness, initial encounter",399,S06309A (88%); S06301A (84%); S06303A (74%); S06304A (74%); S062X9A (69%)
S06300S,"Unspecified focal traumatic brain injury without loss of consciousness, sequela",,
S06301A,"Unspecified focal traumatic brain injury with loss of consciousness of 30 minutes or less, initial encounter",398,S06300A (84%); S06303A (75%); S0630AA (71%); S062X0A (64%); S06304A (63%)
S06301S,"Unspecified focal traumatic brain injury with loss of consciousness of 30 minutes or less, sequela",,
S06302A,"Unspecified focal traumatic brain injury with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06303A (78%); S06300A (68%); S062X3A (66%); S0630AA (57%); S069X3A (57%)
S06302S,"Unspecified focal traumatic brain injury with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06303A,"Unspecified focal traumatic brain injury with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S06302A (78%); S06301A (75%); S06300A (74%); S06309A (66%); S062X2A (66%)
S06303S,"Unspecified focal traumatic brain injury with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S06304A,"Unspecified focal traumatic brain injury with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06300A (74%); S06309A (66%); S06301A (63%); S0630AA (62%); S062X0A (56%)
S06304S,"Unspecified focal traumatic brain injury with loss of consciousness of 6 hours to 24 hours, sequela",,
S06305A,"Unspecified focal traumatic brain injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06300A (64%); S06309A (57%); S06301A (54%); S0630AA (54%); S062X0A (48%)
S06305S,"Unspecified focal traumatic brain injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06306A,"Unspecified focal traumatic brain injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06300A (58%); S06309A (52%); S06301A (49%); S0630AA (49%); S062X0A (44%)
S06306S,"Unspecified focal traumatic brain injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06309A,"Unspecified focal traumatic brain injury with loss of consciousness of unspecified duration, initial encounter",398,S06300A (88%); S0630AA (75%); S06303A (66%); S06304A (66%); S062X0A (66%)
S06309S,"Unspecified focal traumatic brain injury with loss of consciousness of unspecified duration, sequela",,
S0630AA,"Unspecified focal traumatic brain injury with loss of consciousness status unknown, initial encounter",399,S06309A (75%); S06301A (71%); S06303A (63%); S06304A (62%); S062X9A (58%)
S0630AS,"Unspecified focal traumatic brain injury with loss of consciousness status unknown, sequela",,
S06310A,"Contusion and laceration of right cerebrum without loss of consciousness, initial encounter",399,S06319A (87%); S06311A (83%); S06329A (83%); S06339A (82%); S06331A (80%)
S06310S,"Contusion and laceration of right cerebrum without loss of consciousness, sequela",,
S06311A,"Contusion and laceration of right cerebrum with loss of consciousness of 30 minutes or less, initial encounter",398,S06310A (83%); S06330A (80%); S06320A (79%); S06313A (73%); S06333A (71%)
S06311S,"Contusion and laceration of right cerebrum with loss of consciousness of 30 minutes or less, sequela",,
S06312A,"Contusion and laceration of right cerebrum with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06313A (77%); S06333A (75%); S06323A (75%); S06310A (66%); S06330A (63%)
S06312S,"Contusion and laceration of right cerebrum with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06313A,"Contusion and laceration of right cerebrum with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S06312A (77%); S06332A (75%); S06322A (75%); S06311A (73%); S06310A (73%)
S06313S,"Contusion and laceration of right cerebrum with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S06314A,"Contusion and laceration of right cerebrum with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06310A (72%); S06330A (70%); S06320A (69%); S06319A (63%); S06311A (61%)
S06314S,"Contusion and laceration of right cerebrum with loss of consciousness of 6 hours to 24 hours, sequela",,
S06315A,"Contusion and laceration of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06310A (62%); S06330A (60%); S06320A (59%); S06319A (54%); S06311A (52%)
S06315S,"Contusion and laceration of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06316A,"Contusion and laceration of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06310A (56%); S06330A (54%); S06320A (53%); S06319A (49%); S06311A (47%)
S06316S,"Contusion and laceration of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06319A,"Contusion and laceration of right cerebrum with loss of consciousness of unspecified duration, initial encounter",398,S06310A (87%); S06330A (86%); S06320A (83%); S0631AA (73%); S0633AA (72%)
S06319S,"Contusion and laceration of right cerebrum with loss of consciousness of unspecified duration, sequela",,
S0631AA,"Contusion and laceration of right cerebrum with loss of consciousness status unknown, initial encounter",399,S06319A (73%); S06311A (69%); S06329A (69%); S06339A (68%); S06331A (66%)
S0631AS,"Contusion and laceration of right cerebrum with loss of consciousness status unknown, sequela",,
S06320A,"Contusion and laceration of left cerebrum without loss of consciousness, initial encounter",399,S06329A (87%); S06321A (83%); S06319A (83%); S06339A (82%); S06331A (80%)
S06320S,"Contusion and laceration of left cerebrum without loss of consciousness, sequela",,
S06321A,"Contusion and laceration of left cerebrum with loss of consciousness of 30 minutes or less, initial encounter",398,S06320A (83%); S06330A (80%); S06310A (79%); S06323A (73%); S06333A (71%)
S06321S,"Contusion and laceration of left cerebrum with loss of consciousness of 30 minutes or less, sequela",,
S06322A,"Contusion and laceration of left cerebrum with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06323A (77%); S06333A (75%); S06313A (75%); S06320A (66%); S06330A (63%)
S06322S,"Contusion and laceration of left cerebrum with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06323A,"Contusion and laceration of left cerebrum with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S06322A (77%); S06332A (75%); S06312A (75%); S06321A (73%); S06320A (73%)
S06323S,"Contusion and laceration of left cerebrum with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S06324A,"Contusion and laceration of left cerebrum with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06320A (72%); S06330A (70%); S06310A (69%); S06329A (63%); S06321A (61%)
S06324S,"Contusion and laceration of left cerebrum with loss of consciousness of 6 hours to 24 hours, sequela",,
S06325A,"Contusion and laceration of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06320A (62%); S06330A (60%); S06310A (59%); S06329A (54%); S06321A (52%)
S06325S,"Contusion and laceration of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06326A,"Contusion and laceration of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06320A (56%); S06330A (54%); S06310A (53%); S06329A (49%); S06321A (47%)
S06326S,"Contusion and laceration of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06329A,"Contusion and laceration of left cerebrum with loss of consciousness of unspecified duration, initial encounter",398,S06320A (87%); S06330A (86%); S06310A (83%); S0632AA (73%); S0633AA (72%)
S06329S,"Contusion and laceration of left cerebrum with loss of consciousness of unspecified duration, sequela",,
S0632AA,"Contusion and laceration of left cerebrum with loss of consciousness status unknown, initial encounter",399,S06329A (73%); S06321A (69%); S06319A (69%); S06339A (68%); S06331A (66%)
S0632AS,"Contusion and laceration of left cerebrum with loss of consciousness status unknown, sequela",,
S06330A,"Contusion and laceration of cerebrum, unspecified, without loss of consciousness, initial encounter",399,S06339A (87%); S06329A (86%); S06319A (86%); S06331A (83%); S06321A (80%)
S06330S,"Contusion and laceration of cerebrum, unspecified, without loss of consciousness, sequela",,
S06331A,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 30 minutes or less, initial encounter",398,S06330A (83%); S06320A (80%); S06310A (80%); S06333A (73%); S06323A (71%)
S06331S,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 30 minutes or less, sequela",,
S06332A,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06333A (77%); S06323A (75%); S06313A (75%); S06330A (66%); S06320A (63%)
S06332S,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06333A,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S06332A (77%); S06322A (75%); S06312A (75%); S06331A (73%); S06330A (73%)
S06333S,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S06334A,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06330A (72%); S06320A (69%); S06310A (69%); S06339A (63%); S06329A (62%)
S06334S,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, sequela",,
S06335A,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06330A (62%); S06320A (59%); S06310A (59%); S06339A (54%); S06329A (53%)
S06335S,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06336A,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06330A (56%); S06320A (54%); S06310A (54%); S06339A (49%); S06329A (48%)
S06336S,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06339A,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness of unspecified duration, initial encounter",398,S06330A (87%); S06320A (82%); S06310A (82%); S0633AA (73%); S0632AA (68%)
S06339S,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness of unspecified duration, sequela",,
S0633AA,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness status unknown, initial encounter",399,S06339A (73%); S06329A (72%); S06319A (72%); S06331A (69%); S06321A (66%)
S0633AS,"Contusion and laceration of cerebrum, unspecified, with loss of consciousness status unknown, sequela",,
S06340A,"Traumatic hemorrhage of right cerebrum without loss of consciousness, initial encounter",399,S06349A (85%); S06341A (81%); S06359A (80%); S06369A (79%); S06361A (76%)
S06340S,"Traumatic hemorrhage of right cerebrum without loss of consciousness, sequela",,
S06341A,"Traumatic hemorrhage of right cerebrum with loss of consciousness of 30 minutes or less, initial encounter",398,S06340A (81%); S06360A (77%); S06350A (76%); S06343A (65%); S0634AA (65%)
S06341S,"Traumatic hemorrhage of right cerebrum with loss of consciousness of 30 minutes or less, sequela",,
S06342A,"Traumatic hemorrhage of right cerebrum with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06343A (70%); S06363A (68%); S06353A (68%); S066X3A (62%); S06340A (62%)
S06342S,"Traumatic hemorrhage of right cerebrum with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06343A,"Traumatic hemorrhage of right cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, initial encounter",397,S06342A (70%); S06362A (68%); S06352A (68%); S06341A (65%); S06340A (65%)
S06343S,"Traumatic hemorrhage of right cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, sequela",,
S06344A,"Traumatic hemorrhage of right cerebrum with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06340A (69%); S06360A (65%); S06350A (65%); S06349A (59%); S06341A (56%)
S06344S,"Traumatic hemorrhage of right cerebrum with loss of consciousness of 6 hours to 24 hours, sequela",,
S06345A,"Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06340A (58%); S06360A (55%); S06350A (55%); S06349A (49%); S06341A (47%)
S06345S,"Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06346A,"Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06340A (52%); S06360A (50%); S06350A (49%); S06349A (44%); S06341A (42%)
S06346S,"Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06349A,"Traumatic hemorrhage of right cerebrum with loss of consciousness of unspecified duration, initial encounter",398,S06340A (85%); S06360A (84%); S06350A (80%); S0634AA (68%); S0636AA (67%)
S06349S,"Traumatic hemorrhage of right cerebrum with loss of consciousness of unspecified duration, sequela",,
S0634AA,"Traumatic hemorrhage of right cerebrum with loss of consciousness status unknown, initial encounter",399,S06349A (68%); S06341A (65%); S06359A (64%); S06369A (63%); S06361A (61%)
S0634AS,"Traumatic hemorrhage of right cerebrum with loss of consciousness status unknown, sequela",,
S06350A,"Traumatic hemorrhage of left cerebrum without loss of consciousness, initial encounter",399,S06359A (85%); S06351A (81%); S06349A (80%); S06369A (79%); S06361A (76%)
S06350S,"Traumatic hemorrhage of left cerebrum without loss of consciousness, sequela",,
S06351A,"Traumatic hemorrhage of left cerebrum with loss of consciousness of 30 minutes or less, initial encounter",398,S06350A (81%); S06360A (77%); S06340A (76%); S06353A (65%); S0635AA (65%)
S06351S,"Traumatic hemorrhage of left cerebrum with loss of consciousness of 30 minutes or less, sequela",,
S06352A,"Traumatic hemorrhage of left cerebrum with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06353A (70%); S06363A (68%); S06343A (68%); S066X3A (62%); S06350A (62%)
S06352S,"Traumatic hemorrhage of left cerebrum with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06353A,"Traumatic hemorrhage of left cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, initial encounter",397,S06352A (70%); S06362A (68%); S06342A (68%); S06351A (65%); S06350A (65%)
S06353S,"Traumatic hemorrhage of left cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, sequela",,
S06354A,"Traumatic hemorrhage of left cerebrum with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06350A (69%); S06360A (65%); S06340A (65%); S06359A (59%); S06351A (56%)
S06354S,"Traumatic hemorrhage of left cerebrum with loss of consciousness of 6 hours to 24 hours, sequela",,
S06355A,"Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06350A (58%); S06360A (55%); S06340A (55%); S06359A (49%); S06351A (47%)
S06355S,"Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06356A,"Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06350A (52%); S06360A (50%); S06340A (49%); S06359A (44%); S06351A (42%)
S06356S,"Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06359A,"Traumatic hemorrhage of left cerebrum with loss of consciousness of unspecified duration, initial encounter",398,S06350A (85%); S06360A (84%); S06340A (80%); S0635AA (68%); S0636AA (67%)
S06359S,"Traumatic hemorrhage of left cerebrum with loss of consciousness of unspecified duration, sequela",,
S0635AA,"Traumatic hemorrhage of left cerebrum with loss of consciousness status unknown, initial encounter",399,S06359A (68%); S06351A (65%); S06349A (64%); S06369A (63%); S06361A (61%)
S0635AS,"Traumatic hemorrhage of left cerebrum with loss of consciousness status unknown, sequela",,
S06360A,"Traumatic hemorrhage of cerebrum, unspecified, without loss of consciousness, initial encounter",399,S06369A (85%); S06359A (84%); S06349A (84%); S06361A (80%); S06351A (77%)
S06360S,"Traumatic hemorrhage of cerebrum, unspecified, without loss of consciousness, sequela",,
S06361A,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 30 minutes or less, initial encounter",398,S06360A (80%); S06350A (76%); S06340A (76%); S06363A (65%); S0636AA (64%)
S06361S,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 30 minutes or less, sequela",,
S06362A,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06363A (70%); S06353A (68%); S06343A (68%); S066X3A (63%); S06360A (62%)
S06362S,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06363A,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 1 hours to 5 hours 59 minutes, initial encounter",397,S06362A (70%); S06352A (68%); S06342A (68%); S06361A (65%); S06360A (64%)
S06363S,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 1 hours to 5 hours 59 minutes, sequela",,
S06364A,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06360A (68%); S06350A (65%); S06340A (65%); S06369A (59%); S06359A (57%)
S06364S,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, sequela",,
S06365A,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06360A (58%); S06350A (55%); S06340A (55%); S06369A (49%); S06359A (48%)
S06365S,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06366A,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06360A (52%); S06350A (49%); S06340A (49%); S06369A (44%); S06359A (44%)
S06366S,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06369A,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of unspecified duration, initial encounter",398,S06360A (85%); S06350A (79%); S06340A (79%); S0636AA (68%); S0635AA (63%)
S06369S,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of unspecified duration, sequela",,
S0636AA,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness status unknown, initial encounter",399,S06369A (68%); S06359A (67%); S06349A (67%); S06361A (64%); S06351A (61%)
S0636AS,"Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness status unknown, sequela",,
S06370A,"Contusion, laceration, and hemorrhage of cerebellum without loss of consciousness, initial encounter",399,S06379A (89%); S06371A (85%); S06373A (76%); S06374A (75%); S06372A (69%)
S06370S,"Contusion, laceration, and hemorrhage of cerebellum without loss of consciousness, sequela",,
S06371A,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 30 minutes or less, initial encounter",398,S06370A (85%); S06373A (76%); S0637AA (73%); S06374A (64%); S06380A (62%)
S06371S,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 30 minutes or less, sequela",,
S06372A,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06373A (79%); S06370A (69%); S06383A (65%); S06333A (63%); S06323A (63%)
S06372S,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06373A,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S06372A (79%); S06371A (76%); S06370A (76%); S06379A (67%); S06382A (65%)
S06373S,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S06374A,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06370A (75%); S06379A (67%); S06371A (64%); S0637AA (64%); S06380A (55%)
S06374S,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 6 hours to 24 hours, sequela",,
S06375A,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06370A (65%); S06379A (58%); S06371A (56%); S0637AA (56%); S06380A (48%)
S06375S,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06376A,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06370A (59%); S06379A (53%); S06371A (51%); S0637AA (51%); S06380A (43%)
S06376S,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06379A,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of unspecified duration, initial encounter",398,S06370A (89%); S0637AA (76%); S06373A (67%); S06374A (67%); S06380A (65%)
S06379S,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of unspecified duration, sequela",,
S0637AA,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness status unknown, initial encounter",399,S06379A (76%); S06371A (73%); S06373A (65%); S06374A (64%); S06372A (59%)
S0637AS,"Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness status unknown, sequela",,
S06380A,"Contusion, laceration, and hemorrhage of brainstem without loss of consciousness, initial encounter",399,S06389A (89%); S06381A (86%); S06383A (76%); S06384A (76%); S06382A (69%)
S06380S,"Contusion, laceration, and hemorrhage of brainstem without loss of consciousness, sequela",,
S06381A,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 30 minutes or less, initial encounter",398,S06380A (86%); S06383A (76%); S0638AA (73%); S06384A (65%); S06370A (62%)
S06381S,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 30 minutes or less, sequela",,
S06382A,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06383A (79%); S06380A (69%); S06373A (65%); S06333A (63%); S06323A (62%)
S06382S,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06383A,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S06382A (79%); S06381A (76%); S06380A (76%); S06389A (68%); S0638AA (65%)
S06383S,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S06384A,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06380A (76%); S06389A (67%); S06381A (65%); S0638AA (65%); S06370A (55%)
S06384S,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 6 hours to 24 hours, sequela",,
S06385A,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06380A (66%); S06389A (59%); S06381A (56%); S0638AA (56%); S06370A (48%)
S06385S,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06386A,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06380A (60%); S06389A (53%); S06381A (51%); S0638AA (51%); S06370A (44%)
S06386S,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06389A,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of unspecified duration, initial encounter",398,S06380A (89%); S0638AA (76%); S06383A (68%); S06384A (67%); S06370A (65%)
S06389S,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of unspecified duration, sequela",,
S0638AA,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness status unknown, initial encounter",399,S06389A (76%); S06381A (73%); S06383A (65%); S06384A (65%); S06382A (59%)
S0638AS,"Contusion, laceration, and hemorrhage of brainstem with loss of consciousness status unknown, sequela",,
S064X0A,"Epidural hemorrhage without loss of consciousness, initial encounter",399,S064X9A (84%); S064X1A (80%); S064X3A (69%); S064X4A (68%); S064X2A (61%)
S064X0S,"Epidural hemorrhage without loss of consciousness, sequela",,
S064X1A,"Epidural hemorrhage with loss of consciousness of 30 minutes or less, initial encounter",398,S064X0A (80%); S064X3A (69%); S064XAA (64%); S064X4A (55%); S066X0A (46%)
S064X1S,"Epidural hemorrhage with loss of consciousness of 30 minutes or less, sequela",,
S064X2A,"Epidural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S064X3A (75%); S064X0A (61%); S066X3A (57%); S065X3A (55%); S06363A (53%)
S064X2S,"Epidural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S064X3A,"Epidural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S064X2A (75%); S064X1A (69%); S064X0A (69%); S064X9A (58%); S066X2A (57%)
S064X3S,"Epidural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S064X4A,"Epidural hemorrhage with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S064X0A (68%); S064X9A (58%); S064X1A (55%); S064XAA (54%); S064X2A (42%)
S064X4S,"Epidural hemorrhage with loss of consciousness of 6 hours to 24 hours, sequela",,
S064X5A,"Epidural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S064X0A (57%); S064X9A (49%); S064X1A (46%); S064XAA (46%); S064X2A (35%)
S064X5S,"Epidural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S064X6A,"Epidural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S064X0A (51%); S064X9A (44%); S064X1A (41%); S064XAA (41%); S064X2A (32%)
S064X6S,"Epidural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S064X9A,"Epidural hemorrhage with loss of consciousness of unspecified duration, initial encounter",398,S064X0A (84%); S064XAA (67%); S064X3A (58%); S064X4A (58%); S06360A (51%)
S064X9S,"Epidural hemorrhage with loss of consciousness of unspecified duration, sequela",,
S064XAA,"Epidural hemorrhage with loss of consciousness status unknown, initial encounter",399,S064X9A (67%); S064X1A (64%); S064X3A (55%); S064X4A (54%); S064X2A (49%)
S064XAS,"Epidural hemorrhage with loss of consciousness status unknown, sequela",,
S065X0A,"Traumatic subdural hemorrhage without loss of consciousness, initial encounter",399,S065X9A (86%); S065X1A (81%); S065X3A (70%); S065X4A (70%); S065X2A (63%)
S065X0S,"Traumatic subdural hemorrhage without loss of consciousness, sequela",,
S065X1A,"Traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, initial encounter",398,S065X0A (81%); S065X3A (71%); S065XAA (66%); S065X4A (57%); S066X0A (56%)
S065X1S,"Traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, sequela",,
S065X2A,"Traumatic subdural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S065X3A (76%); S065X0A (63%); S066X3A (62%); S06363A (57%); S06353A (57%)
S065X2S,"Traumatic subdural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S065X3A,"Traumatic subdural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S065X2A (76%); S065X1A (71%); S065X0A (70%); S066X2A (61%); S06362A (61%)
S065X3S,"Traumatic subdural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S065X4A,"Traumatic subdural hemorrhage with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S065X0A (70%); S065X9A (60%); S065X1A (57%); S065XAA (57%); S066X0A (48%)
S065X4S,"Traumatic subdural hemorrhage with loss of consciousness of 6 hours to 24 hours, sequela",,
S065X5A,"Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S065X0A (59%); S065X9A (51%); S065X1A (48%); S065XAA (48%); S066X0A (41%)
S065X5S,"Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S065X6A,"Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S065X0A (53%); S065X9A (46%); S065X1A (44%); S065XAA (43%); S066X0A (37%)
S065X6S,"Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S065X9A,"Traumatic subdural hemorrhage with loss of consciousness of unspecified duration, initial encounter",398,S065X0A (86%); S065XAA (70%); S06360A (61%); S065X3A (60%); S065X4A (60%)
S065X9S,"Traumatic subdural hemorrhage with loss of consciousness of unspecified duration, sequela",,
S065XAA,"Traumatic subdural hemorrhage with loss of consciousness status unknown, initial encounter",399,S065X9A (70%); S065X1A (66%); S065X3A (57%); S065X4A (57%); S065X2A (51%)
S065XAS,"Traumatic subdural hemorrhage with loss of consciousness status unknown, sequela",,
S066X0A,"Traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter",399,S066X9A (84%); S066X1A (80%); S066X3A (68%); S066X4A (68%); S066X2A (61%)
S066X0S,"Traumatic subarachnoid hemorrhage without loss of consciousness, sequela",,
S066X1A,"Traumatic subarachnoid hemorrhage with loss of consciousness of 30 minutes or less, initial encounter",398,S066X0A (80%); S066X3A (69%); S066XAA (64%); S06360A (57%); S06350A (57%)
S066X1S,"Traumatic subarachnoid hemorrhage with loss of consciousness of 30 minutes or less, sequela",,
S066X2A,"Traumatic subarachnoid hemorrhage with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S066X3A (74%); S065X3A (61%); S066X0A (61%); S06363A (59%); S06353A (58%)
S066X2S,"Traumatic subarachnoid hemorrhage with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S066X3A,"Traumatic subarachnoid hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S066X2A (74%); S066X1A (69%); S066X0A (68%); S06362A (63%); S06352A (62%)
S066X3S,"Traumatic subarachnoid hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S066X4A,"Traumatic subarachnoid hemorrhage with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S066X0A (68%); S066X9A (57%); S066X1A (54%); S066XAA (54%); S06360A (49%)
S066X4S,"Traumatic subarachnoid hemorrhage with loss of consciousness of 6 hours to 24 hours, sequela",,
S066X5A,"Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S066X0A (57%); S066X9A (48%); S066X1A (46%); S066XAA (45%); S06360A (41%)
S066X5S,"Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S066X6A,"Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S066X0A (51%); S066X9A (43%); S066X1A (41%); S066XAA (41%); S06360A (37%)
S066X6S,"Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S066X9A,"Traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, initial encounter",398,S066X0A (84%); S066XAA (67%); S06360A (64%); S06350A (60%); S06340A (60%)
S066X9S,"Traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, sequela",,
S066XAA,"Traumatic subarachnoid hemorrhage with loss of consciousness status unknown, initial encounter",399,S066X9A (67%); S066X1A (64%); S066X3A (54%); S066X4A (54%); S066X2A (49%)
S066XAS,"Traumatic subarachnoid hemorrhage with loss of consciousness status unknown, sequela",,
S06810A,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified without loss of consciousness, initial encounter",399,S06819A (92%); S06829A (89%); S06811A (89%); S06821A (87%); S06813A (81%)
S06810S,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified without loss of consciousness, sequela",,
S06811A,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less, initial encounter",398,S06810A (89%); S06820A (87%); S06813A (81%); S0681AA (80%); S06823A (79%)
S06811S,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less, sequela",,
S06812A,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06813A (83%); S06823A (81%); S06810A (76%); S06820A (73%); S0681AA (67%)
S06812S,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06813A,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S06812A (83%); S06810A (81%); S06822A (81%); S06811A (81%); S06821A (79%)
S06813S,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S06814A,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06810A (81%); S06820A (79%); S06819A (75%); S06829A (73%); S06811A (72%)
S06814S,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, sequela",,
S06815A,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06810A (72%); S06820A (70%); S06819A (66%); S06829A (65%); S06811A (65%)
S06815S,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06816A,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06810A (67%); S06820A (65%); S06819A (61%); S06829A (60%); S06811A (60%)
S06816S,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06819A,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of unspecified duration, initial encounter",398,S06810A (92%); S06820A (89%); S0681AA (82%); S0682AA (80%); S06813A (75%)
S06819S,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of unspecified duration, sequela",,
S0681AA,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness status unknown, initial encounter",399,S06819A (82%); S06829A (80%); S06811A (80%); S06821A (77%); S06813A (73%)
S0681AS,"Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness status unknown, sequela",,
S06820A,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified without loss of consciousness, initial encounter",399,S06829A (92%); S06819A (89%); S06821A (89%); S06811A (87%); S06823A (81%)
S06820S,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified without loss of consciousness, sequela",,
S06821A,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less, initial encounter",398,S06820A (89%); S06810A (87%); S06823A (81%); S0682AA (80%); S06813A (79%)
S06821S,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less, sequela",,
S06822A,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06823A (83%); S06813A (81%); S06820A (76%); S06810A (73%); S0682AA (67%)
S06822S,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06823A,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S06822A (83%); S06820A (81%); S06812A (81%); S06821A (81%); S06811A (79%)
S06823S,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S06824A,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06820A (81%); S06810A (79%); S06829A (75%); S06819A (73%); S06821A (72%)
S06824S,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, sequela",,
S06825A,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06820A (72%); S06810A (70%); S06829A (66%); S06819A (65%); S06821A (65%)
S06825S,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06826A,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06820A (67%); S06810A (65%); S06829A (61%); S06819A (60%); S06821A (60%)
S06826S,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06829A,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of unspecified duration, initial encounter",398,S06820A (92%); S06810A (89%); S0682AA (82%); S0681AA (80%); S06823A (75%)
S06829S,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of unspecified duration, sequela",,
S0682AA,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness status unknown, initial encounter",399,S06829A (82%); S06819A (80%); S06821A (80%); S06811A (77%); S06823A (73%)
S0682AS,"Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness status unknown, sequela",,
S06890A,"Other specified intracranial injury without loss of consciousness, initial encounter",399,S06899A (84%); S06891A (80%); S069X9A (74%); S069X1A (71%); S06893A (68%)
S06890S,"Other specified intracranial injury without loss of consciousness, sequela",,
S06891A,"Other specified intracranial injury with loss of consciousness of 30 minutes or less, initial encounter",398,S06890A (80%); S069X0A (73%); S06893A (69%); S0689AA (64%); S069X3A (63%)
S06891S,"Other specified intracranial injury with loss of consciousness of 30 minutes or less, sequela",,
S06892A,"Other specified intracranial injury with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S06893A (74%); S069X3A (70%); S06890A (61%); S069X0A (56%); S062X3A (55%)
S06892S,"Other specified intracranial injury with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S06893A,"Other specified intracranial injury with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S06892A (74%); S069X2A (70%); S06891A (69%); S06890A (68%); S069X1A (64%)
S06893S,"Other specified intracranial injury with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S06894A,"Other specified intracranial injury with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S06890A (68%); S069X0A (62%); S06899A (57%); S06891A (54%); S0689AA (54%)
S06894S,"Other specified intracranial injury with loss of consciousness of 6 hours to 24 hours, sequela",,
S06895A,"Other specified intracranial injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S06890A (57%); S069X0A (52%); S06899A (48%); S06891A (46%); S0689AA (45%)
S06895S,"Other specified intracranial injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S06896A,"Other specified intracranial injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S06890A (51%); S069X0A (47%); S06899A (43%); S06891A (41%); S0689AA (41%)
S06896S,"Other specified intracranial injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S06899A,"Other specified intracranial injury with loss of consciousness of unspecified duration, initial encounter",398,S06890A (84%); S069X0A (80%); S0689AA (67%); S069XAA (63%); S06893A (58%)
S06899S,"Other specified intracranial injury with loss of consciousness of unspecified duration, sequela",,
S0689AA,"Other specified intracranial injury with loss of consciousness status unknown, initial encounter",399,S06899A (67%); S06891A (64%); S069X9A (59%); S069X1A (57%); S06893A (54%)
S0689AS,"Other specified intracranial injury with loss of consciousness status unknown, sequela",,
S068A0A,"Primary blast injury of brain, not elsewhere classified without loss of consciousness, initial encounter",399,S068A9A (90%); S068A1A (87%); S068A3A (79%); S068A4A (78%); S068A2A (72%)
S068A0S,"Primary blast injury of brain, not elsewhere classified without loss of consciousness, sequela",,
S068A1A,"Primary blast injury of brain, not elsewhere classified with loss of consciousness of 30 minutes or less, initial encounter",398,S068A0A (87%); S068A3A (78%); S068AAA (76%); S068A4A (68%); S068A5A (60%)
S068A1S,"Primary blast injury of brain, not elsewhere classified with loss of consciousness of 30 minutes or less, sequela",,
S068A2A,"Primary blast injury of brain, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S068A3A (81%); S068A0A (72%); S068AAA (63%); S068A4A (57%); S062X3A (57%)
S068A2S,"Primary blast injury of brain, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S068A3A,"Primary blast injury of brain, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S068A2A (81%); S068A0A (79%); S068A1A (78%); S068A9A (71%); S068AAA (69%)
S068A3S,"Primary blast injury of brain, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S068A4A,"Primary blast injury of brain, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S068A0A (78%); S068A9A (71%); S068A1A (68%); S068AAA (68%); S068A2A (57%)
S068A4S,"Primary blast injury of brain, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, sequela",,
S068A5A,"Primary blast injury of brain, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S068A0A (69%); S068A9A (62%); S068A1A (60%); S068AAA (60%); S068A2A (50%)
S068A5S,"Primary blast injury of brain, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S068A6A,"Primary blast injury of brain, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S068A0A (63%); S068A9A (57%); S068A1A (55%); S068AAA (55%); S068A2A (46%)
S068A6S,"Primary blast injury of brain, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S068A9A,"Primary blast injury of brain, not elsewhere classified with loss of consciousness of unspecified duration, initial encounter",398,S068A0A (90%); S068AAA (79%); S068A3A (71%); S068A4A (71%); S068A5A (62%)
S068A9S,"Primary blast injury of brain, not elsewhere classified with loss of consciousness of unspecified duration, sequela",,
S068AAA,"Primary blast injury of brain, not elsewhere classified with loss of consciousness status unknown, initial encounter",399,S068A9A (79%); S068A1A (76%); S068A3A (69%); S068A4A (68%); S068A2A (63%)
S068AAS,"Primary blast injury of brain, not elsewhere classified with loss of consciousness status unknown, sequela",,
S069X0A,"Unspecified intracranial injury without loss of consciousness, initial encounter",399,S069X9A (84%); S06899A (80%); S069X1A (78%); S06891A (73%); S069X3A (66%)
S069X0S,"Unspecified intracranial injury without loss of consciousness, sequela",,
S069X1A,"Unspecified intracranial injury with loss of consciousness of 30 minutes or less, initial encounter",398,S069X0A (78%); S06890A (71%); S069X3A (67%); S06893A (64%); S069XAA (61%)
S069X1S,"Unspecified intracranial injury with loss of consciousness of 30 minutes or less, sequela",,
S069X2A,"Unspecified intracranial injury with loss of consciousness of 31 minutes to 59 minutes, initial encounter",398,S069X3A (73%); S06893A (70%); S069X0A (59%); S06303A (56%); S062X3A (56%)
S069X2S,"Unspecified intracranial injury with loss of consciousness of 31 minutes to 59 minutes, sequela",,
S069X3A,"Unspecified intracranial injury with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter",397,S069X2A (73%); S06892A (70%); S069X1A (67%); S069X0A (66%); S06891A (63%)
S069X3S,"Unspecified intracranial injury with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela",,
S069X4A,"Unspecified intracranial injury with loss of consciousness of 6 hours to 24 hours, initial encounter",397,S069X0A (66%); S06890A (60%); S069X9A (56%); S06899A (53%); S069X1A (52%)
S069X4S,"Unspecified intracranial injury with loss of consciousness of 6 hours to 24 hours, sequela",,
S069X5A,"Unspecified intracranial injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter",397,S069X0A (55%); S06890A (50%); S069X9A (46%); S06899A (44%); S069X1A (43%)
S069X5S,"Unspecified intracranial injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela",,
S069X6A,"Unspecified intracranial injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter",397,S069X0A (49%); S06890A (45%); S069X9A (42%); S06899A (40%); S069X1A (39%)
S069X6S,"Unspecified intracranial injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela",,
S069X9A,"Unspecified intracranial injury with loss of consciousness of unspecified duration, initial encounter",398,S069X0A (84%); S06890A (74%); S069XAA (66%); S0689AA (59%); S069X3A (56%)
S069X9S,"Unspecified intracranial injury with loss of consciousness of unspecified duration, sequela",,
S069XAA,"Unspecified intracranial injury with loss of consciousness status unknown, initial encounter",399,S069X9A (66%); S06899A (63%); S069X1A (61%); S06891A (57%); S069X3A (52%)
S069XAS,"Unspecified intracranial injury with loss of consciousness status unknown, sequela",,
S06A0XA,"Traumatic brain compression without herniation, initial encounter",399,G935 (64%); G9529 (38%); G9520 (36%); S062X9A (32%); C719 (31%)
S06A0XS,"Traumatic brain compression without herniation, sequela",,
S06A1XA,"Traumatic brain compression with herniation, initial encounter",399,G935 (64%); G9529 (38%); G9520 (36%); S062X9A (32%); C719 (31%)
S06A1XS,"Traumatic brain compression with herniation, sequela",,
S12000A,"Unspecified displaced fracture of first cervical vertebra, initial encounter for closed fracture",401,S728X9A (66%); S7290XA (65%); S7292XA (62%); S7291XA (62%); S72033A (62%)
S12000B,"Unspecified displaced fracture of first cervical vertebra, initial encounter for open fracture",401,S32453B (61%); S32409B (60%); S32483B (57%); S32402B (57%); S32401B (57%)
S12001A,"Unspecified nondisplaced fracture of first cervical vertebra, initial encounter for closed fracture",401,S728X9A (66%); S7290XA (65%); S7292XA (62%); S7291XA (62%); S72036A (62%)
S12001B,"Unspecified nondisplaced fracture of first cervical vertebra, initial encounter for open fracture",401,S32456B (61%); S32409B (60%); S32486B (57%); S32402B (57%); S32401B (57%)
S1201XA,"Stable burst fracture of first cervical vertebra, initial encounter for closed fracture",401,S728X9A (52%); S728X2A (51%); S728X1A (51%); S7292XA (49%); S7291XA (49%)
S1201XB,"Stable burst fracture of first cervical vertebra, initial encounter for open fracture",401,S32402B (45%); S32401B (45%); S02609B (45%); S32409B (44%); S32399B (43%)
S1202XA,"Unstable burst fracture of first cervical vertebra, initial encounter for closed fracture",401,S728X9A (51%); S728X2A (50%); S728X1A (50%); S7292XA (48%); S7291XA (48%)
S1202XB,"Unstable burst fracture of first cervical vertebra, initial encounter for open fracture",401,S32402B (44%); S32401B (44%); S02609B (44%); S32409B (43%); S32399B (42%)
S12030A,"Displaced posterior arch fracture of first cervical vertebra, initial encounter for closed fracture",401,S32423A (56%); S32422A (56%); S32421A (56%); S32463A (50%); S32462A (49%)
S12030B,"Displaced posterior arch fracture of first cervical vertebra, initial encounter for open fracture",401,S32423B (56%); S32422B (55%); S32421B (55%); S32463B (49%); S32423A (49%)
S12031A,"Nondisplaced posterior arch fracture of first cervical vertebra, initial encounter for closed fracture",401,S32426A (56%); S32425A (56%); S32424A (56%); S32466A (50%); S32465A (49%)
S12031B,"Nondisplaced posterior arch fracture of first cervical vertebra, initial encounter for open fracture",401,S32426B (56%); S32425B (56%); S32424B (56%); S32466B (50%); S32426A (49%)
S12040A,"Displaced lateral mass fracture of first cervical vertebra, initial encounter for closed fracture",401,S72423A (62%); S72422A (61%); S72421A (61%); S72426A (52%); S72425A (52%)
S12040B,"Displaced lateral mass fracture of first cervical vertebra, initial encounter for open fracture",401,S72423B (56%); S72422B (55%); S72421B (55%); S72423A (54%); S72422A (54%)
S12041A,"Nondisplaced lateral mass fracture of first cervical vertebra, initial encounter for closed fracture",401,S72426A (62%); S72425A (61%); S72424A (61%); S72423A (52%); S72422A (52%)
S12041B,"Nondisplaced lateral mass fracture of first cervical vertebra, initial encounter for open fracture",401,S72426B (56%); S72425B (55%); S72424B (55%); S72426A (54%); S72425A (54%)
S12090A,"Other displaced fracture of first cervical vertebra, initial encounter for closed fracture",401,S728X9A (62%); S728X2A (61%); S728X1A (61%); S72033A (59%); S72133A (59%)
S12090B,"Other displaced fracture of first cervical vertebra, initial encounter for open fracture",401,S32453B (58%); S32452B (57%); S32451B (57%); S32483B (55%); S32482B (54%)
S12091A,"Other nondisplaced fracture of first cervical vertebra, initial encounter for closed fracture",401,S728X9A (62%); S728X2A (60%); S728X1A (60%); S72036A (59%); S72136A (59%)
S12091B,"Other nondisplaced fracture of first cervical vertebra, initial encounter for open fracture",401,S32456B (58%); S32455B (58%); S32454B (58%); S32486B (55%); S32485B (55%)
S12100A,"Unspecified displaced fracture of second cervical vertebra, initial encounter for closed fracture",401,S728X9A (57%); S7290XA (56%); S7292XA (54%); S7291XA (54%); S72033A (53%)
S12100B,"Unspecified displaced fracture of second cervical vertebra, initial encounter for open fracture",401,S32453B (52%); S32409B (52%); S32483B (50%); S32402B (49%); S32401B (49%)
S12101A,"Unspecified nondisplaced fracture of second cervical vertebra, initial encounter for closed fracture",401,S728X9A (57%); S7290XA (56%); S7292XA (54%); S7291XA (54%); S72036A (53%)
S12101B,"Unspecified nondisplaced fracture of second cervical vertebra, initial encounter for open fracture",401,S32456B (53%); S32409B (52%); S32486B (50%); S32402B (49%); S32401B (49%)
S12110A,"Anterior displaced Type II dens fracture, initial encounter for closed fracture",401,S32413A (57%); S32412A (57%); S32411A (57%); S728X9B (53%); S728X2B (52%)
S12110B,"Anterior displaced Type II dens fracture, initial encounter for open fracture",401,S728X9B (61%); S728X2B (60%); S728X1B (60%); S7292XB (59%); S7291XB (59%)
S12111A,"Posterior displaced Type II dens fracture, initial encounter for closed fracture",401,S32423A (58%); S32422A (57%); S32421A (57%); S728X9B (53%); S728X2B (52%)
S12111B,"Posterior displaced Type II dens fracture, initial encounter for open fracture",401,S728X9B (61%); S728X2B (60%); S728X1B (60%); S7292XB (59%); S7291XB (59%)
S12112A,"Nondisplaced Type II dens fracture, initial encounter for closed fracture",401,S728X9B (57%); S728X2B (57%); S728X1B (56%); S72036B (56%); S72136B (56%)
S12112B,"Nondisplaced Type II dens fracture, initial encounter for open fracture",401,S728X9B (67%); S728X2B (66%); S728X1B (66%); S7292XB (64%); S7291XB (64%)
S12120A,"Other displaced dens fracture, initial encounter for closed fracture",401,S728X9A (57%); S728X2A (56%); S728X1A (56%); S72033A (55%); S72133A (55%)
S12120B,"Other displaced dens fracture, initial encounter for open fracture",401,S32453B (54%); S32452B (53%); S32451B (53%); S32483B (51%); S32482B (50%)
S12121A,"Other nondisplaced dens fracture, initial encounter for closed fracture",401,S728X9A (57%); S728X2A (56%); S728X1A (56%); S72036A (55%); S72136A (55%)
S12121B,"Other nondisplaced dens fracture, initial encounter for open fracture",401,S32456B (54%); S32455B (53%); S32454B (53%); S32486B (51%); S32485B (50%)
S12130A,"Unspecified traumatic displaced spondylolisthesis of second cervical vertebra, initial encounter for closed fracture",401,S7290XA (39%); S72033A (39%); S72133A (39%); S72143A (39%); S7223XA (39%)
S12130B,"Unspecified traumatic displaced spondylolisthesis of second cervical vertebra, initial encounter for open fracture",401,S32453B (38%); S32483B (36%); S32409B (35%); S32313B (35%); S32613B (35%)
S12131A,"Unspecified traumatic nondisplaced spondylolisthesis of second cervical vertebra, initial encounter for closed fracture",401,S72036A (39%); S72136A (39%); S72146A (39%); S7226XA (39%); S7290XA (39%)
S12131B,"Unspecified traumatic nondisplaced spondylolisthesis of second cervical vertebra, initial encounter for open fracture",401,S32456B (38%); S32486B (36%); S32409B (35%); S32316B (35%); S32616B (35%)
S1214XA,"Type III traumatic spondylolisthesis of second cervical vertebra, initial encounter for closed fracture",401,S02112A (45%); S0211FA (44%); S0211EA (44%); S02413A (43%); S02112B (38%)
S1214XB,"Type III traumatic spondylolisthesis of second cervical vertebra, initial encounter for open fracture",401,S02112B (44%); S0211FB (44%); S0211EB (44%); S02413B (42%); S02112A (38%)
S12150A,"Other traumatic displaced spondylolisthesis of second cervical vertebra, initial encounter for closed fracture",401,S72033A (36%); S72133A (36%); S72143A (36%); S7223XA (36%); S32453A (36%)
S12150B,"Other traumatic displaced spondylolisthesis of second cervical vertebra, initial encounter for open fracture",401,S32453B (35%); S32452B (35%); S32451B (35%); S32483B (33%); S32482B (33%)
S12151A,"Other traumatic nondisplaced spondylolisthesis of second cervical vertebra, initial encounter for closed fracture",401,S72036A (36%); S72136A (36%); S72146A (36%); S7226XA (36%); S32456A (36%)
S12151B,"Other traumatic nondisplaced spondylolisthesis of second cervical vertebra, initial encounter for open fracture",401,S32456B (35%); S32455B (35%); S32454B (35%); S32486B (34%); S32485B (33%)
S12190A,"Other displaced fracture of second cervical vertebra, initial encounter for closed fracture",401,S728X9A (53%); S728X2A (52%); S728X1A (52%); S72033A (51%); S72133A (51%)
S12190B,"Other displaced fracture of second cervical vertebra, initial encounter for open fracture",401,S32453B (50%); S32452B (49%); S32451B (49%); S32483B (47%); S32482B (47%)
S12191A,"Other nondisplaced fracture of second cervical vertebra, initial encounter for closed fracture",401,S728X9A (53%); S728X2A (52%); S728X1A (52%); S72036A (51%); S72136A (51%)
S12191B,"Other nondisplaced fracture of second cervical vertebra, initial encounter for open fracture",401,S32456B (50%); S32455B (49%); S32454B (49%); S32486B (47%); S32485B (47%)
S12200A,"Unspecified displaced fracture of third cervical vertebra, initial encounter for closed fracture",401,S728X9A (66%); S7290XA (65%); S7292XA (62%); S7291XA (62%); S72033A (62%)
S12200B,"Unspecified displaced fracture of third cervical vertebra, initial encounter for open fracture",401,S32453B (61%); S32409B (60%); S32483B (57%); S32402B (57%); S32401B (57%)
S12201A,"Unspecified nondisplaced fracture of third cervical vertebra, initial encounter for closed fracture",401,S728X9A (66%); S7290XA (65%); S7292XA (62%); S7291XA (62%); S72036A (62%)
S12201B,"Unspecified nondisplaced fracture of third cervical vertebra, initial encounter for open fracture",401,S32456B (61%); S32409B (60%); S32486B (57%); S32402B (57%); S32401B (57%)
S12230A,"Unspecified traumatic displaced spondylolisthesis of third cervical vertebra, initial encounter for closed fracture",401,S7290XA (44%); S72033A (44%); S72133A (44%); S72143A (44%); S7223XA (44%)
S12230B,"Unspecified traumatic displaced spondylolisthesis of third cervical vertebra, initial encounter for open fracture",401,S32453B (43%); S32483B (40%); S32409B (40%); S32313B (39%); S32613B (39%)
S12231A,"Unspecified traumatic nondisplaced spondylolisthesis of third cervical vertebra, initial encounter for closed fracture",401,S72036A (44%); S72136A (44%); S72146A (44%); S7226XA (44%); S7290XA (44%)
S12231B,"Unspecified traumatic nondisplaced spondylolisthesis of third cervical vertebra, initial encounter for open fracture",401,S32456B (43%); S32486B (40%); S32409B (40%); S32316B (39%); S32616B (39%)
S1224XA,"Type III traumatic spondylolisthesis of third cervical vertebra, initial encounter for closed fracture",401,S02112A (50%); S0211FA (49%); S0211EA (49%); S02413A (47%); S02112B (42%)
S1224XB,"Type III traumatic spondylolisthesis of third cervical vertebra, initial encounter for open fracture",401,S02112B (49%); S0211FB (49%); S0211EB (49%); S02413B (47%); S02112A (42%)
S12250A,"Other traumatic displaced spondylolisthesis of third cervical vertebra, initial encounter for closed fracture",401,S72033A (41%); S72133A (41%); S72143A (41%); S7223XA (41%); S32453A (41%)
S12250B,"Other traumatic displaced spondylolisthesis of third cervical vertebra, initial encounter for open fracture",401,S32453B (40%); S32452B (40%); S32451B (40%); S32483B (38%); S32482B (37%)
S12251A,"Other traumatic nondisplaced spondylolisthesis of third cervical vertebra, initial encounter for closed fracture",401,S72036A (41%); S72136A (41%); S72146A (41%); S7226XA (41%); S32456A (41%)
S12251B,"Other traumatic nondisplaced spondylolisthesis of third cervical vertebra, initial encounter for open fracture",401,S32456B (40%); S32455B (40%); S32454B (40%); S32486B (38%); S32485B (38%)
S12290A,"Other displaced fracture of third cervical vertebra, initial encounter for closed fracture",401,S728X9A (62%); S728X2A (61%); S728X1A (61%); S72033A (59%); S72133A (59%)
S12290B,"Other displaced fracture of third cervical vertebra, initial encounter for open fracture",401,S32453B (58%); S32452B (57%); S32451B (57%); S32483B (55%); S32482B (54%)
S12291A,"Other nondisplaced fracture of third cervical vertebra, initial encounter for closed fracture",401,S728X9A (62%); S728X2A (60%); S728X1A (60%); S72036A (59%); S72136A (59%)
S12291B,"Other nondisplaced fracture of third cervical vertebra, initial encounter for open fracture",401,S32456B (58%); S32455B (58%); S32454B (58%); S32486B (55%); S32485B (55%)
S12300A,"Unspecified displaced fracture of fourth cervical vertebra, initial encounter for closed fracture",401,S728X9A (57%); S7290XA (56%); S7292XA (54%); S7291XA (54%); S72033A (53%)
S12300B,"Unspecified displaced fracture of fourth cervical vertebra, initial encounter for open fracture",401,S32453B (52%); S32409B (52%); S32483B (50%); S32402B (49%); S32401B (49%)
S12301A,"Unspecified nondisplaced fracture of fourth cervical vertebra, initial encounter for closed fracture",401,S728X9A (57%); S7290XA (56%); S7292XA (54%); S7291XA (54%); S72036A (53%)
S12301B,"Unspecified nondisplaced fracture of fourth cervical vertebra, initial encounter for open fracture",401,S32456B (53%); S32409B (52%); S32486B (50%); S32402B (49%); S32401B (49%)
S12330A,"Unspecified traumatic displaced spondylolisthesis of fourth cervical vertebra, initial encounter for closed fracture",401,S7290XA (39%); S72033A (39%); S72133A (39%); S72143A (39%); S7223XA (39%)
S12330B,"Unspecified traumatic displaced spondylolisthesis of fourth cervical vertebra, initial encounter for open fracture",401,S32453B (38%); S32483B (36%); S32409B (35%); S32313B (35%); S32613B (35%)
S12331A,"Unspecified traumatic nondisplaced spondylolisthesis of fourth cervical vertebra, initial encounter for closed fracture",401,S72036A (39%); S72136A (39%); S72146A (39%); S7226XA (39%); S7290XA (39%)
S12331B,"Unspecified traumatic nondisplaced spondylolisthesis of fourth cervical vertebra, initial encounter for open fracture",401,S32456B (38%); S32486B (36%); S32409B (35%); S32316B (35%); S32616B (35%)
S1234XA,"Type III traumatic spondylolisthesis of fourth cervical vertebra, initial encounter for closed fracture",401,S02112A (45%); S0211FA (44%); S0211EA (44%); S02413A (43%); S02112B (38%)
S1234XB,"Type III traumatic spondylolisthesis of fourth cervical vertebra, initial encounter for open fracture",401,S02112B (44%); S0211FB (44%); S0211EB (44%); S02413B (42%); S02112A (38%)
S12350A,"Other traumatic displaced spondylolisthesis of fourth cervical vertebra, initial encounter for closed fracture",401,S72033A (36%); S72133A (36%); S72143A (36%); S7223XA (36%); S32453A (36%)
S12350B,"Other traumatic displaced spondylolisthesis of fourth cervical vertebra, initial encounter for open fracture",401,S32453B (35%); S32452B (35%); S32451B (35%); S32483B (33%); S32482B (33%)
S12351A,"Other traumatic nondisplaced spondylolisthesis of fourth cervical vertebra, initial encounter for closed fracture",401,S72036A (36%); S72136A (36%); S72146A (36%); S7226XA (36%); S32456A (36%)
S12351B,"Other traumatic nondisplaced spondylolisthesis of fourth cervical vertebra, initial encounter for open fracture",401,S32456B (35%); S32455B (35%); S32454B (35%); S32486B (34%); S32485B (33%)
S12390A,"Other displaced fracture of fourth cervical vertebra, initial encounter for closed fracture",401,S728X9A (53%); S728X2A (52%); S728X1A (52%); S72033A (51%); S72133A (51%)
S12390B,"Other displaced fracture of fourth cervical vertebra, initial encounter for open fracture",401,S32453B (50%); S32452B (49%); S32451B (49%); S32483B (47%); S32482B (47%)
S12391A,"Other nondisplaced fracture of fourth cervical vertebra, initial encounter for closed fracture",401,S728X9A (53%); S728X2A (52%); S728X1A (52%); S72036A (51%); S72136A (51%)
S12391B,"Other nondisplaced fracture of fourth cervical vertebra, initial encounter for open fracture",401,S32456B (50%); S32455B (49%); S32454B (49%); S32486B (47%); S32485B (47%)
S12400A,"Unspecified displaced fracture of fifth cervical vertebra, initial encounter for closed fracture",401,S728X9A (56%); S7290XA (55%); S7292XA (53%); S7291XA (53%); S72033A (53%)
S12400B,"Unspecified displaced fracture of fifth cervical vertebra, initial encounter for open fracture",401,S32453B (52%); S32409B (51%); S32483B (49%); S32402B (49%); S32401B (49%)
S12401A,"Unspecified nondisplaced fracture of fifth cervical vertebra, initial encounter for closed fracture",401,S728X9A (56%); S7290XA (55%); S7292XA (53%); S7291XA (53%); S72036A (53%)
S12401B,"Unspecified nondisplaced fracture of fifth cervical vertebra, initial encounter for open fracture",401,S32456B (52%); S32409B (51%); S32486B (49%); S32402B (49%); S32401B (49%)
S12430A,"Unspecified traumatic displaced spondylolisthesis of fifth cervical vertebra, initial encounter for closed fracture",401,S7290XA (38%); S72033A (38%); S72133A (38%); S72143A (38%); S7223XA (38%)
S12430B,"Unspecified traumatic displaced spondylolisthesis of fifth cervical vertebra, initial encounter for open fracture",401,S32453B (37%); S32483B (35%); S32409B (35%); S32313B (34%); S32613B (34%)
S12431A,"Unspecified traumatic nondisplaced spondylolisthesis of fifth cervical vertebra, initial encounter for closed fracture",401,S72036A (38%); S72136A (38%); S72146A (38%); S7226XA (38%); S7290XA (38%)
S12431B,"Unspecified traumatic nondisplaced spondylolisthesis of fifth cervical vertebra, initial encounter for open fracture",401,S32456B (38%); S32486B (35%); S32409B (35%); S32316B (34%); S32616B (34%)
S1244XA,"Type III traumatic spondylolisthesis of fifth cervical vertebra, initial encounter for closed fracture",401,S02112A (44%); S0211FA (44%); S0211EA (44%); S02413A (42%); S02112B (38%)
S1244XB,"Type III traumatic spondylolisthesis of fifth cervical vertebra, initial encounter for open fracture",401,S02112B (44%); S0211FB (43%); S0211EB (43%); S02413B (42%); S02112A (38%)
S12450A,"Other traumatic displaced spondylolisthesis of fifth cervical vertebra, initial encounter for closed fracture",401,S72033A (36%); S72133A (36%); S72143A (36%); S7223XA (36%); S32453A (36%)
S12450B,"Other traumatic displaced spondylolisthesis of fifth cervical vertebra, initial encounter for open fracture",401,S32453B (35%); S32452B (35%); S32451B (35%); S32483B (33%); S32482B (33%)
S12451A,"Other traumatic nondisplaced spondylolisthesis of fifth cervical vertebra, initial encounter for closed fracture",401,S72036A (36%); S72136A (36%); S72146A (36%); S7226XA (36%); S32456A (36%)
S12451B,"Other traumatic nondisplaced spondylolisthesis of fifth cervical vertebra, initial encounter for open fracture",401,S32456B (35%); S32455B (35%); S32454B (35%); S32486B (33%); S32485B (33%)
S12490A,"Other displaced fracture of fifth cervical vertebra, initial encounter for closed fracture",401,S728X9A (53%); S728X2A (51%); S728X1A (51%); S72033A (50%); S72133A (50%)
S12490B,"Other displaced fracture of fifth cervical vertebra, initial encounter for open fracture",401,S32453B (49%); S32452B (49%); S32451B (49%); S32483B (47%); S32482B (46%)
S12491A,"Other nondisplaced fracture of fifth cervical vertebra, initial encounter for closed fracture",401,S728X9A (53%); S728X2A (51%); S728X1A (51%); S72036A (50%); S72136A (50%)
S12491B,"Other nondisplaced fracture of fifth cervical vertebra, initial encounter for open fracture",401,S32456B (49%); S32455B (49%); S32454B (49%); S32486B (47%); S32485B (46%)
S12500A,"Unspecified displaced fracture of sixth cervical vertebra, initial encounter for closed fracture",401,S728X9A (55%); S7290XA (55%); S7292XA (52%); S7291XA (52%); S72033A (52%)
S12500B,"Unspecified displaced fracture of sixth cervical vertebra, initial encounter for open fracture",401,S32453B (51%); S32409B (50%); S32483B (48%); S32402B (48%); S32401B (48%)
S12501A,"Unspecified nondisplaced fracture of sixth cervical vertebra, initial encounter for closed fracture",401,S728X9A (55%); S7290XA (54%); S7292XA (52%); S7291XA (52%); S72036A (52%)
S12501B,"Unspecified nondisplaced fracture of sixth cervical vertebra, initial encounter for open fracture",401,S32456B (51%); S32409B (50%); S32486B (48%); S32402B (48%); S32401B (48%)
S12530A,"Unspecified traumatic displaced spondylolisthesis of sixth cervical vertebra, initial encounter for closed fracture",401,S7290XA (38%); S72033A (38%); S72133A (38%); S72143A (38%); S7223XA (38%)
S12530B,"Unspecified traumatic displaced spondylolisthesis of sixth cervical vertebra, initial encounter for open fracture",401,S32453B (37%); S32483B (35%); S32409B (34%); S32313B (34%); S32613B (34%)
S12531A,"Unspecified traumatic nondisplaced spondylolisthesis of sixth cervical vertebra, initial encounter for closed fracture",401,S72036A (38%); S72136A (38%); S72146A (38%); S7226XA (38%); S7290XA (38%)
S12531B,"Unspecified traumatic nondisplaced spondylolisthesis of sixth cervical vertebra, initial encounter for open fracture",401,S32456B (37%); S32486B (35%); S32409B (34%); S32316B (34%); S32616B (34%)
S1254XA,"Type III traumatic spondylolisthesis of sixth cervical vertebra, initial encounter for closed fracture",401,S02112A (44%); S0211FA (43%); S0211EA (43%); S02413A (42%); S02112B (37%)
S1254XB,"Type III traumatic spondylolisthesis of sixth cervical vertebra, initial encounter for open fracture",401,S02112B (43%); S0211FB (43%); S0211EB (43%); S02413B (41%); S02112A (37%)
S12550A,"Other traumatic displaced spondylolisthesis of sixth cervical vertebra, initial encounter for closed fracture",401,S72033A (35%); S72133A (35%); S72143A (35%); S7223XA (35%); S32453A (35%)
S12550B,"Other traumatic displaced spondylolisthesis of sixth cervical vertebra, initial encounter for open fracture",401,S32453B (34%); S32452B (34%); S32451B (34%); S32483B (33%); S32482B (32%)
S12551A,"Other traumatic nondisplaced spondylolisthesis of sixth cervical vertebra, initial encounter for closed fracture",401,S72036A (35%); S72136A (35%); S72146A (35%); S7226XA (35%); S32456A (35%)
S12551B,"Other traumatic nondisplaced spondylolisthesis of sixth cervical vertebra, initial encounter for open fracture",401,S32456B (35%); S32455B (34%); S32454B (34%); S32486B (33%); S32485B (32%)
S12590A,"Other displaced fracture of sixth cervical vertebra, initial encounter for closed fracture",401,S728X9A (52%); S728X2A (51%); S728X1A (51%); S72033A (49%); S72133A (49%)
S12590B,"Other displaced fracture of sixth cervical vertebra, initial encounter for open fracture",401,S32453B (48%); S32452B (48%); S32451B (48%); S32483B (46%); S32482B (45%)
S12591A,"Other nondisplaced fracture of sixth cervical vertebra, initial encounter for closed fracture",401,S728X9A (52%); S728X2A (51%); S728X1A (51%); S72036A (49%); S72136A (49%)
S12591B,"Other nondisplaced fracture of sixth cervical vertebra, initial encounter for open fracture",401,S32456B (49%); S32455B (48%); S32454B (48%); S32486B (46%); S32485B (45%)
S12600A,"Unspecified displaced fracture of seventh cervical vertebra, initial encounter for closed fracture",401,S728X9A (55%); S7290XA (55%); S7292XA (52%); S7291XA (52%); S72033A (52%)
S12600B,"Unspecified displaced fracture of seventh cervical vertebra, initial encounter for open fracture",401,S32453B (51%); S32409B (50%); S32483B (48%); S32402B (48%); S32401B (48%)
S12601A,"Unspecified nondisplaced fracture of seventh cervical vertebra, initial encounter for closed fracture",401,S728X9A (55%); S7290XA (54%); S7292XA (52%); S7291XA (52%); S72036A (52%)
S12601B,"Unspecified nondisplaced fracture of seventh cervical vertebra, initial encounter for open fracture",401,S32456B (51%); S32409B (50%); S32486B (48%); S32402B (48%); S32401B (48%)
S12630A,"Unspecified traumatic displaced spondylolisthesis of seventh cervical vertebra, initial encounter for closed fracture",401,S7290XA (38%); S72033A (38%); S72133A (38%); S72143A (38%); S7223XA (38%)
S12630B,"Unspecified traumatic displaced spondylolisthesis of seventh cervical vertebra, initial encounter for open fracture",401,S32453B (37%); S32483B (35%); S32409B (34%); S32313B (34%); S32613B (34%)
S12631A,"Unspecified traumatic nondisplaced spondylolisthesis of seventh cervical vertebra, initial encounter for closed fracture",401,S72036A (38%); S72136A (38%); S72146A (38%); S7226XA (38%); S7290XA (38%)
S12631B,"Unspecified traumatic nondisplaced spondylolisthesis of seventh cervical vertebra, initial encounter for open fracture",401,S32456B (37%); S32486B (35%); S32409B (34%); S32316B (34%); S32616B (34%)
S1264XA,"Type III traumatic spondylolisthesis of seventh cervical vertebra, initial encounter for closed fracture",401,S02112A (44%); S0211FA (43%); S0211EA (43%); S02413A (42%); S02112B (37%)
S1264XB,"Type III traumatic spondylolisthesis of seventh cervical vertebra, initial encounter for open fracture",401,S02112B (43%); S0211FB (43%); S0211EB (43%); S02413B (41%); S02112A (37%)
S12650A,"Other traumatic displaced spondylolisthesis of seventh cervical vertebra, initial encounter for closed fracture",401,S72033A (35%); S72133A (35%); S72143A (35%); S7223XA (35%); S32453A (35%)
S12650B,"Other traumatic displaced spondylolisthesis of seventh cervical vertebra, initial encounter for open fracture",401,S32453B (34%); S32452B (34%); S32451B (34%); S32483B (33%); S32482B (32%)
S12651A,"Other traumatic nondisplaced spondylolisthesis of seventh cervical vertebra, initial encounter for closed fracture",401,S72036A (35%); S72136A (35%); S72146A (35%); S7226XA (35%); S32456A (35%)
S12651B,"Other traumatic nondisplaced spondylolisthesis of seventh cervical vertebra, initial encounter for open fracture",401,S32456B (35%); S32455B (34%); S32454B (34%); S32486B (33%); S32485B (32%)
S12690A,"Other displaced fracture of seventh cervical vertebra, initial encounter for closed fracture",401,S728X9A (52%); S728X2A (51%); S728X1A (51%); S72033A (49%); S72133A (49%)
S12690B,"Other displaced fracture of seventh cervical vertebra, initial encounter for open fracture",401,S32453B (48%); S32452B (48%); S32451B (48%); S32483B (46%); S32482B (45%)
S12691A,"Other nondisplaced fracture of seventh cervical vertebra, initial encounter for closed fracture",401,S728X9A (52%); S728X2A (51%); S728X1A (51%); S72036A (49%); S72136A (49%)
S12691B,"Other nondisplaced fracture of seventh cervical vertebra, initial encounter for open fracture",401,S32456B (49%); S32455B (48%); S32454B (48%); S32486B (46%); S32485B (45%)
S128XXA,"Fracture of other parts of neck, initial encounter",401,S3289XB (62%); S3289XA (62%); S72002A (54%); S72001A (54%); S72009A (53%)
S129XXA,"Fracture of neck, unspecified, initial encounter",401,S72009A (83%); S72002A (79%); S72001A (79%); S72009B (74%); S72099A (72%)
S140XXA,"Concussion and edema of cervical spinal cord, initial encounter",182,S14119A (47%); S14111A (41%); S14114A (41%); S14115A (41%); S14117A (41%)
S140XXD,"Concussion and edema of cervical spinal cord, subsequent encounter",182,S14119D (54%); S14111D (48%); S14114D (48%); S14115D (48%); S14117D (48%)
S140XXS,"Concussion and edema of cervical spinal cord, sequela",,
S14101A,"Unspecified injury at C1 level of cervical spinal cord, initial encounter",182,S14111A (76%); S14111D (69%); S14111S (64%); S14119A (58%); S14119D (51%)
S14101D,"Unspecified injury at C1 level of cervical spinal cord, subsequent encounter",182,S14111D (79%); S14111A (69%); S14119D (63%); S14111S (60%); S14114D (53%)
S14101S,"Unspecified injury at C1 level of cervical spinal cord, sequela",,
S14102A,"Unspecified injury at C2 level of cervical spinal cord, initial encounter",182,S14112A (76%); S14112D (69%); S14112S (64%); S14119A (58%); S14119D (50%)
S14102D,"Unspecified injury at C2 level of cervical spinal cord, subsequent encounter",182,S14112D (79%); S14112A (69%); S14119D (63%); S14112S (60%); S14111D (53%)
S14102S,"Unspecified injury at C2 level of cervical spinal cord, sequela",,
S14103A,"Unspecified injury at C3 level of cervical spinal cord, initial encounter",182,S14113A (76%); S14113D (69%); S14113S (64%); S14119A (58%); S14119D (50%)
S14103D,"Unspecified injury at C3 level of cervical spinal cord, subsequent encounter",182,S14113D (79%); S14113A (69%); S14119D (63%); S14113S (60%); S14111D (53%)
S14103S,"Unspecified injury at C3 level of cervical spinal cord, sequela",,
S14104A,"Unspecified injury at C4 level of cervical spinal cord, initial encounter",182,S14114A (76%); S14114D (69%); S14114S (64%); S14119A (58%); S14119D (51%)
S14104D,"Unspecified injury at C4 level of cervical spinal cord, subsequent encounter",182,S14114D (79%); S14114A (69%); S14119D (63%); S14114S (60%); S14111D (53%)
S14104S,"Unspecified injury at C4 level of cervical spinal cord, sequela",,
S14105A,"Unspecified injury at C5 level of cervical spinal cord, initial encounter",182,S14115A (76%); S14115D (69%); S14115S (64%); S14119A (58%); S14119D (51%)
S14105D,"Unspecified injury at C5 level of cervical spinal cord, subsequent encounter",182,S14115D (79%); S14115A (69%); S14119D (63%); S14115S (60%); S14111D (53%)
S14105S,"Unspecified injury at C5 level of cervical spinal cord, sequela",,
S14106A,"Unspecified injury at C6 level of cervical spinal cord, initial encounter",182,S14116A (76%); S14116D (69%); S14116S (64%); S14119A (58%); S14119D (50%)
S14106D,"Unspecified injury at C6 level of cervical spinal cord, subsequent encounter",182,S14116D (79%); S14116A (69%); S14119D (63%); S14116S (60%); S14111D (53%)
S14106S,"Unspecified injury at C6 level of cervical spinal cord, sequela",,
S14107A,"Unspecified injury at C7 level of cervical spinal cord, initial encounter",182,S14117A (76%); S14117D (69%); S14117S (64%); S14119A (58%); S14119D (51%)
S14107D,"Unspecified injury at C7 level of cervical spinal cord, subsequent encounter",182,S14117D (79%); S14117A (69%); S14119D (63%); S14117S (60%); S14111D (53%)
S14107S,"Unspecified injury at C7 level of cervical spinal cord, sequela",,
S14108A,"Unspecified injury at C8 level of cervical spinal cord, initial encounter",182,S14118A (76%); S14118D (69%); S14118S (64%); S14119A (58%); S14119D (50%)
S14108D,"Unspecified injury at C8 level of cervical spinal cord, subsequent encounter",182,S14118D (79%); S14118A (69%); S14119D (63%); S14118S (60%); S14111D (53%)
S14108S,"Unspecified injury at C8 level of cervical spinal cord, sequela",,
S14109A,"Unspecified injury at unspecified level of cervical spinal cord, initial encounter",182,S14119A (69%); S14119D (61%); S14111A (54%); S14114A (54%); S14115A (54%)
S14109D,"Unspecified injury at unspecified level of cervical spinal cord, subsequent encounter",182,S14119D (73%); S14119A (60%); S24119D (60%); S14111D (59%); S14114D (59%)
S14109S,"Unspecified injury at unspecified level of cervical spinal cord, sequela",,
S14111A,"Complete lesion at C1 level of cervical spinal cord, initial encounter",180,S14151A (84%); S14151D (77%); S14101A (76%); S14131A (72%); S14121A (71%)
S14111D,"Complete lesion at C1 level of cervical spinal cord, subsequent encounter",180,S14151D (85%); S14101D (79%); S14151A (77%); S14131D (74%); S24119D (74%)
S14111S,"Complete lesion at C1 level of cervical spinal cord, sequela",180,S24119S (76%); S14151A (71%); S24111S (68%); S14151D (67%); S14101A (64%)
S14112A,"Complete lesion at C2 level of cervical spinal cord, initial encounter",180,S14152A (84%); S14152D (77%); S14102A (76%); S14132A (72%); S14122A (71%)
S14112D,"Complete lesion at C2 level of cervical spinal cord, subsequent encounter",180,S14152D (85%); S14102D (79%); S14152A (77%); S14132D (74%); S14122D (74%)
S14112S,"Complete lesion at C2 level of cervical spinal cord, sequela",180,S24119S (76%); S14152A (71%); S14152D (68%); S24111S (68%); S14102A (64%)
S14113A,"Complete lesion at C3 level of cervical spinal cord, initial encounter",180,S14153A (84%); S14153D (77%); S14103A (76%); S14133A (72%); S14123A (71%)
S14113D,"Complete lesion at C3 level of cervical spinal cord, subsequent encounter",180,S14153D (85%); S14103D (79%); S14153A (77%); S14133D (74%); S14123D (74%)
S14113S,"Complete lesion at C3 level of cervical spinal cord, sequela",180,S24119S (76%); S14153A (71%); S14153D (68%); S24111S (68%); S14103A (64%)
S14114A,"Complete lesion at C4 level of cervical spinal cord, initial encounter",180,S14154A (84%); S14154D (77%); S14104A (76%); S14134A (72%); S14124A (71%)
S14114D,"Complete lesion at C4 level of cervical spinal cord, subsequent encounter",180,S14154D (85%); S14104D (79%); S14154A (77%); S14134D (74%); S24119D (74%)
S14114S,"Complete lesion at C4 level of cervical spinal cord, sequela",180,S24119S (76%); S14154A (71%); S24111S (68%); S14154D (67%); S14104A (64%)
S14115A,"Complete lesion at C5 level of cervical spinal cord, initial encounter",180,S14155A (84%); S14155D (77%); S14105A (76%); S14135A (72%); S14125A (71%)
S14115D,"Complete lesion at C5 level of cervical spinal cord, subsequent encounter",180,S14155D (85%); S14105D (79%); S14155A (77%); S14135D (74%); S24119D (74%)
S14115S,"Complete lesion at C5 level of cervical spinal cord, sequela",180,S24119S (76%); S14155A (71%); S24111S (68%); S14155D (67%); S14105A (64%)
S14116A,"Complete lesion at C6 level of cervical spinal cord, initial encounter",180,S14156A (84%); S14156D (77%); S14106A (76%); S14136A (72%); S14126A (71%)
S14116D,"Complete lesion at C6 level of cervical spinal cord, subsequent encounter",180,S14156D (85%); S14106D (79%); S14156A (77%); S14136D (74%); S14126D (74%)
S14116S,"Complete lesion at C6 level of cervical spinal cord, sequela",180,S24119S (76%); S14156A (71%); S14156D (68%); S24111S (68%); S14106A (64%)
S14117A,"Complete lesion at C7 level of cervical spinal cord, initial encounter",180,S14157A (84%); S14157D (77%); S14107A (76%); S14137A (72%); S14127A (71%)
S14117D,"Complete lesion at C7 level of cervical spinal cord, subsequent encounter",180,S14157D (85%); S14107D (79%); S14157A (77%); S14137D (74%); S24119D (74%)
S14117S,"Complete lesion at C7 level of cervical spinal cord, sequela",180,S24119S (76%); S14157A (71%); S24111S (68%); S14157D (67%); S14107A (64%)
S14118A,"Complete lesion at C8 level of cervical spinal cord, initial encounter",180,S14158A (84%); S14158D (77%); S14108A (76%); S14138A (72%); S14128A (71%)
S14118D,"Complete lesion at C8 level of cervical spinal cord, subsequent encounter",180,S14158D (85%); S14108D (79%); S14158A (77%); S14138D (74%); S14128D (74%)
S14118S,"Complete lesion at C8 level of cervical spinal cord, sequela",180,S24119S (76%); S14158A (71%); S14158D (68%); S24111S (68%); S14108A (64%)
S14119A,"Complete lesion at unspecified level of cervical spinal cord, initial encounter",180,S24119A (84%); S34119A (84%); S14159A (79%); S24119D (75%); S34119D (75%)
S14119D,"Complete lesion at unspecified level of cervical spinal cord, subsequent encounter",180,S24119D (86%); S34119D (86%); S14159D (82%); S24119A (75%); S34119A (75%)
S14119S,"Complete lesion at unspecified level of cervical spinal cord, sequela",180,S24119S (88%); S24111S (76%); S24113S (70%); S24114S (70%); S24112S (69%)
S14121A,"Central cord syndrome at C1 level of cervical spinal cord, initial encounter",182,S14111A (71%); S14111D (65%); S14111S (60%); S14119A (55%); S14119D (49%)
S14121D,"Central cord syndrome at C1 level of cervical spinal cord, subsequent encounter",182,S14111D (74%); S14111A (66%); S14119D (60%); S14111S (58%); S14114D (53%)
S14121S,"Central cord syndrome at C1 level of cervical spinal cord, sequela",,
S14122A,"Central cord syndrome at C2 level of cervical spinal cord, initial encounter",182,S14112A (71%); S14112D (65%); S14112S (60%); S14119A (55%); S14119D (49%)
S14122D,"Central cord syndrome at C2 level of cervical spinal cord, subsequent encounter",182,S14112D (74%); S14112A (66%); S14119D (59%); S14112S (58%); S14111D (53%)
S14122S,"Central cord syndrome at C2 level of cervical spinal cord, sequela",,
S14123A,"Central cord syndrome at C3 level of cervical spinal cord, initial encounter",182,S14113A (71%); S14113D (65%); S14113S (60%); S14119A (55%); S14119D (49%)
S14123D,"Central cord syndrome at C3 level of cervical spinal cord, subsequent encounter",182,S14113D (74%); S14113A (66%); S14119D (59%); S14113S (58%); S14111D (53%)
S14123S,"Central cord syndrome at C3 level of cervical spinal cord, sequela",,
S14124A,"Central cord syndrome at C4 level of cervical spinal cord, initial encounter",182,S14114A (71%); S14114D (65%); S14114S (60%); S14119A (55%); S14119D (49%)
S14124D,"Central cord syndrome at C4 level of cervical spinal cord, subsequent encounter",182,S14114D (74%); S14114A (66%); S14119D (60%); S14114S (58%); S14111D (53%)
S14124S,"Central cord syndrome at C4 level of cervical spinal cord, sequela",,
S14125A,"Central cord syndrome at C5 level of cervical spinal cord, initial encounter",182,S14115A (71%); S14115D (65%); S14115S (60%); S14119A (55%); S14119D (49%)
S14125D,"Central cord syndrome at C5 level of cervical spinal cord, subsequent encounter",182,S14115D (74%); S14115A (66%); S14119D (60%); S14115S (58%); S14111D (53%)
S14125S,"Central cord syndrome at C5 level of cervical spinal cord, sequela",,
S14126A,"Central cord syndrome at C6 level of cervical spinal cord, initial encounter",182,S14116A (71%); S14116D (65%); S14116S (60%); S14119A (55%); S14119D (49%)
S14126D,"Central cord syndrome at C6 level of cervical spinal cord, subsequent encounter",182,S14116D (74%); S14116A (66%); S14119D (59%); S14116S (58%); S14111D (53%)
S14126S,"Central cord syndrome at C6 level of cervical spinal cord, sequela",,
S14127A,"Central cord syndrome at C7 level of cervical spinal cord, initial encounter",182,S14117A (71%); S14117D (65%); S14117S (60%); S14119A (55%); S14119D (49%)
S14127D,"Central cord syndrome at C7 level of cervical spinal cord, subsequent encounter",182,S14117D (74%); S14117A (66%); S14119D (60%); S14117S (58%); S14111D (53%)
S14127S,"Central cord syndrome at C7 level of cervical spinal cord, sequela",,
S14128A,"Central cord syndrome at C8 level of cervical spinal cord, initial encounter",182,S14118A (71%); S14118D (65%); S14118S (60%); S14119A (55%); S14119D (49%)
S14128D,"Central cord syndrome at C8 level of cervical spinal cord, subsequent encounter",182,S14118D (74%); S14118A (66%); S14119D (59%); S14118S (58%); S14111D (53%)
S14128S,"Central cord syndrome at C8 level of cervical spinal cord, sequela",,
S14129A,"Central cord syndrome at unspecified level of cervical spinal cord, initial encounter",182,S14119A (64%); S14119D (57%); S14111A (53%); S14114A (53%); S14115A (53%)
S14129D,"Central cord syndrome at unspecified level of cervical spinal cord, subsequent encounter",182,S14119D (68%); S14111D (58%); S14114D (58%); S14115D (58%); S14117D (58%)
S14129S,"Central cord syndrome at unspecified level of cervical spinal cord, sequela",,
S14131A,"Anterior cord syndrome at C1 level of cervical spinal cord, initial encounter",182,S14111A (72%); G8382 (68%); S14111D (66%); S14111S (61%); S14119A (56%)
S14131D,"Anterior cord syndrome at C1 level of cervical spinal cord, subsequent encounter",182,S14111D (74%); S14111A (66%); G8382 (65%); S14119D (60%); S14111S (58%)
S14131S,"Anterior cord syndrome at C1 level of cervical spinal cord, sequela",,
S14132A,"Anterior cord syndrome at C2 level of cervical spinal cord, initial encounter",182,S14112A (72%); G8382 (68%); S14112D (66%); S14112S (61%); S14119A (56%)
S14132D,"Anterior cord syndrome at C2 level of cervical spinal cord, subsequent encounter",182,S14112D (74%); S14112A (67%); G8382 (65%); S14119D (60%); S14112S (58%)
S14132S,"Anterior cord syndrome at C2 level of cervical spinal cord, sequela",,
S14133A,"Anterior cord syndrome at C3 level of cervical spinal cord, initial encounter",182,S14113A (72%); G8382 (68%); S14113D (66%); S14113S (61%); S14119A (56%)
S14133D,"Anterior cord syndrome at C3 level of cervical spinal cord, subsequent encounter",182,S14113D (74%); S14113A (67%); G8382 (65%); S14119D (60%); S14113S (58%)
S14133S,"Anterior cord syndrome at C3 level of cervical spinal cord, sequela",,
S14134A,"Anterior cord syndrome at C4 level of cervical spinal cord, initial encounter",182,S14114A (72%); G8382 (68%); S14114D (66%); S14114S (61%); S14119A (56%)
S14134D,"Anterior cord syndrome at C4 level of cervical spinal cord, subsequent encounter",182,S14114D (74%); S14114A (66%); G8382 (65%); S14119D (60%); S14114S (58%)
S14134S,"Anterior cord syndrome at C4 level of cervical spinal cord, sequela",,
S14135A,"Anterior cord syndrome at C5 level of cervical spinal cord, initial encounter",182,S14115A (72%); G8382 (68%); S14115D (66%); S14115S (61%); S14119A (56%)
S14135D,"Anterior cord syndrome at C5 level of cervical spinal cord, subsequent encounter",182,S14115D (74%); S14115A (66%); G8382 (65%); S14119D (60%); S14115S (58%)
S14135S,"Anterior cord syndrome at C5 level of cervical spinal cord, sequela",,
S14136A,"Anterior cord syndrome at C6 level of cervical spinal cord, initial encounter",182,S14116A (72%); G8382 (68%); S14116D (66%); S14116S (61%); S14119A (56%)
S14136D,"Anterior cord syndrome at C6 level of cervical spinal cord, subsequent encounter",182,S14116D (74%); S14116A (67%); G8382 (65%); S14119D (60%); S14116S (58%)
S14136S,"Anterior cord syndrome at C6 level of cervical spinal cord, sequela",,
S14137A,"Anterior cord syndrome at C7 level of cervical spinal cord, initial encounter",182,S14117A (72%); G8382 (68%); S14117D (66%); S14117S (61%); S14119A (56%)
S14137D,"Anterior cord syndrome at C7 level of cervical spinal cord, subsequent encounter",182,S14117D (74%); S14117A (66%); G8382 (65%); S14119D (60%); S14117S (58%)
S14137S,"Anterior cord syndrome at C7 level of cervical spinal cord, sequela",,
S14138A,"Anterior cord syndrome at C8 level of cervical spinal cord, initial encounter",182,S14118A (72%); G8382 (68%); S14118D (66%); S14118S (61%); S14119A (56%)
S14138D,"Anterior cord syndrome at C8 level of cervical spinal cord, subsequent encounter",182,S14118D (74%); S14118A (67%); G8382 (65%); S14119D (60%); S14118S (58%)
S14138S,"Anterior cord syndrome at C8 level of cervical spinal cord, sequela",,
S14139A,"Anterior cord syndrome at unspecified level of cervical spinal cord, initial encounter",182,G8382 (75%); S14119A (65%); S14119D (57%); S14111A (54%); S14114A (54%)
S14139D,"Anterior cord syndrome at unspecified level of cervical spinal cord, subsequent encounter",182,G8382 (71%); S14119D (68%); S14111D (58%); S14114D (58%); S14115D (58%)
S14139S,"Anterior cord syndrome at unspecified level of cervical spinal cord, sequela",,
S14141A,"Brown-Sequard syndrome at C1 level of cervical spinal cord, initial encounter",182,G8381 (65%); S14111A (63%); S14111D (58%); S14111S (53%); S14119A (46%)
S14141D,"Brown-Sequard syndrome at C1 level of cervical spinal cord, subsequent encounter",182,S14111D (67%); G8381 (62%); S14111A (58%); S14119D (51%); S14111S (51%)
S14141S,"Brown-Sequard syndrome at C1 level of cervical spinal cord, sequela",,
S14142A,"Brown-Sequard syndrome at C2 level of cervical spinal cord, initial encounter",182,G8381 (65%); S14112A (64%); S14112D (58%); S14112S (53%); S14119A (46%)
S14142D,"Brown-Sequard syndrome at C2 level of cervical spinal cord, subsequent encounter",182,S14112D (67%); G8381 (62%); S14112A (59%); S14112S (51%); S14119D (51%)
S14142S,"Brown-Sequard syndrome at C2 level of cervical spinal cord, sequela",,
S14143A,"Brown-Sequard syndrome at C3 level of cervical spinal cord, initial encounter",182,G8381 (65%); S14113A (64%); S14113D (58%); S14113S (53%); S14119A (46%)
S14143D,"Brown-Sequard syndrome at C3 level of cervical spinal cord, subsequent encounter",182,S14113D (67%); G8381 (62%); S14113A (59%); S14113S (51%); S14119D (51%)
S14143S,"Brown-Sequard syndrome at C3 level of cervical spinal cord, sequela",,
S14144A,"Brown-Sequard syndrome at C4 level of cervical spinal cord, initial encounter",182,G8381 (65%); S14114A (63%); S14114D (58%); S14114S (53%); S14119A (46%)
S14144D,"Brown-Sequard syndrome at C4 level of cervical spinal cord, subsequent encounter",182,S14114D (67%); G8381 (62%); S14114A (58%); S14119D (51%); S14114S (51%)
S14144S,"Brown-Sequard syndrome at C4 level of cervical spinal cord, sequela",,
S14145A,"Brown-Sequard syndrome at C5 level of cervical spinal cord, initial encounter",182,G8381 (65%); S14115A (63%); S14115D (58%); S14115S (53%); S14119A (46%)
S14145D,"Brown-Sequard syndrome at C5 level of cervical spinal cord, subsequent encounter",182,S14115D (67%); G8381 (62%); S14115A (58%); S14119D (51%); S14115S (51%)
S14145S,"Brown-Sequard syndrome at C5 level of cervical spinal cord, sequela",,
S14146A,"Brown-Sequard syndrome at C6 level of cervical spinal cord, initial encounter",182,G8381 (65%); S14116A (64%); S14116D (58%); S14116S (53%); S14119A (46%)
S14146D,"Brown-Sequard syndrome at C6 level of cervical spinal cord, subsequent encounter",182,S14116D (67%); G8381 (62%); S14116A (59%); S14116S (51%); S14119D (51%)
S14146S,"Brown-Sequard syndrome at C6 level of cervical spinal cord, sequela",,
S14147A,"Brown-Sequard syndrome at C7 level of cervical spinal cord, initial encounter",182,G8381 (65%); S14117A (63%); S14117D (58%); S14117S (53%); S14119A (46%)
S14147D,"Brown-Sequard syndrome at C7 level of cervical spinal cord, subsequent encounter",182,S14117D (67%); G8381 (62%); S14117A (58%); S14119D (51%); S14117S (51%)
S14147S,"Brown-Sequard syndrome at C7 level of cervical spinal cord, sequela",,
S14148A,"Brown-Sequard syndrome at C8 level of cervical spinal cord, initial encounter",182,G8381 (65%); S14118A (64%); S14118D (58%); S14118S (53%); S14119A (46%)
S14148D,"Brown-Sequard syndrome at C8 level of cervical spinal cord, subsequent encounter",182,S14118D (67%); G8381 (62%); S14118A (59%); S14118S (51%); S14119D (51%)
S14148S,"Brown-Sequard syndrome at C8 level of cervical spinal cord, sequela",,
S14149A,"Brown-Sequard syndrome at unspecified level of cervical spinal cord, initial encounter",182,G8381 (72%); S14119A (54%); S14119D (47%); S14111A (44%); S14114A (44%)
S14149D,"Brown-Sequard syndrome at unspecified level of cervical spinal cord, subsequent encounter",182,G8381 (69%); S14119D (59%); S14111D (50%); S14114D (50%); S14115D (50%)
S14149S,"Brown-Sequard syndrome at unspecified level of cervical spinal cord, sequela",,
S14151A,"Other incomplete lesion at C1 level of cervical spinal cord, initial encounter",182,S14111A (84%); S14111D (77%); S14111S (71%); S14119A (67%); S14119D (59%)
S14151D,"Other incomplete lesion at C1 level of cervical spinal cord, subsequent encounter",182,S14111D (85%); S14111A (77%); S14119D (70%); S14111S (67%); S14114D (62%)
S14151S,"Other incomplete lesion at C1 level of cervical spinal cord, sequela",,
S14152A,"Other incomplete lesion at C2 level of cervical spinal cord, initial encounter",182,S14112A (84%); S14112D (77%); S14112S (71%); S14119A (66%); S14119D (59%)
S14152D,"Other incomplete lesion at C2 level of cervical spinal cord, subsequent encounter",182,S14112D (85%); S14112A (77%); S14119D (70%); S14112S (68%); S14111D (62%)
S14152S,"Other incomplete lesion at C2 level of cervical spinal cord, sequela",,
S14153A,"Other incomplete lesion at C3 level of cervical spinal cord, initial encounter",182,S14113A (84%); S14113D (77%); S14113S (71%); S14119A (66%); S14119D (59%)
S14153D,"Other incomplete lesion at C3 level of cervical spinal cord, subsequent encounter",182,S14113D (85%); S14113A (77%); S14119D (70%); S14113S (68%); S14111D (62%)
S14153S,"Other incomplete lesion at C3 level of cervical spinal cord, sequela",,
S14154A,"Other incomplete lesion at C4 level of cervical spinal cord, initial encounter",182,S14114A (84%); S14114D (77%); S14114S (71%); S14119A (67%); S14119D (59%)
S14154D,"Other incomplete lesion at C4 level of cervical spinal cord, subsequent encounter",182,S14114D (85%); S14114A (77%); S14119D (70%); S14114S (67%); S14111D (62%)
S14154S,"Other incomplete lesion at C4 level of cervical spinal cord, sequela",,
S14155A,"Other incomplete lesion at C5 level of cervical spinal cord, initial encounter",182,S14115A (84%); S14115D (77%); S14115S (71%); S14119A (67%); S14119D (59%)
S14155D,"Other incomplete lesion at C5 level of cervical spinal cord, subsequent encounter",182,S14115D (85%); S14115A (77%); S14119D (70%); S14115S (67%); S14111D (62%)
S14155S,"Other incomplete lesion at C5 level of cervical spinal cord, sequela",,
S14156A,"Other incomplete lesion at C6 level of cervical spinal cord, initial encounter",182,S14116A (84%); S14116D (77%); S14116S (71%); S14119A (66%); S14119D (59%)
S14156D,"Other incomplete lesion at C6 level of cervical spinal cord, subsequent encounter",182,S14116D (85%); S14116A (77%); S14119D (70%); S14116S (68%); S14111D (62%)
S14156S,"Other incomplete lesion at C6 level of cervical spinal cord, sequela",,
S14157A,"Other incomplete lesion at C7 level of cervical spinal cord, initial encounter",182,S14117A (84%); S14117D (77%); S14117S (71%); S14119A (67%); S14119D (59%)
S14157D,"Other incomplete lesion at C7 level of cervical spinal cord, subsequent encounter",182,S14117D (85%); S14117A (77%); S14119D (70%); S14117S (67%); S14111D (62%)
S14157S,"Other incomplete lesion at C7 level of cervical spinal cord, sequela",,
S14158A,"Other incomplete lesion at C8 level of cervical spinal cord, initial encounter",182,S14118A (84%); S14118D (77%); S14118S (71%); S14119A (66%); S14119D (59%)
S14158D,"Other incomplete lesion at C8 level of cervical spinal cord, subsequent encounter",182,S14118D (85%); S14118A (77%); S14119D (70%); S14118S (68%); S14111D (62%)
S14158S,"Other incomplete lesion at C8 level of cervical spinal cord, sequela",,
S14159A,"Other incomplete lesion at unspecified level of cervical spinal cord, initial encounter",182,S14119A (79%); S14119D (70%); S14111A (66%); S14114A (66%); S14115A (66%)
S14159D,"Other incomplete lesion at unspecified level of cervical spinal cord, subsequent encounter",182,S14119D (82%); S14119A (71%); S14111D (70%); S14114D (70%); S14115D (70%)
S14159S,"Other incomplete lesion at unspecified level of cervical spinal cord, sequela",,
S22000A,"Wedge compression fracture of unspecified thoracic vertebra, initial encounter for closed fracture",401,S728X9A (52%); S7290XA (51%); S7292XA (49%); S7291XA (49%); S32409A (48%)
S22000B,"Wedge compression fracture of unspecified thoracic vertebra, initial encounter for open fracture",401,S32409B (47%); S32402B (45%); S32401B (45%); S02609B (45%); S32309B (43%)
S22001A,"Stable burst fracture of unspecified thoracic vertebra, initial encounter for closed fracture",401,S728X9A (54%); S7290XA (54%); S7292XA (52%); S7291XA (52%); S32409A (50%)
S22001B,"Stable burst fracture of unspecified thoracic vertebra, initial encounter for open fracture",401,S32409B (49%); S32402B (47%); S32401B (47%); S02609B (47%); S32309B (46%)
S22002A,"Unstable burst fracture of unspecified thoracic vertebra, initial encounter for closed fracture",401,S728X9A (53%); S7290XA (53%); S7292XA (51%); S7291XA (51%); S32409A (49%)
S22002B,"Unstable burst fracture of unspecified thoracic vertebra, initial encounter for open fracture",401,S32409B (48%); S32402B (46%); S32401B (46%); S02609B (46%); S32309B (45%)
S22008A,"Other fracture of unspecified thoracic vertebra, initial encounter for closed fracture",401,S728X9A (69%); S7290XA (68%); S7292XA (65%); S7291XA (65%); S32409A (63%)
S22008B,"Other fracture of unspecified thoracic vertebra, initial encounter for open fracture",401,S32409B (63%); S32402B (60%); S32401B (60%); S02609B (60%); S32309B (58%)
S22009A,"Unspecified fracture of unspecified thoracic vertebra, initial encounter for closed fracture",401,S7290XA (73%); S728X9A (70%); S32409A (68%); S7292XA (66%); S7291XA (66%)
S22009B,"Unspecified fracture of unspecified thoracic vertebra, initial encounter for open fracture",401,S32409B (68%); S32309B (62%); S32609B (62%); S7290XB (62%); S32509B (61%)
S22010A,"Wedge compression fracture of first thoracic vertebra, initial encounter for closed fracture",401,S728X9A (48%); S728X2A (47%); S728X1A (47%); S7292XA (46%); S7291XA (46%)
S22010B,"Wedge compression fracture of first thoracic vertebra, initial encounter for open fracture",401,S32402B (42%); S32401B (42%); S02609B (42%); S32409B (41%); S32399B (40%)
S22011A,"Stable burst fracture of first thoracic vertebra, initial encounter for closed fracture",401,S728X9A (51%); S728X2A (50%); S728X1A (50%); S7292XA (48%); S7291XA (48%)
S22011B,"Stable burst fracture of first thoracic vertebra, initial encounter for open fracture",401,S32402B (44%); S32401B (44%); S02609B (44%); S32409B (43%); S32399B (42%)
S22012A,"Unstable burst fracture of first thoracic vertebra, initial encounter for closed fracture",401,S728X9A (50%); S728X2A (49%); S728X1A (49%); S7292XA (47%); S7291XA (47%)
S22012B,"Unstable burst fracture of first thoracic vertebra, initial encounter for open fracture",401,S32402B (43%); S32401B (43%); S02609B (43%); S32409B (42%); S32399B (41%)
S22018A,"Other fracture of first thoracic vertebra, initial encounter for closed fracture",401,S728X9A (65%); S728X2A (64%); S728X1A (64%); S7292XA (62%); S7291XA (62%)
S22018B,"Other fracture of first thoracic vertebra, initial encounter for open fracture",401,S32402B (57%); S32401B (57%); S02609B (56%); S32409B (55%); S32399B (54%)
S22019A,"Unspecified fracture of first thoracic vertebra, initial encounter for closed fracture",401,S728X9A (69%); S7290XA (68%); S7292XA (65%); S7291XA (65%); S32409A (63%)
S22019B,"Unspecified fracture of first thoracic vertebra, initial encounter for open fracture",401,S32409B (63%); S32402B (60%); S32401B (60%); S02609B (60%); S32309B (58%)
S22020A,"Wedge compression fracture of second thoracic vertebra, initial encounter for closed fracture",401,S728X9A (44%); S728X2A (43%); S728X1A (43%); S7292XA (42%); S7291XA (42%)
S22020B,"Wedge compression fracture of second thoracic vertebra, initial encounter for open fracture",401,S32402B (38%); S32401B (38%); S02609B (38%); S32409B (37%); S32399B (36%)
S22021A,"Stable burst fracture of second thoracic vertebra, initial encounter for closed fracture",401,S728X9A (46%); S728X2A (45%); S728X1A (45%); S7292XA (43%); S7291XA (43%)
S22021B,"Stable burst fracture of second thoracic vertebra, initial encounter for open fracture",401,S32402B (40%); S32401B (40%); S02609B (39%); S32409B (38%); S32399B (38%)
S22022A,"Unstable burst fracture of second thoracic vertebra, initial encounter for closed fracture",401,S728X9A (45%); S728X2A (44%); S728X1A (44%); S7292XA (43%); S7291XA (43%)
S22022B,"Unstable burst fracture of second thoracic vertebra, initial encounter for open fracture",401,S32402B (39%); S32401B (39%); S02609B (39%); S32409B (38%); S32399B (37%)
S22028A,"Other fracture of second thoracic vertebra, initial encounter for closed fracture",401,S728X9A (55%); S728X2A (54%); S728X1A (54%); S7292XA (53%); S7291XA (53%)
S22028B,"Other fracture of second thoracic vertebra, initial encounter for open fracture",401,S32402B (48%); S32401B (48%); S02609B (48%); S32409B (46%); S32399B (46%)
S22029A,"Unspecified fracture of second thoracic vertebra, initial encounter for closed fracture",401,S728X9A (59%); S7290XA (58%); S7292XA (56%); S7291XA (56%); S32409A (54%)
S22029B,"Unspecified fracture of second thoracic vertebra, initial encounter for open fracture",401,S32409B (54%); S32402B (51%); S32401B (51%); S02609B (51%); S32309B (49%)
S22030A,"Wedge compression fracture of third thoracic vertebra, initial encounter for closed fracture",401,S728X9A (48%); S728X2A (47%); S728X1A (47%); S7292XA (46%); S7291XA (46%)
S22030B,"Wedge compression fracture of third thoracic vertebra, initial encounter for open fracture",401,S32402B (42%); S32401B (42%); S02609B (42%); S32409B (41%); S32399B (40%)
S22031A,"Stable burst fracture of third thoracic vertebra, initial encounter for closed fracture",401,S728X9A (51%); S728X2A (50%); S728X1A (50%); S7292XA (48%); S7291XA (48%)
S22031B,"Stable burst fracture of third thoracic vertebra, initial encounter for open fracture",401,S32402B (44%); S32401B (44%); S02609B (44%); S32409B (43%); S32399B (42%)
S22032A,"Unstable burst fracture of third thoracic vertebra, initial encounter for closed fracture",401,S728X9A (50%); S728X2A (49%); S728X1A (49%); S7292XA (47%); S7291XA (47%)
S22032B,"Unstable burst fracture of third thoracic vertebra, initial encounter for open fracture",401,S32402B (43%); S32401B (43%); S02609B (43%); S32409B (42%); S32399B (41%)
S22038A,"Other fracture of third thoracic vertebra, initial encounter for closed fracture",401,S728X9A (65%); S728X2A (64%); S728X1A (64%); S7292XA (62%); S7291XA (62%)
S22038B,"Other fracture of third thoracic vertebra, initial encounter for open fracture",401,S32402B (57%); S32401B (57%); S02609B (56%); S32409B (55%); S32399B (54%)
S22039A,"Unspecified fracture of third thoracic vertebra, initial encounter for closed fracture",401,S728X9A (69%); S7290XA (68%); S7292XA (65%); S7291XA (65%); S32409A (63%)
S22039B,"Unspecified fracture of third thoracic vertebra, initial encounter for open fracture",401,S32409B (63%); S32402B (60%); S32401B (60%); S02609B (60%); S32309B (58%)
S22040A,"Wedge compression fracture of fourth thoracic vertebra, initial encounter for closed fracture",401,S728X9A (44%); S728X2A (43%); S728X1A (43%); S7292XA (42%); S7291XA (42%)
S22040B,"Wedge compression fracture of fourth thoracic vertebra, initial encounter for open fracture",401,S32402B (38%); S32401B (38%); S02609B (38%); S32409B (37%); S32399B (36%)
S22041A,"Stable burst fracture of fourth thoracic vertebra, initial encounter for closed fracture",401,S728X9A (46%); S728X2A (45%); S728X1A (45%); S7292XA (43%); S7291XA (43%)
S22041B,"Stable burst fracture of fourth thoracic vertebra, initial encounter for open fracture",401,S32402B (40%); S32401B (40%); S02609B (39%); S32409B (38%); S32399B (38%)
S22042A,"Unstable burst fracture of fourth thoracic vertebra, initial encounter for closed fracture",401,S728X9A (45%); S728X2A (44%); S728X1A (44%); S7292XA (43%); S7291XA (43%)
S22042B,"Unstable burst fracture of fourth thoracic vertebra, initial encounter for open fracture",401,S32402B (39%); S32401B (39%); S02609B (39%); S32409B (38%); S32399B (37%)
S22048A,"Other fracture of fourth thoracic vertebra, initial encounter for closed fracture",401,S728X9A (55%); S728X2A (54%); S728X1A (54%); S7292XA (53%); S7291XA (53%)
S22048B,"Other fracture of fourth thoracic vertebra, initial encounter for open fracture",401,S32402B (48%); S32401B (48%); S02609B (48%); S32409B (46%); S32399B (46%)
S22049A,"Unspecified fracture of fourth thoracic vertebra, initial encounter for closed fracture",401,S728X9A (59%); S7290XA (58%); S7292XA (56%); S7291XA (56%); S32409A (54%)
S22049B,"Unspecified fracture of fourth thoracic vertebra, initial encounter for open fracture",401,S32409B (54%); S32402B (51%); S32401B (51%); S02609B (51%); S32309B (49%)
S22050A,"Wedge compression fracture of T5-T6 vertebra, initial encounter for closed fracture",401,S728X9A (41%); S728X2A (40%); S728X1A (40%); S7292XA (38%); S7291XA (38%)
S22050B,"Wedge compression fracture of T5-T6 vertebra, initial encounter for open fracture",401,S32402B (35%); S32401B (35%); S02609B (35%); S32409B (34%); S32399B (33%)
S22051A,"Stable burst fracture of T5-T6 vertebra, initial encounter for closed fracture",401,S728X9A (42%); S728X2A (41%); S728X1A (41%); S7292XA (40%); S7291XA (40%)
S22051B,"Stable burst fracture of T5-T6 vertebra, initial encounter for open fracture",401,S32402B (36%); S32401B (36%); S02609B (36%); S32409B (35%); S32399B (35%)
S22052A,"Unstable burst fracture of T5-T6 vertebra, initial encounter for closed fracture",401,S728X9A (42%); S728X2A (41%); S728X1A (41%); S7292XA (39%); S7291XA (39%)
S22052B,"Unstable burst fracture of T5-T6 vertebra, initial encounter for open fracture",401,S32402B (36%); S32401B (36%); S02609B (36%); S32409B (35%); S32399B (34%)
S22058A,"Other fracture of T5-T6 vertebra, initial encounter for closed fracture",401,S728X9A (49%); S728X2A (48%); S728X1A (48%); S7292XA (47%); S7291XA (47%)
S22058B,"Other fracture of T5-T6 vertebra, initial encounter for open fracture",401,S32402B (42%); S32401B (42%); S02609B (42%); S32409B (41%); S32399B (41%)
S22059A,"Unspecified fracture of T5-T6 vertebra, initial encounter for closed fracture",401,S728X9A (53%); S7290XA (52%); S7292XA (50%); S7291XA (50%); S32409A (48%)
S22059B,"Unspecified fracture of T5-T6 vertebra, initial encounter for open fracture",401,S32409B (48%); S32402B (45%); S32401B (45%); S02609B (45%); S32309B (44%)
S22060A,"Wedge compression fracture of T7-T8 vertebra, initial encounter for closed fracture",401,S728X9A (41%); S728X2A (40%); S728X1A (40%); S7292XA (38%); S7291XA (38%)
S22060B,"Wedge compression fracture of T7-T8 vertebra, initial encounter for open fracture",401,S32402B (35%); S32401B (35%); S02609B (35%); S32409B (34%); S32399B (33%)
S22061A,"Stable burst fracture of T7-T8 vertebra, initial encounter for closed fracture",401,S728X9A (42%); S728X2A (41%); S728X1A (41%); S7292XA (40%); S7291XA (40%)
S22061B,"Stable burst fracture of T7-T8 vertebra, initial encounter for open fracture",401,S32402B (36%); S32401B (36%); S02609B (36%); S32409B (35%); S32399B (35%)
S22062A,"Unstable burst fracture of T7-T8 vertebra, initial encounter for closed fracture",401,S728X9A (42%); S728X2A (41%); S728X1A (41%); S7292XA (39%); S7291XA (39%)
S22062B,"Unstable burst fracture of T7-T8 vertebra, initial encounter for open fracture",401,S32402B (36%); S32401B (36%); S02609B (36%); S32409B (35%); S32399B (34%)
S22068A,"Other fracture of T7-T8 thoracic vertebra, initial encounter for closed fracture",401,S728X9A (46%); S728X2A (45%); S728X1A (45%); S7292XA (44%); S7291XA (44%)
S22068B,"Other fracture of T7-T8 thoracic vertebra, initial encounter for open fracture",401,S32402B (40%); S32401B (40%); S02609B (40%); S24103A (39%); S32409B (38%)
S22069A,"Unspecified fracture of T7-T8 vertebra, initial encounter for closed fracture",401,S728X9A (53%); S7290XA (52%); S7292XA (50%); S7291XA (50%); S32409A (48%)
S22069B,"Unspecified fracture of T7-T8 vertebra, initial encounter for open fracture",401,S32409B (48%); S32402B (45%); S32401B (45%); S02609B (45%); S32309B (44%)
S22070A,"Wedge compression fracture of T9-T10 vertebra, initial encounter for closed fracture",401,S728X9A (41%); S728X2A (40%); S728X1A (40%); S7292XA (38%); S7291XA (38%)
S22070B,"Wedge compression fracture of T9-T10 vertebra, initial encounter for open fracture",401,S32402B (35%); S32401B (35%); S02609B (35%); S32409B (34%); S32399B (33%)
S22071A,"Stable burst fracture of T9-T10 vertebra, initial encounter for closed fracture",401,S728X9A (42%); S728X2A (41%); S728X1A (41%); S7292XA (40%); S7291XA (40%)
S22071B,"Stable burst fracture of T9-T10 vertebra, initial encounter for open fracture",401,S32402B (36%); S32401B (36%); S02609B (36%); S32409B (35%); S32399B (35%)
S22072A,"Unstable burst fracture of T9-T10 vertebra, initial encounter for closed fracture",401,S728X9A (42%); S728X2A (41%); S728X1A (41%); S7292XA (39%); S7291XA (39%)
S22072B,"Unstable burst fracture of T9-T10 vertebra, initial encounter for open fracture",401,S32402B (36%); S32401B (36%); S02609B (36%); S32409B (35%); S32399B (34%)
S22078A,"Other fracture of T9-T10 vertebra, initial encounter for closed fracture",401,S728X9A (49%); S728X2A (48%); S728X1A (48%); S7292XA (47%); S7291XA (47%)
S22078B,"Other fracture of T9-T10 vertebra, initial encounter for open fracture",401,S32402B (42%); S32401B (42%); S02609B (42%); S32409B (41%); S32399B (41%)
S22079A,"Unspecified fracture of T9-T10 vertebra, initial encounter for closed fracture",401,S728X9A (53%); S7290XA (52%); S7292XA (50%); S7291XA (50%); S32409A (48%)
S22079B,"Unspecified fracture of T9-T10 vertebra, initial encounter for open fracture",401,S32409B (48%); S32402B (45%); S32401B (45%); S02609B (45%); S32309B (44%)
S22080A,"Wedge compression fracture of T11-T12 vertebra, initial encounter for closed fracture",401,S24104A (44%); S24114A (42%); S728X9A (41%); S24154A (41%); S728X2A (40%)
S22080B,"Wedge compression fracture of T11-T12 vertebra, initial encounter for open fracture",401,S24104A (44%); S24114A (42%); S24154A (41%); S24104D (40%); S24144A (38%)
S22081A,"Stable burst fracture of T11-T12 vertebra, initial encounter for closed fracture",401,S24104A (46%); S24114A (43%); S728X9A (43%); S24154A (42%); S728X2A (42%)
S22081B,"Stable burst fracture of T11-T12 vertebra, initial encounter for open fracture",401,S24104A (46%); S24114A (43%); S24154A (42%); S24104D (41%); S24144A (39%)
S22082A,"Unstable burst fracture of T11-T12 vertebra, initial encounter for closed fracture",401,S24104A (45%); S24114A (43%); S728X9A (42%); S24154A (42%); S728X2A (41%)
S22082B,"Unstable burst fracture of T11-T12 vertebra, initial encounter for open fracture",401,S24104A (45%); S24114A (43%); S24154A (42%); S24104D (41%); S24144A (39%)
S22088A,"Other fracture of T11-T12 vertebra, initial encounter for closed fracture",401,S24104A (54%); S24114A (51%); S728X9A (51%); S24154A (50%); S728X2A (49%)
S22088B,"Other fracture of T11-T12 vertebra, initial encounter for open fracture",401,S24104A (54%); S24114A (51%); S24154A (50%); S24104D (49%); S24144A (47%)
S22089A,"Unspecified fracture of T11-T12 vertebra, initial encounter for closed fracture",401,S24104A (55%); S728X9A (54%); S7290XA (53%); S7292XA (51%); S7291XA (51%)
S22089B,"Unspecified fracture of T11-T12 vertebra, initial encounter for open fracture",401,S24104A (56%); S24114A (51%); S24104D (50%); S24154A (49%); S32409B (49%)
S240XXA,"Concussion and edema of thoracic spinal cord, initial encounter",182,S24119A (49%); S24111A (43%); S24119D (43%); S24113A (39%); S24114A (39%)
S240XXD,"Concussion and edema of thoracic spinal cord, subsequent encounter",182,S24119D (56%); S24111D (49%); S24113D (45%); S24114D (45%); S24112D (44%)
S240XXS,"Concussion and edema of thoracic spinal cord, sequela",,
S24101A,"Unspecified injury at T1 level of thoracic spinal cord, initial encounter",182,S24111A (77%); S24111D (71%); S24111S (65%); S24119A (59%); S24119D (52%)
S24101D,"Unspecified injury at T1 level of thoracic spinal cord, subsequent encounter",182,S24111D (80%); S24111A (70%); S24119D (64%); S24111S (62%); S24119A (52%)
S24101S,"Unspecified injury at T1 level of thoracic spinal cord, sequela",,
S24102A,"Unspecified injury at T2-T6 level of thoracic spinal cord, initial encounter",182,S24112A (82%); S24112D (76%); S24112S (71%); S24119A (53%); S24119D (46%)
S24102D,"Unspecified injury at T2-T6 level of thoracic spinal cord, subsequent encounter",182,S24112D (83%); S24112A (76%); S24112S (68%); S24119D (57%); S24111D (48%)
S24102S,"Unspecified injury at T2-T6 level of thoracic spinal cord, sequela",,
S24103A,"Unspecified injury at T7-T10 level of thoracic spinal cord, initial encounter",182,S24113A (81%); S24113D (75%); S24113S (70%); S24119A (54%); S24119D (47%)
S24103D,"Unspecified injury at T7-T10 level of thoracic spinal cord, subsequent encounter",182,S24113D (83%); S24113A (75%); S24113S (67%); S24119D (58%); S24111D (49%)
S24103S,"Unspecified injury at T7-T10 level of thoracic spinal cord, sequela",,
S24104A,"Unspecified injury at T11-T12 level of thoracic spinal cord, initial encounter",182,S24114A (81%); S24114D (75%); S24114S (70%); S22089B (56%); S22089A (55%)
S24104D,"Unspecified injury at T11-T12 level of thoracic spinal cord, subsequent encounter",182,S24114D (83%); S24114A (75%); S24114S (67%); S24119D (58%); S22089B (50%)
S24104S,"Unspecified injury at T11-T12 level of thoracic spinal cord, sequela",,
S24109A,"Unspecified injury at unspecified level of thoracic spinal cord, initial encounter",182,S24119A (70%); S24119D (62%); S24119S (56%); S24111A (55%); S14119A (54%)
S24109D,"Unspecified injury at unspecified level of thoracic spinal cord, subsequent encounter",182,S24119D (74%); S24119A (62%); S24111D (60%); S14119D (60%); S24113D (56%)
S24109S,"Unspecified injury at unspecified level of thoracic spinal cord, sequela",,
S24111A,"Complete lesion at T1 level of thoracic spinal cord, initial encounter",181,S24151A (85%); S24151D (78%); S24101A (77%); S24131A (73%); S14119A (70%)
S24111D,"Complete lesion at T1 level of thoracic spinal cord, subsequent encounter",181,S24151D (86%); S24101D (80%); S24151A (78%); S24131D (75%); S14119D (74%)
S24111S,"Complete lesion at T1 level of thoracic spinal cord, sequela",181,S14119S (76%); S24151A (72%); S24151D (69%); S14111S (68%); S14114S (68%)
S24112A,"Complete lesion at T2-T6 level of thoracic spinal cord, initial encounter",181,S24152A (87%); S24152D (82%); S24102A (82%); S24132A (77%); S24102D (76%)
S24112D,"Complete lesion at T2-T6 level of thoracic spinal cord, subsequent encounter",181,S24152D (88%); S24102D (83%); S24152A (82%); S24132D (79%); S24102A (76%)
S24112S,"Complete lesion at T2-T6 level of thoracic spinal cord, sequela",181,S24152A (77%); S24152D (74%); S24102A (71%); S14119S (69%); S24102D (68%)
S24113A,"Complete lesion at T7-T10 level of thoracic spinal cord, initial encounter",181,S24153A (87%); S24153D (81%); S24103A (81%); S24133A (77%); S24103D (75%)
S24113D,"Complete lesion at T7-T10 level of thoracic spinal cord, subsequent encounter",181,S24153D (88%); S24103D (83%); S24153A (81%); S24133D (78%); S24103A (75%)
S24113S,"Complete lesion at T7-T10 level of thoracic spinal cord, sequela",181,S24153A (76%); S24153D (73%); S24103A (70%); S14119S (70%); S24133A (67%)
S24114A,"Complete lesion at T11-T12 level of thoracic spinal cord, initial encounter",181,S24154A (87%); S24154D (81%); S24104A (81%); S24134A (77%); S24104D (75%)
S24114D,"Complete lesion at T11-T12 level of thoracic spinal cord, subsequent encounter",181,S24154D (88%); S24104D (83%); S24154A (81%); S24134D (78%); S24104A (75%)
S24114S,"Complete lesion at T11-T12 level of thoracic spinal cord, sequela",181,S24154A (76%); S24154D (73%); S24104A (70%); S14119S (70%); S24134A (67%)
S24119A,"Complete lesion at unspecified level of thoracic spinal cord, initial encounter",181,S14119A (84%); S34119A (82%); S24159A (80%); S14119D (75%); S34119D (73%)
S24119D,"Complete lesion at unspecified level of thoracic spinal cord, subsequent encounter",181,S14119D (86%); S34119D (84%); S24159D (82%); S14119A (75%); S24109D (74%)
S24119S,"Complete lesion at unspecified level of thoracic spinal cord, sequela",181,S14119S (88%); S14111S (76%); S14114S (76%); S14115S (76%); S14117S (76%)
S24131A,"Anterior cord syndrome at T1 level of thoracic spinal cord, initial encounter",182,S24111A (73%); S24111D (67%); G8382 (66%); S24111S (62%); S24119A (57%)
S24131D,"Anterior cord syndrome at T1 level of thoracic spinal cord, subsequent encounter",182,S24111D (75%); S24111A (68%); G8382 (64%); S24119D (61%); S24111S (60%)
S24131S,"Anterior cord syndrome at T1 level of thoracic spinal cord, sequela",,
S24132A,"Anterior cord syndrome at T2-T6 level of thoracic spinal cord, initial encounter",182,S24112A (77%); S24112D (72%); S24112S (68%); G8382 (61%); S24119A (52%)
S24132D,"Anterior cord syndrome at T2-T6 level of thoracic spinal cord, subsequent encounter",182,S24112D (79%); S24112A (73%); S24112S (66%); G8382 (59%); S24119D (56%)
S24132S,"Anterior cord syndrome at T2-T6 level of thoracic spinal cord, sequela",,
S24133A,"Anterior cord syndrome at T7-T10 level of thoracic spinal cord, initial encounter",182,S24113A (77%); S24113D (72%); S24113S (67%); G8382 (62%); S24119A (53%)
S24133D,"Anterior cord syndrome at T7-T10 level of thoracic spinal cord, subsequent encounter",182,S24113D (78%); S24113A (72%); S24113S (65%); G8382 (60%); S24119D (57%)
S24133S,"Anterior cord syndrome at T7-T10 level of thoracic spinal cord, sequela",,
S24134A,"Anterior cord syndrome at T11-T12 level of thoracic spinal cord, initial encounter",182,S24114A (77%); S24114D (72%); S24114S (67%); G8382 (62%); S24119A (53%)
S24134D,"Anterior cord syndrome at T11-T12 level of thoracic spinal cord, subsequent encounter",182,S24114D (78%); S24114A (72%); S24114S (65%); G8382 (60%); S24119D (57%)
S24134S,"Anterior cord syndrome at T11-T12 level of thoracic spinal cord, sequela",,
S24139A,"Anterior cord syndrome at unspecified level of thoracic spinal cord, initial encounter",182,G8382 (74%); S24119A (66%); S24119D (59%); S24111A (55%); S24119S (53%)
S24139D,"Anterior cord syndrome at unspecified level of thoracic spinal cord, subsequent encounter",182,G8382 (70%); S24119D (69%); S24119A (60%); S24111D (59%); S14119D (58%)
S24139S,"Anterior cord syndrome at unspecified level of thoracic spinal cord, sequela",,
S24141A,"Brown-Sequard syndrome at T1 level of thoracic spinal cord, initial encounter",182,S24111A (65%); G8381 (64%); S24111D (60%); S24111S (55%); S24119A (47%)
S24141D,"Brown-Sequard syndrome at T1 level of thoracic spinal cord, subsequent encounter",182,S24111D (68%); G8381 (61%); S24111A (60%); S24111S (53%); S24119D (52%)
S24141S,"Brown-Sequard syndrome at T1 level of thoracic spinal cord, sequela",,
S24142A,"Brown-Sequard syndrome at T2-T6 level of thoracic spinal cord, initial encounter",182,S24112A (71%); S24112D (66%); S24112S (62%); G8381 (59%); S24119A (43%)
S24142D,"Brown-Sequard syndrome at T2-T6 level of thoracic spinal cord, subsequent encounter",182,S24112D (73%); S24112A (66%); S24112S (60%); G8381 (57%); S24119D (48%)
S24142S,"Brown-Sequard syndrome at T2-T6 level of thoracic spinal cord, sequela",,
S24143A,"Brown-Sequard syndrome at T7-T10 level of thoracic spinal cord, initial encounter",182,S24113A (70%); S24113D (65%); S24113S (61%); G8381 (59%); S24119A (44%)
S24143D,"Brown-Sequard syndrome at T7-T10 level of thoracic spinal cord, subsequent encounter",182,S24113D (72%); S24113A (65%); S24113S (59%); G8381 (57%); S24119D (49%)
S24143S,"Brown-Sequard syndrome at T7-T10 level of thoracic spinal cord, sequela",,
S24144A,"Brown-Sequard syndrome at T11-T12 level of thoracic spinal cord, initial encounter",182,S24114A (70%); S24114D (65%); S24114S (61%); G8381 (59%); S22088B (47%)
S24144D,"Brown-Sequard syndrome at T11-T12 level of thoracic spinal cord, subsequent encounter",182,S24114D (72%); S24114A (65%); S24114S (59%); G8381 (57%); S24119D (49%)
S24144S,"Brown-Sequard syndrome at T11-T12 level of thoracic spinal cord, sequela",,
S24149A,"Brown-Sequard syndrome at unspecified level of thoracic spinal cord, initial encounter",182,G8381 (71%); S24119A (55%); S24119D (49%); S24111A (46%); S24119S (44%)
S24149D,"Brown-Sequard syndrome at unspecified level of thoracic spinal cord, subsequent encounter",182,G8381 (68%); S24119D (60%); S24111D (51%); S24119A (50%); S14119D (48%)
S24149S,"Brown-Sequard syndrome at unspecified level of thoracic spinal cord, sequela",,
S24151A,"Other incomplete lesion at T1 level of thoracic spinal cord, initial encounter",182,S24111A (85%); S24111D (78%); S24111S (72%); S24119A (67%); S24119D (60%)
S24151D,"Other incomplete lesion at T1 level of thoracic spinal cord, subsequent encounter",182,S24111D (86%); S24111A (78%); S24119D (71%); S24111S (69%); S24119A (61%)
S24151S,"Other incomplete lesion at T1 level of thoracic spinal cord, sequela",,
S24152A,"Other incomplete lesion at T2-T6 level of thoracic spinal cord, initial encounter",182,S24112A (87%); S24112D (82%); S24112S (77%); S24119A (61%); S24119D (54%)
S24152D,"Other incomplete lesion at T2-T6 level of thoracic spinal cord, subsequent encounter",182,S24112D (88%); S24112A (82%); S24112S (74%); S24119D (64%); S24111D (57%)
S24152S,"Other incomplete lesion at T2-T6 level of thoracic spinal cord, sequela",,
S24153A,"Other incomplete lesion at T7-T10 level of thoracic spinal cord, initial encounter",182,S24113A (87%); S24113D (81%); S24113S (76%); S24119A (62%); S24119D (55%)
S24153D,"Other incomplete lesion at T7-T10 level of thoracic spinal cord, subsequent encounter",182,S24113D (88%); S24113A (81%); S24113S (73%); S24119D (65%); S24111D (58%)
S24153S,"Other incomplete lesion at T7-T10 level of thoracic spinal cord, sequela",,
S24154A,"Other incomplete lesion at T11-T12 level of thoracic spinal cord, initial encounter",182,S24114A (87%); S24114D (81%); S24114S (76%); S24119A (62%); S24119D (55%)
S24154D,"Other incomplete lesion at T11-T12 level of thoracic spinal cord, subsequent encounter",182,S24114D (88%); S24114A (81%); S24114S (73%); S24119D (65%); S24111D (58%)
S24154S,"Other incomplete lesion at T11-T12 level of thoracic spinal cord, sequela",,
S24159A,"Other incomplete lesion at unspecified level of thoracic spinal cord, initial encounter",182,S24119A (80%); S24119D (71%); S24111A (67%); S14119A (65%); S24119S (65%)
S24159D,"Other incomplete lesion at unspecified level of thoracic spinal cord, subsequent encounter",182,S24119D (82%); S24119A (72%); S24111D (70%); S14119D (69%); S24113D (65%)
S24159S,"Other incomplete lesion at unspecified level of thoracic spinal cord, sequela",,
S32000A,"Wedge compression fracture of unspecified lumbar vertebra, initial encounter for closed fracture",401,S728X9A (52%); S7290XA (51%); S7292XA (49%); S7291XA (49%); S32409A (47%)
S32000B,"Wedge compression fracture of unspecified lumbar vertebra, initial encounter for open fracture",401,S32409B (47%); S32402B (45%); S32401B (45%); S02609B (45%); S32309B (43%)
S32001A,"Stable burst fracture of unspecified lumbar vertebra, initial encounter for closed fracture",401,S728X9A (54%); S7290XA (53%); S7292XA (51%); S7291XA (51%); S32409A (50%)
S32001B,"Stable burst fracture of unspecified lumbar vertebra, initial encounter for open fracture",401,S32409B (49%); S32402B (47%); S32401B (47%); S02609B (47%); S32309B (45%)
S32002A,"Unstable burst fracture of unspecified lumbar vertebra, initial encounter for closed fracture",401,S728X9A (53%); S7290XA (52%); S7292XA (50%); S7291XA (50%); S32409A (49%)
S32002B,"Unstable burst fracture of unspecified lumbar vertebra, initial encounter for open fracture",401,S32409B (48%); S32402B (46%); S32401B (46%); S02609B (46%); S32309B (45%)
S32008A,"Other fracture of unspecified lumbar vertebra, initial encounter for closed fracture",401,S728X9A (69%); S7290XA (68%); S7292XA (65%); S7291XA (65%); S32409A (63%)
S32008B,"Other fracture of unspecified lumbar vertebra, initial encounter for open fracture",401,S32409B (62%); S32402B (60%); S32401B (60%); S02609B (59%); S32309B (58%)
S32009A,"Unspecified fracture of unspecified lumbar vertebra, initial encounter for closed fracture",401,S7290XA (73%); S728X9A (69%); S32409A (68%); S7292XA (66%); S7291XA (66%)
S32009B,"Unspecified fracture of unspecified lumbar vertebra, initial encounter for open fracture",401,S32409B (67%); S32309B (62%); S32609B (62%); S7290XB (62%); S32509B (61%)
S32010A,"Wedge compression fracture of first lumbar vertebra, initial encounter for closed fracture",401,S728X9A (48%); S728X2A (47%); S728X1A (47%); S7292XA (46%); S7291XA (46%)
S32010B,"Wedge compression fracture of first lumbar vertebra, initial encounter for open fracture",401,S32402B (42%); S32401B (42%); S02609B (42%); S32409B (40%); S32399B (40%)
S32011A,"Stable burst fracture of first lumbar vertebra, initial encounter for closed fracture",401,S728X9A (51%); S728X2A (50%); S728X1A (50%); S7292XA (48%); S7291XA (48%)
S32011B,"Stable burst fracture of first lumbar vertebra, initial encounter for open fracture",401,S32402B (44%); S32401B (44%); S02609B (44%); S32409B (43%); S32399B (42%)
S32012A,"Unstable burst fracture of first lumbar vertebra, initial encounter for closed fracture",401,S728X9A (50%); S728X2A (49%); S728X1A (49%); S7292XA (47%); S7291XA (47%)
S32012B,"Unstable burst fracture of first lumbar vertebra, initial encounter for open fracture",401,S32402B (43%); S32401B (43%); S02609B (43%); S32409B (42%); S32399B (41%)
S32018A,"Other fracture of first lumbar vertebra, initial encounter for closed fracture",401,S728X9A (65%); S728X2A (63%); S728X1A (63%); S7292XA (61%); S7291XA (61%)
S32018B,"Other fracture of first lumbar vertebra, initial encounter for open fracture",401,S32402B (56%); S32401B (56%); S02609B (56%); S32409B (54%); S32399B (54%)
S32019A,"Unspecified fracture of first lumbar vertebra, initial encounter for closed fracture",401,S728X9A (69%); S7290XA (68%); S7292XA (65%); S7291XA (65%); S32409A (63%)
S32019B,"Unspecified fracture of first lumbar vertebra, initial encounter for open fracture",401,S32409B (62%); S32402B (60%); S32401B (60%); S02609B (59%); S32309B (58%)
S32020A,"Wedge compression fracture of second lumbar vertebra, initial encounter for closed fracture",401,S728X9A (44%); S728X2A (43%); S728X1A (43%); S7292XA (42%); S7291XA (41%)
S32020B,"Wedge compression fracture of second lumbar vertebra, initial encounter for open fracture",401,S32402B (38%); S32401B (38%); S02609B (38%); S32409B (37%); S32399B (36%)
S32021A,"Stable burst fracture of second lumbar vertebra, initial encounter for closed fracture",401,S728X9A (46%); S728X2A (45%); S728X1A (45%); S7292XA (43%); S7291XA (43%)
S32021B,"Stable burst fracture of second lumbar vertebra, initial encounter for open fracture",401,S32402B (39%); S32401B (39%); S02609B (39%); S32409B (38%); S32399B (38%)
S32022A,"Unstable burst fracture of second lumbar vertebra, initial encounter for closed fracture",401,S728X9A (45%); S728X2A (44%); S728X1A (44%); S7292XA (43%); S7291XA (43%)
S32022B,"Unstable burst fracture of second lumbar vertebra, initial encounter for open fracture",401,S32402B (39%); S32401B (39%); S02609B (39%); S32409B (38%); S32399B (37%)
S32028A,"Other fracture of second lumbar vertebra, initial encounter for closed fracture",401,S728X9A (55%); S728X2A (54%); S728X1A (54%); S7292XA (52%); S7291XA (52%)
S32028B,"Other fracture of second lumbar vertebra, initial encounter for open fracture",401,S32402B (48%); S32401B (48%); S02609B (48%); S32409B (46%); S32399B (46%)
S32029A,"Unspecified fracture of second lumbar vertebra, initial encounter for closed fracture",401,S728X9A (59%); S7290XA (58%); S7292XA (56%); S7291XA (56%); S32409A (54%)
S32029B,"Unspecified fracture of second lumbar vertebra, initial encounter for open fracture",401,S32409B (53%); S32402B (51%); S32401B (51%); S02609B (51%); S32309B (49%)
S32030A,"Wedge compression fracture of third lumbar vertebra, initial encounter for closed fracture",401,S728X9A (48%); S728X2A (47%); S728X1A (47%); S7292XA (46%); S7291XA (46%)
S32030B,"Wedge compression fracture of third lumbar vertebra, initial encounter for open fracture",401,S32402B (42%); S32401B (42%); S02609B (42%); S32409B (40%); S32399B (40%)
S32031A,"Stable burst fracture of third lumbar vertebra, initial encounter for closed fracture",401,S728X9A (51%); S728X2A (50%); S728X1A (50%); S7292XA (48%); S7291XA (48%)
S32031B,"Stable burst fracture of third lumbar vertebra, initial encounter for open fracture",401,S32402B (44%); S32401B (44%); S02609B (44%); S32409B (43%); S32399B (42%)
S32032A,"Unstable burst fracture of third lumbar vertebra, initial encounter for closed fracture",401,S728X9A (50%); S728X2A (49%); S728X1A (49%); S7292XA (47%); S7291XA (47%)
S32032B,"Unstable burst fracture of third lumbar vertebra, initial encounter for open fracture",401,S32402B (43%); S32401B (43%); S02609B (43%); S32409B (42%); S32399B (41%)
S32038A,"Other fracture of third lumbar vertebra, initial encounter for closed fracture",401,S728X9A (65%); S728X2A (63%); S728X1A (63%); S7292XA (61%); S7291XA (61%)
S32038B,"Other fracture of third lumbar vertebra, initial encounter for open fracture",401,S32402B (56%); S32401B (56%); S02609B (56%); S32409B (54%); S32399B (54%)
S32039A,"Unspecified fracture of third lumbar vertebra, initial encounter for closed fracture",401,S728X9A (69%); S7290XA (68%); S7292XA (65%); S7291XA (65%); S32409A (63%)
S32039B,"Unspecified fracture of third lumbar vertebra, initial encounter for open fracture",401,S32409B (62%); S32402B (60%); S32401B (60%); S02609B (59%); S32309B (58%)
S32040A,"Wedge compression fracture of fourth lumbar vertebra, initial encounter for closed fracture",401,S728X9A (44%); S728X2A (43%); S728X1A (43%); S7292XA (42%); S7291XA (41%)
S32040B,"Wedge compression fracture of fourth lumbar vertebra, initial encounter for open fracture",401,S32402B (38%); S32401B (38%); S02609B (38%); S32409B (37%); S32399B (36%)
S32041A,"Stable burst fracture of fourth lumbar vertebra, initial encounter for closed fracture",401,S728X9A (46%); S728X2A (45%); S728X1A (45%); S7292XA (43%); S7291XA (43%)
S32041B,"Stable burst fracture of fourth lumbar vertebra, initial encounter for open fracture",401,S32402B (39%); S32401B (39%); S02609B (39%); S32409B (38%); S32399B (38%)
S32042A,"Unstable burst fracture of fourth lumbar vertebra, initial encounter for closed fracture",401,S728X9A (45%); S728X2A (44%); S728X1A (44%); S7292XA (43%); S7291XA (43%)
S32042B,"Unstable burst fracture of fourth lumbar vertebra, initial encounter for open fracture",401,S32402B (39%); S32401B (39%); S02609B (39%); S32409B (38%); S32399B (37%)
S32048A,"Other fracture of fourth lumbar vertebra, initial encounter for closed fracture",401,S728X9A (55%); S728X2A (54%); S728X1A (54%); S7292XA (52%); S7291XA (52%)
S32048B,"Other fracture of fourth lumbar vertebra, initial encounter for open fracture",401,S32402B (48%); S32401B (48%); S02609B (48%); S32409B (46%); S32399B (46%)
S32049A,"Unspecified fracture of fourth lumbar vertebra, initial encounter for closed fracture",401,S728X9A (59%); S7290XA (58%); S7292XA (56%); S7291XA (56%); S32409A (54%)
S32049B,"Unspecified fracture of fourth lumbar vertebra, initial encounter for open fracture",401,S32409B (53%); S32402B (51%); S32401B (51%); S02609B (51%); S32309B (49%)
S32050A,"Wedge compression fracture of fifth lumbar vertebra, initial encounter for closed fracture",401,S728X9A (43%); S728X2A (42%); S728X1A (42%); S7292XA (41%); S7291XA (41%)
S32050B,"Wedge compression fracture of fifth lumbar vertebra, initial encounter for open fracture",401,S32402B (37%); S32401B (37%); S02609B (37%); S32409B (36%); S32399B (36%)
S32051A,"Stable burst fracture of fifth lumbar vertebra, initial encounter for closed fracture",401,S728X9A (45%); S728X2A (44%); S728X1A (44%); S7292XA (43%); S7291XA (43%)
S32051B,"Stable burst fracture of fifth lumbar vertebra, initial encounter for open fracture",401,S32402B (39%); S32401B (39%); S02609B (39%); S32409B (38%); S32399B (37%)
S32052A,"Unstable burst fracture of fifth lumbar vertebra, initial encounter for closed fracture",401,S728X9A (45%); S728X2A (44%); S728X1A (43%); S7292XA (42%); S7291XA (42%)
S32052B,"Unstable burst fracture of fifth lumbar vertebra, initial encounter for open fracture",401,S32402B (38%); S32401B (38%); S02609B (38%); S32409B (37%); S32399B (37%)
S32058A,"Other fracture of fifth lumbar vertebra, initial encounter for closed fracture",401,S728X9A (54%); S728X2A (53%); S728X1A (53%); S7292XA (52%); S7291XA (52%)
S32058B,"Other fracture of fifth lumbar vertebra, initial encounter for open fracture",401,S32402B (47%); S32401B (47%); S02609B (47%); S32409B (46%); S32399B (45%)
S32059A,"Unspecified fracture of fifth lumbar vertebra, initial encounter for closed fracture",401,S728X9A (58%); S7290XA (57%); S7292XA (55%); S7291XA (55%); S32409A (53%)
S32059B,"Unspecified fracture of fifth lumbar vertebra, initial encounter for open fracture",401,S32409B (53%); S32402B (50%); S32401B (50%); S02609B (50%); S32309B (49%)
S3210XA,"Unspecified fracture of sacrum, initial encounter for closed fracture",401,S728X9A (71%); S7290XA (70%); S7292XA (67%); S7291XA (67%); S32409A (65%)
S3210XB,"Unspecified fracture of sacrum, initial encounter for open fracture",401,S32409B (64%); S32402B (61%); S32401B (61%); S02609B (61%); S32309B (59%)
S32110A,"Nondisplaced Zone I fracture of sacrum, initial encounter for closed fracture",401,S728X9A (52%); S728X2A (51%); S728X1A (51%); S72036A (50%); S72136A (50%)
S32110B,"Nondisplaced Zone I fracture of sacrum, initial encounter for open fracture",401,S32456B (49%); S32455B (48%); S32454B (48%); S32486B (46%); S32485B (46%)
S32111A,"Minimally displaced Zone I fracture of sacrum, initial encounter for closed fracture",401,S728X9A (44%); S728X2A (43%); S728X1A (43%); S72033A (42%); S72133A (42%)
S32111B,"Minimally displaced Zone I fracture of sacrum, initial encounter for open fracture",401,S32453B (41%); S32452B (41%); S32451B (41%); S32483B (39%); S32482B (39%)
S32112A,"Severely displaced Zone I fracture of sacrum, initial encounter for closed fracture",401,S728X9A (44%); S728X2A (43%); S728X1A (43%); S72033A (42%); S72133A (42%)
S32112B,"Severely displaced Zone I fracture of sacrum, initial encounter for open fracture",401,S32453B (41%); S32452B (41%); S32451B (41%); S32483B (39%); S32482B (39%)
S32119A,"Unspecified Zone I fracture of sacrum, initial encounter for closed fracture",401,S728X9A (59%); S7290XA (58%); S7292XA (56%); S7291XA (56%); S32409A (54%)
S32119B,"Unspecified Zone I fracture of sacrum, initial encounter for open fracture",401,S32409B (54%); S32402B (51%); S32401B (51%); S02609B (51%); S32309B (49%)
S32120A,"Nondisplaced Zone II fracture of sacrum, initial encounter for closed fracture",401,S02412A (49%); S728X9A (49%); S728X2A (48%); S728X1A (48%); S728X9B (47%)
S32120B,"Nondisplaced Zone II fracture of sacrum, initial encounter for open fracture",401,S728X9B (56%); S728X2B (55%); S728X1B (55%); S72036B (54%); S72136B (54%)
S32121A,"Minimally displaced Zone II fracture of sacrum, initial encounter for closed fracture",401,S02412A (42%); S728X9A (42%); S728X2A (41%); S728X1A (41%); S728X9B (40%)
S32121B,"Minimally displaced Zone II fracture of sacrum, initial encounter for open fracture",401,S728X9B (48%); S728X2B (47%); S728X1B (47%); S72033B (46%); S72133B (46%)
S32122A,"Severely displaced Zone II fracture of sacrum, initial encounter for closed fracture",401,S02412A (42%); S728X9A (42%); S728X2A (41%); S728X1A (41%); S728X9B (40%)
S32122B,"Severely displaced Zone II fracture of sacrum, initial encounter for open fracture",401,S728X9B (48%); S728X2B (47%); S728X1B (47%); S72033B (46%); S72133B (46%)
S32129A,"Unspecified Zone II fracture of sacrum, initial encounter for closed fracture",401,S728X9A (55%); S7290XA (54%); S7290XB (52%); S728X9B (52%); S7292XA (52%)
S32129B,"Unspecified Zone II fracture of sacrum, initial encounter for open fracture",401,S728X9B (62%); S7290XB (61%); S7292XB (59%); S7291XB (59%); S728X2B (57%)
S32130A,"Nondisplaced Zone III fracture of sacrum, initial encounter for closed fracture",401,S02413A (54%); S02112A (49%); S0211FA (49%); S0211EA (49%); S728X9A (47%)
S32130B,"Nondisplaced Zone III fracture of sacrum, initial encounter for open fracture",401,S02413B (53%); S02112B (49%); S0211FB (48%); S0211EB (48%); S02413A (46%)
S32131A,"Minimally displaced Zone III fracture of sacrum, initial encounter for closed fracture",401,S02413A (47%); S02112A (43%); S0211FA (42%); S0211EA (42%); S728X9A (41%)
S32131B,"Minimally displaced Zone III fracture of sacrum, initial encounter for open fracture",401,S02413B (46%); S02112B (42%); S0211FB (42%); S0211EB (42%); S02413A (40%)
S32132A,"Severely displaced Zone III fracture of sacrum, initial encounter for closed fracture",401,S02413A (47%); S02112A (43%); S0211FA (42%); S0211EA (42%); S728X9A (41%)
S32132B,"Severely displaced Zone III fracture of sacrum, initial encounter for open fracture",401,S02413B (46%); S02112B (42%); S0211FB (42%); S0211EB (42%); S02413A (40%)
S32139A,"Unspecified Zone III fracture of sacrum, initial encounter for closed fracture",401,S02413A (56%); S02112A (54%); S728X9A (52%); S7290XA (52%); S0211FA (50%)
S32139B,"Unspecified Zone III fracture of sacrum, initial encounter for open fracture",401,S02413B (55%); S02112B (53%); S0211FB (50%); S0211EB (50%); S02413A (48%)
S3214XA,"Type 1 fracture of sacrum, initial encounter for closed fracture",401,S728X9A (63%); S728X2A (62%); S728X1A (62%); S7292XA (60%); S7291XA (60%)
S3214XB,"Type 1 fracture of sacrum, initial encounter for open fracture",401,S728X9B (62%); S728X2B (61%); S728X1B (61%); S7292XB (60%); S7291XB (60%)
S3215XA,"Type 2 fracture of sacrum, initial encounter for closed fracture",401,S728X9A (63%); S728X2A (62%); S728X1A (62%); S7292XA (60%); S7291XA (60%)
S3215XB,"Type 2 fracture of sacrum, initial encounter for open fracture",401,S728X9B (62%); S728X2B (61%); S728X1B (61%); S7292XB (60%); S7291XB (60%)
S3216XA,"Type 3 fracture of sacrum, initial encounter for closed fracture",401,S728X9A (63%); S728X2A (62%); S728X1A (62%); S7292XA (60%); S7291XA (60%)
S3216XB,"Type 3 fracture of sacrum, initial encounter for open fracture",401,S728X9B (62%); S728X2B (61%); S728X1B (61%); S7292XB (60%); S7291XB (60%)
S3217XA,"Type 4 fracture of sacrum, initial encounter for closed fracture",401,S728X9A (63%); S728X2A (62%); S728X1A (62%); S7292XA (60%); S7291XA (60%)
S3217XB,"Type 4 fracture of sacrum, initial encounter for open fracture",401,S728X9B (62%); S728X2B (61%); S728X1B (61%); S7292XB (60%); S7291XB (60%)
S3219XA,"Other fracture of sacrum, initial encounter for closed fracture",401,S728X9A (67%); S728X2A (65%); S728X1A (65%); S7292XA (63%); S7291XA (63%)
S3219XB,"Other fracture of sacrum, initial encounter for open fracture",401,S32402B (58%); S32401B (58%); S02609B (58%); S32409B (56%); S32399B (55%)
S322XXA,"Fracture of coccyx, initial encounter for closed fracture",401,S728X9A (58%); S728X2A (56%); S728X1A (56%); S7292XA (55%); S7291XA (55%)
S322XXB,"Fracture of coccyx, initial encounter for open fracture",401,S32402B (50%); S32401B (50%); S02609B (50%); S32409B (48%); S32399B (48%)
S32301A,"Unspecified fracture of right ilium, initial encounter for closed fracture",402,S02609A (58%); S3210XA (57%); S02601A (56%); S22009A (56%); S32009A (56%)
S32301B,"Unspecified fracture of right ilium, initial encounter for open fracture",402,S02609B (57%); S3210XB (56%); S02601B (56%); S22009B (56%); S32009B (55%)
S32302A,"Unspecified fracture of left ilium, initial encounter for closed fracture",402,S02609A (58%); S3210XA (57%); S02602A (56%); S22009A (56%); S32009A (56%)
S32302B,"Unspecified fracture of left ilium, initial encounter for open fracture",402,S02609B (57%); S3210XB (56%); S02602B (56%); S22009B (56%); S32009B (55%)
S32309A,"Unspecified fracture of unspecified ilium, initial encounter for closed fracture",402,S22009A (63%); S32009A (62%); S02609A (61%); S3210XA (60%); S22008A (59%)
S32309B,"Unspecified fracture of unspecified ilium, initial encounter for open fracture",402,S22009B (62%); S32009B (62%); S02609B (60%); S3210XB (59%); S22008B (58%)
S32311A,"Displaced avulsion fracture of right ilium, initial encounter for closed fracture",402,S12090A (53%); S12290A (53%); S12000A (52%); S12200A (52%); S12120A (49%)
S32311B,"Displaced avulsion fracture of right ilium, initial encounter for open fracture",402,S12090B (53%); S12290B (53%); S12000B (52%); S12200B (52%); S12120B (49%)
S32312A,"Displaced avulsion fracture of left ilium, initial encounter for closed fracture",402,S12090A (53%); S12290A (53%); S12000A (52%); S12200A (52%); S12120A (49%)
S32312B,"Displaced avulsion fracture of left ilium, initial encounter for open fracture",402,S12090B (53%); S12290B (53%); S12000B (52%); S12200B (52%); S12120B (49%)
S32313A,"Displaced avulsion fracture of unspecified ilium, initial encounter for closed fracture",402,S12000A (56%); S12200A (56%); S12090A (54%); S12290A (54%); S12120A (50%)
S32313B,"Displaced avulsion fracture of unspecified ilium, initial encounter for open fracture",402,S12000B (56%); S12200B (56%); S12090B (53%); S12290B (53%); S12120B (49%)
S32314A,"Nondisplaced avulsion fracture of right ilium, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (52%); S12201A (52%); S12121A (49%)
S32314B,"Nondisplaced avulsion fracture of right ilium, initial encounter for open fracture",402,S12091B (53%); S12291B (53%); S12001B (52%); S12201B (52%); S12121B (49%)
S32315A,"Nondisplaced avulsion fracture of left ilium, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (52%); S12201A (52%); S12121A (49%)
S32315B,"Nondisplaced avulsion fracture of left ilium, initial encounter for open fracture",402,S12091B (53%); S12291B (53%); S12001B (52%); S12201B (52%); S12121B (49%)
S32316A,"Nondisplaced avulsion fracture of unspecified ilium, initial encounter for closed fracture",402,S12001A (56%); S12201A (56%); S12091A (54%); S12291A (54%); S12121A (50%)
S32316B,"Nondisplaced avulsion fracture of unspecified ilium, initial encounter for open fracture",402,S12001B (56%); S12201B (56%); S12091B (54%); S12291B (54%); S12121B (49%)
S32391A,"Other fracture of right ilium, initial encounter for closed fracture",402,S0211GA (56%); S0240CA (55%); S3219XA (55%); S02609A (55%); S0240AA (55%)
S32391B,"Other fracture of right ilium, initial encounter for open fracture",402,S0211GB (55%); S0240CB (55%); S3219XB (54%); S0240AB (54%); S0240EB (54%)
S32392A,"Other fracture of left ilium, initial encounter for closed fracture",402,S0211HA (56%); S0240DA (55%); S3219XA (55%); S02609A (55%); S0240BA (55%)
S32392B,"Other fracture of left ilium, initial encounter for open fracture",402,S0211HB (55%); S0240DB (55%); S3219XB (54%); S0240BB (54%); S0240FB (54%)
S32399A,"Other fracture of unspecified ilium, initial encounter for closed fracture",402,S02609A (60%); S3210XA (59%); S22009A (59%); S32009A (58%); S22008A (58%)
S32399B,"Other fracture of unspecified ilium, initial encounter for open fracture",402,S02609B (60%); S3210XB (59%); S22009B (58%); S32009B (58%); S22008B (57%)
S32401A,"Unspecified fracture of right acetabulum, initial encounter for closed fracture",402,S02609A (63%); S3210XA (62%); S02601A (61%); S22009A (61%); S32009A (61%)
S32401B,"Unspecified fracture of right acetabulum, initial encounter for open fracture",402,S02609B (62%); S3210XB (61%); S02601B (61%); S22009B (61%); S32009B (60%)
S32402A,"Unspecified fracture of left acetabulum, initial encounter for closed fracture",402,S02609A (63%); S3210XA (62%); S02602A (61%); S22009A (61%); S32009A (61%)
S32402B,"Unspecified fracture of left acetabulum, initial encounter for open fracture",402,S02609B (62%); S3210XB (61%); S02602B (61%); S22009B (61%); S32009B (60%)
S32409A,"Unspecified fracture of unspecified acetabulum, initial encounter for closed fracture",402,S22009A (68%); S32009A (68%); S02609A (66%); S3210XA (65%); S22008A (63%)
S32409B,"Unspecified fracture of unspecified acetabulum, initial encounter for open fracture",402,S22009B (68%); S32009B (67%); S02609B (65%); S3210XB (64%); S22008B (63%)
S32411A,"Displaced fracture of anterior wall of right acetabulum, initial encounter for closed fracture",402,S12110A (57%); S02831A (55%); S02841A (55%); S12090A (53%); S12290A (53%)
S32411B,"Displaced fracture of anterior wall of right acetabulum, initial encounter for open fracture",402,S12110B (56%); S02831B (55%); S02841B (55%); S12090B (53%); S12290B (53%)
S32412A,"Displaced fracture of anterior wall of left acetabulum, initial encounter for closed fracture",402,S12110A (57%); S02832A (55%); S02842A (55%); S12090A (53%); S12290A (53%)
S32412B,"Displaced fracture of anterior wall of left acetabulum, initial encounter for open fracture",402,S12110B (56%); S02832B (55%); S02842B (54%); S12090B (53%); S12290B (53%)
S32413A,"Displaced fracture of anterior wall of unspecified acetabulum, initial encounter for closed fracture",402,S12110A (57%); S12000A (56%); S12200A (56%); S02839A (54%); S02849A (54%)
S32413B,"Displaced fracture of anterior wall of unspecified acetabulum, initial encounter for open fracture",402,S12110B (57%); S12000B (56%); S12200B (56%); S02839B (54%); S02849B (54%)
S32414A,"Nondisplaced fracture of anterior wall of right acetabulum, initial encounter for closed fracture",402,S02831A (55%); S02841A (55%); S12091A (53%); S12291A (53%); S12001A (52%)
S32414B,"Nondisplaced fracture of anterior wall of right acetabulum, initial encounter for open fracture",402,S02831B (55%); S02841B (54%); S12091B (53%); S12291B (53%); S12001B (52%)
S32415A,"Nondisplaced fracture of anterior wall of left acetabulum, initial encounter for closed fracture",402,S02832A (55%); S02842A (55%); S12091A (53%); S12291A (53%); S12001A (52%)
S32415B,"Nondisplaced fracture of anterior wall of left acetabulum, initial encounter for open fracture",402,S02832B (55%); S02842B (54%); S12091B (53%); S12291B (53%); S12001B (52%)
S32416A,"Nondisplaced fracture of anterior wall of unspecified acetabulum, initial encounter for closed fracture",402,S12001A (56%); S12201A (56%); S02839A (54%); S02849A (54%); S12091A (54%)
S32416B,"Nondisplaced fracture of anterior wall of unspecified acetabulum, initial encounter for open fracture",402,S12001B (56%); S12201B (56%); S02839B (54%); S02849B (54%); S12091B (53%)
S32421A,"Displaced fracture of posterior wall of right acetabulum, initial encounter for closed fracture",402,S12111A (57%); S12030A (56%); S02831A (55%); S02841A (55%); S12090A (53%)
S32421B,"Displaced fracture of posterior wall of right acetabulum, initial encounter for open fracture",402,S12111B (57%); S12030B (55%); S02831B (54%); S02841B (54%); S12090B (52%)
S32422A,"Displaced fracture of posterior wall of left acetabulum, initial encounter for closed fracture",402,S12111A (57%); S12030A (56%); S02832A (55%); S02842A (55%); S12090A (53%)
S32422B,"Displaced fracture of posterior wall of left acetabulum, initial encounter for open fracture",402,S12111B (57%); S12030B (55%); S02832B (54%); S02842B (54%); S12090B (52%)
S32423A,"Displaced fracture of posterior wall of unspecified acetabulum, initial encounter for closed fracture",402,S12111A (58%); S12030A (56%); S12000A (56%); S12200A (56%); S02839A (54%)
S32423B,"Displaced fracture of posterior wall of unspecified acetabulum, initial encounter for open fracture",402,S12111B (57%); S12030B (56%); S12000B (55%); S12200B (55%); S02839B (53%)
S32424A,"Nondisplaced fracture of posterior wall of right acetabulum, initial encounter for closed fracture",402,S12031A (56%); S02831A (55%); S02841A (55%); S12091A (53%); S12291A (53%)
S32424B,"Nondisplaced fracture of posterior wall of right acetabulum, initial encounter for open fracture",402,S12031B (56%); S02831B (54%); S02841B (54%); S12091B (53%); S12291B (53%)
S32425A,"Nondisplaced fracture of posterior wall of left acetabulum, initial encounter for closed fracture",402,S12031A (56%); S02832A (55%); S02842A (55%); S12091A (53%); S12291A (53%)
S32425B,"Nondisplaced fracture of posterior wall of left acetabulum, initial encounter for open fracture",402,S12031B (56%); S02832B (54%); S02842B (54%); S12091B (53%); S12291B (53%)
S32426A,"Nondisplaced fracture of posterior wall of unspecified acetabulum, initial encounter for closed fracture",402,S12031A (56%); S12001A (56%); S12201A (56%); S02839A (54%); S02849A (54%)
S32426B,"Nondisplaced fracture of posterior wall of unspecified acetabulum, initial encounter for open fracture",402,S12031B (56%); S12001B (55%); S12201B (55%); S02839B (53%); S02849B (53%)
S32431A,"Displaced fracture of anterior column [iliopubic] of right acetabulum, initial encounter for closed fracture",402,S12110A (48%); S12090A (45%); S12290A (45%); S12000A (44%); S12200A (44%)
S32431B,"Displaced fracture of anterior column [iliopubic] of right acetabulum, initial encounter for open fracture",402,S12110B (48%); S12090B (45%); S12290B (45%); S12000B (44%); S12200B (44%)
S32432A,"Displaced fracture of anterior column [iliopubic] of left acetabulum, initial encounter for closed fracture",402,S12110A (48%); S12090A (45%); S12290A (45%); S12000A (44%); S12200A (44%)
S32432B,"Displaced fracture of anterior column [iliopubic] of left acetabulum, initial encounter for open fracture",402,S12110B (48%); S12090B (45%); S12290B (45%); S12000B (44%); S12200B (44%)
S32433A,"Displaced fracture of anterior column [iliopubic] of unspecified acetabulum, initial encounter for closed fracture",402,S12110A (49%); S12000A (48%); S12200A (48%); S12090A (46%); S12290A (46%)
S32433B,"Displaced fracture of anterior column [iliopubic] of unspecified acetabulum, initial encounter for open fracture",402,S12110B (48%); S12000B (47%); S12200B (47%); S12090B (45%); S12290B (45%)
S32434A,"Nondisplaced fracture of anterior column [iliopubic] of right acetabulum, initial encounter for closed fracture",402,S12091A (45%); S12291A (45%); S12001A (45%); S12201A (45%); S12121A (42%)
S32434B,"Nondisplaced fracture of anterior column [iliopubic] of right acetabulum, initial encounter for open fracture",402,S12091B (45%); S12291B (45%); S12001B (44%); S12201B (44%); S12121B (42%)
S32435A,"Nondisplaced fracture of anterior column [iliopubic] of left acetabulum, initial encounter for closed fracture",402,S12091A (45%); S12291A (45%); S12001A (45%); S12201A (45%); S12121A (42%)
S32435B,"Nondisplaced fracture of anterior column [iliopubic] of left acetabulum, initial encounter for open fracture",402,S12091B (45%); S12291B (45%); S12001B (44%); S12201B (44%); S12121B (42%)
S32436A,"Nondisplaced fracture of anterior column [iliopubic] of unspecified acetabulum, initial encounter for closed fracture",402,S12001A (48%); S12201A (48%); S12091A (46%); S12291A (46%); S12121A (42%)
S32436B,"Nondisplaced fracture of anterior column [iliopubic] of unspecified acetabulum, initial encounter for open fracture",402,S12001B (47%); S12201B (47%); S12091B (45%); S12291B (45%); S12121B (42%)
S32441A,"Displaced fracture of posterior column [ilioischial] of right acetabulum, initial encounter for closed fracture",402,S12111A (49%); S12030A (48%); S12090A (45%); S12290A (45%); S12000A (44%)
S32441B,"Displaced fracture of posterior column [ilioischial] of right acetabulum, initial encounter for open fracture",402,S12111B (48%); S12030B (47%); S12090B (45%); S12290B (45%); S12000B (44%)
S32442A,"Displaced fracture of posterior column [ilioischial] of left acetabulum, initial encounter for closed fracture",402,S12111A (49%); S12030A (48%); S12090A (45%); S12290A (45%); S12000A (44%)
S32442B,"Displaced fracture of posterior column [ilioischial] of left acetabulum, initial encounter for open fracture",402,S12111B (48%); S12030B (47%); S12090B (45%); S12290B (45%); S12000B (44%)
S32443A,"Displaced fracture of posterior column [ilioischial] of unspecified acetabulum, initial encounter for closed fracture",402,S12111A (49%); S12030A (48%); S12000A (47%); S12200A (47%); S12090A (46%)
S32443B,"Displaced fracture of posterior column [ilioischial] of unspecified acetabulum, initial encounter for open fracture",402,S12111B (49%); S12030B (48%); S12000B (47%); S12200B (47%); S12090B (45%)
S32444A,"Nondisplaced fracture of posterior column [ilioischial] of right acetabulum, initial encounter for closed fracture",402,S12031A (48%); S12091A (45%); S12291A (45%); S12001A (44%); S12201A (44%)
S32444B,"Nondisplaced fracture of posterior column [ilioischial] of right acetabulum, initial encounter for open fracture",402,S12031B (47%); S12091B (45%); S12291B (45%); S12001B (44%); S12201B (44%)
S32445A,"Nondisplaced fracture of posterior column [ilioischial] of left acetabulum, initial encounter for closed fracture",402,S12031A (48%); S12091A (45%); S12291A (45%); S12001A (44%); S12201A (44%)
S32445B,"Nondisplaced fracture of posterior column [ilioischial] of left acetabulum, initial encounter for open fracture",402,S12031B (47%); S12091B (45%); S12291B (45%); S12001B (44%); S12201B (44%)
S32446A,"Nondisplaced fracture of posterior column [ilioischial] of unspecified acetabulum, initial encounter for closed fracture",402,S12031A (48%); S12001A (48%); S12201A (48%); S12091A (46%); S12291A (46%)
S32446B,"Nondisplaced fracture of posterior column [ilioischial] of unspecified acetabulum, initial encounter for open fracture",402,S12031B (48%); S12001B (47%); S12201B (47%); S12091B (45%); S12291B (45%)
S32451A,"Displaced transverse fracture of right acetabulum, initial encounter for closed fracture",402,S12090A (58%); S12290A (58%); S12000A (57%); S12200A (57%); S12120A (54%)
S32451B,"Displaced transverse fracture of right acetabulum, initial encounter for open fracture",402,S12090B (57%); S12290B (57%); S12000B (56%); S12200B (56%); S12120B (53%)
S32452A,"Displaced transverse fracture of left acetabulum, initial encounter for closed fracture",402,S12090A (58%); S12290A (58%); S12000A (57%); S12200A (57%); S12120A (54%)
S32452B,"Displaced transverse fracture of left acetabulum, initial encounter for open fracture",402,S12090B (57%); S12290B (57%); S12000B (56%); S12200B (56%); S12120B (53%)
S32453A,"Displaced transverse fracture of unspecified acetabulum, initial encounter for closed fracture",402,S12000A (61%); S12200A (61%); S12090A (59%); S12290A (59%); S12120A (54%)
S32453B,"Displaced transverse fracture of unspecified acetabulum, initial encounter for open fracture",402,S12000B (61%); S12200B (61%); S12090B (58%); S12290B (58%); S12120B (54%)
S32454A,"Nondisplaced transverse fracture of right acetabulum, initial encounter for closed fracture",402,S12091A (58%); S12291A (58%); S12001A (57%); S12201A (57%); S12121A (54%)
S32454B,"Nondisplaced transverse fracture of right acetabulum, initial encounter for open fracture",402,S12091B (58%); S12291B (58%); S12001B (56%); S12201B (56%); S12121B (53%)
S32455A,"Nondisplaced transverse fracture of left acetabulum, initial encounter for closed fracture",402,S12091A (58%); S12291A (58%); S12001A (57%); S12201A (57%); S12121A (54%)
S32455B,"Nondisplaced transverse fracture of left acetabulum, initial encounter for open fracture",402,S12091B (58%); S12291B (58%); S12001B (56%); S12201B (56%); S12121B (53%)
S32456A,"Nondisplaced transverse fracture of unspecified acetabulum, initial encounter for closed fracture",402,S12001A (61%); S12201A (61%); S12091A (59%); S12291A (59%); S12121A (54%)
S32456B,"Nondisplaced transverse fracture of unspecified acetabulum, initial encounter for open fracture",402,S12001B (61%); S12201B (61%); S12091B (58%); S12291B (58%); S12121B (54%)
S32461A,"Displaced associated transverse-posterior fracture of right acetabulum, initial encounter for closed fracture",402,S12111A (51%); S12030A (49%); S12090A (47%); S12290A (47%); S12000A (46%)
S32461B,"Displaced associated transverse-posterior fracture of right acetabulum, initial encounter for open fracture",402,S12111B (50%); S12030B (49%); S12090B (46%); S12290B (46%); S12000B (45%)
S32462A,"Displaced associated transverse-posterior fracture of left acetabulum, initial encounter for closed fracture",402,S12111A (51%); S12030A (49%); S12090A (47%); S12290A (47%); S12000A (46%)
S32462B,"Displaced associated transverse-posterior fracture of left acetabulum, initial encounter for open fracture",402,S12111B (50%); S12030B (49%); S12090B (46%); S12290B (46%); S12000B (45%)
S32463A,"Displaced associated transverse-posterior fracture of unspecified acetabulum, initial encounter for closed fracture",402,S12111A (51%); S12030A (50%); S12000A (49%); S12200A (49%); S12090A (47%)
S32463B,"Displaced associated transverse-posterior fracture of unspecified acetabulum, initial encounter for open fracture",402,S12111B (51%); S12030B (49%); S12000B (49%); S12200B (49%); S12090B (47%)
S32464A,"Nondisplaced associated transverse-posterior fracture of right acetabulum, initial encounter for closed fracture",402,S12031A (49%); S12091A (47%); S12291A (47%); S12001A (46%); S12201A (46%)
S32464B,"Nondisplaced associated transverse-posterior fracture of right acetabulum, initial encounter for open fracture",402,S12031B (49%); S12091B (46%); S12291B (46%); S12001B (45%); S12201B (45%)
S32465A,"Nondisplaced associated transverse-posterior fracture of left acetabulum, initial encounter for closed fracture",402,S12031A (49%); S12091A (47%); S12291A (47%); S12001A (46%); S12201A (46%)
S32465B,"Nondisplaced associated transverse-posterior fracture of left acetabulum, initial encounter for open fracture",402,S12031B (49%); S12091B (46%); S12291B (46%); S12001B (45%); S12201B (45%)
S32466A,"Nondisplaced associated transverse-posterior fracture of unspecified acetabulum, initial encounter for closed fracture",402,S12031A (50%); S12001A (49%); S12201A (49%); S12091A (47%); S12291A (47%)
S32466B,"Nondisplaced associated transverse-posterior fracture of unspecified acetabulum, initial encounter for open fracture",402,S12031B (50%); S12001B (49%); S12201B (49%); S12091B (47%); S12291B (47%)
S32471A,"Displaced fracture of medial wall of right acetabulum, initial encounter for closed fracture",402,S02831A (75%); S02839A (71%); S02832A (71%); S02831B (68%); S02839B (64%)
S32471B,"Displaced fracture of medial wall of right acetabulum, initial encounter for open fracture",402,S02831B (75%); S02839B (71%); S02832B (70%); S02831A (68%); S02839A (64%)
S32472A,"Displaced fracture of medial wall of left acetabulum, initial encounter for closed fracture",402,S02832A (75%); S02839A (71%); S02831A (71%); S02832B (68%); S02839B (64%)
S32472B,"Displaced fracture of medial wall of left acetabulum, initial encounter for open fracture",402,S02832B (75%); S02839B (71%); S02831B (70%); S02832A (68%); S02839A (64%)
S32473A,"Displaced fracture of medial wall of unspecified acetabulum, initial encounter for closed fracture",402,S02839A (75%); S02832A (71%); S02831A (71%); S02839B (67%); S02832B (64%)
S32473B,"Displaced fracture of medial wall of unspecified acetabulum, initial encounter for open fracture",402,S02839B (74%); S02832B (71%); S02831B (71%); S02839A (67%); S02832A (64%)
S32474A,"Nondisplaced fracture of medial wall of right acetabulum, initial encounter for closed fracture",402,S02831A (75%); S02839A (71%); S02832A (71%); S02831B (68%); S02839B (64%)
S32474B,"Nondisplaced fracture of medial wall of right acetabulum, initial encounter for open fracture",402,S02831B (75%); S02839B (71%); S02832B (70%); S02831A (68%); S02839A (64%)
S32475A,"Nondisplaced fracture of medial wall of left acetabulum, initial encounter for closed fracture",402,S02832A (75%); S02839A (71%); S02831A (71%); S02832B (68%); S02839B (64%)
S32475B,"Nondisplaced fracture of medial wall of left acetabulum, initial encounter for open fracture",402,S02832B (75%); S02839B (71%); S02831B (70%); S02832A (68%); S02839A (64%)
S32476A,"Nondisplaced fracture of medial wall of unspecified acetabulum, initial encounter for closed fracture",402,S02839A (75%); S02832A (71%); S02831A (71%); S02839B (67%); S02832B (64%)
S32476B,"Nondisplaced fracture of medial wall of unspecified acetabulum, initial encounter for open fracture",402,S02839B (74%); S02832B (71%); S02831B (71%); S02839A (67%); S02832A (64%)
S32481A,"Displaced dome fracture of right acetabulum, initial encounter for closed fracture",402,S12090A (55%); S12290A (55%); S12000A (54%); S12200A (54%); S12120A (51%)
S32481B,"Displaced dome fracture of right acetabulum, initial encounter for open fracture",402,S12090B (54%); S12290B (54%); S12000B (53%); S12200B (53%); S12120B (50%)
S32482A,"Displaced dome fracture of left acetabulum, initial encounter for closed fracture",402,S12090A (55%); S12290A (55%); S12000A (54%); S12200A (54%); S12120A (51%)
S32482B,"Displaced dome fracture of left acetabulum, initial encounter for open fracture",402,S12090B (54%); S12290B (54%); S12000B (53%); S12200B (53%); S12120B (50%)
S32483A,"Displaced dome fracture of unspecified acetabulum, initial encounter for closed fracture",402,S12000A (58%); S12200A (58%); S12090A (56%); S12290A (56%); S12120A (51%)
S32483B,"Displaced dome fracture of unspecified acetabulum, initial encounter for open fracture",402,S12000B (57%); S12200B (57%); S12090B (55%); S12290B (55%); S12120B (51%)
S32484A,"Nondisplaced dome fracture of right acetabulum, initial encounter for closed fracture",402,S12091A (55%); S12291A (55%); S12001A (54%); S12201A (54%); S12121A (51%)
S32484B,"Nondisplaced dome fracture of right acetabulum, initial encounter for open fracture",402,S12091B (55%); S12291B (55%); S12001B (53%); S12201B (53%); S12121B (50%)
S32485A,"Nondisplaced dome fracture of left acetabulum, initial encounter for closed fracture",402,S12091A (55%); S12291A (55%); S12001A (54%); S12201A (54%); S12121A (51%)
S32485B,"Nondisplaced dome fracture of left acetabulum, initial encounter for open fracture",402,S12091B (55%); S12291B (55%); S12001B (53%); S12201B (53%); S12121B (50%)
S32486A,"Nondisplaced dome fracture of unspecified acetabulum, initial encounter for closed fracture",402,S12001A (58%); S12201A (58%); S12091A (56%); S12291A (56%); S12121A (51%)
S32486B,"Nondisplaced dome fracture of unspecified acetabulum, initial encounter for open fracture",402,S12001B (57%); S12201B (57%); S12091B (55%); S12291B (55%); S12121B (51%)
S32491A,"Other specified fracture of right acetabulum, initial encounter for closed fracture",402,S0269XA (61%); S0211GA (55%); S0240CA (55%); S3219XA (55%); S02609A (55%)
S32491B,"Other specified fracture of right acetabulum, initial encounter for open fracture",402,S0269XB (61%); S0211GB (55%); S0240CB (54%); S3219XB (54%); S0240AB (54%)
S32492A,"Other specified fracture of left acetabulum, initial encounter for closed fracture",402,S0269XA (61%); S0211HA (55%); S0240DA (55%); S3219XA (55%); S02609A (55%)
S32492B,"Other specified fracture of left acetabulum, initial encounter for open fracture",402,S0269XB (61%); S0211HB (55%); S0240DB (54%); S3219XB (54%); S0240BB (54%)
S32499A,"Other specified fracture of unspecified acetabulum, initial encounter for closed fracture",402,S0269XA (62%); S02609A (60%); S3210XA (59%); S22009A (58%); S32009A (58%)
S32499B,"Other specified fracture of unspecified acetabulum, initial encounter for open fracture",402,S0269XB (62%); S02609B (60%); S3210XB (59%); S22009B (58%); S32009B (57%)
S32501A,"Unspecified fracture of right pubis, initial encounter for closed fracture",402,S02609A (57%); S3210XA (56%); S02601A (56%); S22009A (56%); S32009A (55%)
S32501B,"Unspecified fracture of right pubis, initial encounter for open fracture",402,S02609B (57%); S3210XB (56%); S02601B (55%); S22009B (55%); S32009B (55%)
S32502A,"Unspecified fracture of left pubis, initial encounter for closed fracture",402,S02609A (57%); S3210XA (56%); S02602A (56%); S22009A (56%); S32009A (55%)
S32502B,"Unspecified fracture of left pubis, initial encounter for open fracture",402,S02609B (57%); S3210XB (56%); S02602B (55%); S22009B (55%); S32009B (55%)
S32509A,"Unspecified fracture of unspecified pubis, initial encounter for closed fracture",402,S22009A (62%); S32009A (62%); S02609A (60%); S3210XA (59%); S22008A (58%)
S32509B,"Unspecified fracture of unspecified pubis, initial encounter for open fracture",402,S22009B (61%); S32009B (61%); S02609B (59%); S3210XB (58%); S22008B (57%)
S32511A,"Fracture of superior rim of right pubis, initial encounter for closed fracture",402,S0211GA (38%); S0240CA (38%); S3219XA (38%); S02609A (37%); S0240AA (37%)
S32511B,"Fracture of superior rim of right pubis, initial encounter for open fracture",402,S0211GB (37%); S0240CB (37%); S3219XB (37%); S0240AB (37%); S0240EB (37%)
S32512A,"Fracture of superior rim of left pubis, initial encounter for closed fracture",402,S0211HA (38%); S0240DA (38%); S3219XA (38%); S02609A (37%); S0240BA (37%)
S32512B,"Fracture of superior rim of left pubis, initial encounter for open fracture",402,S0211HB (37%); S0240DB (37%); S3219XB (37%); S0240BB (37%); S0240FB (37%)
S32519A,"Fracture of superior rim of unspecified pubis, initial encounter for closed fracture",402,S02609A (41%); S3210XA (40%); S22009A (40%); S32009A (39%); S22008A (39%)
S32519B,"Fracture of superior rim of unspecified pubis, initial encounter for open fracture",402,S02609B (40%); S3210XB (40%); S22009B (39%); S32009B (39%); S22008B (39%)
S32591A,"Other specified fracture of right pubis, initial encounter for closed fracture",402,S0269XA (56%); S0211GA (51%); S0240CA (50%); S3219XA (50%); S02609A (50%)
S32591B,"Other specified fracture of right pubis, initial encounter for open fracture",402,S0269XB (55%); S0211GB (50%); S0240CB (50%); S3219XB (50%); S0240AB (49%)
S32592A,"Other specified fracture of left pubis, initial encounter for closed fracture",402,S0269XA (56%); S0211HA (51%); S0240DA (50%); S3219XA (50%); S02609A (50%)
S32592B,"Other specified fracture of left pubis, initial encounter for open fracture",402,S0269XB (55%); S0211HB (50%); S0240DB (50%); S3219XB (50%); S0240BB (49%)
S32599A,"Other specified fracture of unspecified pubis, initial encounter for closed fracture",402,S0269XA (57%); S02609A (55%); S3210XA (54%); S22009A (53%); S32009A (53%)
S32599B,"Other specified fracture of unspecified pubis, initial encounter for open fracture",402,S0269XB (56%); S02609B (54%); S3210XB (53%); S22009B (53%); S32009B (52%)
S32601A,"Unspecified fracture of right ischium, initial encounter for closed fracture",402,S02609A (58%); S3210XA (57%); S02601A (56%); S22009A (56%); S32009A (56%)
S32601B,"Unspecified fracture of right ischium, initial encounter for open fracture",402,S02609B (57%); S3210XB (56%); S02601B (56%); S22009B (56%); S32009B (55%)
S32602A,"Unspecified fracture of left ischium, initial encounter for closed fracture",402,S02609A (58%); S3210XA (57%); S02602A (56%); S22009A (56%); S32009A (56%)
S32602B,"Unspecified fracture of left ischium, initial encounter for open fracture",402,S02609B (57%); S3210XB (56%); S02602B (56%); S22009B (56%); S32009B (55%)
S32609A,"Unspecified fracture of unspecified ischium, initial encounter for closed fracture",402,S22009A (63%); S32009A (62%); S02609A (61%); S3210XA (60%); S22008A (59%)
S32609B,"Unspecified fracture of unspecified ischium, initial encounter for open fracture",402,S22009B (62%); S32009B (62%); S02609B (60%); S3210XB (59%); S22008B (58%)
S32611A,"Displaced avulsion fracture of right ischium, initial encounter for closed fracture",402,S12090A (53%); S12290A (53%); S12000A (52%); S12200A (52%); S12120A (49%)
S32611B,"Displaced avulsion fracture of right ischium, initial encounter for open fracture",402,S12090B (53%); S12290B (53%); S12000B (52%); S12200B (52%); S12120B (49%)
S32612A,"Displaced avulsion fracture of left ischium, initial encounter for closed fracture",402,S12090A (53%); S12290A (53%); S12000A (52%); S12200A (52%); S12120A (49%)
S32612B,"Displaced avulsion fracture of left ischium, initial encounter for open fracture",402,S12090B (53%); S12290B (53%); S12000B (52%); S12200B (52%); S12120B (49%)
S32613A,"Displaced avulsion fracture of unspecified ischium, initial encounter for closed fracture",402,S12000A (56%); S12200A (56%); S12090A (54%); S12290A (54%); S12120A (50%)
S32613B,"Displaced avulsion fracture of unspecified ischium, initial encounter for open fracture",402,S12000B (56%); S12200B (56%); S12090B (53%); S12290B (53%); S12120B (49%)
S32614A,"Nondisplaced avulsion fracture of right ischium, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (52%); S12201A (52%); S12121A (49%)
S32614B,"Nondisplaced avulsion fracture of right ischium, initial encounter for open fracture",402,S12091B (53%); S12291B (53%); S12001B (52%); S12201B (52%); S12121B (49%)
S32615A,"Nondisplaced avulsion fracture of left ischium, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (52%); S12201A (52%); S12121A (49%)
S32615B,"Nondisplaced avulsion fracture of left ischium, initial encounter for open fracture",402,S12091B (53%); S12291B (53%); S12001B (52%); S12201B (52%); S12121B (49%)
S32616A,"Nondisplaced avulsion fracture of unspecified ischium, initial encounter for closed fracture",402,S12001A (56%); S12201A (56%); S12091A (54%); S12291A (54%); S12121A (50%)
S32616B,"Nondisplaced avulsion fracture of unspecified ischium, initial encounter for open fracture",402,S12001B (56%); S12201B (56%); S12091B (54%); S12291B (54%); S12121B (49%)
S32691A,"Other specified fracture of right ischium, initial encounter for closed fracture",402,S0269XA (57%); S0211GA (52%); S0240CA (51%); S3219XA (51%); S02609A (51%)
S32691B,"Other specified fracture of right ischium, initial encounter for open fracture",402,S0269XB (56%); S0211GB (51%); S0240CB (51%); S3219XB (50%); S0240AB (50%)
S32692A,"Other specified fracture of left ischium, initial encounter for closed fracture",402,S0269XA (57%); S0211HA (52%); S0240DA (51%); S3219XA (51%); S02609A (51%)
S32692B,"Other specified fracture of left ischium, initial encounter for open fracture",402,S0269XB (56%); S0211HB (51%); S0240DB (51%); S3219XB (50%); S0240BB (50%)
S32699A,"Other specified fracture of unspecified ischium, initial encounter for closed fracture",402,S0269XA (58%); S02609A (56%); S3210XA (55%); S22009A (54%); S32009A (54%)
S32699B,"Other specified fracture of unspecified ischium, initial encounter for open fracture",402,S0269XB (57%); S02609B (55%); S3210XB (54%); S22009B (54%); S32009B (53%)
S32810A,"Multiple fractures of pelvis with stable disruption of pelvic ring, initial encounter for closed fracture",402,S1201XA (29%); S22011A (28%); S22031A (28%); S32011A (28%); S32031A (28%)
S32810B,"Multiple fractures of pelvis with stable disruption of pelvic ring, initial encounter for open fracture",402,S1201XB (29%); S22011B (28%); S22031B (28%); S32011B (28%); S32031B (28%)
S32811A,"Multiple fractures of pelvis with unstable disruption of pelvic ring, initial encounter for closed fracture",402,S1202XA (31%); S22012A (30%); S22032A (30%); S32012A (30%); S32032A (30%)
S32811B,"Multiple fractures of pelvis with unstable disruption of pelvic ring, initial encounter for open fracture",402,S1202XB (30%); S22012B (30%); S22032B (30%); S32012B (29%); S32032B (29%)
S3282XA,"Multiple fractures of pelvis without disruption of pelvic ring, initial encounter for closed fracture",402,M87850 (28%); C763 (27%); M87350 (23%); C142 (23%); S3219XA (22%)
S3282XB,"Multiple fractures of pelvis without disruption of pelvic ring, initial encounter for open fracture",402,M87850 (28%); C763 (27%); M87350 (24%); C142 (23%); S3219XB (21%)
S3289XA,"Fracture of other parts of pelvis, initial encounter for closed fracture",402,S128XXA (62%); S3219XA (48%); S02609A (47%); S22018A (46%); S22038A (46%)
S3289XB,"Fracture of other parts of pelvis, initial encounter for open fracture",402,S128XXA (62%); S3219XB (47%); S02609B (47%); S22018B (46%); S22038B (46%)
S329XXA,"Fracture of unspecified parts of lumbosacral spine and pelvis, initial encounter for closed fracture",402,S128XXA (45%); S02609A (38%); S3210XA (37%); S22009A (37%); S32009A (36%)
S329XXB,"Fracture of unspecified parts of lumbosacral spine and pelvis, initial encounter for open fracture",402,S128XXA (46%); S02609B (37%); S3210XB (37%); S22009B (36%); M4857XA (36%)
S3401XA,"Concussion and edema of lumbar spinal cord, initial encounter",182,C720 (38%); S14119A (33%); D334 (32%); S24119A (32%); S32018B (30%)
S3401XD,"Concussion and edema of lumbar spinal cord, subsequent encounter",182,S14119D (41%); S24119D (40%); S14111D (37%); S14114D (37%); S14115D (37%)
S3401XS,"Concussion and edema of lumbar spinal cord, sequela",,
S3402XA,"Concussion and edema of sacral spinal cord, initial encounter",182,C720 (36%); S14119A (31%); D334 (30%); S24119A (30%); L89152 (30%)
S3402XD,"Concussion and edema of sacral spinal cord, subsequent encounter",182,S14119D (39%); S24119D (38%); S14111D (35%); S14114D (35%); S14115D (35%)
S3402XS,"Concussion and edema of sacral spinal cord, sequela",,
S34101A,"Unspecified injury to L1 level of lumbar spinal cord, initial encounter",182,S14119A (43%); S24119A (42%); S14119D (37%); S24119D (36%); S14111A (35%)
S34101D,"Unspecified injury to L1 level of lumbar spinal cord, subsequent encounter",182,S14119D (50%); S24119D (49%); S14111D (42%); S14114D (42%); S14115D (42%)
S34101S,"Unspecified injury to L1 level of lumbar spinal cord, sequela",,
S34102A,"Unspecified injury to L2 level of lumbar spinal cord, initial encounter",182,S14119A (43%); S24119A (42%); S14119D (37%); S24119D (36%); S14111A (35%)
S34102D,"Unspecified injury to L2 level of lumbar spinal cord, subsequent encounter",182,S14119D (50%); S24119D (49%); S14111D (42%); S14114D (42%); S14115D (42%)
S34102S,"Unspecified injury to L2 level of lumbar spinal cord, sequela",,
S34103A,"Unspecified injury to L3 level of lumbar spinal cord, initial encounter",182,S14119A (43%); S24119A (42%); S14119D (37%); S24119D (36%); S14111A (35%)
S34103D,"Unspecified injury to L3 level of lumbar spinal cord, subsequent encounter",182,S14119D (50%); S24119D (49%); S14111D (42%); S14114D (42%); S14115D (42%)
S34103S,"Unspecified injury to L3 level of lumbar spinal cord, sequela",,
S34104A,"Unspecified injury to L4 level of lumbar spinal cord, initial encounter",182,S14119A (43%); S24119A (42%); S14119D (37%); S24119D (36%); S14111A (35%)
S34104D,"Unspecified injury to L4 level of lumbar spinal cord, subsequent encounter",182,S14119D (50%); S24119D (49%); S14111D (42%); S14114D (42%); S14115D (42%)
S34104S,"Unspecified injury to L4 level of lumbar spinal cord, sequela",,
S34105A,"Unspecified injury to L5 level of lumbar spinal cord, initial encounter",182,S14119A (43%); S24119A (42%); S14119D (37%); S24119D (36%); S14111A (35%)
S34105D,"Unspecified injury to L5 level of lumbar spinal cord, subsequent encounter",182,S14119D (50%); S24119D (49%); S14111D (42%); S14114D (42%); S14115D (42%)
S34105S,"Unspecified injury to L5 level of lumbar spinal cord, sequela",,
S34109A,"Unspecified injury to unspecified level of lumbar spinal cord, initial encounter",182,S14119A (53%); S24119A (52%); S14119D (46%); S24119D (45%); S32009B (44%)
S34109D,"Unspecified injury to unspecified level of lumbar spinal cord, subsequent encounter",182,S14119D (59%); S24119D (58%); S14111D (48%); S14114D (48%); S14115D (48%)
S34109S,"Unspecified injury to unspecified level of lumbar spinal cord, sequela",,
S34111A,"Complete lesion of L1 level of lumbar spinal cord, initial encounter",182,S14119A (69%); S24119A (67%); S14119D (61%); S24119D (60%); S14111A (60%)
S34111D,"Complete lesion of L1 level of lumbar spinal cord, subsequent encounter",182,S14119D (72%); S24119D (71%); S14111D (64%); S14114D (64%); S14115D (64%)
S34111S,"Complete lesion of L1 level of lumbar spinal cord, sequela",,
S34112A,"Complete lesion of L2 level of lumbar spinal cord, initial encounter",182,S14119A (69%); S24119A (67%); S14119D (61%); S24119D (60%); S14111A (60%)
S34112D,"Complete lesion of L2 level of lumbar spinal cord, subsequent encounter",182,S14119D (72%); S24119D (71%); S14111D (64%); S14114D (64%); S14115D (64%)
S34112S,"Complete lesion of L2 level of lumbar spinal cord, sequela",,
S34113A,"Complete lesion of L3 level of lumbar spinal cord, initial encounter",182,S14119A (69%); S24119A (67%); S14119D (61%); S24119D (60%); S14111A (60%)
S34113D,"Complete lesion of L3 level of lumbar spinal cord, subsequent encounter",182,S14119D (72%); S24119D (71%); S14111D (64%); S14114D (64%); S14115D (64%)
S34113S,"Complete lesion of L3 level of lumbar spinal cord, sequela",,
S34114A,"Complete lesion of L4 level of lumbar spinal cord, initial encounter",182,S14119A (69%); S24119A (67%); S14119D (61%); S24119D (60%); S14111A (60%)
S34114D,"Complete lesion of L4 level of lumbar spinal cord, subsequent encounter",182,S14119D (72%); S24119D (71%); S14111D (64%); S14114D (64%); S14115D (64%)
S34114S,"Complete lesion of L4 level of lumbar spinal cord, sequela",,
S34115A,"Complete lesion of L5 level of lumbar spinal cord, initial encounter",182,S14119A (69%); S24119A (67%); S14119D (61%); S24119D (60%); S14111A (60%)
S34115D,"Complete lesion of L5 level of lumbar spinal cord, subsequent encounter",182,S14119D (72%); S24119D (71%); S14111D (64%); S14114D (64%); S14115D (64%)
S34115S,"Complete lesion of L5 level of lumbar spinal cord, sequela",,
S34119A,"Complete lesion of unspecified level of lumbar spinal cord, initial encounter",182,S14119A (84%); S24119A (82%); S14119D (75%); S24119D (73%); S14111A (70%)
S34119D,"Complete lesion of unspecified level of lumbar spinal cord, subsequent encounter",182,S14119D (86%); S24119D (84%); S14119A (75%); S14111D (74%); S14114D (74%)
S34119S,"Complete lesion of unspecified level of lumbar spinal cord, sequela",,
S34121A,"Incomplete lesion of L1 level of lumbar spinal cord, initial encounter",182,S14119A (53%); S24119A (52%); S14119D (46%); S14111A (46%); S14114A (46%)
S34121D,"Incomplete lesion of L1 level of lumbar spinal cord, subsequent encounter",182,S14119D (58%); S24119D (57%); S14111D (51%); S14114D (51%); S14115D (51%)
S34121S,"Incomplete lesion of L1 level of lumbar spinal cord, sequela",,
S34122A,"Incomplete lesion of L2 level of lumbar spinal cord, initial encounter",182,S14119A (53%); S24119A (52%); S14119D (46%); S14111A (46%); S14114A (46%)
S34122D,"Incomplete lesion of L2 level of lumbar spinal cord, subsequent encounter",182,S14119D (58%); S24119D (57%); S14111D (51%); S14114D (51%); S14115D (51%)
S34122S,"Incomplete lesion of L2 level of lumbar spinal cord, sequela",,
S34123A,"Incomplete lesion of L3 level of lumbar spinal cord, initial encounter",182,S14119A (53%); S24119A (52%); S14119D (46%); S14111A (46%); S14114A (46%)
S34123D,"Incomplete lesion of L3 level of lumbar spinal cord, subsequent encounter",182,S14119D (58%); S24119D (57%); S14111D (51%); S14114D (51%); S14115D (51%)
S34123S,"Incomplete lesion of L3 level of lumbar spinal cord, sequela",,
S34124A,"Incomplete lesion of L4 level of lumbar spinal cord, initial encounter",182,S14119A (53%); S24119A (52%); S14119D (46%); S14111A (46%); S14114A (46%)
S34124D,"Incomplete lesion of L4 level of lumbar spinal cord, subsequent encounter",182,S14119D (58%); S24119D (57%); S14111D (51%); S14114D (51%); S14115D (51%)
S34124S,"Incomplete lesion of L4 level of lumbar spinal cord, sequela",,
S34125A,"Incomplete lesion of L5 level of lumbar spinal cord, initial encounter",182,S14119A (53%); S24119A (52%); S14119D (46%); S14111A (46%); S14114A (46%)
S34125D,"Incomplete lesion of L5 level of lumbar spinal cord, subsequent encounter",182,S14119D (58%); S24119D (57%); S14111D (51%); S14114D (51%); S14115D (51%)
S34125S,"Incomplete lesion of L5 level of lumbar spinal cord, sequela",,
S34129A,"Incomplete lesion of unspecified level of lumbar spinal cord, initial encounter",182,S14119A (65%); S24119A (63%); S14119D (57%); S24119D (56%); S14111A (54%)
S34129D,"Incomplete lesion of unspecified level of lumbar spinal cord, subsequent encounter",182,S14119D (69%); S24119D (67%); S14111D (58%); S14114D (58%); S14115D (58%)
S34129S,"Incomplete lesion of unspecified level of lumbar spinal cord, sequela",,
S34131A,"Complete lesion of sacral spinal cord, initial encounter",182,S14119A (70%); S24119A (68%); S14119D (62%); S14111A (61%); S14114A (61%)
S34131D,"Complete lesion of sacral spinal cord, subsequent encounter",182,S14119D (74%); S24119D (72%); S14111D (65%); S14114D (65%); S14115D (65%)
S34131S,"Complete lesion of sacral spinal cord, sequela",,
S34132A,"Incomplete lesion of sacral spinal cord, initial encounter",182,S14119A (51%); S24119A (50%); S14111A (44%); S14114A (44%); S14115A (44%)
S34132D,"Incomplete lesion of sacral spinal cord, subsequent encounter",182,S14119D (57%); S24119D (56%); S14111D (50%); S14114D (50%); S14115D (50%)
S34132S,"Incomplete lesion of sacral spinal cord, sequela",,
S34139A,"Unspecified injury to sacral spinal cord, initial encounter",182,C720 (42%); S14119A (40%); S24119A (39%); D334 (36%); L89152 (35%)
S34139D,"Unspecified injury to sacral spinal cord, subsequent encounter",182,S14119D (48%); S24119D (47%); S14111D (40%); S14114D (40%); S14115D (40%)
S34139S,"Unspecified injury to sacral spinal cord, sequela",,
S343XXA,"Injury of cauda equina, initial encounter",182,C721 (80%); S069X0A (25%); S06890A (24%); S062X0A (21%); S069X9A (20%)
S48011A,"Complete traumatic amputation at right shoulder joint, initial encounter",405,M0080 (35%); M0020 (35%); M0000 (35%); M0010 (35%); M87811 (33%)
S48011S,"Complete traumatic amputation at right shoulder joint, sequela",,
S48012A,"Complete traumatic amputation at left shoulder joint, initial encounter",405,M0080 (35%); M0020 (35%); M0000 (35%); M0010 (35%); M87812 (33%)
S48012S,"Complete traumatic amputation at left shoulder joint, sequela",,
S48019A,"Complete traumatic amputation at unspecified shoulder joint, initial encounter",405,M0080 (39%); M0020 (39%); M0000 (39%); M0010 (39%); M87819 (31%)
S48019S,"Complete traumatic amputation at unspecified shoulder joint, sequela",,
S48021A,"Partial traumatic amputation at right shoulder joint, initial encounter",405,M0080 (34%); M0020 (34%); M0000 (34%); M0010 (34%); M87811 (33%)
S48021S,"Partial traumatic amputation at right shoulder joint, sequela",,
S48022A,"Partial traumatic amputation at left shoulder joint, initial encounter",405,M0080 (34%); M0020 (34%); M0000 (34%); M0010 (34%); M87812 (33%)
S48022S,"Partial traumatic amputation at left shoulder joint, sequela",,
S48029A,"Partial traumatic amputation at unspecified shoulder joint, initial encounter",405,M0080 (38%); M0020 (38%); M0000 (38%); M0010 (38%); M87819 (31%)
S48029S,"Partial traumatic amputation at unspecified shoulder joint, sequela",,
S48111A,"Complete traumatic amputation at level between right shoulder and elbow, initial encounter",405,S14119A (35%); S24119A (34%); S34119A (34%); M87811 (34%); M08821 (32%)
S48111S,"Complete traumatic amputation at level between right shoulder and elbow, sequela",,
S48112A,"Complete traumatic amputation at level between left shoulder and elbow, initial encounter",405,S14119A (35%); S24119A (34%); S34119A (34%); M87812 (34%); M08822 (32%)
S48112S,"Complete traumatic amputation at level between left shoulder and elbow, sequela",,
S48119A,"Complete traumatic amputation at level between unspecified shoulder and elbow, initial encounter",405,S14119A (38%); S24119A (37%); S34119A (37%); S14119D (32%); S24119D (32%)
S48119S,"Complete traumatic amputation at level between unspecified shoulder and elbow, sequela",,
S48121A,"Partial traumatic amputation at level between right shoulder and elbow, initial encounter",405,M87811 (33%); M08821 (32%); M08921 (31%); M86611 (30%); M06821 (30%)
S48121S,"Partial traumatic amputation at level between right shoulder and elbow, sequela",,
S48122A,"Partial traumatic amputation at level between left shoulder and elbow, initial encounter",405,M87812 (33%); M08822 (32%); M08922 (31%); M86612 (30%); M06822 (30%)
S48122S,"Partial traumatic amputation at level between left shoulder and elbow, sequela",,
S48129A,"Partial traumatic amputation at level between unspecified shoulder and elbow, initial encounter",405,M08929 (31%); M87819 (31%); M08829 (29%); M08919 (29%); M08029 (28%)
S48129S,"Partial traumatic amputation at level between unspecified shoulder and elbow, sequela",,
S48911A,"Complete traumatic amputation of right shoulder and upper arm, level unspecified, initial encounter",405,M868X2 (49%); M90521 (42%); M90529 (40%); M89621 (40%); M89629 (39%)
S48911S,"Complete traumatic amputation of right shoulder and upper arm, level unspecified, sequela",,
S48912A,"Complete traumatic amputation of left shoulder and upper arm, level unspecified, initial encounter",405,M868X2 (49%); M90522 (42%); M90529 (40%); M89622 (40%); M89629 (39%)
S48912S,"Complete traumatic amputation of left shoulder and upper arm, level unspecified, sequela",,
S48919A,"Complete traumatic amputation of unspecified shoulder and upper arm, level unspecified, initial encounter",405,M868X2 (48%); M90529 (43%); M89629 (41%); M90522 (37%); M90521 (37%)
S48919S,"Complete traumatic amputation of unspecified shoulder and upper arm, level unspecified, sequela",,
S48921A,"Partial traumatic amputation of right shoulder and upper arm, level unspecified, initial encounter",405,M868X2 (48%); M90521 (42%); M90529 (40%); M89621 (40%); M89629 (38%)
S48921S,"Partial traumatic amputation of right shoulder and upper arm, level unspecified, sequela",,
S48922A,"Partial traumatic amputation of left shoulder and upper arm, level unspecified, initial encounter",405,M868X2 (48%); M90522 (42%); M90529 (40%); M89622 (40%); M89629 (38%)
S48922S,"Partial traumatic amputation of left shoulder and upper arm, level unspecified, sequela",,
S48929A,"Partial traumatic amputation of unspecified shoulder and upper arm, level unspecified, initial encounter",405,M868X2 (48%); M90529 (42%); M89629 (40%); M90522 (36%); M90521 (36%)
S48929S,"Partial traumatic amputation of unspecified shoulder and upper arm, level unspecified, sequela",,
S58011A,"Complete traumatic amputation at elbow level, right arm, initial encounter",405,M868X2 (35%); S14119A (33%); S24119A (32%); S34119A (32%); M90521 (31%)
S58011S,"Complete traumatic amputation at elbow level, right arm, sequela",,
S58012A,"Complete traumatic amputation at elbow level, left arm, initial encounter",405,M868X2 (35%); S14119A (33%); S24119A (32%); S34119A (32%); M90522 (31%)
S58012S,"Complete traumatic amputation at elbow level, left arm, sequela",,
S58019A,"Complete traumatic amputation at elbow level, unspecified arm, initial encounter",405,S14119A (36%); S24119A (35%); S34119A (35%); M868X2 (35%); S14119D (30%)
S58019S,"Complete traumatic amputation at elbow level, unspecified arm, sequela",,
S58021A,"Partial traumatic amputation at elbow level, right arm, initial encounter",405,M868X2 (34%); M90521 (31%); M89621 (30%); M08821 (30%); M08921 (29%)
S58021S,"Partial traumatic amputation at elbow level, right arm, sequela",,
S58022A,"Partial traumatic amputation at elbow level, left arm, initial encounter",405,M868X2 (34%); M90522 (31%); M89622 (30%); M08822 (30%); M08922 (29%)
S58022S,"Partial traumatic amputation at elbow level, left arm, sequela",,
S58029A,"Partial traumatic amputation at elbow level, unspecified arm, initial encounter",405,M868X2 (35%); M90529 (30%); M08929 (29%); M89629 (28%); M08829 (28%)
S58029S,"Partial traumatic amputation at elbow level, unspecified arm, sequela",,
S58111A,"Complete traumatic amputation at level between elbow and wrist, right arm, initial encounter",405,M868X2 (32%); S14119A (30%); S24119A (30%); S34119A (29%); M90521 (29%)
S58111S,"Complete traumatic amputation at level between elbow and wrist, right arm, sequela",,
S58112A,"Complete traumatic amputation at level between elbow and wrist, left arm, initial encounter",405,M868X2 (32%); S14119A (30%); S24119A (30%); S34119A (30%); M90522 (29%)
S58112S,"Complete traumatic amputation at level between elbow and wrist, left arm, sequela",,
S58119A,"Complete traumatic amputation at level between elbow and wrist, unspecified arm, initial encounter",405,S14119A (33%); S24119A (33%); S34119A (32%); M868X2 (32%); M08939 (28%)
S58119S,"Complete traumatic amputation at level between elbow and wrist, unspecified arm, sequela",,
S58121A,"Partial traumatic amputation at level between elbow and wrist, right arm, initial encounter",405,M868X2 (32%); M90521 (29%); M08831 (29%); M08931 (28%); M89621 (28%)
S58121S,"Partial traumatic amputation at level between elbow and wrist, right arm, sequela",,
S58122A,"Partial traumatic amputation at level between elbow and wrist, left arm, initial encounter",405,M868X2 (32%); M90522 (29%); M08832 (29%); M08932 (28%); M89622 (28%)
S58122S,"Partial traumatic amputation at level between elbow and wrist, left arm, sequela",,
S58129A,"Partial traumatic amputation at level between elbow and wrist, unspecified arm, initial encounter",405,M868X2 (32%); M08939 (28%); M90529 (27%); M08929 (27%); M08839 (27%)
S58129S,"Partial traumatic amputation at level between elbow and wrist, unspecified arm, sequela",,
S58911A,"Complete traumatic amputation of right forearm, level unspecified, initial encounter",405,M868X3 (47%); M90531 (40%); M89631 (38%); M90539 (38%); S14119A (37%)
S58911S,"Complete traumatic amputation of right forearm, level unspecified, sequela",,
S58912A,"Complete traumatic amputation of left forearm, level unspecified, initial encounter",405,M868X3 (47%); M90532 (40%); M89632 (38%); M90539 (38%); S14119A (37%)
S58912S,"Complete traumatic amputation of left forearm, level unspecified, sequela",,
S58919A,"Complete traumatic amputation of unspecified forearm, level unspecified, initial encounter",405,M868X3 (46%); M90539 (41%); S14119A (40%); M89639 (39%); S24119A (39%)
S58919S,"Complete traumatic amputation of unspecified forearm, level unspecified, sequela",,
S58921A,"Partial traumatic amputation of right forearm, level unspecified, initial encounter",405,M868X3 (46%); M90531 (39%); M89631 (38%); M90539 (38%); M89639 (36%)
S58921S,"Partial traumatic amputation of right forearm, level unspecified, sequela",,
S58922A,"Partial traumatic amputation of left forearm, level unspecified, initial encounter",405,M868X3 (46%); M90532 (39%); M89632 (38%); M90539 (38%); M89639 (36%)
S58922S,"Partial traumatic amputation of left forearm, level unspecified, sequela",,
S58929A,"Partial traumatic amputation of unspecified forearm, level unspecified, initial encounter",405,M868X3 (46%); M90539 (40%); M89639 (38%); M90532 (33%); M90531 (33%)
S58929S,"Partial traumatic amputation of unspecified forearm, level unspecified, sequela",,
S68011S,"Complete traumatic metacarpophalangeal amputation of right thumb, sequela",,
S68012S,"Complete traumatic metacarpophalangeal amputation of left thumb, sequela",,
S68019S,"Complete traumatic metacarpophalangeal amputation of unspecified thumb, sequela",,
S68021S,"Partial traumatic metacarpophalangeal amputation of right thumb, sequela",,
S68022S,"Partial traumatic metacarpophalangeal amputation of left thumb, sequela",,
S68029S,"Partial traumatic metacarpophalangeal amputation of unspecified thumb, sequela",,
S68110S,"Complete traumatic metacarpophalangeal amputation of right index finger, sequela",,
S68111S,"Complete traumatic metacarpophalangeal amputation of left index finger, sequela",,
S68112S,"Complete traumatic metacarpophalangeal amputation of right middle finger, sequela",,
S68113S,"Complete traumatic metacarpophalangeal amputation of left middle finger, sequela",,
S68114S,"Complete traumatic metacarpophalangeal amputation of right ring finger, sequela",,
S68115S,"Complete traumatic metacarpophalangeal amputation of left ring finger, sequela",,
S68116S,"Complete traumatic metacarpophalangeal amputation of right little finger, sequela",,
S68117S,"Complete traumatic metacarpophalangeal amputation of left little finger, sequela",,
S68118S,"Complete traumatic metacarpophalangeal amputation of other finger, sequela",,
S68119S,"Complete traumatic metacarpophalangeal amputation of unspecified finger, sequela",,
S68120S,"Partial traumatic metacarpophalangeal amputation of right index finger, sequela",,
S68121S,"Partial traumatic metacarpophalangeal amputation of left index finger, sequela",,
S68122S,"Partial traumatic metacarpophalangeal amputation of right middle finger, sequela",,
S68123S,"Partial traumatic metacarpophalangeal amputation of left middle finger, sequela",,
S68124S,"Partial traumatic metacarpophalangeal amputation of right ring finger, sequela",,
S68125S,"Partial traumatic metacarpophalangeal amputation of left ring finger, sequela",,
S68126S,"Partial traumatic metacarpophalangeal amputation of right little finger, sequela",,
S68127S,"Partial traumatic metacarpophalangeal amputation of left little finger, sequela",,
S68128S,"Partial traumatic metacarpophalangeal amputation of other finger, sequela",,
S68129S,"Partial traumatic metacarpophalangeal amputation of unspecified finger, sequela",,
S68411A,"Complete traumatic amputation of right hand at wrist level, initial encounter",405,S14119A (34%); M87841 (34%); S24119A (34%); S34119A (33%); M08831 (33%)
S68411S,"Complete traumatic amputation of right hand at wrist level, sequela",,
S68412A,"Complete traumatic amputation of left hand at wrist level, initial encounter",405,S14119A (34%); M87842 (34%); S24119A (34%); S34119A (33%); M08832 (33%)
S68412S,"Complete traumatic amputation of left hand at wrist level, sequela",,
S68419A,"Complete traumatic amputation of unspecified hand at wrist level, initial encounter",405,S14119A (38%); S24119A (37%); S34119A (37%); M08939 (32%); M87843 (32%)
S68419S,"Complete traumatic amputation of unspecified hand at wrist level, sequela",,
S68421A,"Partial traumatic amputation of right hand at wrist level, initial encounter",405,M87841 (34%); M08831 (33%); M08931 (32%); M86641 (31%); M06831 (31%)
S68421S,"Partial traumatic amputation of right hand at wrist level, sequela",,
S68422A,"Partial traumatic amputation of left hand at wrist level, initial encounter",405,M87842 (34%); M08832 (32%); M08932 (32%); M86642 (31%); M06832 (31%)
S68422S,"Partial traumatic amputation of left hand at wrist level, sequela",,
S68429A,"Partial traumatic amputation of unspecified hand at wrist level, initial encounter",405,M08939 (32%); M87843 (32%); M08839 (30%); M08949 (29%); M08039 (29%)
S68429S,"Partial traumatic amputation of unspecified hand at wrist level, sequela",,
S68511S,"Complete traumatic transphalangeal amputation of right thumb, sequela",,
S68512S,"Complete traumatic transphalangeal amputation of left thumb, sequela",,
S68519S,"Complete traumatic transphalangeal amputation of unspecified thumb, sequela",,
S68521S,"Partial traumatic transphalangeal amputation of right thumb, sequela",,
S68522S,"Partial traumatic transphalangeal amputation of left thumb, sequela",,
S68529S,"Partial traumatic transphalangeal amputation of unspecified thumb, sequela",,
S68610S,"Complete traumatic transphalangeal amputation of right index finger, sequela",,
S68611S,"Complete traumatic transphalangeal amputation of left index finger, sequela",,
S68612S,"Complete traumatic transphalangeal amputation of right middle finger, sequela",,
S68613S,"Complete traumatic transphalangeal amputation of left middle finger, sequela",,
S68614S,"Complete traumatic transphalangeal amputation of right ring finger, sequela",,
S68615S,"Complete traumatic transphalangeal amputation of left ring finger, sequela",,
S68616S,"Complete traumatic transphalangeal amputation of right little finger, sequela",,
S68617S,"Complete traumatic transphalangeal amputation of left little finger, sequela",,
S68618S,"Complete traumatic transphalangeal amputation of other finger, sequela",,
S68619S,"Complete traumatic transphalangeal amputation of unspecified finger, sequela",,
S68620S,"Partial traumatic transphalangeal amputation of right index finger, sequela",,
S68621S,"Partial traumatic transphalangeal amputation of left index finger, sequela",,
S68622S,"Partial traumatic transphalangeal amputation of right middle finger, sequela",,
S68623S,"Partial traumatic transphalangeal amputation of left middle finger, sequela",,
S68624S,"Partial traumatic transphalangeal amputation of right ring finger, sequela",,
S68625S,"Partial traumatic transphalangeal amputation of left ring finger, sequela",,
S68626S,"Partial traumatic transphalangeal amputation of right little finger, sequela",,
S68627S,"Partial traumatic transphalangeal amputation of left little finger, sequela",,
S68628S,"Partial traumatic transphalangeal amputation of other finger, sequela",,
S68629S,"Partial traumatic transphalangeal amputation of unspecified finger, sequela",,
S68711A,"Complete traumatic transmetacarpal amputation of right hand, initial encounter",405,M87841 (33%); M86641 (30%); M08841 (29%); M86141 (28%); M08941 (28%)
S68711S,"Complete traumatic transmetacarpal amputation of right hand, sequela",,
S68712A,"Complete traumatic transmetacarpal amputation of left hand, initial encounter",405,M87842 (33%); M86642 (30%); M08842 (29%); M86142 (28%); M08942 (28%)
S68712S,"Complete traumatic transmetacarpal amputation of left hand, sequela",,
S68719A,"Complete traumatic transmetacarpal amputation of unspecified hand, initial encounter",405,M87843 (30%); M08949 (28%); M86649 (27%); M868X4 (27%); M08849 (27%)
S68719S,"Complete traumatic transmetacarpal amputation of unspecified hand, sequela",,
S68721A,"Partial traumatic transmetacarpal amputation of right hand, initial encounter",405,M87841 (32%); M86641 (29%); M08841 (29%); M86141 (28%); M08941 (28%)
S68721S,"Partial traumatic transmetacarpal amputation of right hand, sequela",,
S68722A,"Partial traumatic transmetacarpal amputation of left hand, initial encounter",405,M87842 (32%); M86642 (29%); M08842 (29%); M86142 (28%); M08942 (28%)
S68722S,"Partial traumatic transmetacarpal amputation of left hand, sequela",,
S68729A,"Partial traumatic transmetacarpal amputation of unspecified hand, initial encounter",405,M87843 (30%); M08949 (28%); M86649 (27%); M868X4 (27%); M08849 (26%)
S68729S,"Partial traumatic transmetacarpal amputation of unspecified hand, sequela",,
S72001A,"Fracture of unspecified part of neck of right femur, initial encounter for closed fracture",402,S129XXA (79%); S02609A (58%); S3210XA (57%); S02601A (57%); S22009A (57%)
S72001B,"Fracture of unspecified part of neck of right femur, initial encounter for open fracture type I or II",402,S129XXA (70%); S0211CB (61%); S02111B (59%); S12112B (57%); S0211DB (55%)
S72001C,"Fracture of unspecified part of neck of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S129XXA (60%); S3214XB (46%); S3215XB (46%); S3216XB (46%); S3217XB (46%)
S72002A,"Fracture of unspecified part of neck of left femur, initial encounter for closed fracture",402,S129XXA (79%); S02609A (58%); S3210XA (57%); S02602A (57%); S22009A (57%)
S72002B,"Fracture of unspecified part of neck of left femur, initial encounter for open fracture type I or II",402,S129XXA (70%); S0211DB (61%); S02111B (59%); S12112B (57%); S0211CB (55%)
S72002C,"Fracture of unspecified part of neck of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S129XXA (60%); S3214XB (46%); S3215XB (46%); S3216XB (46%); S3217XB (46%)
S72009A,"Fracture of unspecified part of neck of unspecified femur, initial encounter for closed fracture",402,S129XXA (83%); S22009A (63%); S32009A (63%); S02609A (61%); S3210XA (60%)
S72009B,"Fracture of unspecified part of neck of unspecified femur, initial encounter for open fracture type I or II",402,S129XXA (74%); S02111B (61%); S12112B (56%); S22009B (55%); S32009B (55%)
S72009C,"Fracture of unspecified part of neck of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S129XXA (64%); S22009B (48%); S32009B (48%); S02609B (47%); S3210XB (46%)
S72011A,"Unspecified intracapsular fracture of right femur, initial encounter for closed fracture",402,S02609A (52%); S3210XA (51%); S02601A (51%); S22009A (51%); S32009A (51%)
S72011B,"Unspecified intracapsular fracture of right femur, initial encounter for open fracture type I or II",402,S0211CB (56%); S02111B (54%); S12112B (53%); S0211DB (51%); S02412B (49%)
S72011C,"Unspecified intracapsular fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (43%); S3215XB (43%); S3216XB (43%); S3217XB (43%); S02609B (41%)
S72012A,"Unspecified intracapsular fracture of left femur, initial encounter for closed fracture",402,S02609A (52%); S3210XA (52%); S02602A (51%); S22009A (51%); S32009A (51%)
S72012B,"Unspecified intracapsular fracture of left femur, initial encounter for open fracture type I or II",402,S0211DB (56%); S02111B (54%); S12112B (53%); S0211CB (51%); S02412B (49%)
S72012C,"Unspecified intracapsular fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (43%); S3215XB (43%); S3216XB (43%); S3217XB (43%); S02609B (41%)
S72019A,"Unspecified intracapsular fracture of unspecified femur, initial encounter for closed fracture",402,S22009A (57%); S32009A (57%); S02609A (55%); S3210XA (54%); S22008A (53%)
S72019B,"Unspecified intracapsular fracture of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (56%); S12112B (52%); S22009B (51%); S32009B (51%); S32129B (50%)
S72019C,"Unspecified intracapsular fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S22009B (45%); S32009B (45%); S02609B (44%); S3210XB (43%); S3214XB (43%)
S72021A,"Displaced fracture of epiphysis (separation) (upper) of right femur, initial encounter for closed fracture",402,S12090A (50%); S12290A (50%); S12000A (49%); S12200A (49%); S12120A (46%)
S72021B,"Displaced fracture of epiphysis (separation) (upper) of right femur, initial encounter for open fracture type I or II",402,S12110B (50%); S12111B (50%); S0211CB (48%); S12090B (46%); S12290B (46%)
S72021C,"Displaced fracture of epiphysis (separation) (upper) of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (41%); S12290B (41%); S12000B (41%); S12200B (41%); S3214XB (39%)
S72022A,"Displaced fracture of epiphysis (separation) (upper) of left femur, initial encounter for closed fracture",402,S12090A (50%); S12290A (50%); S12000A (49%); S12200A (49%); S12120A (46%)
S72022B,"Displaced fracture of epiphysis (separation) (upper) of left femur, initial encounter for open fracture type I or II",402,S12110B (50%); S12111B (50%); S0211DB (48%); S12090B (46%); S12290B (46%)
S72022C,"Displaced fracture of epiphysis (separation) (upper) of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (41%); S12290B (41%); S12000B (41%); S12200B (41%); S3214XB (39%)
S72023A,"Displaced fracture of epiphysis (separation) (upper) of unspecified femur, initial encounter for closed fracture",402,S12000A (52%); S12200A (52%); S12090A (50%); S12290A (50%); S12120A (47%)
S72023B,"Displaced fracture of epiphysis (separation) (upper) of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (51%); S12111B (50%); S12000B (48%); S12200B (48%); S02111B (47%)
S72023C,"Displaced fracture of epiphysis (separation) (upper) of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (43%); S12200B (43%); S12090B (42%); S12290B (42%); S3214XB (39%)
S72024A,"Nondisplaced fracture of epiphysis (separation) (upper) of right femur, initial encounter for closed fracture",402,S12091A (50%); S12291A (50%); S12001A (49%); S12201A (49%); S12121A (46%)
S72024B,"Nondisplaced fracture of epiphysis (separation) (upper) of right femur, initial encounter for open fracture type I or II",402,S12112B (55%); S12112A (48%); S0211CB (48%); S32120B (47%); S12091B (46%)
S72024C,"Nondisplaced fracture of epiphysis (separation) (upper) of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (41%); S12291B (41%); S12001B (41%); S12201B (41%); S12112B (39%)
S72025A,"Nondisplaced fracture of epiphysis (separation) (upper) of left femur, initial encounter for closed fracture",402,S12091A (50%); S12291A (50%); S12001A (49%); S12201A (49%); S12121A (46%)
S72025B,"Nondisplaced fracture of epiphysis (separation) (upper) of left femur, initial encounter for open fracture type I or II",402,S12112B (55%); S12112A (48%); S0211DB (48%); S32120B (47%); S12091B (46%)
S72025C,"Nondisplaced fracture of epiphysis (separation) (upper) of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (41%); S12291B (41%); S12001B (41%); S12201B (41%); S12112B (39%)
S72026A,"Nondisplaced fracture of epiphysis (separation) (upper) of unspecified femur, initial encounter for closed fracture",402,S12001A (53%); S12201A (53%); S12091A (50%); S12291A (50%); S12121A (47%)
S72026B,"Nondisplaced fracture of epiphysis (separation) (upper) of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (55%); S12112A (49%); S12001B (48%); S12201B (48%); S02111B (47%)
S72026C,"Nondisplaced fracture of epiphysis (separation) (upper) of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (44%); S12201B (44%); S12091B (42%); S12291B (42%); S12112B (40%)
S72031A,"Displaced midcervical fracture of right femur, initial encounter for closed fracture",402,S12090A (58%); S12290A (58%); S12000A (57%); S12200A (57%); S12120A (54%)
S72031B,"Displaced midcervical fracture of right femur, initial encounter for open fracture type I or II",402,S12110B (57%); S12111B (57%); S0211CB (55%); S12090B (52%); S12290B (52%)
S72031C,"Displaced midcervical fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (46%); S12290B (46%); S12000B (45%); S12200B (45%); S3214XB (43%)
S72032A,"Displaced midcervical fracture of left femur, initial encounter for closed fracture",402,S12090A (58%); S12290A (58%); S12000A (57%); S12200A (57%); S12120A (54%)
S72032B,"Displaced midcervical fracture of left femur, initial encounter for open fracture type I or II",402,S12110B (57%); S12111B (57%); S0211DB (55%); S12090B (52%); S12290B (52%)
S72032C,"Displaced midcervical fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (46%); S12290B (46%); S12000B (45%); S12200B (45%); S3214XB (43%)
S72033A,"Displaced midcervical fracture of unspecified femur, initial encounter for closed fracture",402,S12000A (62%); S12200A (62%); S12090A (59%); S12290A (59%); S12120A (55%)
S72033B,"Displaced midcervical fracture of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (58%); S12111B (58%); S12000B (55%); S12200B (55%); S02111B (54%)
S72033C,"Displaced midcervical fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (48%); S12200B (48%); S12090B (46%); S12290B (46%); S3214XB (43%)
S72034A,"Nondisplaced midcervical fracture of right femur, initial encounter for closed fracture",402,S12091A (58%); S12291A (58%); S12001A (57%); S12201A (57%); S12121A (54%)
S72034B,"Nondisplaced midcervical fracture of right femur, initial encounter for open fracture type I or II",402,S12112B (62%); S12112A (55%); S0211CB (55%); S32120B (53%); S12091B (52%)
S72034C,"Nondisplaced midcervical fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (46%); S12291B (46%); S12001B (45%); S12201B (45%); S12112B (44%)
S72035A,"Nondisplaced midcervical fracture of left femur, initial encounter for closed fracture",402,S12091A (58%); S12291A (58%); S12001A (57%); S12201A (57%); S12121A (54%)
S72035B,"Nondisplaced midcervical fracture of left femur, initial encounter for open fracture type I or II",402,S12112B (62%); S12112A (55%); S0211DB (55%); S32120B (53%); S12091B (52%)
S72035C,"Nondisplaced midcervical fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (46%); S12291B (46%); S12001B (45%); S12201B (45%); S12112B (44%)
S72036A,"Nondisplaced midcervical fracture of unspecified femur, initial encounter for closed fracture",402,S12001A (62%); S12201A (62%); S12091A (59%); S12291A (59%); S12121A (55%)
S72036B,"Nondisplaced midcervical fracture of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (63%); S12112A (56%); S12001B (55%); S12201B (55%); S02111B (54%)
S72036C,"Nondisplaced midcervical fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (48%); S12201B (48%); S12091B (47%); S12291B (47%); S12112B (44%)
S72041A,"Displaced fracture of base of neck of right femur, initial encounter for closed fracture",402,S02101A (66%); S0219XA (63%); S02109A (62%); S02102A (61%); S129XXA (60%)
S72041B,"Displaced fracture of base of neck of right femur, initial encounter for open fracture type I or II",402,S02101B (60%); S0219XB (57%); S02109B (56%); S02102B (56%); S129XXA (55%)
S72041C,"Displaced fracture of base of neck of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S02101B (54%); S0219XB (51%); S02109B (50%); S02102B (50%); S129XXA (49%)
S72042A,"Displaced fracture of base of neck of left femur, initial encounter for closed fracture",402,S02102A (66%); S0219XA (63%); S02109A (62%); S02101A (61%); S129XXA (60%)
S72042B,"Displaced fracture of base of neck of left femur, initial encounter for open fracture type I or II",402,S02102B (60%); S0219XB (57%); S02109B (56%); S02101B (56%); S129XXA (55%)
S72042C,"Displaced fracture of base of neck of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S02102B (54%); S0219XB (51%); S02109B (50%); S02101B (50%); S129XXA (49%)
S72043A,"Displaced fracture of base of neck of unspecified femur, initial encounter for closed fracture",402,S02109A (66%); S129XXA (65%); S0219XA (64%); S02102A (62%); S02101A (62%)
S72043B,"Displaced fracture of base of neck of unspecified femur, initial encounter for open fracture type I or II",402,S129XXA (60%); S02109B (59%); S0219XB (58%); S02102B (56%); S02101B (56%)
S72043C,"Displaced fracture of base of neck of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S129XXA (54%); S02109B (53%); S0219XB (52%); S02102B (50%); S02101B (50%)
S72044A,"Nondisplaced fracture of base of neck of right femur, initial encounter for closed fracture",402,S02101A (66%); S0219XA (63%); S02109A (62%); S02102A (61%); S129XXA (60%)
S72044B,"Nondisplaced fracture of base of neck of right femur, initial encounter for open fracture type I or II",402,S02101B (60%); S12112B (58%); S0219XB (57%); S02109B (56%); S02102B (56%)
S72044C,"Nondisplaced fracture of base of neck of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S02101B (54%); S0219XB (51%); S02109B (50%); S02102B (50%); S129XXA (49%)
S72045A,"Nondisplaced fracture of base of neck of left femur, initial encounter for closed fracture",402,S02102A (66%); S0219XA (63%); S02109A (62%); S02101A (61%); S129XXA (60%)
S72045B,"Nondisplaced fracture of base of neck of left femur, initial encounter for open fracture type I or II",402,S02102B (60%); S12112B (58%); S0219XB (57%); S02109B (56%); S02101B (56%)
S72045C,"Nondisplaced fracture of base of neck of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S02102B (54%); S0219XB (51%); S02109B (50%); S02101B (50%); S129XXA (49%)
S72046A,"Nondisplaced fracture of base of neck of unspecified femur, initial encounter for closed fracture",402,S02109A (65%); S129XXA (65%); S0219XA (64%); S02102A (62%); S02101A (62%)
S72046B,"Nondisplaced fracture of base of neck of unspecified femur, initial encounter for open fracture type I or II",402,S129XXA (60%); S02109B (59%); S12112B (59%); S0219XB (58%); S02102B (56%)
S72046C,"Nondisplaced fracture of base of neck of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S129XXA (53%); S02109B (53%); S0219XB (52%); S02102B (50%); S02101B (50%)
S72051A,"Unspecified fracture of head of right femur, initial encounter for closed fracture",402,S02609A (58%); S3210XA (57%); S02601A (57%); S22009A (57%); S32009A (56%)
S72051B,"Unspecified fracture of head of right femur, initial encounter for open fracture type I or II",402,S0211CB (61%); S02111B (59%); S12112B (57%); S0211DB (55%); S02412B (54%)
S72051C,"Unspecified fracture of head of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (46%); S3215XB (46%); S3216XB (46%); S3217XB (46%); S02609B (44%)
S72052A,"Unspecified fracture of head of left femur, initial encounter for closed fracture",402,S02609A (58%); S3210XA (57%); S02602A (57%); S22009A (57%); S32009A (56%)
S72052B,"Unspecified fracture of head of left femur, initial encounter for open fracture type I or II",402,S0211DB (61%); S02111B (59%); S12112B (57%); S0211CB (55%); S02412B (54%)
S72052C,"Unspecified fracture of head of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (46%); S3215XB (46%); S3216XB (46%); S3217XB (46%); S02609B (44%)
S72059A,"Unspecified fracture of head of unspecified femur, initial encounter for closed fracture",402,S22009A (63%); S32009A (63%); S02609A (61%); S3210XA (60%); S22008A (59%)
S72059B,"Unspecified fracture of head of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (61%); S12112B (56%); S22009B (55%); S32009B (55%); S32129B (55%)
S72059C,"Unspecified fracture of head of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S22009B (48%); S32009B (48%); S02609B (47%); S3210XB (46%); S3214XB (45%)
S72061A,"Displaced articular fracture of head of right femur, initial encounter for closed fracture",402,S12090A (54%); S12290A (54%); S12000A (53%); S12200A (53%); S12120A (50%)
S72061B,"Displaced articular fracture of head of right femur, initial encounter for open fracture type I or II",402,S12110B (53%); S12111B (53%); S0211CB (51%); S12090B (49%); S12290B (49%)
S72061C,"Displaced articular fracture of head of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (44%); S12290B (44%); S12000B (43%); S12200B (43%); S3214XB (41%)
S72062A,"Displaced articular fracture of head of left femur, initial encounter for closed fracture",402,S12090A (54%); S12290A (54%); S12000A (53%); S12200A (53%); S12120A (50%)
S72062B,"Displaced articular fracture of head of left femur, initial encounter for open fracture type I or II",402,S12110B (53%); S12111B (53%); S0211DB (51%); S12090B (49%); S12290B (49%)
S72062C,"Displaced articular fracture of head of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (44%); S12290B (44%); S12000B (43%); S12200B (43%); S3214XB (41%)
S72063A,"Displaced articular fracture of head of unspecified femur, initial encounter for closed fracture",402,S12000A (56%); S12200A (56%); S12090A (54%); S12290A (54%); S12120A (50%)
S72063B,"Displaced articular fracture of head of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (54%); S12111B (54%); S12000B (51%); S12200B (51%); S02111B (50%)
S72063C,"Displaced articular fracture of head of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (46%); S12200B (46%); S12090B (44%); S12290B (44%); S3214XB (41%)
S72064A,"Nondisplaced articular fracture of head of right femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (53%); S12201A (53%); S12121A (50%)
S72064B,"Nondisplaced articular fracture of head of right femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211CB (51%); S32120B (50%); S12091B (49%)
S72064C,"Nondisplaced articular fracture of head of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (41%)
S72065A,"Nondisplaced articular fracture of head of left femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (53%); S12201A (53%); S12121A (50%)
S72065B,"Nondisplaced articular fracture of head of left femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211DB (51%); S32120B (50%); S12091B (49%)
S72065C,"Nondisplaced articular fracture of head of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (41%)
S72066A,"Nondisplaced articular fracture of head of unspecified femur, initial encounter for closed fracture",402,S12001A (57%); S12201A (57%); S12091A (54%); S12291A (54%); S12121A (50%)
S72066B,"Nondisplaced articular fracture of head of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (59%); S12112A (52%); S12001B (51%); S12201B (51%); S02111B (50%)
S72066C,"Nondisplaced articular fracture of head of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (46%); S12201B (46%); S12091B (44%); S12291B (44%); S12112B (42%)
S72091A,"Other fracture of head and neck of right femur, initial encounter for closed fracture",402,S129XXA (66%); S0211GA (49%); S128XXA (49%); S0240CA (49%); S3219XA (49%)
S72091B,"Other fracture of head and neck of right femur, initial encounter for open fracture type I or II",402,S129XXA (59%); S0211CB (56%); S12112B (53%); S02111B (51%); S0211DB (51%)
S72091C,"Other fracture of head and neck of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S129XXA (52%); S3214XB (43%); S3215XB (43%); S3216XB (43%); S3217XB (43%)
S72092A,"Other fracture of head and neck of left femur, initial encounter for closed fracture",402,S129XXA (66%); S0211HA (49%); S128XXA (49%); S0240DA (49%); S3219XA (49%)
S72092B,"Other fracture of head and neck of left femur, initial encounter for open fracture type I or II",402,S129XXA (59%); S0211DB (56%); S12112B (53%); S02111B (51%); S0211CB (51%)
S72092C,"Other fracture of head and neck of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S129XXA (52%); S3214XB (43%); S3215XB (43%); S3216XB (43%); S3217XB (43%)
S72099A,"Other fracture of head and neck of unspecified femur, initial encounter for closed fracture",402,S129XXA (72%); S02609A (53%); S3210XA (52%); S22009A (52%); S32009A (51%)
S72099B,"Other fracture of head and neck of unspecified femur, initial encounter for open fracture type I or II",402,S129XXA (65%); S02111B (55%); S12112B (53%); S0211DB (52%); S0211CB (51%)
S72099C,"Other fracture of head and neck of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S129XXA (57%); S3214XB (44%); S3215XB (44%); S3216XB (44%); S3217XB (44%)
S72101A,"Unspecified trochanteric fracture of right femur, initial encounter for closed fracture",402,S02609A (52%); S3210XA (51%); S02601A (51%); S22009A (51%); S32009A (51%)
S72101B,"Unspecified trochanteric fracture of right femur, initial encounter for open fracture type I or II",402,S0211CB (56%); S02111B (54%); S12112B (53%); S0211DB (51%); S02412B (49%)
S72101C,"Unspecified trochanteric fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (43%); S3215XB (43%); S3216XB (43%); S3217XB (43%); S02609B (41%)
S72102A,"Unspecified trochanteric fracture of left femur, initial encounter for closed fracture",402,S02609A (52%); S3210XA (52%); S02602A (51%); S22009A (51%); S32009A (51%)
S72102B,"Unspecified trochanteric fracture of left femur, initial encounter for open fracture type I or II",402,S0211DB (56%); S02111B (54%); S12112B (53%); S0211CB (51%); S02412B (49%)
S72102C,"Unspecified trochanteric fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (43%); S3215XB (43%); S3216XB (43%); S3217XB (43%); S02609B (41%)
S72109A,"Unspecified trochanteric fracture of unspecified femur, initial encounter for closed fracture",402,S22009A (57%); S32009A (57%); S02609A (55%); S3210XA (54%); S22008A (53%)
S72109B,"Unspecified trochanteric fracture of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (56%); S12112B (52%); S22009B (51%); S32009B (51%); S32129B (50%)
S72109C,"Unspecified trochanteric fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S22009B (45%); S32009B (45%); S02609B (44%); S3210XB (43%); S3214XB (43%)
S72111A,"Displaced fracture of greater trochanter of right femur, initial encounter for closed fracture",402,S12090A (54%); S12290A (54%); S12000A (53%); S12200A (53%); S12120A (50%)
S72111B,"Displaced fracture of greater trochanter of right femur, initial encounter for open fracture type I or II",402,S12110B (54%); S12111B (53%); S0211CB (51%); S12090B (49%); S12290B (49%)
S72111C,"Displaced fracture of greater trochanter of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (44%); S12290B (44%); S12000B (43%); S12200B (43%); S3214XB (41%)
S72112A,"Displaced fracture of greater trochanter of left femur, initial encounter for closed fracture",402,S12090A (54%); S12290A (54%); S12000A (53%); S12200A (53%); S12120A (50%)
S72112B,"Displaced fracture of greater trochanter of left femur, initial encounter for open fracture type I or II",402,S12110B (54%); S12111B (53%); S0211DB (51%); S12090B (49%); S12290B (49%)
S72112C,"Displaced fracture of greater trochanter of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (44%); S12290B (44%); S12000B (43%); S12200B (43%); S3214XB (41%)
S72113A,"Displaced fracture of greater trochanter of unspecified femur, initial encounter for closed fracture",402,S12000A (57%); S12200A (57%); S12090A (54%); S12290A (54%); S12120A (50%)
S72113B,"Displaced fracture of greater trochanter of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (54%); S12111B (54%); S12000B (51%); S12200B (51%); S02111B (50%)
S72113C,"Displaced fracture of greater trochanter of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (46%); S12200B (46%); S12090B (44%); S12290B (44%); S3214XB (41%)
S72114A,"Nondisplaced fracture of greater trochanter of right femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (53%); S12201A (53%); S12121A (50%)
S72114B,"Nondisplaced fracture of greater trochanter of right femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211CB (51%); S32120B (50%); S12091B (49%)
S72114C,"Nondisplaced fracture of greater trochanter of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (42%)
S72115A,"Nondisplaced fracture of greater trochanter of left femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (53%); S12201A (53%); S12121A (50%)
S72115B,"Nondisplaced fracture of greater trochanter of left femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211DB (51%); S32120B (50%); S12091B (49%)
S72115C,"Nondisplaced fracture of greater trochanter of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (42%)
S72116A,"Nondisplaced fracture of greater trochanter of unspecified femur, initial encounter for closed fracture",402,S12001A (57%); S12201A (57%); S12091A (54%); S12291A (54%); S12121A (50%)
S72116B,"Nondisplaced fracture of greater trochanter of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (59%); S12112A (52%); S12001B (51%); S12201B (51%); S02111B (50%)
S72116C,"Nondisplaced fracture of greater trochanter of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (46%); S12201B (46%); S12091B (44%); S12291B (44%); S12112B (42%)
S72121A,"Displaced fracture of lesser trochanter of right femur, initial encounter for closed fracture",402,S12090A (52%); S12290A (52%); S12000A (51%); S12200A (51%); S12120A (48%)
S72121B,"Displaced fracture of lesser trochanter of right femur, initial encounter for open fracture type I or II",402,S12110B (52%); S12111B (52%); S0211CB (50%); S12090B (47%); S12290B (47%)
S72121C,"Displaced fracture of lesser trochanter of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (42%); S12290B (42%); S12000B (42%); S12200B (42%); S3214XB (40%)
S72122A,"Displaced fracture of lesser trochanter of left femur, initial encounter for closed fracture",402,S12090A (52%); S12290A (52%); S12000A (51%); S12200A (51%); S12120A (48%)
S72122B,"Displaced fracture of lesser trochanter of left femur, initial encounter for open fracture type I or II",402,S12110B (52%); S12111B (52%); S0211DB (50%); S12090B (47%); S12290B (47%)
S72122C,"Displaced fracture of lesser trochanter of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (42%); S12290B (42%); S12000B (42%); S12200B (42%); S3214XB (40%)
S72123A,"Displaced fracture of lesser trochanter of unspecified femur, initial encounter for closed fracture",402,S12000A (54%); S12200A (54%); S12090A (52%); S12290A (52%); S12120A (48%)
S72123B,"Displaced fracture of lesser trochanter of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (52%); S12111B (52%); S12000B (50%); S12200B (50%); S02111B (49%)
S72123C,"Displaced fracture of lesser trochanter of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (45%); S12200B (45%); S12090B (43%); S12290B (43%); S3214XB (40%)
S72124A,"Nondisplaced fracture of lesser trochanter of right femur, initial encounter for closed fracture",402,S12091A (52%); S12291A (52%); S12001A (51%); S12201A (51%); S12121A (48%)
S72124B,"Nondisplaced fracture of lesser trochanter of right femur, initial encounter for open fracture type I or II",402,S12112B (56%); S12112A (50%); S0211CB (50%); S32120B (48%); S12091B (47%)
S72124C,"Nondisplaced fracture of lesser trochanter of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (43%); S12291B (43%); S12001B (42%); S12201B (42%); S12112B (40%)
S72125A,"Nondisplaced fracture of lesser trochanter of left femur, initial encounter for closed fracture",402,S12091A (52%); S12291A (52%); S12001A (51%); S12201A (51%); S12121A (48%)
S72125B,"Nondisplaced fracture of lesser trochanter of left femur, initial encounter for open fracture type I or II",402,S12112B (56%); S12112A (50%); S0211DB (50%); S32120B (48%); S12091B (47%)
S72125C,"Nondisplaced fracture of lesser trochanter of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (43%); S12291B (43%); S12001B (42%); S12201B (42%); S12112B (40%)
S72126A,"Nondisplaced fracture of lesser trochanter of unspecified femur, initial encounter for closed fracture",402,S12001A (55%); S12201A (55%); S12091A (52%); S12291A (52%); S12121A (48%)
S72126B,"Nondisplaced fracture of lesser trochanter of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (57%); S12112A (50%); S12001B (50%); S12201B (50%); S02111B (49%)
S72126C,"Nondisplaced fracture of lesser trochanter of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (45%); S12201B (45%); S12091B (43%); S12291B (43%); S12112B (41%)
S72131A,"Displaced apophyseal fracture of right femur, initial encounter for closed fracture",402,S12090A (58%); S12290A (58%); S12000A (57%); S12200A (57%); S12120A (54%)
S72131B,"Displaced apophyseal fracture of right femur, initial encounter for open fracture type I or II",402,S12110B (57%); S12111B (57%); S0211CB (55%); S12090B (52%); S12290B (52%)
S72131C,"Displaced apophyseal fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (46%); S12290B (46%); S12000B (45%); S12200B (45%); S3214XB (43%)
S72132A,"Displaced apophyseal fracture of left femur, initial encounter for closed fracture",402,S12090A (58%); S12290A (58%); S12000A (57%); S12200A (57%); S12120A (54%)
S72132B,"Displaced apophyseal fracture of left femur, initial encounter for open fracture type I or II",402,S12110B (57%); S12111B (57%); S0211DB (55%); S12090B (52%); S12290B (52%)
S72132C,"Displaced apophyseal fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (46%); S12290B (46%); S12000B (45%); S12200B (45%); S3214XB (43%)
S72133A,"Displaced apophyseal fracture of unspecified femur, initial encounter for closed fracture",402,S12000A (62%); S12200A (62%); S12090A (59%); S12290A (59%); S12120A (55%)
S72133B,"Displaced apophyseal fracture of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (58%); S12111B (58%); S12000B (55%); S12200B (55%); S02111B (54%)
S72133C,"Displaced apophyseal fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (48%); S12200B (48%); S12090B (46%); S12290B (46%); S3214XB (43%)
S72134A,"Nondisplaced apophyseal fracture of right femur, initial encounter for closed fracture",402,S12091A (58%); S12291A (58%); S12001A (57%); S12201A (57%); S12121A (54%)
S72134B,"Nondisplaced apophyseal fracture of right femur, initial encounter for open fracture type I or II",402,S12112B (62%); S12112A (55%); S0211CB (55%); S32120B (53%); S12091B (52%)
S72134C,"Nondisplaced apophyseal fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (46%); S12291B (46%); S12001B (45%); S12201B (45%); S12112B (44%)
S72135A,"Nondisplaced apophyseal fracture of left femur, initial encounter for closed fracture",402,S12091A (58%); S12291A (58%); S12001A (57%); S12201A (57%); S12121A (54%)
S72135B,"Nondisplaced apophyseal fracture of left femur, initial encounter for open fracture type I or II",402,S12112B (62%); S12112A (55%); S0211DB (55%); S32120B (53%); S12091B (52%)
S72135C,"Nondisplaced apophyseal fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (46%); S12291B (46%); S12001B (45%); S12201B (45%); S12112B (44%)
S72136A,"Nondisplaced apophyseal fracture of unspecified femur, initial encounter for closed fracture",402,S12001A (62%); S12201A (62%); S12091A (59%); S12291A (59%); S12121A (55%)
S72136B,"Nondisplaced apophyseal fracture of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (63%); S12112A (56%); S12001B (55%); S12201B (55%); S02111B (54%)
S72136C,"Nondisplaced apophyseal fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (48%); S12201B (48%); S12091B (47%); S12291B (47%); S12112B (44%)
S72141A,"Displaced intertrochanteric fracture of right femur, initial encounter for closed fracture",402,S12090A (58%); S12290A (58%); S12000A (57%); S12200A (57%); S12120A (54%)
S72141B,"Displaced intertrochanteric fracture of right femur, initial encounter for open fracture type I or II",402,S12110B (57%); S12111B (57%); S0211CB (55%); S12090B (52%); S12290B (52%)
S72141C,"Displaced intertrochanteric fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (46%); S12290B (46%); S12000B (45%); S12200B (45%); S3214XB (43%)
S72142A,"Displaced intertrochanteric fracture of left femur, initial encounter for closed fracture",402,S12090A (58%); S12290A (58%); S12000A (57%); S12200A (57%); S12120A (54%)
S72142B,"Displaced intertrochanteric fracture of left femur, initial encounter for open fracture type I or II",402,S12110B (57%); S12111B (57%); S0211DB (55%); S12090B (52%); S12290B (52%)
S72142C,"Displaced intertrochanteric fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (46%); S12290B (46%); S12000B (45%); S12200B (45%); S3214XB (43%)
S72143A,"Displaced intertrochanteric fracture of unspecified femur, initial encounter for closed fracture",402,S12000A (62%); S12200A (62%); S12090A (59%); S12290A (59%); S12120A (55%)
S72143B,"Displaced intertrochanteric fracture of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (58%); S12111B (58%); S12000B (55%); S12200B (55%); S02111B (54%)
S72143C,"Displaced intertrochanteric fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (48%); S12200B (48%); S12090B (46%); S12290B (46%); S3214XB (43%)
S72144A,"Nondisplaced intertrochanteric fracture of right femur, initial encounter for closed fracture",402,S12091A (58%); S12291A (58%); S12001A (57%); S12201A (57%); S12121A (54%)
S72144B,"Nondisplaced intertrochanteric fracture of right femur, initial encounter for open fracture type I or II",402,S12112B (62%); S12112A (55%); S0211CB (55%); S32120B (53%); S12091B (52%)
S72144C,"Nondisplaced intertrochanteric fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (46%); S12291B (46%); S12001B (45%); S12201B (45%); S12112B (44%)
S72145A,"Nondisplaced intertrochanteric fracture of left femur, initial encounter for closed fracture",402,S12091A (58%); S12291A (58%); S12001A (57%); S12201A (57%); S12121A (54%)
S72145B,"Nondisplaced intertrochanteric fracture of left femur, initial encounter for open fracture type I or II",402,S12112B (62%); S12112A (55%); S0211DB (55%); S32120B (53%); S12091B (52%)
S72145C,"Nondisplaced intertrochanteric fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (46%); S12291B (46%); S12001B (45%); S12201B (45%); S12112B (44%)
S72146A,"Nondisplaced intertrochanteric fracture of unspecified femur, initial encounter for closed fracture",402,S12001A (62%); S12201A (62%); S12091A (59%); S12291A (59%); S12121A (55%)
S72146B,"Nondisplaced intertrochanteric fracture of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (63%); S12112A (56%); S12001B (55%); S12201B (55%); S02111B (54%)
S72146C,"Nondisplaced intertrochanteric fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (48%); S12201B (48%); S12091B (47%); S12291B (47%); S12112B (44%)
S7221XA,"Displaced subtrochanteric fracture of right femur, initial encounter for closed fracture",402,S12090A (58%); S12290A (58%); S12000A (57%); S12200A (57%); S12120A (54%)
S7221XB,"Displaced subtrochanteric fracture of right femur, initial encounter for open fracture type I or II",402,S12110B (57%); S12111B (57%); S0211CB (55%); S12090B (52%); S12290B (52%)
S7221XC,"Displaced subtrochanteric fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (46%); S12290B (46%); S12000B (45%); S12200B (45%); S3214XB (43%)
S7222XA,"Displaced subtrochanteric fracture of left femur, initial encounter for closed fracture",402,S12090A (58%); S12290A (58%); S12000A (57%); S12200A (57%); S12120A (54%)
S7222XB,"Displaced subtrochanteric fracture of left femur, initial encounter for open fracture type I or II",402,S12110B (57%); S12111B (57%); S0211DB (55%); S12090B (52%); S12290B (52%)
S7222XC,"Displaced subtrochanteric fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (46%); S12290B (46%); S12000B (45%); S12200B (45%); S3214XB (43%)
S7223XA,"Displaced subtrochanteric fracture of unspecified femur, initial encounter for closed fracture",402,S12000A (62%); S12200A (62%); S12090A (59%); S12290A (59%); S12120A (55%)
S7223XB,"Displaced subtrochanteric fracture of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (58%); S12111B (58%); S12000B (55%); S12200B (55%); S02111B (54%)
S7223XC,"Displaced subtrochanteric fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (48%); S12200B (48%); S12090B (46%); S12290B (46%); S3214XB (43%)
S7224XA,"Nondisplaced subtrochanteric fracture of right femur, initial encounter for closed fracture",402,S12091A (58%); S12291A (58%); S12001A (57%); S12201A (57%); S12121A (54%)
S7224XB,"Nondisplaced subtrochanteric fracture of right femur, initial encounter for open fracture type I or II",402,S12112B (62%); S12112A (55%); S0211CB (55%); S32120B (53%); S12091B (52%)
S7224XC,"Nondisplaced subtrochanteric fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (46%); S12291B (46%); S12001B (45%); S12201B (45%); S12112B (44%)
S7225XA,"Nondisplaced subtrochanteric fracture of left femur, initial encounter for closed fracture",402,S12091A (58%); S12291A (58%); S12001A (57%); S12201A (57%); S12121A (54%)
S7225XB,"Nondisplaced subtrochanteric fracture of left femur, initial encounter for open fracture type I or II",402,S12112B (62%); S12112A (55%); S0211DB (55%); S32120B (53%); S12091B (52%)
S7225XC,"Nondisplaced subtrochanteric fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (46%); S12291B (46%); S12001B (45%); S12201B (45%); S12112B (44%)
S7226XA,"Nondisplaced subtrochanteric fracture of unspecified femur, initial encounter for closed fracture",402,S12001A (62%); S12201A (62%); S12091A (59%); S12291A (59%); S12121A (55%)
S7226XB,"Nondisplaced subtrochanteric fracture of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (63%); S12112A (56%); S12001B (55%); S12201B (55%); S02111B (54%)
S7226XC,"Nondisplaced subtrochanteric fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (48%); S12201B (48%); S12091B (47%); S12291B (47%); S12112B (44%)
S72301A,"Unspecified fracture of shaft of right femur, initial encounter for closed fracture",402,S02609A (59%); S3210XA (58%); S02601A (57%); S22009A (57%); S32009A (57%)
S72301B,"Unspecified fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S0211CB (61%); S02111B (60%); S12112B (58%); S0211DB (56%); S02412B (54%)
S72301C,"Unspecified fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (47%); S3215XB (47%); S3216XB (47%); S3217XB (47%); S02609B (44%)
S72302A,"Unspecified fracture of shaft of left femur, initial encounter for closed fracture",402,S02609A (59%); S3210XA (58%); S02602A (57%); S22009A (57%); S32009A (57%)
S72302B,"Unspecified fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S0211DB (61%); S02111B (60%); S12112B (58%); S0211CB (56%); S02412B (54%)
S72302C,"Unspecified fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (47%); S3215XB (47%); S3216XB (47%); S3217XB (47%); S02609B (44%)
S72309A,"Unspecified fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S22009A (64%); S32009A (64%); S02609A (62%); S3210XA (61%); S22008A (60%)
S72309B,"Unspecified fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (61%); S12112B (57%); S22009B (56%); S32009B (56%); S32129B (55%)
S72309C,"Unspecified fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S22009B (48%); S32009B (48%); S02609B (47%); S3210XB (46%); S3214XB (46%)
S72321A,"Displaced transverse fracture of shaft of right femur, initial encounter for closed fracture",402,S12090A (56%); S12290A (56%); S12000A (54%); S12200A (54%); S12120A (51%)
S72321B,"Displaced transverse fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S12110B (55%); S12111B (55%); S0211CB (53%); S12090B (50%); S12290B (50%)
S72321C,"Displaced transverse fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (45%); S12290B (45%); S12000B (44%); S12200B (44%); S3214XB (42%)
S72322A,"Displaced transverse fracture of shaft of left femur, initial encounter for closed fracture",402,S12090A (56%); S12290A (56%); S12000A (54%); S12200A (54%); S12120A (51%)
S72322B,"Displaced transverse fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S12110B (55%); S12111B (55%); S0211DB (53%); S12090B (50%); S12290B (50%)
S72322C,"Displaced transverse fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (45%); S12290B (45%); S12000B (44%); S12200B (44%); S3214XB (42%)
S72323A,"Displaced transverse fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S12000A (59%); S12200A (59%); S12090A (56%); S12290A (56%); S12120A (52%)
S72323B,"Displaced transverse fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (56%); S12111B (55%); S12000B (53%); S12200B (53%); S02111B (52%)
S72323C,"Displaced transverse fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (47%); S12200B (47%); S12090B (45%); S12290B (45%); S3214XB (42%)
S72324A,"Nondisplaced transverse fracture of shaft of right femur, initial encounter for closed fracture",402,S12091A (56%); S12291A (56%); S12001A (54%); S12201A (54%); S12121A (51%)
S72324B,"Nondisplaced transverse fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S12112B (60%); S12112A (53%); S0211CB (53%); S32120B (51%); S12091B (50%)
S72324C,"Nondisplaced transverse fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (45%); S12291B (45%); S12001B (44%); S12201B (44%); S12112B (42%)
S72325A,"Nondisplaced transverse fracture of shaft of left femur, initial encounter for closed fracture",402,S12091A (56%); S12291A (56%); S12001A (54%); S12201A (54%); S12121A (51%)
S72325B,"Nondisplaced transverse fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S12112B (60%); S12112A (53%); S0211DB (53%); S32120B (51%); S12091B (50%)
S72325C,"Nondisplaced transverse fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (45%); S12291B (45%); S12001B (44%); S12201B (44%); S12112B (42%)
S72326A,"Nondisplaced transverse fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S12001A (59%); S12201A (59%); S12091A (56%); S12291A (56%); S12121A (52%)
S72326B,"Nondisplaced transverse fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (60%); S12112A (53%); S12001B (53%); S12201B (53%); S02111B (52%)
S72326C,"Nondisplaced transverse fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (47%); S12201B (47%); S12091B (45%); S12291B (45%); S12112B (43%)
S72331A,"Displaced oblique fracture of shaft of right femur, initial encounter for closed fracture",402,S12090A (54%); S12290A (54%); S12000A (53%); S12200A (53%); S12120A (50%)
S72331B,"Displaced oblique fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S12110B (54%); S12111B (53%); S0211CB (51%); S12090B (49%); S12290B (49%)
S72331C,"Displaced oblique fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (44%); S12290B (44%); S12000B (43%); S12200B (43%); S3214XB (41%)
S72332A,"Displaced oblique fracture of shaft of left femur, initial encounter for closed fracture",402,S12090A (54%); S12290A (54%); S12000A (53%); S12200A (53%); S12120A (50%)
S72332B,"Displaced oblique fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S12110B (54%); S12111B (53%); S0211DB (51%); S12090B (49%); S12290B (49%)
S72332C,"Displaced oblique fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (44%); S12290B (44%); S12000B (43%); S12200B (43%); S3214XB (41%)
S72333A,"Displaced oblique fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S12000A (57%); S12200A (57%); S12090A (54%); S12290A (54%); S12120A (50%)
S72333B,"Displaced oblique fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (54%); S12111B (54%); S12000B (51%); S12200B (51%); S02111B (50%)
S72333C,"Displaced oblique fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (46%); S12200B (46%); S12090B (44%); S12290B (44%); S3214XB (41%)
S72334A,"Nondisplaced oblique fracture of shaft of right femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (53%); S12201A (53%); S12121A (50%)
S72334B,"Nondisplaced oblique fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211CB (51%); S32120B (50%); S12091B (49%)
S72334C,"Nondisplaced oblique fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (42%)
S72335A,"Nondisplaced oblique fracture of shaft of left femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (53%); S12201A (53%); S12121A (50%)
S72335B,"Nondisplaced oblique fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211DB (51%); S32120B (50%); S12091B (49%)
S72335C,"Nondisplaced oblique fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (42%)
S72336A,"Nondisplaced oblique fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S12001A (57%); S12201A (57%); S12091A (54%); S12291A (54%); S12121A (50%)
S72336B,"Nondisplaced oblique fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (59%); S12112A (52%); S12001B (51%); S12201B (51%); S02111B (50%)
S72336C,"Nondisplaced oblique fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (46%); S12201B (46%); S12091B (44%); S12291B (44%); S12112B (42%)
S72341A,"Displaced spiral fracture of shaft of right femur, initial encounter for closed fracture",402,S12090A (53%); S12290A (53%); S12000A (52%); S12200A (52%); S12120A (49%)
S72341B,"Displaced spiral fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S12110B (53%); S12111B (53%); S0211CB (51%); S12090B (48%); S12290B (48%)
S72341C,"Displaced spiral fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (43%); S12290B (43%); S12000B (43%); S12200B (43%); S3214XB (40%)
S72342A,"Displaced spiral fracture of shaft of left femur, initial encounter for closed fracture",402,S12090A (53%); S12290A (53%); S12000A (52%); S12200A (52%); S12120A (49%)
S72342B,"Displaced spiral fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S12110B (53%); S12111B (53%); S0211DB (51%); S12090B (48%); S12290B (48%)
S72342C,"Displaced spiral fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (43%); S12290B (43%); S12000B (43%); S12200B (43%); S3214XB (40%)
S72343A,"Displaced spiral fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S12000A (56%); S12200A (56%); S12090A (54%); S12290A (54%); S12120A (50%)
S72343B,"Displaced spiral fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (54%); S12111B (53%); S12000B (51%); S12200B (51%); S02111B (50%)
S72343C,"Displaced spiral fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (46%); S12200B (46%); S12090B (44%); S12290B (44%); S3214XB (41%)
S72344A,"Nondisplaced spiral fracture of shaft of right femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (52%); S12201A (52%); S12121A (50%)
S72344B,"Nondisplaced spiral fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211CB (51%); S32120B (50%); S12091B (49%)
S72344C,"Nondisplaced spiral fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (41%)
S72345A,"Nondisplaced spiral fracture of shaft of left femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (52%); S12201A (52%); S12121A (50%)
S72345B,"Nondisplaced spiral fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211DB (51%); S32120B (50%); S12091B (49%)
S72345C,"Nondisplaced spiral fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (41%)
S72346A,"Nondisplaced spiral fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S12001A (56%); S12201A (56%); S12091A (54%); S12291A (54%); S12121A (50%)
S72346B,"Nondisplaced spiral fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (59%); S12112A (52%); S12001B (51%); S12201B (51%); S02111B (50%)
S72346C,"Nondisplaced spiral fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (46%); S12201B (46%); S12091B (44%); S12291B (44%); S12112B (42%)
S72351A,"Displaced comminuted fracture of shaft of right femur, initial encounter for closed fracture",402,S12090A (53%); S12290A (53%); S12000A (52%); S12200A (52%); S12120A (49%)
S72351B,"Displaced comminuted fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S12110B (53%); S12111B (53%); S0211CB (51%); S12090B (48%); S12290B (48%)
S72351C,"Displaced comminuted fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (43%); S12290B (43%); S12000B (43%); S12200B (43%); S3214XB (40%)
S72352A,"Displaced comminuted fracture of shaft of left femur, initial encounter for closed fracture",402,S12090A (53%); S12290A (53%); S12000A (52%); S12200A (52%); S12120A (49%)
S72352B,"Displaced comminuted fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S12110B (53%); S12111B (53%); S0211DB (51%); S12090B (48%); S12290B (48%)
S72352C,"Displaced comminuted fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (43%); S12290B (43%); S12000B (43%); S12200B (43%); S3214XB (40%)
S72353A,"Displaced comminuted fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S12000A (56%); S12200A (56%); S12090A (54%); S12290A (54%); S12120A (50%)
S72353B,"Displaced comminuted fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (54%); S12111B (53%); S12000B (51%); S12200B (51%); S02111B (50%)
S72353C,"Displaced comminuted fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (46%); S12200B (46%); S12090B (44%); S12290B (44%); S3214XB (41%)
S72354A,"Nondisplaced comminuted fracture of shaft of right femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (52%); S12201A (52%); S12121A (50%)
S72354B,"Nondisplaced comminuted fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211CB (51%); S32120B (50%); S12091B (49%)
S72354C,"Nondisplaced comminuted fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (41%)
S72355A,"Nondisplaced comminuted fracture of shaft of left femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (52%); S12201A (52%); S12121A (50%)
S72355B,"Nondisplaced comminuted fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211DB (51%); S32120B (50%); S12091B (49%)
S72355C,"Nondisplaced comminuted fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (41%)
S72356A,"Nondisplaced comminuted fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S12001A (56%); S12201A (56%); S12091A (54%); S12291A (54%); S12121A (50%)
S72356B,"Nondisplaced comminuted fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (59%); S12112A (52%); S12001B (51%); S12201B (51%); S02111B (50%)
S72356C,"Nondisplaced comminuted fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (46%); S12201B (46%); S12091B (44%); S12291B (44%); S12112B (42%)
S72361A,"Displaced segmental fracture of shaft of right femur, initial encounter for closed fracture",402,S12090A (53%); S12290A (53%); S12000A (52%); S12200A (52%); S12120A (49%)
S72361B,"Displaced segmental fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S12110B (53%); S12111B (53%); S0211CB (51%); S12090B (48%); S12290B (48%)
S72361C,"Displaced segmental fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (43%); S12290B (43%); S12000B (43%); S12200B (43%); S3214XB (40%)
S72362A,"Displaced segmental fracture of shaft of left femur, initial encounter for closed fracture",402,S12090A (53%); S12290A (53%); S12000A (52%); S12200A (52%); S12120A (49%)
S72362B,"Displaced segmental fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S12110B (53%); S12111B (53%); S0211DB (51%); S12090B (48%); S12290B (48%)
S72362C,"Displaced segmental fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (43%); S12290B (43%); S12000B (43%); S12200B (43%); S3214XB (40%)
S72363A,"Displaced segmental fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S12000A (56%); S12200A (56%); S12090A (54%); S12290A (54%); S12120A (50%)
S72363B,"Displaced segmental fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (54%); S12111B (53%); S12000B (51%); S12200B (51%); S02111B (50%)
S72363C,"Displaced segmental fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (46%); S12200B (46%); S12090B (44%); S12290B (44%); S3214XB (41%)
S72364A,"Nondisplaced segmental fracture of shaft of right femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (52%); S12201A (52%); S12121A (50%)
S72364B,"Nondisplaced segmental fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211CB (51%); S32120B (50%); S12091B (49%)
S72364C,"Nondisplaced segmental fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (41%)
S72365A,"Nondisplaced segmental fracture of shaft of left femur, initial encounter for closed fracture",402,S12091A (54%); S12291A (54%); S12001A (52%); S12201A (52%); S12121A (50%)
S72365B,"Nondisplaced segmental fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S12112B (58%); S12112A (51%); S0211DB (51%); S32120B (50%); S12091B (49%)
S72365C,"Nondisplaced segmental fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (44%); S12291B (44%); S12001B (43%); S12201B (43%); S12112B (41%)
S72366A,"Nondisplaced segmental fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S12001A (56%); S12201A (56%); S12091A (54%); S12291A (54%); S12121A (50%)
S72366B,"Nondisplaced segmental fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (59%); S12112A (52%); S12001B (51%); S12201B (51%); S02111B (50%)
S72366C,"Nondisplaced segmental fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (46%); S12201B (46%); S12091B (44%); S12291B (44%); S12112B (42%)
S72391A,"Other fracture of shaft of right femur, initial encounter for closed fracture",402,S0211GA (57%); S0240CA (56%); S3219XA (56%); S02609A (56%); S0240AA (56%)
S72391B,"Other fracture of shaft of right femur, initial encounter for open fracture type I or II",402,S0211CB (62%); S12112B (59%); S02111B (57%); S0211DB (57%); S02412B (55%)
S72391C,"Other fracture of shaft of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (47%); S3215XB (47%); S3216XB (47%); S3217XB (47%); S0211AB (44%)
S72392A,"Other fracture of shaft of left femur, initial encounter for closed fracture",402,S0211HA (57%); S0240DA (56%); S3219XA (56%); S02609A (56%); S0240BA (56%)
S72392B,"Other fracture of shaft of left femur, initial encounter for open fracture type I or II",402,S0211DB (62%); S12112B (59%); S02111B (57%); S0211CB (57%); S02412B (55%)
S72392C,"Other fracture of shaft of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (47%); S3215XB (47%); S3216XB (47%); S3217XB (47%); S0211BB (44%)
S72399A,"Other fracture of shaft of unspecified femur, initial encounter for closed fracture",402,S02609A (61%); S3210XA (60%); S22009A (60%); S32009A (59%); S22008A (59%)
S72399B,"Other fracture of shaft of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (61%); S12112B (60%); S0211DB (58%); S0211CB (58%); S02412B (56%)
S72399C,"Other fracture of shaft of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (48%); S3215XB (48%); S3216XB (48%); S3217XB (48%); S02609B (45%)
S72401A,"Unspecified fracture of lower end of right femur, initial encounter for closed fracture",402,S02609A (56%); S3210XA (55%); S02601A (54%); S22009A (54%); S32009A (54%)
S72401B,"Unspecified fracture of lower end of right femur, initial encounter for open fracture type I or II",402,S0211CB (58%); S02111B (57%); S12112B (55%); S0211DB (53%); S02412B (52%)
S72401C,"Unspecified fracture of lower end of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (45%); S3215XB (45%); S3216XB (45%); S3217XB (45%); S02609B (43%)
S72402A,"Unspecified fracture of lower end of left femur, initial encounter for closed fracture",402,S02609A (56%); S3210XA (55%); S02602A (54%); S22009A (54%); S32009A (54%)
S72402B,"Unspecified fracture of lower end of left femur, initial encounter for open fracture type I or II",402,S0211DB (58%); S02111B (57%); S12112B (55%); S0211CB (53%); S02412B (52%)
S72402C,"Unspecified fracture of lower end of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (45%); S3215XB (45%); S3216XB (45%); S3217XB (45%); S02609B (43%)
S72409A,"Unspecified fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S22009A (60%); S32009A (60%); S02609A (58%); S3210XA (57%); S22008A (56%)
S72409B,"Unspecified fracture of lower end of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (58%); S12112B (54%); S22009B (53%); S32009B (53%); S32129B (53%)
S72409C,"Unspecified fracture of lower end of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S22009B (47%); S32009B (46%); S02609B (45%); S3210XB (44%); S3214XB (44%)
S72411A,"Displaced unspecified condyle fracture of lower end of right femur, initial encounter for closed fracture",402,S02113A (59%); S0211AA (59%); S02110A (57%); S12000A (55%); S12200A (55%)
S72411B,"Displaced unspecified condyle fracture of lower end of right femur, initial encounter for open fracture type I or II",402,S0211CB (67%); S02111B (66%); S0211DB (63%); S0211CA (61%); S0211AB (60%)
S72411C,"Displaced unspecified condyle fracture of lower end of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211AB (54%); S02110B (52%); S0211CB (50%); S0211BB (49%); S02111B (49%)
S72412A,"Displaced unspecified condyle fracture of lower end of left femur, initial encounter for closed fracture",402,S02113A (60%); S0211BA (59%); S02110A (57%); S12000A (55%); S12200A (55%)
S72412B,"Displaced unspecified condyle fracture of lower end of left femur, initial encounter for open fracture type I or II",402,S0211DB (67%); S02111B (66%); S0211CB (63%); S0211DA (61%); S0211BB (60%)
S72412C,"Displaced unspecified condyle fracture of lower end of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211BB (54%); S02110B (52%); S0211DB (50%); S0211AB (49%); S02111B (49%)
S72413A,"Displaced unspecified condyle fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S02113A (62%); S02110A (59%); S12000A (58%); S12200A (58%); S02111A (55%)
S72413B,"Displaced unspecified condyle fracture of lower end of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (68%); S0211DB (62%); S0211CB (62%); S02111A (61%); S02110B (60%)
S72413C,"Displaced unspecified condyle fracture of lower end of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S02110B (54%); S02111B (51%); S02113B (51%); S0211BB (49%); S0211AB (49%)
S72414A,"Nondisplaced unspecified condyle fracture of lower end of right femur, initial encounter for closed fracture",402,S02113A (59%); S0211AA (59%); S02110A (57%); S12001A (55%); S12201A (55%)
S72414B,"Nondisplaced unspecified condyle fracture of lower end of right femur, initial encounter for open fracture type I or II",402,S0211CB (67%); S02111B (66%); S0211DB (63%); S0211CA (61%); S0211AB (60%)
S72414C,"Nondisplaced unspecified condyle fracture of lower end of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211AB (54%); S02110B (52%); S0211CB (50%); S0211BB (49%); S02111B (49%)
S72415A,"Nondisplaced unspecified condyle fracture of lower end of left femur, initial encounter for closed fracture",402,S02113A (59%); S0211BA (59%); S02110A (57%); S12001A (55%); S12201A (55%)
S72415B,"Nondisplaced unspecified condyle fracture of lower end of left femur, initial encounter for open fracture type I or II",402,S0211DB (67%); S02111B (66%); S0211CB (63%); S0211DA (61%); S0211BB (60%)
S72415C,"Nondisplaced unspecified condyle fracture of lower end of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211BB (54%); S02110B (52%); S0211DB (50%); S0211AB (49%); S02111B (49%)
S72416A,"Nondisplaced unspecified condyle fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S02113A (61%); S02110A (59%); S12001A (58%); S12201A (58%); S02111A (55%)
S72416B,"Nondisplaced unspecified condyle fracture of lower end of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (68%); S0211DB (62%); S0211CB (62%); S02111A (61%); S02110B (60%)
S72416C,"Nondisplaced unspecified condyle fracture of lower end of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S02110B (54%); S02111B (51%); S02113B (51%); S0211BB (49%); S0211AB (49%)
S72421A,"Displaced fracture of lateral condyle of right femur, initial encounter for closed fracture",402,S12040A (61%); S0211AA (60%); S02841A (60%); S02113A (58%); S0211CA (56%)
S72421B,"Displaced fracture of lateral condyle of right femur, initial encounter for open fracture type I or II",402,S0211CB (68%); S02111B (65%); S0211DB (64%); S0211CA (62%); S0211AB (61%)
S72421C,"Displaced fracture of lateral condyle of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211AB (54%); S0211CB (51%); S02110B (51%); S0211BB (50%); S12040B (49%)
S72422A,"Displaced fracture of lateral condyle of left femur, initial encounter for closed fracture",402,S12040A (61%); S0211BA (60%); S02842A (60%); S02113A (58%); S0211DA (56%)
S72422B,"Displaced fracture of lateral condyle of left femur, initial encounter for open fracture type I or II",402,S0211DB (68%); S02111B (65%); S0211CB (64%); S0211DA (62%); S0211BB (61%)
S72422C,"Displaced fracture of lateral condyle of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211BB (54%); S0211DB (51%); S02110B (51%); S0211AB (50%); S12040B (50%)
S72423A,"Displaced fracture of lateral condyle of unspecified femur, initial encounter for closed fracture",402,S12040A (62%); S02113A (61%); S02849A (59%); S02110A (59%); S12000A (57%)
S72423B,"Displaced fracture of lateral condyle of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (68%); S0211DB (65%); S0211CB (65%); S02111A (61%); S02110B (60%)
S72423C,"Displaced fracture of lateral condyle of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S02110B (54%); S0211BB (50%); S0211AB (50%); S02111B (50%); S12040B (50%)
S72424A,"Nondisplaced fracture of lateral condyle of right femur, initial encounter for closed fracture",402,S12041A (61%); S0211AA (60%); S02841A (60%); S02113A (58%); S0211CA (56%)
S72424B,"Nondisplaced fracture of lateral condyle of right femur, initial encounter for open fracture type I or II",402,S0211CB (68%); S02111B (65%); S0211DB (64%); S0211CA (62%); S0211AB (61%)
S72424C,"Nondisplaced fracture of lateral condyle of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211AB (54%); S0211CB (51%); S02110B (51%); S0211BB (50%); S12041B (50%)
S72425A,"Nondisplaced fracture of lateral condyle of left femur, initial encounter for closed fracture",402,S12041A (61%); S0211BA (60%); S02842A (60%); S02113A (58%); S0211DA (56%)
S72425B,"Nondisplaced fracture of lateral condyle of left femur, initial encounter for open fracture type I or II",402,S0211DB (68%); S02111B (65%); S0211CB (64%); S0211DA (62%); S0211BB (61%)
S72425C,"Nondisplaced fracture of lateral condyle of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211BB (54%); S0211DB (51%); S02110B (51%); S0211AB (50%); S12041B (50%)
S72426A,"Nondisplaced fracture of lateral condyle of unspecified femur, initial encounter for closed fracture",402,S12041A (62%); S02113A (61%); S02849A (59%); S02110A (59%); S12001A (57%)
S72426B,"Nondisplaced fracture of lateral condyle of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (68%); S0211DB (65%); S0211CB (64%); S02111A (61%); S02110B (60%)
S72426C,"Nondisplaced fracture of lateral condyle of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S02110B (54%); S0211BB (50%); S0211AB (50%); S02111B (50%); S12041B (50%)
S72431A,"Displaced fracture of medial condyle of right femur, initial encounter for closed fracture",402,S0211AA (60%); S02831A (60%); S02113A (58%); S0211CA (56%); S02839A (55%)
S72431B,"Displaced fracture of medial condyle of right femur, initial encounter for open fracture type I or II",402,S0211CB (69%); S02111B (65%); S0211DB (64%); S0211CA (62%); S0211AB (61%)
S72431C,"Displaced fracture of medial condyle of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211AB (54%); S0211CB (51%); S02110B (51%); S0211BB (50%); S0211EB (49%)
S72432A,"Displaced fracture of medial condyle of left femur, initial encounter for closed fracture",402,S0211BA (60%); S02832A (60%); S02113A (58%); S0211DA (56%); S02839A (56%)
S72432B,"Displaced fracture of medial condyle of left femur, initial encounter for open fracture type I or II",402,S0211DB (69%); S02111B (65%); S0211CB (64%); S0211DA (62%); S0211BB (61%)
S72432C,"Displaced fracture of medial condyle of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211BB (54%); S0211DB (51%); S02110B (51%); S0211AB (50%); S0211FB (49%)
S72433A,"Displaced fracture of medial condyle of unspecified femur, initial encounter for closed fracture",402,S02113A (61%); S02110A (59%); S02839A (59%); S12000A (57%); S12200A (57%)
S72433B,"Displaced fracture of medial condyle of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (68%); S0211DB (65%); S0211CB (65%); S02111A (61%); S02110B (60%)
S72433C,"Displaced fracture of medial condyle of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S02110B (54%); S0211BB (51%); S0211AB (51%); S02111B (50%); S02113B (50%)
S72434A,"Nondisplaced fracture of medial condyle of right femur, initial encounter for closed fracture",402,S0211AA (60%); S02831A (60%); S02113A (58%); S0211CA (56%); S02839A (55%)
S72434B,"Nondisplaced fracture of medial condyle of right femur, initial encounter for open fracture type I or II",402,S0211CB (69%); S02111B (65%); S0211DB (64%); S0211CA (62%); S0211AB (61%)
S72434C,"Nondisplaced fracture of medial condyle of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211AB (54%); S0211CB (51%); S02110B (51%); S0211BB (50%); S0211EB (49%)
S72435A,"Nondisplaced fracture of medial condyle of left femur, initial encounter for closed fracture",402,S0211BA (60%); S02832A (60%); S02113A (58%); S0211DA (56%); S02839A (55%)
S72435B,"Nondisplaced fracture of medial condyle of left femur, initial encounter for open fracture type I or II",402,S0211DB (68%); S02111B (65%); S0211CB (64%); S0211DA (62%); S0211BB (61%)
S72435C,"Nondisplaced fracture of medial condyle of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S0211BB (54%); S0211DB (51%); S02110B (51%); S0211AB (50%); S0211FB (49%)
S72436A,"Nondisplaced fracture of medial condyle of unspecified femur, initial encounter for closed fracture",402,S02113A (61%); S02110A (59%); S02839A (59%); S12001A (57%); S12201A (57%)
S72436B,"Nondisplaced fracture of medial condyle of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (68%); S0211DB (65%); S0211CB (65%); S02111A (61%); S02110B (60%)
S72436C,"Nondisplaced fracture of medial condyle of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S02110B (54%); S0211BB (51%); S0211AB (51%); S02111B (50%); S02113B (50%)
S72441A,"Displaced fracture of lower epiphysis (separation) of right femur, initial encounter for closed fracture",402,S12090A (51%); S12290A (51%); S12000A (50%); S12200A (50%); S12120A (47%)
S72441B,"Displaced fracture of lower epiphysis (separation) of right femur, initial encounter for open fracture type I or II",402,S12110B (51%); S12111B (51%); S0211CB (49%); S12090B (46%); S12290B (46%)
S72441C,"Displaced fracture of lower epiphysis (separation) of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (42%); S12290B (42%); S12000B (41%); S12200B (41%); S3214XB (39%)
S72442A,"Displaced fracture of lower epiphysis (separation) of left femur, initial encounter for closed fracture",402,S12090A (51%); S12290A (51%); S12000A (50%); S12200A (50%); S12120A (47%)
S72442B,"Displaced fracture of lower epiphysis (separation) of left femur, initial encounter for open fracture type I or II",402,S12110B (51%); S12111B (51%); S0211DB (49%); S12090B (46%); S12290B (46%)
S72442C,"Displaced fracture of lower epiphysis (separation) of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (42%); S12290B (42%); S12000B (41%); S12200B (41%); S3214XB (39%)
S72443A,"Displaced fracture of lower epiphysis (separation) of unspecified femur, initial encounter for closed fracture",402,S12000A (53%); S12200A (53%); S12090A (51%); S12290A (51%); S12120A (47%)
S72443B,"Displaced fracture of lower epiphysis (separation) of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (51%); S12111B (51%); S12000B (49%); S12200B (49%); S02111B (48%)
S72443C,"Displaced fracture of lower epiphysis (separation) of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (44%); S12200B (44%); S12090B (42%); S12290B (42%); S3214XB (39%)
S72444A,"Nondisplaced fracture of lower epiphysis (separation) of right femur, initial encounter for closed fracture",402,S12091A (51%); S12291A (51%); S12001A (50%); S12201A (50%); S12121A (47%)
S72444B,"Nondisplaced fracture of lower epiphysis (separation) of right femur, initial encounter for open fracture type I or II",402,S12112B (56%); S12112A (49%); S0211CB (49%); S32120B (47%); S12091B (46%)
S72444C,"Nondisplaced fracture of lower epiphysis (separation) of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (42%); S12291B (42%); S12001B (41%); S12201B (41%); S12112B (40%)
S72445A,"Nondisplaced fracture of lower epiphysis (separation) of left femur, initial encounter for closed fracture",402,S12091A (51%); S12291A (51%); S12001A (50%); S12201A (50%); S12121A (47%)
S72445B,"Nondisplaced fracture of lower epiphysis (separation) of left femur, initial encounter for open fracture type I or II",402,S12112B (56%); S12112A (49%); S0211DB (49%); S32120B (47%); S12091B (46%)
S72445C,"Nondisplaced fracture of lower epiphysis (separation) of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (42%); S12291B (42%); S12001B (41%); S12201B (41%); S12112B (40%)
S72446A,"Nondisplaced fracture of lower epiphysis (separation) of unspecified femur, initial encounter for closed fracture",402,S12001A (54%); S12201A (54%); S12091A (51%); S12291A (51%); S12121A (48%)
S72446B,"Nondisplaced fracture of lower epiphysis (separation) of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (56%); S12112A (49%); S12001B (49%); S12201B (49%); S02111B (48%)
S72446C,"Nondisplaced fracture of lower epiphysis (separation) of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (44%); S12201B (44%); S12091B (42%); S12291B (42%); S12112B (40%)
S72451A,"Displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture",402,S12090A (44%); S12290A (44%); S12000A (43%); S12200A (43%); S12120A (40%)
S72451B,"Displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for open fracture type I or II",402,S12110B (45%); S12111B (45%); S0211CB (43%); S12090B (41%); S12290B (41%)
S72451C,"Displaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (38%); S12290B (38%); S12000B (37%); S12200B (37%); S3214XB (35%)
S72452A,"Displaced supracondylar fracture without intracondylar extension of lower end of left femur, initial encounter for closed fracture",402,S12090A (44%); S12290A (44%); S12000A (43%); S12200A (43%); S12120A (40%)
S72452B,"Displaced supracondylar fracture without intracondylar extension of lower end of left femur, initial encounter for open fracture type I or II",402,S12110B (45%); S12111B (45%); S0211DB (43%); S12090B (41%); S12290B (41%)
S72452C,"Displaced supracondylar fracture without intracondylar extension of lower end of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (38%); S12290B (38%); S12000B (37%); S12200B (37%); S3214XB (35%)
S72453A,"Displaced supracondylar fracture without intracondylar extension of lower end of unspecified femur, initial encounter for closed fracture",402,S12000A (46%); S12200A (46%); S12090A (44%); S12290A (44%); S12120A (41%)
S72453B,"Displaced supracondylar fracture without intracondylar extension of lower end of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (45%); S12111B (45%); S12000B (43%); S12200B (43%); S02111B (42%)
S72453C,"Displaced supracondylar fracture without intracondylar extension of lower end of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (39%); S12200B (39%); S12090B (38%); S12290B (38%); S3214XB (35%)
S72454A,"Nondisplaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for closed fracture",402,S12091A (44%); S12291A (44%); S12001A (43%); S12201A (43%); S12121A (41%)
S72454B,"Nondisplaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for open fracture type I or II",402,S12112B (49%); S12112A (43%); S0211CB (43%); S32120B (42%); S12091B (41%)
S72454C,"Nondisplaced supracondylar fracture without intracondylar extension of lower end of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (38%); S12291B (38%); S12001B (37%); S12201B (37%); S12112B (36%)
S72455A,"Nondisplaced supracondylar fracture without intracondylar extension of lower end of left femur, initial encounter for closed fracture",402,S12091A (44%); S12291A (44%); S12001A (43%); S12201A (43%); S12121A (41%)
S72455B,"Nondisplaced supracondylar fracture without intracondylar extension of lower end of left femur, initial encounter for open fracture type I or II",402,S12112B (49%); S12112A (43%); S0211DB (43%); S32120B (42%); S12091B (41%)
S72455C,"Nondisplaced supracondylar fracture without intracondylar extension of lower end of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (38%); S12291B (38%); S12001B (37%); S12201B (37%); S12112B (36%)
S72456A,"Nondisplaced supracondylar fracture without intracondylar extension of lower end of unspecified femur, initial encounter for closed fracture",402,S12001A (46%); S12201A (46%); S12091A (44%); S12291A (44%); S12121A (41%)
S72456B,"Nondisplaced supracondylar fracture without intracondylar extension of lower end of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (49%); S12112A (43%); S12001B (43%); S12201B (43%); S02111B (42%)
S72456C,"Nondisplaced supracondylar fracture without intracondylar extension of lower end of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (39%); S12201B (39%); S12091B (38%); S12291B (38%); S12112B (36%)
S72461A,"Displaced supracondylar fracture with intracondylar extension of lower end of right femur, initial encounter for closed fracture",402,S12090A (44%); S12290A (44%); S12000A (43%); S12200A (43%); S12120A (40%)
S72461B,"Displaced supracondylar fracture with intracondylar extension of lower end of right femur, initial encounter for open fracture type I or II",402,S12110B (45%); S12111B (45%); S0211CB (43%); S12090B (41%); S12290B (41%)
S72461C,"Displaced supracondylar fracture with intracondylar extension of lower end of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (38%); S12290B (38%); S12000B (37%); S12200B (37%); S3214XB (35%)
S72462A,"Displaced supracondylar fracture with intracondylar extension of lower end of left femur, initial encounter for closed fracture",402,S12090A (44%); S12290A (44%); S12000A (43%); S12200A (43%); S12120A (40%)
S72462B,"Displaced supracondylar fracture with intracondylar extension of lower end of left femur, initial encounter for open fracture type I or II",402,S12110B (45%); S12111B (45%); S0211DB (43%); S12090B (41%); S12290B (41%)
S72462C,"Displaced supracondylar fracture with intracondylar extension of lower end of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12090B (38%); S12290B (38%); S12000B (37%); S12200B (37%); S3214XB (35%)
S72463A,"Displaced supracondylar fracture with intracondylar extension of lower end of unspecified femur, initial encounter for closed fracture",402,S12000A (46%); S12200A (46%); S12090A (44%); S12290A (44%); S12120A (41%)
S72463B,"Displaced supracondylar fracture with intracondylar extension of lower end of unspecified femur, initial encounter for open fracture type I or II",402,S12110B (45%); S12111B (45%); S12000B (43%); S12200B (43%); S02111B (42%)
S72463C,"Displaced supracondylar fracture with intracondylar extension of lower end of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12000B (39%); S12200B (39%); S12090B (38%); S12290B (38%); S3214XB (35%)
S72464A,"Nondisplaced supracondylar fracture with intracondylar extension of lower end of right femur, initial encounter for closed fracture",402,S12091A (44%); S12291A (44%); S12001A (43%); S12201A (43%); S12121A (41%)
S72464B,"Nondisplaced supracondylar fracture with intracondylar extension of lower end of right femur, initial encounter for open fracture type I or II",402,S12112B (49%); S12112A (43%); S0211CB (43%); S32120B (42%); S12091B (41%)
S72464C,"Nondisplaced supracondylar fracture with intracondylar extension of lower end of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (38%); S12291B (38%); S12001B (37%); S12201B (37%); S12112B (36%)
S72465A,"Nondisplaced supracondylar fracture with intracondylar extension of lower end of left femur, initial encounter for closed fracture",402,S12091A (44%); S12291A (44%); S12001A (43%); S12201A (43%); S12121A (41%)
S72465B,"Nondisplaced supracondylar fracture with intracondylar extension of lower end of left femur, initial encounter for open fracture type I or II",402,S12112B (49%); S12112A (43%); S0211DB (43%); S32120B (42%); S12091B (41%)
S72465C,"Nondisplaced supracondylar fracture with intracondylar extension of lower end of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12091B (38%); S12291B (38%); S12001B (37%); S12201B (37%); S12112B (36%)
S72466A,"Nondisplaced supracondylar fracture with intracondylar extension of lower end of unspecified femur, initial encounter for closed fracture",402,S12001A (46%); S12201A (46%); S12091A (44%); S12291A (44%); S12121A (41%)
S72466B,"Nondisplaced supracondylar fracture with intracondylar extension of lower end of unspecified femur, initial encounter for open fracture type I or II",402,S12112B (49%); S12112A (43%); S12001B (43%); S12201B (43%); S02111B (42%)
S72466C,"Nondisplaced supracondylar fracture with intracondylar extension of lower end of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S12001B (39%); S12201B (39%); S12091B (38%); S12291B (38%); S12112B (36%)
S72471A,"Torus fracture of lower end of right femur, initial encounter for closed fracture",402,S0211GA (42%); S0240CA (42%); S3219XA (42%); S02609A (41%); S0240AA (41%)
S72472A,"Torus fracture of lower end of left femur, initial encounter for closed fracture",402,S0211HA (42%); S0240DA (42%); S3219XA (42%); S02609A (41%); S0240BA (41%)
S72479A,"Torus fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S02609A (45%); S3210XA (44%); S22009A (44%); S32009A (44%); S22008A (43%)
S72491A,"Other fracture of lower end of right femur, initial encounter for closed fracture",402,S0211GA (53%); S0240CA (53%); S3219XA (53%); S02609A (52%); S0240AA (52%)
S72491B,"Other fracture of lower end of right femur, initial encounter for open fracture type I or II",402,S0211CB (59%); S12112B (56%); S02111B (55%); S0211DB (54%); S02412B (53%)
S72491C,"Other fracture of lower end of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (45%); S3215XB (45%); S3216XB (45%); S3217XB (45%); S0211AB (43%)
S72492A,"Other fracture of lower end of left femur, initial encounter for closed fracture",402,S0211HA (53%); S0240DA (53%); S3219XA (53%); S02609A (52%); S0240BA (52%)
S72492B,"Other fracture of lower end of left femur, initial encounter for open fracture type I or II",402,S0211DB (59%); S12112B (56%); S02111B (55%); S0211CB (54%); S02412B (53%)
S72492C,"Other fracture of lower end of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (45%); S3215XB (45%); S3216XB (45%); S3217XB (45%); S0211BB (43%)
S72499A,"Other fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S02609A (57%); S3210XA (57%); S22009A (56%); S32009A (55%); S22008A (55%)
S72499B,"Other fracture of lower end of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (58%); S12112B (57%); S0211DB (55%); S0211CB (55%); S02412B (53%)
S72499C,"Other fracture of lower end of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (46%); S3215XB (46%); S3216XB (46%); S3217XB (46%); S02609B (43%)
S728X1A,"Other fracture of right femur, initial encounter for closed fracture",402,S0211GA (66%); S0240CA (65%); S3219XA (65%); S02609A (65%); S0240AA (65%)
S728X1B,"Other fracture of right femur, initial encounter for open fracture type I or II",402,S0211CB (70%); S12112B (66%); S02111B (64%); S0211DB (64%); S02412B (62%)
S728X1C,"Other fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (51%); S3215XB (51%); S3216XB (51%); S3217XB (51%); S0211AB (48%)
S728X2A,"Other fracture of left femur, initial encounter for closed fracture",402,S0211HA (66%); S0240DA (65%); S3219XA (65%); S02609A (65%); S0240BA (65%)
S728X2B,"Other fracture of left femur, initial encounter for open fracture type I or II",402,S0211DB (70%); S12112B (66%); S02111B (64%); S0211CB (64%); S02412B (62%)
S728X2C,"Other fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (51%); S3215XB (51%); S3216XB (51%); S3217XB (51%); S0211BB (48%)
S728X9A,"Other fracture of unspecified femur, initial encounter for closed fracture",402,S02609A (72%); S3210XA (71%); S22009A (70%); S32009A (69%); S22008A (69%)
S728X9B,"Other fracture of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (69%); S12112B (67%); S0211DB (65%); S0211CB (65%); S02412B (63%)
S728X9C,"Other fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (52%); S3215XB (52%); S3216XB (52%); S3217XB (52%); S02609B (49%)
S7290XA,"Unspecified fracture of unspecified femur, initial encounter for closed fracture",402,S22009A (73%); S32009A (73%); S02609A (71%); S3210XA (70%); S22008A (68%)
S7290XB,"Unspecified fracture of unspecified femur, initial encounter for open fracture type I or II",402,S02111B (68%); S12112B (63%); S22009B (62%); S32009B (62%); S32129B (61%)
S7290XC,"Unspecified fracture of unspecified femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S22009B (52%); S32009B (52%); S02609B (51%); S3210XB (50%); S3214XB (49%)
S7291XA,"Unspecified fracture of right femur, initial encounter for closed fracture",402,S02609A (68%); S3210XA (67%); S02601A (66%); S22009A (66%); S32009A (66%)
S7291XB,"Unspecified fracture of right femur, initial encounter for open fracture type I or II",402,S0211CB (68%); S02111B (66%); S12112B (64%); S0211DB (62%); S02412B (61%)
S7291XC,"Unspecified fracture of right femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (50%); S3215XB (50%); S3216XB (50%); S3217XB (50%); S02609B (48%)
S7292XA,"Unspecified fracture of left femur, initial encounter for closed fracture",402,S02609A (68%); S3210XA (67%); S02602A (66%); S22009A (66%); S32009A (66%)
S7292XB,"Unspecified fracture of left femur, initial encounter for open fracture type I or II",402,S0211DB (68%); S02111B (66%); S12112B (64%); S0211CB (62%); S02412B (61%)
S7292XC,"Unspecified fracture of left femur, initial encounter for open fracture type IIIA, IIIB, or IIIC",402,S3214XB (50%); S3215XB (50%); S3216XB (50%); S3217XB (50%); S02609B (48%)
S73001A,"Unspecified subluxation of right hip, initial encounter",402,M08951 (42%); M08051 (38%); M08851 (37%); S78911A (36%); M08959 (36%)
S73002A,"Unspecified subluxation of left hip, initial encounter",402,M08952 (42%); M08052 (38%); M08852 (37%); S78912A (36%); M08959 (36%)
S73003A,"Unspecified subluxation of unspecified hip, initial encounter",402,M08959 (45%); M08059 (41%); S78919A (39%); M08859 (39%); S78929A (39%)
S73004A,"Unspecified dislocation of right hip, initial encounter",402,M08951 (42%); M08051 (38%); M08851 (37%); S78911A (36%); M08959 (36%)
S73005A,"Unspecified dislocation of left hip, initial encounter",402,M08952 (42%); M08052 (38%); M08852 (37%); S78912A (36%); M08959 (36%)
S73006A,"Unspecified dislocation of unspecified hip, initial encounter",402,M08959 (45%); M08059 (41%); S78919A (39%); M08859 (39%); S78929A (39%)
S73011A,"Posterior subluxation of right hip, initial encounter",402,M08851 (33%); G8383 (33%); M08951 (32%); M06851 (31%); S78111A (30%)
S73012A,"Posterior subluxation of left hip, initial encounter",402,M08852 (33%); G8383 (33%); M08952 (32%); M06852 (31%); S78112A (30%)
S73013A,"Posterior subluxation of unspecified hip, initial encounter",402,G8383 (34%); M08959 (32%); M08859 (30%); M08059 (30%); S78919A (29%)
S73014A,"Posterior dislocation of right hip, initial encounter",402,M08851 (33%); G8383 (33%); M08951 (32%); M06851 (31%); S78111A (30%)
S73015A,"Posterior dislocation of left hip, initial encounter",402,M08852 (33%); G8383 (33%); M08952 (32%); M06852 (31%); S78112A (30%)
S73016A,"Posterior dislocation of unspecified hip, initial encounter",402,G8383 (34%); M08959 (32%); M08859 (30%); M08059 (30%); S78919A (29%)
S73021A,"Obturator subluxation of right hip, initial encounter",402,M08851 (30%); M08951 (29%); M06851 (28%); S78111A (26%); S78011A (26%)
S73022A,"Obturator subluxation of left hip, initial encounter",402,M08852 (29%); M08952 (29%); M06852 (28%); S78112A (26%); S78012A (26%)
S73023A,"Obturator subluxation of unspecified hip, initial encounter",402,M08959 (29%); M08859 (27%); M08059 (26%); S78919A (26%); S78929A (26%)
S73024A,"Obturator dislocation of right hip, initial encounter",402,M08851 (30%); M08951 (29%); M06851 (28%); S78111A (26%); S78011A (26%)
S73025A,"Obturator dislocation of left hip, initial encounter",402,M08852 (29%); M08952 (29%); M06852 (28%); S78112A (26%); S78012A (26%)
S73026A,"Obturator dislocation of unspecified hip, initial encounter",402,M08959 (29%); M08859 (27%); M08059 (26%); S78919A (26%); S78929A (26%)
S73031A,"Other anterior subluxation of right hip, initial encounter",402,M08851 (33%); M08951 (32%); G8382 (32%); M06851 (31%); S78111A (30%)
S73032A,"Other anterior subluxation of left hip, initial encounter",402,M08852 (33%); M08952 (32%); G8382 (32%); M06852 (31%); S78112A (30%)
S73033A,"Other anterior subluxation of unspecified hip, initial encounter",402,M08959 (33%); G8382 (32%); M08859 (31%); M08059 (30%); S78919A (30%)
S73034A,"Other anterior dislocation of right hip, initial encounter",402,M08851 (33%); M08951 (32%); G8382 (32%); M06851 (31%); S78111A (30%)
S73035A,"Other anterior dislocation of left hip, initial encounter",402,M08852 (33%); M08952 (32%); G8382 (32%); M06852 (31%); S78112A (30%)
S73036A,"Other anterior dislocation of unspecified hip, initial encounter",402,M08959 (33%); G8382 (32%); M08859 (31%); M08059 (30%); S78919A (30%)
S73041A,"Central subluxation of right hip, initial encounter",402,M08851 (33%); M08951 (32%); M06851 (31%); S78111A (29%); S78011A (29%)
S73042A,"Central subluxation of left hip, initial encounter",402,M08852 (33%); M08952 (32%); M06852 (31%); S78112A (29%); S78012A (29%)
S73043A,"Central subluxation of unspecified hip, initial encounter",402,C729 (32%); M08959 (32%); S14129A (31%); M08859 (30%); M08059 (29%)
S73044A,"Central dislocation of right hip, initial encounter",402,M08851 (33%); M08951 (32%); M06851 (31%); S78111A (29%); S78011A (29%)
S73045A,"Central dislocation of left hip, initial encounter",402,M08852 (33%); M08952 (32%); M06852 (31%); S78112A (29%); S78012A (29%)
S73046A,"Central dislocation of unspecified hip, initial encounter",402,C729 (32%); M08959 (32%); S14129A (31%); M08859 (30%); M08059 (29%)
S78011A,"Complete traumatic amputation at right hip joint, initial encounter",405,M9701XA (41%); M9702XA (37%); M0080 (35%); M0020 (35%); M0000 (35%)
S78011D,"Complete traumatic amputation at right hip joint, subsequent encounter",,
S78011S,"Complete traumatic amputation at right hip joint, sequela",,
S78012A,"Complete traumatic amputation at left hip joint, initial encounter",405,M9702XA (41%); M9701XA (37%); M0080 (35%); M0020 (35%); M0000 (35%)
S78012D,"Complete traumatic amputation at left hip joint, subsequent encounter",,
S78012S,"Complete traumatic amputation at left hip joint, sequela",,
S78019A,"Complete traumatic amputation at unspecified hip joint, initial encounter",405,M0080 (39%); M0020 (39%); M0000 (39%); M0010 (39%); M9702XA (37%)
S78019D,"Complete traumatic amputation at unspecified hip joint, subsequent encounter",,
S78019S,"Complete traumatic amputation at unspecified hip joint, sequela",,
S78021A,"Partial traumatic amputation at right hip joint, initial encounter",405,M9701XA (40%); M9702XA (36%); M0080 (34%); M0020 (34%); M0000 (34%)
S78021D,"Partial traumatic amputation at right hip joint, subsequent encounter",,
S78021S,"Partial traumatic amputation at right hip joint, sequela",,
S78022A,"Partial traumatic amputation at left hip joint, initial encounter",405,M9702XA (40%); M9701XA (36%); M0080 (34%); M0020 (34%); M0000 (34%)
S78022D,"Partial traumatic amputation at left hip joint, subsequent encounter",,
S78022S,"Partial traumatic amputation at left hip joint, sequela",,
S78029A,"Partial traumatic amputation at unspecified hip joint, initial encounter",405,M0080 (38%); M0020 (38%); M0000 (38%); M0010 (38%); M9702XA (37%)
S78029D,"Partial traumatic amputation at unspecified hip joint, subsequent encounter",,
S78029S,"Partial traumatic amputation at unspecified hip joint, sequela",,
S78111A,"Complete traumatic amputation at level between right hip and knee, initial encounter",405,S14119A (35%); S24119A (34%); S34119A (34%); S73001A (33%); S73004A (33%)
S78111D,"Complete traumatic amputation at level between right hip and knee, subsequent encounter",,
S78111S,"Complete traumatic amputation at level between right hip and knee, sequela",,
S78112A,"Complete traumatic amputation at level between left hip and knee, initial encounter",405,S14119A (35%); S24119A (34%); S34119A (34%); S73002A (33%); S73005A (33%)
S78112D,"Complete traumatic amputation at level between left hip and knee, subsequent encounter",,
S78112S,"Complete traumatic amputation at level between left hip and knee, sequela",,
S78119A,"Complete traumatic amputation at level between unspecified hip and knee, initial encounter",405,S14119A (38%); S24119A (38%); S34119A (37%); S73003A (34%); S73006A (34%)
S78119D,"Complete traumatic amputation at level between unspecified hip and knee, subsequent encounter",,
S78119S,"Complete traumatic amputation at level between unspecified hip and knee, sequela",,
S78121A,"Partial traumatic amputation at level between right hip and knee, initial encounter",405,S73001A (33%); S73004A (33%); M08861 (32%); M08961 (31%); M06861 (30%)
S78121D,"Partial traumatic amputation at level between right hip and knee, subsequent encounter",,
S78121S,"Partial traumatic amputation at level between right hip and knee, sequela",,
S78122A,"Partial traumatic amputation at level between left hip and knee, initial encounter",405,S73002A (33%); S73005A (33%); M08862 (32%); M08962 (31%); M06862 (30%)
S78122D,"Partial traumatic amputation at level between left hip and knee, subsequent encounter",,
S78122S,"Partial traumatic amputation at level between left hip and knee, sequela",,
S78129A,"Partial traumatic amputation at level between unspecified hip and knee, initial encounter",405,S73003A (33%); S73006A (33%); M08969 (31%); S73002A (31%); S73005A (31%)
S78129D,"Partial traumatic amputation at level between unspecified hip and knee, subsequent encounter",,
S78129S,"Partial traumatic amputation at level between unspecified hip and knee, sequela",,
S78911A,"Complete traumatic amputation of right hip and thigh, level unspecified, initial encounter",405,S14119A (37%); S73001A (36%); S73004A (36%); S24119A (36%); S34119A (36%)
S78911D,"Complete traumatic amputation of right hip and thigh, level unspecified, subsequent encounter",,
S78911S,"Complete traumatic amputation of right hip and thigh, level unspecified, sequela",,
S78912A,"Complete traumatic amputation of left hip and thigh, level unspecified, initial encounter",405,S14119A (37%); S73002A (36%); S73005A (36%); S24119A (36%); S34119A (36%)
S78912D,"Complete traumatic amputation of left hip and thigh, level unspecified, subsequent encounter",,
S78912S,"Complete traumatic amputation of left hip and thigh, level unspecified, sequela",,
S78919A,"Complete traumatic amputation of unspecified hip and thigh, level unspecified, initial encounter",405,S14119A (39%); S73003A (39%); S73006A (39%); S24119A (38%); S34119A (38%)
S78919D,"Complete traumatic amputation of unspecified hip and thigh, level unspecified, subsequent encounter",,
S78919S,"Complete traumatic amputation of unspecified hip and thigh, level unspecified, sequela",,
S78921A,"Partial traumatic amputation of right hip and thigh, level unspecified, initial encounter",405,S73001A (36%); S73004A (36%); M86651 (35%); M868X5 (33%); M86659 (32%)
S78921D,"Partial traumatic amputation of right hip and thigh, level unspecified, subsequent encounter",,
S78921S,"Partial traumatic amputation of right hip and thigh, level unspecified, sequela",,
S78922A,"Partial traumatic amputation of left hip and thigh, level unspecified, initial encounter",405,S73002A (36%); S73005A (36%); M86652 (35%); M868X5 (33%); M86659 (32%)
S78922D,"Partial traumatic amputation of left hip and thigh, level unspecified, subsequent encounter",,
S78922S,"Partial traumatic amputation of left hip and thigh, level unspecified, sequela",,
S78929A,"Partial traumatic amputation of unspecified hip and thigh, level unspecified, initial encounter",405,S73003A (39%); S73006A (39%); M86659 (36%); M08959 (35%); S73002A (32%)
S78929D,"Partial traumatic amputation of unspecified hip and thigh, level unspecified, subsequent encounter",,
S78929S,"Partial traumatic amputation of unspecified hip and thigh, level unspecified, sequela",,
S79001A,"Unspecified physeal fracture of upper end of right femur, initial encounter for closed fracture",402,S02609A (47%); S3210XA (46%); S02601A (46%); S22009A (46%); S32009A (45%)
S79002A,"Unspecified physeal fracture of upper end of left femur, initial encounter for closed fracture",402,S02609A (47%); S3210XA (46%); S02602A (46%); S22009A (46%); S32009A (45%)
S79009A,"Unspecified physeal fracture of upper end of unspecified femur, initial encounter for closed fracture",402,S22009A (51%); S32009A (51%); S02609A (50%); S3210XA (49%); S22008A (48%)
S79011A,"Salter-Harris Type I physeal fracture of upper end of right femur, initial encounter for closed fracture",402,S3214XA (39%); S3215XA (39%); S3216XA (39%); S3217XA (39%); S0211AA (36%)
S79012A,"Salter-Harris Type I physeal fracture of upper end of left femur, initial encounter for closed fracture",402,S3214XA (39%); S3215XA (39%); S3216XA (39%); S3217XA (39%); S0211BA (36%)
S79019A,"Salter-Harris Type I physeal fracture of upper end of unspecified femur, initial encounter for closed fracture",402,S3214XA (39%); S3215XA (39%); S3216XA (39%); S3217XA (39%); S02609A (37%)
S79091A,"Other physeal fracture of upper end of right femur, initial encounter for closed fracture",402,S0211GA (45%); S0240CA (44%); S3219XA (44%); S02609A (44%); S0240AA (44%)
S79092A,"Other physeal fracture of upper end of left femur, initial encounter for closed fracture",402,S0211HA (45%); S0240DA (44%); S3219XA (44%); S02609A (44%); S0240BA (44%)
S79099A,"Other physeal fracture of upper end of unspecified femur, initial encounter for closed fracture",402,S02609A (48%); S3210XA (47%); S22009A (47%); S32009A (46%); S22008A (46%)
S79101A,"Unspecified physeal fracture of lower end of right femur, initial encounter for closed fracture",402,S02609A (48%); S3210XA (47%); S02601A (47%); S22009A (47%); S32009A (46%)
S79102A,"Unspecified physeal fracture of lower end of left femur, initial encounter for closed fracture",402,S02609A (48%); S3210XA (47%); S02602A (47%); S22009A (47%); S32009A (46%)
S79109A,"Unspecified physeal fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S22009A (52%); S32009A (52%); S02609A (51%); S3210XA (50%); S22008A (49%)
S79111A,"Salter-Harris Type I physeal fracture of lower end of right femur, initial encounter for closed fracture",402,S3214XA (39%); S3215XA (39%); S3216XA (39%); S3217XA (39%); S0211AA (37%)
S79112A,"Salter-Harris Type I physeal fracture of lower end of left femur, initial encounter for closed fracture",402,S3214XA (39%); S3215XA (39%); S3216XA (39%); S3217XA (39%); S0211BA (37%)
S79119A,"Salter-Harris Type I physeal fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S3214XA (40%); S3215XA (40%); S3216XA (40%); S3217XA (40%); S02609A (38%)
S79121A,"Salter-Harris Type II physeal fracture of lower end of right femur, initial encounter for closed fracture",402,S0211CA (43%); S12112A (40%); S02111A (39%); S0211DA (39%); S02412A (38%)
S79122A,"Salter-Harris Type II physeal fracture of lower end of left femur, initial encounter for closed fracture",402,S0211DA (43%); S12112A (40%); S02111A (39%); S0211CA (39%); S02412A (38%)
S79129A,"Salter-Harris Type II physeal fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S02111A (42%); S12112A (41%); S0211DA (39%); S0211CA (39%); S02412A (38%)
S79131A,"Salter-Harris Type III physeal fracture of lower end of right femur, initial encounter for closed fracture",402,S0211EA (46%); S02112A (43%); S0211FA (43%); S02413A (42%); S0211EB (41%)
S79132A,"Salter-Harris Type III physeal fracture of lower end of left femur, initial encounter for closed fracture",402,S0211FA (46%); S02112A (43%); S0211EA (43%); S02413A (42%); S0211FB (41%)
S79139A,"Salter-Harris Type III physeal fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S02112A (46%); S0211FA (43%); S0211EA (43%); S02413A (43%); S32139A (42%)
S79141A,"Salter-Harris Type IV physeal fracture of lower end of right femur, initial encounter for closed fracture",402,S3214XA (35%); S3215XA (35%); S3216XA (35%); S3217XA (35%); S0211AA (33%)
S79142A,"Salter-Harris Type IV physeal fracture of lower end of left femur, initial encounter for closed fracture",402,S3214XA (35%); S3215XA (35%); S3216XA (35%); S3217XA (35%); S0211BA (33%)
S79149A,"Salter-Harris Type IV physeal fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S3214XA (35%); S3215XA (35%); S3216XA (35%); S3217XA (35%); S02609A (33%)
S79191A,"Other physeal fracture of lower end of right femur, initial encounter for closed fracture",402,S0211GA (46%); S0240CA (45%); S3219XA (45%); S02609A (45%); S0240AA (45%)
S79192A,"Other physeal fracture of lower end of left femur, initial encounter for closed fracture",402,S0211HA (45%); S0240DA (45%); S3219XA (45%); S02609A (45%); S0240BA (45%)
S79199A,"Other physeal fracture of lower end of unspecified femur, initial encounter for closed fracture",402,S02609A (49%); S3210XA (48%); S22009A (48%); S32009A (47%); S22008A (47%)
S88011A,"Complete traumatic amputation at knee level, right lower leg, initial encounter",405,Z89511 (34%); Z89611 (34%); S14119A (34%); M868X6 (34%); S24119A (33%)
S88011D,"Complete traumatic amputation at knee level, right lower leg, subsequent encounter",,
S88011S,"Complete traumatic amputation at knee level, right lower leg, sequela",,
S88012A,"Complete traumatic amputation at knee level, left lower leg, initial encounter",405,Z89512 (34%); Z89612 (34%); S14119A (34%); M868X6 (34%); S24119A (33%)
S88012D,"Complete traumatic amputation at knee level, left lower leg, subsequent encounter",,
S88012S,"Complete traumatic amputation at knee level, left lower leg, sequela",,
S88019A,"Complete traumatic amputation at knee level, unspecified lower leg, initial encounter",405,S14119A (37%); S24119A (36%); S34119A (36%); M868X6 (34%); Z44119 (34%)
S88019D,"Complete traumatic amputation at knee level, unspecified lower leg, subsequent encounter",,
S88019S,"Complete traumatic amputation at knee level, unspecified lower leg, sequela",,
S88021A,"Partial traumatic amputation at knee level, right lower leg, initial encounter",405,Z89511 (34%); Z89611 (34%); M868X6 (33%); Z44129 (32%); I70738 (32%)
S88021D,"Partial traumatic amputation at knee level, right lower leg, subsequent encounter",,
S88021S,"Partial traumatic amputation at knee level, right lower leg, sequela",,
S88022A,"Partial traumatic amputation at knee level, left lower leg, initial encounter",405,Z89512 (34%); Z89612 (34%); M868X6 (33%); Z44129 (32%); I70748 (32%)
S88022D,"Partial traumatic amputation at knee level, left lower leg, subsequent encounter",,
S88022S,"Partial traumatic amputation at knee level, left lower leg, sequela",,
S88029A,"Partial traumatic amputation at knee level, unspecified lower leg, initial encounter",405,Z44129 (35%); M868X6 (34%); Z89519 (32%); Z89619 (32%); M08969 (30%)
S88029D,"Partial traumatic amputation at knee level, unspecified lower leg, subsequent encounter",,
S88029S,"Partial traumatic amputation at knee level, unspecified lower leg, sequela",,
S88111A,"Complete traumatic amputation at level between knee and ankle, right lower leg, initial encounter",405,Z89511 (32%); Z89611 (32%); S14119A (32%); M868X6 (32%); S24119A (31%)
S88111D,"Complete traumatic amputation at level between knee and ankle, right lower leg, subsequent encounter",,
S88111S,"Complete traumatic amputation at level between knee and ankle, right lower leg, sequela",,
S88112A,"Complete traumatic amputation at level between knee and ankle, left lower leg, initial encounter",405,Z89512 (32%); Z89612 (32%); S14119A (32%); M868X6 (32%); S24119A (31%)
S88112D,"Complete traumatic amputation at level between knee and ankle, left lower leg, subsequent encounter",,
S88112S,"Complete traumatic amputation at level between knee and ankle, left lower leg, sequela",,
S88119A,"Complete traumatic amputation at level between knee and ankle, unspecified lower leg, initial encounter",405,S14119A (35%); S24119A (34%); S34119A (34%); M868X6 (32%); Z44119 (32%)
S88119D,"Complete traumatic amputation at level between knee and ankle, unspecified lower leg, subsequent encounter",,
S88119S,"Complete traumatic amputation at level between knee and ankle, unspecified lower leg, sequela",,
S88121A,"Partial traumatic amputation at level between knee and ankle, right lower leg, initial encounter",405,Z89511 (32%); Z89611 (32%); M868X6 (31%); Z44129 (31%); I70738 (30%)
S88121D,"Partial traumatic amputation at level between knee and ankle, right lower leg, subsequent encounter",,
S88121S,"Partial traumatic amputation at level between knee and ankle, right lower leg, sequela",,
S88122A,"Partial traumatic amputation at level between knee and ankle, left lower leg, initial encounter",405,Z89512 (32%); Z89612 (32%); M868X6 (31%); Z44129 (31%); I70748 (30%)
S88122D,"Partial traumatic amputation at level between knee and ankle, left lower leg, subsequent encounter",,
S88122S,"Partial traumatic amputation at level between knee and ankle, left lower leg, sequela",,
S88129A,"Partial traumatic amputation at level between knee and ankle, unspecified lower leg, initial encounter",405,Z44129 (33%); M868X6 (32%); Z89519 (30%); Z89619 (30%); M08969 (29%)
S88129D,"Partial traumatic amputation at level between knee and ankle, unspecified lower leg, subsequent encounter",,
S88129S,"Partial traumatic amputation at level between knee and ankle, unspecified lower leg, sequela",,
S88911A,"Complete traumatic amputation of right lower leg, level unspecified, initial encounter",405,S14119A (40%); S24119A (39%); S34119A (39%); I70338 (37%); I70338 (37%)
S88911D,"Complete traumatic amputation of right lower leg, level unspecified, subsequent encounter",,
S88911S,"Complete traumatic amputation of right lower leg, level unspecified, sequela",,
S88912A,"Complete traumatic amputation of left lower leg, level unspecified, initial encounter",405,S14119A (40%); S24119A (39%); S34119A (39%); I70348 (37%); I70348 (37%)
S88912D,"Complete traumatic amputation of left lower leg, level unspecified, subsequent encounter",,
S88912S,"Complete traumatic amputation of left lower leg, level unspecified, sequela",,
S88919A,"Complete traumatic amputation of unspecified lower leg, level unspecified, initial encounter",405,S14119A (42%); S24119A (41%); S34119A (41%); Z44119 (38%); L97909 (37%)
S88919D,"Complete traumatic amputation of unspecified lower leg, level unspecified, subsequent encounter",,
S88919S,"Complete traumatic amputation of unspecified lower leg, level unspecified, sequela",,
S88921A,"Partial traumatic amputation of right lower leg, level unspecified, initial encounter",405,Z44129 (37%); I70338 (37%); I70338 (37%); M868X6 (36%); I70738 (35%)
S88921D,"Partial traumatic amputation of right lower leg, level unspecified, subsequent encounter",,
S88921S,"Partial traumatic amputation of right lower leg, level unspecified, sequela",,
S88922A,"Partial traumatic amputation of left lower leg, level unspecified, initial encounter",405,Z44129 (37%); I70348 (37%); I70348 (37%); M868X6 (36%); I70748 (35%)
S88922D,"Partial traumatic amputation of left lower leg, level unspecified, subsequent encounter",,
S88922S,"Partial traumatic amputation of left lower leg, level unspecified, sequela",,
S88929A,"Partial traumatic amputation of unspecified lower leg, level unspecified, initial encounter",405,Z44129 (39%); L97909 (37%); M868X6 (35%); I70348 (34%); I70348 (34%)
S88929D,"Partial traumatic amputation of unspecified lower leg, level unspecified, subsequent encounter",,
S88929S,"Partial traumatic amputation of unspecified lower leg, level unspecified, sequela",,
S98011A,"Complete traumatic amputation of right foot at ankle level, initial encounter",405,M86671 (44%); M08871 (43%); M868X7 (43%); M86171 (43%); M08971 (42%)
S98011D,"Complete traumatic amputation of right foot at ankle level, subsequent encounter",,
S98011S,"Complete traumatic amputation of right foot at ankle level, sequela",,
S98012A,"Complete traumatic amputation of left foot at ankle level, initial encounter",405,M86672 (44%); M08872 (43%); M868X7 (43%); M86172 (43%); M08972 (42%)
S98012D,"Complete traumatic amputation of left foot at ankle level, subsequent encounter",,
S98012S,"Complete traumatic amputation of left foot at ankle level, sequela",,
S98019A,"Complete traumatic amputation of unspecified foot at ankle level, initial encounter",405,M868X7 (43%); M86679 (42%); M08979 (42%); M08879 (42%); M86179 (41%)
S98019D,"Complete traumatic amputation of unspecified foot at ankle level, subsequent encounter",,
S98019S,"Complete traumatic amputation of unspecified foot at ankle level, sequela",,
S98021A,"Partial traumatic amputation of right foot at ankle level, initial encounter",405,M86671 (44%); M08871 (43%); M868X7 (42%); M86171 (42%); M08971 (42%)
S98021D,"Partial traumatic amputation of right foot at ankle level, subsequent encounter",,
S98021S,"Partial traumatic amputation of right foot at ankle level, sequela",,
S98022A,"Partial traumatic amputation of left foot at ankle level, initial encounter",405,M86672 (44%); M08872 (43%); M868X7 (42%); M86172 (42%); M08972 (42%)
S98022D,"Partial traumatic amputation of left foot at ankle level, subsequent encounter",,
S98022S,"Partial traumatic amputation of left foot at ankle level, sequela",,
S98029A,"Partial traumatic amputation of unspecified foot at ankle level, initial encounter",405,M868X7 (43%); M86679 (42%); M08979 (42%); M08879 (41%); M86179 (40%)
S98029D,"Partial traumatic amputation of unspecified foot at ankle level, subsequent encounter",,
S98029S,"Partial traumatic amputation of unspecified foot at ankle level, sequela",,
S98111A,"Complete traumatic amputation of right great toe, initial encounter",,
S98111D,"Complete traumatic amputation of right great toe, subsequent encounter",,
S98111S,"Complete traumatic amputation of right great toe, sequela",,
S98112A,"Complete traumatic amputation of left great toe, initial encounter",,
S98112D,"Complete traumatic amputation of left great toe, subsequent encounter",,
S98112S,"Complete traumatic amputation of left great toe, sequela",,
S98119A,"Complete traumatic amputation of unspecified great toe, initial encounter",,
S98119D,"Complete traumatic amputation of unspecified great toe, subsequent encounter",,
S98119S,"Complete traumatic amputation of unspecified great toe, sequela",,
S98121A,"Partial traumatic amputation of right great toe, initial encounter",,
S98121D,"Partial traumatic amputation of right great toe, subsequent encounter",,
S98121S,"Partial traumatic amputation of right great toe, sequela",,
S98122A,"Partial traumatic amputation of left great toe, initial encounter",,
S98122D,"Partial traumatic amputation of left great toe, subsequent encounter",,
S98122S,"Partial traumatic amputation of left great toe, sequela",,
S98129A,"Partial traumatic amputation of unspecified great toe, initial encounter",,
S98129D,"Partial traumatic amputation of unspecified great toe, subsequent encounter",,
S98129S,"Partial traumatic amputation of unspecified great toe, sequela",,
S98131A,"Complete traumatic amputation of one right lesser toe, initial encounter",,
S98131D,"Complete traumatic amputation of one right lesser toe, subsequent encounter",,
S98131S,"Complete traumatic amputation of one right lesser toe, sequela",,
S98132A,"Complete traumatic amputation of one left lesser toe, initial encounter",,
S98132D,"Complete traumatic amputation of one left lesser toe, subsequent encounter",,
S98132S,"Complete traumatic amputation of one left lesser toe, sequela",,
S98139A,"Complete traumatic amputation of one unspecified lesser toe, initial encounter",,
S98139D,"Complete traumatic amputation of one unspecified lesser toe, subsequent encounter",,
S98139S,"Complete traumatic amputation of one unspecified lesser toe, sequela",,
S98141A,"Partial traumatic amputation of one right lesser toe, initial encounter",,
S98141D,"Partial traumatic amputation of one right lesser toe, subsequent encounter",,
S98141S,"Partial traumatic amputation of one right lesser toe, sequela",,
S98142A,"Partial traumatic amputation of one left lesser toe, initial encounter",,
S98142D,"Partial traumatic amputation of one left lesser toe, subsequent encounter",,
S98142S,"Partial traumatic amputation of one left lesser toe, sequela",,
S98149A,"Partial traumatic amputation of one unspecified lesser toe, initial encounter",,
S98149D,"Partial traumatic amputation of one unspecified lesser toe, subsequent encounter",,
S98149S,"Partial traumatic amputation of one unspecified lesser toe, sequela",,
S98211A,"Complete traumatic amputation of two or more right lesser toes, initial encounter",,
S98211D,"Complete traumatic amputation of two or more right lesser toes, subsequent encounter",,
S98211S,"Complete traumatic amputation of two or more right lesser toes, sequela",,
S98212A,"Complete traumatic amputation of two or more left lesser toes, initial encounter",,
S98212D,"Complete traumatic amputation of two or more left lesser toes, subsequent encounter",,
S98212S,"Complete traumatic amputation of two or more left lesser toes, sequela",,
S98219A,"Complete traumatic amputation of two or more unspecified lesser toes, initial encounter",,
S98219D,"Complete traumatic amputation of two or more unspecified lesser toes, subsequent encounter",,
S98219S,"Complete traumatic amputation of two or more unspecified lesser toes, sequela",,
S98221A,"Partial traumatic amputation of two or more right lesser toes, initial encounter",,
S98221D,"Partial traumatic amputation of two or more right lesser toes, subsequent encounter",,
S98221S,"Partial traumatic amputation of two or more right lesser toes, sequela",,
S98222A,"Partial traumatic amputation of two or more left lesser toes, initial encounter",,
S98222D,"Partial traumatic amputation of two or more left lesser toes, subsequent encounter",,
S98222S,"Partial traumatic amputation of two or more left lesser toes, sequela",,
S98229A,"Partial traumatic amputation of two or more unspecified lesser toes, initial encounter",,
S98229D,"Partial traumatic amputation of two or more unspecified lesser toes, subsequent encounter",,
S98229S,"Partial traumatic amputation of two or more unspecified lesser toes, sequela",,
S98311A,"Complete traumatic amputation of right midfoot, initial encounter",405,S06340A (29%); T794XXA (28%); L97419 (28%); T791XXA (27%); I70734 (27%)
S98311D,"Complete traumatic amputation of right midfoot, subsequent encounter",,
S98311S,"Complete traumatic amputation of right midfoot, sequela",,
S98312A,"Complete traumatic amputation of left midfoot, initial encounter",405,S06350A (29%); T794XXA (28%); L97429 (28%); T791XXA (27%); I70744 (27%)
S98312D,"Complete traumatic amputation of left midfoot, subsequent encounter",,
S98312S,"Complete traumatic amputation of left midfoot, sequela",,
S98319A,"Complete traumatic amputation of unspecified midfoot, initial encounter",405,S14119A (31%); S24119A (30%); S34119A (30%); T794XXA (29%); L97409 (28%)
S98319D,"Complete traumatic amputation of unspecified midfoot, subsequent encounter",,
S98319S,"Complete traumatic amputation of unspecified midfoot, sequela",,
S98321A,"Partial traumatic amputation of right midfoot, initial encounter",405,S06340A (28%); T794XXA (28%); L97419 (27%); T791XXA (27%); I70734 (27%)
S98321D,"Partial traumatic amputation of right midfoot, subsequent encounter",,
S98321S,"Partial traumatic amputation of right midfoot, sequela",,
S98322A,"Partial traumatic amputation of left midfoot, initial encounter",405,S06350A (28%); T794XXA (28%); L97429 (27%); T791XXA (27%); I70744 (26%)
S98322D,"Partial traumatic amputation of left midfoot, subsequent encounter",,
S98322S,"Partial traumatic amputation of left midfoot, sequela",,
S98329A,"Partial traumatic amputation of unspecified midfoot, initial encounter",405,T794XXA (28%); L97409 (28%); T791XXA (27%); S06360A (27%); S12230B (26%)
S98329D,"Partial traumatic amputation of unspecified midfoot, subsequent encounter",,
S98329S,"Partial traumatic amputation of unspecified midfoot, sequela",,
S98911A,"Complete traumatic amputation of right foot, level unspecified, initial encounter",405,S14119A (41%); S24119A (40%); S34119A (40%); S14119D (35%); M87874 (35%)
S98911D,"Complete traumatic amputation of right foot, level unspecified, subsequent encounter",,
S98911S,"Complete traumatic amputation of right foot, level unspecified, sequela",,
S98912A,"Complete traumatic amputation of left foot, level unspecified, initial encounter",405,S14119A (41%); S24119A (40%); S34119A (40%); S14119D (35%); M87875 (35%)
S98912D,"Complete traumatic amputation of left foot, level unspecified, subsequent encounter",,
S98912S,"Complete traumatic amputation of left foot, level unspecified, sequela",,
S98919A,"Complete traumatic amputation of unspecified foot, level unspecified, initial encounter",405,S14119A (44%); S24119A (43%); S34119A (43%); S14119D (37%); M87876 (36%)
S98919D,"Complete traumatic amputation of unspecified foot, level unspecified, subsequent encounter",,
S98919S,"Complete traumatic amputation of unspecified foot, level unspecified, sequela",,
S98921A,"Partial traumatic amputation of right foot, level unspecified, initial encounter",405,M87874 (34%); M87876 (31%); M08971 (30%); M87374 (28%); S06340A (27%)
S98921D,"Partial traumatic amputation of right foot, level unspecified, subsequent encounter",,
S98921S,"Partial traumatic amputation of right foot, level unspecified, sequela",,
S98922A,"Partial traumatic amputation of left foot, level unspecified, initial encounter",405,M87875 (34%); M87876 (31%); M08972 (30%); M87375 (28%); S06350A (27%)
S98922D,"Partial traumatic amputation of left foot, level unspecified, subsequent encounter",,
S98922S,"Partial traumatic amputation of left foot, level unspecified, sequela",,
S98929A,"Partial traumatic amputation of unspecified foot, level unspecified, initial encounter",405,M87876 (36%); S14109A (34%); M08979 (33%); S24109A (33%); S34109A (33%)
S98929D,"Partial traumatic amputation of unspecified foot, level unspecified, subsequent encounter",,
S98929S,"Partial traumatic amputation of unspecified foot, level unspecified, sequela",,
T1491XA,"Suicide attempt, initial encounter",155,S129XXA (11%); S728X9A (9%); S728X2A (9%); S728X1A (9%); S7292XA (8%)
T1491XD,"Suicide attempt, subsequent encounter",,
T1491XS,"Suicide attempt, sequela",,
T3111,Burns involving 10-19% of body surface with 10-19% third degree burns,385,C754 (10%); C162 (10%); C251 (9%); C602 (9%); C6940 (9%)
T3121,Burns involving 20-29% of body surface with 10-19% third degree burns,385,C754 (13%); C162 (12%); C251 (11%); C602 (11%); C6940 (11%)
T3122,Burns involving 20-29% of body surface with 20-29% third degree burns,385,C754 (10%); C162 (10%); C251 (9%); C602 (9%); C6940 (9%)
T3131,Burns involving 30-39% of body surface with 10-19% third degree burns,385,S061X1A (13%); S069X1A (13%); C754 (13%); S066X1A (13%); S06891A (13%)
T3132,Burns involving 30-39% of body surface with 20-29% third degree burns,385,S061X1A (13%); S069X1A (13%); C754 (13%); S066X1A (13%); S06891A (13%)
T3133,Burns involving 30-39% of body surface with 30-39% third degree burns,385,S061X1A (22%); S069X1A (22%); S066X1A (22%); S06891A (22%); S064X1A (22%)
T3141,Burns involving 40-49% of body surface with 10-19% third degree burns,385,Z6841 (17%); Z6842 (17%); C754 (13%); C162 (12%); C251 (11%)
T3142,Burns involving 40-49% of body surface with 20-29% third degree burns,385,Z6841 (17%); Z6842 (17%); C754 (13%); C162 (12%); C251 (11%)
T3143,Burns involving 40-49% of body surface with 30-39% third degree burns,385,Z6841 (17%); Z6842 (17%); S061X1A (13%); S069X1A (13%); C754 (13%)
T3144,Burns involving 40-49% of body surface with 40-49% third degree burns,385,Z6841 (24%); Z6842 (24%); C754 (11%); C162 (10%); C251 (10%)
T3151,Burns involving 50-59% of body surface with 10-19% third degree burns,385,Z6843 (27%); C754 (13%); C162 (12%); C251 (12%); C602 (11%)
T3152,Burns involving 50-59% of body surface with 20-29% third degree burns,385,Z6843 (27%); C754 (13%); C162 (12%); C251 (12%); C602 (11%)
T3153,Burns involving 50-59% of body surface with 30-39% third degree burns,385,Z6843 (28%); S061X1A (13%); S069X1A (13%); C754 (13%); S066X1A (13%)
T3154,Burns involving 50-59% of body surface with 40-49% third degree burns,385,Z6843 (27%); Z6841 (17%); Z6842 (17%); C754 (13%); C162 (12%)
T3155,Burns involving 50-59% of body surface with 50-59% third degree burns,385,Z6843 (42%); S061X3A (17%); S069X3A (17%); S066X3A (16%); S06893A (16%)
T3161,Burns involving 60-69% of body surface with 10-19% third degree burns,385,Z6844 (30%); C754 (13%); C162 (12%); C251 (11%); C602 (11%)
T3162,Burns involving 60-69% of body surface with 20-29% third degree burns,385,Z6844 (30%); C754 (13%); C162 (12%); C251 (11%); C602 (11%)
T3163,Burns involving 60-69% of body surface with 30-39% third degree burns,385,Z6844 (30%); S061X1A (13%); S069X1A (13%); C754 (13%); S066X1A (13%)
T3164,Burns involving 60-69% of body surface with 40-49% third degree burns,385,Z6844 (30%); Z6841 (17%); Z6842 (17%); C754 (13%); C162 (12%)
T3165,Burns involving 60-69% of body surface with 50-59% third degree burns,385,Z6844 (30%); Z6843 (27%); C754 (13%); C162 (12%); C251 (12%)
T3166,Burns involving 60-69% of body surface with 60-69% third degree burns,385,Z6844 (45%); C754 (11%); C162 (10%); C251 (10%); C602 (9%)
T3171,Burns involving 70-79% of body surface with 10-19% third degree burns,385,Z6845 (18%); C754 (13%); C162 (12%); C251 (11%); C602 (11%)
T3172,Burns involving 70-79% of body surface with 20-29% third degree burns,385,Z6845 (18%); C754 (13%); C162 (12%); C251 (11%); C602 (11%)
T3173,Burns involving 70-79% of body surface with 30-39% third degree burns,385,Z6845 (18%); S061X1A (13%); S069X1A (13%); C754 (13%); S066X1A (13%)
T3174,Burns involving 70-79% of body surface with 40-49% third degree burns,385,Z6845 (18%); Z6841 (17%); Z6842 (17%); C754 (13%); C162 (12%)
T3175,Burns involving 70-79% of body surface with 50-59% third degree burns,385,Z6843 (27%); Z6845 (19%); C754 (13%); C162 (12%); C251 (12%)
T3176,Burns involving 70-79% of body surface with 60-69% third degree burns,385,Z6844 (30%); Z6845 (18%); C754 (13%); C162 (12%); C251 (11%)
T3177,Burns involving 70-79% of body surface with 70-79% third degree burns,385,Z6845 (25%); C754 (10%); C162 (10%); C251 (10%); C602 (9%)
T3181,Burns involving 80-89% of body surface with 10-19% third degree burns,385,C754 (13%); C162 (12%); C251 (11%); C602 (11%); C6940 (11%)
T3182,Burns involving 80-89% of body surface with 20-29% third degree burns,385,C754 (13%); C162 (12%); C251 (11%); C602 (11%); C6940 (11%)
T3183,Burns involving 80-89% of body surface with 30-39% third degree burns,385,S061X1A (13%); S069X1A (13%); C754 (13%); S066X1A (13%); S06891A (13%)
T3184,Burns involving 80-89% of body surface with 40-49% third degree burns,385,Z6841 (17%); Z6842 (17%); C754 (13%); C162 (12%); C251 (11%)
T3185,Burns involving 80-89% of body surface with 50-59% third degree burns,385,Z6843 (27%); C754 (13%); C162 (12%); C251 (12%); C602 (11%)
T3186,Burns involving 80-89% of body surface with 60-69% third degree burns,385,Z6844 (30%); C754 (13%); C162 (12%); C251 (11%); C602 (11%)
T3187,Burns involving 80-89% of body surface with 70-79% third degree burns,385,Z6845 (18%); C754 (13%); C162 (12%); C251 (11%); C602 (11%)
T3188,Burns involving 80-89% of body surface with 80-89% third degree burns,385,C754 (10%); C162 (10%); C251 (9%); C602 (9%); C6940 (9%)
T3191,Burns involving 90% or more of body surface with 10-19% third degree burns,385,C754 (13%); C162 (12%); C251 (12%); C602 (12%); C6940 (11%)
T3192,Burns involving 90% or more of body surface with 20-29% third degree burns,385,C754 (13%); C162 (12%); C251 (12%); C602 (12%); C6940 (11%)
T3193,Burns involving 90% or more of body surface with 30-39% third degree burns,385,S061X1A (14%); S069X1A (14%); C754 (14%); S066X1A (13%); S06891A (13%)
T3194,Burns involving 90% or more of body surface with 40-49% third degree burns,385,Z6841 (18%); Z6842 (18%); C754 (13%); C162 (12%); C251 (12%)
T3195,Burns involving 90% or more of body surface with 50-59% third degree burns,385,Z6843 (29%); C754 (14%); C162 (12%); C251 (12%); C602 (12%)
T3196,Burns involving 90% or more of body surface with 60-69% third degree burns,385,Z6844 (31%); C754 (13%); C162 (12%); C251 (12%); C602 (12%)
T3197,Burns involving 90% or more of body surface with 70-79% third degree burns,385,Z6845 (19%); C754 (13%); C162 (12%); C251 (12%); C602 (12%)
T3198,Burns involving 90% or more of body surface with 80-89% third degree burns,385,C754 (13%); C162 (12%); C251 (12%); C602 (12%); C6940 (11%)
T3199,Burns involving 90% or more of body surface with 90% or more third degree burns,385,C754 (13%); C162 (12%); C251 (11%); C602 (11%); C6940 (11%)
T3211,Corrosions involving 10-19% of body surface with 10-19% third degree corrosion,385,C754 (11%); C162 (10%); C251 (10%); C602 (10%); C6940 (9%)
T3221,Corrosions involving 20-29% of body surface with 10-19% third degree corrosion,385,C754 (14%); C162 (13%); C251 (13%); C602 (12%); C6940 (12%)
T3222,Corrosions involving 20-29% of body surface with 20-29% third degree corrosion,385,C754 (11%); C162 (10%); C251 (10%); C602 (10%); C6940 (9%)
T3231,Corrosions involving 30-39% of body surface with 10-19% third degree corrosion,385,S061X1A (14%); S069X1A (14%); C754 (14%); S066X1A (14%); S06891A (14%)
T3232,Corrosions involving 30-39% of body surface with 20-29% third degree corrosion,385,S061X1A (14%); S069X1A (14%); C754 (14%); S066X1A (14%); S06891A (14%)
T3233,Corrosions involving 30-39% of body surface with 30-39% third degree corrosion,385,S061X1A (24%); S069X1A (24%); S066X1A (23%); S06891A (23%); S064X1A (23%)
T3241,Corrosions involving 40-49% of body surface with 10-19% third degree corrosion,385,Z6841 (19%); Z6842 (19%); C754 (14%); C162 (13%); C251 (13%)
T3242,Corrosions involving 40-49% of body surface with 20-29% third degree corrosion,385,Z6841 (19%); Z6842 (19%); C754 (14%); C162 (13%); C251 (13%)
T3243,Corrosions involving 40-49% of body surface with 30-39% third degree corrosion,385,Z6841 (19%); Z6842 (19%); S061X1A (14%); S069X1A (14%); C754 (14%)
T3244,Corrosions involving 40-49% of body surface with 40-49% third degree corrosion,385,Z6841 (25%); Z6842 (25%); C754 (11%); C162 (10%); C251 (10%)
T3251,Corrosions involving 50-59% of body surface with 10-19% third degree corrosion,385,Z6843 (30%); C754 (14%); C162 (13%); C251 (13%); C602 (12%)
T3252,Corrosions involving 50-59% of body surface with 20-29% third degree corrosion,385,Z6843 (30%); C754 (14%); C162 (13%); C251 (13%); C602 (12%)
T3253,Corrosions involving 50-59% of body surface with 30-39% third degree corrosion,385,Z6843 (30%); S061X1A (15%); S069X1A (15%); C754 (14%); S066X1A (14%)
T3254,Corrosions involving 50-59% of body surface with 40-49% third degree corrosion,385,Z6843 (30%); Z6841 (19%); Z6842 (19%); C754 (14%); C162 (13%)
T3255,Corrosions involving 50-59% of body surface with 50-59% third degree corrosion,385,Z6843 (45%); S061X3A (18%); S069X3A (18%); S066X3A (18%); S06893A (18%)
T3261,Corrosions involving 60-69% of body surface with 10-19% third degree corrosion,385,Z6844 (33%); C754 (14%); C162 (13%); C251 (13%); C602 (12%)
T3262,Corrosions involving 60-69% of body surface with 20-29% third degree corrosion,385,Z6844 (33%); C754 (14%); C162 (13%); C251 (13%); C602 (12%)
T3263,Corrosions involving 60-69% of body surface with 30-39% third degree corrosion,385,Z6844 (33%); S061X1A (14%); S069X1A (14%); C754 (14%); S066X1A (14%)
T3264,Corrosions involving 60-69% of body surface with 40-49% third degree corrosion,385,Z6844 (33%); Z6841 (19%); Z6842 (19%); C754 (14%); C162 (13%)
T3265,Corrosions involving 60-69% of body surface with 50-59% third degree corrosion,385,Z6844 (33%); Z6843 (30%); C754 (14%); C162 (13%); C251 (13%)
T3266,Corrosions involving 60-69% of body surface with 60-69% third degree corrosion,385,Z6844 (47%); C754 (11%); C162 (10%); C251 (10%); C602 (10%)
T3271,Corrosions involving 70-79% of body surface with 10-19% third degree corrosion,385,Z6845 (20%); C754 (14%); C162 (13%); C251 (13%); C602 (12%)
T3272,Corrosions involving 70-79% of body surface with 20-29% third degree corrosion,385,Z6845 (20%); C754 (14%); C162 (13%); C251 (13%); C602 (12%)
T3273,Corrosions involving 70-79% of body surface with 30-39% third degree corrosion,385,Z6845 (20%); S061X1A (14%); S069X1A (14%); C754 (14%); S066X1A (14%)
T3274,Corrosions involving 70-79% of body surface with 40-49% third degree corrosion,385,Z6845 (20%); Z6841 (19%); Z6842 (19%); C754 (14%); C162 (13%)
T3275,Corrosions involving 70-79% of body surface with 50-59% third degree corrosion,385,Z6843 (30%); Z6845 (20%); C754 (14%); C162 (13%); C251 (13%)
T3276,Corrosions involving 70-79% of body surface with 60-69% third degree corrosion,385,Z6844 (33%); Z6845 (20%); C754 (14%); C162 (13%); C251 (13%)
T3277,Corrosions involving 70-79% of body surface with 70-79% third degree corrosion,385,Z6845 (27%); C754 (11%); C162 (10%); C251 (10%); C602 (10%)
T3281,Corrosions involving 80-89% of body surface with 10-19% third degree corrosion,385,C754 (14%); C162 (13%); C251 (13%); C602 (12%); C6940 (12%)
T3282,Corrosions involving 80-89% of body surface with 20-29% third degree corrosion,385,C754 (14%); C162 (13%); C251 (13%); C602 (12%); C6940 (12%)
T3283,Corrosions involving 80-89% of body surface with 30-39% third degree corrosion,385,S061X1A (14%); S069X1A (14%); C754 (14%); S066X1A (14%); S06891A (14%)
T3284,Corrosions involving 80-89% of body surface with 40-49% third degree corrosion,385,Z6841 (19%); Z6842 (19%); C754 (14%); C162 (13%); C251 (13%)
T3285,Corrosions involving 80-89% of body surface with 50-59% third degree corrosion,385,Z6843 (30%); C754 (14%); C162 (13%); C251 (13%); C602 (12%)
T3286,Corrosions involving 80-89% of body surface with 60-69% third degree corrosion,385,Z6844 (33%); C754 (14%); C162 (13%); C251 (13%); C602 (12%)
T3287,Corrosions involving 80-89% of body surface with 70-79% third degree corrosion,385,Z6845 (20%); C754 (14%); C162 (13%); C251 (13%); C602 (12%)
T3288,Corrosions involving 80-89% of body surface with 80-89% third degree corrosion,385,C754 (11%); C162 (10%); C251 (10%); C602 (10%); C6940 (9%)
T3291,Corrosions involving 90% or more of body surface with 10-19% third degree corrosion,385,C754 (15%); C162 (14%); C251 (14%); C602 (13%); C6940 (13%)
T3292,Corrosions involving 90% or more of body surface with 20-29% third degree corrosion,385,C754 (15%); C162 (14%); C251 (14%); C602 (13%); C6940 (13%)
T3293,Corrosions involving 90% or more of body surface with 30-39% third degree corrosion,385,S061X1A (15%); S069X1A (15%); C754 (15%); S066X1A (15%); S06891A (15%)
T3294,Corrosions involving 90% or more of body surface with 40-49% third degree corrosion,385,Z6841 (20%); Z6842 (20%); C754 (15%); C162 (14%); C251 (14%)
T3295,Corrosions involving 90% or more of body surface with 50-59% third degree corrosion,385,Z6843 (32%); C754 (15%); C162 (14%); C251 (14%); C602 (13%)
T3296,Corrosions involving 90% or more of body surface with 60-69% third degree corrosion,385,Z6844 (35%); C754 (15%); C162 (14%); C251 (14%); C602 (13%)
T3297,Corrosions involving 90% or more of body surface with 70-79% third degree corrosion,385,Z6845 (22%); C754 (15%); C162 (14%); C251 (14%); C602 (13%)
T3298,Corrosions involving 90% or more of body surface with 80-89% third degree corrosion,385,C754 (15%); C162 (14%); C251 (14%); C602 (13%); C6940 (13%)
T3299,Corrosions involving 90% or more of body surface with 90% or more third degree corrosion,385,C754 (14%); C162 (13%); C251 (13%); C602 (12%); C6940 (12%)
T360X2A,"Poisoning by penicillins, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T360X2S,"Poisoning by penicillins, intentional self-harm, sequela",,
T361X2A,"Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter",155,D561 (25%); D562 (19%); D565 (18%); T405X4A (15%); D5742 (15%)
T361X2S,"Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, sequela",,
T362X2A,"Poisoning by chloramphenicol group, intentional self-harm, initial encounter",155,A400 (33%); A401 (33%); P360 (31%); T405X4A (19%); T40694A (17%)
T362X2S,"Poisoning by chloramphenicol group, intentional self-harm, sequela",,
T363X2A,"Poisoning by macrolides, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T363X2S,"Poisoning by macrolides, intentional self-harm, sequela",,
T364X2A,"Poisoning by tetracyclines, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T364X2S,"Poisoning by tetracyclines, intentional self-harm, sequela",,
T365X2A,"Poisoning by aminoglycosides, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T365X2S,"Poisoning by aminoglycosides, intentional self-harm, sequela",,
T366X2A,"Poisoning by rifampicins, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T366X2S,"Poisoning by rifampicins, intentional self-harm, sequela",,
T367X2A,"Poisoning by antifungal antibiotics, systemically used, intentional self-harm, initial encounter",155,T405X4A (14%); T40694A (13%); T40604A (13%); T43694A (13%); T43604A (13%)
T367X2S,"Poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela",,
T368X2A,"Poisoning by other systemic antibiotics, intentional self-harm, initial encounter",155,M3489 (28%); M349 (27%); M3482 (23%); E853 (23%); M3483 (23%)
T368X2S,"Poisoning by other systemic antibiotics, intentional self-harm, sequela",,
T3692XA,"Poisoning by unspecified systemic antibiotic, intentional self-harm, initial encounter",155,M349 (30%); M3489 (27%); M329 (22%); M3482 (22%); E853 (22%)
T3692XS,"Poisoning by unspecified systemic antibiotic, intentional self-harm, sequela",,
T370X2A,"Poisoning by sulfonamides, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T370X2S,"Poisoning by sulfonamides, intentional self-harm, sequela",,
T371X2A,"Poisoning by antimycobacterial drugs, intentional self-harm, initial encounter",155,T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%); T43604A (18%)
T371X2S,"Poisoning by antimycobacterial drugs, intentional self-harm, sequela",,
T372X2A,"Poisoning by antimalarials and drugs acting on other blood protozoa, intentional self-harm, initial encounter",155,D6101 (19%); T405X4A (14%); T40694A (13%); T40604A (12%); T43694A (12%)
T372X2S,"Poisoning by antimalarials and drugs acting on other blood protozoa, intentional self-harm, sequela",,
T373X2A,"Poisoning by other antiprotozoal drugs, intentional self-harm, initial encounter",155,T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%); T43604A (18%)
T373X2S,"Poisoning by other antiprotozoal drugs, intentional self-harm, sequela",,
T374X2A,"Poisoning by anthelminthics, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T374X2S,"Poisoning by anthelminthics, intentional self-harm, sequela",,
T375X2A,"Poisoning by antiviral drugs, intentional self-harm, initial encounter",155,T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%); T43604A (18%)
T375X2S,"Poisoning by antiviral drugs, intentional self-harm, sequela",,
T378X2A,"Poisoning by other specified systemic anti-infectives and antiparasitics, intentional self-harm, initial encounter",155,M082A (21%); M3489 (20%); M349 (20%); D7584 (17%); M3482 (17%)
T378X2S,"Poisoning by other specified systemic anti-infectives and antiparasitics, intentional self-harm, sequela",,
T3792XA,"Poisoning by unspecified systemic anti-infective and antiparasitics, intentional self-harm, initial encounter",155,M349 (23%); M3489 (21%); M329 (17%); D7584 (17%); M3482 (17%)
T3792XS,"Poisoning by unspecified systemic anti-infective and antiparasitics, intentional self-harm, sequela",,
T380X2A,"Poisoning by glucocorticoids and synthetic analogues, intentional self-harm, initial encounter",155,T40494A (37%); T40491A (33%); T405X4A (16%); T40694A (15%); T40604A (15%)
T380X2S,"Poisoning by glucocorticoids and synthetic analogues, intentional self-harm, sequela",,
T381X2A,"Poisoning by thyroid hormones and substitutes, intentional self-harm, initial encounter",155,C73 (36%); T405X4A (17%); T40694A (15%); T40604A (15%); T43694A (15%)
T381X2S,"Poisoning by thyroid hormones and substitutes, intentional self-harm, sequela",,
T382X2A,"Poisoning by antithyroid drugs, intentional self-harm, initial encounter",155,T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%); T43604A (18%)
T382X2S,"Poisoning by antithyroid drugs, intentional self-harm, sequela",,
T383X2A,"Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm, initial encounter",155,E10638 (25%); E11638 (25%); E13638 (25%); E08638 (22%); Z794 (22%)
T383X2S,"Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm, sequela",,
T384X2A,"Poisoning by oral contraceptives, intentional self-harm, initial encounter",155,E10638 (35%); E11638 (35%); E13638 (34%); E08638 (30%); C148 (21%)
T384X2S,"Poisoning by oral contraceptives, intentional self-harm, sequela",,
T385X2A,"Poisoning by other estrogens and progestogens, intentional self-harm, initial encounter",155,T405X4A (18%); T40694A (17%); T40604A (16%); T43694A (16%); T43604A (16%)
T385X2S,"Poisoning by other estrogens and progestogens, intentional self-harm, sequela",,
T386X2A,"Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, initial encounter",155,I96 (16%); T405X4A (15%); M4850XA (15%); M4852XA (14%); T40694A (14%)
T386X2S,"Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, sequela",,
T387X2A,"Poisoning by androgens and anabolic congeners, intentional self-harm, initial encounter",155,T405X4A (16%); T40694A (14%); T40604A (14%); T43694A (14%); T43604A (14%)
T387X2S,"Poisoning by androgens and anabolic congeners, intentional self-harm, sequela",,
T38802A,"Poisoning by unspecified hormones and synthetic substitutes, intentional self-harm, initial encounter",155,T40494A (38%); T40491A (34%); T40604A (18%); T43604A (17%); T405X4A (17%)
T38802S,"Poisoning by unspecified hormones and synthetic substitutes, intentional self-harm, sequela",,
T38812A,"Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm, initial encounter",155,C751 (30%); D352 (27%); D443 (23%); E220 (22%); E240 (22%)
T38812S,"Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm, sequela",,
T38892A,"Poisoning by other hormones and synthetic substitutes, intentional self-harm, initial encounter",155,T40494A (39%); T40491A (35%); T405X4A (17%); T40694A (16%); T40604A (15%)
T38892S,"Poisoning by other hormones and synthetic substitutes, intentional self-harm, sequela",,
T38902A,"Poisoning by unspecified hormone antagonists, intentional self-harm, initial encounter",155,T40604A (20%); T43604A (20%); T405X4A (19%); T40694A (18%); T43694A (17%)
T38902S,"Poisoning by unspecified hormone antagonists, intentional self-harm, sequela",,
T38992A,"Poisoning by other hormone antagonists, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (18%); T40604A (17%); T43694A (17%); T43604A (17%)
T38992S,"Poisoning by other hormone antagonists, intentional self-harm, sequela",,
T39012A,"Poisoning by aspirin, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T39012S,"Poisoning by aspirin, intentional self-harm, sequela",,
T39092A,"Poisoning by salicylates, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T39092S,"Poisoning by salicylates, intentional self-harm, sequela",,
T391X2A,"Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%); T43604A (17%)
T391X2S,"Poisoning by 4-Aminophenol derivatives, intentional self-harm, sequela",,
T392X2A,"Poisoning by pyrazolone derivatives, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%); T43604A (17%)
T392X2S,"Poisoning by pyrazolone derivatives, intentional self-harm, sequela",,
T39312A,"Poisoning by propionic acid derivatives, intentional self-harm, initial encounter",155,T405X4A (17%); T40694A (15%); T40604A (15%); T43694A (15%); T43604A (15%)
T39312S,"Poisoning by propionic acid derivatives, intentional self-harm, sequela",,
T39392A,"Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter",155,M064 (21%); M3581 (20%); K5140 (18%); K51418 (18%); K51419 (18%)
T39392S,"Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, sequela",,
T394X2A,"Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, initial encounter",155,I96 (22%); T405X4A (21%); M4850XA (21%); M4852XA (19%); T40694A (19%)
T394X2S,"Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, sequela",,
T398X2A,"Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, initial encounter",155,I96 (16%); T405X4A (15%); M4850XA (15%); M4852XA (14%); T40694A (14%)
T398X2S,"Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, sequela",,
T3992XA,"Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, initial encounter",155,T40604A (14%); T43604A (14%); T405X4A (14%); T40694A (13%); T43694A (12%)
T3992XS,"Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, sequela",,
T400X1A,"Poisoning by opium, accidental (unintentional), initial encounter",137,T400X2A (59%); T405X2A (20%); T40712A (20%); T40692A (19%); T40602A (18%)
T400X2A,"Poisoning by opium, intentional self-harm, initial encounter",155,T400X4A (68%); T400X1A (59%); T405X4A (23%); T40694A (21%); T40604A (21%)
T400X2S,"Poisoning by opium, intentional self-harm, sequela",,
T400X4A,"Poisoning by opium, undetermined, initial encounter",137,T400X2A (68%); T405X2A (23%); T40712A (23%); T40692A (21%); T40602A (21%)
T401X1A,"Poisoning by heroin, accidental (unintentional), initial encounter",137,T401X2A (59%); T405X2A (20%); T40712A (20%); T40692A (19%); T40602A (18%)
T401X2A,"Poisoning by heroin, intentional self-harm, initial encounter",155,T401X4A (68%); T401X1A (59%); T405X4A (23%); T40694A (21%); T40604A (21%)
T401X2S,"Poisoning by heroin, intentional self-harm, sequela",,
T401X4A,"Poisoning by heroin, undetermined, initial encounter",137,T401X2A (68%); T405X2A (23%); T40712A (23%); T40692A (21%); T40602A (21%)
T402X1A,"Poisoning by other opioids, accidental (unintentional), initial encounter",137,T402X2A (59%); T405X2A (20%); T40712A (20%); T40692A (19%); T40602A (18%)
T402X2A,"Poisoning by other opioids, intentional self-harm, initial encounter",155,T402X4A (68%); T402X1A (59%); T405X4A (23%); T40694A (21%); T40604A (21%)
T402X2S,"Poisoning by other opioids, intentional self-harm, sequela",,
T402X4A,"Poisoning by other opioids, undetermined, initial encounter",137,T402X2A (68%); T405X2A (23%); T40712A (23%); T40692A (21%); T40602A (21%)
T403X1A,"Poisoning by methadone, accidental (unintentional), initial encounter",137,T403X2A (59%); T405X2A (20%); T40712A (20%); T40692A (19%); T40602A (18%)
T403X2A,"Poisoning by methadone, intentional self-harm, initial encounter",155,T403X4A (68%); T403X1A (59%); T405X4A (23%); T40694A (21%); T40604A (21%)
T403X2S,"Poisoning by methadone, intentional self-harm, sequela",,
T403X4A,"Poisoning by methadone, undetermined, initial encounter",137,T403X2A (68%); T405X2A (23%); T40712A (23%); T40692A (21%); T40602A (21%)
T40411A,"Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), initial encounter",137,T40412A (84%); T405X2A (13%); T40712A (12%); T40692A (12%); T40602A (11%)
T40412A,"Poisoning by fentanyl or fentanyl analogs, intentional self-harm, initial encounter",155,T40414A (89%); T40411A (84%); T405X4A (14%); T40694A (12%); T40604A (12%)
T40412S,"Poisoning by fentanyl or fentanyl analogs, intentional self-harm, sequela",,
T40414A,"Poisoning by fentanyl or fentanyl analogs, undetermined, initial encounter",137,T40412A (89%); T405X2A (13%); T40712A (13%); T40692A (12%); T40602A (12%)
T40421A,"Poisoning by tramadol, accidental (unintentional), initial encounter",137,T40422A (59%); T405X2A (20%); T40712A (20%); T40692A (19%); T40602A (18%)
T40422A,"Poisoning by tramadol, intentional self-harm, initial encounter",155,T40424A (68%); T40421A (59%); T405X4A (23%); T40694A (21%); T40604A (21%)
T40422S,"Poisoning by tramadol, intentional self-harm, sequela",,
T40424A,"Poisoning by tramadol, undetermined, initial encounter",137,T40422A (68%); T405X2A (23%); T40712A (23%); T40692A (21%); T40602A (21%)
T40491A,"Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter",137,T40492A (68%); T40692A (48%); T40602A (47%); T40722A (39%); T38892A (35%)
T40492A,"Poisoning by other synthetic narcotics, intentional self-harm, initial encounter",155,T40494A (75%); T40491A (68%); T40694A (54%); T40604A (53%); T40691A (46%)
T40492S,"Poisoning by other synthetic narcotics, intentional self-harm, sequela",,
T40494A,"Poisoning by other synthetic narcotics, undetermined, initial encounter",137,T40492A (75%); T40692A (53%); T40602A (53%); T40722A (43%); T38892A (39%)
T405X1A,"Poisoning by cocaine, accidental (unintentional), initial encounter",137,T405X2A (49%); F14259 (36%); F14159 (36%); F14959 (35%); F14250 (33%)
T405X2A,"Poisoning by cocaine, intentional self-harm, initial encounter",155,T405X4A (58%); T405X1A (49%); F14288 (46%); F14188 (45%); F1429 (45%)
T405X2S,"Poisoning by cocaine, intentional self-harm, sequela",,
T405X4A,"Poisoning by cocaine, undetermined, initial encounter",137,T405X2A (58%); F14259 (43%); F14159 (43%); F14959 (42%); F14250 (40%)
T40601A,"Poisoning by unspecified narcotics, accidental (unintentional), initial encounter",137,T40602A (57%); T40692A (55%); T40492A (46%); T43602A (21%); T43202A (21%)
T40602A,"Poisoning by unspecified narcotics, intentional self-harm, initial encounter",155,T40604A (66%); T40694A (63%); T40601A (57%); T40691A (55%); T40494A (53%)
T40602S,"Poisoning by unspecified narcotics, intentional self-harm, sequela",,
T40604A,"Poisoning by unspecified narcotics, undetermined, initial encounter",137,T40602A (66%); T40692A (63%); T40492A (53%); T43602A (25%); T43202A (25%)
T40691A,"Poisoning by other narcotics, accidental (unintentional), initial encounter",137,T40692A (55%); T40602A (55%); T40492A (46%); T405X2A (21%); T40712A (20%)
T40692A,"Poisoning by other narcotics, intentional self-harm, initial encounter",155,T40694A (64%); T40604A (63%); T40691A (55%); T40601A (55%); T40494A (53%)
T40692S,"Poisoning by other narcotics, intentional self-harm, sequela",,
T40694A,"Poisoning by other narcotics, undetermined, initial encounter",137,T40692A (64%); T40602A (63%); T40492A (54%); T405X2A (24%); T40712A (24%)
T40712A,"Poisoning by cannabis, intentional self-harm, initial encounter",155,F12288 (50%); F12188 (50%); F1229 (49%); F12988 (49%); F12280 (47%)
T40712S,"Poisoning by cannabis, intentional self-harm, sequela",,
T40722A,"Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter",155,T40494A (43%); T40491A (39%); T405X4A (19%); T40694A (17%); T40604A (17%)
T40722S,"Poisoning by synthetic cannabinoids, intentional self-harm, sequela",,
T408X1A,"Poisoning by lysergide [LSD], accidental (unintentional), initial encounter",137,T408X2A (71%); T405X2A (17%); T40712A (17%); T40692A (16%); T40602A (16%)
T408X2A,"Poisoning by lysergide [LSD], intentional self-harm, initial encounter",155,T408X4A (78%); T408X1A (71%); T405X4A (19%); T40694A (17%); T40604A (17%)
T408X2S,"Poisoning by lysergide [LSD], intentional self-harm, sequela",,
T408X4A,"Poisoning by lysergide [LSD], undetermined, initial encounter",137,T408X2A (78%); T405X2A (19%); T40712A (18%); T40692A (17%); T40602A (17%)
T40901A,"Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter",137,T40902A (69%); T40992A (68%); T40602A (18%); T43602A (18%); T43202A (18%)
T40902A,"Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter",155,T40904A (76%); T40994A (75%); T40901A (69%); T40991A (68%); P0442 (29%)
T40902S,"Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, sequela",,
T40904A,"Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter",137,T40902A (76%); T40992A (75%); T40602A (21%); T43602A (20%); T43202A (20%)
T40991A,"Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter",137,T40992A (68%); T40902A (68%); T405X2A (18%); T40712A (17%); T40692A (16%)
T40992A,"Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter",155,T40994A (76%); T40904A (75%); T40991A (68%); T40901A (68%); P0442 (29%)
T40992S,"Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, sequela",,
T40994A,"Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter",137,T40992A (76%); T40902A (75%); T405X2A (20%); T40712A (19%); T40692A (18%)
T410X2A,"Poisoning by inhaled anesthetics, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%); T43604A (17%)
T410X2S,"Poisoning by inhaled anesthetics, intentional self-harm, sequela",,
T411X2A,"Poisoning by intravenous anesthetics, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%); T43604A (17%)
T411X2S,"Poisoning by intravenous anesthetics, intentional self-harm, sequela",,
T41202A,"Poisoning by unspecified general anesthetics, intentional self-harm, initial encounter",155,T40604A (20%); T43604A (19%); T405X4A (19%); T40694A (17%); T43694A (17%)
T41202S,"Poisoning by unspecified general anesthetics, intentional self-harm, sequela",,
T41292A,"Poisoning by other general anesthetics, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (18%); T40604A (17%); T43694A (17%); T43604A (17%)
T41292S,"Poisoning by other general anesthetics, intentional self-harm, sequela",,
T413X2A,"Poisoning by local anesthetics, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (18%); T40604A (17%); T43694A (17%); T43604A (17%)
T413X2S,"Poisoning by local anesthetics, intentional self-harm, sequela",,
T4142XA,"Poisoning by unspecified anesthetic, intentional self-harm, initial encounter",155,T40604A (23%); T43604A (22%); T405X4A (22%); T40694A (20%); T43694A (20%)
T4142XS,"Poisoning by unspecified anesthetic, intentional self-harm, sequela",,
T415X2A,"Poisoning by therapeutic gases, intentional self-harm, initial encounter",155,P962 (32%); J681 (22%); J689 (22%); J688 (21%); J684 (20%)
T415X2S,"Poisoning by therapeutic gases, intentional self-harm, sequela",,
T420X2A,"Poisoning by hydantoin derivatives, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%); T43604A (17%)
T420X2S,"Poisoning by hydantoin derivatives, intentional self-harm, sequela",,
T421X2A,"Poisoning by iminostilbenes, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T421X2S,"Poisoning by iminostilbenes, intentional self-harm, sequela",,
T422X2A,"Poisoning by succinimides and oxazolidinediones, intentional self-harm, initial encounter",155,T405X4A (18%); T40694A (17%); T40604A (16%); T43694A (16%); T43604A (16%)
T422X2S,"Poisoning by succinimides and oxazolidinediones, intentional self-harm, sequela",,
T423X2A,"Poisoning by barbiturates, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T423X2S,"Poisoning by barbiturates, intentional self-harm, sequela",,
T424X2A,"Poisoning by benzodiazepines, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T424X2S,"Poisoning by benzodiazepines, intentional self-harm, sequela",,
T425X2A,"Poisoning by mixed antiepileptics, intentional self-harm, initial encounter",155,C8120 (24%); C8127 (23%); F3160 (22%); D5913 (21%); F3162 (21%)
T425X2S,"Poisoning by mixed antiepileptics, intentional self-harm, sequela",,
T426X2A,"Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter",155,F13288 (38%); F13188 (38%); F1329 (38%); F13988 (38%); F1319 (38%)
T426X2S,"Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, sequela",,
T4272XA,"Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter",155,F1399 (40%); F1329 (39%); F13988 (39%); F1319 (39%); F13959 (39%)
T4272XS,"Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, sequela",,
T428X2A,"Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, initial encounter",155,S73043A (19%); S73046A (19%); S73042A (19%); S73045A (19%); S73041A (19%)
T428X2S,"Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, sequela",,
T43012A,"Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter",155,P0415 (28%); T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%)
T43012S,"Poisoning by tricyclic antidepressants, intentional self-harm, sequela",,
T43022A,"Poisoning by tetracyclic antidepressants, intentional self-harm, initial encounter",155,P0415 (28%); T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%)
T43022S,"Poisoning by tetracyclic antidepressants, intentional self-harm, sequela",,
T431X2A,"Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter",155,P0415 (21%); T405X4A (14%); T40694A (13%); T40604A (13%); T43694A (13%)
T431X2S,"Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, sequela",,
T43202A,"Poisoning by unspecified antidepressants, intentional self-harm, initial encounter",155,P0415 (35%); T40604A (25%); T43604A (24%); T405X4A (24%); T40694A (22%)
T43202S,"Poisoning by unspecified antidepressants, intentional self-harm, sequela",,
T43212A,"Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter",155,D804 (19%); D802 (18%); D803 (16%); T405X4A (13%); T40694A (12%)
T43212S,"Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, sequela",,
T43222A,"Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter",155,D804 (21%); D802 (20%); D803 (18%); T405X4A (15%); T40694A (14%)
T43222S,"Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, sequela",,
T43292A,"Poisoning by other antidepressants, intentional self-harm, initial encounter",155,P0415 (36%); T405X4A (24%); T40694A (22%); T40604A (22%); T43694A (22%)
T43292S,"Poisoning by other antidepressants, intentional self-harm, sequela",,
T433X2A,"Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, initial encounter",155,T405X4A (16%); T40694A (15%); T40604A (15%); T43694A (15%); T43604A (14%)
T433X2S,"Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, sequela",,
T434X2A,"Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, initial encounter",155,T405X4A (16%); T40694A (15%); T40604A (14%); T43694A (14%); T43604A (14%)
T434X2S,"Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, sequela",,
T43502A,"Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, initial encounter",155,T40604A (20%); T43604A (19%); T405X4A (19%); T40694A (17%); T43694A (17%)
T43502S,"Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, sequela",,
T43592A,"Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (18%); T40604A (17%); T43694A (17%); T43604A (17%)
T43592S,"Poisoning by other antipsychotics and neuroleptics, intentional self-harm, sequela",,
T43601A,"Poisoning by unspecified psychostimulants, accidental (unintentional), initial encounter",137,T43602A (58%); T43692A (56%); T40602A (21%); T43202A (21%); T405X2A (20%)
T43602A,"Poisoning by unspecified psychostimulants, intentional self-harm, initial encounter",155,T43604A (67%); T43694A (65%); T43601A (58%); T43691A (56%); T40604A (25%)
T43602S,"Poisoning by unspecified psychostimulants, intentional self-harm, sequela",,
T43604A,"Poisoning by unspecified psychostimulants, undetermined, initial encounter",137,T43602A (67%); T43692A (65%); T40602A (25%); T43202A (24%); T405X2A (24%)
T43611A,"Poisoning by caffeine, accidental (unintentional), initial encounter",137,T43612A (59%); T405X2A (20%); T40712A (20%); T40692A (19%); T40602A (18%)
T43612A,"Poisoning by caffeine, intentional self-harm, initial encounter",155,T43614A (68%); T43611A (59%); T405X4A (23%); T40694A (21%); T40604A (21%)
T43612S,"Poisoning by caffeine, intentional self-harm, sequela",,
T43614A,"Poisoning by caffeine, undetermined, initial encounter",137,T43612A (68%); T405X2A (23%); T40712A (23%); T40692A (21%); T40602A (21%)
T43621A,"Poisoning by amphetamines, accidental (unintentional), initial encounter",137,T43622A (58%); T405X2A (20%); T40712A (20%); T40692A (19%); T40602A (18%)
T43622A,"Poisoning by amphetamines, intentional self-harm, initial encounter",155,T43624A (67%); T43621A (58%); P0416 (38%); T405X4A (24%); T40694A (22%)
T43622S,"Poisoning by amphetamines, intentional self-harm, sequela",,
T43624A,"Poisoning by amphetamines, undetermined, initial encounter",137,T43622A (67%); T405X2A (24%); T40712A (23%); T40692A (22%); T40602A (21%)
T43631A,"Poisoning by methylphenidate, accidental (unintentional), initial encounter",137,T43632A (59%); T405X2A (20%); T40712A (20%); T40692A (19%); T40602A (18%)
T43632A,"Poisoning by methylphenidate, intentional self-harm, initial encounter",155,T43634A (68%); T43631A (59%); T405X4A (23%); T40694A (21%); T40604A (21%)
T43632S,"Poisoning by methylphenidate, intentional self-harm, sequela",,
T43634A,"Poisoning by methylphenidate, undetermined, initial encounter",137,T43632A (68%); T405X2A (23%); T40712A (23%); T40692A (21%); T40602A (21%)
T43641A,"Poisoning by ecstasy, accidental (unintentional), initial encounter",137,T43642A (59%); T405X2A (20%); T40712A (20%); T40692A (19%); T40602A (18%)
T43642A,"Poisoning by ecstasy, intentional self-harm, initial encounter",155,T43644A (68%); T43641A (59%); T405X4A (23%); T40694A (21%); T40604A (21%)
T43642S,"Poisoning by ecstasy, intentional self-harm, sequela",,
T43644A,"Poisoning by ecstasy, undetermined, initial encounter",137,T43642A (68%); T405X2A (23%); T40712A (23%); T40692A (21%); T40602A (21%)
T43651A,"Poisoning by methamphetamines accidental (unintentional), initial encounter",137,T43652A (59%); T405X2A (20%); T40712A (20%); T40692A (19%); T40602A (18%)
T43652A,"Poisoning by methamphetamines intentional self-harm, initial encounter",155,T43654A (68%); T43651A (59%); T405X4A (23%); T40694A (21%); T40604A (21%)
T43652S,"Poisoning by methamphetamines intentional self-harm, sequela",,
T43654A,"Poisoning by methamphetamines, undetermined, initial encounter",137,T43652A (68%); T405X2A (23%); T40712A (23%); T40692A (21%); T40602A (21%)
T43691A,"Poisoning by other psychostimulants, accidental (unintentional), initial encounter",137,T43692A (57%); T43602A (56%); T405X2A (21%); T40712A (20%); T40692A (19%)
T43692A,"Poisoning by other psychostimulants, intentional self-harm, initial encounter",155,T43694A (66%); T43604A (65%); T43691A (57%); T43601A (56%); T405X4A (24%)
T43692S,"Poisoning by other psychostimulants, intentional self-harm, sequela",,
T43694A,"Poisoning by other psychostimulants, undetermined, initial encounter",137,T43692A (66%); T43602A (65%); T405X2A (24%); T40712A (23%); T40692A (22%)
T438X2A,"Poisoning by other psychotropic drugs, intentional self-harm, initial encounter",155,T405X4A (21%); T40694A (19%); T40604A (18%); T43694A (18%); T43604A (18%)
T438X2S,"Poisoning by other psychotropic drugs, intentional self-harm, sequela",,
T4392XA,"Poisoning by unspecified psychotropic drug, intentional self-harm, initial encounter",155,T40604A (20%); T43604A (19%); T405X4A (19%); T40694A (17%); T43694A (17%)
T4392XS,"Poisoning by unspecified psychotropic drug, intentional self-harm, sequela",,
T440X2A,"Poisoning by anticholinesterase agents, intentional self-harm, initial encounter",155,D612 (22%); T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%)
T440X2S,"Poisoning by anticholinesterase agents, intentional self-harm, sequela",,
T441X2A,"Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter",155,T405X4A (18%); T40694A (17%); T40604A (16%); T43694A (16%); T43604A (16%)
T441X2S,"Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, sequela",,
T442X2A,"Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter",155,T405X4A (17%); T40694A (16%); T40604A (15%); T43694A (15%); T43604A (15%)
T442X2S,"Poisoning by ganglionic blocking drugs, intentional self-harm, sequela",,
T443X2A,"Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter",155,T405X4A (14%); T40694A (13%); T40604A (12%); T43694A (12%); T43604A (12%)
T443X2S,"Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela",,
T444X2A,"Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter",155,E8801 (24%); G710341 (19%); T405X4A (15%); T40694A (13%); T40604A (13%)
T444X2S,"Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela",,
T445X2A,"Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter",155,D561 (26%); D562 (19%); D565 (18%); T405X4A (15%); D5742 (15%)
T445X2S,"Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela",,
T446X2A,"Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter",155,E8801 (28%); G710341 (21%); T405X4A (17%); T40694A (16%); T40604A (15%)
T446X2S,"Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, sequela",,
T447X2A,"Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter",155,D561 (30%); D562 (22%); D565 (21%); T405X4A (18%); D5742 (18%)
T447X2S,"Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, sequela",,
T448X2A,"Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, initial encounter",155,G1229 (26%); G1220 (25%); G1224 (21%); D612 (15%); T405X4A (13%)
T448X2S,"Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, sequela",,
T44902A,"Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, initial encounter",155,C479 (41%); G903 (38%); C478 (35%); C7940 (27%); C729 (27%)
T44902S,"Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, sequela",,
T44992A,"Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, initial encounter",155,C479 (37%); G903 (36%); C478 (33%); C7940 (24%); C729 (23%)
T44992S,"Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, sequela",,
T450X2A,"Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter",155,T405X4A (17%); T40694A (15%); T40604A (15%); T43694A (15%); T43604A (15%)
T450X2S,"Poisoning by antiallergic and antiemetic drugs, intentional self-harm, sequela",,
T451X2A,"Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter",155,P0411 (27%); T405X4A (17%); T40694A (16%); T40604A (15%); T43694A (15%)
T451X2S,"Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela",,
T452X2A,"Poisoning by vitamins, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T452X2S,"Poisoning by vitamins, intentional self-harm, sequela",,
T453X2A,"Poisoning by enzymes, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T453X2S,"Poisoning by enzymes, intentional self-harm, sequela",,
T454X2A,"Poisoning by iron and its compounds, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (18%); T40604A (17%); T43694A (17%); T43604A (17%)
T454X2S,"Poisoning by iron and its compounds, intentional self-harm, sequela",,
T45512A,"Poisoning by anticoagulants, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T45512S,"Poisoning by anticoagulants, intentional self-harm, sequela",,
T45522A,"Poisoning by antithrombotic drugs, intentional self-harm, initial encounter",155,T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%); T43604A (18%)
T45522S,"Poisoning by antithrombotic drugs, intentional self-harm, sequela",,
T45602A,"Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter",155,G8330 (25%); G8190 (24%); T40604A (20%); T43604A (20%); T405X4A (19%)
T45602S,"Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, sequela",,
T45612A,"Poisoning by thrombolytic drug, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%); T43604A (17%)
T45612S,"Poisoning by thrombolytic drug, intentional self-harm, sequela",,
T45622A,"Poisoning by hemostatic drug, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%); T43604A (17%)
T45622S,"Poisoning by hemostatic drug, intentional self-harm, sequela",,
T45692A,"Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter",155,T405X4A (19%); G8330 (18%); T40694A (18%); T40604A (17%); T43694A (17%)
T45692S,"Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela",,
T457X2A,"Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter",155,T405X4A (14%); T40694A (13%); T40604A (13%); T43694A (13%); T43604A (13%)
T457X2S,"Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela",,
T458X2A,"Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter",155,M3489 (22%); M349 (22%); D612 (19%); M3482 (18%); E853 (18%)
T458X2S,"Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela",,
T4592XA,"Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter",155,M349 (24%); B180 (23%); B181 (23%); M3489 (21%); M329 (18%)
T4592XS,"Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela",,
T460X2A,"Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter",155,I462 (29%); F15288 (23%); F15188 (23%); F1529 (22%); F15988 (22%)
T460X2S,"Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela",,
T461X2A,"Poisoning by calcium-channel blockers, intentional self-harm, initial encounter",155,T405X4A (16%); T40694A (14%); T40604A (14%); T43694A (14%); T43604A (14%)
T461X2S,"Poisoning by calcium-channel blockers, intentional self-harm, sequela",,
T462X2A,"Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter",155,T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%); T43604A (18%)
T462X2S,"Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela",,
T463X2A,"Poisoning by coronary vasodilators, intentional self-harm, initial encounter",155,I2481 (24%); I21B (22%); I240 (21%); T405X4A (20%); I25790 (19%)
T463X2S,"Poisoning by coronary vasodilators, intentional self-harm, sequela",,
T464X2A,"Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter",155,T405X4A (14%); T40694A (13%); T40604A (13%); T43694A (13%); T43604A (12%)
T464X2S,"Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela",,
T465X2A,"Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter",155,T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%); T43604A (18%)
T465X2S,"Poisoning by other antihypertensive drugs, intentional self-harm, sequela",,
T466X2A,"Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter",155,T405X4A (17%); T40694A (15%); T40604A (15%); T43694A (15%); T43604A (15%)
T466X2S,"Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela",,
T467X2A,"Poisoning by peripheral vasodilators, intentional self-harm, initial encounter",155,C8440 (24%); C8447 (23%); C475 (22%); C8442 (21%); C8446 (21%)
T467X2S,"Poisoning by peripheral vasodilators, intentional self-harm, sequela",,
T468X2A,"Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter",155,K654 (29%); K8301 (26%); A811 (25%); D612 (17%); C4370 (15%)
T468X2S,"Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela",,
T46902A,"Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter",155,G8330 (22%); G8190 (21%); D612 (19%); T40604A (17%); T43604A (17%)
T46902S,"Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela",,
T46992A,"Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter",155,D612 (19%); T405X4A (17%); G8330 (16%); T40694A (15%); T40604A (15%)
T46992S,"Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela",,
T470X2A,"Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter",155,T405X4A (14%); T40694A (13%); T40604A (13%); T43694A (13%); T43604A (12%)
T470X2S,"Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela",,
T471X2A,"Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter",155,K255 (26%); K251 (26%); K256 (24%); K252 (24%); D7584 (15%)
T471X2S,"Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela",,
T472X2A,"Poisoning by stimulant laxatives, intentional self-harm, initial encounter",155,F15288 (36%); F15188 (36%); F1529 (36%); F15988 (36%); F1519 (35%)
T472X2S,"Poisoning by stimulant laxatives, intentional self-harm, sequela",,
T473X2A,"Poisoning by saline and osmotic laxatives, intentional self-harm, initial encounter",155,T405X4A (16%); T40694A (15%); T40604A (14%); T43694A (14%); T43604A (14%)
T473X2S,"Poisoning by saline and osmotic laxatives, intentional self-harm, sequela",,
T474X2A,"Poisoning by other laxatives, intentional self-harm, initial encounter",155,T405X4A (23%); T40694A (21%); T40604A (21%); T43694A (21%); T43604A (21%)
T474X2S,"Poisoning by other laxatives, intentional self-harm, sequela",,
T475X2A,"Poisoning by digestants, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T475X2S,"Poisoning by digestants, intentional self-harm, sequela",,
T476X2A,"Poisoning by antidiarrheal drugs, intentional self-harm, initial encounter",155,T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%); T43604A (18%)
T476X2S,"Poisoning by antidiarrheal drugs, intentional self-harm, sequela",,
T477X2A,"Poisoning by emetics, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T477X2S,"Poisoning by emetics, intentional self-harm, sequela",,
T478X2A,"Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, initial encounter",155,B462 (30%); C49A9 (25%); C49A0 (24%); C464 (24%); C49A2 (22%)
T478X2S,"Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, sequela",,
T4792XA,"Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, initial encounter",155,B462 (30%); C49A0 (26%); C49A9 (24%); C464 (24%); G8330 (23%)
T4792XS,"Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, sequela",,
T480X2A,"Poisoning by oxytocic drugs, intentional self-harm, initial encounter",155,T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%); T43604A (18%)
T480X2S,"Poisoning by oxytocic drugs, intentional self-harm, sequela",,
T481X2A,"Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, initial encounter",155,D612 (15%); L98423 (14%); T405X4A (13%); L97303 (12%); L97503 (12%)
T481X2S,"Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, sequela",,
T48202A,"Poisoning by unspecified drugs acting on muscles, intentional self-harm, initial encounter",155,T40604A (18%); T43604A (18%); T405X4A (18%); T40694A (16%); T43694A (16%)
T48202S,"Poisoning by unspecified drugs acting on muscles, intentional self-harm, sequela",,
T48292A,"Poisoning by other drugs acting on muscles, intentional self-harm, initial encounter",155,T405X4A (18%); T40694A (16%); T40604A (16%); T43694A (16%); T43604A (16%)
T48292S,"Poisoning by other drugs acting on muscles, intentional self-harm, sequela",,
T483X2A,"Poisoning by antitussives, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T483X2S,"Poisoning by antitussives, intentional self-harm, sequela",,
T484X2A,"Poisoning by expectorants, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T484X2S,"Poisoning by expectorants, intentional self-harm, sequela",,
T485X2A,"Poisoning by other anti-common-cold drugs, intentional self-harm, initial encounter",155,D5912 (26%); D839 (26%); D838 (24%); D832 (19%); D7584 (18%)
T485X2S,"Poisoning by other anti-common-cold drugs, intentional self-harm, sequela",,
T486X2A,"Poisoning by antiasthmatics, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T486X2S,"Poisoning by antiasthmatics, intentional self-harm, sequela",,
T48902A,"Poisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, initial encounter",155,R092 (21%); C7830 (21%); M3391 (21%); M3391 (21%); P285 (21%)
T48902S,"Poisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, sequela",,
T48992A,"Poisoning by other agents primarily acting on the respiratory system, intentional self-harm, initial encounter",155,R092 (22%); P285 (21%); M3311 (20%); M3311 (20%); D612 (19%)
T48992S,"Poisoning by other agents primarily acting on the respiratory system, intentional self-harm, sequela",,
T490X2A,"Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, initial encounter",155,D7584 (25%); M064 (17%); M3581 (15%); K5140 (14%); K51418 (14%)
T490X2S,"Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, sequela",,
T491X2A,"Poisoning by antipruritics, intentional self-harm, initial encounter",155,T405X4A (22%); T40694A (20%); T40604A (20%); T43694A (20%); T43604A (20%)
T491X2S,"Poisoning by antipruritics, intentional self-harm, sequela",,
T492X2A,"Poisoning by local astringents and local detergents, intentional self-harm, initial encounter",155,T405X4A (12%); T40694A (11%); T40604A (11%); T43694A (11%); T43604A (11%)
T492X2S,"Poisoning by local astringents and local detergents, intentional self-harm, sequela",,
T493X2A,"Poisoning by emollients, demulcents and protectants, intentional self-harm, initial encounter",155,T405X4A (16%); T40694A (14%); T40604A (14%); T43694A (14%); T43604A (14%)
T493X2S,"Poisoning by emollients, demulcents and protectants, intentional self-harm, sequela",,
T494X2A,"Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, initial encounter",155,E1037X3 (14%); E1137X3 (14%); E1037X9 (14%); E1137X9 (14%); E1037X2 (14%)
T494X2S,"Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, sequela",,
T495X2A,"Poisoning by ophthalmological drugs and preparations, intentional self-harm, initial encounter",155,T405X4A (17%); T40694A (16%); T40604A (15%); T43694A (15%); T43604A (15%)
T495X2S,"Poisoning by ophthalmological drugs and preparations, intentional self-harm, sequela",,
T496X2A,"Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, initial encounter",155,T405X4A (17%); T40694A (16%); T40604A (15%); T43694A (15%); T43604A (15%)
T496X2S,"Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, sequela",,
T497X2A,"Poisoning by dental drugs, topically applied, intentional self-harm, initial encounter",155,T405X4A (15%); T40694A (14%); T40604A (13%); T43694A (13%); T43604A (13%)
T497X2S,"Poisoning by dental drugs, topically applied, intentional self-harm, sequela",,
T498X2A,"Poisoning by other topical agents, intentional self-harm, initial encounter",155,D612 (23%); T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%)
T498X2S,"Poisoning by other topical agents, intentional self-harm, sequela",,
T4992XA,"Poisoning by unspecified topical agent, intentional self-harm, initial encounter",155,B180 (27%); B181 (27%); T40604A (20%); T43604A (19%); T405X4A (19%)
T4992XS,"Poisoning by unspecified topical agent, intentional self-harm, sequela",,
T500X2A,"Poisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%); T43604A (17%)
T500X2S,"Poisoning by mineralocorticoids and their antagonists, intentional self-harm, sequela",,
T501X2A,"Poisoning by loop [high-ceiling] diuretics, intentional self-harm, initial encounter",155,I5083 (24%); T405X4A (14%); T40694A (13%); T40604A (13%); T43694A (13%)
T501X2S,"Poisoning by loop [high-ceiling] diuretics, intentional self-harm, sequela",,
T502X2A,"Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, initial encounter",155,T405X4A (13%); T40694A (12%); T40604A (12%); T43694A (12%); T43604A (11%)
T502X2S,"Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, sequela",,
T503X2A,"Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, initial encounter",155,D612 (15%); T405X4A (13%); T40694A (12%); T40604A (12%); T43694A (12%)
T503X2S,"Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, sequela",,
T504X2A,"Poisoning by drugs affecting uric acid metabolism, intentional self-harm, initial encounter",155,E8300 (28%); E8309 (27%); T405X4A (15%); G8330 (14%); T40694A (14%)
T504X2S,"Poisoning by drugs affecting uric acid metabolism, intentional self-harm, sequela",,
T505X2A,"Poisoning by appetite depressants, intentional self-harm, initial encounter",155,T405X4A (18%); T40694A (17%); T40604A (17%); T43694A (16%); T43604A (16%)
T505X2S,"Poisoning by appetite depressants, intentional self-harm, sequela",,
T506X2A,"Poisoning by antidotes and chelating agents, intentional self-harm, initial encounter",155,D612 (19%); T405X4A (17%); T40694A (15%); T40604A (15%); T43694A (15%)
T506X2S,"Poisoning by antidotes and chelating agents, intentional self-harm, sequela",,
T507X2A,"Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, initial encounter",155,F11288 (27%); F11188 (27%); F1129 (27%); F11988 (27%); F1119 (27%)
T507X2S,"Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, sequela",,
T508X2A,"Poisoning by diagnostic agents, intentional self-harm, initial encounter",155,D612 (22%); T405X4A (20%); T40694A (18%); T40604A (18%); T43694A (18%)
T508X2S,"Poisoning by diagnostic agents, intentional self-harm, sequela",,
T50902A,"Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter",155,P0489 (20%); T40604A (18%); T43604A (17%); T405X4A (17%); I70549 (16%)
T50902S,"Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, sequela",,
T50912A,"Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter",155,M0899 (19%); P0489 (19%); M868X0 (19%); G35 (19%); M8789 (18%)
T50912S,"Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, sequela",,
T50992A,"Poisoning by other drugs, medicaments and biological substances, intentional self-harm, initial encounter",155,P0489 (20%); T405X4A (17%); P045 (16%); I7055 (16%); I7055 (16%)
T50992S,"Poisoning by other drugs, medicaments and biological substances, intentional self-harm, sequela",,
T50A12A,"Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, initial encounter",155,C4370 (11%); C4372 (11%); C4371 (11%); T405X4A (11%); C4360 (11%)
T50A12S,"Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, sequela",,
T50A22A,"Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm, initial encounter",155,P368 (27%); P369 (27%); K652 (21%); C8120 (17%); C8127 (16%)
T50A22S,"Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm, sequela",,
T50A92A,"Poisoning by other bacterial vaccines, intentional self-harm, initial encounter",155,P368 (38%); P369 (37%); K652 (30%); T405X4A (20%); T40694A (18%)
T50A92S,"Poisoning by other bacterial vaccines, intentional self-harm, sequela",,
T50B12A,"Poisoning by smallpox vaccines, intentional self-harm, initial encounter",155,T405X4A (19%); T40694A (17%); T40604A (17%); T43694A (17%); T43604A (17%)
T50B12S,"Poisoning by smallpox vaccines, intentional self-harm, sequela",,
T50B92A,"Poisoning by other viral vaccines, intentional self-harm, initial encounter",155,B3324 (38%); B182 (38%); B188 (38%); B189 (37%); B180 (26%)
T50B92S,"Poisoning by other viral vaccines, intentional self-harm, sequela",,
T50Z12A,"Poisoning by immunoglobulin, intentional self-harm, initial encounter",155,D804 (33%); D802 (33%); D805 (32%); D803 (29%); T405X4A (24%)
T50Z12S,"Poisoning by immunoglobulin, intentional self-harm, sequela",,
T50Z92A,"Poisoning by other vaccines and biological substances, intentional self-harm, initial encounter",155,P0489 (22%); T405X4A (19%); P045 (18%); I7055 (17%); I7055 (17%)
T50Z92S,"Poisoning by other vaccines and biological substances, intentional self-harm, sequela",,
T510X1A,"Toxic effect of ethanol, accidental (unintentional), initial encounter",,
T510X2A,"Toxic effect of ethanol, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T510X2S,"Toxic effect of ethanol, intentional self-harm, sequela",,
T510X4A,"Toxic effect of ethanol, undetermined, initial encounter",,
T511X2A,"Toxic effect of methanol, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T511X2S,"Toxic effect of methanol, intentional self-harm, sequela",,
T512X2A,"Toxic effect of 2-Propanol, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T512X2S,"Toxic effect of 2-Propanol, intentional self-harm, sequela",,
T513X2A,"Toxic effect of fusel oil, intentional self-harm, initial encounter",155,A483 (14%); K5931 (14%); G701 (12%); K713 (10%); K714 (9%)
T513X2S,"Toxic effect of fusel oil, intentional self-harm, sequela",,
T518X2A,"Toxic effect of other alcohols, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T518X2S,"Toxic effect of other alcohols, intentional self-harm, sequela",,
T5192XA,"Toxic effect of unspecified alcohol, intentional self-harm, initial encounter",155,F1029 (42%); F10988 (42%); F10959 (41%); F10288 (40%); F10188 (40%)
T5192XS,"Toxic effect of unspecified alcohol, intentional self-harm, sequela",,
T520X2A,"Toxic effect of petroleum products, intentional self-harm, initial encounter",155,A483 (14%); K5931 (14%); G701 (12%); K713 (10%); K714 (9%)
T520X2S,"Toxic effect of petroleum products, intentional self-harm, sequela",,
T521X2A,"Toxic effect of benzene, intentional self-harm, initial encounter",155,A483 (18%); K5931 (17%); G701 (15%); K713 (12%); K714 (12%)
T521X2S,"Toxic effect of benzene, intentional self-harm, sequela",,
T522X2A,"Toxic effect of homologues of benzene, intentional self-harm, initial encounter",155,A483 (15%); K5931 (14%); G701 (12%); K713 (10%); K714 (10%)
T522X2S,"Toxic effect of homologues of benzene, intentional self-harm, sequela",,
T523X2A,"Toxic effect of glycols, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T523X2S,"Toxic effect of glycols, intentional self-harm, sequela",,
T524X2A,"Toxic effect of ketones, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T524X2S,"Toxic effect of ketones, intentional self-harm, sequela",,
T528X2A,"Toxic effect of other organic solvents, intentional self-harm, initial encounter",155,J678 (24%); J679 (23%); J668 (22%); A483 (15%); K5931 (14%)
T528X2S,"Toxic effect of other organic solvents, intentional self-harm, sequela",,
T5292XA,"Toxic effect of unspecified organic solvent, intentional self-harm, initial encounter",155,J679 (25%); J678 (23%); J668 (22%); A483 (15%); K5931 (14%)
T5292XS,"Toxic effect of unspecified organic solvent, intentional self-harm, sequela",,
T530X2A,"Toxic effect of carbon tetrachloride, intentional self-harm, initial encounter",155,A483 (15%); K5931 (14%); G701 (13%); K713 (10%); K714 (10%)
T530X2S,"Toxic effect of carbon tetrachloride, intentional self-harm, sequela",,
T531X2A,"Toxic effect of chloroform, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T531X2S,"Toxic effect of chloroform, intentional self-harm, sequela",,
T532X2A,"Toxic effect of trichloroethylene, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T532X2S,"Toxic effect of trichloroethylene, intentional self-harm, sequela",,
T533X2A,"Toxic effect of tetrachloroethylene, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T533X2S,"Toxic effect of tetrachloroethylene, intentional self-harm, sequela",,
T534X2A,"Toxic effect of dichloromethane, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T534X2S,"Toxic effect of dichloromethane, intentional self-harm, sequela",,
T535X2A,"Toxic effect of chlorofluorocarbons, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T535X2S,"Toxic effect of chlorofluorocarbons, intentional self-harm, sequela",,
T536X2A,"Toxic effect of other halogen derivatives of aliphatic hydrocarbons, intentional self-harm, initial encounter",155,A483 (12%); K5931 (12%); G701 (10%); K713 (8%); K714 (8%)
T536X2S,"Toxic effect of other halogen derivatives of aliphatic hydrocarbons, intentional self-harm, sequela",,
T537X2A,"Toxic effect of other halogen derivatives of aromatic hydrocarbons, intentional self-harm, initial encounter",155,A483 (12%); K5931 (12%); G701 (10%); K713 (8%); K714 (8%)
T537X2S,"Toxic effect of other halogen derivatives of aromatic hydrocarbons, intentional self-harm, sequela",,
T5392XA,"Toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, intentional self-harm, initial encounter",155,A483 (11%); K5931 (10%); S7290XA (9%); S129XXA (9%); G701 (9%)
T5392XS,"Toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, intentional self-harm, sequela",,
T540X2A,"Toxic effect of phenol and phenol homologues, intentional self-harm, initial encounter",155,A483 (10%); K5931 (10%); G701 (9%); K713 (7%); K714 (7%)
T540X2S,"Toxic effect of phenol and phenol homologues, intentional self-harm, sequela",,
T541X2A,"Toxic effect of other corrosive organic compounds, intentional self-harm, initial encounter",155,J678 (22%); J679 (22%); J668 (20%); A483 (14%); K5931 (13%)
T541X2S,"Toxic effect of other corrosive organic compounds, intentional self-harm, sequela",,
T542X2A,"Toxic effect of corrosive acids and acid-like substances, intentional self-harm, initial encounter",155,C863 (19%); G4042 (16%); P0489 (16%); P045 (13%); P046 (12%)
T542X2S,"Toxic effect of corrosive acids and acid-like substances, intentional self-harm, sequela",,
T543X2A,"Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, initial encounter",155,C863 (19%); G4042 (16%); P0489 (15%); P045 (13%); P046 (12%)
T543X2S,"Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, sequela",,
T5492XA,"Toxic effect of unspecified corrosive substance, intentional self-harm, initial encounter",155,F1999 (27%); F19959 (26%); F1929 (25%); F19988 (25%); F1919 (25%)
T5492XS,"Toxic effect of unspecified corrosive substance, intentional self-harm, sequela",,
T550X2A,"Toxic effect of soaps, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (14%); K713 (12%); K714 (11%)
T550X2S,"Toxic effect of soaps, intentional self-harm, sequela",,
T551X2A,"Toxic effect of detergents, intentional self-harm, initial encounter",155,A483 (17%); K5931 (17%); G701 (15%); K713 (12%); K714 (12%)
T551X2S,"Toxic effect of detergents, intentional self-harm, sequela",,
T560X2A,"Toxic effect of lead and its compounds, intentional self-harm, initial encounter",155,A483 (15%); K5931 (15%); G701 (13%); K713 (10%); K714 (10%)
T560X2S,"Toxic effect of lead and its compounds, intentional self-harm, sequela",,
T561X2A,"Toxic effect of mercury and its compounds, intentional self-harm, initial encounter",155,A483 (15%); K5931 (15%); G701 (13%); K713 (10%); K714 (10%)
T561X2S,"Toxic effect of mercury and its compounds, intentional self-harm, sequela",,
T562X2A,"Toxic effect of chromium and its compounds, intentional self-harm, initial encounter",155,A483 (15%); K5931 (15%); G701 (13%); K713 (10%); K714 (10%)
T562X2S,"Toxic effect of chromium and its compounds, intentional self-harm, sequela",,
T563X2A,"Toxic effect of cadmium and its compounds, intentional self-harm, initial encounter",155,A483 (15%); K5931 (15%); G701 (13%); K713 (10%); K714 (10%)
T563X2S,"Toxic effect of cadmium and its compounds, intentional self-harm, sequela",,
T564X2A,"Toxic effect of copper and its compounds, intentional self-harm, initial encounter",155,E8300 (36%); E8309 (34%); A483 (15%); K5931 (15%); G701 (13%)
T564X2S,"Toxic effect of copper and its compounds, intentional self-harm, sequela",,
T565X2A,"Toxic effect of zinc and its compounds, intentional self-harm, initial encounter",155,A483 (15%); K5931 (15%); G701 (13%); K713 (10%); K714 (10%)
T565X2S,"Toxic effect of zinc and its compounds, intentional self-harm, sequela",,
T566X2A,"Toxic effect of tin and its compounds, intentional self-harm, initial encounter",155,
T566X2S,"Toxic effect of tin and its compounds, intentional self-harm, sequela",,
T567X2A,"Toxic effect of beryllium and its compounds, intentional self-harm, initial encounter",155,
T567X2S,"Toxic effect of beryllium and its compounds, intentional self-harm, sequela",,
T56812A,"Toxic effect of thallium, intentional self-harm, initial encounter",155,
T56812S,"Toxic effect of thallium, intentional self-harm, sequela",,
T56822A,"Toxic effect of gadolinium, intentional self-harm, initial encounter",155,
T56822S,"Toxic effect of gadolinium, intentional self-harm, sequela",,
T56892A,"Toxic effect of other metals, intentional self-harm, initial encounter",155,
T56892S,"Toxic effect of other metals, intentional self-harm, sequela",,
T5692XA,"Toxic effect of unspecified metal, intentional self-harm, initial encounter",155,
T5692XS,"Toxic effect of unspecified metal, intentional self-harm, sequela",,
T570X2A,"Toxic effect of arsenic and its compounds, intentional self-harm, initial encounter",155,
T570X2S,"Toxic effect of arsenic and its compounds, intentional self-harm, sequela",,
T571X2A,"Toxic effect of phosphorus and its compounds, intentional self-harm, initial encounter",155,
T571X2S,"Toxic effect of phosphorus and its compounds, intentional self-harm, sequela",,
T572X2A,"Toxic effect of manganese and its compounds, intentional self-harm, initial encounter",155,
T572X2S,"Toxic effect of manganese and its compounds, intentional self-harm, sequela",,
T573X2A,"Toxic effect of hydrogen cyanide, intentional self-harm, initial encounter",155,
T573X2S,"Toxic effect of hydrogen cyanide, intentional self-harm, sequela",,
T578X2A,"Toxic effect of other specified inorganic substances, intentional self-harm, initial encounter",155,
T578X2S,"Toxic effect of other specified inorganic substances, intentional self-harm, sequela",,
T5792XA,"Toxic effect of unspecified inorganic substance, intentional self-harm, initial encounter",155,
T5792XS,"Toxic effect of unspecified inorganic substance, intentional self-harm, sequela",,
T5802XA,"Toxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, initial encounter",155,
T5802XS,"Toxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, sequela",,
T5812XA,"Toxic effect of carbon monoxide from utility gas, intentional self-harm, initial encounter",155,
T5812XS,"Toxic effect of carbon monoxide from utility gas, intentional self-harm, sequela",,
T582X2A,"Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, initial encounter",155,
T582X2S,"Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, sequela",,
T588X2A,"Toxic effect of carbon monoxide from other source, intentional self-harm, initial encounter",155,
T588X2S,"Toxic effect of carbon monoxide from other source, intentional self-harm, sequela",,
T5892XA,"Toxic effect of carbon monoxide from unspecified source, intentional self-harm, initial encounter",155,
T5892XS,"Toxic effect of carbon monoxide from unspecified source, intentional self-harm, sequela",,
T590X2A,"Toxic effect of nitrogen oxides, intentional self-harm, initial encounter",155,
T590X2S,"Toxic effect of nitrogen oxides, intentional self-harm, sequela",,
T591X2A,"Toxic effect of sulfur dioxide, intentional self-harm, initial encounter",155,
T591X2S,"Toxic effect of sulfur dioxide, intentional self-harm, sequela",,
T592X2A,"Toxic effect of formaldehyde, intentional self-harm, initial encounter",155,
T592X2S,"Toxic effect of formaldehyde, intentional self-harm, sequela",,
T593X2A,"Toxic effect of lacrimogenic gas, intentional self-harm, initial encounter",155,
T593X2S,"Toxic effect of lacrimogenic gas, intentional self-harm, sequela",,
T594X2A,"Toxic effect of chlorine gas, intentional self-harm, initial encounter",155,
T594X2S,"Toxic effect of chlorine gas, intentional self-harm, sequela",,
T595X2A,"Toxic effect of fluorine gas and hydrogen fluoride, intentional self-harm, initial encounter",155,
T595X2S,"Toxic effect of fluorine gas and hydrogen fluoride, intentional self-harm, sequela",,
T596X2A,"Toxic effect of hydrogen sulfide, intentional self-harm, initial encounter",155,
T596X2S,"Toxic effect of hydrogen sulfide, intentional self-harm, sequela",,
T597X2A,"Toxic effect of carbon dioxide, intentional self-harm, initial encounter",155,
T597X2S,"Toxic effect of carbon dioxide, intentional self-harm, sequela",,
T59812A,"Toxic effect of smoke, intentional self-harm, initial encounter",155,
T59812S,"Toxic effect of smoke, intentional self-harm, sequela",,
T59892A,"Toxic effect of other specified gases, fumes and vapors, intentional self-harm, initial encounter",155,
T59892S,"Toxic effect of other specified gases, fumes and vapors, intentional self-harm, sequela",,
T5992XA,"Toxic effect of unspecified gases, fumes and vapors, intentional self-harm, initial encounter",155,
T5992XS,"Toxic effect of unspecified gases, fumes and vapors, intentional self-harm, sequela",,
T600X2A,"Toxic effect of organophosphate and carbamate insecticides, intentional self-harm, initial encounter",155,
T600X2S,"Toxic effect of organophosphate and carbamate insecticides, intentional self-harm, sequela",,
T601X2A,"Toxic effect of halogenated insecticides, intentional self-harm, initial encounter",155,
T601X2S,"Toxic effect of halogenated insecticides, intentional self-harm, sequela",,
T602X2A,"Toxic effect of other insecticides, intentional self-harm, initial encounter",155,
T602X2S,"Toxic effect of other insecticides, intentional self-harm, sequela",,
T603X2A,"Toxic effect of herbicides and fungicides, intentional self-harm, initial encounter",155,
T603X2S,"Toxic effect of herbicides and fungicides, intentional self-harm, sequela",,
T604X2A,"Toxic effect of rodenticides, intentional self-harm, initial encounter",155,
T604X2S,"Toxic effect of rodenticides, intentional self-harm, sequela",,
T608X2A,"Toxic effect of other pesticides, intentional self-harm, initial encounter",155,
T608X2S,"Toxic effect of other pesticides, intentional self-harm, sequela",,
T6092XA,"Toxic effect of unspecified pesticide, intentional self-harm, initial encounter",155,
T6092XS,"Toxic effect of unspecified pesticide, intentional self-harm, sequela",,
T6102XA,"Ciguatera fish poisoning, intentional self-harm, initial encounter",155,
T6102XS,"Ciguatera fish poisoning, intentional self-harm, sequela",,
T6112XA,"Scombroid fish poisoning, intentional self-harm, initial encounter",155,
T6112XS,"Scombroid fish poisoning, intentional self-harm, sequela",,
T61772A,"Other fish poisoning, intentional self-harm, initial encounter",155,
T61772S,"Other fish poisoning, intentional self-harm, sequela",,
T61782A,"Other shellfish poisoning, intentional self-harm, initial encounter",155,
T61782S,"Other shellfish poisoning, intentional self-harm, sequela",,
T618X2A,"Toxic effect of other seafood, intentional self-harm, initial encounter",155,
T618X2S,"Toxic effect of other seafood, intentional self-harm, sequela",,
T6192XA,"Toxic effect of unspecified seafood, intentional self-harm, initial encounter",155,
T6192XS,"Toxic effect of unspecified seafood, intentional self-harm, sequela",,
T620X2A,"Toxic effect of ingested mushrooms, intentional self-harm, initial encounter",155,
T620X2S,"Toxic effect of ingested mushrooms, intentional self-harm, sequela",,
T621X2A,"Toxic effect of ingested berries, intentional self-harm, initial encounter",155,
T621X2S,"Toxic effect of ingested berries, intentional self-harm, sequela",,
T622X2A,"Toxic effect of other ingested (parts of) plant(s), intentional self-harm, initial encounter",155,
T622X2S,"Toxic effect of other ingested (parts of) plant(s), intentional self-harm, sequela",,
T628X2A,"Toxic effect of other specified noxious substances eaten as food, intentional self-harm, initial encounter",155,
T628X2S,"Toxic effect of other specified noxious substances eaten as food, intentional self-harm, sequela",,
T6292XA,"Toxic effect of unspecified noxious substance eaten as food, intentional self-harm, initial encounter",155,
T6292XS,"Toxic effect of unspecified noxious substance eaten as food, intentional self-harm, sequela",,
T63002A,"Toxic effect of unspecified snake venom, intentional self-harm, initial encounter",155,
T63002S,"Toxic effect of unspecified snake venom, intentional self-harm, sequela",,
T63012A,"Toxic effect of rattlesnake venom, intentional self-harm, initial encounter",155,
T63012S,"Toxic effect of rattlesnake venom, intentional self-harm, sequela",,
T63022A,"Toxic effect of coral snake venom, intentional self-harm, initial encounter",155,
T63022S,"Toxic effect of coral snake venom, intentional self-harm, sequela",,
T63032A,"Toxic effect of taipan venom, intentional self-harm, initial encounter",155,
T63032S,"Toxic effect of taipan venom, intentional self-harm, sequela",,
T63042A,"Toxic effect of cobra venom, intentional self-harm, initial encounter",155,
T63042S,"Toxic effect of cobra venom, intentional self-harm, sequela",,
T63062A,"Toxic effect of venom of other North and South American snake, intentional self-harm, initial encounter",155,
T63062S,"Toxic effect of venom of other North and South American snake, intentional self-harm, sequela",,
T63072A,"Toxic effect of venom of other Australian snake, intentional self-harm, initial encounter",155,
T63072S,"Toxic effect of venom of other Australian snake, intentional self-harm, sequela",,
T63082A,"Toxic effect of venom of other African and Asian snake, intentional self-harm, initial encounter",155,
T63082S,"Toxic effect of venom of other African and Asian snake, intentional self-harm, sequela",,
T63092A,"Toxic effect of venom of other snake, intentional self-harm, initial encounter",155,
T63092S,"Toxic effect of venom of other snake, intentional self-harm, sequela",,
T63112A,"Toxic effect of venom of gila monster, intentional self-harm, initial encounter",155,
T63112S,"Toxic effect of venom of gila monster, intentional self-harm, sequela",,
T63122A,"Toxic effect of venom of other venomous lizard, intentional self-harm, initial encounter",155,
T63122S,"Toxic effect of venom of other venomous lizard, intentional self-harm, sequela",,
T63192A,"Toxic effect of venom of other reptiles, intentional self-harm, initial encounter",155,
T63192S,"Toxic effect of venom of other reptiles, intentional self-harm, sequela",,
T632X2A,"Toxic effect of venom of scorpion, intentional self-harm, initial encounter",155,
T632X2S,"Toxic effect of venom of scorpion, intentional self-harm, sequela",,
T63302A,"Toxic effect of unspecified spider venom, intentional self-harm, initial encounter",155,
T63302S,"Toxic effect of unspecified spider venom, intentional self-harm, sequela",,
T63312A,"Toxic effect of venom of black widow spider, intentional self-harm, initial encounter",155,
T63312S,"Toxic effect of venom of black widow spider, intentional self-harm, sequela",,
T63322A,"Toxic effect of venom of tarantula, intentional self-harm, initial encounter",155,
T63322S,"Toxic effect of venom of tarantula, intentional self-harm, sequela",,
T63332A,"Toxic effect of venom of brown recluse spider, intentional self-harm, initial encounter",155,
T63332S,"Toxic effect of venom of brown recluse spider, intentional self-harm, sequela",,
T63392A,"Toxic effect of venom of other spider, intentional self-harm, initial encounter",155,
T63392S,"Toxic effect of venom of other spider, intentional self-harm, sequela",,
T63412A,"Toxic effect of venom of centipedes and venomous millipedes, intentional self-harm, initial encounter",155,
T63412S,"Toxic effect of venom of centipedes and venomous millipedes, intentional self-harm, sequela",,
T63422A,"Toxic effect of venom of ants, intentional self-harm, initial encounter",155,
T63422S,"Toxic effect of venom of ants, intentional self-harm, sequela",,
T63432A,"Toxic effect of venom of caterpillars, intentional self-harm, initial encounter",155,
T63432S,"Toxic effect of venom of caterpillars, intentional self-harm, sequela",,
T63442A,"Toxic effect of venom of bees, intentional self-harm, initial encounter",155,
T63442S,"Toxic effect of venom of bees, intentional self-harm, sequela",,
T63452A,"Toxic effect of venom of hornets, intentional self-harm, initial encounter",155,
T63452S,"Toxic effect of venom of hornets, intentional self-harm, sequela",,
T63462A,"Toxic effect of venom of wasps, intentional self-harm, initial encounter",155,
T63462S,"Toxic effect of venom of wasps, intentional self-harm, sequela",,
T63482A,"Toxic effect of venom of other arthropod, intentional self-harm, initial encounter",155,
T63482S,"Toxic effect of venom of other arthropod, intentional self-harm, sequela",,
T63512A,"Toxic effect of contact with stingray, intentional self-harm, initial encounter",155,
T63512S,"Toxic effect of contact with stingray, intentional self-harm, sequela",,
T63592A,"Toxic effect of contact with other venomous fish, intentional self-harm, initial encounter",155,
T63592S,"Toxic effect of contact with other venomous fish, intentional self-harm, sequela",,
T63612A,"Toxic effect of contact with Portuguese Man-o-war, intentional self-harm, initial encounter",155,
T63612S,"Toxic effect of contact with Portuguese Man-o-war, intentional self-harm, sequela",,
T63622A,"Toxic effect of contact with other jellyfish, intentional self-harm, initial encounter",155,
T63622S,"Toxic effect of contact with other jellyfish, intentional self-harm, sequela",,
T63632A,"Toxic effect of contact with sea anemone, intentional self-harm, initial encounter",155,
T63632S,"Toxic effect of contact with sea anemone, intentional self-harm, sequela",,
T63692A,"Toxic effect of contact with other venomous marine animals, intentional self-harm, initial encounter",155,
T63692S,"Toxic effect of contact with other venomous marine animals, intentional self-harm, sequela",,
T63712A,"Toxic effect of contact with venomous marine plant, intentional self-harm, initial encounter",155,
T63712S,"Toxic effect of contact with venomous marine plant, intentional self-harm, sequela",,
T63792A,"Toxic effect of contact with other venomous plant, intentional self-harm, initial encounter",155,
T63792S,"Toxic effect of contact with other venomous plant, intentional self-harm, sequela",,
T63812A,"Toxic effect of contact with venomous frog, intentional self-harm, initial encounter",155,
T63812S,"Toxic effect of contact with venomous frog, intentional self-harm, sequela",,
T63822A,"Toxic effect of contact with venomous toad, intentional self-harm, initial encounter",155,
T63822S,"Toxic effect of contact with venomous toad, intentional self-harm, sequela",,
T63832A,"Toxic effect of contact with other venomous amphibian, intentional self-harm, initial encounter",155,
T63832S,"Toxic effect of contact with other venomous amphibian, intentional self-harm, sequela",,
T63892A,"Toxic effect of contact with other venomous animals, intentional self-harm, initial encounter",155,
T63892S,"Toxic effect of contact with other venomous animals, intentional self-harm, sequela",,
T6392XA,"Toxic effect of contact with unspecified venomous animal, intentional self-harm, initial encounter",155,
T6392XS,"Toxic effect of contact with unspecified venomous animal, intentional self-harm, sequela",,
T6402XA,"Toxic effect of aflatoxin, intentional self-harm, initial encounter",155,
T6402XS,"Toxic effect of aflatoxin, intentional self-harm, sequela",,
T6482XA,"Toxic effect of other mycotoxin food contaminants, intentional self-harm, initial encounter",155,
T6482XS,"Toxic effect of other mycotoxin food contaminants, intentional self-harm, sequela",,
T650X2A,"Toxic effect of cyanides, intentional self-harm, initial encounter",155,
T650X2S,"Toxic effect of cyanides, intentional self-harm, sequela",,
T651X2A,"Toxic effect of strychnine and its salts, intentional self-harm, initial encounter",155,
T651X2S,"Toxic effect of strychnine and its salts, intentional self-harm, sequela",,
T65212A,"Toxic effect of chewing tobacco, intentional self-harm, initial encounter",155,
T65212S,"Toxic effect of chewing tobacco, intentional self-harm, sequela",,
T65222A,"Toxic effect of tobacco cigarettes, intentional self-harm, initial encounter",155,
T65222S,"Toxic effect of tobacco cigarettes, intentional self-harm, sequela",,
T65292A,"Toxic effect of other tobacco and nicotine, intentional self-harm, initial encounter",155,
T65292S,"Toxic effect of other tobacco and nicotine, intentional self-harm, sequela",,
T653X2A,"Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues, intentional self-harm, initial encounter",155,
T653X2S,"Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues, intentional self-harm, sequela",,
T654X2A,"Toxic effect of carbon disulfide, intentional self-harm, initial encounter",155,
T654X2S,"Toxic effect of carbon disulfide, intentional self-harm, sequela",,
T655X2A,"Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, initial encounter",155,
T655X2S,"Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, sequela",,
T656X2A,"Toxic effect of paints and dyes, not elsewhere classified, intentional self-harm, initial encounter",155,
T656X2S,"Toxic effect of paints and dyes, not elsewhere classified, intentional self-harm, sequela",,
T65812A,"Toxic effect of latex, intentional self-harm, initial encounter",155,
T65812S,"Toxic effect of latex, intentional self-harm, sequela",,
T65822A,"Toxic effect of harmful algae and algae toxins, intentional self-harm, initial encounter",155,
T65822S,"Toxic effect of harmful algae and algae toxins, intentional self-harm, sequela",,
T65832A,"Toxic effect of fiberglass, intentional self-harm, initial encounter",155,
T65832S,"Toxic effect of fiberglass, intentional self-harm, sequela",,
T65892A,"Toxic effect of other specified substances, intentional self-harm, initial encounter",155,
T65892S,"Toxic effect of other specified substances, intentional self-harm, sequela",,
T6592XA,"Toxic effect of unspecified substance, intentional self-harm, initial encounter",155,
T6592XS,"Toxic effect of unspecified substance, intentional self-harm, sequela",,
T71112A,"Asphyxiation due to smothering under pillow, intentional self-harm, initial encounter",155,
T71112S,"Asphyxiation due to smothering under pillow, intentional self-harm, sequela",,
T71122A,"Asphyxiation due to plastic bag, intentional self-harm, initial encounter",155,
T71122S,"Asphyxiation due to plastic bag, intentional self-harm, sequela",,
T71132A,"Asphyxiation due to being trapped in bed linens, intentional self-harm, initial encounter",155,
T71132S,"Asphyxiation due to being trapped in bed linens, intentional self-harm, sequela",,
T71152A,"Asphyxiation due to smothering in furniture, intentional self-harm, initial encounter",155,
T71152S,"Asphyxiation due to smothering in furniture, intentional self-harm, sequela",,
T71162A,"Asphyxiation due to hanging, intentional self-harm, initial encounter",155,
T71162S,"Asphyxiation due to hanging, intentional self-harm, sequela",,
T71192A,"Asphyxiation due to mechanical threat to breathing due to other causes, intentional self-harm, initial encounter",155,
T71192S,"Asphyxiation due to mechanical threat to breathing due to other causes, intentional self-harm, sequela",,
T71222A,"Asphyxiation due to being trapped in a car trunk, intentional self-harm, initial encounter",155,
T71222S,"Asphyxiation due to being trapped in a car trunk, intentional self-harm, sequela",,
T71232A,"Asphyxiation due to being trapped in a (discarded) refrigerator, intentional self-harm, initial encounter",155,
T71232S,"Asphyxiation due to being trapped in a (discarded) refrigerator, intentional self-harm, sequela",,
T790XXA,"Air embolism (traumatic), initial encounter",267,
T791XXA,"Fat embolism (traumatic), initial encounter",267,
T792XXA,"Traumatic secondary and recurrent hemorrhage and seroma, initial encounter",,
T794XXA,"Traumatic shock, initial encounter",2,
T795XXA,"Traumatic anuria, initial encounter",,
T796XXA,"Traumatic ischemia of muscle, initial encounter",,
T797XXA,"Traumatic subcutaneous emphysema, initial encounter",,
T798XXA,"Other early complications of trauma, initial encounter",,
T799XXA,"Unspecified early complication of trauma, initial encounter",,
T79A0XA,"Compartment syndrome, unspecified, initial encounter",,
T79A11A,"Traumatic compartment syndrome of right upper extremity, initial encounter",,
T79A12A,"Traumatic compartment syndrome of left upper extremity, initial encounter",,
T79A19A,"Traumatic compartment syndrome of unspecified upper extremity, initial encounter",,
T79A21A,"Traumatic compartment syndrome of right lower extremity, initial encounter",,
T79A22A,"Traumatic compartment syndrome of left lower extremity, initial encounter",,
T79A29A,"Traumatic compartment syndrome of unspecified lower extremity, initial encounter",,
T79A3XA,"Traumatic compartment syndrome of abdomen, initial encounter",,
T79A9XA,"Traumatic compartment syndrome of other sites, initial encounter",,
T8111XA,"Postprocedural cardiogenic shock, initial encounter",,
T8112XA,"Postprocedural septic shock, initial encounter",,
T8144XA,"Sepsis following a procedure, initial encounter",,
T81502A,"Unspecified complication of foreign body accidentally left in body following kidney dialysis, initial encounter",,
T81502D,"Unspecified complication of foreign body accidentally left in body following kidney dialysis, subsequent encounter",,
T81502S,"Unspecified complication of foreign body accidentally left in body following kidney dialysis, sequela",,
T81512A,"Adhesions due to foreign body accidentally left in body following kidney dialysis, initial encounter",,
T81512D,"Adhesions due to foreign body accidentally left in body following kidney dialysis, subsequent encounter",,
T81512S,"Adhesions due to foreign body accidentally left in body following kidney dialysis, sequela",,
T81522A,"Obstruction due to foreign body accidentally left in body following kidney dialysis, initial encounter",,
T81522D,"Obstruction due to foreign body accidentally left in body following kidney dialysis, subsequent encounter",,
T81522S,"Obstruction due to foreign body accidentally left in body following kidney dialysis, sequela",,
T81532A,"Perforation due to foreign body accidentally left in body following kidney dialysis, initial encounter",,
T81532D,"Perforation due to foreign body accidentally left in body following kidney dialysis, subsequent encounter",,
T81532S,"Perforation due to foreign body accidentally left in body following kidney dialysis, sequela",,
T81592A,"Other complications of foreign body accidentally left in body following kidney dialysis, initial encounter",,
T81592D,"Other complications of foreign body accidentally left in body following kidney dialysis, subsequent encounter",,
T81592S,"Other complications of foreign body accidentally left in body following kidney dialysis, sequela",,
T82310A,"Breakdown (mechanical) of aortic (bifurcation) graft (replacement), initial encounter",,
T82311A,"Breakdown (mechanical) of carotid arterial graft (bypass), initial encounter",,
T82312A,"Breakdown (mechanical) of femoral arterial graft (bypass), initial encounter",,
T82318A,"Breakdown (mechanical) of other vascular grafts, initial encounter",,
T82319A,"Breakdown (mechanical) of unspecified vascular grafts, initial encounter",,
T82320A,"Displacement of aortic (bifurcation) graft (replacement), initial encounter",,
T82321A,"Displacement of carotid arterial graft (bypass), initial encounter",,
T82322A,"Displacement of femoral arterial graft (bypass), initial encounter",,
T82328A,"Displacement of other vascular grafts, initial encounter",,
T82329A,"Displacement of unspecified vascular grafts, initial encounter",,
T82330A,"Leakage of aortic (bifurcation) graft (replacement), initial encounter",,
T82331A,"Leakage of carotid arterial graft (bypass), initial encounter",,
T82332A,"Leakage of femoral arterial graft (bypass), initial encounter",,
T82338A,"Leakage of other vascular grafts, initial encounter",,
T82339A,"Leakage of unspecified vascular graft, initial encounter",,
T82390A,"Other mechanical complication of aortic (bifurcation) graft (replacement), initial encounter",,
T82391A,"Other mechanical complication of carotid arterial graft (bypass), initial encounter",,
T82392A,"Other mechanical complication of femoral arterial graft (bypass), initial encounter",,
T82398A,"Other mechanical complication of other vascular grafts, initial encounter",,
T82399A,"Other mechanical complication of unspecified vascular grafts, initial encounter",,
T8241XA,"Breakdown (mechanical) of vascular dialysis catheter, initial encounter",,
T8241XD,"Breakdown (mechanical) of vascular dialysis catheter, subsequent encounter",,
T8241XS,"Breakdown (mechanical) of vascular dialysis catheter, sequela",,
T8242XA,"Displacement of vascular dialysis catheter, initial encounter",,
T8242XD,"Displacement of vascular dialysis catheter, subsequent encounter",,
T8242XS,"Displacement of vascular dialysis catheter, sequela",,
T8243XA,"Leakage of vascular dialysis catheter, initial encounter",,
T8243XD,"Leakage of vascular dialysis catheter, subsequent encounter",,
T8243XS,"Leakage of vascular dialysis catheter, sequela",,
T8249XA,"Other complication of vascular dialysis catheter, initial encounter",,
T8249XD,"Other complication of vascular dialysis catheter, subsequent encounter",,
T8249XS,"Other complication of vascular dialysis catheter, sequela",,
T82510A,"Breakdown (mechanical) of surgically created arteriovenous fistula, initial encounter",,
T82511A,"Breakdown (mechanical) of surgically created arteriovenous shunt, initial encounter",,
T82512A,"Breakdown (mechanical) of artificial heart, initial encounter",223,
T82513A,"Breakdown (mechanical) of balloon (counterpulsation) device, initial encounter",,
T82514A,"Breakdown (mechanical) of infusion catheter, initial encounter",,
T82515A,"Breakdown (mechanical) of umbrella device, initial encounter",,
T82518A,"Breakdown (mechanical) of other cardiac and vascular devices and implants, initial encounter",,
T82520A,"Displacement of surgically created arteriovenous fistula, initial encounter",,
T82521A,"Displacement of surgically created arteriovenous shunt, initial encounter",,
T82522A,"Displacement of artificial heart, initial encounter",223,
T82523A,"Displacement of balloon (counterpulsation) device, initial encounter",,
T82524A,"Displacement of infusion catheter, initial encounter",,
T82525A,"Displacement of umbrella device, initial encounter",,
T82528A,"Displacement of other cardiac and vascular devices and implants, initial encounter",,
T82530A,"Leakage of surgically created arteriovenous fistula, initial encounter",,
T82531A,"Leakage of surgically created arteriovenous shunt, initial encounter",,
T82532A,"Leakage of artificial heart, initial encounter",223,
T82533A,"Leakage of balloon (counterpulsation) device, initial encounter",,
T82534A,"Leakage of infusion catheter, initial encounter",,
T82535A,"Leakage of umbrella device, initial encounter",,
T82538A,"Leakage of other cardiac and vascular devices and implants, initial encounter",,
T82590A,"Other mechanical complication of surgically created arteriovenous fistula, initial encounter",,
T82591A,"Other mechanical complication of surgically created arteriovenous shunt, initial encounter",,
T82592A,"Other mechanical complication of artificial heart, initial encounter",223,
T82593A,"Other mechanical complication of balloon (counterpulsation) device, initial encounter",,
T82594A,"Other mechanical complication of infusion catheter, initial encounter",,
T82595A,"Other mechanical complication of umbrella device, initial encounter",,
T82598A,"Other mechanical complication of other cardiac and vascular devices and implants, initial encounter",,
T826XXA,"Infection and inflammatory reaction due to cardiac valve prosthesis, initial encounter",,
T827XXA,"Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter",,
T82818A,"Embolism due to vascular prosthetic devices, implants and grafts, initial encounter",,
T82828A,"Fibrosis due to vascular prosthetic devices, implants and grafts, initial encounter",,
T82838A,"Hemorrhage due to vascular prosthetic devices, implants and grafts, initial encounter",,
T82848A,"Pain due to vascular prosthetic devices, implants and grafts, initial encounter",,
T82856A,"Stenosis of peripheral vascular stent, initial encounter",,
T82858A,"Stenosis of other vascular prosthetic devices, implants and grafts, initial encounter",,
T82868A,"Thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter",,
T82898A,"Other specified complication of vascular prosthetic devices, implants and grafts, initial encounter",,
T83010A,"Breakdown (mechanical) of cystostomy catheter, initial encounter",,
T83011A,"Breakdown (mechanical) of indwelling urethral catheter, initial encounter",,
T83012A,"Breakdown (mechanical) of nephrostomy catheter, initial encounter",,
T83018A,"Breakdown (mechanical) of other urinary catheter, initial encounter",,
T83020A,"Displacement of cystostomy catheter, initial encounter",,
T83021A,"Displacement of indwelling urethral catheter, initial encounter",,
T83022A,"Displacement of nephrostomy catheter, initial encounter",,
T83028A,"Displacement of other urinary catheter, initial encounter",,
T83030A,"Leakage of cystostomy catheter, initial encounter",,
T83031A,"Leakage of indwelling urethral catheter, initial encounter",,
T83032A,"Leakage of nephrostomy catheter, initial encounter",,
T83038A,"Leakage of other urinary catheter, initial encounter",,
T83090A,"Other mechanical complication of cystostomy catheter, initial encounter",,
T83091A,"Other mechanical complication of indwelling urethral catheter, initial encounter",,
T83092A,"Other mechanical complication of nephrostomy catheter, initial encounter",,
T83098A,"Other mechanical complication of other urinary catheter, initial encounter",,
T83110A,"Breakdown (mechanical) of urinary electronic stimulator device, initial encounter",,
T83111A,"Breakdown (mechanical) of implanted urinary sphincter, initial encounter",,
T83112A,"Breakdown (mechanical) of indwelling ureteral stent, initial encounter",,
T83113A,"Breakdown (mechanical) of other urinary stents, initial encounter",,
T83118A,"Breakdown (mechanical) of other urinary devices and implants, initial encounter",,
T83120A,"Displacement of urinary electronic stimulator device, initial encounter",,
T83121A,"Displacement of implanted urinary sphincter, initial encounter",,
T83122A,"Displacement of indwelling ureteral stent, initial encounter",,
T83123A,"Displacement of other urinary stents, initial encounter",,
T83128A,"Displacement of other urinary devices and implants, initial encounter",,
T83190A,"Other mechanical complication of urinary electronic stimulator device, initial encounter",,
T83191A,"Other mechanical complication of implanted urinary sphincter, initial encounter",,
T83192A,"Other mechanical complication of indwelling ureteral stent, initial encounter",,
T83193A,"Other mechanical complication of other urinary stent, initial encounter",,
T83198A,"Other mechanical complication of other urinary devices and implants, initial encounter",,
T8321XA,"Breakdown (mechanical) of graft of urinary organ, initial encounter",,
T8322XA,"Displacement of graft of urinary organ, initial encounter",,
T8323XA,"Leakage of graft of urinary organ, initial encounter",,
T8324XA,"Erosion of graft of urinary organ, initial encounter",,
T8325XA,"Exposure of graft of urinary organ, initial encounter",,
T8329XA,"Other mechanical complication of graft of urinary organ, initial encounter",,
T83410A,"Breakdown (mechanical) of implanted penile prosthesis, initial encounter",,
T83411A,"Breakdown (mechanical) of implanted testicular prosthesis, initial encounter",,
T83418A,"Breakdown (mechanical) of other prosthetic devices, implants and grafts of genital tract, initial encounter",,
T83420A,"Displacement of implanted penile prosthesis, initial encounter",,
T83421A,"Displacement of implanted testicular prosthesis, initial encounter",,
T83428A,"Displacement of other prosthetic devices, implants and grafts of genital tract, initial encounter",,
T83490A,"Other mechanical complication of implanted penile prosthesis, initial encounter",,
T83491A,"Other mechanical complication of implanted testicular prosthesis, initial encounter",,
T83498A,"Other mechanical complication of other prosthetic devices, implants and grafts of genital tract, initial encounter",,
T83510A,"Infection and inflammatory reaction due to cystostomy catheter, initial encounter",,
T83511A,"Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter",,
T83512A,"Infection and inflammatory reaction due to nephrostomy catheter, initial encounter",,
T83518A,"Infection and inflammatory reaction due to other urinary catheter, initial encounter",,
T83590A,"Infection and inflammatory reaction due to implanted urinary neurostimulation device, initial encounter",,
T83591A,"Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter",,
T83592A,"Infection and inflammatory reaction due to indwelling ureteral stent, initial encounter",,
T83593A,"Infection and inflammatory reaction due to other urinary stents, initial encounter",,
T83598A,"Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system, initial encounter",,
T8361XA,"Infection and inflammatory reaction due to implanted penile prosthesis, initial encounter",,
T8362XA,"Infection and inflammatory reaction due to implanted testicular prosthesis, initial encounter",,
T8369XA,"Infection and inflammatory reaction due to other prosthetic device, implant and graft in genital tract, initial encounter",,
T83711A,"Erosion of implanted vaginal mesh to surrounding organ or tissue, initial encounter",,
T83712A,"Erosion of implanted urethral mesh to surrounding organ or tissue, initial encounter",,
T83713A,"Erosion of implanted urethral bulking agent to surrounding organ or tissue, initial encounter",,
T83714A,"Erosion of implanted ureteral bulking agent to surrounding organ or tissue, initial encounter",,
T83718A,"Erosion of other implanted mesh to organ or tissue, initial encounter",,
T83719A,"Erosion of other prosthetic materials to surrounding organ or tissue, initial encounter",,
T83721A,"Exposure of implanted vaginal mesh into vagina, initial encounter",,
T83722A,"Exposure of implanted urethral mesh into urethra, initial encounter",,
T83723A,"Exposure of implanted urethral bulking agent into urethra, initial encounter",,
T83724A,"Exposure of implanted ureteral bulking agent into ureter, initial encounter",,
T83728A,"Exposure of other implanted mesh into organ or tissue, initial encounter",,
T83729A,"Exposure of other prosthetic materials into organ or tissue, initial encounter",,
T8379XA,"Other specified complications due to other genitourinary prosthetic materials, initial encounter",,
T8381XA,"Embolism due to genitourinary prosthetic devices, implants and grafts, initial encounter",,
T8382XA,"Fibrosis due to genitourinary prosthetic devices, implants and grafts, initial encounter",,
T8383XA,"Hemorrhage due to genitourinary prosthetic devices, implants and grafts, initial encounter",,
T8384XA,"Pain due to genitourinary prosthetic devices, implants and grafts, initial encounter",,
T8385XA,"Stenosis due to genitourinary prosthetic devices, implants and grafts, initial encounter",,
T8386XA,"Thrombosis due to genitourinary prosthetic devices, implants and grafts, initial encounter",,
T8389XA,"Other specified complication of genitourinary prosthetic devices, implants and grafts, initial encounter",,
T839XXA,"Unspecified complication of genitourinary prosthetic device, implant and graft, initial encounter",,
T84010A,"Broken internal right hip prosthesis, initial encounter",,
T84011A,"Broken internal left hip prosthesis, initial encounter",,
T84012A,"Broken internal right knee prosthesis, initial encounter",,
T84013A,"Broken internal left knee prosthesis, initial encounter",,
T84018A,"Broken internal joint prosthesis, other site, initial encounter",,
T84019A,"Broken internal joint prosthesis, unspecified site, initial encounter",,
T84020A,"Dislocation of internal right hip prosthesis, initial encounter",,
T84021A,"Dislocation of internal left hip prosthesis, initial encounter",,
T84022A,"Instability of internal right knee prosthesis, initial encounter",,
T84023A,"Instability of internal left knee prosthesis, initial encounter",,
T84028A,"Dislocation of other internal joint prosthesis, initial encounter",,
T84029A,"Dislocation of unspecified internal joint prosthesis, initial encounter",,
T84030A,"Mechanical loosening of internal right hip prosthetic joint, initial encounter",,
T84031A,"Mechanical loosening of internal left hip prosthetic joint, initial encounter",,
T84032A,"Mechanical loosening of internal right knee prosthetic joint, initial encounter",,
T84033A,"Mechanical loosening of internal left knee prosthetic joint, initial encounter",,
T84038A,"Mechanical loosening of other internal prosthetic joint, initial encounter",,
T84039A,"Mechanical loosening of unspecified internal prosthetic joint, initial encounter",,
T84050A,"Periprosthetic osteolysis of internal prosthetic right hip joint, initial encounter",,
T84051A,"Periprosthetic osteolysis of internal prosthetic left hip joint, initial encounter",,
T84052A,"Periprosthetic osteolysis of internal prosthetic right knee joint, initial encounter",,
T84053A,"Periprosthetic osteolysis of internal prosthetic left knee joint, initial encounter",,
T84058A,"Periprosthetic osteolysis of other internal prosthetic joint, initial encounter",,
T84059A,"Periprosthetic osteolysis of unspecified internal prosthetic joint, initial encounter",,
T84060A,"Wear of articular bearing surface of internal prosthetic right hip joint, initial encounter",,
T84061A,"Wear of articular bearing surface of internal prosthetic left hip joint, initial encounter",,
T84062A,"Wear of articular bearing surface of internal prosthetic right knee joint, initial encounter",,
T84063A,"Wear of articular bearing surface of internal prosthetic left knee joint, initial encounter",,
T84068A,"Wear of articular bearing surface of other internal prosthetic joint, initial encounter",,
T84069A,"Wear of articular bearing surface of unspecified internal prosthetic joint, initial encounter",,
T84090A,"Other mechanical complication of internal right hip prosthesis, initial encounter",,
T84091A,"Other mechanical complication of internal left hip prosthesis, initial encounter",,
T84092A,"Other mechanical complication of internal right knee prosthesis, initial encounter",,
T84093A,"Other mechanical complication of internal left knee prosthesis, initial encounter",,
T84098A,"Other mechanical complication of other internal joint prosthesis, initial encounter",,
T84099A,"Other mechanical complication of unspecified internal joint prosthesis, initial encounter",,
T84110A,"Breakdown (mechanical) of internal fixation device of right humerus, initial encounter",,
T84111A,"Breakdown (mechanical) of internal fixation device of left humerus, initial encounter",,
T84112A,"Breakdown (mechanical) of internal fixation device of bone of right forearm, initial encounter",,
T84113A,"Breakdown (mechanical) of internal fixation device of bone of left forearm, initial encounter",,
T84114A,"Breakdown (mechanical) of internal fixation device of right femur, initial encounter",,
T84115A,"Breakdown (mechanical) of internal fixation device of left femur, initial encounter",,
T84116A,"Breakdown (mechanical) of internal fixation device of bone of right lower leg, initial encounter",,
T84117A,"Breakdown (mechanical) of internal fixation device of bone of left lower leg, initial encounter",,
T84119A,"Breakdown (mechanical) of internal fixation device of unspecified bone of limb, initial encounter",,
T84120A,"Displacement of internal fixation device of right humerus, initial encounter",,
T84121A,"Displacement of internal fixation device of left humerus, initial encounter",,
T84122A,"Displacement of internal fixation device of bone of right forearm, initial encounter",,
T84123A,"Displacement of internal fixation device of bone of left forearm, initial encounter",,
T84124A,"Displacement of internal fixation device of right femur, initial encounter",,
T84125A,"Displacement of internal fixation device of left femur, initial encounter",,
T84126A,"Displacement of internal fixation device of bone of right lower leg, initial encounter",,
T84127A,"Displacement of internal fixation device of bone of left lower leg, initial encounter",,
T84129A,"Displacement of internal fixation device of unspecified bone of limb, initial encounter",,
T84190A,"Other mechanical complication of internal fixation device of right humerus, initial encounter",,
T84191A,"Other mechanical complication of internal fixation device of left humerus, initial encounter",,
T84192A,"Other mechanical complication of internal fixation device of bone of right forearm, initial encounter",,
T84193A,"Other mechanical complication of internal fixation device of bone of left forearm, initial encounter",,
T84194A,"Other mechanical complication of internal fixation device of right femur, initial encounter",,
T84195A,"Other mechanical complication of internal fixation device of left femur, initial encounter",,
T84196A,"Other mechanical complication of internal fixation device of bone of right lower leg, initial encounter",,
T84197A,"Other mechanical complication of internal fixation device of bone of left lower leg, initial encounter",,
T84199A,"Other mechanical complication of internal fixation device of unspecified bone of limb, initial encounter",,
T84210A,"Breakdown (mechanical) of internal fixation device of bones of hand and fingers, initial encounter",,
T84213A,"Breakdown (mechanical) of internal fixation device of bones of foot and toes, initial encounter",,
T84216A,"Breakdown (mechanical) of internal fixation device of vertebrae, initial encounter",,
T84218A,"Breakdown (mechanical) of internal fixation device of other bones, initial encounter",,
T84220A,"Displacement of internal fixation device of bones of hand and fingers, initial encounter",,
T84223A,"Displacement of internal fixation device of bones of foot and toes, initial encounter",,
T84226A,"Displacement of internal fixation device of vertebrae, initial encounter",,
T84228A,"Displacement of internal fixation device of other bones, initial encounter",,
T84290A,"Other mechanical complication of internal fixation device of bones of hand and fingers, initial encounter",,
T84293A,"Other mechanical complication of internal fixation device of bones of foot and toes, initial encounter",,
T84296A,"Other mechanical complication of internal fixation device of vertebrae, initial encounter",,
T84298A,"Other mechanical complication of internal fixation device of other bones, initial encounter",,
T84310A,"Breakdown (mechanical) of electronic bone stimulator, initial encounter",,
T84318A,"Breakdown (mechanical) of other bone devices, implants and grafts, initial encounter",,
T84320A,"Displacement of electronic bone stimulator, initial encounter",,
T84328A,"Displacement of other bone devices, implants and grafts, initial encounter",,
T84390A,"Other mechanical complication of electronic bone stimulator, initial encounter",,
T84398A,"Other mechanical complication of other bone devices, implants and grafts, initial encounter",,
T84410A,"Breakdown (mechanical) of muscle and tendon graft, initial encounter",,
T84418A,"Breakdown (mechanical) of other internal orthopedic devices, implants and grafts, initial encounter",,
T84420A,"Displacement of muscle and tendon graft, initial encounter",,
T84428A,"Displacement of other internal orthopedic devices, implants and grafts, initial encounter",,
T84490A,"Other mechanical complication of muscle and tendon graft, initial encounter",,
T84498A,"Other mechanical complication of other internal orthopedic devices, implants and grafts, initial encounter",,
T8450XA,"Infection and inflammatory reaction due to unspecified internal joint prosthesis, initial encounter",,
T8451XA,"Infection and inflammatory reaction due to internal right hip prosthesis, initial encounter",,
T8452XA,"Infection and inflammatory reaction due to internal left hip prosthesis, initial encounter",,
T8453XA,"Infection and inflammatory reaction due to internal right knee prosthesis, initial encounter",,
T8454XA,"Infection and inflammatory reaction due to internal left knee prosthesis, initial encounter",,
T8459XA,"Infection and inflammatory reaction due to other internal joint prosthesis, initial encounter",,
T8460XA,"Infection and inflammatory reaction due to internal fixation device of unspecified site, initial encounter",,
T84610A,"Infection and inflammatory reaction due to internal fixation device of right humerus, initial encounter",,
T84611A,"Infection and inflammatory reaction due to internal fixation device of left humerus, initial encounter",,
T84612A,"Infection and inflammatory reaction due to internal fixation device of right radius, initial encounter",,
T84613A,"Infection and inflammatory reaction due to internal fixation device of left radius, initial encounter",,
T84614A,"Infection and inflammatory reaction due to internal fixation device of right ulna, initial encounter",,
T84615A,"Infection and inflammatory reaction due to internal fixation device of left ulna, initial encounter",,
T84619A,"Infection and inflammatory reaction due to internal fixation device of unspecified bone of arm, initial encounter",,
T84620A,"Infection and inflammatory reaction due to internal fixation device of right femur, initial encounter",,
T84621A,"Infection and inflammatory reaction due to internal fixation device of left femur, initial encounter",,
T84622A,"Infection and inflammatory reaction due to internal fixation device of right tibia, initial encounter",,
T84623A,"Infection and inflammatory reaction due to internal fixation device of left tibia, initial encounter",,
T84624A,"Infection and inflammatory reaction due to internal fixation device of right fibula, initial encounter",,
T84625A,"Infection and inflammatory reaction due to internal fixation device of left fibula, initial encounter",,
T84629A,"Infection and inflammatory reaction due to internal fixation device of unspecified bone of leg, initial encounter",,
T8463XA,"Infection and inflammatory reaction due to internal fixation device of spine, initial encounter",,
T8469XA,"Infection and inflammatory reaction due to internal fixation device of other site, initial encounter",,
T847XXA,"Infection and inflammatory reaction due to other internal orthopedic prosthetic devices, implants and grafts, initial encounter",,
T8481XA,"Embolism due to internal orthopedic prosthetic devices, implants and grafts, initial encounter",,
T8482XA,"Fibrosis due to internal orthopedic prosthetic devices, implants and grafts, initial encounter",,
T8483XA,"Hemorrhage due to internal orthopedic prosthetic devices, implants and grafts, initial encounter",,
T8484XA,"Pain due to internal orthopedic prosthetic devices, implants and grafts, initial encounter",,
T8485XA,"Stenosis due to internal orthopedic prosthetic devices, implants and grafts, initial encounter",,
T8486XA,"Thrombosis due to internal orthopedic prosthetic devices, implants and grafts, initial encounter",,
T8489XA,"Other specified complication of internal orthopedic prosthetic devices, implants and grafts, initial encounter",,
T849XXA,"Unspecified complication of internal orthopedic prosthetic device, implant and graft, initial encounter",,
T8501XA,"Breakdown (mechanical) of ventricular intracranial (communicating) shunt, initial encounter",,
T8502XA,"Displacement of ventricular intracranial (communicating) shunt, initial encounter",,
T8503XA,"Leakage of ventricular intracranial (communicating) shunt, initial encounter",,
T8509XA,"Other mechanical complication of ventricular intracranial (communicating) shunt, initial encounter",,
T85110A,"Breakdown (mechanical) of implanted electronic neurostimulator of brain electrode (lead), initial encounter",,
T85111A,"Breakdown (mechanical) of implanted electronic neurostimulator of peripheral nerve electrode (lead), initial encounter",,
T85112A,"Breakdown (mechanical) of implanted electronic neurostimulator of spinal cord electrode (lead), initial encounter",,
T85113A,"Breakdown (mechanical) of implanted electronic neurostimulator, generator, initial encounter",,
T85118A,"Breakdown (mechanical) of other implanted electronic stimulator of nervous system, initial encounter",,
T85120A,"Displacement of implanted electronic neurostimulator of brain electrode (lead), initial encounter",,
T85121A,"Displacement of implanted electronic neurostimulator of peripheral nerve electrode (lead), initial encounter",,
T85122A,"Displacement of implanted electronic neurostimulator of spinal cord electrode (lead), initial encounter",,
T85123A,"Displacement of implanted electronic neurostimulator, generator, initial encounter",,
T85128A,"Displacement of other implanted electronic stimulator of nervous system, initial encounter",,
T85190A,"Other mechanical complication of implanted electronic neurostimulator of brain electrode (lead), initial encounter",,
T85191A,"Other mechanical complication of implanted electronic neurostimulator of peripheral nerve electrode (lead), initial encounter",,
T85192A,"Other mechanical complication of implanted electronic neurostimulator of spinal cord electrode (lead), initial encounter",,
T85193A,"Other mechanical complication of implanted electronic neurostimulator, generator, initial encounter",,
T85199A,"Other mechanical complication of other implanted electronic stimulator of nervous system, initial encounter",,
T85611A,"Breakdown (mechanical) of intraperitoneal dialysis catheter, initial encounter",,
T85611D,"Breakdown (mechanical) of intraperitoneal dialysis catheter, subsequent encounter",,
T85611S,"Breakdown (mechanical) of intraperitoneal dialysis catheter, sequela",,
T85615A,"Breakdown (mechanical) of other nervous system device, implant or graft, initial encounter",,
T85621A,"Displacement of intraperitoneal dialysis catheter, initial encounter",,
T85621D,"Displacement of intraperitoneal dialysis catheter, subsequent encounter",,
T85621S,"Displacement of intraperitoneal dialysis catheter, sequela",,
T85625A,"Displacement of other nervous system device, implant or graft, initial encounter",,
T85631A,"Leakage of intraperitoneal dialysis catheter, initial encounter",,
T85631D,"Leakage of intraperitoneal dialysis catheter, subsequent encounter",,
T85631S,"Leakage of intraperitoneal dialysis catheter, sequela",,
T85635A,"Leakage of other nervous system device, implant or graft, initial encounter",,
T85691A,"Other mechanical complication of intraperitoneal dialysis catheter, initial encounter",,
T85691D,"Other mechanical complication of intraperitoneal dialysis catheter, subsequent encounter",,
T85691S,"Other mechanical complication of intraperitoneal dialysis catheter, sequela",,
T85695A,"Other mechanical complication of other nervous system device, implant or graft, initial encounter",,
T8571XA,"Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter",,
T8571XD,"Infection and inflammatory reaction due to peritoneal dialysis catheter, subsequent encounter",,
T8571XS,"Infection and inflammatory reaction due to peritoneal dialysis catheter, sequela",,
T8572XA,"Infection and inflammatory reaction due to insulin pump, initial encounter",,
T85730A,"Infection and inflammatory reaction due to ventricular intracranial (communicating) shunt, initial encounter",,
T85731A,"Infection and inflammatory reaction due to implanted electronic neurostimulator of brain, electrode (lead), initial encounter",,
T85732A,"Infection and inflammatory reaction due to implanted electronic neurostimulator of peripheral nerve, electrode (lead), initial encounter",,
T85733A,"Infection and inflammatory reaction due to implanted electronic neurostimulator of spinal cord, electrode (lead), initial encounter",,
T85734A,"Infection and inflammatory reaction due to implanted electronic neurostimulator, generator, initial encounter",,
T85735A,"Infection and inflammatory reaction due to cranial or spinal infusion catheter, initial encounter",,
T85738A,"Infection and inflammatory reaction due to other nervous system device, implant or graft, initial encounter",,
T8579XA,"Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, initial encounter",,
T85810A,"Embolism due to nervous system prosthetic devices, implants and grafts, initial encounter",,
T85820A,"Fibrosis due to nervous system prosthetic devices, implants and grafts, initial encounter",,
T85830A,"Hemorrhage due to nervous system prosthetic devices, implants and grafts, initial encounter",,
T85840A,"Pain due to nervous system prosthetic devices, implants and grafts, initial encounter",,
T85850A,"Stenosis due to nervous system prosthetic devices, implants and grafts, initial encounter",,
T85860A,"Thrombosis due to nervous system prosthetic devices, implants and grafts, initial encounter",,
T85890A,"Other specified complication of nervous system prosthetic devices, implants and grafts, initial encounter",,
T8600,Unspecified complication of bone marrow transplant,454,
T8601,Bone marrow transplant rejection,454,
T8602,Bone marrow transplant failure,454,
T8603,Bone marrow transplant infection,454,
T8609,Other complications of bone marrow transplant,454,
T8610,Unspecified complication of kidney transplant,,
T8611,Kidney transplant rejection,,
T8612,Kidney transplant failure,,
T8613,Kidney transplant infection,,
T8619,Other complication of kidney transplant,,
T8620,Unspecified complication of heart transplant,221,
T8621,Heart transplant rejection,221,
T8622,Heart transplant failure,221,
T8623,Heart transplant infection,221,
T86290,Cardiac allograft vasculopathy,221,
T86298,Other complications of heart transplant,221,
T8630,Unspecified complication of heart-lung transplant,221,
T8630,Unspecified complication of heart-lung transplant,276,
T8631,Heart-lung transplant rejection,221,
T8631,Heart-lung transplant rejection,276,
T8632,Heart-lung transplant failure,221,
T8632,Heart-lung transplant failure,276,
T8633,Heart-lung transplant infection,221,
T8633,Heart-lung transplant infection,276,
T8639,Other complications of heart-lung transplant,221,
T8639,Other complications of heart-lung transplant,276,
T8640,Unspecified complication of liver transplant,62,
T8641,Liver transplant rejection,62,
T8642,Liver transplant failure,62,
T8643,Liver transplant infection,62,
T8649,Other complications of liver transplant,62,
T865,Complications of stem cell transplant,454,
T86810,Lung transplant rejection,276,
T86811,Lung transplant failure,276,
T86812,Lung transplant infection,276,
T86818,Other complications of lung transplant,276,
T86819,Unspecified complication of lung transplant,276,
T868421,"Corneal transplant infection, right eye",,
T868422,"Corneal transplant infection, left eye",,
T868423,"Corneal transplant infection, bilateral",,
T868429,"Corneal transplant infection, unspecified eye",,
T86850,Intestine transplant rejection,77,
T86851,Intestine transplant failure,77,
T86852,Intestine transplant infection,77,
T86858,Other complications of intestine transplant,77,
T86859,Unspecified complication of intestine transplant,77,
T870X1,Complications of reattached (part of) right upper extremity,405,
T870X2,Complications of reattached (part of) left upper extremity,405,
T870X9,Complications of reattached (part of) unspecified upper extremity,405,
T871X1,Complications of reattached (part of) right lower extremity,405,
T871X2,Complications of reattached (part of) left lower extremity,405,
T871X9,Complications of reattached (part of) unspecified lower extremity,405,
T872,Complications of other reattached body part,,
T8730,"Neuroma of amputation stump, unspecified extremity",409,
T8731,"Neuroma of amputation stump, right upper extremity",409,
T8732,"Neuroma of amputation stump, left upper extremity",409,
T8733,"Neuroma of amputation stump, right lower extremity",409,
T8734,"Neuroma of amputation stump, left lower extremity",409,
T8740,"Infection of amputation stump, unspecified extremity",409,
T8741,"Infection of amputation stump, right upper extremity",409,
T8742,"Infection of amputation stump, left upper extremity",409,
T8743,"Infection of amputation stump, right lower extremity",409,
T8744,"Infection of amputation stump, left lower extremity",409,
T8750,"Necrosis of amputation stump, unspecified extremity",409,
T8751,"Necrosis of amputation stump, right upper extremity",409,
T8752,"Necrosis of amputation stump, left upper extremity",409,
T8753,"Necrosis of amputation stump, right lower extremity",409,
T8754,"Necrosis of amputation stump, left lower extremity",409,
T8781,Dehiscence of amputation stump,409,
T8789,Other complications of amputation stump,409,
T879,Unspecified complications of amputation stump,409,
X710XXA,"Intentional self-harm by drowning and submersion while in bathtub, initial encounter",155,
X710XXD,"Intentional self-harm by drowning and submersion while in bathtub, subsequent encounter",,
X710XXS,"Intentional self-harm by drowning and submersion while in bathtub, sequela",,
X711XXA,"Intentional self-harm by drowning and submersion while in swimming pool, initial encounter",155,
X711XXD,"Intentional self-harm by drowning and submersion while in swimming pool, subsequent encounter",,
X711XXS,"Intentional self-harm by drowning and submersion while in swimming pool, sequela",,
X712XXA,"Intentional self-harm by drowning and submersion after jump into swimming pool, initial encounter",155,
X712XXD,"Intentional self-harm by drowning and submersion after jump into swimming pool, subsequent encounter",,
X712XXS,"Intentional self-harm by drowning and submersion after jump into swimming pool, sequela",,
X713XXA,"Intentional self-harm by drowning and submersion in natural water, initial encounter",155,
X713XXD,"Intentional self-harm by drowning and submersion in natural water, subsequent encounter",,
X713XXS,"Intentional self-harm by drowning and submersion in natural water, sequela",,
X718XXA,"Other intentional self-harm by drowning and submersion, initial encounter",155,
X718XXD,"Other intentional self-harm by drowning and submersion, subsequent encounter",,
X718XXS,"Other intentional self-harm by drowning and submersion, sequela",,
X719XXA,"Intentional self-harm by drowning and submersion, unspecified, initial encounter",155,
X719XXD,"Intentional self-harm by drowning and submersion, unspecified, subsequent encounter",,
X719XXS,"Intentional self-harm by drowning and submersion, unspecified, sequela",,
X72XXXA,"Intentional self-harm by handgun discharge, initial encounter",155,
X72XXXD,"Intentional self-harm by handgun discharge, subsequent encounter",,
X72XXXS,"Intentional self-harm by handgun discharge, sequela",,
X730XXA,"Intentional self-harm by shotgun discharge, initial encounter",155,
X730XXD,"Intentional self-harm by shotgun discharge, subsequent encounter",,
X730XXS,"Intentional self-harm by shotgun discharge, sequela",,
X731XXA,"Intentional self-harm by hunting rifle discharge, initial encounter",155,
X731XXD,"Intentional self-harm by hunting rifle discharge, subsequent encounter",,
X731XXS,"Intentional self-harm by hunting rifle discharge, sequela",,
X732XXA,"Intentional self-harm by machine gun discharge, initial encounter",155,
X732XXD,"Intentional self-harm by machine gun discharge, subsequent encounter",,
X732XXS,"Intentional self-harm by machine gun discharge, sequela",,
X738XXA,"Intentional self-harm by other larger firearm discharge, initial encounter",155,
X738XXD,"Intentional self-harm by other larger firearm discharge, subsequent encounter",,
X738XXS,"Intentional self-harm by other larger firearm discharge, sequela",,
X739XXA,"Intentional self-harm by unspecified larger firearm discharge, initial encounter",155,
X739XXD,"Intentional self-harm by unspecified larger firearm discharge, subsequent encounter",,
X739XXS,"Intentional self-harm by unspecified larger firearm discharge, sequela",,
X7401XA,"Intentional self-harm by airgun, initial encounter",155,
X7401XD,"Intentional self-harm by airgun, subsequent encounter",,
X7401XS,"Intentional self-harm by airgun, sequela",,
X7402XA,"Intentional self-harm by paintball gun, initial encounter",155,
X7402XD,"Intentional self-harm by paintball gun, subsequent encounter",,
X7402XS,"Intentional self-harm by paintball gun, sequela",,
X7409XA,"Intentional self-harm by other gas, air or spring-operated gun, initial encounter",155,
X7409XD,"Intentional self-harm by other gas, air or spring-operated gun, subsequent encounter",,
X7409XS,"Intentional self-harm by other gas, air or spring-operated gun, sequela",,
X748XXA,"Intentional self-harm by other firearm discharge, initial encounter",155,
X748XXD,"Intentional self-harm by other firearm discharge, subsequent encounter",,
X748XXS,"Intentional self-harm by other firearm discharge, sequela",,
X749XXA,"Intentional self-harm by unspecified firearm discharge, initial encounter",155,
X749XXD,"Intentional self-harm by unspecified firearm discharge, subsequent encounter",,
X749XXS,"Intentional self-harm by unspecified firearm discharge, sequela",,
X75XXXA,"Intentional self-harm by explosive material, initial encounter",155,
X75XXXD,"Intentional self-harm by explosive material, subsequent encounter",,
X75XXXS,"Intentional self-harm by explosive material, sequela",,
X76XXXA,"Intentional self-harm by smoke, fire and flames, initial encounter",155,
X76XXXD,"Intentional self-harm by smoke, fire and flames, subsequent encounter",,
X76XXXS,"Intentional self-harm by smoke, fire and flames, sequela",,
X770XXA,"Intentional self-harm by steam or hot vapors, initial encounter",155,
X770XXD,"Intentional self-harm by steam or hot vapors, subsequent encounter",,
X770XXS,"Intentional self-harm by steam or hot vapors, sequela",,
X771XXA,"Intentional self-harm by hot tap water, initial encounter",155,
X771XXD,"Intentional self-harm by hot tap water, subsequent encounter",,
X771XXS,"Intentional self-harm by hot tap water, sequela",,
X772XXA,"Intentional self-harm by other hot fluids, initial encounter",155,
X772XXD,"Intentional self-harm by other hot fluids, subsequent encounter",,
X772XXS,"Intentional self-harm by other hot fluids, sequela",,
X773XXA,"Intentional self-harm by hot household appliances, initial encounter",155,
X773XXD,"Intentional self-harm by hot household appliances, subsequent encounter",,
X773XXS,"Intentional self-harm by hot household appliances, sequela",,
X778XXA,"Intentional self-harm by other hot objects, initial encounter",155,
X778XXD,"Intentional self-harm by other hot objects, subsequent encounter",,
X778XXS,"Intentional self-harm by other hot objects, sequela",,
X779XXA,"Intentional self-harm by unspecified hot objects, initial encounter",155,
X779XXD,"Intentional self-harm by unspecified hot objects, subsequent encounter",,
X779XXS,"Intentional self-harm by unspecified hot objects, sequela",,
X780XXA,"Intentional self-harm by sharp glass, initial encounter",155,
X780XXD,"Intentional self-harm by sharp glass, subsequent encounter",,
X780XXS,"Intentional self-harm by sharp glass, sequela",,
X781XXA,"Intentional self-harm by knife, initial encounter",155,
X781XXD,"Intentional self-harm by knife, subsequent encounter",,
X781XXS,"Intentional self-harm by knife, sequela",,
X782XXA,"Intentional self-harm by sword or dagger, initial encounter",155,
X782XXD,"Intentional self-harm by sword or dagger, subsequent encounter",,
X782XXS,"Intentional self-harm by sword or dagger, sequela",,
X788XXA,"Intentional self-harm by other sharp object, initial encounter",155,
X788XXD,"Intentional self-harm by other sharp object, subsequent encounter",,
X788XXS,"Intentional self-harm by other sharp object, sequela",,
X789XXA,"Intentional self-harm by unspecified sharp object, initial encounter",155,
X789XXD,"Intentional self-harm by unspecified sharp object, subsequent encounter",,
X789XXS,"Intentional self-harm by unspecified sharp object, sequela",,
X79XXXA,"Intentional self-harm by blunt object, initial encounter",155,
X79XXXD,"Intentional self-harm by blunt object, subsequent encounter",,
X79XXXS,"Intentional self-harm by blunt object, sequela",,
X80XXXA,"Intentional self-harm by jumping from a high place, initial encounter",155,
X80XXXD,"Intentional self-harm by jumping from a high place, subsequent encounter",,
X80XXXS,"Intentional self-harm by jumping from a high place, sequela",,
X810XXA,"Intentional self-harm by jumping or lying in front of motor vehicle, initial encounter",155,
X810XXD,"Intentional self-harm by jumping or lying in front of motor vehicle, subsequent encounter",,
X810XXS,"Intentional self-harm by jumping or lying in front of motor vehicle, sequela",,
X811XXA,"Intentional self-harm by jumping or lying in front of (subway) train, initial encounter",155,
X811XXD,"Intentional self-harm by jumping or lying in front of (subway) train, subsequent encounter",,
X811XXS,"Intentional self-harm by jumping or lying in front of (subway) train, sequela",,
X818XXA,"Intentional self-harm by jumping or lying in front of other moving object, initial encounter",155,
X818XXD,"Intentional self-harm by jumping or lying in front of other moving object, subsequent encounter",,
X818XXS,"Intentional self-harm by jumping or lying in front of other moving object, sequela",,
X820XXA,"Intentional collision of motor vehicle with other motor vehicle, initial encounter",155,
X820XXD,"Intentional collision of motor vehicle with other motor vehicle, subsequent encounter",,
X820XXS,"Intentional collision of motor vehicle with other motor vehicle, sequela",,
X821XXA,"Intentional collision of motor vehicle with train, initial encounter",155,
X821XXD,"Intentional collision of motor vehicle with train, subsequent encounter",,
X821XXS,"Intentional collision of motor vehicle with train, sequela",,
X822XXA,"Intentional collision of motor vehicle with tree, initial encounter",155,
X822XXD,"Intentional collision of motor vehicle with tree, subsequent encounter",,
X822XXS,"Intentional collision of motor vehicle with tree, sequela",,
X828XXA,"Other intentional self-harm by crashing of motor vehicle, initial encounter",155,
X828XXD,"Other intentional self-harm by crashing of motor vehicle, subsequent encounter",,
X828XXS,"Other intentional self-harm by crashing of motor vehicle, sequela",,
X830XXA,"Intentional self-harm by crashing of aircraft, initial encounter",155,
X830XXD,"Intentional self-harm by crashing of aircraft, subsequent encounter",,
X830XXS,"Intentional self-harm by crashing of aircraft, sequela",,
X831XXA,"Intentional self-harm by electrocution, initial encounter",155,
X831XXD,"Intentional self-harm by electrocution, subsequent encounter",,
X831XXS,"Intentional self-harm by electrocution, sequela",,
X832XXA,"Intentional self-harm by exposure to extremes of cold, initial encounter",155,
X832XXD,"Intentional self-harm by exposure to extremes of cold, subsequent encounter",,
X832XXS,"Intentional self-harm by exposure to extremes of cold, sequela",,
X838XXA,"Intentional self-harm by other specified means, initial encounter",155,
X838XXD,"Intentional self-harm by other specified means, subsequent encounter",,
X838XXS,"Intentional self-harm by other specified means, sequela",,
Y622,Failure of sterile precautions during kidney dialysis and other perfusion,,
Z21,Asymptomatic human immunodeficiency virus [HIV] infection status,1,
Z430,Encounter for attention to tracheostomy,211,
Z431,Encounter for attention to gastrostomy,463,
Z432,Encounter for attention to ileostomy,463,
Z433,Encounter for attention to colostomy,463,
Z434,Encounter for attention to other artificial openings of digestive tract,463,
Z435,Encounter for attention to cystostomy,463,
Z436,Encounter for attention to other artificial openings of urinary tract,463,
Z438,Encounter for attention to other artificial openings,463,
Z439,Encounter for attention to unspecified artificial opening,463,
Z44101,Encounter for fitting and adjustment of unspecified right artificial leg,409,
Z44102,Encounter for fitting and adjustment of unspecified left artificial leg,409,
Z44109,"Encounter for fitting and adjustment of unspecified artificial leg, unspecified leg",409,
Z44111,Encounter for fitting and adjustment of complete right artificial leg,409,
Z44112,Encounter for fitting and adjustment of complete left artificial leg,409,
Z44119,"Encounter for fitting and adjustment of complete artificial leg, unspecified leg",409,
Z44121,Encounter for fitting and adjustment of partial artificial right leg,409,
Z44122,Encounter for fitting and adjustment of partial artificial left leg,409,
Z44129,"Encounter for fitting and adjustment of partial artificial leg, unspecified leg",409,
Z4821,Encounter for aftercare following heart transplant,221,
Z4822,Encounter for aftercare following kidney transplant,,
Z4823,Encounter for aftercare following liver transplant,62,
Z4824,Encounter for aftercare following lung transplant,276,
Z48280,Encounter for aftercare following heart-lung transplant,221,
Z48280,Encounter for aftercare following heart-lung transplant,276,
Z48290,Encounter for aftercare following bone marrow transplant,454,
Z4901,Encounter for fitting and adjustment of extracorporeal dialysis catheter,,
Z4902,Encounter for fitting and adjustment of peritoneal dialysis catheter,,
Z4931,Encounter for adequacy testing for hemodialysis,,
Z4932,Encounter for adequacy testing for peritoneal dialysis,,
Z6841,"Body mass index [BMI] 40.0-44.9, adult",48,
Z6842,"Body mass index [BMI] 45.0-49.9, adult",48,
Z6843,"Body mass index [BMI] 50.0-59.9, adult",48,
Z6844,"Body mass index [BMI] 60.0-69.9, adult",48,
Z6845,"Body mass index [BMI] 70 or greater, adult",48,
Z794,Long term (current) use of insulin,38,
Z89411,Acquired absence of right great toe,,
Z89412,Acquired absence of left great toe,,
Z89419,Acquired absence of unspecified great toe,,
Z89421,Acquired absence of other right toe(s),,
Z89422,Acquired absence of other left toe(s),,
Z89429,"Acquired absence of other toe(s), unspecified side",,
Z89431,Acquired absence of right foot,409,
Z89432,Acquired absence of left foot,409,
Z89439,Acquired absence of unspecified foot,409,
Z89441,Acquired absence of right ankle,409,
Z89442,Acquired absence of left ankle,409,
Z89449,Acquired absence of unspecified ankle,409,
Z89511,Acquired absence of right leg below knee,409,
Z89512,Acquired absence of left leg below knee,409,
Z89519,Acquired absence of unspecified leg below knee,409,
Z89611,Acquired absence of right leg above knee,409,
Z89612,Acquired absence of left leg above knee,409,
Z89619,Acquired absence of unspecified leg above knee,409,
Z9115,Patient's noncompliance with renal dialysis,,
Z91151,Patient's noncompliance with renal dialysis due to financial hardship,,
Z91158,Patient's noncompliance with renal dialysis for other reason,,
Z91A5,Caregiver's noncompliance with patient's renal dialysis,,
Z91A51,Caregiver's noncompliance with patient's renal dialysis due to financial hardship,,
Z91A58,Caregiver's noncompliance with patient's renal dialysis for other reason,,
Z930,Tracheostomy status,211,
Z931,Gastrostomy status,463,
Z932,Ileostomy status,463,
Z933,Colostomy status,463,
Z934,Other artificial openings of gastrointestinal tract status,463,
Z9350,Unspecified cystostomy status,463,
Z9351,Cutaneous-vesicostomy status,463,
Z9352,Appendico-vesicostomy status,463,
Z9359,Other cystostomy status,463,
Z936,Other artificial openings of urinary tract status,463,
Z938,Other artificial opening status,463,
Z939,"Artificial opening status, unspecified",463,
Z940,Kidney transplant status,,
Z941,Heart transplant status,221,
Z942,Lung transplant status,276,
Z943,Heart and lungs transplant status,221,
Z943,Heart and lungs transplant status,276,
Z944,Liver transplant status,62,
Z9481,Bone marrow transplant status,454,
Z9482,Intestine transplant status,77,
Z9483,Pancreas transplant status,35,
Z9484,Stem cells transplant status,454,
Z95811,Presence of heart assist device,223,
Z95812,Presence of fully implantable artificial heart,223,
Z9713,Presence of artificial right leg (complete) (partial),409,
Z9714,Presence of artificial left leg (complete) (partial),409,
Z9716,"Presence of artificial legs, bilateral (complete) (partial)",409,
Z9911,Dependence on respirator [ventilator] status,211,
Z9912,Encounter for respirator [ventilator] dependence during power failure,211,
Z992,Dependence on renal dialysis,,
,,,
Notes:,,,
"1. If an ICD-10 code includes clinical concepts comparable to two or more ICD-9 codes, it may map to more than one payment HCC or RxHCC. If that occurs, the ICD-10 code will repeat in separate rows for each of the multiple HCCs or RxHCCs, with dashes in the repeating rows for the models in which the ICD-10 code maps only to a single HCC or RxHCC.",,,
,,,
"2. V28 HCC 223 [Heart Assist Device/Artificial Heart] requires ICD-10 diagnosis codes additional to those shown in the crosswalk. Beneficiaries with any of the six ICD-10 codes shown as mapping to V28 HCC 223 will receive credit for HCC 223 only if they also have an ICD-10 code shown as mapping to HCC 224 [Acute on Chronic Heart Failure], HCC 225 [Acute Heart Failure (Excludes Acute on Chronic)], or HCC 226 [Heart Failure, Except End Stage and Acute]. Beneficiaries with codes for heart transplant status/complications or for end stage heart failure will be assigned to HCC 221 [Heart Transplant Status/Complications] or HCC 222 [End Stage Heart Failure], respectively.",,,
,,,
,,,
,,,
Output: icd10_udxgv0124_v21v22v24v28v05v08_p1.xlsx,,,
Source: RTI International,,,
